0001493152-24-005769.txt : 20240209 0001493152-24-005769.hdr.sgml : 20240209 20240209173305 ACCESSION NUMBER: 0001493152-24-005769 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 96 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AiXin Life International, Inc. CENTRAL INDEX KEY: 0000835662 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 841085935 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-268190 FILM NUMBER: 24616349 BUSINESS ADDRESS: STREET 1: HONGXING INTL BUSINESS BUILDING 2, STREET 2: 14TH FLR, NO. 69, QINGYUN SOUVE AVE., CITY: JINJIANG DISTRICT,CHENGDU CITY STATE: F4 ZIP: 610021 BUSINESS PHONE: 212-739-7689 MAIL ADDRESS: STREET 1: HONGXING INTL BUSINESS BUILDING 2, STREET 2: 14TH FLR, NO. 69, QINGYUN SOUVE AVE., CITY: JINJIANG DISTRICT,CHENGDU CITY STATE: F4 ZIP: 610021 FORMER COMPANY: FORMER CONFORMED NAME: MERCARI COMMUNICATIONS GROUP LTD DATE OF NAME CHANGE: 19880707 S-1/A 1 forms-1a.htm
true 0000835662 0000835662 2023-01-01 2023-09-30 0000835662 2022-12-31 0000835662 2021-12-31 0000835662 2023-09-30 0000835662 us-gaap:RelatedPartyMember 2023-09-30 0000835662 us-gaap:RelatedPartyMember 2022-12-31 0000835662 us-gaap:NonrelatedPartyMember 2023-09-30 0000835662 us-gaap:NonrelatedPartyMember 2022-12-31 0000835662 2022-01-01 2022-12-31 0000835662 2021-01-01 2021-12-31 0000835662 us-gaap:ProductMember 2022-01-01 2022-12-31 0000835662 us-gaap:ProductMember 2021-01-01 2021-12-31 0000835662 us-gaap:AdvertisingMember 2022-01-01 2022-12-31 0000835662 us-gaap:AdvertisingMember 2021-01-01 2021-12-31 0000835662 AIXN:RoomRevenueMember 2022-01-01 2022-12-31 0000835662 AIXN:RoomRevenueMember 2021-01-01 2021-12-31 0000835662 AIXN:FoodAndBeverageRevenuesMember 2022-01-01 2022-12-31 0000835662 AIXN:FoodAndBeverageRevenuesMember 2021-01-01 2021-12-31 0000835662 AIXN:OtherMember 2022-01-01 2022-12-31 0000835662 AIXN:OtherMember 2021-01-01 2021-12-31 0000835662 2023-07-01 2023-09-30 0000835662 2022-07-01 2022-09-30 0000835662 2022-01-01 2022-09-30 0000835662 us-gaap:ProductMember 2023-07-01 2023-09-30 0000835662 us-gaap:ProductMember 2022-07-01 2022-09-30 0000835662 us-gaap:ProductMember 2023-01-01 2023-09-30 0000835662 us-gaap:ProductMember 2022-01-01 2022-09-30 0000835662 AIXN:RoomRevenueMember 2023-07-01 2023-09-30 0000835662 AIXN:RoomRevenueMember 2022-07-01 2022-09-30 0000835662 AIXN:RoomRevenueMember 2023-01-01 2023-09-30 0000835662 AIXN:RoomRevenueMember 2022-01-01 2022-09-30 0000835662 AIXN:FoodAndBeverageRevenuesMember 2023-07-01 2023-09-30 0000835662 AIXN:FoodAndBeverageRevenuesMember 2022-07-01 2022-09-30 0000835662 AIXN:FoodAndBeverageRevenuesMember 2023-01-01 2023-09-30 0000835662 AIXN:FoodAndBeverageRevenuesMember 2022-01-01 2022-09-30 0000835662 AIXN:OtherMember 2023-07-01 2023-09-30 0000835662 AIXN:OtherMember 2022-07-01 2022-09-30 0000835662 AIXN:OtherMember 2023-01-01 2023-09-30 0000835662 AIXN:OtherMember 2022-01-01 2022-09-30 0000835662 us-gaap:CommonStockMember 2020-12-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000835662 AIXN:StatutoryReservesMember 2020-12-31 0000835662 us-gaap:RetainedEarningsMember 2020-12-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000835662 2020-12-31 0000835662 us-gaap:CommonStockMember 2021-12-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000835662 AIXN:StatutoryReservesMember 2021-12-31 0000835662 us-gaap:RetainedEarningsMember 2021-12-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000835662 us-gaap:CommonStockMember 2022-12-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000835662 AIXN:StatutoryReservesMember 2022-12-31 0000835662 us-gaap:RetainedEarningsMember 2022-12-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000835662 us-gaap:CommonStockMember 2023-03-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000835662 AIXN:StatutoryReservesMember 2023-03-31 0000835662 us-gaap:RetainedEarningsMember 2023-03-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000835662 2023-03-31 0000835662 us-gaap:CommonStockMember 2023-06-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000835662 AIXN:StatutoryReservesMember 2023-06-30 0000835662 us-gaap:RetainedEarningsMember 2023-06-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000835662 2023-06-30 0000835662 us-gaap:CommonStockMember 2022-03-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000835662 AIXN:StatutoryReservesMember 2022-03-31 0000835662 us-gaap:RetainedEarningsMember 2022-03-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000835662 2022-03-31 0000835662 us-gaap:CommonStockMember 2022-06-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000835662 AIXN:StatutoryReservesMember 2022-06-30 0000835662 us-gaap:RetainedEarningsMember 2022-06-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000835662 2022-06-30 0000835662 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000835662 AIXN:StatutoryReservesMember 2021-01-01 2021-12-31 0000835662 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000835662 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000835662 AIXN:StatutoryReservesMember 2022-01-01 2022-12-31 0000835662 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000835662 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000835662 AIXN:StatutoryReservesMember 2023-01-01 2023-03-31 0000835662 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000835662 2023-01-01 2023-03-31 0000835662 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000835662 AIXN:StatutoryReservesMember 2023-04-01 2023-06-30 0000835662 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000835662 2023-04-01 2023-06-30 0000835662 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000835662 AIXN:StatutoryReservesMember 2023-07-01 2023-09-30 0000835662 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000835662 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000835662 AIXN:StatutoryReservesMember 2022-01-01 2022-03-31 0000835662 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000835662 2022-01-01 2022-03-31 0000835662 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000835662 AIXN:StatutoryReservesMember 2022-04-01 2022-06-30 0000835662 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000835662 2022-04-01 2022-06-30 0000835662 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000835662 AIXN:StatutoryReservesMember 2022-07-01 2022-09-30 0000835662 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000835662 us-gaap:CommonStockMember 2023-09-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000835662 AIXN:StatutoryReservesMember 2023-09-30 0000835662 us-gaap:RetainedEarningsMember 2023-09-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000835662 us-gaap:CommonStockMember 2022-09-30 0000835662 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000835662 AIXN:StatutoryReservesMember 2022-09-30 0000835662 us-gaap:RetainedEarningsMember 2022-09-30 0000835662 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000835662 2022-09-30 0000835662 us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0000835662 us-gaap:NonrelatedPartyMember 2022-01-01 2022-09-30 0000835662 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0000835662 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0000835662 AIXN:QuanzhongLinMember 2017-02-02 0000835662 AIXN:ChinaConcentricCapitalGroupMember 2017-02-02 0000835662 AIXN:ChinaConcentricCapitalGroupMember 2017-02-01 2017-02-02 0000835662 AIXN:QuanzhongLinMember 2017-12-11 2017-12-12 0000835662 AIXN:EquityTransferAgreementMember AIXN:AixinShangyanHotelManagementMember 2021-05-25 0000835662 AIXN:AixinShangyanHotelManagementMember 2021-05-24 2021-05-25 0000835662 AIXN:AixintangPharmacisesMember 2021-06-01 2021-06-02 0000835662 AIXN:YunnanShengshengyuanTechnologyCoLtdMember AIXN:TransferAgreementMember 2022-07-17 2022-07-19 0000835662 AIXN:YunnanShengshengyuanTechnologyCoLtdMember 2022-07-18 2022-07-19 0000835662 2023-02-17 0000835662 AIXN:ChinaConcentricCapitalGroupMember 2017-02-01 2017-02-02 0000835662 AIXN:ChinaConcentricCapitalGroupMember 2017-12-12 0000835662 AIXN:ChengduAixintangPharmacyCoLtdMember AIXN:PharmaciesPurchaseAgreementMember 2021-06-01 2021-06-02 0000835662 AIXN:YunnanShengshengyuanTechnologyCoLtdMember AIXN:TransferAgreementMember 2022-07-18 2022-07-19 0000835662 2023-02-17 2023-02-17 0000835662 AIXN:PriorToMayOneTwpThousandEighteenMember 2022-01-01 2022-12-31 0000835662 srt:HotelMember 2022-01-01 2022-12-31 0000835662 us-gaap:HealthCareMember 2022-01-01 2022-12-31 0000835662 AIXN:ManufactureAndSaleMember 2022-01-01 2022-12-31 0000835662 AIXN:SinceAprilOneTwoThousandNineteenMember 2023-01-01 2023-09-30 0000835662 srt:HotelMember 2023-01-01 2023-09-30 0000835662 us-gaap:HealthCareMember 2023-01-01 2023-09-30 0000835662 AIXN:ManufactureAndSaleMember 2023-01-01 2023-09-30 0000835662 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AIXN:NoCustomerMember 2022-01-01 2022-09-30 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierOneMember 2023-07-01 2023-09-30 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierOneMember 2023-01-01 2023-09-30 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierTwoMember 2023-01-01 2023-09-30 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierOneMember 2022-07-01 2022-09-30 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierOneMember 2022-01-01 2022-09-30 0000835662 AIXN:OfficeFurnitureMember 2022-12-31 0000835662 AIXN:ElectronicEquipmentMember srt:MinimumMember 2022-12-31 0000835662 AIXN:ElectronicEquipmentMember srt:MaximumMember 2022-12-31 0000835662 AIXN:MachineryMember 2022-12-31 0000835662 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000835662 us-gaap:VehiclesMember 2022-12-31 0000835662 AIXN:OfficeFurnitureMember 2023-09-30 0000835662 AIXN:OfficeFurnitureMember srt:MinimumMember 2023-09-30 0000835662 AIXN:ElectronicEquipmentMember srt:MaximumMember 2023-09-30 0000835662 AIXN:MachineryMember 2023-09-30 0000835662 us-gaap:LeaseholdImprovementsMember 2023-09-30 0000835662 us-gaap:VehiclesMember 2023-09-30 0000835662 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AIXN:CustomerAMember 2021-01-01 2021-12-31 0000835662 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AIXN:CustomerBMember 2021-01-01 2021-12-31 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierCMember 2022-01-01 2022-12-31 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierDMember 2022-01-01 2022-12-31 0000835662 us-gaap:CostOfSalesMember us-gaap:SupplierConcentrationRiskMember AIXN:SupplierEMember 2021-01-01 2021-12-31 0000835662 AIXN:AdvertisingAndProductMember 2022-01-01 2022-12-31 0000835662 AIXN:AdvertisingAndProductMember 2021-01-01 2021-12-31 0000835662 AIXN:PharmaciesMember 2022-01-01 2022-12-31 0000835662 AIXN:PharmaciesMember 2021-01-01 2021-12-31 0000835662 srt:HotelMember 2021-01-01 2021-12-31 0000835662 AIXN:ManufactueAndSaleMember 2022-01-01 2022-12-31 0000835662 AIXN:ManufactueAndSaleMember 2021-01-01 2021-12-31 0000835662 AIXN:ManufactureAndSaleMember 2021-01-01 2021-12-31 0000835662 AIXN:AdvertisingAndProductMember 2022-12-31 0000835662 AIXN:AdvertisingAndProductMember 2021-12-31 0000835662 AIXN:PharmaciesMember 2022-12-31 0000835662 AIXN:PharmaciesMember 2021-12-31 0000835662 srt:HotelMember 2022-12-31 0000835662 srt:HotelMember 2021-12-31 0000835662 AIXN:ManufactureAndSaleMember 2022-12-31 0000835662 AIXN:ManufactureAndSaleMember 2021-12-31 0000835662 AIXN:ProductSMember 2023-07-01 2023-09-30 0000835662 AIXN:ProductSMember 2022-07-01 2022-09-30 0000835662 AIXN:PharmaciesMember 2023-07-01 2023-09-30 0000835662 AIXN:PharmaciesMember 2022-07-01 2022-09-30 0000835662 srt:HotelMember 2023-07-01 2023-09-30 0000835662 srt:HotelMember 2022-07-01 2022-09-30 0000835662 AIXN:ManufactureAndSaleMember 2023-07-01 2023-09-30 0000835662 AIXN:ManufactureAndSaleMember 2022-07-01 2022-09-30 0000835662 AIXN:ProductSMember 2023-01-01 2023-09-30 0000835662 AIXN:ProductSMember 2022-01-01 2022-09-30 0000835662 AIXN:PharmaciesMember 2023-01-01 2023-09-30 0000835662 AIXN:PharmaciesMember 2022-01-01 2022-09-30 0000835662 srt:HotelMember 2022-01-01 2022-09-30 0000835662 AIXN:ManufactureAndSaleMember 2022-01-01 2022-09-30 0000835662 AIXN:ProductSMember 2023-09-30 0000835662 AIXN:ProductSMember 2022-12-31 0000835662 AIXN:PharmaciesMember 2023-09-30 0000835662 srt:HotelMember 2023-09-30 0000835662 AIXN:ManufactureAndSaleMember 2023-09-30 0000835662 AIXN:VehicleMember 2022-12-31 0000835662 AIXN:VehicleMember 2021-12-31 0000835662 AIXN:OfficeFurnitureMember 2021-12-31 0000835662 AIXN:ElectronicEquipmentMember 2022-12-31 0000835662 AIXN:ElectronicEquipmentMember 2021-12-31 0000835662 AIXN:MachineryMember 2021-12-31 0000835662 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000835662 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2022-12-31 0000835662 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2021-12-31 0000835662 AIXN:ElectronicEquipmentMember 2023-09-30 0000835662 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2023-09-30 0000835662 AIXN:ValueAddedMember 2022-12-31 0000835662 AIXN:ValueAddedMember 2021-12-31 0000835662 AIXN:IncomeMember 2022-12-31 0000835662 AIXN:IncomeMember 2021-12-31 0000835662 AIXN:CityConstructionMember 2022-12-31 0000835662 AIXN:CityConstructionMember 2021-12-31 0000835662 AIXN:EducationMember 2022-12-31 0000835662 AIXN:EducationMember 2021-12-31 0000835662 AIXN:OtherMember 2022-12-31 0000835662 AIXN:OtherMember 2021-12-31 0000835662 AIXN:ValueAddedMember 2023-09-30 0000835662 AIXN:IncomeMember 2023-09-30 0000835662 AIXN:CityConstructionMember 2023-09-30 0000835662 AIXN:EducationMember 2023-09-30 0000835662 AIXN:OtherMember 2023-09-30 0000835662 us-gaap:RelatedPartyMember 2022-12-31 0000835662 us-gaap:RelatedPartyMember 2021-12-31 0000835662 2019-03-31 0000835662 srt:MinimumMember 2022-12-31 0000835662 srt:MaximumMember 2022-12-31 0000835662 AIXN:AixinShangyanHotelManagementMember 2022-12-31 0000835662 AIXN:AixintangPharmacisesMember srt:MinimumMember 2022-12-31 0000835662 AIXN:AixintangPharmacisesMember srt:MaximumMember 2022-12-31 0000835662 srt:MinimumMember AIXN:AiXinZhonghongBiologicalTechnologyCoLtdMember 2023-09-30 0000835662 srt:MaximumMember AIXN:AiXinZhonghongBiologicalTechnologyCoLtdMember 2023-09-30 0000835662 AIXN:AixinShangyanHotelManagementMember 2023-09-30 0000835662 AIXN:AixintangPharmacisesMember srt:MinimumMember 2023-09-30 0000835662 AIXN:AixintangPharmacisesMember srt:MaximumMember 2023-09-30 0000835662 AIXN:RuncanshengMember 2023-09-30 0000835662 us-gaap:RelatedPartyMember 2021-12-31 0000835662 2014-05-31 0000835662 AIXN:RenewedMember 2014-05-31 0000835662 us-gaap:AccountsReceivableMember 2023-09-30 0000835662 us-gaap:AccountsReceivableMember 2022-12-31 0000835662 2014-05-01 2014-05-31 0000835662 AIXN:RenewedMember 2014-05-01 2014-05-31 0000835662 AIXN:OfficeLeasesMember 2023-09-30 0000835662 AIXN:XiaoyanZhouMember AIXN:OfficeLeasesMember 2023-07-01 2023-12-31 0000835662 AIXN:XiaoyanZhouMember AIXN:OfficeLeasesMember 2020-04-01 2023-02-28 0000835662 AIXN:YunnanRuncangshengMember AIXN:OfficeLeasesMember 2020-04-01 2023-02-28 0000835662 AIXN:XiaoyanZhouMember AIXN:OfficeLeasesMember 2023-07-01 2023-12-31 0000835662 AIXN:ChengduWenJiangAixinNanjiangPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduWenJiangAixinNanjiangPharmacyCoLtdMember 2021-12-31 0000835662 AIXN:SichuanAixinInvestmentCoLtdMember 2022-12-31 0000835662 AIXN:SichuanAixinInvestmentCoLtdMember 2021-12-31 0000835662 AIXN:ChengduFuxiangTangPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduFuxiangTangPharmacyCoLtdMember 2021-12-31 0000835662 AIXN:ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember 2021-12-31 0000835662 AIXN:ChengduLishengHuirenTangPharmacyCoLimitedMember 2022-12-31 0000835662 AIXN:ChengduLishengHuirenTangPharmacyCoLimitedMember 2021-12-31 0000835662 AIXN:QuanzhongLinMember 2022-12-31 0000835662 AIXN:QuanzhongLinMember 2021-12-31 0000835662 AIXN:YirongShenMember 2022-12-31 0000835662 AIXN:YirongShenMember 2021-12-31 0000835662 AIXN:BranchManagerMember 2022-12-31 0000835662 AIXN:BranchManagerMember 2021-12-31 0000835662 AIXN:ChengduAixinECommerceCompanyLtdMember 2022-12-31 0000835662 AIXN:ChengduAixinECommerceCompanyLtdMember 2021-12-31 0000835662 AIXN:ChengduAixinInternationalTravelserviceCoLtdMember 2022-12-31 0000835662 AIXN:ChengduAixinInternationalTravelserviceCoLtdMember 2021-12-31 0000835662 AIXN:AixinLifeBeautyMember 2022-12-31 0000835662 AIXN:AixinLifeBeautyMember 2021-12-31 0000835662 AIXN:ChengduWenJiangAixinNanjiangPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:SichuanAixinInvestmentCoLtdMember 2023-09-30 0000835662 AIXN:HuiliangJiaoMember 2023-09-30 0000835662 AIXN:HuiliangJiaoMember 2022-12-31 0000835662 AIXN:XiaoyanMember 2023-09-30 0000835662 AIXN:XiaoyanMember 2022-12-31 0000835662 AIXN:ChengduFuxiangTangPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduWenJiangAixinHuiwanPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduWenJiangAixinHuiwanPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduHeshengyuanPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduHeshengyuanPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduZhiweibingPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduZhiweibingPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduTongtaiTangPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduTongtaiTangPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:WuhouDistrictXiaofeiPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:WuhouDistrictXiaofeiPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:AixinHuiPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:AixinHuiPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:SichuanXintangXinfuPharmacyChainCoLtdMember 2023-09-30 0000835662 AIXN:SichuanXintangXinfuPharmacyChainCoLtdMember 2022-12-31 0000835662 AIXN:SichuanAixintangXinfuPharmacyChainCoLtdMember 2023-09-30 0000835662 AIXN:SichuanAixintangXinfuPharmacyChainCoLtdMember 2022-12-31 0000835662 AIXN:ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduCiguFoshouPharmacyMember 2023-09-30 0000835662 AIXN:ChengduCiguFoshouPharmacyMember 2022-12-31 0000835662 AIXN:MianyangAixinCunshanPharmacyMember 2023-09-30 0000835662 AIXN:MianyangAixinCunshanPharmacyMember 2022-12-31 0000835662 AIXN:ChengduAixinInternationalTravelserviceCoLtdMember 2023-09-30 0000835662 AIXN:ChengduLishengHuirenTangPharmacyCoLimitedMember 2023-09-30 0000835662 AIXN:QuanzhongLinMember 2023-09-30 0000835662 AIXN:YirongShenMember 2023-09-30 0000835662 AIXN:SichuanHaosenHaichuanBusinessManagementCoLtdMember 2023-09-30 0000835662 AIXN:SichuanHaosenHaichuanBusinessManagementCoLtdMember 2022-12-31 0000835662 AIXN:SichuanYunxiPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:SichuanYunxiPharmacyCoLtdMember 2022-12-31 0000835662 AIXN:ChengduYiYanTangPharmacyCoLtdMember 2023-09-30 0000835662 AIXN:ChengduYiYanTangPharmacyCoLtdMember 2022-12-31 0000835662 us-gaap:ForeignCountryMember 2022-01-01 2022-12-31 0000835662 us-gaap:ForeignCountryMember AIXN:AixinShangyanHotelAndAixintangPharmaciesMember 2022-12-31 0000835662 us-gaap:ForeignCountryMember 2023-01-01 2023-09-30 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNinettenEquityIncentivePlanMember 2019-10-21 2019-10-22 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNinettenEquityIncentivePlanMember 2019-10-22 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNinettenEquityIncentivePlanMember 2019-10-23 2019-10-24 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNinettenEquityIncentivePlanMember 2019-10-24 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNinettenEquityIncentivePlanMember 2022-01-01 2022-12-31 0000835662 AIXN:QuanzhongLinMember 2021-01-01 2021-12-31 0000835662 AIXN:AixinShangyanHotelAndAixintangPharmaciesMember 2021-01-01 2021-12-31 0000835662 2020-08-16 2020-08-17 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNineteenEquityIncentivePlanMember 2019-10-21 2019-10-22 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNineteenEquityIncentivePlanMember 2019-10-22 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNineteenEquityIncentivePlanMember 2019-10-23 2019-10-24 0000835662 AIXN:EmployeesAndContractorsMember AIXN:TwoThousandAndNineteenEquityIncentivePlanMember 2019-10-24 0000835662 AIXN:EmployeesAndContractorsMember 2023-01-01 2023-09-30 0000835662 AIXN:YunnanShengshengyuanTechnologyCoLtdMember 2023-01-01 2023-09-30 0000835662 srt:MinimumMember 2022-01-01 2022-12-31 0000835662 srt:MaximumMember 2022-01-01 2022-12-31 0000835662 srt:MinimumMember 2023-01-01 2023-09-30 0000835662 srt:MaximumMember 2023-01-01 2023-09-30 0000835662 us-gaap:IndemnificationGuaranteeMember 2020-12-01 2020-12-31 0000835662 2020-12-01 2020-12-31 0000835662 AIXN:AixinShangyanHotelManagementMember 2022-01-01 2022-12-31 0000835662 AIXN:AixintangPharmacisesMember 2020-12-31 0000835662 AIXN:AixintangPharmacisesMember 2020-01-01 2020-12-31 0000835662 AIXN:YunnanShengshengyuanMember 2022-07-19 0000835662 AIXN:YunnanRuncangshengMember 2022-07-19 0000835662 AIXN:YunnanRuncangshengMember AIXN:TransferAgreementMember 2021-01-01 2021-12-31 0000835662 AIXN:YunChenMember 2022-07-19 0000835662 AIXN:YunnanRuncangshengMember 2022-07-17 2022-07-19 0000835662 AIXN:YunnanRuncangshengMember 2022-07-19 0000835662 AIXN:RuncangshengAixinShangyanHotelAndAixintangPharmaciesMember 2022-01-01 2022-12-31 0000835662 AIXN:RuncangshengAixinShangyanHotelAndAixintangPharmaciesMember 2021-01-01 2021-12-31 0000835662 AIXN:LuquanShengcaofengBiotechnologyCoLtdMember 2023-09-30 0000835662 AIXN:LuquanShengcaofengBiotechnologyCoLtdMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CNY

 

As filed with the Securities and Exchange Commission on February 9, 2024

 

Registration No. 333-268190

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM S-1/A

(Amendment No.7)

 

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 

AIXIN LIFE INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

colorado   5149   84-1085935

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China

+(86) 313-6732526
(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

 

Corporation Service Company

1900 W. Littleton Boulevard

Littleton, Colorado 80120

Tel: (303) 832 7579

(Name, address, including zip code, and telephone number,

including area code, of agent for service of process)

 

Copies To:

 

Vincent J. McGill, Esq.

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, NY 10105

Telephone: (516) 220-6569

 

Louis A. Bevilacqua, Esq.

Bevilacqua PLLC

1050 Connecticut Avenue, NW, Suite 500

Washington, DC 20036

(202) 869-0888

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement is declared effective.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐

 

The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission acting pursuant to said Section 8(a), may determine.

 

 

 

 
 

  

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

SUBJECT TO COMPLETION, DATED FEBRUARY 9, 2024

 

PRELIMINARY PROSPECTUS

 

AiXin Life International, Inc.

 

 

[$9,500,000]

 

Shares of Common Stock

 

This is a public offering of common stock, par value $0.00001 per share (“common stock”), by AiXin Life International, Inc., a Colorado company. Throughout this prospectus, unless the context requires otherwise, all references to “AiXin Colorado” refer to AiXin Life International, Inc., a holding company, and references to “Aixin Life,” we,” “us,” “our,” the “Registrant,” the “Company” or “our Company” are to AiXin Colorado collectively with our PRC Subsidiaries and AiXin BVI. We are offering 2,375,000 shares of common stock on a firm commitment basis. We currently expect the public offering price to be $4.00 per share.

 

The offering is being made on a “firm commitment” basis by Boustead Securities, LLC. See “Underwriting.”

 

Our shares of common stock offered in this prospectus are shares of AiXin Colorado which has no material operations of its own. AiXin Colorado conducts substantially all of its operations through operating companies established in the People’s Republic of China, or the PRC, specifically, Chengdu AiXinZhonghong Biological Technology Co., Ltd, (“AiXinZhonghong”), AiXin Shangyan Hotel Management Co. Ltd. (“AiXin Hotel”), Chengdu Aixintang Haichuan Pharmacy (which together with certain affiliated entities is referred to as “Chengdu Aixintang Pharmacies”), and Yunnan Runcangsheng Technology Co., Ltd. (“Runcangsheng,” collectively with AiXinZhonghong, Aixin Hotel and Chengdu Aixintang Pharmacies, the “Chinese Operating Companies”). The Chinese Operating Companies are wholly owned through an intermediary company established in Hong Kong named HK AiXin International Group Co., Limited (“AiXin HK” and collectively with our Chinese Operating Companies our “PRC Subsidiaries”), which is owned by an intermediary company (AiXin (BVI) International Group, Ltd., “AiXin BVI”) established in the British Virgin Islands. We are not a Chinese operating company. We are a holding company and do not directly own any substantive business operations in China. Therefore, you will not directly hold any equity interests in our Chinese Operating Companies, AiXin BVI or AiXin HK. Our holding company structure involves unique risks to investors. Chinese regulatory authorities could disallow our operating structure, which would likely result in a material change in our operations and/or the value of our common stock, including causing the value of our common stock to significantly decline or become worthless. For a detailed description of risks related to our corporate structure, see “Risk Factors—Risks Relating to Our Holding Company Structure” for detailed discussions.

 

 
 

 

Additionally, as we conduct substantially all of our operations in China, we are subject to legal and operational risks associated with our business operations in China and our holding company in Hong Kong including risks related to the legal, political and economic policies of the PRC government, the relations between China and the United States, or Chinese or United States regulations, which risks could result in a material change in our operations or cause the value of our common stock to significantly decline or become worthless and affect our ability to offer or continue to offer securities to investors. PRC laws and regulations governing our current business operations are sometimes vague and uncertain, and we face the risk that changes in the policies of the PRC government could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business. These risks associated with our being based in or conducting substantially all of our operations through operating companies established in China could cause the value of our securities to significantly decline or become worthless. Furthermore, these risks may result in a material change in our business operations or a complete hinderance of our ability to offer or continue to offer our securities to investors. The PRC government initiated a series of regulatory actions and statements to regulate business operations in China with little advance notice, including cracking down on illegal activities in securities markets, enhancing supervision over China-based companies listed overseas, adopting new measures to extend the scope of cybersecurity reviews, and expanding efforts to enforce anti-monopoly laws and regulations. As confirmed by our PRC counsel, Beijing Dentons Law Offices, LLP (Chengdu) (“Dentons” or “PRC Counsel”) the business conducted by our subsidiaries until now is not subject to cybersecurity review with the Cyberspace Administration of China, or CAC, given that we are not an operator of critical information infrastructure or an online platform operator as defined by the Measures for Cybersecurity Review (2021 version). In addition, as confirmed by our PRC Counsel, we are not subject to merger control review by China’s anti-monopoly enforcement agency due to the level of revenues reported by us and audited by our auditor KCCW Accountancy Corp, and the fact that we currently do not expect to propose or implement any acquisition of control of, or decisive influence over, any company with revenues within China of more than RMB400 million. To date, the statements and regulatory actions related to cybersecurity and anti-monopoly policies have had no impact on our daily business operations, the ability to accept foreign investments and list our securities on a U.S. or other foreign exchange. As of the date of this prospectus, no effective laws or regulations in the PRC explicitly require us to seek approval from the China Securities Regulatory Commission (the “CSRC”) or any other PRC governmental authorities for our overseas listing, nor has our Company or any of our subsidiaries received any inquiry, notice, warning or sanctions regarding our overseas listing from the CSRC or any other PRC governmental authorities. However, since these statements and regulatory actions are new, it is highly uncertain as to how soon legislative or administrative regulation making bodies will respond to ongoing developments and what existing or new laws or regulations or detailed implementation policies and interpretations will be promulgated or modified and the potential impact such new laws or modified laws and regulations will have on our daily business operations, the ability to accept foreign investments and list our securities on a U.S. or other foreign exchange. The Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (the “Trial Measures”), came into effect March 31, 2023. The Trial Measures apply to overseas securities offerings and/or listings conducted by companies incorporated in the PRC, PRC domestic companies, and companies incorporated overseas with operations primarily in the PRC, indirect offerings. The Trial Measures require (1) the filing of the overseas offering and listing plan by the PRC domestic companies with the CSRC under certain conditions, and (2) the filing by the underwriter with the CSRC under certain conditions and (3) the submission of an annual report to the CSRC within the required timeline. Based on the advice of our PRC Counsel, this offering will be considered an indirect offering. However, our PRC Counsel has advised that because our common stock currently trades in the U.S., we are not required to submit filings to the CSRC before this offering is completed and this offering is not conditioned on CSRC approval. Rather, within three days of the closing of this offering we must submit filings to the CSRC in accordance with the Trial Measures. If we were to fail to comply with the post-offering filing obligations imposed by the Trial Measures or make a misrepresentation, misleading statement or material omission in the materials we submit to the CSRC, the CSRC would have the right to order rectification, issue a warning and impose a fine on us of between RMB1 million and RMB10 million and issuing a warning to the parties responsible for such failure, misrepresentation or material omission and impose a fine on each of such individuals ranging from RMB500,000 to RMB5 million. See “Risk Factors” for a discussion of these legal and operational risks and other information that should be considered before making a decision to purchase our common stock.

 

As a holding company, our ability to pay dividends to our shareholders and to service any debt we may incur at the holding company level may depend upon dividends or interest paid by our Chinese Operating Companies and AiXin HK (collectively, our “PRC Subsidiaries”). Current PRC regulations permit our PRC Subsidiaries to pay dividends to us only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, each of our PRC Subsidiaries is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve reaches 50% of its registered capital. As of the date hereof, we have had no transactions that involved the transfer of cash or assets throughout our corporate structure. In order for us to pay dividends to our shareholders we will rely on the distribution of dividends through AiXin HK from our Chinese Operating Companies. As of the date hereof, none of our Chinese Operating Companies has distributed any cash or other assets to AiXin HK, including by way of dividends or interest payments, AiXin HK has not distributed any cash or other assets to AiXin BVI, and AiXin Colorado and Aixin BVI have not transferred any cash or other assets to any of our PRC Subsidiaries. AiXin Colorado does not currently plan or anticipate transferring cash or other assets from our operations in China to any non-Chinese entity. As of the date hereof, no transfers, dividends or distributions have been made to our investors. To the extent our cash or other assets is in one of our Chinese Operating Companies or AiXin HK, the funds or assets may not be available to fund operations or for use outside of mainland China or Hong Kong including for the payment of dividends to the shareholders of AiXin Colorado, due to interventions by the governments of PRC or Hong Kong, or the imposition of restrictions and limitations on the ability of the PRC Subsidiaries to use such cash or assets imposed by the government of mainland China or Hong Kong. See “Prospectus Summary – Summary of Risk Factors – Risks Relating to Our Holding Company Structure,” and “Risk Factors – Risks Relating to Our Holding Company Structure - We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC Subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.” For a detailed description of limitations on the Company’s ability to transfer cash through our corporate structure, see “Prospectus Summary - Transfers of Cash to and from our Subsidiaries.”

 

Except for such limitations on our Company’s ability to transfer cash and other assets among our entities currently or hereafter imposed by the governments of the PRC and Hong Kong, there are no limitations on our Company’s ability to transfer cash and other assets through our corporate structure. Our Company does not have any cash management policies with respect to the transfer of cash among our entities other than requirements for the approval of management for transfers in excess of specified amounts and none of our entities is currently party to any debenture, loan or other agreement which imposes restrictions or otherwise limits our Company’s ability to transfer our cash and other assets. We have not adopted any policies that dictate how funds are transferred among our entities other than as necessary to comply with applicable laws. See “Prospectus Summary - Transfers of Cash to and from our Subsidiaries.”

 

 
 

 

Pursuant to the Holding Foreign Companies Accountable Act (“HFCAA”), the Public Company Accounting Oversight Board (United States) (the “PCAOB”) issued a Determination Report on December 16, 2021 which found that the PCAOB was then unable to inspect or investigate completely registered public accounting firms headquartered in mainland China of the PRC and Hong Kong, a Special Administrative Region and dependency of the PRC. In addition, the PCAOB’s report identified the specific registered public accounting firms which are subject to these determinations. Our registered public accounting firm, KCCW Accountancy Corp. is not headquartered in mainland China or Hong Kong and was not identified in this report as a firm subject to the PCAOB’s determinations. KCCW Accountancy Corp. is registered with the PCAOB and is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess KCCW Accountancy Corp.’s compliance with applicable professional standards. KCCW Accountancy Corp. has been inspected by the PCAOB on a regular basis, with the last inspection in 2022. On December 15, 2022, the PCAOB determined that the PCAOB was able to secure complete access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong and voted to vacate its previous determinations to the contrary. However, should PRC authorities obstruct or otherwise fail to facilitate the PCAOB’s access in the future, the PCAOB will consider the need to issue a new determination. On December 29, 2022, the Accelerating Holding Foreign Companies Accountable Act (“AHFCAA”) was enacted, which amended the HFCA Act by decreasing the number of non-inspection years from three years to two, thus reducing the time period before our common stock may be prohibited from trading or delisted if the PCAOB was unable to inspect our auditor. Notwithstanding the foregoing, if the PCAOB is not able to inspect and investigate completely our auditor’s work papers in China, you may be deprived of the benefits of such inspection which could result in a limitation on or a restriction to our access to the U.S. capital markets. Further, trading of our securities may be prohibited under the HFCAA and Nasdaq may determine to delist our securities if the PCAOB determines that it cannot inspect or investigate completely our auditor under the HFCAA. For more details, see “Risk Factors – Risk Associated with Our Company -A recent joint statement by the SEC and the Public Company Accounting Oversight Board (United States), or the “PCAOB,” proposed rule changes submitted by Nasdaq, and the newly enacted “Holding Foreign Companies Accountable Act” all call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments could add uncertainties to our offering.”

 

We are a reporting company under Section 12(g) of the Securities Exchange Act of 1934, as amended. Our common stock is currently quoted on the OTCQB (the “OTCQB”) under the symbol “AIXN.” The last reported closing price for our common stock on February 8, 2024, was $0.50 per share. There is a limited public trading market for our common stock. We have applied to list our common stock on the Nasdaq Capital Market under the symbol “AIXN.” There can be no assurance that our application will be approved. The closing of this offering is contingent upon the successful listing of our common stock on the Nasdaq Capital Market.

 

Investing in our securities involves a significant degree of risks. You should carefully consider the risk factors beginning on page 15 of this prospectus and set forth in the documents incorporated by reference herein before making any decision to invest in our securities.

 

Neither the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this registration statement. Any representation to the contrary is a criminal offense.

 

   Per share   Total 
Public offering price  $4.00   $9,500,000 
Underwriting discounts and commissions (1)  $

0.32

   $760,000 
Offering proceeds to us, before expenses  $

3.68

   $8,740,000 

 

(1) Does not include additional items of compensation payable to Boustead Securities, LLC, the underwriter, which includes warrants to purchase 5% of the aggregate number of shares issued in this offering, with an exercise price equal to 125% of the price per share sold in this offering. We have also agreed to reimburse the underwriter for certain accountable expenses incurred by them. See “Underwriting.”

 

We have also granted a 45-day option to the underwriter to purchase up to additional [356,250] shares of common stock solely to cover over-allotments, if any.

 

The underwriter expects to deliver our shares of common stock to purchasers in this offering on or about [●], 2024.

 

 

The date of this prospectus is [●], 2024

 

 
 

 

TABLE OF CONTENTS

 

  Page
   
About This Prospectus 1
Prospectus Summary 2
The Offering 13
Forward-Looking Statements 14
Risk Factors 15
Use of Proceeds 38
Capitalization 38
Dilution 39
Market for Common Equity and Related Stockholder Matters 40
Selected Historical Financial and Operating Data 41
Management’s Discussion and Analysis of Financial Condition and Results of Operations 43
Business 57
Directors and Executive Officers 62
Executive Compensation 67
Certain Relationships and Related Party Transactions 68
Security Ownership of Certain Beneficial Owners and Management 69
Description of Capital Stock 70
Shares Eligible for Future Sale 72
Underwriting 73
Experts 81
Where You Can Find More Information 81
Financial Statements F-1

 

i
 

 

ABOUT THIS PROSPECTUS

 

This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC” or the “Commission”). You should rely only on the information contained in this prospectus or any supplement or amendment hereto. Neither we, nor the underwriter have authorized any person to provide you with different information. Neither we, nor the underwriter are offering to sell, or seeking an offer to buy, our common stock in any jurisdiction where such offer or sale is not permitted. You should assume that the information contained in this prospectus and any supplement or amendment hereto is accurate only as of their respective dates, regardless of the time of delivery of this prospectus or of any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date.

 

On October 27, 2020, we effected a 1-for-4 reverse split of our shares of common stock. Concurrently with the reverse split we reduced the number of our authorized shares of common stock from 900,000,000 shares to 500,000,000 shares. On February 17, 2023, we effected a 1-for-2 reverse split of our shares of common stock. At such time the number of our authorized shares of common stock remained 500,000,000 shares. On March 1, 2023, Quanzhong Lin entered into a Contribution Agreement wherein he agreed to contribute to the capital of AiXin Colorado seven million shares of common stock of AiXin Colorado effective upon effectiveness of the Registration Statement of which this prospectus is a part. Except as otherwise indicated, all share and per share numbers contained herein other than those set forth in the financial statements beginning on page F-1, have been adjusted to give effect to the 1-for-4 and 1-for-2 reverse stock splits and the reduction in the number of our shares of our common stock outstanding to occur as result of a contribution to our capital of 7 million shares of our common stock to be made by Mr. Quanzhong Lin, our Chairman, President, Chief Executive Officer and principal shareholder.

 

You should read this prospectus, together with additional information described under “Where You Can Find More Information”, beginning on page 81, before making an investment decision.

 

The market data and certain other statistical information used throughout this prospectus is based on independent industry publications, reports by market research firms or other independent sources that we believe to be reliable sources. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the disclosure contained in this prospectus, and we believe these industry publications and third-party research, surveys and studies are reliable. While we are not aware of any misstatements regarding any third-party information presented in this prospectus, their estimates, in particular, as they relate to projections, involve numerous assumptions, are subject to risks and uncertainties, and are subject to change based on various factors. Some market and other data included herein, as well as the data of competitors as they relate to Aixin, is also based on our good faith estimates.

 

Unless the context otherwise requires, all references in this prospectus to:

 

  “AiXin Colorado” refers to AiXin Life International, Inc., a Colorado corporation;
  “AiXin BVI” refers to AiXin (BVI) International Group, Ltd., a British Virgin Islands corporation;
  “AiXin HK” refers to HK AiXin International Group Co., Limited, a Hong Kong limited company;
  “AiXinZhonghong” refers to Chengdu AiXinZhonghong Biological Technology Co., Ltd, a Chinese limited company and each of the affiliated Chinese limited companies owned by AiXinZhonghong which operates a pharmacy;
  “AiXin Hotel” refers to Chengdu AiXin Shangyan Hotel Management Co., Ltd., a Chinese limited company;
  “Aixintang Pharmacy” refers to Chengdu Aixintang Haichuan Pharmacy, a Chinese limited Company;
  “Chengdu Aixintang Pharmacies” refers to Aixintang Pharmacy and each of the affiliated Chinese limited companies owned by Aixintang Pharmacy which operates a pharmacy;
  “Runcangsheng” refers to Yunnan Runcangsheng Technology Co., Ltd. a Chinese limited company;
  “Chinese Operating Companies” refers to, collectively, AiXinZhonghong, AiXin Hotel, Chengdu Aixintang Pharmacies and Runcangsheng;
  “PRC Subsidiaries refers to, collectively, AiXin HK and the Chinese Operating Companies;
  Aixin Life,” “we,” “us,” “our,” the “Registrant”, the “Company,” or “our Company” refer to AiXin Colorado and our PRC Subsidiaries and Chinese Operating Companies, as appropriate;
  Exchange Act” refers to the Securities Exchange Act of 1934, as amended;
  SEC” or the “Commission” refers to the United States Securities and Exchange Commission;
  Securities Act” refers to the Securities Act of 1933, as amended;
  China,” “Chinese” or the “PRC” refers to the People’s Republic of China, including Hong Kong and Macau and excluding Taiwan;
  all references to “RMB” or “Chinese Yuan” is to the legal currency of the People’s Republic of China; and
  all references to “U.S. dollars,” “dollars,” “USD” or “$” are to the legal currency of the United States;

 

AiXin Colorado’s reporting currency is the U.S. dollar. The functional currency of AiXin Colorado is the U.S. dollar and the functional currency of the Chinese Subsidiaries is the Chinese Renminbi (“RMB”). For the subsidiaries whose functional currencies are the RMB, all assets and liabilities are translated at exchange rates at the balance sheet date, which are 7.2960 and 6.8972 as of September 30, 2023 and December 31, 2022, respectively. Revenue and expenses are translated at the average yearly exchange rates, which are 7.0467, 6.7290 and 6.4508 for the three years ended December 31, 2023, 2022 and 2021, respectively, and 7.0343 for the nine months ended September 30, 2023. The equity is translated at historical exchange rates. Any translation adjustments resulting are not included in determining net income but are included in foreign exchange adjustments to other comprehensive loss, a component of equity.

 

1

 

 

PROSPECTUS SUMMARY

 

This summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should consider in making your investment decision. Before investing in our securities, you should carefully read this entire prospectus, especially the risks of investing in our securities as discussed under “Risk Factors” and the financial statements and notes thereto herein. The following summary is qualified in its entirety by the detailed information appearing elsewhere in this prospectus.

 

Overview

 

Our Business

 

We, AiXin Life International, Inc. (“AiXin Colorado,” together with our Chinese Operating Companies and PRC Subsidiaries, as appropriate, referred to as “AiXin Life,” the “Company”, “we”, “us” and “our” unless specified otherwise) are a Colorado holding company with no material operations of our own. We conduct substantially all of our operations through our wholly-owned operating companies in the PRC. This is an offering of common stock of our Colorado holding company. Therefore, you will not directly own any equity interests in our operating companies.

 

Our subsidiaries are (i) AiXin (BVI) International Group Co., Ltd. (“AiXin BVI”), 100% owned by AiXin Colorado, (ii) HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), 100% owned by AiXin BVI, and the following entities, each of which was organized in the PRC, is wholly-owned by AiXin HK and which are collectively referred to as our “Chinese Operating Companies” (iii) Chengdu AiXinZhonghong Biological Technology Co., Ltd. and its wholly-owned subsidiaries, each of which operates a pharmacy (“AiXinZhonghong”), (iv) Yunnan Runcangsheng Technology Co., Ltd (“Yunnan Runcangsheng”), (v) Chengdu Aixintang Haichuan Pharmacy Co., Ltd. and its wholly-owned subsidiaries, each of which operates a pharmacy (“Chengdu Aixintang Pharmacies”) and (vi) AiXin Shangyan Hotel Management Co., Ltd. Our Chinese Operating Companies and AiXin HK are collectively referred to as our “PRC Subsidiaries.”

 

Our holding company structure involves unique risks to investors. Chinese regulatory authorities could disallow our operating structure, which would likely result in a material change in our operations and/or the value of our common stock, including causing the value of our common stock to significantly decline or become worthless. AiXin Colorado is listed on the OTCQB under the symbol “AIXN”.

 

2

 

 

We are focused on providing health and wellness products to the growing middle class in China. We currently develop, manufacture, market and sell premium-quality healthcare, nutritional products and wellness supplements, including herbs and greens, traditional Chinese remedies, functional products, such as weight management tools, probiotics, foods and drinks. We also offer products purchased from third parties. In addition, we have provided advertising and marketing services to clients which engaged us to market and distribute their products, though we have decreased this activity as we focus on distributing our products. We offer our products and those of clients for which we provide marketing services, through a diversified, omni-channel business model which generates revenues through retail and wholesale product sales, through company-owned pharmacies, direct marketing and on-line activities. Our marketing approach emphasizes proactively approaching customers such as by hosting marketing events for clients, which we believe is ideally suited to marketing the products we offer because sales of healthcare, nutritional products and supplements are strengthened by ongoing personal contact and support, coaching and education among the Company and our clients towards how to achieve a healthy and active lifestyle.

 

In December 2017, when we acquired AiXin BVI, it indirectly owned all of the capital stock of AiXinZhonghong, which began distributing nutritional products in 2013.

 

In September 2021, we completed the acquisition of nine retail pharmacies in Chengdu. Since that time we have added additional pharmacies and currently operate 25 pharmacies. We utilize these pharmacies to distribute health and wellness products and serve as learning centers for our clients. We intend to seek to continue to expand our chain of pharmacies and to use these outlets as part of our overall marketing strategy.

 

In September 2022, we acquired Yunnan Runcangsheng based in Yunnan Province which engages in the research, development, manufacture and wholesale distribution of health foods. Yunnan Runcangsheng operates a 13,000 square meter production facility, which houses R&D centers, extraction facilities, preparation workshops and a warehouse. Yunnan Runcangsheng has more than 30 sub brands and operates planting facilities where it grows some of the key ingredients used in its products. Many of the products it has developed are specifically targeted to disorders associated with changing eating habits and the presence of environmental toxins that are becoming more widespread through the use of western style pesticides and fertilizers.

 

In addition to our acquisitions in the health and nutritional sector, in July 2021, we acquired a hotel located in the Jinniu District, Chengdu City. The hotel covers more than 8,000 square meters and has a large restaurant that can accommodate 600 people, six luxury dining rooms, a 200 square meter music tea house, 13 private tea rooms, 108 guest rooms and other supporting facilities. We envision utilizing the hotel to conduct marketing events and seminars for our customers, and training sessions for our personnel at which we introduce new products and services intended to promote healthy living.

 

Business Objectives

 

Key elements of our business strategy are detailed below:

 

Leading brand of nutritional supplements. Our primary goal is to develop recognized brand names with a reputation as a provider of quality health and wellness products which deliver demonstrable benefits to our customers. Our objective is to provide potential customers with the information necessary to maintain a healthy lifestyle and to offer a variety of products whether the customer is looking to treat a specific health-related issue, maintain their overall wellness or improve their performance. Our premium, value-added offerings will include both proprietary branded products and other branded products provided by third parties to meet needs not met by our in-house products.

 

We believe that by offering a variety of branded exclusive products and a wide range of merchandise, and close customer support and services, we will be able to differentiate our Company from competitors and effectively compete against other food, drug and mass channel players, specialty stores, independent vitamin, supplement and natural food shops and online retailers.

 

3

 

 

Product development and innovation. With the acquisition of Yunnan Runcangsheng, we have the facilities and, more importantly, knowledgeable, experienced personnel to develop high-quality, innovative health foods and nutritional supplements that will be offered by our direct marketing team and available through our Company-owned pharmacies, our website and, as demand grows other select marketplaces and wholesale partners. To the extent desirable we will grow our own key ingredients. When we choose to use ingredients of third parties, they will be rigorously tested before they are added to our products, undergoing multiple quality checks to ensure that they meet our high standards for purity, composition and absence of contaminants.

 

We believe our ability to innovate and respond to customer needs by designing new products gives us a significant competitive advantage. At Yunnan Runcangsheng we directly employ scientists, nutritionists, formulators, and quality control experts who work at our research and manufacturing facilities.

 

A differentiated customer experience. We believe one of the key differentiators to our marketing strategy is the continued development of well-trained team members first used at AiXinZhonghong that work closely with customers. We will provide our team members with regular training and education focused on the benefits of a healthy lifestyle, the advantages of our products and solution-based selling. With their knowledge of the available products, our team members can engage customers in conversation, access the customer’s purchasing history through our data base, share product information and testimonials, and recommend solutions and help customers add complimentary products and build wellness regimens. We operate in a highly personalized, aspirational sector and believe that health food and nutritional supplement consumers often desire and seek out product expertise and knowledgeable customer service.

 

Our loyalty programs used early on by AiXinZhonghong will allow us to develop and maintain a large and loyal customer base, provide targeted offers and information, and connect with our customers on a regular basis. We routinely harness data generated by these programs to better understand customers’ buying behaviors and needs, so we can deliver a stronger experience, bring like-minded consumers into the channel and make well-informed decisions about our business.

 

As we grow and develop our customer base, we can use our hotel as a site for educational seminars, conferences and marketing events featuring well known experts in the wellness sector. These events can be used to increase customer loyalty and to educate our team members as to the benefits of a healthy lifestyle and our products so they can better serve our customers by guiding them to products that meet their needs.

 

Omni-channel development. We believe our diversified, omni-channel model, which includes company-owned pharmacies, direct marketing by our team members, individually and at large scale company sponsored marketing events, wholesale locations and on-line promotional activities, can differentiate us from many of our competitors, particularly those that rely exclusively on online marketing efforts. Our strategy is to give consumers a seamless, integrated experience across digital, mobile and in-store channels and in every interaction with us and our products. Through our website and in conversations with our well-trained team members, customers can research our products and purchase them online or at one of our local pharmacies or sales offices. We believe our physical store base provides a competitive advantage, allowing customers to experience our products and get expert advice from our team members.

 

Vertical Integration. We believe that our multi-channel distribution model, combined with our research, development and manufacturing capabilities offers us a unique advantage over our competitors. The daily feedback received from interactions between our team members and customers will be monitored to recognize what our customers want and rapidly develop products to meet their desires. Instead of simply responding to trends in the market, we will seek to bring new topical products to the market before they are generally available in the market.

 

4

 

 

Our Corporate Structure

 

We, AiXin Life International, Inc. (“AiXin Life” or “AiXin Colorado”), are a corporation organized under the laws of Colorado. We are a holding company with no material operations of our own. We conduct all of our operations through our wholly owned subsidiaries which are operating companies established in the PRC. Our operating companies in the PRC are wholly owned by HK AiXin International Group Co., Limited (“AiXin HK”), our wholly owned subsidiary organized in Hong Kong which, in turn is wholly owned by AiXin (BVI) International Group Co., Ltd. (“AiXin BVI”), an entity organized in the British Virgin Islands which is wholly owned by us.

 

Our subsidiaries are (i) AiXin BVI, (ii) AiXin HK, and the following entities, each of which was organized in the PRC and which are collectively referred to as our “Chinese Operating Companies” (iii) Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company and its subsidiaries, each of which operates a pharmacy (“AiXinZhonghong”), (iv) Yunnan Runcangsheng Technology Co., Ltd (“Yunnan Runcangsheng”), (v) Chengdu Aixintang Haichuan Pharmacy Co., Ltd. and its subsidiaries, each of which operates a pharmacy and (“Chengdu Aixintang Pharmacies”) (vi) AiXin Shangyan Hotel Management Co., Ltd. Our Chinese Operating Companies and AiXin HK are collectively referred to as our “PRC Subsidiaries.” Unless the context otherwise requires, all references in this prospectus to “AiXin Colorado” refer to AiXin Life International, Inc., and references to “AiXin Life,” “we,” “us,” “our,” the “Registrant”, the “Company,” or “our Company” refer collectively to AiXin Colorado and its consolidated subsidiaries.

 

You will be purchasing shares of AiXin Colorado and will not hold a direct interest in any of its subsidiaries. For the avoidance of doubt, Chengdu Aixintang Haichuan Pharmacy Co., Ltd. owns 100% of the equity interests in each of the nine remaining pharmacy companies.

 

 

Summary of Risk Factors

 

Investing in our common stock involves a high degree of risk. Below is a summary of material factors that make an investment in our common stock speculative or risky. This summary does not address all of the risks that we face. Please refer to the information contained in and incorporated by reference under the heading “Risk Factors” on page 15 of this prospectus.

 

5

 

 

Risks Associated with Our Company

 

The health and wellness industry is highly competitive and we face fierce competition from numerous industry participants, including many larger, well capitalized nationally and internationally recognized companies, see “Risk Factors — Risks Associated with Our Company — We operate in a highly competitive industry and our failure to compete effectively could adversely affect our market share, revenues and growth prospects.
   
We first entered the health and wellness business in 2017 when we acquired AiXin BVI. Consequently, we have a limited operating history on which to evaluate our prospects, see “Risk Factors — Risks Associated with Our Company — We have a limited operating history on which to judge our performance and assess our prospects for success.”
   
We recently completed a significant acquisition and intend to seek to expand through future acquisitions. Our future expansion plans are subject to uncertainties and risks. For more details, see “Risk Factors – Risks Associated with Our Company – Our recently completed acquisition is subject to uncertainties and risks” and – “Our future expansion plans are subject to uncertainties and risks.
   
Our success depends upon our ability to anticipate and timely react to changes in consumers demands, see “Risk Factors – Risks Associated with Our Company - Failure to effectively anticipate consumer preferences could negatively impact the demand for our products and our ability to generate revenues and the market price of our common stock.”
   
We may not succeed in our efforts to develop new products which could cause us to devote our resources to projects that do not succeed, see “Risk Factors – Risks Associated with Our Company—Resources devoted to product innovation may not yield new products that achieve commercial success.”
   
Our success depends on our ability to attract and retain customers through a coordinated omni channel distribution network which includes pharmacies, direct marketing and online activities. If we do not succeed in these efforts we may fail to grow our customer base. For more details, see “Risk Factors – Risks Associated with Our Company – If we do not successfully develop and maintain a robust omni-channel experience for our customers, our business and results of operations could be materially and adversely affected.”
   
If we fail to succeed in developing and protecting our brand names we could fail in our efforts to grow our customer base, see “Risk Factors – Risks Associated with Our Company —If we fail to develop and protect our brand names and reputation, we may not attract and retain new customers which could adversely affect our revenues and financial performance.”
   
We are highly dependent upon consumer perception of our products and unfavorable publicity about us or our business may materially and adversely affect our reputation, business, results of operations and financial condition. For more details, see “Risk Factors – Risks Associated with Our Company –Unfavorable publicity about us or consumer perception of our products, the ingredients they contain and any similar products distributed by other companies could cause fluctuations in our operating results and could have a material adverse effect on our reputation, the demand for our products and our ability to generate revenues and the market price of our common stock.”
   

We face risks related to our ability to effectively source raw materials and any adverse change in the supply or cost of raw materials may adversely affect our business. See “Risk Factors – Risks Associated with Our Company -A significant disruption to our timely receipt of raw materials and inventory could adversely impact sales and operations or increase our transportation costs, which would decrease our profits.

   
We are highly dependent upon the services of Quanzhong Lin, our President, Chief Executive Officer and principal shareholder. The loss of his services could have a Material adverse impact on our business. See, Risk Factors – Risks Associated with Our Company - Our business depends on the continued contributions made by Mr. Quanzhong Lin, our key executive officer. The loss of his services may result in a severe impediment to our business.”

 

6

 

 

General Risks Associated with Business Operations in China

 

The Chinese government may intervene or influence our operations at any time or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in material changes in our operations and/or the value of your common stock. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - The PRC government has significant oversight and discretion over the conduct of a PRC company’s business operations or to exert control over any offering of securities conducted overseas and/or foreign investment in China-based issuers, and may intervene with or influence our operations, may limit or completely hinder our ability to offer or continue to offer securities to investors, and may cause the value of such securities to significantly decline or become worthless, as the government deems appropriate to further regulatory, political and societal goals.”
   

On February 17, 2023, the CSRC released the Trial Measures, which came into effect March 31, 2023. The Trial Measures apply to overseas securities offerings and/or listings conducted by companies incorporated in the PRC, PRC domestic companies, directly and companies incorporated overseas with operations primarily in the PRC, indirect offerings. The Trial Measures require (1) the filings of the overseas offering and listing plan by the PRC domestic companies with the CSRC under certain conditions, (2) filings by the underwriter with the CSRC under certain conditions and (3) the submission of an annual report to the CSRC within the required timeline.

 

On the day it released the Trial Measures, the CSRC held a press conference and issued the Notice on Administration for the Filing of Overseas Offering and Listing by Domestic Companies (“Notice on Overseas Filing”), which, among others, clarified that: (i) PRC domestic companies that have submitted applications for an overseas offering and listing on or prior to the effective date of the Trial Measures but have not obtained approval from overseas regulatory authorities or stock exchanges may reasonably arrange the timing for submitting their filing applications with the CSRC, and should complete the filing before the completion of their overseas offering and listing; (ii) a six-month transition period will be granted to PRC companies in which they can complete an overseas offering and listing provided they obtained the approval for the offering from an overseas regulatory authority or stock exchange (such as the effectiveness of a registration statement in the United States) prior to March 31, 2023 and (iii) companies subject to the Trial Measures which have securities which trade in an overseas market prior to the effectiveness of the Trial Measures will need to file with the CSRC within three days of the completion of a follow-on offering.

 

Based on the advice of our PRC Counsel, this offering will be considered an indirect offering and we will need to fulfill filing obligations pursuant to the Trial Measures within three days of the completion of this offering. If we fail to comply with the post-offering filing obligations imposed by the Trial Measures or make a misrepresentation, misleading statement or material omission in the materials we submit to the CSRC, the CSRC would have the right to order rectification, issue a warning and impose a fine on us of between RMB1 million and RMB10 million and issuing a warning to the parties responsible for such failure, misrepresentation or material omission and impose a fine on each of such individuals ranging from RMB500,000 to RMB5 million.

 

The Trial Measures may subject us to additional compliance requirement in the future. Any failure to fully comply with new regulatory requirements may significantly limit or completely hinder our ability to offer or continue to offer our shares, cause significant disruption to our business operations, and severely damage our reputation, which would materially and adversely affect our financial condition and results of operations and cause our common stock to significantly decline in value or become worthless. See “Risk Factors – General Risks Associated with Business Operations in China — The CSRC has released the Trial Measures requiring Chinese domestic companies to complete filings with the CSRC if they complete an overseas offering and listing of their securities.”

   
The Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises (the “Confidentiality and Archives Provisions”), went into effect March 31, 2023. The Confidentiality and Archives Provisions require, among other items, that PRC domestic enterprises seeking to offer and list securities in overseas markets, establish an archival system which will maintain the confidentiality of information in accordance with applicable laws and regulations. Further, if a PRC domestic enterprise plans, directly or indirectly, to release documents or provide material that contain state secrets or government work secrets, or that will jeopardize national security or the public interest, it must strictly comply with all relevant governmental procedures and obtain approval of the appropriate regulatory before doing so. Although our PR Counsel has advised us that although we are subject to the Confidentiality and Archives Provisions, we believe that none of the documents or materials we intend to provide to parties outside of the PRC contains materials that would require us to make any filing or obtain any approval of a Chinese regulatory authority. Nevertheless, the determination of whether information contains state secrets, government work secrets or jeopardizes national security or the public interest is subjective and any failure or perceived failure by us or our subsidiaries to comply with the confidentiality and archive administration requirements under the Confidentiality and Archives Provisions could cause us to be referred for criminal investigation and held liable for such violations by the authorities in China. Further, PRC regulatory authorities could use these regulations to limit our disclosures or interfere with our operations. Any determination that we have violated the Confidentiality and Archives Provisions or use of these provisions to limit our disclosures could cause the value of our common stock to significantly decline in value or become worthless. See “Risk Factors – General Risks Associated with Business Operations in China — The CSRC has released rules for China-based companies seeking to conduct initial public offerings in foreign markets. The Chinese government may exert more oversight and control over offerings that are conducted overseas and foreign investment in China-based issuers, which could significantly limit or completely hinder our ability to offer or continue to offer our common stock to investors and could cause the value of our common stock to significantly decline or become worthless.”
   

Article 26 of the Trial Measures came into effect on March 31, 2023. Article 26 provides, among other things, that any domestic entity or individual intending to provide documents and materials requested by an overseas securities regulatory agency in connection with an investigation may not provide such information without prior approval from the CSRC and competent authorities under the State Council. In addition, Article 11 of the Provisions on Strengthening Confidentiality and Archives Administration in Respect of Overseas Issuance and Listing of Securities by Domestic Enterprises, or Article 11 came into effect on March 31, 2023. Article 11 provides among other things, that any domestic company, securities firm and securities service agency shall obtain the consent of the CSRC or the relevant administrative authorities prior to cooperating in an inspection or investigation carried out by an overseas securities regulator or relevant administrative authorities or providing documents and materials for cooperating in the inspection or investigation.

 

If the Company were to provide information to any securities regulatory agency in violation of Article 26 or Article 11, it would be subject to fines and, if the information were deemed a state secret, government work secret or might jeopardize the national security of China or the public interest, as provided in the Confidentiality and Archives Provisions, it could cause the Company or the individuals responsible for the disclosure to be subject to criminal investigation. Likewise, if the Company refuses to provide information requested by any U.S. securities regulatory agency in circumstances that the Company believes would have caused it to violate Article 26 or Article 11, it will be subject in the United States to fines, penalties or delisting from Nasdaq. While detailed interpretation of or implementation rules of Article 26 and Article 11 have yet to be promulgated, the inability of an overseas securities regulator to directly conduct an investigation or evidence collection activities within China may further increase difficulties that you may face in protecting your interests, see “We could be subject to conflicting demands placed upon us by regulatory authorities in the United States and the PRC which could result in disciplinary actions if not resolved.”

   
You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in the prospectus based on foreign laws, including U. S. court judgements based on violations of the civil liability provisions of the U. S. federal securities laws. For more details, see “Risk Factors – General Risks Associated with Business Operations in China - You may have difficulty enforcing judgments against us.

 

7

 

 

Changes in the policies, regulations, rules and the enforcement of laws of the PRC government may be quick with little advance notice and could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business. For more details, see “Risk Factors - General Risks Associated with Business Operations in China - Changes in the policies, regulations, rules and the enforcement of laws of the PRC government may be quick with little advance notice and could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business.”
   
Inflation could pose a risk to our business. For more details, see “Risk Factors - General Risks Associated with Business Operations in China - Inflation could pose a risk to our business.”
   
There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations.”.
   
PRC regulations regarding acquisitions impose significant regulatory approval and review requirements, which could make it more difficult for us to pursue growth through acquisitions. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - PRC regulations regarding acquisitions impose significant regulatory approval and review requirements, which could make it more difficult for us to pursue growth through acquisitions.
   
While the approval of the China Securities Regulatory Commission is not currently required for this offering, it may be required in the future in connection with this offering under the M&A Rules and, if required, we cannot predict whether we will be able to obtain such approval. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - While the approval of the China Securities Regulatory Commission is not currently required for this offering, it may be required in the future in connection with this offering under the M&A Rules and, if required, we cannot predict whether we will be able to obtain such approval.”
   
Our business may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - Our business may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection.
   
PRC regulations relating to investments in offshore companies by PRC residents may subject our PRC-resident beneficial owners or our PRC Subsidiaries to liability or penalties, limit our ability to inject capital into our PRC Subsidiaries or limit our PRC Subsidiaries’ ability to increase their registered capital or distribute profits. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - PRC regulations relating to investments in offshore companies by PRC residents may subject our PRC-resident beneficial owners or our PRC Subsidiaries to liability or penalties, limit our ability to inject capital into our PRC Subsidiaries or limit our PRC Subsidiaries’ ability to increase their registered capital or distribute profits.”

 

8

 

 

We may be treated as a resident enterprise for PRC tax purposes under the PRC Enterprise Income Tax Law, and we may therefore be subject to PRC income tax on our global income. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - We may be treated as a resident enterprise for PRC tax purposes under the PRC Enterprise Income Tax Law, and we may therefore be subject to PRC income tax on our global income.”
   
Restrictions on currency exchange may limit our ability to utilize our PRC revenue effectively. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - Restrictions on currency exchange may limit our ability to utilize our PRC revenue effectively.”
   
Introduction of new laws or regulations or changes to existing laws or regulations by the PRC government may adversely affect our business. For more details, see “Risk Factors – General Risks Associated with Business Operation in China - Introduction of new laws or changes to existing laws by the PRC government may adversely affect our business.”

 

Risks Relating to Our Holding Company Structure

 

Substantial uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact the viability of our current corporate structure, corporate governance and business operations. For more details, see “Risk Factors – Risks Relating to Our Holding Company Structure - Substantial uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact the viability of our current corporate structure, corporate governance and business operations.”
   

We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries and loans between us and our PRC Subsidiaries to fund any cash and financing requirements we or any of our PRC Subsidiaries may have, and any limitation on the ability of our PRC Subsidiaries to make payments to or transfer funds to us or our other PRC Subsidiaries could have a material and adverse effect on our ability to conduct our business and the ability of our PRC Subsidiaries to conduct their respective businesses. Current PRC regulations permit our PRC Subsidiaries to pay dividends to us only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, each of our PRC Subsidiaries is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve reaches 50% of its registered capital. As of the date hereof, we have had no transactions that involved the transfer of cash or assets throughout our corporate structure. The PRC Subsidiaries have not transferred cash or other assets to AiXin BVI or AiXin Colorado, including by way of dividends or interest payments and AiXin BVI and AiXin Colorado have not transferred cash or other assets to any of our PRC Subsidiaries. AiXin Colorado does not currently plan or anticipate transferring cash or other assets from our operations in China to any non-Chinese entity. As of the date hereof, no transfers, dividends or distributions have been made to our investors. To the extent our cash or other assets is in one of our Chinese Operating Companies or AiXin HK, the funds or assets may not be available to fund operations or for use outside of mainland China or Hong Kong due to interventions by the governments of PRC or Hong Kong, or the imposition of restrictions and limitations on the ability of the PRC Subsidiaries to use such cash or assets imposed by the government of mainland China or Hong Kong. Except for such limitations on our Company’s ability to transfer cash and other assets among our entities currently or hereafter imposed by the governments of the PRC and Hong Kong, there are no limitations on our Company’s ability to transfer cash and other assets through our corporate structure. Our Company does not have any cash management policies with respect to the transfer of cash among our entities other than requirements for the approval of management for transfers in excess of specified amounts and none of our entities is currently party to any debenture, loan or other agreement which imposes restrictions or otherwise limits our Company’s ability to transfer our cash and other assets. We have not adopted any policies that dictate how funds are transferred among our entities other than as necessary to comply with applicable laws. For more details, see “Risk Factors – Risks Relating to Our Holding Company Structure - We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC Subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.” and “Prospectus Summary - Transfers of Cash to and from our Subsidiaries.”

   
PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay or prevent us from using the proceeds of this offering to make loans or additional capital contributions to our PRC Subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business. For more details, see “Risk Factors – Risks Relating to Our Holding Company Structure - PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay or prevent us from using the proceeds of this offering to make loans or additional capital contributions to our PRC Subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business.”

 

Risks Relating to this Offering and Our Common Stock

 

Prior to this offering, we had a limited public market for our common stock and you may not be able to resell our shares at or above the price you paid, or at all. For more details, see “Risk Factors – Risks Relating to this Offering and Our Common Stock - Prior to this offering, we had a limited public market for our common stock and you may not be able to resell our shares at or above the price you paid, or at all.”

   
Future sales of substantial amounts of our common stock by existing shareholders, including sales resulting from a foreclosure of shares pledged by holders of a substantial number of shares of our common stock, could adversely affect the price of our common stock. For more details, see “Risk Factors – Risks Relating to this Offering and Our Common Stock - The sale or availability for sale of substantial amounts of our common stock could adversely affect its market price.

 

9

 

 

The market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to various factors. For more details, see “Risk Factors – Risks Relating to this Offering and Our Common Stock - The market price of our shares is likely to be highly volatile, which could result in substantial losses to investors.”

   
We may never be able to pay dividends and are unlikely to do so. For more details, see “Risk Factors – Risks Relating to this Offering and Our Common Stock - Because we do not expect to pay dividends in the foreseeable future after this offering, you must rely on price appreciation of our common stock for return on your investment.”

 

PRC Limitation on Overseas Listing and Share Issuances

 

As confirmed by our PRC Counsel, neither we nor our subsidiaries are currently required to obtain approval from Chinese authorities, including the China Securities Regulatory Commission, or CSRC, or Cybersecurity Administration Committee, or CAC, to list on U.S. exchanges or issue securities to foreign investors. We are, however, required by the Trial Measures to submit a filing with the CSRC within three days after the completion of this offering. If we were to fail to comply with the post-offering filing obligations imposed by the Trial Measures or make a misrepresentation, misleading statement or material omission in the materials we submit to the CSRC, the CSRC would have the right to order rectification, issue a warning and impose a fine on us of between RMB1 million and RMB10 million and issuing a warning to the parties responsible for such failure, misrepresentation or material omission and impose a fine on each of such individuals ranging from RMB500,000 to RMB5 million.

 

If our PRC Subsidiaries or AiXin Colorado were required to obtain approval in the future and were denied permission from Chinese authorities to list on U.S. exchanges, we would not be able to continue listing on any U.S. exchange, which would materially affect the interests of investors in our securities. It is uncertain when and whether we will be required to obtain permission from the PRC government to list on U.S. exchanges in the future, and even if such permission is obtained, whether it will be rescinded. Although we currently are not required to obtain permission from any of the PRC central or local government agencies and have not been denied the right to list on a U.S. exchange by any Chinese governmental authority, our operations could be adversely affected, directly or indirectly, by existing or future laws and regulations denying us the right to list on any U.S. exchange. If we inadvertently conclude that such approvals are not required when they are, or applicable laws, regulations, or interpretations change and we are required to obtain approval in the future, our operations and the interests of our shareholders could be adversely affected. For more detailed information, see “Risk Factors – General Risks Associated with Business Operations in China – While the approval of the China Securities Regulatory Commission is not currently required for this offering, it may be required in the future in connection with this offering under the M&A Rules and, if required, we cannot predict whether we will be able to obtain such approval.”

 

On February 17, 2023, the CSRC released regulations for the filing-based administration of direct and indirect overseas securities offerings and listings by domestic companies incorporated in Mainland China. The regulations became effective March 31, 2023. The regulations are comprised of the Trial Administrative Measures of Overseas Securities Offering and Listing by China-based Companies (the “Trial Measures”) and five supporting guidelines. The Trial Measures lay out the filing regulations for both direct and indirect overseas listings and clarify the criteria for determining whether a listing constitutes an indirect overseas listing in an overseas market.

 

An offering and listing by an overseas company will be deemed an indirect offering by a China-based company: if (i) more than 50% of the overseas company’s consolidated revenues, profit, total assets or net assets as indicated by its audited consolidated financial statements for the most recently completed fiscal year are attributable to PRC domestic companies, and (ii) one of (a) key components of its operations are carried out in Mainland China; (b) its principal places of business are located in Mainland China; or (c) the majority of the senior management members in charge of operations are Mainland China citizens or residents, is true. The determination is made on the basis of a “substance over form” review.

 

If a China-based company seeks to indirectly offer and list securities in an overseas market, it is required to designate a major Chinese operating entity to be responsible for processing all filings with the CSRC. With respect to an initial offering and listing overseas, the initial filing with the CSRC is to be made within three business days of the date on which the overseas application is submitted. In the case of a follow-on offering in the same overseas market where a Chinese based company has previously offered and listed securities, the issuer shall submit filings with the CSRC within three business days after the follow-on offering is completed.

 

In addition, an overseas offering and listing is prohibited if: (1) the intended securities offering and listing is specifically prohibited by PRC law, regulations or relevant national provisions; (2) the State Council determines that the intended securities offering and listing endanger the national security of the PRC; (3) in the past three years, the issuer or its controlling shareholders or the actual parties controlling the issuer have been convicted of committing corruption, bribery, embezzlement, misappropriation of property, or other criminal offenses disruptive to the order of the Chinese socialist market economy, or are under judicial investigation for suspicion of criminal offenses or major violations; (4) the issuer is suspected of committing any crimes or serious violations of laws and regulations and is under an investigation which has not been concluded; (5) there are material disputes with regard to the ownership of the securities of the relevant Chinese entity by its controlling shareholders or shareholders or by the parties actually in control of the issuer. The Trial Measures provide that in the event of an issuer’s breach of the Trial Measures, such as a failure to comply with the filing obligations, conducting an overseas securities offering and listing in violation of the Trial Measures or making a misrepresentation, misleading statement or material omission in the materials submitted to the CSRC by the issuer, the CSRC shall order rectification, issue warnings to the issuer, and, impose a fine between RMB1 million and RMB10 million on the issuer, and further, that the parties responsible for such breach, failure, misrepresentation or material omission shall be warned and each shall be subject to a fine ranging from RMB500,000 to RMB5 million.

 

On the date of the release of the Trial Measures, the CSRC held a press conference and issued the Notice on Administration for the Filing of Overseas Offering and Listing by China-based Companies, which clarified that: (i) China-based companies that have submitted applications for an overseas offering and listing on or prior to the effective date of the Trial Measures, but have not obtained approval from overseas regulatory authorities or stock exchanges may reasonably arrange the timing for submitting their filing applications with the CSRC and should complete the filing before the completion of their overseas offering and listing; (ii) a six-month transition period will be granted to China-based companies in which they can complete an overseas offering and listing provided that they have obtained approval from an overseas regulatory authority or stock exchange (such as effectiveness of a registration statement in the market of the United States) prior to March 31, 2023 and (iii) companies which have securities which trade in an overseas market prior to the effective date of the Trial Measures will need to file with the CSRC pursuant to the Trial Measures within three days of completion of a follow-on offering. 

 

Because our PRC Subsidiaries have accounted for more than 50% of our consolidated revenues, profit, total assets and net assets from inception of our Company to date and key components of our operations are carried out in Mainland China, the offering by us pursuant to this registration statement is deemed by the CSRC to be an indirect offering and we will need to fulfill filing obligations pursuant to the Trial Measures after we have completed this offering. “Risk Factors – General Risks Associated with Business Operations in China — The CSRC has released the Trial Measures requiring Chinese domestic companies to complete filings with the CSRC if they complete an overseas offering and listing of their securities.”

 

The Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises (the “Confidentiality and Archives Provisions”), came into effect March 31, 2023. The Confidentiality and Archives Provisions require, among other items, that PRC domestic enterprises seeking to offer and list securities in overseas markets, shall establish an archival system which will maintain the confidentiality of information in accordance with applicable laws and regulations. Further, if a PRC domestic enterprise plans, directly or indirectly, to release documents or provide material that contain state secrets or government work secrets, or that will jeopardize national security or the public interest, it must strictly comply with all relevant governmental procedures and obtain approval of the appropriate regulatory before doing so. Although our PRC Counsel has advised us that we are subject to the Confidentiality and Archives Provisions, we believe that none of the documents or materials we intend to provide to parties outside of the PRC contains materials that would require us to make any filing or obtain any approval of a Chinese regulatory authority. Nevertheless, the determination of whether information contains state secrets, government work secrets or jeopardizes national security or the public interest is subjective and any failure or perceived failure by us or our subsidiaries to comply with the confidentiality and archive administration requirements under the Confidentiality and Archives Provisions could cause us to be referred for criminal investigation and held liable for such violations by the authorities in China. Further, PRC regulatory authorities could use these regulations to limit our disclosures or interfere with our operations. Any determination that we have violated the Confidentiality and Archives Provisions or use of these provisions to limit our disclosures could cause the value of our common stock to significantly decline in value or become worthless. See “Risk Factors – General Risks Associated with Business Operations in China — The CSRC has released rules for China-based companies seeking to conduct initial public offerings in foreign markets. The Chinese government may exert more oversight and control over offerings that are conducted overseas and foreign investment in China-based issuers, which could significantly limit or completely hinder our ability to offer or continue to offer our common stock to investors and could cause the value of our common stock to significantly decline or become worthless.”

 

We also reviewed our operations with our PRC Counsel as to the applicability of the Measures for Cybersecurity review administered by the CAC. During this review we and our PRC Counsel determined that we are not a “critical information infrastructure operator” as we do not operate or maintain any infrastructure used by the public to communicate or transmit information. We further determined that we possess only limited personal information with respect to any individual, currently have personal information pertaining to fewer than 1 million individuals and the data we process in our business does not have a bearing on national security and thus may not be classified as core or important data by the authorities and, consequently, we and our PRC Counsel concluded that we are not subject to cybersecurity review by the CAC. See “Risk Factors - Our business may be subject to a variety of PRC laws and obligations regarding cybersecurity and date protection.”

 

As of the date of this prospectus, other than confirming with our PRC Counsel that our offering under this prospectus does not require the examination and approval of the CSRC in accordance with the existing PRC legislation and regulations, we have not received any inquiry, notice, warning, sanctions or regulatory objection to this offering from the CSRC, CAC or any other PRC governmental authorities, and we believe our PRC Subsidiaries have obtained all requisite permissions and approvals from PRC governmental authorities to operate our business as currently conducted under relevant PRC laws and regulations.

 

Currently, each of our Chinese Operating Companies holds and maintains a business license issued by the local market supervision and administration bureau and has received all requisite permissions and approvals in order to conduct and operate its business. As of the date of this prospectus, none of our Chinese Operating Companies has been denied a business license or punished by relevant governmental authorities due to its business operations. In addition, we and our non-PRC Subsidiaries have also received all requisite permissions and approvals in order to conduct and operate our business.

 

10

 

 

Transfers of Cash to and from our Subsidiaries

 

We (AiXin Colorado) are a Colorado holding company with no material operations of our own. We conduct all of our operations through operating companies established in the PRC. As a result, our ability to pay dividends to our shareholders and to service any debt we may incur may depend upon dividends paid by our PRC Subsidiaries. If any of our subsidiaries incur debt on its own, the instruments governing such debt may restrict its ability to pay dividends to us or otherwise transfer funds to us or any of our other subsidiaries. In addition, our PRC Subsidiaries are required to make appropriations to certain statutory reserve funds, which are not distributable as cash dividends except in the event of a liquidation of the Company at a time when it is solvent.

 

Current PRC regulations permit our PRC Subsidiaries to pay dividends to us through AiXin HK, our intermediate holding subsidiary in Hong Kong, only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. As of the date hereof, none of our PRC Subsidiaries has distributed any dividends to AiXin HK. Except for such limitations on our Company’s ability to transfer cash and other assets among our entities currently or hereafter imposed by the governments of the PRC and Hong Kong, there are no limitations on our Company’s ability to transfer cash and other assets through our corporate structure. Our Company does not have any cash management policies with respect to the transfer of cash among our entities other than requirements for the approval of management for transfers in excess of specified amounts and none of our entities is currently party to any debenture, loan or other agreement which imposes restrictions or otherwise limits our Company’s ability to transfer our cash and other assets. We have not adopted any policies that dictate how funds are transferred among our entities other than as necessary to comply with applicable laws.

 

The PRC government also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies outside the PRC. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from our profits, if any, or for any other purpose. To the extent our cash or other assets is in one of our Chinese Operating Companies or AiXin HK, the funds or assets may not be available to fund operations or for use outside of mainland China or Hong Kong including for the payment of dividends to the shareholders of AiXin Colorado, due to interventions by the governments of PRC or Hong Kong, or the imposition of restrictions and limitations on the ability of the PRC Subsidiaries to use such cash or assets imposed by the government of mainland China or Hong Kong. See “Risk Factors – Risks Relating to Our Holding Company Structure - We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC Subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.”

 

Cash dividends, if any, on our common stock will be paid in U.S. dollars. If we are considered a PRC tax resident enterprise for tax purposes, any dividends we pay to our overseas shareholders may be regarded as China-sourced income and as a result may be subject to PRC withholding tax at a rate of up to 10.0%.

 

Pursuant to the Arrangement between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income, or the Double Tax Avoidance Arrangement, the 10% withholding tax rate may be lowered to 5% if a Hong Kong resident enterprise owns no less than 25% of a PRC project. However, the 5% withholding tax rate does not automatically apply and certain requirements must be satisfied, including without limitation that (a) the Hong Kong enterprise must be the beneficial owner of the relevant dividends; and (b) the Hong Kong enterprise must directly hold no less than 25% share ownership in the PRC project during the 12 consecutive months preceding its receipt of the dividends. In current practice, a Hong Kong entity must obtain a tax resident certificate from the Hong Kong tax authority to apply for the 5% lower PRC withholding tax rate. As the Hong Kong tax authority will issue such a tax resident certificate on a case-by-case basis, we cannot assure you that we will be able to obtain the tax resident certificate from the relevant Hong Kong tax authority and enjoy the preferential withholding tax rate of 5% under the Double Taxation Arrangement with respect to dividends to be paid by any of our Chinese Operating Companies to AiXin HK. As of the date of this prospectus, we have not applied for the tax resident certificate from the relevant Hong Kong tax authority. AiXin HK intends to apply for the tax resident certificate at such time as one of our Chinese Operating Companies plans to declare and pay a dividend to AiXin HK. See “Risk Factors – Risks Relating to Our Holding Company Structure – We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC Subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.

 

As of the date hereof, we have had no transactions that involved the transfer of cash or assets throughout our corporate structure. The PRC Subsidiaries have not transferred cash or other assets to AiXin BVI or AiXin Colorado, including by way of dividends, and AiXin BVI and AiXin Colorado have not transferred cash or other assets to any of our PRC Subsidiaries. AiXin Colorado does not currently plan or anticipate causing any of our PRC Subsidiaries to transfer cash or other assets from our operations in China to any non-Chinese entity. As of the date hereof, no transfers, dividends, or distributions have been made to our investors. Our Company is not currently party to any debenture, loan or other agreement which imposes restrictions or otherwise limits our Company’s ability to transfer our cash and other assets and we have not adopted any policies that dictate how funds are transferred other than requirements for the approval of management for transfers in excess of specified amounts and as necessary to comply with applicable laws. Except for such limitations on our Company’s ability to transfer cash and other assets among our entities currently or hereafter imposed by the governments of the PRC and Hong Kong, there are no limitations on our Company’s ability to transfer cash and other assets through our corporate structure. See “Prospectus Summary - Transfers of Cash to and from our Subsidiaries.”

 

You may not have the Ability to Obtain an Adequate Remedy at Law Against us or our Management

 

AiXin Colorado, the entity in which you will acquire shares is a holding company. All of our operations are conducted by and practically all of our cash and other assets are owned by operating businesses in the PRC. In addition, nearly all of our officers and directors, specifically, Quanzhong Lin, Huiliang Jiao and Tianfeng Li are PRC nationals and residents of China and all of their assets are located outside the United States. In addition, Yao-Te Wang one of our directors is a resident of Taiwan, and all of his assets are located outside the United States. Christopher Lee, our remaining director, resides outside of the United States for a significant portion of time and portions of his assets are located outside the United States. In order to commence an action against any of our directors and officers, a United States Court may require that you effect personal service of the complaint on the intended defendant. Although there are international conventions for serving process on prospective defendants outside the United States, such service may take an extraordinary amount of time and in order to be completed, may require the cooperation of courts in the jurisdiction where the intended defendant resides. Further, should the individual seek to avoid service of process, it may be more difficult to effect service than it would be in the United States. As a result, it may be difficult for you to effect service of process upon us or our directors and officers outside of the United States and, in particular, inside China or to bring actions against us or our management in China.

 

Shareholder claims and other causes of action that are common in the United States, including securities law class actions and fraud claims, generally are difficult to pursue as a matter of law or practicality in China. For example, in China, there are significant legal and other obstacles to obtaining information needed for shareholder investigations or litigation outside China. Although the local authorities in China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement cross-border supervision and administration, such regulatory cooperation with the securities regulatory authorities in the Unities States has not been effective. According to Article 177 of the PRC Securities Law which became effective in March 2020, no overseas securities regulator is allowed to directly conduct an investigation or evidence collection activities within the territory of the PRC. Accordingly, without the consent of competent PRC securities regulators and relevant authorities, no organization or individual may provide the documents and materials relating to securities business activities to overseas parties outside of the PRC.

 

China does not have treaties providing for the reciprocal recognition and enforcement of judgments of courts with the United States and many other countries and regions. Thus, there is no mechanism currently in place for enforcing a judgement in China. Even judgements from countries that have an enforcement treaty with China are often not enforceable in China. Therefore, recognition and enforcement in China of judgments of a court in any non-PRC jurisdiction in relation to any matter may be difficult or impossible. Further, although we are not s state owned enterprise, many businesses in China are owned in whole or in part by the Chinese government. If enforcement of a judgement against us would have an adverse impact on a state owned enterprise, local officials may be reluctant to cooperate in any enforcement action. Further, to the extent that a substantial portion of our outstanding shares of common stock are owned by Chinese residents that might be harmed by enforcement of a judgement against us, such residents may seek to prevent such enforcement.

 

We currently do not have Directors and Officers Insurance (“D&O Insurance”). Even if we obtain such insurance prior to completion of this offering, there is no guarantee that it will remain in place. The prevalence of D&O Insurance may be one of the reasons there is an active group of attorneys that seek to bring shareholder claims and other causes of action that are common in the United States, including securities law class actions and fraud claims, against public companies and their management. The absence of such insurance may make it more difficult for our shareholders to engage an attorney willing to commence an action against us or our management.

 

11

 

 

Holding Foreign Companies Accountable Act

 

Trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act, or the HFCAA, if the PCAOB determines that it cannot inspect or investigate completely our auditor.

 

Pursuant to the HFCAA, the PCAOB issued a Determination Report on December 16, 2021 which found that the PCAOB was then unable to inspect or investigate completely registered public accounting firms headquartered in: (1) mainland China of the People’s Republic of China because of a position taken by one or more authorities in mainland China; and (2) Hong Kong, a Special Administrative Region and dependency of the PRC, because of a position taken by one or more authorities in Hong Kong. In addition, the PCAOB’s report identified the specific registered public accounting firms which are subject to these determinations. On August 26, 2022, the CSRC, the Ministry of Finance, and the PCAOB signed the Protocol to allow the PCAOB to inspect and investigate completely registered public accounting firms headquartered in mainland China and Hong Kong, consistent with the HFCAA. Pursuant to the fact sheet with respect to the Protocol disclosed by the SEC, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the unfettered ability to transfer information to the SEC. On December 15, 2022, the PCAOB determined that the PCAOB was able to secure complete access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong and voted to vacate its previous determinations to the contrary. However, should PRC authorities obstruct or otherwise fail to facilitate the PCAOB’s access in the future, the PCAOB will consider the need to issue a new determination. On December 29, 2022, the AHCAA was enacted, which amended the HFCAA by decreasing the number of non-inspection years from three years to two, thus reducing the time period before our common stock may be prohibited from trading or delisted.

 

Our auditor, KCCW Accountancy Corp., is an independent public accounting firm registered with the PCAOB, and as an auditor of publicly traded companies in the U.S., is subject to laws in the U.S. pursuant to which the PCAOB conducts regular inspections to assess its compliance with the applicable professional standards. KCCW Accountancy Corp. is based in the United States and has been inspected by the PCAOB on a regular basis, with the last inspection in 2022. KCCW Accountancy Corp., is not headquartered in mainland China or Hong Kong and was not identified as a firm subject to the determinations announced by the PCAOB on December 16, 2021. Nevertheless, should the PCAOB be unable to fully conduct inspection of our auditor’s work papers in China, it will make it difficult to evaluate the effectiveness of our auditor’s audit procedures or equity control procedures. Investors may consequently lose confidence in our reported financial information and procedures or quality of the financial statements, which would adversely affect us and our securities. See “Risk Factors—Risks Associated with Our Company— A recent joint statement by the SEC and the Public Company Accounting Oversight Board (United States), or the “PCAOB,” proposed rule changes submitted by Nasdaq, and the newly enacted “Holding Foreign Companies Accountable Act” all call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments could add uncertainties to our offering.”

 

Corporate Information

 

AiXin Life International, Inc. was incorporated in the State of Colorado in 2001. We have a fiscal year-end of December 31. Our principal executive offices are located at Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District, Chengdu City, Sichuan Province, China and our telephone number is + (86) 313-6732526. We maintain a website at www.aixinjituan.com. The information contained on our website is not, and should not be interpreted to be, a part of this prospectus.

 

12

 

 

 

THE OFFERING

 

Shares of common stock offered by us:   [2,375,000] shares of common stock, or [2,731,250] shares if the underwriter exercises the over-allotment option in full.
     
Number of shares of common stock outstanding after this offering: (1)   [20,374,842] shares of common stock will be outstanding after this offering is completed, [20,731,092] shares if the underwriter exercises the over-allotment option in full.
     
Over-allotment option:   We have granted the underwriter the right to purchase up to [356,250] additional shares of common stock from us at the public offering price less the underwriting discounts and commissions within 45 days from the date of this prospectus to cover over-allotments.
     
Underwriter’s warrants:   We will issue to Boustead Securities, LLC, the underwriter, upon closing of this offering, compensation warrants, or the Underwriter’s Warrants, entitling the underwriter to purchase 5% of the aggregate number of shares of common stock issued in this offering, including shares issued pursuant to the exercise of the over-allotment option, at an exercise price of $5.00 per share (125% of the public offering price). The Underwriter’s Warrants will have a term of 5 years beginning on date of commencement of sales of the shares offered hereby and may be exercised upon commencement of sales of the shares offered hereby. The Underwriter’s Warrants may be exercised on a cashless basis.
     
Use of proceeds:   Our proceeds from this offering are expected to be approximately $[9,500,000], before payment of the underwriter’s commissions and other expenses. We intend to use the proceeds from this offering for the purchase and sale of raw materials and developing our own brands, including working capital and general corporate purposes. See “Use of Proceeds” on page 38.
     
Proposed Nasdaq Capital Market symbol:   We have applied to list our common stock on the Nasdaq Capital Market under the symbol “AIXN”. There can be no assurance that our application will be approved. The closing of this offering is contingent upon the successful listing of our common stock on the Nasdaq Capital Market.
     
Lock-Up Agreements:   See “Underwriting” for more information.
     
Risk factors:   Investing in our common stock is highly speculative and involves a significant degree of risk. As an investor you should be able to bear a complete loss of your investment. You should carefully consider the information set forth in the “Risk Factors” section beginning on page 15.
     
OTCQB Market Symbol:   AIXN.
     
Transfer Agent:   Securities Transfer Corporation.

 

  (1) The number of shares of our common stock to be outstanding after this offering is based on the number of shares outstanding as of February 8, 2024, reduced by seven million shares to be contributed to our capital by Quanzhong Lin upon effectiveness of the Registration Statement of which this prospectus is a part and gives no effect to shares which may be issued upon exercise of (i) the underwriter’s over-allotment option and (ii) the Underwriter’s Warrants.

 

 

13

 

 

FORWARD-LOOKING STATEMENTS

 

This prospectus contains forward-looking statements within the meaning of Section 27A of the Securities Act and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements are based on our management’s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

 

In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Risk Factors” and elsewhere in this prospectus. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this prospectus and those documents which we have filed with the SEC as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.

 

The forward-looking statements in this prospectus represent our views as of the date of this prospectus. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this prospectus.

 

You should also consider carefully the statements under “Risk Factors” and other sections of this prospectus, which address additional facts that could cause our actual results to differ from those set forth in the forward-looking statements. We caution investors not to place significant reliance on the forward-looking statements contained in this prospectus. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by law.

 

14

 

 

RISK FACTORS

 

You should carefully consider the risks described below and elsewhere in this prospectus, which could materially and adversely affect our business, results of operations or financial condition. Our business faces significant risks and the risks described below may not be the only risks we face. Additional risks not presently known to us or that we currently believe are immaterial may materially affect our business, results of operations, or financial condition. If any of these risks occur, the trading price of our common stock could decline, and you may lose all or part of your investment. You should consider our business and prospects in light of the challenges we face, including the ones discussed in this section. In the event that any of the events described in the risk factors below occur, it could have a material adverse effect on our operations and cash flow and cause the value of our securities to decline in value or become worthless.

 

Risks Associated with Our Company

 

We operate in a highly competitive industry and our failure to compete effectively could adversely affect our market share, revenues and growth prospects.

 

The market for health and wellness products is large, highly fragmented and intensely competitive. Current and prospective participants include specialty retailers, supermarkets, drugstores, mass merchants, multi-level marketing organizations, online merchants, mail-order companies and a variety of other smaller participants. The market is also highly sensitive to the introduction of new products, which may rapidly gain consumer acceptance. We compete for sales with heavily advertised brands manufactured by large pharmaceutical and food companies, as well as other brands, some of which have greater market presence, name recognition and financial, marketing and other resources, including some competitors that may spend more aggressively on advertising and promotional activities than we do. If we fail to compete effectively, we may lose business to other retailers.

 

Further, the ability of consumers to compare prices on a real-time basis through the use of smartphones and digital technology puts additional pressure on us to maintain competitive pricing. We compete in multiple product categories and sales channels, including pharmaceutical stores, wholesale to specialty store formats, direct marketing and increasingly internet-based and direct-sell retailers and vendors. Many factors affect the extent to which competition could affect our results, including as it relates to pricing, quality, assortment, marketing, promotions and advertising, service, locations, capital expenditures, category share and reputation, any of which could have a material effect on our results of operations.

 

We have a limited operating history on which to judge our performance and assess our prospects for future success.

 

We first entered the health and wellness business in December 2017 when we acquired AiXin BVI, which at that time owned all of the equity of AiXin Zhonghong, then engaged in the distribution of health and wellness foods. Consequently, we have a limited operating history on which to evaluate our prospects in the health and wellness industry. We may fail to continue our growth. You should not consider our historical growth and expansion of our business through acquisitions as indicative of our ability to grow in the future.

 

Our recently completed acquisition is subject to uncertainties and risks.

 

We recently completed a significant acquisition. There is no assurance that we will realize the benefits anticipated from our acquisition of Yunnan Runcangsheng. There is no assurance that the members of the management of Yunnan Runcangsheng that choose to join our Company can be successfully integrated into our management. The process of combining the operations of Yunnan Runcangsheng with our existing operations could have a material adverse effect on us and our financial condition.

 

Our future expansion plans are subject to uncertainties and risks.

 

We intend to seek to expand our operations through acquisitions. The implementation of such plan requires us to integrate any newly acquired business and its management teams. If we fail to effectively and efficiently implement our plan for acquisitions, we may not be successful in achieving profitable results. Even if we effectively and efficiently implement our future plans, there may be other unexpected events or factors that prevent us from achieving success. Our management has limited experience in effecting a rapid expansion and in managing larger operations. Our business, financial condition, results of operations and growth prospects may be materially and adversely affected if our future expansion plans fail to achieve positive results.

 

Failure to effectively anticipate consumer preferences could negatively impact the demand for our products and our ability to generate revenues and the market price of our common stock.

 

Our success also depends on our ability to anticipate and respond in a timely manner to changing consumer demand, consumer preferences, and shopping patterns regarding health and wellness products. Consumer preferences cannot be predicted with certainty and are subject to continual change and evolution. Additionally, our customers may have expectations about how they shop in stores or online, or more generally engage with businesses across different channels or media (through online and other digital or mobile channels or particular forms of social media), which may change over time which may make it more difficult for us to adapt to rapid changes in consumer preferences.

 

15

 

 

Our sales may decline significantly if we misjudge the market for our new products, which may result in significant inventory markdowns and lower margins, missed opportunities for other products, or inventory write-downs, and could have a negative impact on our reputation and profitability.

 

Resources devoted to product innovation may not yield new products that achieve commercial success.

 

Our ability to develop new and innovative products or identify and acquire new and innovative products from third-party vendors, depends on, among other factors, our ability to understand evolving market trends and translate our insights into identifying, and then designing and manufacturing or otherwise obtaining, commercially successful new products. If we are unable to do so, our customer relationships and product sales could be harmed significantly. The health and wellness industry is characterized by rapid and frequent changes in demand for products. Our failure to accurately predict these trends could harm our customer relationships and cause us to fail to grow our revenues. The development of new and innovative products requires significant investment in research and development and testing of new ingredients, formulas and possibly new production processes. The research and development process entails considerable uncertainty. Products may appear promising in development but fail to reach market within the expected time frame, or at all. Further, products also may fail to achieve commercial success. Finally, there is no guarantee that our development teams will be able to successfully respond to competitive products that could render some of our offerings obsolete.

 

If we do not successfully develop and maintain a robust omni-channel experience for our customers, our business and results of operations could be materially and adversely affected.

 

Omni-channel retailing, where customers are accessed through various coordinated channels, is rapidly evolving, and we must keep pace with changing customer expectations and new developments by our competitors. The growing middle class in China is increasingly seeking relevant information regarding healthy lifestyles and products that promote a healthy life. In addition, customers are increasingly shopping for products online instead of in traditional brick-and-mortar shopping centers and retail locations. As part of our omni-channel strategy, we anticipate the need to continue making investments in technology and to provide ready means for our customers to access the information and products they want in a comfortable environment. If we are unable to make, improve, or develop relevant channels to interact with customers in a timely manner, our ability to compete and our business and results of operations could be materially and adversely affected. In addition, if our online activities or our other customer-facing technology systems do not function as designed or we are unable to effectively blend our online and in-store platforms, we may experience a loss of customer confidence, lost sales, or data security breaches, any of which could materially and adversely affect our business and results of operations.

 

The lease with respect to our hotel expires at the end of 2025.

 

The term of the lease for our hotel in Chengdu expires December 31, 2025, and we do not have the unilateral right to extend the lease. There is no assurance that we will be able to renew the lease or that the rent we will be obligated to pay to secure such renewal will not be significantly above our current rent. Any failure to renew the lease will have a material adverse impact on our business. If the rent we are required to pay is substantially above the rent we are currently paying, unless we can increase our revenues, it will lead to a decrease in the net income derived from operating the hotel.

 

The operation of our hotel is subject to the business, financial and operating risks inherent to the hospitality industry, any of which could reduce the revenues derived at our hotel.

 

The operation of a hotel is subject to a number of business, financial and operating risks inherent to the hospitality industry.  These include significant competition from multiple hospitality providers in which compete for the business of our guests; the financial condition of the owner of the property on which our hotel is situated; decreases in business and leisure travel; changes in operating costs, including employee compensation and benefits, energy, insurance, food and beverage and other supplies; increases in costs due to inflation or other factors that may not be fully offset by increases in revenues in our business, as well as increases in overall prices and the prices of our offerings due to inflation, which could weaken consumer demand for travel and the products and services we offer and adversely affect our revenues; changes in taxes and governmental regulations that influence or increase our operating costs; the costs and administrative burdens associated with complying with applicable laws and regulations; significant increases in cost for health care coverage for employees and potential government regulation with respect to health care coverage; shortages of labor or labor disruptions; changes in the desirability of the region in which our hotel is located; changes in the supply and demand for hotel services, including rooms, food and beverage and other products and services; and the costs required for climate change initiatives, including those resulting from regulatory changes or stakeholder or customer expectations.

 

Any of these factors could increase our costs or limit or reduce the prices we are able to charge hotel customers for hospitality products and services, or otherwise affect our ability to maintain our hotel. As a result, any of these factors can reduce our revenues and limit opportunities for growth.

 

Our efforts to utilize our hotel in Chengdu City to conduct marketing events for customers and training sessions for our employees may not anticipated benefits.

 

We envision using the hotel we acquired in Chengdu City to conduct marketing events for our customers and training sessions for our personnel. These efforts may not result in increased sales and may not improve our ability to train our personnel.

 

The failure to maintain permits and licenses could adversely impact our operations.

 

The manufacture and distribution of food products, and the sale of food and beverages at our hotel, as well as other aspects of our business, require that we maintain various permits and licenses and conduct our operations in accordance with applicable safety requirements and other regulations. Should we be unable to renew any of our licenses and permits, it could have a material adverse effect on our results of operations and the profitability of our business, even if the disruption is for only a limited period of time.

 

We may incur material product liability claims, or experience product recalls, which could increase our costs and adversely affect our sales and margin, reputation, revenues and operating income.

 

As a retailer, distributor and manufacturer of products for human consumption, we are subject to product liability claims if the use of our products is alleged to result in injury. The products that we sell consist of minerals, herbs, supplements and other ingredients that are classified as foods or dietary supplements. The products that we sell could contain contaminated substances, and some of the products we sell contain ingredients that do not have long histories of human consumption. Previously unknown adverse reactions resulting from human consumption of these ingredients could occur.

 

In addition, third-party manufacturers produce many of the products we sell. We rely on these manufacturers to ensure the integrity of their ingredients and formulations. As a distributor of products manufactured by third parties, we may also be liable for various product liability claims for products we do not manufacture. Our ultimate liability for these products that are manufactured by third parties depends on a number of factors, including our contractual relationship with the vendor, the creditworthiness of the vendor and any insurance that we have. Therefore, we may be unable to adequately protect ourselves against claims with respect to products manufactured by a third-party.

 

We may be subject to product liability claims, including, among others, that our products include inadequate instructions for use or inadequate warnings concerning possible side effects and interactions with other substances. Product liability claims could significantly damage our reputation and consumer confidence in our products, regardless of the merits or outcomes of such claims. Our litigation expenses could increase as well, which also could have a material adverse effect on our results of operations even if a product liability claim is unsuccessful or is not fully pursued.

 

We may be subject to product recalls, withdrawals or seizures if any of the products we manufacture or sell are believed to be adulterated, cause injury or illness or if we are alleged to have violated governmental regulations in the manufacturing, labeling, promotion, sale or distribution of such products. A significant recall, withdrawal or seizure of any of the products may require significant management attention, would likely result in substantial and unexpected costs and may materially and adversely affect our business, financial condition or results of operations. Furthermore, a recall, withdrawal or seizure of any of the products that we sell may adversely affect consumer confidence in our brands and thus decrease consumer demand for such products.

 

If we fail to develop and protect our brand names and reputation, we may not attract and retain new customers, which could adversely affect our revenues and financial performance.

 

We will invest significant resources to promote our brand names to obtain favorable public recognition for us and our products. If we do not achieve the reputation we envision, we may not be able to attract and retain a significant customer base, which could in turn adversely affect our revenues, profitability and the market price of our common stock.

 

Our ability to adequately protect our trade names, trademarks and patents could have an impact on our brand images and ability to penetrate new markets.

 

We believe that trade names and trademarks will be an important aspect of our business and an essential element of our strategy. We have applied for the registration of many of our trade names, trademarks and patents in China. Some of these applications have been granted and some of these registrations are currently pending approval from the corresponding departments. There can be no assurance that we will obtain such registrations or that the registrations we obtain will prevent the imitation of our products or infringement of our intellectual property rights by others. In particular, the laws of the PRC may not protect proprietary rights to the same extent as the laws of the U.S. Claims that others are infringing our intellectual property would be costly and would divert the attention of management and key personnel. Our failure to successfully protect our trademarks could diminish the value and effectiveness of our past and future marketing efforts and could cause customer confusion. This could in turn adversely affect our revenues, profitability and the market price of our common stock.

 

16

 

 

Unfavorable publicity about us or consumer perception of our products, including the nutritional supplements we distribute, the ingredients they contain and any similar products distributed by other companies could cause fluctuations in our operating results and could have a material adverse effect on our reputation, the demand for our products and our ability to generate revenues and the market price of our common stock.

 

We are highly dependent upon consumer perception of the safety and quality of our products, including our nutritional supplements, and the ingredients they contain, as well as that of similar products distributed by other companies. Consumer perception of products and the ingredients they contain can be significantly influenced by scientific research, national media attention and other publicity, including that generated via social media. A research report or publicity related to our products and the ingredients they contain that is perceived by our consumers as less favorable or that questions earlier favorable research or publicity could have a material adverse effect on our ability to generate revenues. Adverse publicity in the form of published scientific research or otherwise, whether or not accurate, that associates consumption of our products or the ingredients they contain or similar products distributed by other companies with illness or other adverse effects, that questions the benefits of our or similar products, or that claims that such products are ineffective could have a material adverse effect on our reputation, the demand for our products, our ability to generate revenues and the market price of our common stock.

 

We may be subject to health or advertising claims related to our customers.

 

Our products do are not medical treatments and we do not provide or medical advice, and we do not engage physicians or nurses to monitor the progress of our customers. A customer who uses our products and experiences health problems could allege or bring a lawsuit against us on the basis that those problems were caused or worsened by using our products. Further, customers who allege that they were deceived by any statements that we made in advertising or labeling could bring a lawsuit against us under consumer protection laws. We may ultimately be unsuccessful in defending ourselves against such claims. Also, defending ourselves against such claims, regardless of their merit and ultimate outcome, may be lengthy and costly, and could adversely affect our brand image, customer loyalty and results of operations.

 

We rely on third parties to provide us with nutritional supplements, fulfillment, customer service and Internet and networking services, the loss of any of which could cause our revenue, earnings or reputation to suffer.

 

In addition to the nutritional supplements we manufacture, we rely on third-parties to supply us with additional manufacturer the nutritional supplements we sell. We do not know if our vendors vendor directly sells the same product under a different brand or provides their supplements to other parties under private label brands. In each of these instances, sales of the same product under different brands could cause us to lose revenues and adversely impact our abilities to market our products. While we believe we could locate replacement suppliers for all supplements we acquire from third parties, it would likely take time to engage replacement suppliers which could adversely impact our revenues during such transition period and there are no assurances our costs would not increase to a level which makes the product unattractive to our customers.

 

We depend on the services of key executives and other skilled professionals and our ability to attract, train and retain highly qualified associates. Any failure to attract or retain such individuals could affect our business strategy and adversely impact our performance and results of operations.

 

Our senior executives are instrumental in setting our strategic direction, operating our business, identifying, recruiting and training personnel, identifying opportunities, designing new products and arranging necessary financing. In addition, other key employees below the executive level, with deep knowledge of our business, are critical to the execution and success of our strategy. We must attract, train and retain a growing number of qualified individuals.

 

Losing the services of any of these groups of individuals could adversely affect our business and we may be unable to identify candidates of sufficient experience and capabilities in a timely fashion or at all, which could negatively impact our business and operations. Further, our ability to control labor and benefit costs is subject to numerous external factors, including regulatory changes, prevailing wage rates, and healthcare and other insurance costs. We compete with other retail and non-retail businesses for these store and field associates and invest significant resources in training and motivating them. There is no assurance that we will be able to attract or retain qualified store and field associates in the future, which could have a material adverse effect on our business, financial condition and results of operations.

 

Compliance with new and existing laws and governmental regulations could increase our costs significantly and adversely affect our results of operations.

 

The processing, formulation, safety, manufacturing, packaging, labeling, advertising and distribution of our products are subject to numerous Chinese laws and regulations as well as laws and regulations imposed by provincial and local governments and agencies. Government regulations may prevent or delay the introduction, or require the reformulation, of our products, which could result in lost revenues and increased costs to us. Manufacturers and distributors of health and wellness products and dietary supplements and dietary ingredients are prohibited from marketing products that are adulterated or misbranded, and the governing agencies may take enforcement action against any adulterated or misbranded health and wellness product or dietary supplement on the market. If we violate applicable regulatory requirements, we may be subject to enforcement actions against us, which could have a material adverse effect on our business, prospects, financial condition, and results of operations. The government may not accept the evidence of safety for any new product or ingredient we may wish to market, may determine that a particular product or ingredient presents an unacceptable health risk based on reported serious adverse events or other information, and may determine that a particular claim or statement of efficacy or nutritional value that we use to support the marketing of a product is not substantiated, or is an unauthorized version of a “health claim.” Any of these actions could prevent us from marketing particular products or making certain claims or statements with respect to those products. We could also be required to remove a particular product from the market. Any future recall or removal would result in costs to us, including lost revenues from any products that we are required to remove from the market, any of which could be material. Any product recalls or removals could also lead to an increased risk of litigation and liability, substantial costs, and reduced growth prospects.

 

17

 

 

Additional or more stringent laws and regulations of health and wellness products have been considered from time to time. These developments could require reformulation of some products to meet new standards, recalls or discontinuance of some products not able to be reformulated, additional record-keeping requirements, increased documentation of the properties of some products, additional or different labeling, additional scientific substantiation, or other new requirements. Any of these developments could increase our costs significantly. In addition, regulators’ evolving interpretation of existing laws could have similar effects.

 

We depend upon a limited number of suppliers for certain raw materials and any significant disruption to our timely receipt of raw materials and inventory could adversely impact sales and operations or increase our transportation costs, which would decrease our profits.

 

We depend upon a limited number of suppliers for the raw materials necessary to produce certain of our products. Unexpected delays in the deliveries of raw materials from our vendors or inventories or increases in transportation costs (including through increased fuel costs) could significantly decrease our ability to make sales and earn profits. We must maintain sufficient levels of raw materials and inventories to operate our business successfully. However, we also must guard against accumulating excess inventory. If we fail to anticipate accurately either the market for the merchandise we offer or our customers’ purchasing habits, we may be forced to rely on markdowns or promotional sales to dispose of excess or slow-moving inventory, which could have a material adverse effect on our business, financial condition, and results of operations.

 

In addition, sales of adulterated products received from third parties could result in a product liability judgment or a widespread product recall that may negatively impact our sales and profitability for a period of time depending on product availability, competition reaction and consumer attitudes. Even if the product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertions could adversely impact our reputation with existing and potential customers and our brand image.

 

Natural disasters (whether or not caused by climate change), unusually adverse weather conditions, pandemic outbreaks and terrorist acts in China and the response of the Chinese governments to such occurrences, could impair our ability to purchase, receive or replenish inventory or raw materials or cause customer traffic to decline, all of which could result in lost sales and otherwise adversely affect our financial performance.

 

The occurrence of one or more natural disasters, such as hurricanes, fires, floods and earthquakes (whether or not caused by climate change), unusually adverse weather conditions, pandemic outbreaks (including the recent outbreak of the coronavirus, or COVID-19) or terrorist acts in China and the response of the Chinese government to such occurrences, could adversely affect our operations and financial performance. To the extent these events result in the closure of one or more of our pharmacies, manufacturing facility or our corporate headquarters, or impact one or more of our key suppliers, our operations and financial performance could be materially adversely affected through lost sales. Such events could also cause a disruption in travel making it difficult for consumers to order our products, such as has happened as a result of lock-downs in Chengdu. In addition, these events could result in increases in fuel (or other energy) prices or a fuel shortage, the temporary lack of an adequate work force in a market, the temporary or long-term disruption in the supply of products from some suppliers, the temporary disruption in the transport of goods, the temporary reduction in the availability of products in our stores, expiration of inventory and disruption to our information systems.

 

18

 

 

We rely on third parties for the vast majority of our computing, storage, and other services related to our business. Any disruption of or interference with our use of the services of these third parties would negatively affect our operations and could seriously harm our business.

 

We rely upon third parties, including cloud based platforms and services, to process and store information and for online interactions with our customers. Any transition of the cloud services currently provided by the parties we rely upon to other platforms or to another cloud provider could be difficult to implement and would cause us to incur significant time and expense. Given this, any significant disruption of or interference with the cloud based services utilized by us, whether temporary, regular, or prolonged, would negatively impact our operations and our business would be seriously harmed.

 

As we increase the amount of personal and user data we store and process, we may become subject to complex and evolving laws, regulations, executive actions, rules, contractual obligations, policies, and other obligations regarding privacy, data protection, content, and other matters. Many of these obligations are subject to change and uncertain interpretations.

 

Currently, we collect, store, and use limited amounts of personal data and other sensitive information. As our business grows and we increase the amount of such data collect, store and use, we will become subject to a variety of laws, regulations, industry standards, policies, contractual requirements, executive actions, and other obligations relating to privacy, security, and data protection which are becoming increasingly stringent and subject to rapid change and uncertain interpretation. Preparing for and complying with these obligations could require us to devote significant resources. These obligations may necessitate changes to our services, information technologies, systems, and practices. In addition, these obligations may require us to change our business model.

 

Cyber-attacks could have a disruptive effect on our business.

 

From time to time we and our third-party service providers experience cyber-attacks, attempted and actual breaches of our or their information technology systems and networks or similar events, which could result in a loss of sensitive business or customer information, systems interruption or the disruption of our operations. The techniques that are used to obtain unauthorized access, disable or degrade service or sabotage systems change frequently and may be difficult to detect for long periods of time, we are accordingly unable to anticipate and prevent all data security incidents.

 

Even if we are fully compliant with legal standards and contractual or other requirements, we still may not be able to prevent security breaches involving sensitive data. The sophistication of efforts by hackers to gain unauthorized access to information systems has continued to increase in recent years and may continue to do so. Breaches, thefts, losses or fraudulent uses of customer, employee or company data could cause consumers to lose confidence in the security of our websites, mobile applications, point of sale systems and other information technology systems and, as a result of this loss in confidence, choose not to purchase from us. Such security breaches also could expose us to risks of data loss, business disruption, litigation, fines, regulatory charges and other costs or liabilities, any of which could adversely affect our business.

 

Our business may be materially adversely affected by global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the Israel-Hamas conflict.

 

Global markets are experiencing volatility and disruption as a result of the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the Israel-Hamas conflict. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

 

Any of the abovementioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect our business. The extent and duration of the ongoing conflicts, resulting sanctions and any related market disruptions are impossible to predict, but could be substantial, particularly if current or new sanctions continue for an extended period of time or if geopolitical tensions result in expanded military operations on a global scale. Any such disruptions may also have the effect of heightening many of the other risks described in this section. If these disruptions or other matters of global concern continue for an extensive period of time, our business may be materially adversely affected.

 

We may be impacted by our ability to attract, develop and retain qualified associates and manage labor-related costs.

 

We believe one of our competitive advantages is providing a positive, engaging and satisfying experience for each customer, which requires us to have highly trained and engaged associates. Our success depends in part upon our ability to attract, develop and retain a sufficient number of qualified associates to enable us to grow our customer base. The turnover rate in the health and wellness industry is generally high, and qualified individuals of the requisite caliber and number needed may be in short supply. Competition for such qualified individuals or changes in labor laws could require us to incur higher labor costs. Our inability to recruit a sufficient number of qualified individuals may delay the expansion of our customer base and our growth. Significant increases in associate turnover rates or significant increases in labor-related costs could have a material adverse effect on our results of operations, financial condition and cash flows.

 

Large and similar sized competitors could steal our market share by offering lower prices.

 

We endeavor to provide high quality service to our clients at the best possible price, however, large and similar sized competitors might steal some of our market share by offering lower prices, causing us to lose some of our clients which could have a material adverse effect on our results of operations, financial condition and cash flows.

 

Our insurance may not be sufficient.

 

We carry insurance that we consider adequate in regard to the nature of the covered risks and the costs of coverage. We are not fully insured against all possible risks, nor are all such risks insurable.

 

Our business depends on the continued contributions made by Mr. Quanzhong Lin, our key executive officer. The loss of his services may result in a severe impediment to our business.

 

Our success is dependent upon the continued contributions made by our CEO and President, Mr. Quanzhong Lin. The Company has no “Key Man” insurance to cover the resulting losses in the event that any of our officer or directors should die or resign.

 

If Mr. Lin cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives in a timely manner or at all. This would likely result in severe damage to our business operations and would have an adverse material impact on our financial position and operational results. To continue as a viable operation, the Company may have to recruit and train replacement personnel at a higher cost.

 

Our key executive does not devote his full business time to our operations.

 

Our President and Chief Executive Officer, Mr. Quanzhong Lin, is involved in a number of businesses and does not devote all of his working time to our business. Our positive reputation in Chengdu is derived from the standing of Mr. Lin in the Chengdu business community. If Mr. Lin does not devote sufficient time to our business, our operations could suffer, which would have an adverse material impact on our financial position and operational results.

 

Some of the other businesses engaged in by Mr. Lin could be deemed competitive with aspects of our business. Should such other businesses prove more successful than ours, Mr. Lin could choose to focus his attention on such businesses which could cause him to fail to devote sufficient attention to our business and our operations could suffer and our financial conditions and results of operations may be materially and adversely affected.

 

Our principal shareholder is not familiar with American business practices.

 

Mr. Quanzhong Lin, our founder and principal shareholder, is a citizen of the PRC and an active entrepreneur in Chengdu. Mr. Lin is not familiar with American business practices and is heavily influenced by the business culture in the PRC. There is a certain level of respect and prestige associated with being the Chinese principal of a company which is publicly traded in the U.S. Mr. Lin’s motivation for causing the business of AiXinZhonghong to become a part of a U.S. publicly-traded company may differ from those of American entrepreneurs and his values may cause him to operate the business differently than would an American entrepreneur which could have a material adverse effect on our results of operations, financial condition and cash flows

 

19

 

 

We may be adversely impacted by certain compliance or legal matters.

 

We, along with third parties with which we do business, are subject to complex compliance and litigation risks. The cost of defending against claims that might be brought against us or the ultimate resolution of such claims, whether by settlement or adverse court decision, may harm our business. Further, potential claimants may be encouraged to bring lawsuits based on a settlement from us or adverse court decisions against us. We cannot currently assess the likely outcome of such suits, but if the outcome were negative, it could have a material adverse effect on our reputation, results of operations, financial condition and cash flows.

 

In addition, we may be impacted by litigation trends, including class action lawsuits involving consumers and shareholders, that could have a material adverse effect on our reputation, the market price of our common stock, results of operations, financial condition and cash flows.

 

Failure to make adequate contributions to various employee benefits plans as required by PRC regulations may subject us to penalties.

 

Companies operating in China are required to participate in various government sponsored employee benefit plans, including certain social insurance, housing funds and other welfare-oriented payment obligations, and contribute to the plans in amounts equal to certain percentage of salaries, including bonuses and allowances, of employees up to a maximum amount specified by the local government from time to time at locations where they operate their businesses. The requirement of employee benefit plans has not been implemented consistently by the local governments in China given the different levels of economic development in different locations. Employers that fail to make adequate social insurance and housing provident fund contributions may be subject to late payment fees, fines and sanctions. If the relevant PRC authorities determine that we need to make supplemental contributions or that we are subject to late payment fees, fines or other legal sanctions, such as order of timely rectification, in relation to our failure to make social insurance and housing fund contributions in full for our employees, our business and financial condition may be adversely affected.

 

Our common stock may be delisted under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditors. The delisting of our common stock or the threat of their being delisted, may materially and adversely affect the value of your investment.

 

The HFCAA was enacted on December 18, 2020. The HFCAA states if the SEC determines that a company has filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit the securities of such company from being traded on a national securities exchange or in the over the counter trading market in the U.S. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act which, if enacted, would amend the HFCAA and require the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchange if its auditor is not subject to PCAOB inspections for two consecutive years instead of three.

 

On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. A company will be required to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to be subsequently established by the SEC. The SEC is assessing how to implement other requirements of the HFCAA, including the listing and trading prohibition requirements described above. On September 22, 2021, the PCAOB adopted a final rule implementing the HFCAA, which provides a framework for the PCAOB to use when determining whether the PCAOB is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. On December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the HFCAA. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that PCAOB is unable to inspect or investigate completely because of a position taken by an authority in foreign jurisdictions. On December 16, 2021, the PCAOB issued a Determination Report which found that the PCAOB is unable to inspect or investigate completely registered public accounting firms headquartered in: (i) China, and (ii) Hong Kong. On August 26, 2022, the CSRC, the Ministry of Finance of the PRC, and the PCAOB signed a Statement of Protocol, or the Protocol, governing inspections and investigations of audit firms based in China and Hong Kong. Pursuant to the Protocol, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the unfettered ability to transfer information to the SEC. Notwithstanding the foregoing, if the PCAOB is not able to inspect and investigate completely our auditor’s work papers in China, you may be deprived of the benefits of such inspection which could result in limitation or restriction to our access to the U.S. capital markets and trading of our securities may be prohibited under the HFCAA and Nasdaq may determine to delist our securities if the PCAOB determines that it cannot inspect or investigate completely our auditor under the HFCAA.

 

Our auditor is not headquartered in China or Hong Kong and was not identified in this report as a firm subject to the PCAOB’s determination.

 

20

 

 

The SEC may propose additional rules or guidance that could impact us if our auditor is not subject to PCAOB inspection. For example, on August 6, 2020, the President’s Working Group on Financial Markets, or the PWG, issued the Report on Protecting United States Investors from Significant Risks from Chinese Companies to the then President of the United States. This report recommended the SEC implement five recommendations to address companies from jurisdictions that do not provide the PCAOB with sufficient access to fulfil its statutory mandate. Some of the concepts of these recommendations were implemented with the enactment of the HFCAA. However, some of the recommendations were more stringent than the HFCAA. For example, if a company’s auditor was not subject to PCAOB inspection, the report recommended that the transition period before a company would be delisted would end on January 1, 2022.

 

The SEC has announced that the SEC staff is preparing a consolidated proposal for the rules regarding the implementation of the HFCAA and to address the recommendations in the PWG report. The implications of possible additional regulation in addition to the requirements of the HFCAA and what was recently adopted on December 2, 2021 are uncertain. While we understand that there has been dialogue among the CSRC, the SEC and the PCAOB regarding the inspection of PCAOB-registered accounting firms in China, there can be no assurance that we will be able to comply with requirements imposed by U.S. regulators. Such uncertainty could cause the market price of our common stock to be materially and adversely affected, and our securities could be delisted and prohibited from being traded on the national securities exchange earlier than would be required by the HFCAA. If our securities are unable to be listed on another securities exchange by then, such a delisting would substantially impair your ability to sell or purchase our common stock when you wish to do so, and the risk and uncertainty associated with a potential delisting would have a negative impact on the price of our common stock.

 

Further, new laws and regulations or changes in laws and regulations in both the United States and China could affect our ability to list our common stock on the Nasdaq Capital Market, which could materially impair the market for and market price of our common stock.

 

21

 

 

A joint statement by the SEC and the Public Company Accounting Oversight Board (United States), or the “PCAOB,” proposed rule changes submitted by Nasdaq, and the newly enacted “Holding Foreign Companies Accountable Act” and the Accelerating Holding Foreign Companies Accountable Act all call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments could add uncertainties to our offering.

 

On April 21, 2020, the SEC and the PCAOB released a joint statement highlighting the risks associated with investing in companies based in or having substantial operations in emerging markets including China. The joint statement emphasized the risks associated with lack of access for the PCAOB to inspect auditors and audit work papers in China and higher risks of fraud in emerging markets.

 

On May 18, 2020, Nasdaq filed three proposals with the SEC to (i) apply a minimum offering size requirement for companies primarily operating in a “Restrictive Market,” (ii) adopt a new requirement relating to the qualification of management or the board of directors for Restrictive Market companies, and (iii) apply additional and more stringent criteria to an applicant or listed company based on the qualifications of the company’s auditor. We are very likely to be deemed as a company primarily operating in a Restrictive Market under such proposed rules of Nasdaq. Therefore, Nasdaq might apply the additional and more stringent criteria for our initial and continued listing, which might cause delay or even denial of our listing application.

 

On December 18, 2020, the HFCAA was signed and became law. This legislation requires certain issuers of securities to establish that they are not owned or controlled by a foreign government. Specifically, an issuer must make this certification if the PCAOB is unable to audit specified reports because the issuer has retained a foreign public accounting firm not subject to inspection by the PCAOB. Furthermore, if the PCAOB is unable to inspect the issuer’s public accounting firm for three consecutive years, the issuer’s securities are banned from trade on a national exchange or through other methods. On December 29, 2022, the AHFCAA was enacted, which amended the HFCAA by decreasing the number of non-inspection years from three years to two, thus reducing the time period before our common stock may be prohibited from trading or delisted if the PCAOB were to determine that it could not inspect our auditor.

 

On March 24, 2021, the SEC announced that it had adopted interim final amendments to implement congressionally mandated submission and disclosure requirements of the HFCAA. The interim final amendments will apply to registrants that the SEC identifies as having filed an annual report on Forms 10-K, 20-F, 40-F or N-CSR with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB has determined it is unable to inspect or investigate completely because of a position taken by an authority in that jurisdiction. The SEC will implement a process for identifying such a registrant and any such identified registrant will be required to submit documentation to the SEC establishing that it is not owned or controlled by a governmental entity in that foreign jurisdiction, and will also require disclosure in the registrant’s annual report regarding the audit arrangements of, and governmental influence on, such a registrant.

 

On September 22, 2021, the PCAOB adopted rules to create a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether it is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction.

 

On December 2, 2021, the SEC issued amendments to finalize the interim final rules previously adopted in March 2021 to implement the submission and disclosure requirements in the HFCAA. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB is unable to inspect or investigate completely because of a position taken by an authority in a foreign jurisdiction.

 

22

 

 

On December 16, 2021, the PCAOB issued a Determination Report which found that the PCAOB was then unable to inspect or investigate completely registered public accounting firms headquartered in: (1) mainland China of the People’s Republic of China, because of a position taken by one or more authorities in mainland China; and (2) Hong Kong, a Special Administrative Region and dependency of the PRC, because of a position taken by one or more authorities in Hong Kong. The PCAOB has made such designations as mandated under the HFCAA. Pursuant to each annual determination by the PCAOB, the SEC will, on an annual basis, identify issuers that have used non-inspected audit firms and thus are at risk of such suspensions in the future.

 

On August 26, 2022, the CSRC, the Ministry of Finance of the PRC, and the PCAOB signed a Statement of Protocol, or the Protocol, governing inspections and investigations of audit firms based in China and Hong Kong. Pursuant to the Protocol, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the unfettered ability to transfer information to the SEC. On December 15, 2022, the PCAOB determined that the PCAOB was able to secure complete access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong and voted to vacate its previous determinations to the contrary. However, should PRC authorities obstruct or otherwise fail to facilitate the PCAOB’s access in the future, the PCAOB will consider the need to issue a new determination. Notwithstanding the foregoing, if the PCAOB is not able to inspect and investigate completely our auditor’s work papers in China, you may be deprived of the benefits of such inspection which could result in limitation or restriction to our access to the U.S. capital markets and trading of our securities may be prohibited under the HFCAA and Nasdaq may determine to delist our securities if the PCAOB determines that it cannot inspect or investigate completely our auditor under the HFCAA.

 

Our auditor, KCCW Accountancy Corp. (“KCCW CPA”), an independent public accounting firm registered with the PCAOB, and an auditor of publicly traded companies in the U.S., is subject to laws in the U.S. pursuant to which the PCAOB conducts regular inspections to assess its compliance with the applicable professional standards. Our auditor is based in the United States and has been inspected by the PCAOB on a regular basis, with the last inspection in 2022. Our auditor is not headquartered in mainland China or Hong Kong and was not identified as a firm subject to the determinations announced by the PCAOB on December 16, 2021. Nevertheless, should the PCAOB be unable to fully conduct inspection of our auditor’s work papers in China, it will make it difficult to evaluate the effectiveness of our auditor’s audit procedures or equity control procedures. Investors may consequently lose confidence in our reported financial information and procedures or quality of the financial statements, which would adversely affect us and our securities. Moreover, if trading in our securities is prohibited under the HFCAA in the future because the PCAOB determines that it cannot inspect or fully investigate our auditor at such future time, an exchange may determine to delist our securities.

 

There are uncertainties under the PRC Securities Law relating to the procedures and requisite timing for the U.S. securities regulatory agencies to conduct investigations and collect evidence within the territory of the PRC.

 

On December 28, 2019, the newly amended Securities Law of the PRC (the “PRC Securities Law”) was promulgated, which became effective on March 1, 2020. According to Article 177 of the PRC Securities Law (“Article 177”), the securities regulatory authority of the State Council may establish a regulatory cooperation mechanism with securities regulatory authorities of another country or region for the implementation of cross-border supervision and administration. Article 177 further provides that overseas securities regulatory authorities shall not engage in activities pertaining to investigations or evidence collection directly conducted within the territories of the PRC, and that no Chinese entities or individuals shall provide documents and information in connection with securities business activities to any organizations and/or persons aboard without the prior consent of the securities regulatory authority of the State Council and the competent departments of the State Council. As of the date of this prospectus, we are not aware of any implementing rules or regulations which have been published regarding application of Article 177.

 

As advised by our PRC Counsel, Article 177 is only applicable where the activities of overseas authorities constitute a direct investigation or evidence collection by such authorities within the territory of the PRC. Our principal business operation is conducted in the PRC. In the event that the U.S. securities regulatory agencies carry out an investigation on us such as an enforcement action by the Department of Justice, the SEC or other authorities, such agencies’ activities will constitute conducting an investigation or collecting evidence directly within the territory of the PRC and accordingly fall within the scope of Article 177. In that case, the U.S. securities regulatory agencies may have to consider establishing cross-border cooperation with the securities regulatory authority of the PRC by way of judicial assistance, diplomatic channels or establishing a regulatory cooperation mechanism with the securities regulatory authority of the PRC. However, there is no assurance that the U.S. securities regulatory agencies will succeed in establishing such cross-border cooperation in this particular case and/or establish such cooperation in a timely manner.

 

Furthermore, as the date of this prospectus, there have not been implementing rules or regulations regarding the application of Article 177, it remains unclear as to how it will be interpreted, implemented or applied by the Chinese Securities Regulatory Commission or other relevant government authorities. As such, there are uncertainties as to the procedures and requisite timing for the U.S. securities regulatory agencies to conduct investigations and collect evidence within the territory of the PRC. If the U.S. securities regulatory agencies are unable to conduct such investigations, there exists a risk that they may determine to suspend or de-register our registration with the SEC and may also delist our securities from the Nasdaq Capital Market or other applicable trading market within the US.

 

We could be subject to conflicting demands placed upon us by regulatory authorities in the United States and the PRC which could result in disciplinary actions if not resolved.

 

Article 26 of the Trial Measures issued by the CSRC on February 17, 2023 came into effect on March 31, 2023. Article 26 provides that if an overseas securities regulatory agency intends to conduct an investigation and collect evidence regarding an overseas offering or listing activities by a domestic company, and request assistance of the CSRC under relevant cross-border securities regulatory cooperation agreements, the CSRC may provide necessary assistance in accordance with the laws of the PRC. Any domestic entity or individual intending to provide documents and materials requested by an overseas securities regulatory agency in connection with an investigation may not provide such information without prior approval from the CSRC and competent authorities under the State Council. In addition, Article 11 of the Provisions on Strengthening Confidentiality and Archives Administration in Respect of Overseas Issuance and Listing of Securities by Domestic Enterprises which was jointly issued by the CSRC, the Ministry of Finance, the State Secrecy Administration and the State Archives Bureau on February 24, 2023 came into effect on March 31, 2023, and provides that, when an overseas securities regulator and the relevant competent authorities intends to conduct inspections or investigations to collect evidence from a domestic enterprise and any domestic securities firms and securities service agencies providing services regarding the overseas offering and listing activities of the domestic enterprise, the inspection or investigation shall be carried out under the appropriate cross-border regulatory cooperation agreement, and the CSRC or the relevant authorities shall provide the requisite assistance pursuant to the bilateral and multilateral cooperation mechanism. Further, any domestic company, securities firm and securities service agency shall obtain the consent of the CSRC or the relevant administrative authorities prior to cooperating in an inspection or investigation carried out by an overseas securities regulator or relevant administrative authorities or providing documents and materials for cooperating in the inspection or investigation.

 

As advised by our PRC Counsel, Article 26 and Article 11 are only applicable to information to be provided in response to a request made in connection with an investigation or other evidentiary collection proceeding instigated by a securities regulatory agency located outside of China. As this regulation has recently been adopted, clarifying regulations have not been issued and companies in China and their counsel generally have little experience in assessing when permission must be obtained before releasing information to a foreign regulatory agency. If the Company were to provide information to any securities regulatory agency in violation of Article 26 or Article 11, it would be subject to fines and, if the information were deemed a state secret, government work secret or might jeopardize the national security of China or the public interest, as provided in the Confidentiality and Archives Provisions, it could cause the Company or the individuals responsible for the disclosure to be subject to criminal investigation. Likewise, if the Company refuses to provide information requested by any U.S. securities regulatory agency in circumstances that the Company believes would have caused it to violate Article 26 or Article 11, it will be subject in the United States to fines, penalties or delisting from the Nasdaq Capital Market. While detailed interpretation of or implementation rules under Article 177, of Article 26 and Article 11 have yet to be promulgated, the inability of an overseas securities regulator to directly conduct an investigation or evidence collection activities within China may further increase difficulties that you may face in protecting your interests.

 

23

 

 

We are exposed to liabilities relating to environmental protection and safety laws and regulations.

 

Our operations are subject to comprehensive and frequently changing laws and regulations relating to environmental protection and health and safety. The discharge of waste and pollutants from our manufacturing operations into the environment may give rise to liabilities that may require us to incur costs to remedy such discharge. If we violate such laws or regulations, we may be required to implement corrective actions and could be subject to civil or criminal fines or penalties or other sanctions.

 

However, we cannot assure you that any environmental laws adopted in the future will not materially increase our operating costs and other expenses. We cannot assure you that we will not have to make significant capital or operating expenditures in the future in order to comply with existing or new laws and regulations or that we will comply with applicable environmental laws at all times. Such violations or liability could have a material adverse effect on our business, financial condition and results of operations.

 

We may require additional financing and our operations could be curtailed if we are unable to obtain required additional financing when needed.

 

We may need to obtain additional debt or equity financing to fund the immediate development of Yunnan Runcangsheng and future capital expenditures. While we do not anticipate seeking additional financing in the immediate future, any additional equity may result in dilution to the holders of our outstanding shares of capital stock. Additional debt financing may include conditions that would restrict our freedom to operate our business, such as conditions that:

 

  limit our ability to pay dividends or require us to seek consent for the payment of dividends;
     
  increase our vulnerability to general adverse economic and industry conditions;
     
  require us to dedicate a portion of our cash flow from operations to payments on our debt, thereby reducing the availability of our cash flow to fund capital expenditures, working capital and other general corporate purposes; and
     
  limit our flexibility in planning for, or reacting to, changes in our business and our industry.

 

We cannot guarantee that we will be able to obtain any additional financing on terms that are acceptable to us, or at all.

 

General Risks Associated with Business Operations in China

 

24

 

 

The PRC government has significant oversight and discretion over the conduct of a PRC company’s business operations or to exert control over any offering of securities conducted overseas and/or foreign investment in China-based issuers, and may intervene with or influence our operations, may limit or completely hinder our ability to offer or continue to offer securities to investors, and may cause the value of such securities to significantly decline or become worthless, as the government deems appropriate to further regulatory, political and societal goals.

 

The PRC government may intervene or influence our operations at any time, which could result in a material change in our operations and/or the value of our common stock. For example, the PRC government has recently published new policies that significantly affected certain industries such as the education and internet industries, and we cannot rule out the possibility that it will release regulations or policies regarding any industry that could adversely affect the business, financial condition and results of operations of our Company. Furthermore, the PRC government has also recently indicated an intent to exert more oversight and control over securities offerings and other capital markets activities that are conducted overseas and foreign investment in China-based companies. Any such action, once taken by the PRC government, could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or in extreme cases, become worthless.

 

The PRC government initiated a series of regulatory actions and statements to regulate business operations in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over China-based companies listed overseas using variable interest entity (“VIE”) structures, adopting new measures to extend the scope of cybersecurity reviews, and expanding anti-monopoly enforcement efforts. As confirmed by our PRC Counsel, we are not subject to cybersecurity review with the Cyberspace Administration of China, or CAC, given that we are not an operator of critical information infrastructure or an online platform operator as defined by the Measures for Cybersecurity Review (2021 version). See also “Risk Factors - General Risks Associated with Business Operations in China - Our business may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection.” In addition, as confirmed by our PRC Counsel, we are not subject to merger control review by China’s anti-monopoly enforcement agency due to the level of our revenues and the fact that we currently do not expect to propose or implement any acquisition of control of, or decisive influence over, any company with revenues within China of more than RMB400 million. Currently, these statements and regulatory actions have had no impact on our daily business operations, the ability to accept foreign investments or list our securities on a U.S. or other foreign exchange. Since these statements and regulatory actions are new, it is highly uncertain how soon legislative or administrative regulation making bodies will respond and what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated, if any, and the potential impact such modified or new laws and regulations will have on our daily business operation, the ability to accept foreign investments and list our securities on an U.S. or other foreign exchange.

 

25

 

 

The CSRC has released draft rules for China-based companies seeking to conduct initial public offerings in foreign markets. The Chinese government may exert more oversight and control over offerings that are conducted overseas and foreign investment in China-based issuers, which could significantly limit or completely hinder our ability to offer or continue to offer our common stock to investors and could cause the value of our common stock to significantly decline or become worthless.

 

On December 24, 2021, the CSRC released the Administrative Provisions of the State Council Regarding the Overseas Issuance and Listing of Securities by Domestic Enterprises (Draft for Comments) (the “Administrative Provisions”) and the Measures for the Overseas Issuance of Securities and Listing Record-Filings by Domestic Enterprises (Draft for Comments) (the “Measures”). The Administrative Provisions and Measures lay out the filing regulation arrangement for both direct and indirect overseas listing and clarify the determination criteria for indirect overseas listing in overseas markets. The Administrative Provisions and Measures, if enacted, may subject us to additional compliance requirement in the future. Any failure of us to fully comply with new regulatory requirements may significantly limit or completely hinder our ability to offer or continue to offer our common stock, cause significant disruption to our business operations, and severely damage our reputation, which would materially and adversely affect our financial condition and results of operations and cause our common stock shares to significantly decline in value or become worthless.

 

The CSRC has released the Trial Measures requiring Chinese domestic companies to complete filings with the CSRC if they complete an overseas offering and listing of their securities.

 

The Trial Measures, regulations for the filing-based administration of direct and indirect overseas securities offerings and listings by domestic companies incorporated in Mainland China went into effect March 31, 2023. The offering by us pursuant to this registration statement is deemed an indirect offering by the CSRC and we will need to fulfill filing obligations pursuant to the Trial Measures after we have completed this offering. If we were to fail to comply with the post-offering filing obligations imposed by the Trial Measures or make a misrepresentation, misleading statement or material omission in the materials we submit to the CSRC, the CSRC would have the right to order rectification, issue a warning and impose a fine on us of between RMB1 million and RMB10 million and issuing a warning to the parties responsible for such failure, misrepresentation or material omission and impose a fine on each of such individuals ranging from RMB500,000 to RMB5 million.

  

Any filings we make in accordance with the Trial Measures will provide the Chinese Government with additional information regarding our operations. Reviewing information we provide may cause the PRC government to exert oversight and control over our operations, securities offerings and other capital markets activities. Any such action could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or in extreme cases, become worthless.

 

The CSRC has released Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises which may limit the activities of or disclosures made by companies in the PRC which, directly or indirectly, list their securities overseas.

 

The Confidentiality and Archives Provisions came into effect March 31, 2023. The Confidentiality and Archives Provisions require, among other items, that PRC domestic enterprises seeking to offer and list securities in overseas markets, establish an archival system which will maintain the confidentiality of information in accordance with applicable laws and regulations. Further, if a PRC domestic enterprise plans, directly or indirectly, to release documents or provide material that contain state secrets or government work secrets, or that will jeopardize national security or the public interest, it must strictly comply with all relevant governmental procedures and obtain approval of the appropriate regulatory before doing so. Although our PRC Counsel has advised us that we are subject to the Confidentiality and Archives Provisions, we believe that none of the documents or materials we intend to provide to parties outside of the PRC contains materials that would require us to make any filing or obtain any approval of a Chinese regulatory authority. Nevertheless, the determination of whether information contains state secrets, government work secrets or jeopardizes national security or the public interest is subjective and any failure or perceived failure by us or our subsidiaries to comply with the confidentiality and archive administration requirements under the Confidentiality and Archives Provisions could cause us to be referred for criminal investigation and held liable for such violations by the authorities in China. Further, PRC regulatory authorities could use these regulations to limit our disclosures or interfere with our operations. Any determination that we have violated the Confidentiality and Archives Provisions or use of these provisions to limit our disclosures could cause the value of our common stock to significantly decline in value or become worthless.

 

You may have difficulty in effecting service of legal process or bringing actions in China against us or our management named in the prospectus based on foreign laws.

 

We are a Colorado company conducting our operations in China through wholly owned subsidiaries with direct equity ownership and most of our assets are and will be located outside the United States. Almost all of our operations will be conducted in China. In addition, nearly all of our officers and directors, including Quanzhong Lin, Huiliang Jiao and Tianfeng Li are PRC nationals and residents of China and all of their assets are located outside the United States. In addition, Yao-Te Wang is a resident of Taiwan and resides in Taiwan. Christopher Lee, our remaining director, resides outside of the United States for a significant portion of time. As a result, it may be difficult for you to effect service of process upon us or our directors and officers inside China or to bring actions against us or our management in China.

 

Shareholder claims that are common in the United States, including securities law class actions and fraud claims, generally are difficult to pursue as a matter of law or practicality in China. For example, in China, there are significant legal and other obstacles to obtaining information needed for shareholder investigations or litigation outside China or otherwise with respect to foreign entities. Although the local authorities in China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement cross-border supervision and administration, such regulatory cooperation with the securities regulatory authorities in the Unities States have not been efficient in the absence of mutual and practical cooperation mechanism. According to Article 177 of the PRC Securities Law which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC. Accordingly, without the consent of the competent PRC securities regulators and relevant authorities, no organization or individual may provide the documents and materials relating to securities business activities to overseas parties outside of the PRC.

 

You may have difficulty in enforcing foreign judgements in China against us or our management named in the prospectus.

 

China does not have treaties providing for the reciprocal recognition and enforcement of judgments of courts with the United States and many other countries and regions. Even judgements from countries that have an enforcement treaty with China are often not enforceable in China. Therefore, recognition and enforcement in China of judgments of a court in any non-PRC jurisdiction in relation to any matter not subject to a binding arbitration provision may be difficult or impossible.

 

It may also be difficult for you to enforce U.S. courts judgments based on violations of the civil liability provisions of the U.S. federal securities laws against us and our officers and directors, since most of them are residents of the PRC and those who are not residents of the PRC reside outside of the United States for all or a significant portion of time. In addition, there is uncertainty as to whether the courts of China would recognize or enforce judgments of U.S. courts.

 

Foreign exchange fluctuations may affect our business.

 

We accept payment for our products in RMB. Therefore, foreign exchange fluctuations may influence our business in unpredictable ways.

 

The value of the Renminbi against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in political and economic conditions and the foreign exchange policy adopted by the PRC government. For instance, in August 2015, the People’s Bank of China, or PBOC, changed the way it calculates the mid-point price of Renminbi against the U.S. dollar, requiring the market-makers who submit for reference rates to consider the previous day’s closing spot rate, foreign-exchange demand and supply as well as changes in major currency rates. In fiscal year 2019 and 2020, the value of the Renminbi depreciated by approximately 6.9% and 5.5% against the U.S. dollar, respectively. In fiscal year 2021 and 2022 the value of the Renminbi appreciated by approximately 7.4% and 3.2% against the U.S. dollar. It is difficult to predict how market forces or PRC or U.S. government policy, including any interest rate increases by the Federal Reserve, may impact the exchange rate between the Renminbi and the U.S. dollar in the future. There remains significant international pressure on the PRC government to adopt a more flexible currency policy, including from the U.S. government, which has threatened to label China as a “currency manipulator,” which could result in greater fluctuation of the Renminbi against the U.S. dollar.

 

26

 

 

A substantial percentage of our revenues and costs are denominated in Renminbi, and a significant portion of our assets are also denominated in Renminbi. We are a holding company and we rely on dividends, loans and other distributions on equity paid by our operating subsidiaries in China. Any significant fluctuations in the value of the Renminbi may materially and adversely affect our liquidity and cash flows. Appreciation of the U.S. dollar against the Renminbi would have a negative effect on the U.S. dollar amount we would receive. Conversely, to the extent that we need to convert U.S. dollars into Renminbi for our operations, appreciation of the Renminbi against the U.S. dollar would have an adverse effect on the Renminbi amount we would receive.

 

Inflation could pose a risk to our business.

 

Inflation is an important factor that must be considered as we move forward. A change in the rate of inflation could influence the profits that we generate from our business. When the rate of inflation rises, the operational costs of running our Company would increase, such as labor costs, raw materials and public utilities, affecting our ability to provide our services at competitive prices. An increase in the rate of inflation would force our clients to search for other service providers, causing us to lose business and revenue.

 

Changes in the policies, regulations, rules and the enforcement of laws of the PRC government may be quick with little advance notice and could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business.

 

The PRC’s economy is in a transition from a planned economy to a market oriented economy subject to five-year and annual plans adopted by the central government that set national economic development goals. Policies of the PRC government can have significant effects on the economic conditions of the PRC. The PRC government has confirmed that economic development will follow the model of a market economy. Under this direction, we believe that the PRC will continue to strengthen its economic and trading relationships with foreign countries and business development in the PRC will follow market forces. While we believe that this trend will continue, we cannot assure you that this will be the case. Changes in policies, regulations, rules and the enforcement of laws by the PRC government, which changes may be quick with little advance notice, could adversely affect our interests by. Although the PRC government has been pursuing economic reform policies for more than two decades, we cannot assure you that the government will continue to pursue such policies or that such policies may not be significantly altered, especially in the event of a change in leadership, social or political disruption, or other circumstances affecting the PRC’s political, economic and social environment.

 

There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations.

 

Most of our operations are conducted in the PRC, and are governed by PRC laws, rules and regulations. Our PRC Subsidiaries are subject to laws, rules and regulations applicable to foreign investment in China. The PRC legal system is a civil law system based on written statutes. Unlike the common law system, prior court decisions may be cited for reference but have limited precedential value.

 

In 1979, the PRC government began to promulgate a comprehensive system of laws, rules and regulations governing economic matters in general. However, China has not developed a fully integrated legal system, and recently enacted laws, rules and regulations may not sufficiently cover all aspects of economic activities in China or may be subject to significant degree of interpretation by PRC regulatory agencies and courts. In particular, because these laws, rules and regulations are relatively new, and because of the limited number of published decisions and the non-precedential nature of these decisions, and because the laws, rules and regulations often give the relevant regulator significant discretion in how to enforce them, the interpretation and enforcement of these laws, rules and regulations involve uncertainties and can be inconsistent and unpredictable. Therefore, it is possible that our existing operations may be found not to be in full compliance with relevant laws and regulations. In addition, the PRC legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or at all, and which may have a retroactive effect. As a result, we may not be aware of our violation of these policies and rules until after the occurrence of the violation.

 

27

 

 

Any administrative and court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention. Since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These uncertainties may impede our ability to enforce the contracts we have entered into and could materially and adversely affect our business, financial condition and results of operations.

 

PRC regulations regarding acquisitions impose significant regulatory approval and review requirements, which could make it more difficult for us to pursue growth through acquisitions.

 

Under the PRC Anti-Monopoly Law, companies undertaking acquisitions relating to businesses in China must notify the anti-monopoly enforcement agency in advance of any transaction where the parties’ revenues in the China market exceed certain thresholds and the buyer would obtain control of, or decisive influence over, the other party. In addition, on August 8, 2006, six PRC regulatory agencies, including the MOFCOM, the State-Owned Assets Supervision and Administration Commission, the State Administration of Taxation, the SAIC, the China Securities Regulatory Commission, or the CSRC, and the State Administration of Foreign Exchange, or SAFE, jointly adopted Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&A Rules, which came into effect on September 8, 2006 and was amended on June 22, 2009. Under the M&A Rules, the approval of MOFCOM must be obtained in circumstances where overseas companies established or controlled by PRC enterprises or residents acquire domestic companies affiliated with such PRC enterprises or residents. Applicable PRC laws, rules and regulations also require certain merger and acquisition transactions to be subject to security review.

 

While the approval of the China Securities Regulatory Commission under the M & A Rules is not currently required for this offering, it may be required in the future in connection with this offering under the M&A Rules and, if required, we cannot predict whether we will be able to obtain such approval.

 

The application of the M&A Rules remains unclear. According to the results of the searches conducted by our PRC Counsel on the official website of the CSRC and its administrative license processing hall (https://neris.csrc.gov.cn/alappl/home/guideH), at present, only one administrative license related to overseas public offering and listing is enacted, that is, “examination and approval of overseas public offering shares and listing (including additional issuance) of joint-stock companies”. Such examination and approval license requirements are only applicable to issuers which are formed as PRC joint-stock companies in China under PRC law. None of our operating PRC Subsidiaries is formed as a PRC joint-stock company in China, and as such, we do not believe that we need CSRC approval. We do not believe that the current PRC regulations and rules including China Securities Law require explicitly and directly that the overseas listing of foreign issuers who indirectly hold the rights and interests of Chinese domestic enterprises be examined and approved by the CSRC. If CSRC approval is required, it is uncertain whether it would be possible for us to obtain the approval. Any failure to obtain or delay in obtaining CSRC approval for this offering would subject us to sanctions imposed by the CSRC and other PRC regulatory agencies.

 

28

 

 

While the application of the M&A Rules remains unclear, we believe, based on the advice of our PRC Counsel, based on its understanding of the current PRC laws, regulations and rules, that the CSRC’s approval is not required for this offering. We neither received nor were denied permission from CSRC or other PRC government agencies to list our securities on the Nasdaq Capital Market and issue our securities to foreign investors.

 

There remains some uncertainty as to how the M&A Rules will be interpreted or implemented in the context of an overseas offering. We cannot assure you that relevant PRC government agencies, including the CSRC, would reach the same conclusion as we do. If it is determined that CSRC approval is required for this offering, we may face sanctions by the CSRC or other PRC regulatory agencies for failure to obtain or delay in obtaining CSRC approval for this offering. These sanctions may include fines and penalties on our operations in China, limitations on our operating privileges in China, delays in or restrictions on the repatriation of the proceeds from this offering into the PRC, restrictions on or prohibition of the payments or remittance of dividends by our subsidiaries in China, or other actions that could have a material and adverse effect on our business, financial condition, results of operations, reputation and prospects, as well as the trading price of our securities. The CSRC or other PRC regulatory agencies may also take actions requiring us, or making it advisable for us, to halt this offering before the settlement and delivery of the securities that we are offering. Consequently, if you engage in market trading or other activities in anticipation of and prior to the settlement and delivery of the securities we are offering, you would be doing so at the risk that the settlement and delivery may not occur. In addition, if the CSRC or other regulatory agencies later promulgate new rules or explanations requiring that we obtain their approvals for this offering, we may be unable to obtain a waiver of such approval requirements.

 

As of the date of this prospectus, we have not received any inquiry, notice, warning, sanctions or regulatory objection to this offering from the CSRC or any other PRC governmental authorities, and our PRC Subsidiaries have obtained all requisite permissions and approvals from PRC governmental authorities to operate our business as currently conducted under relevant PRC laws and regulations.

 

As of the date of this prospectus, none of our PRC Subsidiaries has been denied or punished by relevant governmental authorities due to its business qualifications.

 

Our business may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection.

 

Our business may be subject to PRC laws relating to the collection, use, sharing, retention, security, and transfer of confidential and private information, such as personal information and other data. These laws continue to develop, and the PRC government may adopt other rules and regulations in the future. Non-compliance could result in penalties or other significant legal liabilities.

 

Pursuant to the PRC Cybersecurity Law, which was promulgated by the Standing Committee of the National People’s Congress on November 7, 2016 and took effect on June 1, 2017, personal information and important data collected and generated by a critical information infrastructure operator in the course of its operations in China must be stored in China, and if a critical information infrastructure operator purchases internet products and services that affects or may affect national security, it should be subject to cybersecurity review by the Cyberspace Administration of China (“CAC”). Due to the lack of further interpretations, the exact scope of “critical information infrastructure operator” remains unclear.

 

29

 

 

On December 28, 2021, twelve Chinese government agencies jointly promulgated the Measures for Cybersecurity Review, which became effective on February 15, 2022, set forth the cybersecurity review mechanism for critical information infrastructure operators, and provided that critical information infrastructure operators who intend to purchase internet products and services that affect or may affect national security shall be subject to a cybersecurity review. On June 10, 2021, the Standing Committee of the National People’s Congress promulgated the PRC Data Security Law, which took effect in September 2021. The Data Security Law provides for a security review procedure for data activities that may affect national security. Moreover, the State Internet Information Office issued the Measures of Cybersecurity Review (Revised Draft for Comments, not yet effective) on July 10, 2021, which requires operators with personal information of more than 1 million users who want to list abroad to file a cybersecurity review with the CAC. Furthermore, the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued the Opinions on Severe and Lawful Crackdown on Illegal Securities Activities, which was available to the public on July 6, 2021. These opinions emphasized the need to strengthen the administration over illegal securities activities and the supervision of overseas listings by China-based companies. These opinions proposed to take effective measures, such as promoting the construction of relevant regulatory systems, to deal with the risks and incidents facing China-based overseas-listed companies and the demand for cybersecurity and data privacy protection. As these laws, opinions and the draft measures were recently issued, official guidance and interpretation of these remain unclear in several respects at this time, and the PRC government authorities have wide discretion in the interpretation and enforcement of these laws, opinions and draft measures. Therefore, it is uncertain whether the future regulatory changes would impose additional restrictions on our business.

 

The Data Security Law also sets forth the data security protection obligations for entities and individuals handling personal data, including that no entity or individual may acquire such data by stealing or other illegal means, and the collection and use of such data should not exceed the necessary limits The costs of compliance with, and other burdens imposed by, PRC Cybersecurity Law and any other cybersecurity and related laws may limit the utility of our internet sales channel of distribution and could have an adverse impact on our business. Further, if the enacted version of the Measures for Cybersecurity Review mandates clearance of cybersecurity review and other specific actions to be completed by companies like us, we face uncertainties as to whether such clearance can be timely obtained, or at all.

 

As confirmed by our PRC Counsel, we are not subject to the cybersecurity review by the CAC for this offering, given that we are not an operator of critical information infrastructure or an online platform operator as defined by the Measures for Cybersecurity Review (2021 version). However, there remains uncertainty as to how the Draft Measures will be interpreted or implemented and whether the PRC regulatory agencies, including the CAC, may adopt new laws, regulations, rules, or detailed implementation and interpretation related to the Draft Measures. If any such new laws, regulations, rules, or implementation and interpretation comes into effect, we will take all reasonable measures and actions to comply and to minimize the adverse effect of such laws on us.

 

We cannot assure you that PRC regulatory agencies, including the CAC, would take the same view as we do, and there is no assurance that we can fully or timely comply with such laws. In the event that we are subject to any mandatory cybersecurity review and other specific actions required by the CAC, we face uncertainty as to whether any clearance or other required actions can be timely completed, or at all. Given such uncertainty, we may be further required to shut down our website, or face other penalties, which could materially and adversely affect our business, financial condition, and results of operations.

 

30

 

 

PRC regulations relating to investments in offshore companies by PRC residents may subject our PRC-resident beneficial owners or our PRC Subsidiaries to liability or penalties, limit our ability to inject capital into our PRC Subsidiaries or limit our PRC Subsidiaries’ ability to increase their registered capital or distribute profits.

 

SAFE promulgated the Circular on Relevant Issues Concerning Foreign Exchange Control on Domestic Residents’ Offshore Investment and Financing and Roundtrip Investment through Special Purpose Vehicles, or SAFE Circular 37, on July 4, 2014, which replaced the former circular commonly known as “SAFE Circular 75.” SAFE Circular 37 requires PRC residents to register with local branches of SAFE in connection with their direct establishment or indirect control of an offshore entity, for the purpose of overseas investment and financing, with such PRC residents’ legally owned assets or equity interests in domestic enterprises or offshore assets or interests, referred to in SAFE Circular 37 as a “special purpose vehicle.” SAFE Circular 37 further requires amendment to the registration in the event of any significant changes with respect to the special purpose vehicle, such as changes in capital contributed by PRC individuals, share transfers or exchanges, mergers, divisions or other material events. In the event that a PRC shareholder holding interests in a special purpose vehicle fails to fulfill the required SAFE registration, the PRC Subsidiaries of that special purpose vehicle may be prohibited from making profit distributions to the offshore parent and from carrying out subsequent cross-border foreign exchange activities, and the special purpose vehicle may be restricted in its ability to contribute additional capital into its PRC Subsidiaries. Moreover, failure to comply with the various SAFE registration requirements could result in liability under PRC law for evasion of foreign exchange controls.

 

As we have little control over the registration procedures, we cannot assure you of the outcome of such registration, and we cannot assure you that any of our shareholders who are PRC residents will submit the required registration or amend or update their registration as required under Circular 37 and the Notice of the State Administration of Foreign Exchange on Further Simplifying and Improving the Foreign Exchange Administration Policies for Direct Investment [Hui Fa (2015) No.13] issued by SAFE with effect from June 1, 2015, or SAFE Notice 13, in a timely manner or at all. In addition, we may not be aware of the identities of all of our beneficial owners who are PRC residents. We do not have control over our beneficial owners and cannot assure you that all of our PRC-resident beneficial owners will comply with SAFE Circular 37 and subsequent implementation rules. The failure of our current and future beneficial owners who are PRC residents to register or amend their SAFE registrations in a timely manner pursuant to SAFE Circular 37 and subsequent implementation rules, may subject the beneficial owners or our PRC Subsidiaries to fines and legal sanctions. On February 13, 2015, SAFE promulgated a Notice on Further Simplifying and Improving Foreign Exchange Administration Policy on Direct Investment, or SAFE Notice 13, which became effective on June 1, 2015. Pursuant to SAFE Notice 13, entities and individuals are required to apply for foreign exchange registration of foreign direct investment and overseas direct investment, including those required under the SAFE Circular 37, with designated domestic banks, instead of SAFE. The designated domestic banks will directly review the applications and conduct the registration.

 

Furthermore, since it is unclear how the new SAFE regulations, and any future regulation concerning offshore or cross-border transactions, will be interpreted, amended and implemented by the relevant PRC government authorities, we cannot predict how these regulations will affect our business operations or future strategy. Failure to register or comply with relevant requirements may also limit our ability to contribute additional capital to our PRC Subsidiaries and limit our PRC Subsidiaries’ ability to distribute dividends to our Company. These risks may have a material adverse effect on our business, financial condition and results of operations.

 

We may be treated as a resident enterprise for PRC tax purposes under the PRC Enterprise Income Tax Law, and we may therefore be subject to PRC income tax on our global income.

 

Under the PRC Enterprise Income Tax Law and its implementing rules, both of which came into effect on January 1, 2008, enterprises established under the laws of jurisdictions outside of China with “de facto management bodies” located in China may be considered PRC tax resident enterprises for tax purposes and may be subject to the PRC enterprise income tax at the rate of 25% on their global income. “De facto management body” refers to a managing body that exercises substantive and overall management and control over the production and business, personnel, accounting books and assets of an enterprise. The State Administration of Taxation issued the Notice Regarding the Determination of Chinese-Controlled Offshore-Incorporated Enterprises as PRC Tax Resident Enterprises on the basis of de facto management bodies, or Circular 82, on April 22, 2009. Circular 82 provides certain specific criteria for determining whether the “de facto management body” of a Chinese-controlled offshore-incorporated enterprise is located in China. Although Circular 82 only applies to offshore enterprises controlled by PRC enterprises, not those controlled by foreign enterprises or individuals, the determining criteria set forth in Circular 82 may reflect the State Administration of Taxation’s general position on how the “de facto management body” test should be applied in determining the tax resident status of offshore enterprises, regardless of whether they are controlled by PRC enterprises. If we, AiXin Colorado and AiXin BVI, were to be considered a PRC resident enterprise, we would be subject to PRC enterprise income tax at the rate of 25% on our global income. In such case, our profitability and cash flow may be materially reduced as a result of our global income being taxed under the Enterprise Income Tax Law. We believe that none of our entities outside of China is a PRC resident enterprise for PRC tax purposes. However, the tax resident status of an enterprise is subject to determination by the PRC tax authorities and uncertainties remain with respect to the interpretation of the term “de facto management body.”

 

31

 

 

Restrictions on currency exchange may limit our ability to utilize our PRC revenue effectively.

 

We (AiXin Colorado) are a Colorado holding company with no material operations of our own. We conduct substantially all of our operations through the operating companies established in the PRC. We are a holding company and do not directly own any substantive business operations in China. Substantially all of our revenue is denominated in Renminbi. The Renminbi is currently convertible under the “current account,” which includes dividends, trade and service-related foreign exchange transactions, but requires approval from or registration with appropriate government authorities or designated banks under the “capital account,” which includes foreign direct investment and loans, including loans we may secure from our onshore subsidiaries.

 

The relevant PRC governmental authorities or the local bank may limit or eliminate our ability to purchase foreign currencies in the future for current account transactions.

 

Since 2016, PRC governmental authorities have imposed more stringent restrictions on outbound capital flows, including heightened scrutiny over “irrational” overseas investments for certain industries, as well as over four kinds of “abnormal” offshore investments, which are:

 

● investments through enterprises established for only a few months without substantive operation;

 

● investments with amounts far exceeding the registered capital of the onshore parent and not supported by its business performance shown on financial statements;

 

● investments in targets which are unrelated to an onshore parent’s main business; and

 

● investments with abnormal sources of Renminbi funding suspected to be involved in illegal transfer of assets or illegal operation of underground banking.

 

On January 26, 2017, SAFE promulgated the Circular on Further Improving Reform of Foreign Exchange Administration and Optimizing Genuineness and Compliance Verification, which tightened the authenticity and compliance verification of cross-border transactions and cross-border capital flow, including requiring banks to verify board resolutions, tax filing forms and audited financial statements before wiring foreign invested enterprises’ foreign exchange dividend distribution of over US$50,000. In addition, the Outbound Investment Sensitive Industry Catalogue (2018) lists certain sensitive industries that are subject to NDRC pre-approval requirements prior to remitting investment funds offshore, which subjects us to increased approval requirements and restrictions should we have overseas investments. Since a significant amount of our PRC revenue is denominated in Renminbi, any existing and future restrictions on currency exchange may limit our ability to utilize revenue generated in Renminbi to fund our business activities outside of the PRC, make investments, service any debt we may incur outside of China or pay dividends in foreign currencies to our shareholders.

 

Fluctuations in foreign exchange rates will impact our reported results.

 

The functional currency utilized by our PRC Subsidiaries is the RMB. Our financial results are reported in U.S. Dollars. Therefore, foreign exchange fluctuations will impact the reporting of our financial results and significant fluctuations in the value of the RMB relative to the U.S. Dollar may materially and adversely affect our financial results as reported in our filings with the SEC. Such variations in our perceived operating results may increase the volatility in the market for our common stock.

 

The disclosures in our reports and other filings with the SEC and our other public pronouncements are not subject to the scrutiny of any regulatory bodies in the PRC.

 

We are subject to the regulations of the SEC and our reports and other filings with the SEC are subject to SEC review in accordance with the rules and regulations promulgated by the SEC under the Securities Act and the Exchange Act. Our SEC reports and other disclosure and public pronouncements are not subject to the review or scrutiny of any PRC regulatory authority. For example, the disclosure in our SEC reports and other filings are not subject to the review by China Securities Regulatory Commission, a PRC regulator that is responsible for oversight of the capital markets in China. Accordingly, you should review our SEC reports, filings and our other public pronouncements with the understanding that no local regulator has done any review of us, our SEC reports, other filings or any of our other public pronouncements.

 

32

 

 

Introduction of new laws or changes to existing laws by the PRC government may adversely affect our business.

 

The PRC legal system is a codified legal system made up of written laws, regulations, circulars, administrative directives and internal guidelines. Unlike common law jurisdictions like the U.S., decided cases (which may be taken as reference) do not form part of the legal structure of the PRC and thus have no binding effect on subsequent cases with similar issues and fact patterns. Furthermore, in line with its transformation from a centrally-planned economy to a more free market-oriented economy, the PRC government is still in the process of developing a comprehensive set of laws and regulations. As the legal system in the PRC is still evolving, laws and regulations or the interpretation of the same may be subject to further changes. For example, the PRC government may impose more stringent environmental regulations which would affect our ability to comply with, or our costs to comply with, such regulations. Such changes, if implemented, may adversely affect our business operations and may reduce our profitability.

 

Risks Relating to Our Holding Company Structure

 

Substantial uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact the viability of our current corporate structure, corporate governance and business operations.

 

On March 15, 2019, the PRC National People’s Congress approved the Foreign Investment Law, which came into effect on January 1, 2020 and replaced existing laws regulating foreign investment in the PRC and become the legal foundation for foreign investment in the PRC. Meanwhile, the Implementation Regulation of the Foreign Investment Law and the Measures for Reporting of Information on Foreign Investment came into effect as of January 1, 2020, which clarified and elaborated the relevant provisions of the Foreign Investment Law.

 

The Foreign Investment Law sets out the basic regulatory framework for foreign investments and proposes to implement a system of pre-entry national treatment with a restricted list for foreign investments, pursuant to which (i) foreign entities and individuals are prohibited from investing in the areas that are not open to foreign investments, (ii) foreign investments in the restricted industries must satisfy certain requirements under the law, and (iii) foreign investments in business sectors outside of the restricted list will be treated equally with domestic investments. The Foreign Investment Law also sets forth necessary mechanisms to facilitate, protect and manage foreign investments and proposes to establish a foreign investment information reporting system, through which foreign investors or foreign-invested enterprises are required to submit initial report, report of changes, report of deregistration and annual report relating to their investments to the Ministry of Commerce, or MOFCOM, or its local branches.

 

Although our operating structure is legal and permissible under the current Chinese law and regulations, including the Foreign Investment Law, Chinese regulatory authorities could disallow our operating structure, which would likely result in a material change in our operations and/or could cause the value of our common stock to significantly decline or become worthless.

 

We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC Subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.

 

We are a Colorado holding company and we rely on dividends and other distributions on equity paid by our PRC Subsidiaries and loans between us and our PRC Subsidiaries to fund any cash and financing requirements we or any of our PRC Subsidiaries may have, including for the payment of dividends to our investors, the shareholders of AiXin Colorado. Any limitation on the ability of our PRC Subsidiaries to make payments to or transfer funds to us or our other PRC Subsidiaries could have a material and adverse effect on our ability to conduct our business and the ability of our PRC Subsidiaries to conduct their respective businesses. If our PRC Subsidiaries incur debt, the instruments governing the debt may restrict their ability to pay dividends or make other distributions to us. Under PRC laws and regulations, our PRC Subsidiaries may pay dividends only out of their respective accumulated profits as determined in accordance with PRC accounting standards and regulations. In addition, each of our PRC Subsidiaries is required to set aside at least 10% of its accumulated after-tax profits each year, if any, to fund a certain statutory reserve fund, until the aggregate amount of such fund reaches 50% of its registered capital. Such reserve funds cannot be distributed to us as dividends. At its discretion, each of our PRC Subsidiaries may allocate a portion of its after-tax profits based on PRC accounting standards to an enterprise expansion fund, or a staff welfare and bonus fund.

 

As of the date hereof, we have had no transactions that involved the transfer of cash or assets throughout our corporate structure. None of our Chinese Operating Companies has distributed any cash or other assets to AiXin HK, including by way of dividends or interest payments and AiXin Colorado has not transferred any cash or other assets to any of our PRC Subsidiaries. As of the date hereof, no transfers, dividends or distributions have been made to our investors. To the extent our cash or other assets is in one of our Chinese Operating Companies or AiXin HK, the funds or assets may not be available to fund operations or for use outside of mainland China or Hong Kong including for the payment of dividends to the shareholders of AiXin Life, due to interventions by the governments of PRC or Hong Kong, or the imposition of restrictions and limitations on the ability of the PRC Subsidiaries to use such cash or assets imposed by the government of mainland China or Hong Kong.

 

33

 

 

The PRC government may continue to strengthen its capital controls, and more restrictions and substantial vetting processes may be put forward by SAFE for cross-border transactions falling under both the current account and the capital account. Any limitation on the ability of our PRC Subsidiaries to pay dividends or make other kinds of payments to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our business, pay dividends, or otherwise fund and conduct our business.

 

Except for such limitations on our Company’s ability to transfer cash and other assets among our entities currently or hereafter imposed by the governments of the PRC and Hong Kong, there are no limitations on our Company’s ability to transfer cash and other assets through our corporate structure. Our Company does not have any cash management policies with respect to the transfer of cash among our entities other than requirements for the approval of management for transfers in excess of specified amounts and none of our entities is currently party to any debenture, loan or other agreement which imposes restrictions or otherwise limits our Company’s ability to transfer our cash and other assets and we have not adopted any policies that dictate how funds are transferred other than as necessary to comply with applicable laws. See “Prospectus Summary - Transfers of Cash to and from our Subsidiaries.”

 

In addition, the Enterprise Income Tax Law and its implementation rules provide that a withholding tax rate of up to 10% will be applicable to dividends payable by Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties or arrangements between the PRC central government and governments of other countries or regions where the non-PRC-resident enterprises are incorporated.

 

PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay or prevent us from using the proceeds of this offering to make loans or additional capital contributions to our PRC Subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business.

 

We are an offshore holding company conducting our operations in China through our PRC Subsidiaries. We may make loans or provide guarantees for the benefit of our PRC Subsidiaries subject to the approval of or registration with governmental authorities and limitations of the amount, or we may make additional capital contributions to our PRC Subsidiaries. Any loans to our PRC Subsidiaries, which are treated as foreign-invested enterprises under PRC law, are subject to foreign exchange loan registrations. In addition, a foreign-invested enterprise, or FIE, shall use its capital pursuant to the principle of authenticity and self-use within its business scope. The capital of an FIE shall not be used for the following purposes: (i) directly or indirectly for payments beyond the business scope of the enterprise or payments prohibited by relevant laws and regulations; (ii) directly or indirectly for investments in securities or investments other than in banks’ principal-secured products unless otherwise provided by relevant laws and regulations; (iii) the granting of loans to non-affiliated enterprises, except where it is expressly permitted in the business license; and (iv) paying the expenses related to the purchase of real estate that is not for self-use (except for foreign-invested real estate enterprises).

 

In light of the requirements imposed by PRC regulations on loans to and direct investments in PRC entities by offshore holding companies, we cannot assure you that we will be able to complete the necessary government registrations or obtain the necessary government approvals on a timely basis, if at all, with respect to future loans by us to our PRC Subsidiaries or with respect to future capital contributions by us to our PRC Subsidiaries. If we fail to complete such registrations or obtain such approvals, our ability to use the proceeds from this offering and to capitalize or otherwise fund our PRC operations may be negatively affected, which could materially and adversely affect our liquidity and our ability to fund and expand our business.

 

Risks Related to this Offering and our Common Stock

 

Prior to this offering, we had a limited public market for our common stock and you may not be able to resell our shares at or above the price you paid or at all.

 

Prior to this offering, there was a limited public market for our common stock in the OTCQB. On many days during the years ended December 31, 2022, and 2023, and to date in 2024, no shares were traded. We cannot assure you that an active public market for our common stock will develop or that the market price of our shares will not decline below the public offering price. The public offering price of our shares may not be indicative of prices that will prevail in the trading market following the offering.

 

34

 

 

An active trading market for our common stock may not develop and the trading price for our common stock may fluctuate significantly.

 

We have applied to have our common stock approved for listing on the Nasdaq Capital Market. Prior to the completion of this offering, there has not been an active public market for our common stock, and we cannot assure you that a liquid public market for our common stock will develop even if it is listed on the Nasdaq Capital Market. The public offering price for our common stock offered hereby was determined by negotiation between us and the underwriter based upon several factors, and we can provide no assurance that the trading price of our common stock after this offering will not decline below the public offering price. As a result, investors in our securities may experience a significant decrease in the value of their common stock.

 

Nasdaq may apply additional and more stringent criteria for our initial and continued listing because we plan to have a small public offering and insiders will hold a large portion of our listed securities.

 

Nasdaq Listing Rule 5101 provides Nasdaq with broad discretionary authority over the initial and continued listing of securities in Nasdaq and Nasdaq may use such discretion to deny initial listing, apply additional or more stringent criteria for the initial or continued listing of particular securities, or suspend or delist particular securities based on any event, condition, or circumstance that exists or occurs that makes initial or continued listing of the securities on Nasdaq inadvisable or unwarranted in the opinion of Nasdaq, even though the securities meet all enumerated criteria for initial or continued listing on Nasdaq. In addition, Nasdaq has used its discretion to deny initial or continued listing or to apply additional and more stringent criteria in the instances, including but not limited to: (i) where the company engaged an auditor that has not been subject to an inspection by PCAOB, an auditor that PCAOB cannot inspect, or an auditor that has not demonstrated sufficient resources, geographic reach, or experience to adequately perform the company’s audit; (ii) where the company planned a small public offering, which would result in insiders holding a large portion of the company’s listed securities and Nasdaq was concerned that the offering size was insufficient to establish the company’s initial valuation, and there would not be sufficient liquidity to support a public market for the company; and (iii) where the company did not demonstrate sufficient nexus to the U.S. capital market, including having no U.S. shareholders, operations, or members of the board of directors or management. Nasdaq might apply the additional and more stringent criteria for our initial and continued listing, which might cause delay or even denial of our listing application.

 

The market price of securities of certain small cap companies, including companies whose operations are based in China, have been highly volatile and have raised the concerns of market regulators and if our common stock were to have such high volatility could cause Nasdaq to temporarily halt trading in or delist our securities.

 

The market prices of certain small cap companies, including companies whose operations are based in China, recently have been highly volatile. Such volatility in the market price of our common stock may cause Nasdaq, under the authority of Listing Rule 5101, to halt trading in our common stock or apply additional or more stringent criteria for the continued listing of our common stock, assuming initial listing is granted, even though our common stock then meets all enumerated criteria for initial or continued listing on the Nasdaq Capital Market.

 

If a limited number of participants in this offering purchase a significant percentage of the offering, the effective public float may be smaller than anticipated and the trading price of our common stock may be volatile which could subject us to securities litigation and make it more difficult for you to sell your shares and could cause Nasdaq to temporarily halt trading in or delist our common stock.

 

The market prices of certain small cap companies, including companies whose operations are based in China, recently have been highly volatile. As a company conducting a public offering, we are subject to the risk that a small number of investors will purchase a high percentage of the offering. We have not imposed any obligations on the underwriter as to the maximum number of shares it may place with individual investors. If, in the course of marketing the offering, the underwriter was to determine that demand for our shares was concentrated in a limited number of investors and such investors determined to hold their shares after the offering rather than trade them in the market, other shareholders could find the trading and price of our shares affected (positively or negatively) by the limited availability of our shares. If this were to happen, investors could find our shares to be more volatile than they might otherwise anticipate. Companies that experience such volatility in their share price may be more likely to be the subject of securities litigation. In addition, if a large portion of our public float were to be held by a few investors, smaller investors may find it more difficult to sell their shares. Further, such volatility in the market price of our common stock could cause Nasdaq, under the authority of Listing Rule 5101, to halt trading in our common stock or apply additional or more stringent criteria for the continued listing of our common stock, assuming initial listing is granted, even though our common stock then meets all enumerated criteria for initial or continued listing on the Nasdaq Capital Market.

 

35

 

 

The trading price of our common stock has been volatile.

 

The trading price for our common stock varied during the twelve-month period ended December 31, 2023, between a high of $11.00 on April 13, 2023 and a low of $1.00 on November 20, 2023. The last reported trade in our common stock on February 8, 2024, was $0.50. Our stock price is likely to continue to be volatile and subject to significant price and volume fluctuations in response to market and other factors. In addition, a substantial decline in the price of our securities that persists for a significant period of time could cause our securities to be delisted from the Nasdaq Capital Market, further reducing market liquidity. If an active market for our securities does not develop or cannot be sustained, the liquidity of an investor’s investment may be limited, and the price of our securities may decline. If an active market does not exist, investors may lose their entire investment. As a result of any of these factors, the market price of our securities at any given point in time may not accurately reflect our long-term value.

 

The market price of our shares is likely to be highly volatile, which could result in substantial losses to investors.

 

The trading price of our common stock may be volatile and could fluctuate widely due to factors beyond our control. This may happen because of the broad market and industry factors, like the performance and fluctuation of the market prices of other companies with business operations located mainly in China that have listed their securities in the United States. The securities of some companies with operations in China and securities listed in the United States have experienced significant volatility, including price declines in connection with their initial public offerings. The trading performance of these Chinese companies’ securities after their offerings may affect the attitudes of investors toward Chinese companies listed in the United States, including those of investors based in China, in general and consequently may impact the trading performance of our common stock, regardless of our actual operating performance. Such volatility in the price of our common stock including any stock-run up, may be unrelated to our actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our common stock.

 

In addition to market and industry factors, the trading price and volume of our common stock may be highly volatile due to factors specific to our operations, including the following:

 

variations in our actual and perceived operating results;
   
news regarding gains or losses of customers or partners by us or our competitors;
   
news regarding gains or losses of key personnel by us or our competitors;
   
announcements of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;
   
changes in earnings estimates or buy/sell recommendations by financial analysts;
   
potential litigation;
   
the imposition of fines or penalties related to our activities in the PRC and failure to comply with applicable rules and regulations;
   
general market conditions or other developments affecting us or our industry; and
   
the operating and stock price performance of other companies, other industries and other events or factors beyond our control.

 

In addition, the stock market has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of particular companies. These fluctuations may be even more pronounced in the trading market for our shares shortly following this offering. If the market price of our common stock after this offering does not exceed the offering price, you may not realize any return on your investment in us and may lose some or all of your investment. Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company’s securities. This litigation, if instituted against us, could result in very substantial costs, divert our management’s attention and resources, and harm our business, operating results and financial condition. In addition, recent fluctuations in the financial and capital markets have resulted in volatility in securities prices.

 

36

 

 

Military or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities which could adversely impact the price of our common stock.

 

Military or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial condition of companies, and lead to national, regional or international economic disruptions and economic uncertainty, any of which could adversely impact the price of our common stock.

 

The sale or availability for sale of substantial amounts of our common stock could adversely affect its market price.

 

Sales of substantial amounts of our common stock in the public market after the completion of this offering, or the perception that these sales could occur, could adversely affect the market price of our common stock and could materially impair our ability to raise capital through equity offerings in the future. The common stock sold in this offering will be freely tradable without restriction or further registration under the Securities Act, and shares held by our existing shareholders may also be sold in the public market in the future subject to the restrictions in Rule 144 under the Securities Act and the applicable lock-up agreements. There will be [20,374,842] shares of common stock outstanding immediately after this offering or [20,731,092] shares assuming the full exercise of the underwriter’s over-allotment option. In connection with this offering, we and each of our directors and officers named in the section “Management,” have agreed not to sell any common stock for six months from the date of this prospectus without the prior written consent of the underwriter, subject to certain exceptions. However, the underwriter may release these securities from these restrictions at any time, subject to applicable regulations of the Financial Industry Regulatory Authority, Inc. (“FINRA”). We cannot predict what effect, if any, market sales of securities held by our significant shareholders or any other shareholder or the availability of these securities for future sale will have on the market price of our common stock. See “Underwriting” and “Shares Eligible for Future Sale” for a more detailed description of the restrictions on selling our securities after this offering.

 

If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding our common stock, the market price for our common stock and trading volume could decline.

 

The trading market for our common stock will be influenced by research or reports that industry or securities analysts publish about our business. If one or more analysts who cover us downgrade our common stock, the market price for our common stock would likely decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the market price or trading volume for our common stock to decline.

 

Because we do not expect to pay dividends in the foreseeable future after this offering, you must rely on price appreciation of our common stock for return on your investment.

 

To date, we have not paid dividends on our common stock. We currently intend to retain all of our available funds and any future earnings after this offering to fund the development and growth of our business. As a result, we do not expect to pay any cash dividends in the foreseeable future. Therefore, you should not rely on an investment in our common stock as a source for dividend income.

 

Our board of directors has complete discretion as to whether to distribute dividends. The timing, amount and form of future dividends, if any, will depend on, among other things, our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by us from our subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by our board of directors. Accordingly, the return on your investment in our common stock will likely depend entirely upon any future price appreciation of our common stock. There is no guarantee that our common stock will appreciate in value after this offering or even maintain the price at which you purchased our common stock and you may even lose your entire investment.

 

You must rely on the judgment of our management as to the use of the net proceeds from this offering, and such use may not produce income or increase our share price.

 

We plan to use the net proceeds of this offering primarily for expanding our manufacturing facilities, pursuing business development opportunities and working capital and other general corporate purposes. See “Use of Proceeds.” However, our management will have considerable discretion in the application of the net proceeds received by us. You will not have the opportunity, as part of your investment decision, to assess whether proceeds are being used appropriately. The net proceeds may be used for corporate purposes that do not improve our efforts to achieve or maintain profitability or increase our share price. The net proceeds from this offering may be placed in investments that do not produce income or that lose value.

 

Our CEO has substantial influence over our Company. His interests may not be aligned with the interests of our other shareholders, and he could prevent or cause a change of control or other transactions.

 

As of the date of this prospectus, Quanzhong Lin, our Chairman of the Board of Directors and Chief Executive Officer, beneficially owns an aggregate of [58.14]% of our outstanding common stock. Upon completion of this offering, Mr. Lin will beneficially own approximately [36.98]% of our outstanding common stock.

 

Accordingly, Mr. Lin could have significant influence in determining the outcome of any corporate transaction or other matter submitted to the shareholders for approval, including mergers, consolidations, the appointment of directors and other significant corporate actions. Mr. Lin will also have the power to prevent or cause a change in control. Without the consent of Mr. Lin, we may be prevented from entering into transactions that could be beneficial to us or our minority shareholders. In addition, Mr. Lin could violate his fiduciary duties by diverting business opportunities from us to himself or others. The interests of Mr. Lin may differ from the interests of our other shareholders. The concentration in the ownership of our common stock shares may cause a material decline in the value of our common stock. For more information regarding Mr. Lin, see “Principal Shareholders.”

 

37

 

 

USE OF PROCEEDS

 

After deducting the underwriting commissions and estimated offering expenses payable by us, we expect to receive net proceeds of approximately $[7,695,000] from this offering. We anticipate that the proceeds will be applied as follows:

 

Planned Actions  Amount 
Working capital and general corporate purposes  $2,355,000 
Satisfaction of a portion of accrued liabilities   1,250,000 
Purchase of raw materials and supplies   750,000 
Fund existing businesses operation (product design and manufacture)   500,000 
Expansion of manufacturing facility   1,250,000 
Expand online activities   250,000 
Branding and marketing   1,250,000 
Satisfaction of loans due third parties   90,000 
Offering expenses   950,000 
Underwriting commissions and expenses   855,000 
      
TOTAL  $9,500,000 

 

The amount and timing of these expenditures will vary depending on a number of factors, including the amount of cash generated by our operations and the rate of growth, if any, of our business.

 

Although we may use a portion of the proceeds for the acquisition of, or investment in, companies, technologies, products or assets that complement our business, we have no present understandings, commitments or agreements to enter into any acquisitions or make any investments. We cannot assure you that we will make any acquisitions or investments in the future.

 

CAPITALIZATION

 

The following table sets forth our cash and cash equivalents, accounts payable, loans and advances from third parties and capitalization as of September 30, 2023:

 

  on an actual basis; and
     
  on a pro forma, as adjusted basis, to give effect to the sale of the shares of our common stock offered hereby at the public offering price of $4.00 and after deducting the underwriter’s commissions and estimated offering expenses payable by us and prior to the application of the net proceeds as described under “Use of Proceeds.”

 

You should read this table in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the financial statements and related notes included elsewhere in this prospectus.

 

   September 30, 2023   September 30, 2023   September 30, 2023 
   Actual   Pro Forma As Adjusted   Pro Forma
As Adjusted,
Assuming
Exercise
of the
Over-Allotment
Option in Full
 
    (unaudited)    (unaudited)    (unaudited) 
Cash and cash equivalents  $412,659   $8,107,659   $9,418,659 
Inventory, net   643,623    643,623    643,623 
Accounts Payable   599,373    599,373    599,373 
Loans from third parties   82,237    82,237    82,237 
                
Accrued liabilities and other payables  $2,136,132   $2,136,132   $2,136,132 
Common Stock, actual and pro forma as adjusted   250    274    277 
Additional Paid in Capital, actual and pro forma as adjusted   14,882,538    22,577,514    23,888,511 
Statutory Reserve   151,988    151,988    151,988 
Accumulated Deficit   (16,195,184)   (16,195,184)   (16,195,184)
Accumulated other comprehensive income   215,322    215,322    215,322 
Total Stockholders’ equity (deficit)  $(945,086)  $6,749,914   $8,060,914 

 

38

 

 

DILUTION

 

If you invest in our common stock in this offering, you will experience immediate and substantial dilution to the extent of the difference between the public offering price per share you will pay in this offering and the pro forma as adjusted net tangible book value per share of our common stock after this offering.

 

Our net tangible book value as of September 30, 2023 was a deficit of $(947,926), or a deficit of approximately $(0.04) per share of common stock(1). Net tangible book value represents total tangible assets less total liabilities. Tangible assets represent total assets excluding goodwill and other intangible assets. Net tangible book value per share represents net tangible book value divided by the aggregate number of shares of common stock outstanding as of September 30, 2023.

 

If our common stock is sold in this offering at the public offering price of $4.00, assuming the underwriter does not exercise the option to purchase additional shares of our common stock after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, and the application of such net proceeds as described under “Use of Proceeds” our pro forma as adjusted net tangible book value as of September 30, 2023 would have been approximately $6,747,074, or approximately $0.33 per share of common stock(1). This represents an immediate increase in pro forma as adjusted net tangible book value of $0.37 per share of common stock to our existing stockholders and an immediate dilution (i.e., the difference between the offering price and the pro forma as adjusted net tangible book value after this offering) to investors participating in this offering of $3.67 per share of common stock. The following table illustrates this per share dilution to the new investors purchasing shares of common stock in this offering:

 

   Offering(2)  

Full Over-allotment

Post-offering(3)

 
Assumed offering price per share  $4.00  $4.00 
Net tangible book value per share as of September 30, 2023  $(0.04)   (0.04)
Increase in net tangible book value per share attributable to
this offering
  $0.37    0.43 
Pro forma as adjusted net tangible book value per common stock
after the offering
  $0.33    0.39 
Dilution in pro forma as adjusted net tangible book value per share
to investors in this offering
  $3.67    3.61 

 

(1) All per share amounts in this section give effect to the reduction in the number of our shares of common stock outstanding as a result of the contribution to our capital by Quanzhong Lin of seven million shares of our common stock to be effective upon effectiveness of the Registration Statement of which this prospectus is a part.
(2)

Assumes gross proceeds from offering of 2,375,000 shares.

(3) Assumes gross proceeds from offering of 2,731,250 shares, if over-allotment option is exercised in full.

 

A $1.00 increase (decrease) in the public offering price of the shares offered hereby would increase (decrease) the pro forma as adjusted net tangible book value by $2,185,000, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the underwriter’s commissions and estimated offering expenses payable by us.

 

39

 

 

MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

 

Our common stock is currently quoted on the OTCQB under the symbol “AIXN.” From January 22, 2021, until June 5, 2023, our common stock traded on the OTCQX

 

Trading in stocks quoted on the OTCQX and OTCQB is often thin and is characterized by wide fluctuations in trading prices due to many factors that may have little to do with a company’s operations or business prospects. We cannot assure you that there will be a market for our common stock in the future.

 

The following table sets forth the high and low trading prices of one share of our common stock for each fiscal quarter over the past two fiscal years, and from January 1, 2023 to the date of this prospectus. The quotations provided are for the over-the-counter market, which reflect interdealer prices without retail mark-up, mark-down or commissions, and may not represent actual transactions. Our common stock trades on a limited, sporadic and volatile basis. These high and low bid prices per share of common stock have been adjusted to give effect to the 1 for 4 reverse stock split of our common stock effected on October 27, 2020, and the 1 for 2 reverse stock split of our common stock effected on February 17, 2023. The prices set forth in the table below have not been adjusted to reflect any change as a result of the reduction in the number of our shares of common stock to be outstanding as a result of the seven million shares of our common stock to be contributed to our capital by Quanzhong Lin upon effectiveness of the Registration Statement of which this prospectus is a part.

 

Year ended December 31, 2024   High     Low  
First Quarter (through February 8, 2024)  

$

0.80

    

$

0.50  

 

Year ended December 31, 2023  High   Low 
First Quarter  $6.86   $1.60 
Second Quarter  $11.01   $1.17 
Third Quarter  $4.50   $2.25 
Fourth Quarter  $2.25   $1.00 

 

Year ended December 31, 2022  High   Low 
First Quarter  $6.98   $3.22 
Second Quarter  $5.49   $3.32 
Third Quarter  $4.00   $3.32 
Fourth Quarter  $6.80   $3.35 

 

Holders of Our Common Stock

 

As of February 8, 2024. there were [24,999,842] shares of common stock issued and outstanding. They were held by a total of approximately [650] shareholders of record. The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. Holders of the common stock have no pre-emptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock.

 

Transfer Agent

 

The transfer agent for the common stock is Securities Transfer Corporation. The transfer agent’s address is 2901 N. Dallas Parkway, Suite 380, Plano Texas 75093, and its telephone number is +1 (469) 633-0101.

 

Dividend Policy

 

No cash dividends were paid on our shares of common stock since we acquired AiXin BVI. We do not foresee declaring any cash dividends on our common stock in the foreseeable future.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

In 2019 we adopted the 2019 Equity Incentive Plan (the “2019 Plan”), which authorizes the issuance of shares of common stock for grants of stock options, stock appreciation rights, restricted stock, stock units, bonus stock, dividend equivalents, other stock related awards and performance awards that may be settled in cash, stock, or other property. The 2019 Plan authorizes the issuance of up to 625,000 shares.

 

We adopted the 2019 Plan to provide a means by which employees, directors, and consultants of our Company and those of our subsidiaries and other designated affiliates, which we refer to together as our affiliates, may be given an opportunity to purchase our common stock, to assist in retaining the services of such persons, to secure and retain the services of persons capable of filling such positions, and to provide incentives for such persons to exert maximum efforts for our success and the success of our affiliates. The material features of the 2019 Plan are outlined below. This summary is qualified in its entirety by reference to the complete text of the 2019 Plan which has been filed with the SEC.

 

40

 

 

SELECTED HISTORICAL FINANCIAL AND OPERATING DATA

 

The following tables set forth our summary historical financial data for the periods presented. The following summary financial data for the years ended December 31, 2022 and 2021 are derived from our audited financial statements appearing elsewhere in this prospectus; the summary financial data for the nine months ended September 30, 2023 and 2022 is unaudited.

 

This summary financial data should be read together with the historical financial statements and related notes to those statements, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which are included elsewhere in this prospectus.

 

Balance Sheet Data

 

   December 31,   December 31,   September 30,   September 30, 
   2022   2021   2023   2022 
Assets                    
Current assets                    
Cash and cash equivalents  $510,128   $8,556,642   $412,659   $5,298,503 
Restricted cash   109,772    44,211    85,676    80,303 
Accounts receivable, including related party, net   562,581    45,923    250,561    196,376 
Other receivables and prepaid expenses   42,631    143,281    143,324    162,640 
Advances to suppliers   168,523    162,969    144,613    137,362 
Inventory   499,252    233,454    643,623    857,754 
Advances to related parties   83,102    19,055    384,588    92,642 
Total current assets   1,975,989    9,205,535    2,065,044    6,825,580 
Property and equipment, net   1,971,793    290,148    1,658,885    1,910,691 
Intangible asset, net   1,269    1,940    2,840    1,393 
Deferred tax asset   15,556    18,795    13,278    15,522 
Security deposit   86,992    94,153    82,237    84,347 
Operating lease right-of-use assets   999,285    2,049,775    457,793    1,173,616 
Goodwill, net   -    -    -    - 
Total assets  $5,050,884   $11,660,346   $4,280,077   $10,011,149 
                     
Liabilities and stockholders’ equity                    
Current liabilities                    
Accounts payable  $398,469   $406,163   $599,373   $507,993 
Accounts payable-related party   165,958    -    -    160,911 
Unearned revenue   139,502    171,408    466,804    153,163 
Taxes payable   104,100    232,637    110,246    55,942 
Accrued liabilities and other payables   2,356,490    752,400    2,136,132    5,903,738 
Government grant   950,371    -    898,424    921,473 
Loan from third parties   86,992    94,153    82,237    84,347 
Operating lease liabilities   883,583    848,230    439,959    772,632 
Advance from related parties   236,882    1,947,154    333,919    726,650 
Total current liabilities   5,322,347    4,452,145    5,067,094    9,286,849 
Operating lease liabilities - non-current   194,725    1,138,710    158,069    382,152 
Total liabilities   5,517,072    5,590,855    5,225,163    9,669,001 
Total stockholders’ equity (deficit)   (466,188)   6,069,491    (945,086)   342,148 
                     
Total liabilities and stockholders’ equity (deficit)  $5,050,884   $11,660,346   $4,280,077   $10,011,149 

 

41

 

 

Statement of Operations Data:

 

   Years Ended December 31,   Nine Months Ended September 30, 
   2022   2021   2023   2022 
                 
Sales revenue:                    
Products  $1,851,676   $742,624   $2,405,280   $888,690 
Advertising   -    1,944,811    -    - 
Room revenues   262,605    114,086    473,167    166,278 
Food and beverage revenues   475,746    201,755    356,009    356,840 
Others   118,533    62,957    63,233    100,543 
Total revenue, net   2,708,560    3,066,233    3,297,689    1,512,351 
                     
Operating costs and expenses                    
Cost of goods sold   1,103,160    535,485    1,136,411    493,905 
Hotel operating costs   1,739,948    744,594    1,387,993    1,334,041 
Selling   787,637    470,798    628,754    583,438 
General and administrative   1,395,008    1,033,830    1,268,119    752,113 
(Reversal of) provision for bad debts   (119,274)   (63,076)   (10,250)   115,495 
Stock-based compensation   371,540    371,540    278,655    278,655 
Total operating costs and expenses   5,278,019    3,093,171    4,689,682    3,557,647 
                     
Loss from operations   (2,569,459)   (26,938)   (1,391,993)   (2,045,296)
                     
Non-operating income (expenses)                    
Interest income   4,876    4,113    692    3,636 
Impairment loss   (3,823,770)   -    -    (3,823,770)
Other income   51,856    63,064    52,395    41,789 
Government grant income   -    -    284,321    - 
Other expenses   (31,651)   (33,154)   (5,022)   (29,577)
Total non-operating income (expenses), net   (3,798,689)   34,023    332,386    (3,807,922)
                     
(Loss) income before income tax   (6,368,148)   7,085    (1,059,607)   (5,853,218)
                     
Income tax expense   1,097    274,321    5,879    643 
                     
Net loss   (6,369,245)   (267,236)   (1,065,486)   (5,853,861)
                     
Other comprehensive items                    
Foreign currency translation (loss) gain   (537,974)   122,283    42,473    (152,137)
                     
Comprehensive loss  $(6,907,219)  $(144,953)  $(1,023,013)  $(6,005,998)

 

42

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Statements

 

The following discussion should be read in conjunction with our consolidated audited financial statements and related notes thereto and other financial information appearing elsewhere in this prospectus. In addition to historical information, the following discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Where possible, we have tried to identify these forward-looking statements by using words such as “anticipate,” “believe,” “intends,” or similar expressions. As a result of many factors, including those factors set forth in the “Risk Factors” section of this prospectus, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in this prospectus.

 

This prospectus contains statements that we believe are, or may be considered to be, “forward-looking statements”. All statements other than statements of historical fact included in this prospectus regarding the prospects of our industry or our prospects, plans, financial position or business strategy, may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “project,” “anticipate,” “believe,” “plans,” “forecasts,” “continue” or “could” or the negatives of these terms or variations of them or similar terms. Furthermore, such forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission or press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements contained herein, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this prospectus.

 

You should read the matters described in “Risk Factors” and the other cautionary statements made in this prospectus, and incorporated by reference herein, as being applicable to all related forward-looking statements wherever they appear in this prospectus. We cannot assure you that the forward-looking statements in this prospectus will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements.

 

Corporate History

 

AiXin Life International, Inc. (“AiXin Life” or “AiXin Colorado”) was incorporated under the laws of the State of Colorado on August 31, 2001. In February 2, 2017, Mr. Quanzhong Lin (Mr. Lin) purchased shares representing 65.0% of our then outstanding shares for $300,000. In December 2017, we issued additional shares of common stock to Mr. Lin increasing the percentage of our outstanding shares then owned by him to 80%, the sole stockholder of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), for all of the outstanding shares of AiXin BVI. As a result, AiXin BVI became our wholly-owned subsidiary, and through AiXin BVI we now own all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXinZhonghong”), which markets and sells premium-quality nutritional products in China. AiXinZhonghong began distributing nutritional products in 2013.

 

For accounting purposes, the acquisition of AiXin BVI was accounted for as a reverse acquisition and treated as a recapitalization of the Company effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to the date on which we acquired AiXin BVI, the historical consolidated financial statements of AiXinZhonghong are now the historical consolidated financial statements of the Company. The assets and liabilities of AiXinZhonghong were brought forward at their book value and no goodwill was recognized.

 

43

 

 

In September 2021 we completed the acquisition of nine pharmacies located in Chengdu. Since that time we have added additional pharmacies and currently operate 25 pharmacies. We utilize these pharmacies to distribute health and wellness products and serve as learning centers for our clients. The staff at our pharmacies is being trained to reach out to customers and make them aware of the benefits of our health and wellness products. In addition, the pharmacies serve as convenient locations where repeat customers can buy our products.

 

In September 2022, we acquired Yunnan Runcangsheng based in Yunnan Province which engages in the research, development, manufacture and wholesale distribution of health foods. Yunnan Runcangsheng operates a 13,000 square meter production facility, which houses R&D centers, extraction facilities, preparation workshops and a warehouse. Yunnan Runcangsheng has more than 30 sub brands and operates planting facilities where it grows some of the key ingredients used in its products. Many of the products it has developed are specifically targeted to alleviate symptoms associated with the increasingly competitive and pressured lifestyle of the Chinese middle class.

 

In addition to our acquisitions in the health and nutritional sector, in July 2021, we acquired a hotel located in the Jinniu District, Chengdu City. We envision utilizing the hotel to conduct marketing events and seminars for our customers, and training sessions for our personnel at which we introduce new products and services intended to promote healthy living.

 

We intend to look for additional opportunities to profit from the growing healthcare market in China. Though currently we are not party to any agreements, we will explore, among other opportunities, expanding our product line through internal research and acquiring complementary products from third parties, acquiring additional pharmacies and other retail outlets and operating nursing homes and possibly clinics which provide medical care to clients.

 

Our Business

 

We are focused on providing health and wellness products to the growing middle class in China. We currently develop, manufacture, market and sell premium-quality healthcare, nutritional products and wellness supplements, including herbs and greens, traditional Chinese remedies, functional products, such as weight management tools, probiotics, foods and drinks. We also offer products purchased from third parties. In addition, we have provided advertising and marketing services to clients which engage us to market and distribute their products, though we are likely to decrease this activity as we focus on distributing out products. We offer our products and those of clients for which we provide marketing services, through a diversified, omni-channel business model which generates revenues through retail and wholesale product sales, through company-owned pharmacies, direct marketing and online activities. Our marketing approach emphasizes proactively approaching customers such as by hosting marketing events for clients, which we believe is ideally suited to marketing the products we offer because sales of healthcare, nutritional products and supplements are strengthened by ongoing personal contact and support, coaching and education among the Company and our clients towards how to achieve a healthy and active lifestyle.

 

We believe the competitive strengths that will enable us to grow in the health and wellness market include our ability to design and manufacture products that are responsive to consumers’ needs as the lifestyle of China’s middle class evolves, our coordinated omni-channel distribution network where we enable consumers to obtain the information they need to improve their lifestyle on our website, at our pharmacies and through individual meetings with our team members.

 

Our ability to operate profitably and generate positive cash flow will be determined by our ability to attract a large and loyal customer base and provide the information and products they need cost effectively. Our revenue will largely be determined by our ability to achieve and maintain a strong brand name and company image, the volume of products we sell and the prices we can charge for such products, which will require that we compete effectively. Our costs will largely be determined by the cost of raw materials and acquired inventory, the labor used to design and manufacture products, and the costs incurred to deliver these products to the consumer.

 

Our Current Strategy

 

We intend to build a reputation as a provider of premium health and wellness products that seeks to improve our customers’ health and well-being. Our objective is to offer a variety of products for consumers interested in living well, whether they are looking to treat a health-related issue or simply maintain their overall wellness. Our premium, value-added offerings include both proprietary products developed and manufactured by us as well as products acquired from or sold on behalf of third parties. We believe our range of products and ability to develop new products, combined with the customer support and service we offer, differentiate us and allow us to effectively compete against food, drug and mass channel players, specialty stores, independent vitamin, supplement and natural food shops and online retailers.

 

44

 

 

We believe that the innovative capability we have as a result of our acquisition of Yunnan Runcangsheng is a significant competitive advantage. The vertical integration this gives us allows us to monitor the changing buying patterns of our customers to quickly and efficiently design new products they desire and drives increased efficiencies in manufacturing and supply chain.

 

Our retail strategy is to deliver a compelling experience at every customer touch point. We recognize that the growing Chinese middle class is searching for product expertise and knowledgeable customer service in choosing health and wellness products. We differentiate ourselves from competitors by educating our team members as to the benefits of our products with regular training that focuses on solution-based selling. With this training and information regarding a customer’s purchasing habits available in our data bases, members of our sales team can engage customers in conversation, share product information and testimonials, recommend solutions and help customers add complimentary products and build wellness regimens.

 

Our loyalty programs will allow us to develop and maintain a large and loyal customer base, provide targeted offers and information, and connect with our customers on a regular basis. We harness data generated by these programs to better understand customers’ buying behaviors and needs, so we can deliver a stronger experience, bring like-minded consumers into the channel and make well-informed decisions about the business. We currently collect, maintain and use customers’ data in accordance with all applicable laws and regulations and will strive to do so in the future.

 

We believe our diversified, omni-channel model, which includes company-owned pharmacies, direct marketing, large scale marketing events, and on-line activities, differentiates us from online-only competitors. Our strategy is to give consumers a seamless, integrated experience across all distribution channels. We believe our sales offices and pharmacies are a competitive advantage which enhances our ability to satisfy our customers, for example, by, allowing customers to experience our products and get expert advice from a coach. Our omni-channel model can enhance the customer experience and increase the lifetime value of our customers and we are implementing strategies to increase the use of on-line promotional activities to enhance our customers’ experiences.

 

Our business is dependent on consumer demand for our products and services. We believe that the significant growing middle class and changing lifestyles in China offer an opportunity to provide consumers with products that will enable them to maintain their health and well-being and deal with the ailments that accompany their changing lifestyles. Many of these customers are highly sensitive to the cost of our products and lack the knowledge to choose the optimal products. We believe that the combination of information and products we will provide will best serve to meet our customers’ needs.

 

45

 

 

Critical Accounting Policies and Estimates

 

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities. On an on-going basis, management evaluates past judgments and estimates, including those related to bad debts, accrued liabilities, and contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We describe below those critical accounting policies that, as a result of judgments, uncertainties, uniqueness and complexities of the underlying accounting standards and operation involved could result in material changes to our financial position or results of operations under different conditions or using different assumptions.

 

Nine Months ended September 30, 2023 and 2022

 

The following table sets forth the results of our operations for the periods indicated as a percentage of net revenue. Because Runcangsheng was acquired in September 2022, it did not contribute to our financial results for the nine months ended September 30, 2022. Certain columns may not add due to rounding:

 

 

   Nine Months Ended September 30, 
   2023   2022 
   $  

% of

Revenue

   $   % of Revenue 
Revenue  $3,297,689    100%  $1,512,351    100%
Operating costs and expenses   4,689,682    142%   3,557,647    235%
Income (loss) from operations   (1,391,993)   (42)%   (2,045,296)   (135)%
Non-operating income (expense), net   332,386    10%   (3,807,922)   (252)%
Loss before income tax   (1,059,607)   (32)%   (5,853,218)   (387)%
Income tax expense   5,879    0.2%   643    0.04%
Net loss  $(1,065,486)   (32)%  $(5,853,861)   (387)%

 

The following table shows our operations by business segment for the nine months ended September 30, 2023 and 2022.

 

   For the Nine Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $1,064,668   $371,016 
Pharmacies   802,118    517,674 
Hotel   892,409    623,661 
Manufacture and sale   538,494    - 
Total revenues, net  $3,297,689   $1,512,351 
           
Operating costs and expenses          
Products          
Cost of goods sold  $367,237   $98,809 
Operating expenses   1,249,461    961,885 
Pharmacies          
Cost of goods sold   446,967    395,096 
Operating expenses   361,200    467,315 
Hotel          
Hotel operating costs   1,387,993    1,334,041 
Operating expenses   106,219   300,501 
Manufacture and sale          
Cost of goods sold   322,207    - 
Operating expenses   448,398    - 
Total operating costs and expenses  $4,689,682   $3,557,647 
           
Loss from operations          
Products  $(552,030)  $(689,678)
Pharmacies   (6,049)   (344,737)
Hotel   (601,803)   (1,010,881)
Manufacture and sale   (232,111)   - 
Loss from operations  $(1,391,993)  $(2,045,296)

 

46

 

 

Revenue

 

Revenue was $3,297,689 in the nine months ending September 30, 2023, compared to $1,512,351 in the same period of 2022, an increase of $1,785,338 or 118%. The increase in revenue was mainly due to increases in direct sales of our nutritional products, increases in revenues from our hotel and pharmacies, and the generation of revenue by Runcangsheng which we did not own in the nine months of 2022. For the nine months ended September 30, 2023, we had $2,405,280 in product revenues (of which $1,064,668 were from direct sales, $802,118 were from sales at our pharmacies and $538,494 from sales by Runcangsheng) and hotel revenue of $892,409. For the nine months ended September 30, 2022, we had $888,690 product revenues (of which $371,016 were from direct sales and $517,674 were from the sales at our pharmacies), and hotel revenue of $623,661.

 

Operation Costs and Expenses

 

Cost of Goods Sold

 

Cost of goods sold was $1,136,411 for the nine months ended September 30, 2023, compared to $493,905 for the nine months ended September 30, 2022, an increase of $642,506 or 130%. The increase in our cost of goods sold is attributable to the increase in direct product sales, pharmacy sales and sales by Runcangsheng. The cost of goods sold for our direct product sales as a percentage of sales was 34% in 2023, compared to 27% for 2022. The cost of goods sold for products sold through our pharmacies as a percentage of pharmacy product sales was 56% in 2023, compared to 76% in 2022. The cost of goods sold as a percentage of sales by Runcangsheng was 60% in 2023, and no comparable costs were incurred in the nine months ended September 30, 2022. We were able to lower our cost of goods sold and increase our profit margin at out pharmacies significantly as a result of the manufacturing business we acquired when we purchased Runcangsheng, which enabled us to sell products we manufactured.

 

Hotel Operating Costs

 

Hotel operating costs were $1,387,993 and $1,334,041 for the nine months ended September 30, 2023 and 2022. The increase in hotel operating costs was mainly due to the increase in hotel sales but was partly offset by decreases in the cost of foods and fruits.

 

Operating Expenses

 

Operating expenses were $2,165,278 for the nine months ended September 30, 2023, compared to $1,729,701 for the same period of 2022, an increase of $435,577 or 25%. The increase in operating expenses was mainly due to the inclusion of the operating expenses of Runcangsheng.

 

Loss from Operations

 

Loss from operations was $1,391,993 in the nine months ended September 30, 2023, compared to $2,045,296 in the same period of 2022, a decrease of $653,303 or 32%. The decrease in our loss from operations for 2023 was due to the increases in our revenues which decreased the losses from our direct sales activities, pharmacies and hotel, partly offset by the loss incurred by our new subsidiary, Runcangsheng.

 

Non-operating Income

 

Non-operating income was $332,386 for the nine months ended September 30, 2023, compared to non-operating expenses of $3,807,922 for the nine months ended September 30, 2022. For the nine months ended September 30, 2023, we had interest income of $692 and other income $336,716, partly offset by other expenses of $5,022. For the nine months ended September 30, 2023, other income mainly consisted of a government grant of $284,321. For the nine months ended September 30, 2022, we had an impairment loss of $3,823,770 attributed to the acquisition of Runcangsheng and other expenses of $29,577, partly offset by interest income of $3,636 and other income of $41,789.

 

47

 

 

Income Tax Expense

 

Income tax expense was $5,879 and $643 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $5,236 or 814% for the nine months ended September 30, 2023 compared with the same period of 2022.

 

Net Loss

 

Our net loss for the nine months ended September 30, 2023 was $1,065,486, compared to a net loss of $5,853,861 in the same period of 2022, a decrease of $4,788,375 or 82%. The decrease in the nine months ended September 30, 2023 was mainly due to increased sales and the absence of an impairment loss, partly offset by increased operating costs and expenses as explained above.

 

Results of Operations for the years ended December 31, 2022 and 2021

 

The following table sets forth the results of our operations for the periods indicated as a percentage of net revenue, certain columns may not add due to rounding:

 

   Years Ended December 31, 
   2022   2021 
   $   % of Revenue   $   % of Revenue 
Revenue  $2,708,560    100%  $3,066,233    100%
Operating costs and expenses   5,278,019    195%   3,093,171    101%
Loss from operations   (2,569,459)   (95)%   (26,938)   (1)%
Non-operating income (expenses), net   (3,798,689)   (140)%   34,023    1%
Income (loss) before income tax   (6,368,148)   (235)%   7,085    (0.2)%
Income tax expense   1,097    0.04%   274,321    (9)%
Net loss  $(6,369,245)   (235)%  $(267,236)   (9)%

 

The following table shows our operations by business segment for the years ended December 31, 2022 and 2021.

 

   For the Years Ended December 31, 
   2022   2021 
Net revenue          
Advertising and products  $823,930   $2,406,988 
Pharmacies   789,347    280,447 
Hotel   856,884    378,798 
Manufacture and Sale   238,399    - 
Total revenues, net  $2,708,560   $3,066,233 
           
Operating costs and expenses          
Advertising and products          
Cost of goods sold  $171,345   $316,750 
Operating expenses   1,526,246    1,344,543 
Pharmacies          
Cost of goods sold   578,092    218,735 
Operating expenses   622,835    252,513 
Hotel          
Hotel operating costs   1,739,948    744,594 
Operating expenses   310,902    216,036 
Manufacture and Sale          
Cost of goods sold   353,723    - 
Operating expenses   (25,072)   - 
Total operating costs and expenses  $5,278,019   $3,093,171 
           
(Loss) income from operations          
Advertising and products  $(873,661)  $745,695 
Pharmacies   (411,580)   (190,801)
Hotel   (1,193,966)   (581,832)
Manufacture and Sale   (90,252)   - 
Loss from operations  $(2,569,459)  $(26,938)

 

48

 

 

Revenue

 

Revenue was $2,708,560 for the year ending December 31, 2022, compared to $3,066,233 in 2021, a decrease of $357,673 or 12%. The decrease in revenue was mainly due to the absence of advertising revenues. The imposition of COVID-19 restrictions prevented us from staging the types of events at which we market nutritional products. The decrease in advertising revenues was partly offset by increases in the revenues generated by our pharmacies and hotel and revenues resulting from the acquisition of Runcangsheng. Revenues and expenses as a result of the acquisition of our pharmacies, hotel and Runcangsheng began to be included in our financial results from their respective dates of acquisition. We completed the acquisition of our hotel in August 2021, our pharmacies in September 2021 and Runcangsheng in September 2022. For the year ended of December 31, 2022, we had no advertising revenues and $1,851,676 in product revenues (of which $823,930 were from direct sales, $789,347 represented sales at our pharmacies and $238,399 represented sales from Runcangsheng), and hotel revenue of $856,884. For 2021, we had advertising and product revenues of $2,406,988, pharmacies revenue of $280,447, and hotel revenue of $378,798.

 

Operating Costs and Expenses

 

Cost of Goods Sold

 

Cost of goods sold was $1,103,160 for the year ended December 31, 2022, compared to $535,485 for the year ended December 31, 2021, an increase of $567,675 or 106%. The increase in our cost of goods sold is attributable to an increase in pharmacy products sales, sales by Runcangsheng, and direct product sales as opposed to advertising revenues for which there is no cost of goods. The cost of goods sold for our direct product sales as a percentage of sales was 21% in 2022, compared to 69% for 2021. The cost of goods sold for products sold through our pharmacies as a percentage of pharmacy product sales was 73% in 2022, compared to 78% in 2021.

 

Hotel Operating Costs

 

Hotel operating costs were $1,739,948 for the year ended December 31, 2022. compared to $744,594 for 2021. The increase in hotel operating costs in 2022 was mainly due to the increased revenue as a result of increased activity at our hotel and the inclusion of the results of operations of the hotel for all of 2022 as opposed to the months beginning in August 2021.

 

Operating Expenses

 

Operating expenses were $2,434,911 for the year ended December 31, 2022, compared to $1,813,092 for the same period of 2021, an increase of $621,819 or 34%. The increase in operating expenses was mainly due to the inclusion of the operating expenses of our pharmacies and hotel for the entire year as opposed to only a portion of 2021 and the expenses of Runcangsheng.

 

Loss from Operations

 

Loss from operations was $2,569,459 in the year ended December 31, 2022, compared to $26,938 in 2021, an increase of $2,542,521 or 9,438%. The increase in our loss from operations for 2022 was due to the losses incurred by each of our segments. All of our operations and in particular our direct marketing activities and hotel business were materially adversely impacted by travel and work restrictions and limits on the number of people that might gather in one place imposed on a temporary basis in China and Chengdu to limit the spread of COVID-19.

 

Non-Operating Income (Expense)

 

Non-operating expense was $3,798,689 for the year ended December 31, 2022, compared to non-operating income of $34,023 for the year ended December 31, 2021. For the year ended December 31, 2022, we had an impairment loss of goodwill of $3,823,770 arising from the acquisition of Runcangsheng, and other expenses of $31,651,partly offset by interest income of $4,876 and other income of $51,856. For the year ended December 31, 2021, we had interest income of $4,113 and other income of $63,064 and other expenses of $33,154. The determination to write off all the goodwill resulting from the acquisition of Runcangsheng reflects the need to provide it with capital to achieve its business goals.

 

Income Tax Expense

 

Income tax expense was $1,097 and $274,321 for the years ended December 31, 2022 and 2021, respectively, a decrease of $273,224 or 100% for the year ended December 31, 2022 compared with 2021.

 

Net Loss

 

Our net loss for the year ended December 31, 2022 was $6,369,245, compared to $267,236 in 2021, an increase of $6,102,009 or 2,283%. The increased net loss in 2022 was mainly due to decreased sales revenue, increased operating costs and expense, and an impairment loss of $3,823,770 as explained above. The impairment loss was the result of our decision to write-off the entire amount of the goodwill resulting from the acquisition of Runcangsheng as the Company was in the development stage and will need additional capital to achieve its business goals.

 

49

 

 

Liquidity and Capital Resources

 

Summary of cash flows

 

Years ended December 31, 2022 and 2021

 

During the year ended of December 31, 2022, we used $1,624,565 in operations. As of December 31, 2022, cash and cash equivalents were $510,128 (excluding $109,772 of restricted cash), compared to $8,556,642 (excluding $44,211 of restricted cash) as of December 31, 2021. At December 31, 2022, we had a working capital deficit of $3,346,358 compared to working capital of $4,753,390 at December 31, 2021.

 

The following is a summary of cash provided by or used in each of the indicated types of activities during the years ended December 31, 2022 and 2021, respectively.

 

   December 31, 2022   December 31, 2021 
Net cash used in operating activities  $(1,624,565)  $(57,804)
Net cash used in investing activities  $(3,522,369)  $(4,431,513)
Net cash (used in) provided by financing activities  $(2,389,593)  $5,221,864 

 

Net cash used in operating activities

 

For the year ended December 31, 2022, net cash used in operating activities was $1,624,565. This reflects our net loss of $6,369,245, increased by a goodwill impairment of $3,823,770, non-cash related expenses including depreciation and amortization expense of $185,565, the change in deferred tax of $1,858, operating lease expenses of $837,425, stock-based compensation of $371,540, and an inventory impairment of $54,899, less changes in working capital of $576,330. The cash outflow from changes in working capital mainly resulted from an increase in outstanding accounts receivable of $425,961, payments of lease liabilities of $710,865, a change in accounts payable of $71,153, unearned revenue of $24,401 and taxes payable of $137,711, which was partly offset by cash inflows from accrued liabilities and other payables of $289,868, other receivable and prepaid expense of $109,439, inventory of $150,872, accounts payable to related party of $140,608, and advances to suppliers of $103,016.

 

For the year ended December 31, 2021, net cash used in operating activities was $57,804. This reflects our net loss of $267,236, adjusted by non-cash related expenses including depreciation and amortization expense of $96,106, operating lease expense of $411,607 and stock-based compensation of $371,540, and then decreased by change in deferred tax of $18,570, and changes in working capital of $651,251. The cash outflow from changes in working capital mainly resulted from unearned revenue of $122,897, payments of taxes payable of $57,467, payments of lease liabilities of $473,508 and payments of accrued liabilities of $142,027, partly offset by cash inflow from other receivables and prepaid expenses $94,992 and inventory of $69,738.

 

Net cash used in investing activities

 

For the year ended December 31, 2022, net cash used in investing activities was $3,522,369, mainly as a result of $3,812,027 paid for the acquisition of Runcangsheng, and purchases of property and equipment of $156,723, partly offset by cash acquired in connection with the acquisition of Runcangsheng of $446,381.

 

For the year ended December 31, 2021, net cash used in investing activities was $4,431,513, mainly for the acquisitions of our hotel and pharmacies of $4,517,620, partly offset by cash acquired in connection with the acquisitions of $87,448.

 

Net cash provided by (used in) financing activities

 

For the year ended December 31, 2022, net cash used in financing activities was $2,389,593 as a result of payments made against advances from related parties of $2,389,593.

 

For the year ended December 31, 2021, net cash provided by financing activities reflected a capital contribution of $4,386,070 and the proceeds from advances from related parties of $1,204,442, partially offset by the repayment of loans from third parties of $368,648.

 

50

 

 

Nine months ended September 30, 2023 and 2022

 

During the nine months ended September 30, 2023, we used $219,874 in operations. As of September 30, 2023, cash and cash equivalents were $412,659 (excluding $85,676 of restricted cash), compared to $510,128 (excluding $109,772 of restricted cash) as of December 31, 2022. At September 30, 2023, we had a working capital deficit of $3,002,050 compared to $3,346,358 at December 31, 2022.

 

The following is a summary of cash provided by or used in each of the indicated types of activities during the nine months ended September 30, 2023 and 2022, respectively.

 

   September 30, 2023   September 30, 2022 
Net cash used in operating activities  $(219,874)  $(1,412,550)
Net cash (used in) provided by investing activities  $(218,556)  $393,896 
Net cash provided by (used in) financing activities  $347,449   $(1,525,860)

 

Net cash used in operating activities

 

For the nine months ended September 30, 2023, net cash used in operating activities was $219,874. This reflects our net loss of $1,065,486, adjusted by non-cash related expenses including depreciation and amortization expense of $308,114, a change in deferred tax of $1,481, a bad debt reversal of $10,250, an inventory impairment of $8,558, operating lease expenses of $618,085, government grant income $284,321 and stock-based compensation of $278,655, and then decreased by changes in working capital of $74,710. The cash outflow from changes in working capital mainly resulted from increases in other receivables and prepaid expense, including related parties of $116,468, in inventory of $186,658, in accounts payable from related party of $162,768, and in accrued liabilities and other payables of $136,638, and payments of lease liabilities of $500,056, partly offset by cash inflows from accounts receivable, including from related parties in the amount of $301,626, cash inflows from advances to suppliers of $133,520, cash inflows from accounts payable of $233,112, cash inflow from unearned revenue of $347,347, and taxes payable of $12,273.

 

For the nine months ended September 30, 2022, net cash used in operating activities was $1,412,550. This reflects our net loss of $5,853,861, increased by non-cash related expenses including depreciation and amortization expense of $82,921, the change in deferred tax of $1,419, bad debt expense of $115,495, operating lease expense of $632,496, stock-based compensation of $278,655, and impairment loss of 3,823,770, less changes in working capital of $493,445. The cash outflow from changes in working capital mainly resulted from an increase in accounts receivable of $126,720, payments of lease liabilities of $525,979, a change in inventory of $192,791, unearned revenue of $9,444 and taxes payable of $187,009, partly offset by cash inflows from accrued liabilities and other payables of $232,910, other receivable and prepaid expense of $100,801, accounts payable of $201,749, and advances to suppliers of $13,038. 

 

Net cash used in investing activities

 

For the nine months ended September 30, 2023 and 2022, net cash used in investing activities was $218,556 included $212,607 for the purchase of fixed assets, $2,608 for the purchase of intangible assets, and $3,341 cash disposed of at the termination of a non-operating subsidiary. For the nine months ended September 30, 2022, net cash provided by investing activities was $393,896, mainly as a result of cash acquired in connection with the acquisition of subsidiaries of $446,381, partly offset by purchases of property and equipment of $52,485.

 

51

 

 

Net cash provided by financing activities

 

For the nine months ended September 30, 2023, net cash provided by financing activities were the result of capital contributions of $142,200 and proceeds from government grant of $284,321, partly offset by payments made against advances from related parties of $79,072. For the nine months ended September 30, 2022, net cash used in by financing activities was $1,525,860 as a result of payments made against advances from related parties of $1,525,860.

 

We substantially depleted our available cash and working capital during 2022 supporting our operations and completing the acquisition of Runcangsheng, further, in late 2023, we repaid to the Yizu Autonomous County People’s Government $978,647 received by Runcangsheng as a grant during the first half of 2022, and generated a $232,111 loss from operations in the nine months of 2023. It is likely that Runcangsheng will require additional capital to achieve its short-term operational goals and long range business plans. Further, we may need additional capital to maintain our other businesses. We may also have to raise additional financing as our working capital requirements are expected to increase in line with the growth of our business. In the past we have funded our operations through proceeds from private placements of equity and advances from our principal shareholder. Should we require capital to fund our business, we intend to finance our business by raising additional capital or, when available, borrowing additional funds. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders and could cause the price of our common stock to decrease. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

 

We are subject to all of the substantial risks inherent in the development of a new business enterprise within an extremely competitive industry. Due to the absence of a long-standing operating history and the emerging nature of the markets in which we compete, we anticipate operating losses until we can successfully implement our business strategy. Our revenue model is new and evolving, and we cannot be certain that it will be successful. The potential profitability of our business model is unproven. We may never ever achieve profitable operations. Our future operating results depend on many factors, including demand for our products, the level of competition, and the ability of our officers to manage our business and growth. As a result of the emerging nature of the market in which we compete, we may incur operating losses until such time as we can develop a substantial and stable revenue base. Additional development expenses may delay or negatively impact our ability to generate profits. Accordingly, we cannot assure you that our business model will be successful or that we can sustain revenue growth, achieve or sustain profitability, or continue as a going concern.

 

52

 

 

Our ability to obtain funds through the issuance of debt or equity is dependent upon the state of the financial markets at such time as we may seek to raise funds. The state of the capital market markets may be adversely impacted by various risks and uncertainties, including, but not limited to future and current impacts of global events such as COVID-19, the war in the Ukraine and the conflict in Palestine, increases in inflation and other risks detailed herein.

 

Impact of Inflation

 

Our results of operations may be affected by inflation, particularly rising prices for labor, raw materials, products and other operating costs, if we cannot pass such increases along to our customers in the form of higher prices for our products and services. Generally, our inventory turns multiple times per year and we anticipate that we will be able to increase prices on products to reflect increases in the cost of inventory.

 

Contingencies

 

We have no long-term fixed contractual obligations or commitments other than our operating lease obligations detailed in Note 11 to our financial statements.

 

Foreign Currency Translation Risk

 

Our operations are located in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility in foreign exchange rates between the U.S. dollar and the Chinese Renminbi (“RMB”). All of our sales are in RMB. In the past years, RMB continued to appreciate against the U.S. dollar. As of December 31, 2022, the market foreign exchange rate had decreased to RMB6.8972 to one U.S. dollar. Our financial statements are translated into U.S. dollars using the closing rate method. The balance sheet items are translated into U.S. dollars using the exchange rates at the respective balance sheet dates. The capital and various reserves are translated at historical exchange rates prevailing at the time of the transactions while income and expenses items are translated at the average exchange rate for the period. All translation adjustments are included in accumulated other comprehensive income in the statement of equity. The foreign currency translation gain (loss) for the years ended December 31, 2022 and 2021 was a loss of $537,974 and a gain of $122,283, respectively.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements (as that term is defined in Item 303(a)(4)(ii) of Regulation S-K) as of September 30, 2023 that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Contingencies

 

Our operations are conducted in the PRC and are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments in China and foreign currency exchange rates. Our results may be adversely affected by changes in PRC government policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad and rates and methods of taxation, among other things.

 

53

 

 

Our sales, purchases and expense transactions in China are denominated in RMB and all of our assets and liabilities in China are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current PRC law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation in order to affect the remittance.

 

Significant Accounting Policies

 

Our management’s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which were prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported net sales and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

While our significant accounting policies are more fully described in Note 2 to our consolidated financial statements, we believe the following accounting policies are the most critical to assist you in fully understanding and evaluating this management discussion and analysis.

 

Basis of Presentation

 

The accompanying financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXin is Chinese Renminbi (“RMB”). The accompanying financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

Accounts Receivable

 

We maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of September 30, 2023 and December 31, 2022, the bad debt allowance was $247,753 and $272,550, respectively.

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for us on January 1, 2018. Our revenue recognition disclosure reflects updated accounting policies that are affected by this new standard. We applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and have been primarily from the delivery of products and the performance of services, and we have no significant post-delivery obligations, this did not result in a material recognition of revenue on the accompanying consolidated financial statements for the cumulative impact of applying this new standard. We made no adjustments to previously-reported total revenues, as those periods continue to be presented in accordance with our historical accounting practices under Topic 605, Revenue Recognition.

 

54

 

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of our products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that we believe are legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when we satisfy each performance obligation.

 

Our revenue recognition policies for our operating segments are as follows:

 

Advertising and Products

 

Advertising Revenue

 

Commencing in the third quarter of 2019 we began to provide advertising services to our clients. Advertising contracts are signed to establish the price and advertising services to be provided. Pursuant to the advertising contracts, we provided advertising and marketing services to clients through exhibition events, conferences, and person-to-person marketing. We perform a credit assessment of each customer to assess the collectability of the contract price prior to entering into contracts.

 

Most of the advertisement contracts designated that we perform advertising services for the client through exhibition events, conferences, and person-to-person marketing during the contracted period, regardless of the number of such events. As such, we determined that the performance obligation is satisfied over time during the contracted period and revenue is recognized accordingly. Such advertising revenue amounted to $0 and $1,944,811 for the years ended December 31, 2022 and 2021, respectively.

  

All of the advertising revenue is subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by us for raw materials and other materials purchased in China.

 

Product Revenues

 

Our revenue from sales of products is recognized when goods are delivered to the customer and no other obligation exists. We do not provide unconditional return or other concessions to customers. Our sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to returning a product, customers may request an exchange for products with the same value.

 

Product sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of our products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by for raw materials and other materials purchased in China. We record VAT payables and VAT receivables net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as we act as an agent for the government.

 

55

 

 

Pharmacies

 

Our retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. We generally receive payment from pharmacy customers we satisfy our performance obligations. We record a receivable when we have an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of the products sold in our pharmacies are exempt from VAT as the pharmacies qualify for a small business exemption.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservations. Each of these products and services represents a distinct performance obligation and, in exchange for these services, we receive fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by on raw materials and other materials purchased in China.

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for the sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small subject to exemption.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of our business operations is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

We use FASB ASC Topic 220, “Comprehensive Income”. Comprehensive income (loss) is comprised of net income (loss) and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive loss for years ended December 31, 2022 and 2021 consisted of net loss and foreign currency translation adjustments.

 

56

 

 

BUSINESS

 

Overview

 

We (AiXin Life International, Inc.) are a Colorado holding company with no material operations of our own. We conduct substantially all of our operations through our operating companies established in the PRC. From the time we acquired AiXin BVI in December 2017, our focus has been providing health and wellness products to the growing middle class in China. We currently develop, manufacture, market and sell premium-quality healthcare, nutritional products and wellness supplements, including herbs and greens, traditional Chinese remedies, functional products, such as weight management products, probiotics, foods and drinks. We also provide advertising and marketing services to clients which engage us to market and distribute their products. We offer our products and those of clients for which we provide marketing services, through a diversified, omni-channel business model which generates revenues through retail and wholesale product sales, through company-owned pharmacies, direct marketing and online activities.

 

In December 2017, when we acquired AiXin BVI, it indirectly owned all of the capital stock of AiXinZhonghong. AiXinZhonghong began distributing nutritional products in 2013. AiXinZhonghong offers nutritional products to its customers through a direct marketing team, at large scale entertainment style events which it organizes for the benefit of its clients and more recently, through online activities. In 2019, AiXinZhonghong began to provide marketing and distribution services to other manufacturers and suppliers of healthcare products. AiXinZhonghong has a proactive approach reaching out to customers to provide them with information as to how to live a healthy lifestyle. We believe this approach is ideally suited to marketing health and wellness products as sales of these products are strengthened by ongoing personal contact and support, coaching and education of clients, as to the benefits of a healthy and active lifestyle.

 

In September 2021 we completed the acquisition of nine pharmacies located in Chengdu. Since that time we have added additional pharmacies and currently operate 25 pharmacies. We utilize these pharmacies to distribute our health and wellness products and serve as learning centers for our clients along with their traditional business. We intend to seek to continue to expand our chain of pharmacies and to use these outlets as part of our overall marketing strategy. As part of our marketing efforts, we will educate the employees at our pharmacies as to the benefits of our health and wellness products so they can closely work with our clients.

 

In September 2022, we acquired Yunnan Runcangsheng which engages in the research, development, manufacture and wholesale distribution of health and wellness products. Yunnan Runcangsheng operates a 13,000 square meter production facility, including, R&D centers, extraction facilities, preparation workshops and a warehouse. Yunnan Runcangsheng has more than 30 brand names under which it distributes products and maintains and operates planting facilities where it grows some of the key ingredients used in its products. Many of the products it has developed are specifically targeted to alleviate ailments associated with the increasingly competitive and pressured lifestyle of Chinese people, such as hypertension and obesity which result from a more pressured yet sedentary lifestyle, symptoms associated with changing eating habits and the presence of environmental toxins that are becoming more widespread through the use of western style pesticides and fertilizers. When we entered into the agreement to acquire Yunnan Runcangsheng we began to distribute its products through our distribution channels and continue to do so.

 

In addition to our acquisitions in the health and nutritional sector, in July 2021, we acquired Chengdu AiXin Shangyan Hotel Management Co., Ltd (“AiXin Shangyan Hotel”) which operates the Shangyan Hotel located in the Jinniu District, Chengdu City. While we have continued the hotel’s pre-acquisition business, we intend to use the hotel to host events at which we educate our team members and customers as to the benefits of a healthy lifestyle, introduce new products and offer our complete product line for sale.

 

We intend to look for additional opportunities to profit from the growing healthcare market in China. Though currently we are not party to any agreements, we will explore, among other opportunities, expanding our product line through internal research and acquiring complementary products from third parties, acquiring additional pharmacies and other retail outlets and operating nursing homes and possibly clinics which provide medical care to clients.

 

Business Objectives

 

Key elements of our strategy are detailed below:

 

Leading brand of nutritional supplements. Our primary goal is to develop recognized brand names with a reputation as a provider of quality health and wellness products which deliver demonstrable benefits to our customers. Our objective is to provide members of the growing Chinese middle class with the information necessary to maintain a healthy lifestyle and to offer them a variety of products whether the customer is looking to treat a specific health-related issue, maintain their overall wellness or improve their performance. Our premium, value-added offerings will include both proprietary branded products and other branded products provided by third parties to meet needs not met by our in-house products.

 

We believe that by offering a variety of branded exclusive products and a wide range of merchandise, and close customer support and services, we will be able to differentiate our Company from competitors and effectively compete against other food, drug and mass channel players, specialty stores, independent vitamin, supplement and natural food shops and online retailers. We further believe that if we succeed in developing and maintaining a positive reputation, we will be able to offer additional products and services to our clients.

 

57

 

 

Product development and innovation. With the acquisition of Yunnan Runcangsheng we have the facilities and, more importantly, knowledgeable, experienced personnel, to develop high-quality, innovative health foods and nutritional supplement products that will be offered by our direct marketing team and available through our Company-owned pharmacies, our website and, as demand grows other select marketplaces and wholesale partners. To the extent desirable we will grow some of the key ingredients in our products. When we choose to use ingredients of third parties, they will be rigorously tested before they are added to our products, undergoing multiple quality checks to ensure that they meet our high standards for purity, composition and absence of contaminants.

 

We believe our capability to innovate and respond to customer needs by designing new products gives us a significant competitive advantage. At Yunnan Runcangsheng we directly employ scientists, nutritionists, formulators, and quality control experts who work at our research and manufacturing facilities.

 

A differentiated customer experience. We believe one of the key differentiators to our marketing strategy is the continued development of well-trained team members first used at AiXinZhonghong that work closely with customers. We will provide our team members with regular training and education focused on the benefits of a healthy lifestyle, the advantages of our products and solution-based selling. We will also maintain and make available to our team members data bases of our customers purchasing patterns. With their knowledge of the available products, our team members can engage customers in conversation, access the customer’s purchasing history through our data base, share product information and testimonials, and recommend solutions and help customers add complimentary products and build wellness regimens. We operate in a highly personalized, aspirational sector and believe that health food and nutritional supplement consumers often desire and seek out product expertise and knowledgeable customer service.

 

At AiXinZhonghong we developed loyalty programs to reward customers and incentivize them to introduce our products to their friends. A number of AiXinZhonghong’s customers in fact acted as independent marketers, buying products from us and distributing them to others at a profit. We intend to continue to use loyalty programs to develop and maintain a large and loyal customer base, provide targeted offers and information, and connect with our customers on a regular basis. We will harness data generated by these programs to better understand customers’ buying behaviors and needs, so we can deliver a more rewarding experience, encourage our customers to introduce our products to their friends and make well-informed decisions about the direction of our business.

 

As we grow and develop our customer base, we can use our hotel as a site for educational seminars, conferences and marketing events featuring well known experts in the wellness sector. These events can be used to increase customer loyalty and to educate our team members as to the benefits of a healthy lifestyle and our products so they can better serve our customers by guiding them to products that meet their needs.

 

Omni-channel development. We believe our diversified, omni-channel model, which includes company-owned offices open to clients, pharmacies, direct marketing by our team members, individually and at large scale company sponsored marketing events, wholesale locations and online activities, can differentiate us from many of our competitors, particularly those that rely exclusively on online marketing efforts. Our strategy is to give consumers a seamless, integrated experience across digital, mobile and in-store channels and in every interaction with us and our products.

 

Through our website and in conversations with our well-trained team members, customers can research our products and purchase them online or at one of our local pharmacies or sales offices. We believe our physical store base provides a competitive advantage, allowing customers to experience our products and get expert advice from our team members.

 

Our omni-channel model can enhance the customer experience and increase the value of a customer to us and we will implement strategies to blend our digital, online and in-store platforms, always stressing the availability and benefits of a conversation with one of our team members. These initiatives will include increased cross-channel marketing, online and in-store subscription services, giving customers the option of picking up online purchases at our stores, delivering products purchased online directly from stores, and providing educational content, information and advice online, at our pharmacies o through a personal visit by one of our team members.

 

58

 

 

Vertical Integration. We believe that our multi-channel distribution model, combined with our research, development and manufacturing capabilities offers us a unique advantage over our competitors. The daily feedback received from interactions between our team members and customers will be monitored to recognize what our customers want and rapidly develop products to meet their desires. Instead of simply responding to trends in the market, we will seek to bring new topical products to the market before they are generally available.

 

Products

 

Our pharmacies offer a wide variety of personal healthcare products and traditional Chinese remedies in addition to our health and wellness products. They began to carry the products developed by Yunnan Runcangsheng prior to completion of that acquisition. The primary products currently distributed by us, including those of Yunnan Runcangsheng, include rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules.

 

Marketing

 

Our target customer is the growing population of middle- and upper-class Chinese who are willing to devote increasing amounts to healthcare products as their incomes grow. We believe that as this group grows, becomes more affluent and adopts a more western sedentary life-style and diet, it will experience obesity, hypertension, heart disease, back pain and some of the negative symptoms common in developed countries. Our marketing efforts include proactively approaching these customers through person-to-person marketing and by hosting educational and informative events, which we believe is ideally suited to marketing our products and those of our clients for which we perform advertising services because sales of health and wellness products and supplements are strengthened by ongoing personal contact and support, coaching and education towards how to achieve a healthy and active lifestyle.

 

We currently market our products through our pharmacies, at large scale marketing events which feature popular local entertainers, at our offices which customers are encouraged to use for social gatherings at wholesale and online. Key to our marketing efforts are the members of our marketing team who make themselves available to individual customers and work with such customers to develop a healthy well balanced dietary regimen. As part of our educational efforts, we distribute informational videos to our clients on-line and make multiple posts on social media daily. Off-line, in addition to distributing products through our pharmacies, we utilize person-to-person marketing to promote and sell products. These personal marketing efforts include hosting educational events and allowing customers to utilize our facilities for social gatherings.

 

In addition to our marketing efforts, through our loyalty program we encourage our customers to distribute our products to others. Our program for increasing the number of clients interested in reselling the products we offer and for developing new clients who demonstrate the ability to sell our products to others, is to provide them with compensation, in the form of quantity purchase discounts and other incentives, such as free meals, travel or vacations.

 

We offer our clients a customer satisfaction guarantee. Our sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to returning a product, customers can exchange a product for another of the same value.

 

Manufacturing

 

As a result of the acquisition of Yunnan Runcangsheng, we have a 13,000 square meter manufacturing center inclusive of office space, R&D centers, extraction workshops, preparation workshops, traditional Chinese medicine decoction pieces workshops and storage areas. The activities include research and development, extraction and intensive processing of traditional Chinese medicines and processing to incorporate active ingredients into tablets, capsules, granules and pills according to market demand and product attributes. The facility was designed and constructed and is operated in compliance with applicable national health food and pharmaceutical standards (GMP), and has achieved ISO quality system certification and HACCP food safety system certification.

 

59

 

 

Raw Materials

 

The raw materials used in products we manufacture are generally readily available, subject to fluctuations in price due to supply and demand issues. We do not look to enter into long-term contracts with any of our suppliers as the materials we need shifts as demand for our products changes.

 

Intellectual Property

 

We believe that we need to develop well recognized brand names and, when possible, obtain patents covering products we develop, their formulae or the processes by which they are manufactured. Runcangsheng has received patents on certain manufacturing processes and has used multiple brand names for its products. Given the early stage of Runcangsheng’s development and the limited historical operations of AiXinZhonghong, our products and brand names have yet to achieve the widespread recognition we envision. Further, we have yet to determine whether the patents Runcangsheng has received will prevent others from marketing competitive products or using manufacturing processes similar to those we have developed. See, “Risk Factors – Risks Associated with Our Company -, Our ability to adequately protect our trade names, trademarks and patents could have an impact on our brand images and ability to penetrate new markets.

 

Competition

 

The category of nutritional products is very competitive and there are various channels through which such products are marketed to consumers, including direct selling, through the internet, through specialty retailers, pharmacies and discount channels of food, drug and mass merchandisers. We seek to differentiate ourselves by being familiar with our clients and providing a personalized sales experience and focusing on after-sale services where sales employees focus on the consultative sales process through product education and the frequent contact and support that many sales employees have with the clients. From a competitive standpoint, there are many providers and sales outlets of nutritional products in China. We believe that none have effectively combined the product, personal coaching, education and the product access provided by our sales employees and, further, that these efforts are compounded by the peer pressure our clients generate through our organized group sales presentations.

 

Employees

 

As of January 10, 2024, we had 207 employees allocated among the functions set forth in the table below

 

Function 

Number of

employees

 
Administration   37 
Finance   20 
Manufacturing   11 
Marketing (sales)   118 
R&D   6 
Procurement   15 

 

We believe that we maintain a good working relationship with our employees, and to date we have not experienced any significant labor disputes.

 

Government Regulations

 

We are subject to numerous regulations applicable to businesses generally, including regulations relating to working conditions, employee compensation and the maintenance of welfare plans, environmental regulation and truth in advertising. In addition, the manufacture and distribution of nutritional products is subject to many laws, governmental regulations, administrative determinations and guidance. Such laws, regulations and other constraints exist at the national, provincial and local levels, including regulations pertaining to: (1) the formulation, manufacturing, packaging, labeling, distribution, importation, sale and storage of products; (2) product claims and advertising, including direct claims and advertising by us, as well as claims and advertising by manufacturers and distributors of the products we offer, for which we may be held responsible; and (3) taxes. As a distributor, we are subject to only a portion of these laws and regulations. We believe that we are fully compliant with those applicable to our activities.

 

Prior to commencing manufacture or distribution of a product, the manufacturer or distributor may be required to obtain an approval, license or certification from the national, provincial or local government in China. Although we attempt to determine whether all regulatory requirements have been met, we cannot monitor the manufacture of products we acquire for distribution from third parties and cannot be certain that all applicable regulations are satisfied. Moreover, even if we were to determine that a manufacturer or distributor had the requisite license or certification at the beginning of a relationship, we might not become aware if it were to forfeit any regulatory approvals or fail to adhere to applicable requirements.

 

60

 

 

Dietary supplements are subject to regulation by the China Food and Drug Administration. China has highly restrictive nutritional supplement product regulations. Products marketed as “health foods” are subject to extensive laboratory and clinical analysis by government authorities, and the product registration process in China generally takes one to two years but may be substantially longer. We market both “health foods” and “general foods.” For products we distribute on behalf of or acquired from others, we are not in a position to obtain any required license, though we may be held liable if we were to distribute a product which had not been properly tested and registered with the authorities. There is some risk associated with the common practice in China of marketing a product as a “general food” while seeking “health food” classification. If government officials feel the categorization of a product distributed by us is inconsistent with product claims, ingredients or function, this could end or limit our ability to market such products.

 

As the middle class has grown, the number of manufacturers and distributors of nutritional supplements in China has dramatically increased. Many of these enterprises have often ignored applicable laws and distributed adulterated or inferior products. We believe this has created a marketing opportunity which we have tried to exploit as a trusted source of products on which our clients can rely. To the extent our reputation results from reviewing and testing products prior to distributing them, and then distributing only products determined to be safe, it is incumbent upon us to ensure that the manufacturers and distributors upon which we rely are trustworthy. A failure by any of these third parties could cause substantial damage to our reputation, business and financial results.

 

Direct selling and multi-level marketing are two forms of marketing regulated by various national, provincial and local government agencies in China. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, including “pyramid” schemes, which compensate participants primarily for recruiting additional participants without significant emphasis on product sales to consumers.

 

Under PRC regulations, “direct selling” refers to a type of business mode in which a company recruits door-to-door salesmen to sell products directly to ultimate consumers outside the companies’ fixed places of business. Businesses engaged in “direct selling” are required to obtain a license from the PRC government. A direct selling company is required to provide vocational training for, and conduct an examination of, any sales promoter it recruits, and obtain a certificate for each sales promoter after the sales promoter has passed the examination. A direct selling company is also required, when commencing operations, to deposit RMB20 million ($2.9 million) in a special account with a designated bank, which deposit is adjusted on a monthly basis to equal 15% of the operator’s sales from direct selling products up to RMB0.1 billion ($14.5 million).

 

We do not engage in direct selling activities subject to regulations prevalent in China since we do not employ sales personnel engaged in door-to-door sales outside our place of business.

 

Under PRC regulations, “multi-level marketing” refers to marketing, promotional and sales activities whereby organizers or operators take in new members and compensate each member based upon the number of new members introduced by such member, directly or indirectly, or based upon the level of sales generated by the members introduced by such member. The regulations also prohibit an organizer from requiring new members to deposit a sum of money as a condition to membership or requiring that members recruit additional members to establish a multi-level relationship. PRC regulations distinguish direct selling from multi-level marketing in that all direct sellers are normally trained by the direct selling company and any direct seller is not allowed to develop new followers or form multiple levels.

 

We are not in the direct selling category or multi-level marketing category since (i) we do not pay salaries or commissions to our member distributors, who decide as a matter of personal preference whether to introduce our products to relatives or friends based on their own personal experience of usage and/or trust of our Company’s products; (ii) we do not require individuals to deposit a sum of money to become a member; and (iii) we do not pay members to recruit individuals to join in or to form a multi-level relationship.

 

61

 

 

Nevertheless, the laws and regulations governing direct selling and multi-level marketing may be modified or reinterpreted from time to time, which may cause us to change our business model. Regulations are subject to discretionary interpretation by regulators and governmental authorities. There is often ambiguity and uncertainty with respect to the implication of direct selling and anti-pyramiding laws and regulations.

 

Properties

 

We currently operate 25 retail pharmacies in Chengdu. The pharmacies are operated subject to short term leases at market rate rents. In addition to the pharmacies, we maintain our administrative offices in Chengdu.

 

Yunnan Runcangsheng operates a 13,000 square meter production facility, including, R&D centers, extraction facilities, preparation workshops and a warehouse. Yunnan Runcangsheng has more than 30 brand names under which it distributes products and maintains and operates planting facilities where it grows some of the key ingredients used in its products. Runcangsheng acquired the right to use the production facility pursuant to a Development Agreement with the People’s Government of Luquan Li and Miao Autonomous County. The Development Agreement grants Runcangsheng the rights to use the facility for a period of five years ending November 25, 2025, provided Runcangsheng invests certain amounts in the development of the property and its business, including the construction of office space, manufacturing facilities and workshops. The governmental authorities appear to be satisfied with the progress Runcangsheng has made in the development of the property to date and have not expressed any intent to terminate the Agreement.

 

Shangyan Hotel Company owns and operates a hotel located in the Jinniu District, Chengdu City. The hotel covers more than 8,000 square meters and has a large restaurant that can accommodate 600 people, six luxury dining rooms, a 200 square meter music tea house, 13 private tea rooms, 108 guest rooms and other supporting facilities. The hotel is conveniently located, connected to the express ring line of Chengdu and the Chengdu bus system, within a 30-minute drive to Shuangliu International Airport. The hotel is equipped with all modern facilities, including central air conditioning and each guest room features luxury bedding, high-speed internet, a safe for valuables and minibar. To accommodate businesses, the banquet hall is equipped with advanced audio-visual equipment and dedicated high-speed wireless Internet to facilitate large group presentations. The staff includes a professional banquet team to ensure the success of any private function or business gathering. A full range of catering services, including Chinese-style boutique Sichuan cuisine are provided in a stylish environment. The hotel is leased pursuant to an agreement which expires at the end of December 2025 at an annual rent of approximately RMB5,856,000/.

 

Legal Proceedings

 

From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows.

 

In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Mr. Yiao is entitled to $392,305 (RMB2,500,000) from Aixintang Pharmacy for breaching a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was the result of a forgery by an employee, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $392,305 (RMB2,500,000) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the verdict.

 

In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied Aixintang Pharmacy’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.

 

The incident which is the subject to the above lawsuit occurred before Aixintang Pharmacy was acquired by the Company. In November 2021, the Company and Mr. Lin agreed that Mr. Lin shall indemnify the Company against any losses arising from this legal proceeding.

 

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

 

DIRECTORS AND EXECUTIVE OFFICERS

 

The name, address, age and titles of our executive officers and director are as follows:

 

The following table sets forth the names and ages of all directors and executive officers as of the end of the last fiscal year and on the date of this report:

 

Name   Age   Position
Quanzhong Lin   45   Director, Chairman, President and Chief Executive Officer
Yao-Te Wang (1) (2) (3)   46   Director and Secretary
Christopher Lee (1) (2) (3)   52   Director
Huiliang Jiao (1) (2) (3)   49   Director
Tianfeng Li   36   Chief Financial Officer

 

(1) Member of the Audit Committee
(2) Member of the Compensation Committee
(3) Member of the Nominating and Corporate Governance Committee

 

62

 

 

Quanzhong Lin has served as a director, Chairman, President and Chief Executive Officer of our Company since February 2, 2017. Mr. Lin is a highly active entrepreneur in China, and currently serves as Chairman of AiXin Company Group, a diversified company which he founded in 2008. In addition to AiXin Company Group, Mr. Lin has founded a number of companies located in Chengdu City, Sichuan Province, China, engaged in various types of business, including pharmacies, retail outlets, hotel management services and global tourism.

 

In 2009, Mr. Lin founded QingBaiJiangJinWanXiang Daily Necessities store, predecessor to AiXinZhonghong Biotechnology Co., Ltd. From 2010 to 2013, Mr. Lin opened branches in Xindu and Xinjin district, officially entering the Chengdu market.

 

In September 2013, Mr. Lin founded Chengdu AiXin E-Commerce Company Ltd., which in the following twelve months opened branches in cities and counties including Huayuan and Wenjiang district, and Mianyang and Jianyang city. In April 2015, AiXin E-commerce Co., Ltd. changed its name to Chengdu AiXinZhonghong Biotechnology Co., Ltd., whose shares became listed on the Shanghai Stock Exchange (Ticker Symbol: 207448) in October 2015; and during 2015, AiXinZhonghong opened branches in Dujiangyan City, and Chongzhou City.

 

Yao-Te Wang has served as a director of our Company since December 12, 2017. He became our Secretary on June 20, 2023. Mr. Wang has been the Chief Executive Officer of Ivy Service Group (China), which is a transnational consultant company in China, since 2015. From January 2016 to June 2016, Mr. Wang participated in the overall operation planning for Chongqing Cultural Assets and Equity Exchange. From June 2015 to January 2016, Mr. Wang helped with the overall brand strategy development for Swire Group, who merged the biggest baking brand in Southwest China within more than 150 million RMB. From September 2014 to February 2015, Mr. Wang was the chairman special assistant for JECUI Health Science Company. From July 2012 to August 2014, Mr. Wang was the Chief Executive Officer of Ivy Service Group (Taipei). From August 2007 to June 2012, Mr. Wang was an instructor of National Defense University (Taipei), taught International Politics and Economic Analysis.

 

Christopher Lee was appointed as a Member of the Board of Directors of the Company on February 5, 2021. Mr. Lee has served as Chief Financial Officer of Semileds Corporation since September 2015. Mr. Lee joined Semileds Corporation in September 2014 and from November 2014 until his appointment as Chief Financial Officer, Mr. Lee was the interim Chief Financial Officer of Semileds Corporation. Semileds develops, manufactures and sells high performance light emitting diodes and is currently listed on The Nasdaq Stock Market. Mr. Lee has over 20 years of experience in accounting and finance, including US GAAP, PCAOB standards and SEC rules and regulations. Mr. Lee was a partner of KEDP CPA Group from August 2009 to June 2011 and a self-employed accountant from July 2011 to August 2014. Mr. Lee holds a BS degree in accounting from Ohio State University and a MS degree in business taxation from Golden Gate University and is licensed as a Certified Public Accountant (CPA) in the United States.

 

Huiliang Jiao was elected to the Board of Directors of our Company on December 1, 2022. Mr. Jiao received his degree from China Pharmaceutical University in 1997 where he majored in Pharmacy. Mr. Jiao joined Yunnan Runcangsheng Technology Co., Ltd. in April 2020, most recently serving as Chief Executive Officer. Mr. Jiao served as the general manager of Yunnan Shengshengyuan Technology Co., Ltd. from June 2016 until he joined Runcangsheng. From January 2007 until May 2016, Mr. Jiao was the general manager of Yunnan Shengcaofeng Biotechnology Co., Ltd. Throughout his career Mr. Jiao has been involved in the research and development of new products intended to improve individuals’ health and well-being, with an emphasis on functional products comprised of natural plants, foods and supplements intended to address obesity and other chronic conditions. He was named as an inventor on more than forty patents relating to the composition and manufacture of health foods. In addition to the development of health foods, Mr. Jiao has participated in the design and maintenance of production systems intended to meet the latest manufacturing standards.

 

Tianfeng Li, has been our Chief Financial Officer since December 1, 2022. Ms. Li also serves as Chief Financial Officer of the Company’s subsidiaries. Ms. Li has held various positions, most recently, Finance Manager, within the Finance Department of our subsidiary, Chengdu AiXin Pharmacy Co., Ltd., which she joined in May 2019. While serving at AiXin Pharmacy Ms. Li helped build the company’s finance team and established the development of its financial reporting and risk management systems. In addition, she presided over the preparation of the company’s financial statements, the completion of its annual audit, daily cash management, the preparation of the annual budget and the integration of newly acquired pharmacies. From May 2013 until joining AiXin Pharmacy in May 2019, Ms. Li served as the Finance Manager of Sichuan Jinxin Clean Energy Equipment Co., Ltd., where she was responsible for developing the company’s financial systems, preparing its budget and managing all aspects of cash management. At Sichuan Jinxin Clean Energy Equipment Co Ms. Li supervised a staff of five assistants. Ms. Li received a bachelor’s degree from The Open University of China in 2017, and has received a Certificate of Honor as an Intermediate Accountant.

 

63

 

 

There are no family relationships among any of our officers and directors.

 

Directors hold office until the next annual meeting of shareholders and until their successors have been duly elected and qualified. Officers are elected by the board of directors and hold office until the earliest of their death, resignation or removal from office.

 

Independence

 

Our board of directors has determined that each of Christopher Lee, Yao-Te Wang and Huiliang Jiao satisfies the definition of “independent director” in accordance with Rule 5605(a)(2) of the Marketplace Rules of The Nasdaq Stock Market, Inc. and Section 10(A)(m)(3) of the Securities Exchange Act of 1934, as amended.

 

Board Committees

 

Our board of directors has established standing committees in connection with the discharge of its responsibilities. These committees include an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Our board of directors has adopted written charters for each of these committees. Upon completion of this offering, copies of the charters will be available on our website. Our board of directors may establish other committees as it deems necessary or appropriate from time to time.

 

Audit Committee. Our Audit Committee consists of Messrs. Lee, Jiao and Wang, each of whom is independent. The Audit Committee assists the Board of Directors oversight of (i) the integrity of financial statements, (ii) our compliance with legal and regulatory requirements, (iii) the independent auditor’s qualifications and independence, and (iv) the performance of our internal audit function and independent auditor and prepares the report that the SEC requires to be included in our annual proxy statement. The Audit Committee operates under a written charter. Mr. Lee is the Chairman of our Audit Committee.

 

The Board of Directors determined that Mr. Lee possesses accounting or related financial management experience that qualifies him as financially sophisticated within the meaning of Rule 4350(d)(2)(A) of the Nasdaq Marketplace Rules and that he is an “audit committee financial expert” as defined by the rules and regulations of the SEC.

 

According to its charter, the Audit Committee shall consist of at least three members, each of whom shall be a non-employee director who has been determined by the Board to meet the independence requirements of Nasdaq, and also Rule 10A-3(b)(1) of the SEC, subject to the exemptions provided in Rule 10A-3(c). We do not have a website containing a copy of the Audit Committee Charter. The Audit Committee Charter describes the primary functions of the Audit Committee, including the following:

 

  Oversee the Company’s accounting and financial reporting processes;
     
  Oversee audits of the Company’s financial statements;
     
  Discuss policies with respect to risk assessment and risk management, and discuss the Company’s major financial risk exposures and the steps management has taken to monitor and control such exposures;
     
  Review and discuss with management the Company’s audited financial statements and review with management and the Company’s independent registered public accounting firm the Company’s financial statements prior to the filing with the SEC of any report containing such financial statements.
     
  Recommend to the board that the Company’s audited financial statements be included in its annual report on Form 10-K for the last fiscal year;
     
  Meet separately, periodically, with management, with the Company’s internal auditors (or other personnel responsible for the internal audit function) and with the Company’s independent registered public accounting firm;

 

64

 

 

  Be directly responsible for the appointment, compensation, retention and oversight of the work of any independent registered public accounting firm engaged to prepare or issue an audit report for the Company;
     
  Take, or recommend that the board take, appropriate action to oversee and ensure the independence of the Company’s independent registered public accounting firm; and
     
  Review major changes to the Company’s auditing and accounting principles and practices as suggested by the Company’s independent registered public accounting firm, internal auditors or management.

 

Nominating and Corporate Governance Committee

 

The purpose of the Nominating and Corporate Governance Committee is to assist the Board of Directors in identifying qualified individuals to become members of our Board of Directors, in determining the composition of the Board of Directors and in monitoring the process to assess Board effectiveness. Each of Messrs. Lee, Jiao and Wang are members of the Nominating and Corporate Governance Committee. Mr. Wang serves as Chairman of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee operates under a written charter.

 

  Our Nominating and Corporate Governance Committee has, among the others, the following authority and responsibilities:
     
  To determine and recommend to the Board, the criteria to be considered in selecting nominees for the director;
     
  To identify and screen candidate consistent with such criteria and consider any candidates recommended by our stockholders pursuant to the procedures described in our proxy statement or in accordance with applicable laws, rules and regulations and provisions of our charter documents.
     
  To select and approve the nominees for director to be submitted to a stockholder vote at the annual meeting of stockholders.

 

Compensation Committee

 

The Compensation Committee is responsible for overseeing and, as appropriate, making recommendations to the Board of Directors regarding the annual salaries and other compensation of our executive officers and general employees and other policies, and for providing assistance and recommendations with respect to our compensation policies and practices. Each of Messrs. Lee, Jiao and Wang are members of the Compensation Committee. The Compensation Committee operates under a written charter. Mr. Jiao is the Chairman of Compensation Committee.

 

Our Compensation Committee has, among the others, the following responsibilities and authority.

 

  The compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser.
     
  The compensation committee shall be directly responsible for the appointment, compensation and oversight of the work of any compensation consultant, legal counsel and other adviser retained by the compensation committee or said group.
     
  The Company must provide for appropriate funding, as determined by the compensation committee, for payment of reasonable compensation to a compensation consultant, legal counsel or any other adviser retained by the compensation committee or said group.

 

65

 

 

  The compensation committee select, or receive advice from, a compensation consultant, legal counsel or other adviser to the compensation committee or said group, other than in-house legal counsel, only after conducting an independence assessment with respect to the adviser as provided for in the Exchange Act.

 

Board Leadership Structure and Role in Risk Oversight

 

Mr. Quanzhong Lin holds the positions of chief executive officer and chairman of the board of the Company. The board believes that Mr. Lin’s services as both chief executive officer and chairman of the board is in the best interest of the Company and its shareholders. Mr. Lin is a well-recognized successful entrepreneur in Chengdu. He possesses detailed and in-depth knowledge of the issues, opportunities and challenges facing the Company in its business and is thus best positioned to develop agendas that ensure that the Board’s time and attention are focused on the most critical matters relating to the business of the Company. His combined role enables decisive leadership, ensures clear accountability, and enhances the Company’s ability to communicate its message and strategy clearly and consistently to the Company’s shareholders, employees and customers.

 

The board has not designated a lead director. Given the limited number of directors comprising the Board, the independent directors call and plan their executive sessions collaboratively and, between meetings of the Board, communicate with management and one another directly. Under these circumstances, the directors believe designating a lead director to take on responsibility for functions in which they all currently participate might detract from rather than enhance performance of their responsibilities as directors.

 

Management is responsible for assessing and managing risk, subject to oversight by the board of directors. The board oversees our risk management policies and risk appetite, including operational risks and risks relating to our business strategy and transactions. Various committees of the board assist the board in this oversight responsibility in their respective areas of expertise.

 

Code of Ethics

 

We have adopted a Code of Ethical Business Conduct that applies to, among other persons, members of our board of directors, our Company’s officers including our Chief Executive Officer, employees, consultants and advisors. As adopted, our Code of Business Conduct and Ethics sets forth written standards that are designed to deter wrongdoing and to promote:

 

  1. honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
     
  2. full, fair, accurate, timely, and understandable disclosure in reports and documents that we file with, or submit to, the SEC and in other public communications made by us;
     
  3. compliance with applicable governmental laws, rules and regulations;
     
  4. the prompt internal reporting of violations of the Code of Ethical Business Conduct to an appropriate person or persons identified in the Code of Ethical Business Conduct; and
     
  5. accountability for adherence to the Code of Ethical Business Conduct.

 

Our Code of Code of Ethical Business Conduct requires, among other things, that all of our Company’s senior officers commit to timely, accurate and consistent disclosure of information; that they maintain confidential information; and that they act with honesty and integrity.

 

In addition, our Code of Ethical Business Conduct emphasizes that all employees, and particularly senior officers, have a responsibility for maintaining financial integrity within our Company, consistent with generally accepted accounting principles, and federal and state securities laws. Any senior officer who becomes aware of any incidents involving financial or accounting manipulation or other irregularities, whether by witnessing the incident or being told of it, must report it to our Company. Any failure to report such inappropriate or irregular conduct of others is to be treated as a severe disciplinary matter. It is against our Company policy to retaliate against any individual who reports in good faith the violation or potential violation of our Company’s Code of Ethical Business Conduct by another.

 

66

 

 

A copy of the Code of Ethics and Business Conduct was filed as an Exhibit to our report on Form 8-K filed on September 25, 2020, and is available on the SEC’s website, www.sec.gov.

 

EXECUTIVE COMPENSATION

 

The following table sets forth certain information about compensation paid, earned or accrued for services by each individual who served as our chief executive officer and chief financial officer for services rendered in all capacities during the year ended December 31, 2023. No other executive officer of our Company or other individual received total annual salary and bonus compensation in excess of $100,000 for the year ended December 31, 2023.

 

Summary Compensation Table

 

Name and Principal Position  Year   Salary ($)   Bonus ($)   Total ($) 
Quanzhong Lin, President(1)  2023   $20,100   $          $20,100 
   2022    20,822         20,822 
Tiangfeng Li, Chief Financial Officer (2)  2023   $26,500   $   $26,500 
  2022   $20,533   $   $

20,533

 

 

(1) Amounts attributed to Mr. Lin represent amounts paid as President and CEO of AiXinZhonghong.

 

(2) Amounts attributed to Ms. Li represent amounts paid as CFO of AiXinZhonghong.

 

Neither Mr. Lin nor Ms. Li has an employment agreement with the Company.

 

Narrative Disclosure to Summary Compensation Table

 

There are no annuity, pension or retirement benefits proposed to be paid to the officer or director or employees in the event of retirement at normal retirement date pursuant to any presently existing plan provided or contributed to by the Company or any of its subsidiaries, if any.

 

Stock Option Plan

 

In 2019 we adopted the 2019 Equity Incentive Plan (the “2019 Plan”), which authorizes the issuance of shares of common stock for grants of stock options, stock appreciation rights, restricted stock, stock units, bonus stock, dividend equivalents, other stock related awards and performance awards that may be settled in cash, stock, or other property. The 2019 Plan authorizes the issuance of up to 625,000 shares.

 

We adopted the 2019 Plan to provide a means by which employees, directors, and consultants of our Company and those of our subsidiaries and other designated affiliates, which we refer to together as our affiliates, may be given an opportunity to purchase our common stock, to assist in retaining the services of such persons, to secure and retain the services of persons capable of filling such positions, and to provide incentives for such persons to exert maximum efforts for our success and the success of our affiliates. The material features of the 2019 Plan are outlined below. This summary is qualified in its entirety by reference to the complete text of the 2019 Plan which has been filed with the SEC.

 

67

 

 

Grants of Plan-Based Awards

 

None of our executive officers was granted any options or equity awards during 2021 or 2020 or held any options or other equity awards as of the date hereof.

 

In October 2019, we issued an aggregate of 293,750 shares to employees and contractors under the 2019 Equity Incentive Plan.

 

Outstanding Equity Awards

 

There are no outstanding equity awards granted pursuant to the 2019 Equity Incentive Plan.

 

Compensation of Directors

 

The following table sets forth information regarding the compensation paid to, earned by or accrued for our directors during the fiscal year ended December 31, 2023.

 

   DIRECTOR COMPENSATION 
Name 

Fees Earned
or Paid

In Cash
($)

   Stock
Awards
($)
   Option
Awards
($)
   Non-Equity
Incentive Plan
Compensation
($)
   Non-Qualified
Deferred
Compensation
Earnings ($)
   All Other
Compensation
($)
   Total ($) 
Yao-Te Wang  $37,000                   —        0   $37,000 
Quanzhong Lin  $0                    0   $0 
Christopher Lee  $9,600                            $9,600 
Huiliang Jiao  $12,000                       $12,000 

 

Pension, Retirement or Similar Benefit Plans

 

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. We have no material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of the board of directors or a committee thereof.

 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

 

Transactions with Related Persons

 

The following includes a summary of transactions since January 1, 2022 and certain ongoing transactions, or any currently proposed transaction, in which we were or are to be a participant and the amount involved exceeded or exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years, and in which any related person had or will have a direct or indirect material interest (other than compensation described under “Executive Compensation”). We believe the terms obtained or consideration that we paid or received, as applicable, in connection with the transactions described below were comparable to terms available or the amounts that would be paid or received, as applicable, in arm’s-length transactions.

 

68

 

 

Advance to/from related parties

 

As of December 31, 2022 and 2021, the Company had accounts payable in the amount of $165,958 and $0, respectively, due to Luquan Shengcaofeng Biotechnology Co., Ltd., an affiliate of Runcangsheng, for the purchase of raw materials. This payable was satisfied during 2023.

 

From time to time, we have advanced certain amounts to pharmacies owned by Quanzhong Lin. The amount due from each of such entities as of the end of 2022 and 2021, and as of September 30, 2023, was as follows:

 

  

September 30,

2023

  

December 31,

2022

  

December 31,

2021

 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $7,573   $9,708   $4,583 
Sichuan Aixin Investment Co., Ltd   8,983    145    4,237 
Huiliang Jiao   135,328    -    - 
Xiaoyan Zhou   11,668    -    - 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   25,056    26,125    - 
Chengdu WenJiang Aixin Huiwan Pharmacy Co., Ltd.   3,888    -    - 
Chengdu Heshengyuan Pharmacy Co., Ltd.   3,379    -    - 
Chengdu Zhiweibing Pharmacy Co., Ltd.   7,859    -    - 
Chengdu Tongtai Tang Pharmacy Co. Ltd.   2,810    -    - 
Chengdu city Wuhou District Xiaofei Pharmacy Co., Ltd   8,115    -    - 
Chongqing Aixin Hui Pharmacy Co., Ltd.   402    -    - 
Sichuan Xintang Xinfu Pharmacy Chain Co, Ltd   344    -    - 
Sichuan Aixintang Xinfu Chain Pharmacy Co., Ltd.   302    -    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   26,822    34,622    - 
Chengdu Cigu Foshou Pharmacy   2,028    -    - 
Mianyang Aixin Cunshan Pharmacy   5,874    -    - 
Chengdu Aixin International Travel Service Co., Ltd   356    -    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   133,801    12,502    10,235 
Total  $384,588   $83,102   $19,055 

 

From time to time, we have received advances from certain affiliates. The amounts due to such affiliates as of the end of 2022 and 2021, and as of September 30, 2023 was as follows:

 

  

September 30,

2023

  

December 31,

2022

  

December 31,

2021

 
Quanzhong Lin  $243,323   $140,644   $1,822,705 
Yirong Shen   84,978    89,892    97,292 
Branch Manager   -    -    1,667 
Sichuan Haosen Haichuan business management Co. Ltd   57    -    - 
Sichuan Yunxi Pharmacy Co. Ltd   449    -    - 
Aixin Life Beauty   -    -    7,724 
Chengdu Yi Yan Tang Pharmacy Co. Ltd.   162    -    - 
Chengdu Aixin E-Commerce Company Ltd   -    -    15,378 
Chengdu Aixin International travel service Co, Ltd   4,950    6,346    2,388 
Total  $333,919   $236,882   $1,947,154 

 

All the entities in the above list are controlled by Quanzhong Lin. These advances to and from related parties were for working capital purposes, payable on demand, and bear no interest. Yirong Shen was a shareholder of Aixin Shangyan Hotel prior to the closing of Hotel Purchase Agreement and serves as the supervisor of Aixin Shangyan Hotel.

 

Acquisitions from a Major Shareholder

 

In September 2021, we completed the acquisition of nine pharmacies located in Chengdu by acquiring the entities which owned the pharmacies for an aggregate purchase price of RMB34,635,845, or approximately US$5.31 million (“Transfer Price”). Our Chairman, Quanzhong Lin, was the principal shareholder of the entity which owned the pharmacies we acquired.

 

In July we completed the acquisition of AiXin Shangyan Hotel. Shangyan Hotel Company, which owns and operates a hotel located in the Jinniu District, Chengdu City. The hotel covers more than 8,000 square meters and has a large restaurant that can accommodate 600 people, six luxury dining rooms, a 200 square meter music tea house, 13 private tea rooms, 108 guest rooms and other supporting facilities. We acquired the hotel through an acquisition of the outstanding equity of AiXin Shangyan Hotel of which Mr. Lin was the principal shareholder, for a purchase price of RMB7,598,887, or approximately $1.16 million (“Transfer Price”).

 

In connection with the acquisitions of the pharmacies and hotel we made payments to Mr. Lin in the aggregate amount of $4.50 million.

 

Forgiveness of Loan; Contribution of Shares

 

On December 31, 2021, Mr. Lin forgave a loan previously made to the Company in the amount of $6,912,513. This was treated as a contribution to capital. On March 1, 2023, for no consideration other than the expenses to be incurred by the Company in connection with this offering, Mr. Lin agreed to contribute to the capital of the Company seven million shares of the common stock of the Company.

 

In May 2014, we entered into a lease with Mr. Lin for use of an office. We renewed the lease until April 30, 2024 2023, with monthly rent of RMB5,000 ($[ ]), payable quarterly.

 

Other than the foregoing, none of the directors or executive officers of the Company, nor any person who owned of record or was known to own beneficially more than 5% of the Company’s outstanding shares of its common stock, nor any associate or affiliate of such persons or companies, had any material interest, direct or indirect, in any transaction that occurred since January 1, 2019, or in any proposed transaction, which has materially affected or will affect the Company.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth, as of February 8, 2024, certain information concerning the beneficial ownership of our common stock by (i) each stockholder known by us to own beneficially five percent or more of our outstanding common stock; (ii) each director; (iii) each named executive officer; and (iv) all of our executive officers and directors as a group, and their percentage ownership and voting power. The column entitled “Percentage of Shares Beneficially Owned—Before Offering” is based on [24,999,842] shares of our common stock outstanding and does not give effect to the reduction in the number of our shares of common stock to be outstanding as a result of the seven million shares of our common stock to be contributed to our capital by Quanzhong Lin upon effectiveness of the Registration Statement of which this prospectus is a part.

 

69

 

 

The information presented below regarding beneficial ownership of our voting securities has been presented in accordance with the rules of the Securities and Exchange Commission and is not necessarily indicative of ownership for any other purpose. Under these rules, a person is deemed to be a “beneficial owner” of a security if that person has or shares the power to vote or direct the voting of the security or the power to dispose or direct the disposition of the security. A person is deemed to own beneficially any security which such person has the right to acquire sole or shared voting or investment power within sixty (60) days through the conversion or exercise of any convertible security, warrant, option, or other right. More than one (1) person may be deemed to be a beneficial owner of the same securities. The percentage of beneficial ownership by any person as of a particular date is calculated by dividing the number of shares beneficially owned by such person, which includes the number of shares as to which such person has the right to acquire voting or investment power within sixty (60) days, by the sum of the number of shares outstanding as of such date including the number of such shares which such person has the right to acquire. Consequently, the denominator used for calculating such percentage may be different for each beneficial owner. Except as otherwise indicated below and under applicable community property laws, we believe that the beneficial owners of our common stock listed below have sole voting and investment power with respect to the shares shown.

 

Name of Shareholder (1)  Amount and Nature of Beneficial Ownership   Percent of Common Stock Before the Offering   Percent of Common Stock After the Offering 
Directors and Executive Officers:              
                
Quanzhong Lin, Chairman and CEO    14,534,676(2)   58.14%(2)   

36.98

%(3)
                         
Yao-Te Wang, Director    1,884,336    7.54%(2)   

9.25

%(3)
                         

Christopher Lee, Director

   

0

    

-

      
                

Huiliang Jiao, Director

   

0

    

-

      
               

Tianfeng Li, CFO

   

0

    

-

      
                
All directors and executive officers as a group (five persons)   16,419,012(2)   65.68%(2)   

46.23

%(3)

 

  (1) The address of each beneficial owner is c/o AiXin Life International, Inc., Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District, Chengdu City, Sichuan Province, China
  (2) Does not give effect to the reduction in the number of our shares of common stock held by Mr. Lin as a result of the seven (7) million shares of our common stock to be contributed to our capital by him upon effectiveness of the Registration Statement of which this prospectus is a part.
  (3) Gives effect to the reduction in the number of our shares of common stock held by Mr. Lin to 7,534,676 shares as a result of the contribution to our capital of the seven (7) million shares of our common stock referred to in footnote (2).

 

DESCRIPTION OF CAPITAL STOCK

 

We have authorized capital stock consisting of 500,000,000 shares of common stock, $0.00001 par value per share and 20,000,000 shares of preferred stock, $0.001 par value per share.

 

As of the date of this prospectus, we have 24,999,842 shares of our common stock outstanding, without giving effect to the reduction in the number of our shares of common stock to be outstanding as a result of the seven million shares of our common stock to be contributed to our capital by Quanzhong Lin upon effectiveness of the Registration Statement of which this prospectus is a part.

 

The following description of our capital stock is a summary only and is subject to and qualified in its entirety by reference to the applicable provisions of the Colorado Business Corporations Act (“Colorado Act”), and our charter and Bylaws, copies of which have been filed as exhibits to the registration statement of which this prospectus is part. You should refer to, and read this summary together with, our Articles of Incorporation and Bylaws, each as amended and restated to date, to review all of the terms of our capital stock. Our Articles of Incorporation and amendments thereto are incorporated by reference as exhibits to the registration statement of which this prospectus is a part.

 

Common Stock

 

Holders of Shares of common stock have the right to cast one vote for each share of common stock in their name on the books of our Company, whether represented in person or by proxy, on all matters submitted to a vote of holders of common stock, including election of directors. There is no right to cumulative voting in election of directors. Except where a greater requirement is provided by statute, by our articles of incorporation, or by our bylaws, the presence, in person or by proxy duly authorized, of one or more holders of a majority of the outstanding Shares of our common stock constitutes a quorum for the transaction of business. The vote by the holders of a majority of outstanding Shares is required to effect certain fundamental corporate changes such as liquidation, merger, or amendment of our articles of incorporation.

 

70

 

 

There are no restrictions in our articles of incorporation or bylaws that prevent us from declaring dividends. The Colorado Act does, however, prohibit us from declaring dividends where, after giving effect to the distribution of the dividend (1) we would not be able to pay our debts as they become due in the usual course of business or (2) our total assets would be less than the sum of our total liabilities plus the amount that would be needed to satisfy the rights of stockholders who have preferential rights superior to those receiving the distribution.

 

Holders of Shares of our common stock are not entitled to preemptive or subscription or conversion rights, and no redemption or sinking fund provisions are applicable to our common stock. All outstanding Shares of common stock sold in the offering are, or when issued pursuant to the terms of any convertible securities or warrants will be, fully paid and non-assessable.

 

Each share of our common stock is entitled to equal dividends and distributions per share with respect to the common stock when, as and if declared by our Board of Directors. No holder of any shares of our common stock has a preemptive right to subscribe for any of our securities, nor are any shares of our common stock subject to redemption or convertible into other securities. Upon liquidation, dissolution or winding-up of the Company, and after payment to our creditors and preferred stockholders, if any, our assets will be divided pro rata on a share-for-share basis among the holders of our common stock. Each share of our common stock is entitled to one vote on all stockholder matters. Shares of our common stock do not possess any cumulative voting rights.

 

The presence of the persons entitled to vote a majority of the outstanding voting shares on a matter before the stockholders constitute the quorum necessary for the consideration of the matter at a stockholders’ meeting.

 

Except as otherwise required by law, the Articles of Incorporation, or any certificate of designations, (i) at all meetings of stockholders for the election of directors, a plurality of votes cast are sufficient to elect such directors; (ii) any other action taken by stockholders are be valid and binding upon the Company if the number of votes cast in favor of the action exceeds the number of votes cast in opposition to the action, at a meeting at which a quorum is present, except that adoption, amendment or repeal of the Bylaws by stockholders requires the vote of a majority of the shares entitled to vote; and (iii) broker non-votes and abstentions are considered for purposes of establishing a quorum but not considered as votes cast for or against a proposal or director nominee. Each stockholder has one vote for every share of stock having voting rights registered in his or her name, except as otherwise provided in any preferred stock designation setting forth the right of preferred stock stockholders.

 

The common stock does not have cumulative voting rights, which means that the holders of 51% of the common stock voting for election of directors can elect 100% of our directors if they choose to do so.

 

Preferred Stock

 

Our Articles of Incorporation gives our Board of Directors authority to issue shares of “blank check” preferred stock from time to time in one or more series, pursuant to resolutions adopted by the Board in accordance with the Colorado Act each having the voting powers, if any, designations, powers, preferences, and the relative, participating, optional, or other rights, if any, and the qualifications, limitations, or restrictions thereof, of any unissued series of preferred stock, to fix the number of shares constituting such series, and to increase or decrease the number of shares of any such series, but not below the number of shares thereof then outstanding, without the delay attendant to obtaining stockholder approval for such issuance.

 

We may issue preferred stock to effect a business combination, to raise capital or for other reasons. In addition, preferred stock could be utilized as a method of discouraging, delaying or preventing a change in control of our Company.

 

Our board of directors has no intention at the present time to create any additional series of preferred stock. The issuance of any new series of preferred stock could, depending on the terms of such series, impede the completion of a merger, tender offer or other takeover attempt.

 

71

 

 

Any future issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of us without further action by the shareholders and may adversely affect the voting and/or other rights of the holders of common stock or any other securities we may issue in the future. The issuance of shares of preferred stock, or the issuance of rights to purchase such shares, could be used to discourage an unsolicited acquisition proposal. For instance, the issuance of a series of preferred stock might impede a business combination by including class voting rights that would enable the holders to block such a transaction or facilitate a business combination by including voting rights that would provide a required percentage vote of the stockholders. In addition, under certain circumstances, the issuance of preferred stock could adversely affect the voting power of the holders of the common stock. Although our board of directors is required to make any determination to issue such stock based on its judgment as to the best interests of our stockholders, the board of directors could act in a manner that would discourage an acquisition attempt or other transaction that some, or a majority, of the stockholders might believe to be in their best interests or in which stockholders might receive a premium for their stock over the then market price of such stock. Our board of directors does not at present intend to seek stockholder approval prior to any issuance of currently authorized preferred stock, unless otherwise required by law.

 

SHARES ELIGIBLE FOR FUTURE SALE

 

Prior to this offering, there existed only a limited public market for our common stock. Future sales of substantial amounts of our common stock in the public market, including shares issued upon exercise of outstanding warrants, or the anticipation of such sales, could adversely affect prevailing market prices of our common stock from time to time and could impair our ability to raise equity capital in the future.

 

Upon the closing of this offering, we will have [20,374,842] shares of our common stock issued and outstanding. In addition, we will have [118,750] shares of common stock issuable upon the exercise of the Underwriter’s Warrants.

 

Lock-Up

 

For further details on the lock-up agreements, see the section entitled “Underwriting – Lock-Up Agreements.”

 

Rule 144

 

In general, under Rule 144 of the Securities Act, as in effect on the date of this prospectus, any person who is not our affiliate at any time during the preceding three months, and who has beneficially owned their shares for at least six months, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of shares of our common stock provided current public information about us is available, and, after owning such shares for at least one year, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of shares of our common stock without restriction.

 

A person who is our affiliate or who was our affiliate at any time during the preceding three months, and who has beneficially owned restricted securities for at least six months, including the holding period of any prior owner other than one of our affiliates, is entitled to sell within any three-month period a number of shares that does not exceed the greater of:

 

  1% of the number of shares of our common stock then outstanding, which will equal approximately 242,499 shares immediately after this offering; or
     
  the average weekly trading volume of our common stock during the four calendar weeks preceding the filing of a Notice of Proposed Sale of Securities pursuant to Rule 144 with respect to the sale.

 

Sales under Rule 144 by our affiliates are also subject to manner of sale provisions and notice requirements and to the availability of current public information about us.

 

72

 

 

UNDERWRITING

 

In connection with this offering, we will enter into an underwriting agreement with Boustead Securities, LLC, as the underwriter, with respect to the common stock in this offering. Under the terms and subject to the conditions contained in the underwriting agreement, the underwriter will agree to purchase from us on a firm commitment basis, and we have agreed to sell to the underwriter, the number of shares set opposite its name below, at the offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus:

 

Name   Number of shares  
Boustead Securities, LLC        
Total        

 

The common stock sold by the underwriter to the public will initially be offered at the offering price set forth on the cover page of this prospectus. Any common stock sold by the underwriter to securities dealers may be sold at a discount from the public offering price not to exceed $[*] per share. If all of the shares of common stock are not sold at the public offering price, the underwriter may change the offering price and the other selling terms. The underwriter has advised us that that it does not intend to make sales to discretionary accounts.

 

The underwriting agreement will provide that the obligations of the underwriter to pay for and accept delivery of the common stock are subject to the passing upon certain legal matters by counsel and certain conditions such as confirmation of the accuracy of representations and warranties by us about our financial condition and operations and other matters. The obligation of the underwriter to purchase the common stock is conditioned upon our receiving approval to list the common stock on the Nasdaq Capital Market.

 

Over-Allotment Option

 

If the underwriter sells more shares of common stock than the total number set forth in the table above, we have granted to the underwriter an option, exercisable one or more times in whole or in part, not later than 45 days after the date of this prospectus, to purchase from us up to additional [356,250] shares of common stock (constituting up to 15% of the shares of common stock sold in this offering, excluding the shares subject to this option), at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus. The underwriter may exercise this option solely for the purpose of covering over-allotments, if any, made in connection with this offering. Any shares of common stock issued or sold under the option will be issued and sold on the same terms and conditions as the other shares of common stock that are the subject of this offering.

 

Discounts and Commissions; Expenses

 

The underwriting discounts and commissions are a cash fee equal to eight percent (8%) of gross proceeds from the sale of securities in this offering. We have been advised by the underwriter that it proposes to offer the common stock to the public at the public offering price set forth on the cover of this prospectus and to dealers at a price that represents a concession not in excess of US$     per share under the public offering price. After the offering, the underwriter may change the public offering price and other selling terms.

 

The following table summarizes the public offering price and underwriting discounts and commissions payable to the underwriter by us in connection with this offering, assuming both the non-exercise and full exercise of the underwriter’s over-allotment option to purchase additional shares of common stock.

 

   Total 
   Per Share   Total Without
Exercise of
Over- Allotment
Option
  

Total With Full

Exercise of Over- Allotment Option
 
Public offering price  $4.00   $9,500,000   $10,925,000 
Underwriting discounts and commissions (8%)(1)  $0.32   $760,000   $874,000 
Proceeds, before expenses, to us  $3.68   $8,740,000   $10,051,000 

 

(1) Does not include (i) the warrant to purchase a number of shares of common stock equal to 5% of the number of shares sold in the offering, (ii) a 1% non-accountable expense allowance or (iii) amounts representing reimbursement of certain out-of-pocket expenses, each as described below.

 

We have agreed to pay a non-accountable expense allowance to the underwriter equal to 1% of the gross proceeds received at the closing of the offering.

 

We have agreed to reimburse the underwriter for reasonable out-of-pocket expenses incurred relating to the offering, regardless of whether the offering is consummated, not to exceed $125,000. Such accountable out-of-pocket expenses include no more than $75,000 in underwriter’s legal counsel fees, due diligence and other like expenses not to exceed $2,500; expenses relating to the preparation of bound volumes and Lucite cube mementos not to exceed $2,500; and background checks expenses not to exceed $7,500. Other than the aforementioned, any expense exceeding $2,500 shall be pre-approved in writing by us. Any advance that we pay to the underwriter to be applied against actual out-of-pocket accountable expenses will be refunded to us to the extent any portion of the advance is not actually incurred, in compliance with FINRA Rule 5110(g)(4)(A).

 

73

 

 

Underwriter’s Warrants

 

We have agreed to issue to the underwriter (or its permitted assignees) warrants to purchase up to a total of [*] shares of common stock, or [*] shares of common stock if the underwriter’s over-allotment option is exercised in full (constituting five percent (5%) of the shares of common stock sold in the offering) at an exercise price of $5.00 per share (125% of the public offering price). The Underwriter’s Warrants will be exercisable  at any time, and from time to time, in whole or in part, commencing on the closing of the offering and expiring five (5) years from the date on which sales of the shares offered hereby commence, will have a cashless exercise provision and will terminate on the fifth (5th) anniversary of the effective date of the registration statement of which this prospectus is a part. The Underwriter’s Warrant will also provide for customary anti-dilution provisions and “piggyback” registration rights with respect to the registration of the common stock underlying the warrants for a period of seven (7) years from the commencement of sales of this offering. We have registered the Underwriter’s Warrant and the common stock underlying the Underwriter’s Warrant in this offering.

 

The Underwriter’s Warrants and the underlying shares are deemed compensation by FINRA and therefore will be subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The underwriter (or permitted assignees) under FINRA Rule 5110(e)(1) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days immediately following commencement of sale of this offering subject to certain exceptions permitted by FINRA Rule 5110(e)(2).

 

The registration statement of which this prospectus is a part also registers for sale the Underwriter’s Warrants and the common stock issuable upon exercise of such warrants, as a portion of the underwriting compensation payable in connection with this offering.

 

Indemnification

 

We have agreed to indemnify the underwriter and certain of its controlling persons against certain liabilities, including liabilities under the Securities Act. If we are unable to provide this indemnification, we will contribute to payments that the underwriter may be required to make for these liabilities.

 

Future Services

 

In the event we pursue a future financing, including a registered, underwritten public offering of securities (in addition to this offering), a public or private offering of securities (debt or equity), a merger, acquisition of another company or business, change of control, sale of substantially all assets, business combination, recapitalization or other similar transaction (regardless of whether we would be considered an acquiring party, a selling party or neither in such transaction), and such future financing is consummated (a) solely with investors with whom the Company has had a conference call or a meeting arranged by the underwriter within the twelve (12) month period ended December 30, 2024, and (b) within twelve (12) months from the completion of this offering, the underwriter shall be entitled to a cash fee equal to eight percent (8%) of the proceeds of such future financing and warrants to purchase five percent (5%) of the securities sold in such future financing, which warrants shall have an exercise price equal to 125% of the exercise price of the purchase price of the securities sold in such future financing and having a term of five years.

 

74

 

 

No Sales of Similar Securities

 

We have agreed not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any shares of our common stock or other securities convertible into or exercisable or exchangeable for shares of our common stock at a price per share that is less than the price per share in this offering, or modify the terms of any existing securities, whether in conjunction with another broker-dealer or on the Company’s own volition, for a period of twelve months following the date on which shares of our common stock are trading on the Nasdaq Capital Market, without the prior written consent of the underwriter.

 

Lock-Up Agreements

 

Our officers, directors, and holders of 5% or greater of our common stock have agreed to be locked up for a period of twelve months from the date on which the trading of our common stock commences on the Nasdaq Capital Market. Holders of 1%-4.99% of our common stock have agreed to be locked up for a period of six months from the date on which the trading of our common stock commences on the Nasdaq Capital Market, provided that if the aggregate of such holders shares were to equal or exceed 20% of our issued and outstanding shares on a fully diluted basis prior to the completing of this offering, then their lock up period shall be for twelve months from the date of trading of our common stock commences on the Nasdaq Capital Market. Holders of less than 1% of our common stock are not subject to any lock up provided that if the aggregate of such holders shares were to equal or exceed 5% of our issued and outstanding shares on a fully diluted basis prior to the completing of this offering, then their lock up period shall be for six months from the date of trading of our common stock commences on the Nasdaq Capital Market. During the lock-up period, without the prior written consent of the underwriter, they shall not, directly or indirectly, (i) offer, pledge, assign, encumber, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock, owned either of record or beneficially by any signatory of the lock-up agreement on the date of the prospectus or thereafter acquired; (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the shares of common stock or any securities convertible into or exercisable or exchangeable for common stock, whether any such transaction described in clauses (i) or (ii) above is to be settled by delivery of common stock or such other securities, in cash or otherwise, or publicly announce an intention to do any of the foregoing; and (iii) make any demand for or exercise any right with respect to, the registration of any shares of common stock or any security convertible into or exercisable or exchangeable for common stock.

 

Trading; Nasdaq Listing

 

We have applied to list our common stock on the Nasdaq Capital Market under the symbol “AIXN”. There can be no assurance that our listing application will be approved by Nasdaq. The approval of our listing on the Nasdaq Capital Market is a condition of closing this offering.

 

Price Stabilization, Short Positions and Penalty Bids

 

In connection with the offering, the underwriter may purchase and sell shares in the open market. Purchases and sales in the open market may include short sales, purchases to cover short positions, which may include purchases pursuant to the over-allotment option, and stabilizing purchases. Short sales involve secondary market sales by an underwriter of a greater number of shares than they are required to purchase in the offering.

 

  “Covered” short sales are sales of shares in an amount up to the number of shares represented by the over-allotment option.
     
  “Naked” short sales are sales of shares in an amount in excess of the number of shares represented by the over-allotment option.
     
  Covering transactions involve purchases of shares either pursuant to the over-allotment option or in the open market after the distribution has been completed in order to cover short positions.
     
  To close a naked short position, an underwriter must purchase shares in the open market after the distribution has been completed. A naked short position is more likely to be created if an underwriter is concerned that there may be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering.
     
  To close a covered short position, an underwriter must purchase shares in the open market after the distribution has been completed or must exercise the over-allotment option. In determining the source of shares to close the covered short position, the underwriter will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option.
  Stabilizing transactions involve bids to purchase shares so long as the stabilizing bids do not exceed a specified maximum.

 

Purchases to cover short positions and stabilizing purchases, as well as other purchases by an underwriter for its own account, may have the effect of preventing or retarding a decline in the market price of the common stock. They may also cause the price of the common stock to be higher than the price that would otherwise exist in the open market in the absence of these transactions. The underwriter may conduct these transactions in the over-the-counter market or otherwise. If the underwriter commence any of these transactions, they may discontinue them at any time.

 

75

 

 

Determination of Offering Price

 

In determining the public offering price, we and the underwriter have considered a number of factors, including:

 

  the information set forth in this prospectus and otherwise available to the underwriter;
     
  our prospects and the history and prospects for the industry in which we compete;
     
  an assessment of our management;
     
  our prospects for future revenues and earnings;
     
  the general condition of the securities markets at the time of this offering;
     
  the recent market prices of, and demand for, publicly traded securities of generally comparable companies; and
     
  Other factors deemed relevant by the underwriter and us.

 

The estimated public offering price set forth on the cover page of this preliminary prospectus is subject to change as a result of market conditions and other factors. Neither we nor the underwriter can assure investors that an active trading market will develop for our common stock, or that the common stock will trade in the public market at or above the initial public offering price.

 

Electronic Distribution

 

A prospectus in electronic format may be made available on the websites maintained by the underwriter. In addition, the common stock may be sold by the underwriter to securities dealers who resell the common stock to online brokerage account holders. Other than the prospectus in electronic format, the information on the underwriter’s website and any information contained in any other website maintained by the underwriter is not part of the prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or the underwriter in its capacity as underwriter and should not be relied upon by investors.

 

76

 

 

Other Relationships

 

The underwriter and its respective affiliates may in the future engage in investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They may in the future receive customary fees and commissions for these transactions. Except for services provided in connection with this offering, the underwriter has not provided any financing, investment and/or advisory services to us during the 180 day period preceding the initial filing of the registration statement of which this prospectus forms a part, and as of the date of this prospectus, we do not have any agreement or arrangement with the underwriter to provide any of such services during the 60 day period following the effective date of such registration statement.

 

Offers Outside the United States

 

Other than in the United States, no action has been taken by us or the underwriter that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.

 

The underwriter is expected to make offers and sales both in and outside the United States through its selling agents. Any offers and sales in the United States will be conducted by broker-dealers registered with the SEC.

 

Canada

 

The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.

 

Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser’s province or territory for particulars of these rights or consult with a legal advisor.

 

Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriter is not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.

 

European Economic Area — Belgium, Germany, Luxembourg and Netherlands

 

The information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under the Regulation (EU) 2017/1129 (the “Prospectus Regulation”), as implemented in Member States of the European Economic Area (the “Relevant Member States”), from the requirement to produce a prospectus for offers of securities.

 

An offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following exemptions under the Prospectus Regulation:

 

  to legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;
     
  to any legal entity that has two or more of (i) an average of at least 250 employees during its last financial year, (ii) a total balance sheet of more than €43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements), and (iii) an annual net turnover of more than €50,000,000 (as shown in its last annual unconsolidated or consolidated financial statements);
     
  to fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive) subject to obtaining the prior consent of our Company or any underwriter for any such offer; or
     
  in any other circumstances falling within Article 3(2) of the Prospectus Regulation, provided that no such offer of securities shall result in a requirement for the publication by our Company of a prospectus pursuant to Article 3 of the Prospectus Regulation;

 

77

 

 

France

 

This document is not being distributed in the context of a public offering of financial securitestroffre au public de titres financiers) in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code monétaire et financier) and Articles 211-1, et seq. of the General Regulation of the French Autoritéestrairchés financiers (the “AMF”). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.

 

This document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.

 

Such offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investissestraintifiés) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2° and D.411-1 to D.411-3, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or (ii) a restricted number of non-qualified investors (ceestraintreint d’investisseurs non-qualifiés) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2° and D.411-4, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation.

 

Pursuant to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3 of the French Monetary and Financial Code.

 

Ireland

 

The information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering of securities in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the “Prospectus Regulations”). The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of a public offering, except to (i) qualified investors as defined in Regulation 2(l) of the Prospectus Regulations and (ii) fewer than 100 natural or legal persons who are not qualified investors.

 

Italy

 

The offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione Nazionale per le Societá e la Borsa (“CONSOB”)) pursuant to the Italian securities legislation and, accordingly, no offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (“Decree No. 58”), other than:

 

  to Italian qualified investors, as defined in Article 100 of Decree No. 58 by reference to Article 34-3 of CONSOB Regulation no. 11971 of 14 May 1999, as amended (“Regulation no. 11971”); and

 

  in other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of Regulation No. 11971 as amended.

 

Any offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements where a qualified investor solicits an offer from the issuer) under the paragraphs above must be:

 

  made by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable laws; and

 

  in compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.

 

Any subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules provided under Decree No. 58 and the Regulation No. 11971 as amended unless an exception from those rules applies. Failure to comply with such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring the securities for any damages suffered by the investors.

 

78

 

 

Portugal

 

This document is not being distributed in the context of a public offer of financial securities (oferta pública de valores mobiliários) in Portugal, within the meaning of Article 109 of the Portuguese Securities Code (Código dos Valores Mobiliários). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market Commission (Comissão do Mercado de Valores Mobiliários) for approval in Portugal and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to persons who are “qualified investors” (as defined in the Portuguese Securities Code). Only such investors may receive this document and they may not distribute it or the information contained in it to any other person.

 

Switzerland

 

The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (the “SIX”), or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering material relating to the securities may be publicly distributed or otherwise made publicly available in Switzerland.

 

Neither this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market Supervisory Authority.

 

This document is personal to the recipient only and not for general circulation in Switzerland.

 

United Kingdom

 

Neither the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services Authority in the United Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as amended (the “FSMA”)) has been published or is intended to be published in respect of the securities. This document is issued on a confidential basis to “qualified investors” (within the meaning of section 86(7) of FSMA) in the United Kingdom, and the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document, except in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in the United Kingdom.

 

Any invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply to our Company.

 

79

 

 

In the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (the “FPO”), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated. The investments to which this document relates are available only to, and any invitation, offer or agreement to purchase will be engaged in only with, such persons. Any person who is not such a person should not act or rely on this document or any of its contents.

 

Japan

 

The securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948), as amended (the “FIEL”), pursuant to an exemption from the registration requirements applicable to a private placement of securities to Qualified Institutional Investors (as defined in and in accordance with Article 2, paragraph 3 of the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan other than Qualified Institutional Investors. Any Qualified Institutional Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition by any such person of securities is conditional upon the execution of an agreement to that effect.

 

China

 

The information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People’s Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan). The securities may not be offered or sold directly or indirectly in the People’s Republic of China to legal or natural persons other than directly to “qualified domestic institutional investors.”

 

Hong Kong

 

The securities have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a) to “professional investors” as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b) in other circumstances which do not result in the document being a “prospectus” as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the securities has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to securities which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” as defined in the Securities and Futures Ordinance and any rules made under that Ordinance.

 

80

 

 

All applicable provisions of the FSMA with respect to anything done by the underwriter in relation to the shares must be complied with in, from or otherwise involving the United Kingdom.]

 

LEGAL MATTERS

 

We are being represented by Ellenoff Grossman & Schole LLP with respect to certain legal matters as to United States federal securities and New York State law. The validity of the shares of our common stock offered hereby has been passed upon for us by Armstrong Teasdale LLP, Denver, Colorado. The underwriter has been represented in connection with this offering by Bevilacqua PLLC. Certain legal matters relating to the offering as to PRC law will be passed upon for us by Beijing Dentons Law Offices, LLP (Chengdu) and for the underwriter by [  ]. Ellenoff Grossman & Schole LLP may rely upon Beijing Dentons Law Offices, LLP (Chengdu) with respect to matters governed by PRC Law. Bevilacqua PLLC may rely upon [  ] with respect to matters governed by PRC law.

 

EXPERTS

 

KCCW Accountancy Corp., independent registered public accounting firm, has audited our financial statements as of and for the years ended December 31, 2022 and 2021 as set forth in their report.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a registration statement on Form S-1 under the Securities Act, with respect to the shares of common stock being offered by this prospectus. This prospectus does not contain all of the information in the registration statement and its exhibits. For further information with respect to us and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference.

 

You can read our SEC filings, including the registration statement, over the Internet at the SEC’s website at www.sec.gov. You may also read and copy any document we file with the SEC at its public reference facilities at 100 F Street NE, Washington, D.C. 20549. You may also obtain copies of these documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street NE, Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities. You may also request a copy of these filings, at no cost, by writing us at AiXin Life International Inc., Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District, Chengdu City, Sichuan Province, China

 

We are subject to the information reporting requirements of the Exchange Act, and file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information are available for inspection and copying at the public reference room and web site of the SEC referred to above. We also maintain a website at www.addentax.com, at which, following the closing of this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website incorporated by reference in, and is not part of, this prospectus.

 

81

 

 

FINANCIAL STATEMENTS

 

Index to Consolidated Financial Statements   Page
Audited Financial Statements of AiXin Life International, Inc.    
Report of Independent Registered Public Accounting Firm (PCAOB ID: 2851)   F-2
Consolidated Balance Sheets as of December 31, 2022 and 2021   F-4
Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2022 and 2021   F-5
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2022 and 2021   F-6
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021   F-7
Notes to Consolidated Financial Statements for the years ended December 31, 2022 and 2021   F-8 – F-28
     

Unaudited Financial Statements of AiXin Life International, Inc.

   
Consolidated Balance sheets as of September 30, 2023 and December 31, 2022   F-29
Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2023 and 2022   F-30
Consolidated Statements of Stockholders Equity for the nine months ended September 30, 2023 and 2022   F-31
Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022   F-32
Notes to Consolidated Financial Statements for the nine months ended September 30, 2023 and 2022   F-33 – F-51

 

F-1

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

AiXin Life International, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of AiXin Life International, Inc. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for the years ended December 31, 2022 and 2021, in conformity with generally accepted accounting principles in the United States of America.

 

Consideration of the Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As described in Note 2 to the financial statements, the Company incurred recurring losses from operations and has an accumulated deficit, which raises substantial doubt about its ability to continue as a going concern. Management’s plans with regard to these matters are described in Note 2. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

F-2

 

 

Critical Audit Matter Description

 

As described in Note 2 to the consolidated financial statements, the Company’s products revenue is derived from the delivery of its products. The sale of products by the Company is considered complete when the products are delivered at that time the ownership and risk of loss have been transferred to the customer.

 

The Company considers the contracts with its customer contain one performance obligation, and the Company is entitled to the consideration when performance obligation is satisfied at a point in time. The amount of revenue to be recognized is determined by the contracts between the Company and its customer. The Company recognizes revenue when the product is delivered.

 

The principal considerations for our determination that performing procedures relating to revenue recognition, specifically the identification and evaluation of the timing and amount of revenue recognition, is a critical audit matter, involved judgment exercised by management in identifying and evaluating the performance obligation. Auditor judgement is involved in performing our audit procedures to evaluate whether the timing and amount of revenue recognition was appropriately stated.

 

How the Critical Audit Matter Will Be Addressed in the Audit

 

Our audit procedures over determining the timing and amount of revenue recognition involved, among others, evaluation of management’s assessment in regard to the identification of performance obligation of revenue. We selected sales transactions and performed the following procedures:

 

- Evaluated the terms and conditions of each selected transaction and the appropriateness of the accounting treatment within the context of the five-step model prescribed by ASC 606, Revenue from Contracts with Customers, and evaluated whether management’s conclusions were appropriate.

 

- Tested the accuracy of management’s recognition of revenue for the performance obligation.

 

/s/ KCCW Accountancy Corp.  

 

We have served as the Company’s auditor since 2019.

Diamond Bar, California

April 27, 2023

 

 

F-3

 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

 

   December 31,   December 31, 
   2022   2021 
Assets          
Current assets          
Cash and cash equivalents  $510,128   $8,556,642 
Restricted cash   109,772    44,211 
Accounts receivable, including related party, net   562,581    45,923 
Other receivables and prepaid expenses   42,631    143,281 
Advances to suppliers   168,523    162,969 
Inventory   499,252    233,454 
Advances to related parties   83,102    19,055 
Total current assets   1,975,989    9,205,535 
           
Property and equipment, net   1,971,793    290,148 
Intangible asset, net   1,269    1,940 
Deferred tax asset   15,556    18,795 
Security deposit   86,992    94,153 
Operating lease right-of-use assets   999,285    2,049,775 
Goodwill, net   -    - 
Total assets  $5,050,884   $11,660,346 
           
Liabilities and stockholders’ equity          
Current liabilities          
Accounts payable  $398,469   $406,163 
Accounts payable-related party   165,958    - 
Unearned revenue   139,502    171,408 
Taxes payable   104,100    232,637 
Accrued liabilities and other payables   2,356,490    752,400 
Government grant   950,371    - 
Loan from third parties   86,992    94,153 
Operating lease liabilities   883,583    848,230 
Advance from related parties   236,882    1,947,154 
Total current liabilities   5,322,347    4,452,145 
Operating lease liabilities - non-current   194,725    1,138,710 
Total liabilities   5,517,072    5,590,855 
           
Stockholders’ equity (deficit)          
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding   -    - 
Common stock, par value $0.00001 per share, 500,000,000 shares authorized; 24,999,842 shares issued and outstanding as of December 31, 2022 and 2021   250    250 
Additional paid in capital   14,458,583    14,087,043 
Statutory reserve   151,988    151,988 
Accumulated deficit   (15,249,858)   (8,880,613)
Accumulated other comprehensive income   172,849    710,823 
Total stockholders’ equity (deficit)   (466,188)   6,069,491 
           
Total liabilities and stockholders’ equity (deficit)  $5,050,884   $11,660,346 

 

The accompanying notes are an integral part of these financial statements

 

F-4

 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
         
Sales revenue:          
Products  $1,851,676   $742,624 
Advertising   -    1,944,811 
Room revenues   262,605    114,086 
Food and beverage revenues   475,746    201,755 
Others   118,533    62,957 
Total revenue, net   2,708,560    3,066,233 
           
Operating costs and expenses          
Cost of goods sold   1,103,160    535,485 
Hotel operating costs   1,739,948    744,594 
Selling   787,637    470,798 
General and administrative   1,395,008    1,033,830 
(Reversal of) provision for bad debts   (119,274)   (63,076)
Stock-based compensation   371,540    371,540 
Total operating costs and expenses   5,278,019    3,093,171 
           
Loss from operations   (2,569,459)   (26,938)
           
Non-operating income (expenses)          
Interest income   4,876    4,113 
Impairment loss   (3,823,770)   - 
Other income   51,856    63,064 
Other expenses   (31,651)   (33,154)
Total non-operating income (expenses), net   (3,798,689)   34,023 
           
(Loss) income before income tax   (6,368,148)   7,085 
           
Income tax expense   1,097    274,321 
           
Net loss   (6,369,245)   (267,236)
           
Other comprehensive items          
Foreign currency translation (loss) gain   (537,974)   122,283 
           
Comprehensive loss  $(6,907,219)  $(144,953)
           
Loss per share - basic and diluted  $(0.255)  $(0.011)
           
Weighted average shares outstanding - basic and diluted   24,999,842    24,999,842 

 

The accompanying notes are an integral part of these financial statements

 

F-5

 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

 

   Shares   Amount   paid in capital   Statutory reserves   Accumulated deficit   comprehensive income   Total 
   Common Stock   Additional           Accumulated other     
   Shares   Amount   paid in capital   Statutory reserves   Accumulated deficit   comprehensive income   Total 
                             
Balance at December 31, 2020   24,999,842   $250   $11,116,015   $151,988   $(4,964,711)  $588,540   $6,892,082 
Stock-based compensation   -    -    371,540    -    -    -    371,540 
Acquisition of subsidiaries   -    -    (4,313,025)   -    (3,648,666)   -    (7,961,691)
Debt forgiven by major shareholder   -    -    6,912,513    -    -    -    6,912,513 
Net loss   -    -    -    -    (267,236)   -    (267,236)
Foreign currency translation   -    -    -    -    -    122,283    122,283 
Balance at December 31, 2021   24,999,842    250    14,087,043    151,988    (8,880,613)   710,823    6,069,491 
Stock-based compensation   -    -    371,540    -    -    -    371,540 
Net loss   -    -    -    -    (6,369,245)   -    (6,369,245)
Foreign currency translation   -    -    -    -    -    (537,974)   (537,974)
Balance at December 31, 2022   24,999,842   $250   $14,458,583   $151,988   $(15,249,858)  $172,849   $(466,188)

 

The accompanying notes are an integral part of these financial statements

 

F-6

 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(6,369,245)  $(267,236)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   185,565    96,106 
Provision for bad debt   45,953    - 
Provision for inventory reserve   54,899    - 
Operating lease expense   837,425    411,607 
Stock-based compensation   371,540    371,540 
Deferred tax   1,858    (18,570)
Impairment loss   3,823,770    - 
Changes in assets and liabilities:          
Accounts receivable   (425,961)   (7,731)
Accounts receivable - related parties   (42)   13,618 
Other receivables and prepaid expenses   109,439    94,992 
Advances to suppliers   103,016    1,372 
Inventory   150,872    69,738 
Accounts payable   (71,153)   (27,341)
Accounts payable - related party   140,608    - 
Unearned revenue   (24,401)   (122,897)
Taxes payable   (137,711)   (57,467)
Payment of operating lease liabilities   (710,865)   (473,508)
Accrued liabilities and other payables   289,868    (142,027)
Net cash used in operating activities   (1,624,565)   (57,804)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Cash acquired from acquisition of subsidiaries   446,381    87,448 
Purchase of property and equipment   (156,723)   (1,341)
Payment for acquisition of subsidiaries   (3,812,027)   (4,517,620)
Net cash used in investing activities   (3,522,369)   (4,431,513)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Change in advance from related parties   (2,389,593)   1,204,442 
Repayment of loan from third parties   -    (368,648)
Capital contribution   -    4,386,070 
Net cash (used in) provided by financing activities   (2,389,593)   5,221,864 
           
EFFECT OF EXCHANGE RATE CHANGE ON CASH AND CASH EQUIVALENTS AND RESTRICTED CASH   (444,426)   191,617 
           
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH   (7,980,953)   924,164 
           
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR   8,600,853    7,676,689 
           
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR  $619,900   $8,600,853 
           
Supplemental Cash flow data:          
Income tax paid  $71,163   $404,276 
Interest paid  $-   $- 
           
           
Non-cash investing and financing activities          
Capital contribution from forgiveness of related party loan  $-   $2,446,238 

 

The accompanying notes are an integral part of these financial statements

 

F-7

 

 

AIXIN LIFE INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Aixin Life International, Inc. (the “Company” or “Aixin Life” or “we”) was incorporated under the laws of the State of Colorado on August 31, 2001 under the name Mercari Communications Group, Ltd (“Mercari”). On February 2, 2017, Mr. Quanzhong Lin (Mr. Lin) purchased 3,690,176 shares of the Company’s common stock, 65.0% of its outstanding shares from China Concentric Capital Group for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of our Company.

 

On December 12, 2017, the Company issued 28,419,075 shares of common stock to Mr. Lin, the sole stockholder of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), for his shares of AiXin BVI, pursuant to a Share Exchange Agreement.

 

As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXinZhonghong”), which markets and sells premium-quality nutritional products in China.

 

AiXin BVI was incorporated on September 21, 2017 as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 as an intermediate holding company. AiXinZhonghong was established in the People’s Republic of China (“PRC”) on March 4, 2013, and on May 27, 2017, the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXinZhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

 

For accounting purposes, the acquisition of AiXin BVI was accounted for as a reverse acquisition and treated as a recapitalization of the Company effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical consolidated financial statements of AiXinZhonghong are now the historical consolidated financial statements of the Company. The assets and liabilities of AiXinZhonghong were brought forward at their book value and no goodwill was recognized.

 

Effective February 1, 2018, the Company changed its name to AiXin Life International, Inc. (“Aixin Life”).

 

The Company, through its indirectly owned AiXinZhonghong subsidiary, develops and distributes consumer products by offering a line of nutritional products. The Company sells the products through exhibition events, conferences, and person-to-person marketing. Beginning in 2019, the Company began to provide advertising services to clients who engaged the Company to help distribute their products. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which it believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

 

On May 25, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Hotel Purchase Agreement”) with Chengdu Aixin Shangyan Hotel Management Co., Ltd (“Aixin Shangyan Hotel”), and its two shareholders Quanzhong Lin and Yirong Shen (“Transferor”). Pursuant to the Hotel Purchase Agreement, Aixin Life purchased 100% ownership of Aixin Shangyan Hotel from Transferor. Eighty percent of the equity of Aixin Shangyan Hotel was owned by Mr. Lin, and the remaining balance was owned by Ms. Shen. Under the terms of the Hotel Purchase Agreement, Aixin Life purchased all of the outstanding equity of Aixin Shangyan Hotel for a purchase price of RMB7,598,887, or approximately $1.16 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by Aixin Shangyan Hotel to the Transferor after December 31, 2020 and will be increased by an amount equal to any amounts contributed to Aixin Shangyan Hotel by the Transferor after December 31, 2020. The acquisition was completed in July 2021.

 

F-8

 

 

On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Pharmacies Purchase Agreement”) with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its three shareholders, Quanzhong Lin, Ting Li and Xiao Ling Li (“Transferor”). Mr. Lin owned in excess of 95% of the outstanding equity the Aixintang Pharmacies. The remaining equity interest was owned by Ting Li and Xiao Ling Li. Pursuant to the Pharmacies Purchase Agreement, AiXin HK purchased all of the outstanding equity of Aixintang Pharmacies for an aggregate purchase price of RMB34,635,845, or approximately US$5.31 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by any of the Aixintang Pharmacies to the Transferor after December 31, 2020 and increased by an amount contributed to any of the Aixintang Pharmacies by the Transferor after such date. The acquisition was completed in September 2021.

 

On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. The remaining equity interest is owned by Yun Chen. Pursuant to the Transfer Agreement, HK Aixin agreed to purchase all of the outstanding equity of Runcangsheng for an aggregate purchase price of $4,418,095 (RMB31,557,820), adjusted by $116,802 the amount equal to the initial net worth minus the audited net worth. In addition to transferring their respective equity interest in Runcangsheng by the Sellers, both Sellers agree to forgive any loans Runcangsheng due to them. The acquisition was completed on September 30, 2022 (see Note 17).

 

On February 17, 2023, the Company effected a 1 for 2 reverse stock split. As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.00001 per share. The Company has approximately 24,999,842 shares of outstanding common stock after the effect of reverse stock split. All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies and Runcangsheng is the Chinese Renminbi (“RMB”). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies and Runcangsheng. Intercompany transactions and accounts were eliminated in consolidation.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.

 

The Company has suffered losses from operations of $2,569,459, used net cash in operating activities of $1,624,565 for the year ended December 31, 2022, and has accumulated deficit of $15,249,858 as of December 31, 2022. These facts and conditions have raised substantial doubt about the Company’s ability to continue as a going concern. During the year ended December 31, 2022, the Company’s cash and cash equivalents decreased from $8,556,642 to $510,128 mainly due to operating losses, and net cash used in investing and financing activities.

 

F-9

 

 

Management believes that it has developed a liquidity plan, as summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business. The plan includes:

 

Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of higher margin products.

Raising additional cash through loans from related parties and potential equity offerings

 

While the Company’s management believes that the measures described in the above liquidity plan will be adequate to satisfy its liquidity requirements for the twelve months after the date that the financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.

 

COVID – 19; The Invasion of Ukraine

 

On March 11, 2020, the World Health Organization announced that infections caused by the corona virus disease of 2019 (“COVID-19”) had become pandemic. In furtherance of its zero tolerance policy, the Government of China has adopted various regulations and orders, including mandatory quarantines, limits on the number of people that may gather in one location, closing non-essential businesses and travel bans to limit the spread of the disease. Many of these measures have been relaxed from time to time in various localities. However, beginning in the second half of 2021 to the end of 2022, the rate of COVID-19 cases has fluctuated in China and has increased in many provinces and cities including in Sichuan Province, where the Company is located. As a result of such increases there have been periodic short-term lockdowns and restrictions on travel in Sichuan Province. All of the Company’s operations, in particular its direct sales business and hotel, have been adversely impacted by the travel and work restrictions imposed on a temporary basis in China and Chengdu to limit the spread of COVID-19. Since January 2023, China has dropped all COVID restrictions.

 

In response to COVID-19, the Company has implemented procedures to promote employee and customer safety. These measures will not significantly increase its operating costs. However, the Company cannot predict with certainty what measures may be taken by its suppliers and customers and the impact these measures may have on its future financial position, results of operations or cash flows.

 

The invasion of Ukraine by the Russian Federation had an immediate impact on the global economy resulting in higher prices for oil and other commodities. The United States, United Kingdom, European Union and other countries responded to Russia’s invasion of Ukraine by imposing various economic sanctions and bans. Russia has responded with its own retaliatory measures. These measures have disrupted financial and economic markets. The global impact of these measures is continually evolving and cannot be predicted with certainty and there is no assurance that Russia’s invasion of Ukraine and responses thereto will not further disrupt the global economy and financial markets.

 

While the invasion of Ukraine and responses thereto have not interrupted the Company’s operations, these or future developments resulting from the invasion of Ukraine could make it difficult to access debt and equity capital on attractive terms, if at all, and impact the Company’s ability to fund business activities, including proposed acquisitions.

 

Use of Estimates

 

In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

F-10

 

 

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

 

Cash and Cash Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

 

Restricted Cash

 

The restricted cash reflects the temporary freeze of bank accounts of Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”) and its branches by the court during the appeal of a judgement against Aixintang Pharmacy (see Note 16 – litigation).

 

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of December 31, 2022 and 2021, the bad debt allowance was $272,550 and $213,787, respectively.

 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the years ended December 31, 2022 and 2021:

 

               
   Years Ended December 31, 
   2022   2021 
         
Beginning balance  $213,787   $148,520 
Additions*   196,164    124,242 
Provisions for bad debt   45,953    - 
Recoveries/Write offs   (165,227)   (63,076)
Effect of translation   (18,127)   4,101 
Ending balance  $272,550   $213,787 

 

*Due to the acquisition of subsidiaries during the years ended December 31, 2022 and 2021

 

Inventories

 

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. Management periodically evaluates the composition of its inventories to identify slow-moving and obsolete inventories to determine if a valuation allowance is required. The balance of reserve for inventory valuation as of December 31, 2022 and 2021 was $73,821 and $0, respectively.

 

F-11

 

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of December 31, 2022 and 2021, there were no significant impairments of its long-lived assets.

 

Goodwill

 

The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.

 

The Company completed the required testing of goodwill for impairment as of December 31, 2022, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the Company anticipates future cash flows indicate that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $3,823,770, in non-operating expenses in the statement of operation and comprehensive income(loss).

 

F-12

 

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At December 31, 2022 and 2021, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and have been primarily from the delivery of products and the performance of services, and the Company has no significant post-delivery obligations, this did not result in a material recognition of revenue on the Company’s accompanying consolidated financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

 

F-13

 

 

The Company’s revenue recognition policies for its various operating segments are as follows:

 

Advertising and Products

 

Advertising Revenue

 

Commencing in the third quarter of 2019, AiXin Zhonghong began to provide advertising services to its clients. Advertising contracts are signed to establish the price and advertising services to be provided. Pursuant to the advertising contracts, the Company provides advertising and marketing services to its clients through exhibition events, conferences, and person-to-person marketing. The Company performs a credit assessment of the customer to assess the collectability of the contract price prior to entering into contracts.

 

Most of the advertisement contracts designated that the Company perform such advertising services for its clients through exhibition events, conferences, and person-to-person marketing during the contracted period, regardless of the number of such events. As such, the Company determined that the performance obligation is satisfied over time during the contracted period and revenue is recognized accordingly. Such advertising revenue amounted to $0 and $1,944,811 for the years ended December 31, 2022 and 2021, respectively.

 

All of the advertising revenue is subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Product Revenue

 

The Company’s revenue from sale of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have options of asking for an exchange for products with the same value.

 

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Pharmacies

 

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligation. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are eligible for the PRC VAT of 0% as it qualifies as a small business.

 

F-14

 

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for the sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small subject to exemption.

 

Unearned Revenue

 

The Company’s unearned revenue primarily consists of advances received from customers for the rental of hotel rooms prior to the delivery of service. The room rental services are delivered (normally within one year) based upon contract terms and customer demand.

 

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

 

During the year ended December 31, 2022, the Company had no customer that accounted for over 10% of its total revenue.

 

During the year ended December 31, 2021, the Company had two major customers that accounted for over 10% of its total revenue.

 

Customer  Net sales for the year ended
December 31, 2021
   % of total revenue 
A(1)  $1,286,792    42%
B   658,018    21%

 

During the year ended December 31, 2022, the Company had three major suppliers that accounted for over 10% of its total purchases.

 

Supplier  Net purchases for the
year ended
December 31, 2022
   % of total purchase 
C  $189,150    14%
D (2)   149,806    11%

 

F-15

 

 

During the year ended December 31, 2021, the Company had one major supplier accounted for over 10% of its total purchase.

 

Supplier  Net purchases for the
year ended
December 31, 2021
   % of total purchase 
E  $233,187    40%

 

(1) Represented advertising revenues from this customer during the year ended December 31, 2021. The Company also purchased inventory from this customer in year ended December 31, 2021.
(2) The Company purchased inventory from this supplier, Runcangsheng, in the year ended December 31, 2022. The Company acquired all of the outstanding equity of Runcangsheng on September 30, 2022 (see Note 17).

 

Leases

 

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

 

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

 

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of December 31, 2022 and 2021. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

 

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Fair Value of Financial Instruments

 

The carrying amounts of certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

F-16

 

 

  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

As of December 31, 2022 and 2021, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the year ended December 31, 2022 and 2021 consisted of net income (loss) and foreign currency translation adjustments.

 

Earnings per Share

 

Basic income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of December 31, 2022 and 2021, the Company did not have any potentially dilutive instruments.

 

Stock-Based Compensation

 

The Company periodically grants stock options, warrants and stock awards to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option, stock warrant and stock award grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option, stock warrant and stock award grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

F-17

 

 

The Company manages its business as four operating segments, advertising and products, pharmacies, hotels, and manufacture and sale, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

 

The following table shows the Company’s operations by business segment for the year ended December 31, 2022 and 2021. Revenues and expenses for the Pharmacies, Hotel and Manufacture and sale segments commenced as of the respective dates of the completion of their acquisitions:

 

               
   For the Years Ended December 31, 
   2022   2021 
Net revenue          
Advertising and products  $823,930   $2,406,988 
Pharmacies   789,347    280,447 
Hotel   856,884    378,798 
Manufacture and sale   238,399    - 
Total revenues, net  $2,708,560   $3,066,233 
           
Operating costs and expenses          
Advertising and products          
Cost of goods sold  $171,345   $316,750 
Operating expenses   1,526,246    1,344,543 
Pharmacies          
Cost of goods sold   578,092    218,735 
Operating expenses   622,835    252,513 
Hotel          
Hotel operating costs   1,739,948    744,594 
Operating expenses   310,902    216,036 
Manufacture and sale          
Cost of goods sold   353,723    - 
Operating expense   (25,072)   - 
Total operating costs and expenses  $5,278,019   $3,093,171 
           
(Loss) income from operations          
Advertising and products  $(873,661)  $745,695 
Pharmacies   (411,580)   (190,801)
Hotel   (1,193,966)   (581,832)
Manufacture and Sale   (90,252)   - 
(Loss) income from operations  $(2,569,459)  $(26,938)

 

         
Segment assets  As of
December 31, 2022
   As of
December 31, 2021
 
Advertising and products  $410,754   $8,914,211 
Pharmacies   758,675    931,706 
Hotel   970,385    1,814,429 
Manufacture and sale   2,911,070    - 
Total assets  $5,050,884   $11,660,346 

 

As the acquisition of Runcangsheng has been consummated as of December 31, 2022 (see Note 17), the revenues and operating results of the manufacture and sale segment will be included in the financial statements of the Company beginning on October 1, 2022.

 

F-18

 

 

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis. As a smaller reporting company, the standard will be effective for the Company for interim and annual reporting periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on the Company’s consolidated financial statements presentation or disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

 

3. OTHER RECEIVABLES AND PREPAID EXPENSES

 

Other receivables and prepaid expenses consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Deposits  $15,546   $68,433 
Prepaid expenses   9,490    50,221 
Employees’ social insurance   10,124    13,839 
Others   7,471    10,788 
Total  $42,631   $143,281 

 

F-19

 

 

4. ADVANCES TO SUPPLIERS

 

The Company had advances to suppliers of $168,523 and $162,969 as of December 31, 2022 and 2021, respectively. Advances to suppliers primarily include prepayments for products and equipment expected to be delivered subsequent to balance sheet dates.

 

5. INVENTORIES

 

Inventories consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Raw material  $62,462   $- 
Work in process   15,315    - 
Finished goods-health supplements   521    6,201 
Drugs, pharmaceutical and nutritional products   412,129    122,966 
Food and beverage, hotel supplies and consumables   82,646    104,287 
Total  $573,073   $233,454 
Less: reserve for inventory   73,821    - 
Total inventories, net  $499,252   $233,454 

 

6. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Vehicles  $426,836   $295,502 
Office furniture   82,549    64,263 
Electronic equipment   20,607    22,304 
Machinery   1,241,778    106,080 
Leasehold improvements   1,139,087    256,548 
Other   17,485    6,374 
Total   2,928,342    751,071 
Less: Accumulated depreciation   (956,549)   (460,923)
Property and equipment, net  $1,971,793   $290,148 

 

 

Depreciation expense for the years ended December 31, 2022 and 2021 was $183,542 and $95,026, respectively.

 

7. INTANGIBLE ASSET, NET

 

Intangible asset consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Software  $8,564   $7,896 
Less: Accumulated amortization   (7,295)   (5,956)
Intangible asset, net  $1,269   $1,940 

 

Amortization expense for the years ended December 31, 2022 and 2021 was $2,023 and $1,080.

 

F-20

 

 

8. TAXES PAYABLE

 

Taxes payable consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Value-added  $56,806   $97,917 
Income   30,919    109,396 
City construction   3,746    7,018 
Education   2,184    5,064 
Other   10,445    13,242 
Taxes payable  $104,100   $232,637 

 

9. ACCRUED LIABILITIES AND OTHER PAYABLES

 

Accrued liabilities and other payables consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Accrued employees’ social insurance  $270,349   $327,735 
Accrued payroll and commission   307,331    179,183 
Accrued rent expense   32,746    29,000 
Construction payable   1,384,674    111,807 
Payable for equipment purchase   32,278    - 
Accrued professional fees   233,894    50,840 
Deposit   11,308    12,239 
Other payables   83,910    41,596 
Total  $2,356,490   $752,400 

 

10. LOAN FROM THIRD PARTIES

 

As of December 31, 2022 and 2021, the Company had advances from former shareholders and unrelated third parties in an aggregate amount of $86,992 and $94,153, respectively. There was no written agreement, and these loans are payable on demand and bear no interest.

 

11. LEASE

 

Concurrent with the completion of the sale of its rights to a portion of a building completed in 2019, the Company entered into an agreement to lease a portion of the building back from the buyer over a lease term of 2 years. The Company accounted for this lease as an operating lease right-of-use asset and a corresponding operating lease liability in accordance with the Lease Standard. As a result, $207,049 (RMB1,389,731) was recorded as operating lease right-of-use asset and lease liability on March 31, 2019 when the lease commenced based on a 4.75% discount factor. The lease agreement expired on March 31, 2021. Commencing in April, 2021, the Company continues to lease the office on a monthly basis.

 

The Company also has operating leases for other sales locations under various operating lease arrangements. The leases have remaining lease terms of approximately 0.41 to 3.44 years.

 

Aixin Shangyan Hotel leases its hotel premises under an operating lease arrangement. The lease has a remaining lease term of approximately 1.00 year.

 

Aixintang Pharmacies lease retail pharmacy stores under operating lease arrangements, with remaining lease terms of 0.37 to 3.67 years.

 

F-21

 

 

Balance sheet information related to the Company’s leases is presented below:

 

   December 31, 2022   December 31, 2021 
Operating Leases          
Operating lease right-of-use assets  $999,285   $2,049,775 
           
Operating lease liabilities – current  $883,583   $848,230 
Operating lease liability – non-current   194,725    1,138,710 
Total operating lease liabilities  $1,078,308   $1,986,940 

 

The following provides details of the Company’s lease expenses:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Operating lease expenses  $837,425   $411,607 
           

 

Other information related to leases is presented below:

 

   Years Ended December 31, 
   2022   2021 
Cash Paid For Amounts Included In Measurement of Liabilities:        
Operating cash flows from operating leases  $710,865   $473,508 
           
Weighted Average Remaining Lease Term:          
Operating leases   1.45 years    2.32 years 
           
Weighted Average Discount Rate:          
Operating leases   4.75%   4.75%

 

Maturities of lease liabilities were as follows:

 

    
For the year ending December 31:    
2023  $899,044 
2024   127,361 
2025   53,196 
2026   22,433 
Total lease payments   1,102,034 
Less: imputed interest   (23,726)
Total lease liabilities   1,078,308 
Less: current portion   (883,583)
Lease liabilities – non-current portion  $194,725 

 

12. RELATED PARTY TRANSACTIONS

 

Account payables to related parties

 

As of December 31, 2022 and 2021, the Company had accounts payable to related party in the amount of $165,958 and $0, respectively, which was for the purchase of raw materials from Luquan Shengcaofeng Biotechnology Co., Ltd. (“Shengcaofeng”), an affiliate entity of Runcangsheng.

 

Advance to related parties

 

Advance to related parties consisted of the following as of the periods indicated:

 

   December 31, 2022   December 31, 2021 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $9,708   $4,583 
Sichuan Aixin Investment Co., Ltd.   145    4,237 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   26,125    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   34,622    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   12,502    10,235 
Total  $83,102   $19,055 

 

F-22

 

 

Advance from related parties

 

Advance from related parties consisted of the following as of the periods indicated:

 

   December 31, 2022   December 31, 2021 
Quanzhong Lin  $140,644   $1,822,705 
Yirong Shen   89,892    97,292 
Branch manager   -    1,667 
Chengdu Aixin E-Commerce Company Ltd.   -    15,378 
Chengdu Aixin International travel service Co, Ltd   6,346    2,388 
Aixin Life Beauty   -    7,724 
Total  $236,882   $1,947,154 

 

All the related party entities are controlled by Mr. Quanzhong Lin (the Chairman, President and major shareholder of Aixin Life). These advances to and from related parties were for working capital purpose, payable on demand, and bear no interest. Yirong Shen was a major shareholder of Aixin Shangyan Hotel prior to the closing of Hotel Purchase Agreement, and she serves as the supervisor of Aixin Shangyan Hotel.

 

Office lease from a Major Shareholder

 

In May 2014, the Company entered a lease with its major shareholder for an office. The lease term was for three years expiring in May 2017 with an option to renew. The monthly rent was RMB5,000 ($725), the Company was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease until May 28, 2023 with monthly rent of RMB5,000 ($725), payable quarterly. The future annual minimum lease payment at December 31, 2022 is $3,625 for the year ended December 31, 2023.

 

13. INCOME TAXES

 

The Company was incorporated in the United States of America (“USA”) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its sales from its operations in the PRC for the years ended December 31, 2022 and 2021, and recorded income tax provision for the periods.

 

China has a tax rate of 25% for all enterprises (including foreign-invested enterprises).

 

The components of the provision for income taxes for the years ended December 31, 2022 and 2021 consisted of the following:

 

   2022   2021 
   For the Year Ended December 31, 
   2022   2021 
Current:        
China  $(761)  $292,891 
Total current   (761)   292,891 
Deferred:          
China   1,858    (18,570)
Total deferred   1,858    (18,570)
Total income tax expense  $1,097   $274,321 

 

Deferred tax assets as of December 31, 2022 and 2021 consisted of the following:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Accumulated amortization  $15,556   $18,795 

 

F-23

 

 

The following table reconciles the statutory rates to the Company’s effective tax rate for years ended December 31, 2022 and 2021:

 

   2022   2021 
Statutory U.S. federal income tax rate   (21.0)%   21.0%
Foreign tax rate differential   (3.8)%   216.5%
Change in valuation allowances   25.0%   3,634.4%
Other   (0.2)%   -%
Effective combined tax rate   0.0%   3,871.9%

 

 

As of December 31, 2022, the Company had approximately $4,139,357 net operating loss carry-forwards available to offset future taxable income in China primarily from Aixin Shangyan Hotel and Aixintang Pharmacies. The Company’s net operating loss carry-forwards begins to expire in 2023. After consideration of all information available, management believes that uncertainty exists with respect to future realization of its deferred tax assets resulted from net operating loss carry-forwards due to the Company’s net loss, and established a full valuation allowance of deferred tax assets resulted from net operating loss carry-forwards.

 

Uncertain Tax Positions

 

Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the years ended December 31, 2022 and 2021, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

 

14. STOCKHOLDERS’ EQUITY

 

On August 17, 2020, by unanimous written consent in lieu of a meeting, the Board adopted resolutions authorizing a one (1)-for-four (4) reverse stock. The reverse stock split became effective on October 27, 2020. According to the Articles of Amendment, the Company is authorized to issue 20,000,000 shares of blank check preferred stock at $0.001 par value and 500,000,000 shares of common stock at $.00001 par value per share

 

Pursuant to resolutions adopted by the Board of Directors and the holders of a majority of the outstanding shares of common stock of AiXin Life International, Inc. on January 6, 2023, the Company filed an amendment to its Articles of Incorporation with respect to a proposed 1 for 2 “reverse” split of our common stock (the “Amendment”). Completion of the proposed reverse stock split was to be effected on a date determined by our Board of Directors only upon receipt of notice from the Financial Industry Regulatory Authority (“FINRA”) that it would process the proposed reverse stock split. The Company received notice from FINRA and its common stock began trading on a post-split basis on February 17, 2023.

 

As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock. The Company has approximately 24,999,842 shares of outstanding common stock after the effect of reverse stock split.

 

All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

As of December 31, 2022 and 2021, the Company had 24,999,842 common shares issued and outstanding.

 

Stock Awards Issued for Services

 

On October 22, 2019, the Company granted and issued 18,750 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $337,500 based on the post-split closing price of $18 on the grant date.

 

F-24

 

 

On October 24, 2019, the Company granted and issued 275,000 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $1,520,200 based on the post-split closing price of $5.528 on the grant date.

 

The stock awards will vest over five (5) years from the grant date, and the grantee will forfeit a portion of the shares granted (“Shares Granted”) if the grantee is no longer employed by or contracted with the Company. Specifically, the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture.

 

For the years ended December 31, 2022 and 2021, stock-based compensation expenses were $371,540 each. As of December 31, 2022, unrecognized compensation expenses related to these stock awards are $672,667. These expenses are expected to be recognized over 2 years.

 

Forgiveness of shareholder’s loan

 

As of December 31, 2021, the Company’s major shareholder Mr. Lin forgave his loan to the Company for $6,912,513. The Company recorded this forgiveness of shareholder loan as additional paid-in capital.

 

Acquisition of Subsidiaries

 

As of December 31, 2021, the Company completed the acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies (see Note 1). The acquisitions were accounted for as acquisitions of entities under common control. In connection with the acquisitions, the Company made payments to Mr. Lin in the aggregate amount of $4.50 million, or RMB29 million. The difference between the consideration given and the net assets received was recognized in equity, resulting in a decrease of additional paid-in capital of $4,313,025.

 

15. STATUTORY RESERVES

 

Pursuant to the PRC corporate law, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings.

 

Surplus reserve fund

 

The Company is required to transfer 10% of its net income, as determined under PRC accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the Company’s registered capital. During the years ended December 31, 2022 and 2021, the Company make $0 and $0 contribution to statutory reserve fund.

 

The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital.

 

Common welfare fund

 

Common welfare fund is a voluntary fund to which the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations. The Company did not make any contribution to this fund during the years ended December 31, 2022 and 2021.

 

F-25

 

 

This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

 

16. OPERATING CONTINGENCIES

 

The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

 

The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.

 

Litigation

 

The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.

 

In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Haichuan Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang City People’s Court of Jiangsu Province. The complaint alleges that Jian Yiao is entitled to RMB2,500,000 ($392,305) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay RMB2,500,000 ($392,305) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court of Jiangsu Province against the determination reached from the first trial.

 

In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. As of the date of this report, this legal proceeding remains pending.

 

In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of December 31, 2022 and 2021.

 

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

 

17. ACQUISITIONS OF SUBSIDIARIES

 

 ACQUISITION OF SUBSIDIARIES

Aixin Shangyan Hotel and Aixintang Pharmacies

 

In July and September, 2021, the Company completed the required governmental procedures and obtained the documents necessary to consider the acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies completed.

 

F-26

 

 

Pursuant to the Hotel Purchase Agreement, AiXin HK purchased all of the outstanding equity of Aixin Shangyan Hotel from Mr. Lin and the other shareholder for a purchase price of RMB7,598,887, or $1.16 million.

 

Pursuant to the Pharmacies Purchase Agreement, AiXin HK purchased 100% ownership of Aixintang Pharmacies from Mr. Lin and the other two shareholders for a purchase price of RMB34,635,845 or $5.31 million.

 

The acquisitions will be accounted for as acquisitions of entities under common control under ASC 805-50-15-6, and the assets and liabilities acquired will be measured and recorded at the carrying amount under ASC 805-50-30-5.

 

Runcangsheng

 

On July 19, 2022, the Company entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd (“Shengshengyuan”) and Yun Chen (collectively “the Sellers”), who own 95% and 5% equity interest of Yunnan Runcangsheng Technology Co., Ltd (“Runcangsheng”), respectively.

 

Under the terms of the Transfer Agreement, the Company agreed to purchase all of the outstanding equity interest of Yunnan Runcangsheng for an aggregate purchase price of RMB31,557,820, or $4,418,095, adjusted by $116,802, the amount equal to the initial net worth estimate minus the audited net worth of Runcangsheng as of December 31, 2021. In addition to transferring their respective equity interest in Runcangsheng, both Sellers agree to forgive any loans due to them from Runcangsheng. The acquisition was completed on September 30, 2022.

 

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition. Goodwill as a result of the acquisition of Runcangsheng is calculated as follows:

 

     
Total purchase considerations  $4,301,293 
Estimated fair value of assets acquired:     
Cash  $446,381 
Accounts receivable   144,813 
Accounts receivable-related party   133,011 
Advance to suppliers   3,455 
Other receivables and prepaid expense   127,909 
Inventory   469,594 
Property and equipment   1,677,272 
Intangible assets   1,406 
Operating lease right-of-use assets   1,990 
Total assets acquired   3,005,831 
Estimated fair value of liabilities assumed:     
Accounts payable   (89,801)
Accounts payable-related party   (160,911)
Advance from customers   (4,790)
Government grant   (921,473)
Taxes payable   (21,156)
Operating lease liability   (15,182)
Accrued liabilities and other payables   (1,314,995)
Total liabilities assumed   (2,528,308)
Total net assets acquired   477,523 
Goodwill as a result of the acquisition  $3,823,770 

 

During the year ended December 31, 2022, the Company has recorded goodwill impairment in full amount.

 

The following condensed unaudited pro forma consolidated results of operations for the Company, Runcangsheng, Aixin Shangyan Hotel and Aixintang Pharmacies for the years ended December 31, 2022 and 2021 present the results of operations of the Company, Runcangsheng, Aixin Shangyan Hotel, and Aixintang Pharmacies as if the acquisitions occurred on January 1, 2022 and 2021, respectively.

 

F-27

 

 

The pro forma results are not necessarily indicative of the actual results that would have occurred had the acquisitions been completed as of the beginning of the periods presented, nor are they necessarily indicative of future consolidated results.

 

  

For the

Year Ended

December 31, 2022

 
Revenue  $3,168,061 
Operating costs and expenses   5,605,508 
Loss from operations   (2,437,447)
Other income   34,839 
Income tax expense   1,097 
Net loss  $(2,403,705)

 

  

For the

Year Ended

December 31, 2021

 
Revenue  $5,025,140 
Operating costs and expenses   6,052,664 
Loss from operations   (1,027,524)
Other income   100,086 
Income tax expense   284,903 
Net loss  $(1,212,341)

 

18. SUBSEQUENT EVENT

 

The Company follows the guidance in FASB ASC 855-10 for the disclosure of subsequent events. The Company evaluated subsequent events through the date the financial statements were issued and determined the Company has no material subsequent events need to be disclosed.

 

F-28

 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2023   2022 
   (Unaudited)     
         
Assets          
Current assets          
Cash and cash equivalents  $412,659   $510,128 
Restricted cash   85,676    109,772 
Accounts receivable, including related parties, net   250,561    562,581 
Other receivables and prepaid expenses, including related party   143,324    42,631 
Advances to suppliers   144,613    168,523 
Inventory, net   643,623    499,252 
Due from related parties   384,588    83,102 
Total current assets   2,065,044    1,975,989 
           
Property and equipment, net   1,658,885    1,971,793 
Intangible asset, net   2,840    1,269 
Deferred tax asset   13,278    15,556 
Security deposit   82,237    86,992 
Operating lease right-of-use assets   457,793    999,285 
Total assets  $4,280,077   $5,050,884 
           
Liabilities and stockholders’ equity          
Current liabilities          
Accounts payable  $599,373   $398,469 
Accounts payable-related party   -    165,958 
Unearned revenue   466,804    139,502 
Taxes payable   110,246    104,100 
Accrued liabilities and other payables   2,136,132    2,356,490 
Government grant   898,424    950,371 
Loan from third parties   82,237    86,992 
Operating lease liabilities   439,959    883,583 
Due to related parties   333,919    236,882 
Total current liabilities   5,067,094    5,322,347 
Operating lease liabilities - non-current   158,069    194,725 
Total liabilities   5,225,163    5,517,072 
           
Stockholders’ deficit          
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding   -    - 
Common stock, par value $0.00001 per share, 500,000,000 shares authorized; 24,999,842 shares issued and outstanding as of September 30, 2023 and December 31, 2022   250    250 
Additional paid in capital   14,882,538    14,458,583 
Statutory reserve   151,988    151,988 
Accumulated deficit   (16,195,184)   (15,249,858)
Accumulated other comprehensive income   215,322    172,849 
Total stockholders’ deficit   (945,086)   (466,188)
           
Total liabilities and stockholders’ deficit  $4,280,077   $5,050,884 

 

F-29
 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

      2023       2022    2023   2022 
     

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
      2023       2022    2023   2022 
                     
Sales revenue:                          
Products   $ 897,457     $ 503,062    $2,405,280   $888,690 
Room revenues     74,265       71,562     473,167    166,278 
Food and beverage revenues     77,524       64,321     356,009    356,840 
Others     17,673       33,841     63,233    100,543 
Total revenue, net     1,066,919       672,786     3,297,689    1,512,351 
                           
Operating costs and expenses                          
Cost of goods sold     509,723       215,383     1,136,411    493,905 
Hotel operating costs     447,419       404,322     1,387,993    1,334,041 
Selling     210,906       193,820     628,754    583,438 
General and administrative     499,638       232,642     1,268,119    752,113 
(Reversal of) provision for bad debts     41,603       67,638     (10,250)   115,495 
Stock-based compensation     92,885       92,885     278,655    278,655 
Total operating costs and expenses     1,802,174       1,206,690     4,689,682    3,557,647 
                           
Loss from operations     (735,255 )     (533,904 )   (1,391,993)   (2,045,296)
                           
Non-operating income (expenses)                          
Interest income     135       1,024     692    3,636 
Impairment loss     -       (3,823,770 )   -    (3,823,770)
Other income     13,293       12,134     52,395    41,789 
Government grant income     284,321       -     284,321    - 
Other expenses     (135 )     (29,317 )   (5,022)   (29,577)
Total non-operating income (loss), net     297,614       (3,839,929 )   332,386    (3,807,922)
                           
Loss before income tax     (437,641 )     (4,373,833 )   (1,059,607)   (5,853,218)
                           
Income tax expense (benefit)     515       (322 )   5,879    643 
                           
Net loss     (438,156 )     (4,373,511 )   (1,065,486)   (5,853,861)
                           
Other comprehensive items                          
Foreign currency translation gain (loss)     16,086       (139,053 )   42,473    (152,137)
                           
Comprehensive loss   $ (422,070 )   $ (4,512,564 )  $(1,023,013)  $(6,005,998)
                           
Loss per share - basic and diluted   $ (0.018 )   $ (0.175 )  $(0.043)  $(0.234)
                           
Weighted average shares outstanding     24,999,842       24,999,842     24,999,842    24,999,842 

 

F-30
 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

 

   Shares   Amount  

capital

   reserves   deficit   income   Total 
   Common Stock  

Additional

paid in

   Statutory   Accumulated  

Accumulated other

comprehensive

     
   Shares   Amount  

capital

   reserves   deficit   income   Total 
                             
Balance at December 31, 2022   24,999,842   $250   $14,458,583   $151,988   $(15,249,858)  $172,849   $(466,188)
Stock-based compensation   -    -    92,885    -    -    -    92,885 
Disposal of subsidiary   -    -    -    -    120,160    -    120,160 
Net loss   -    -    -    -    (529,784)   -    (529,784)
Foreign currency translation   -    -    -    -    -    24,542    24,542 
Balance at March 31, 2023   24,999,842    250    14,551,468    151,988    (15,659,482)   197,391    (758,385)
Stock-based compensation   -    -    92,885    -    -    -    92,885 
Shareholder contribution   -    -    145,300    -    -    -    145,300 
Net loss   -    -    -    -    (97,546)   -    (97,546)
Foreign currency translation   -    -    -    -    -    1,845    1,845 
Balance at June 30, 2023   24,999,842    250    14,789,653    151,988    (15,757,028)   199,236    (615,901)
Stock-based compensation   -    -    92,885    -    -    -    92,885 
Net loss   -    -    -    -    (438,156)   -    (438,156)
Foreign currency translation   -    -    -    -    -    16,086    16,086 
Balance at September 30, 2023   24,999,842   $250   $14,882,538   $151,988   $(16,195,184)  $215,322   $(945,086)
                                    
Balance at December 31, 2021   24,999,842   $250   $14,087,043   $151,988   $(8,880,613)  $710,823   $6,069,491 
Stock-based compensation   -    -    92,885    -    -    -    92,885 
Net loss   -    -    -    -    (752,081)   -    (752,081)
Foreign currency translation   -    -    -    -    -    31,864    31,864 
Balance at March 31, 2022   24,999,842    250    14,179,928    151,988    (9,632,694)   742,687    5,442,159 
Stock-based compensation   -    -    92,885    -    -    -    92,885 
Net loss   -    -    -    -    (728,269)   -    (728,269)
Foreign currency translation   -    -    -    -    -    (44,948)   (44,948)
Balance at June 30, 2022   24,999,842    250    14,272,813    151,988    (10,360,963)   697,739    4,761,827 
Stock-based compensation   -    -    92,885    -    -    -    92,885 
Net loss   -    -    -    -    (4,373,511)   -    (4,373,511)
Foreign currency translation   -    -    -    -    -    (139,053)   (139,053)
Balance at September 30, 2022   24,999,842   $250   $14,365,698   $151,988   $(14,734,474)  $558,686   $342,148 

 

F-31
 

 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   2023   2022 
   Nine Months Ended September 30, 
   2023   2022 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(1,065,486)  $(5,853,861)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   308,114    82,921 
(Reversal of) provision for bad debts   (10,250)   115,495 
Provision for inventory reserve   8,558    - 
Operating lease expense   618,085    632,496 
Stock based compensation   278,655    278,655 
Deferred tax   1,481    1,419 
Impairment loss   -    3,823,770 
Government grant income   (284,321)   - 
Changes in assets and liabilities:          
Accounts receivable   313,060    (126,720)
Accounts receivable - related parties   (11,434)   - 
Other receivables and prepaid expenses   (18,596)   100,801 
Prepaid expense - related party   (97,872)   - 
Advances to suppliers   133,520    13,038 
Inventory   (186,658)   (192,791)
Accounts payable   233,112    58,507 
Accounts payable - related party   (162,768)   143,242 
Unearned revenue   347,347    (9,444)
Taxes payable   12,273    (187,009)
Payment of lease liability   (500,056)   (525,979)
Accrued liabilities and other payables   (136,638)   232,910 
Net cash used in operating activities   (219,874)   (1,412,550)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Cash disposed at disposal of subsidiary   (3,341)   - 
Cash acquired at acquisition of subsidiaries   -    446,381 
Purchase of property and equipment   (212,607)   (52,485)
Purchase of intangible asset   (2,608)   - 
Net cash used in investing activities   (218,556)   393,896 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Change in advance from related parties   (79,072)   (1,525,860)
Capital contribution   142,200    - 
Proceeds from government grant   284,321    - 
Net cash provided by (used in) financing activities   347,449    (1,525,860)
           
EFFECT OF EXCHANGE RATE CHANGE ON CASH   (30,584)   (677,533)
           
NET DECREASE IN CASH & RESTRICTED CASH   (121,565)   (3,222,047)
           
CASH & RESTRICTED CASH, BEGINNING OF PERIOD   619,900    8,600,853 
           
CASH & RESTRICTED CASH, END OF PERIOD  $498,335   $5,378,806 
           
Supplemental Cash flow data:          
Income tax paid  $4,398   $72,495 
Interest paid  $-   $- 
           
Non-cash investing and financing activities:          
Accrual of unpaid investment in subsidiary  $-   $3,907,139 
Investment in subsidiary paid by shareholder on behalf of the Company  $-   $734,290 

 

F-32
 

 

AIXIN LIFE INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Aixin Life International, Inc. (the “Company” or “Aixin Life” or “we”) was incorporated under the laws of the State of Colorado on August 31, 2001. On February 2, 2017, Mr. Quanzhong Lin (Mr. Lin) purchased 65.0% of the Company’s outstanding shares from China Concentric Capital Group for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of the Company.

 

On December 12, 2017, pursuant to a Share Exchange Agreement, in consideration for all of the outstanding shares of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), the Company issued to Mr. Lin, the sole stockholder of AiXin BVI, shares of common stock then representing 71% of the outstanding of common stock of the Company.

 

As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXinZhonghong”), which markets and sells premium-quality nutritional products in China.

 

AiXin BVI was incorporated on September 21, 2017 as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 as an intermediate holding company. AiXinZhonghong was established in the People’s Republic of China (“PRC”) on March 4, 2013, and on May 27, 2017, the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXinZhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

 

For accounting purposes, the acquisition of AiXin BVI was accounted for as a reverse acquisition and treated as a recapitalization of the Company effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical consolidated financial statements of AiXinZhonghong are now the historical consolidated financial statements of the Company. The assets and liabilities of AiXinZhonghong were brought forward at their book value and no goodwill was recognized.

 

Effective February 1, 2018, the Company changed its name to AiXin Life International, Inc. (“Aixin Life”).

 

The Company, through its indirectly owned AiXinZhonghong subsidiary, develops and distributes consumer products by offering a line of nutritional products. The Company sells the products through exhibition events, conferences, and person-to-person marketing. Beginning in 2019, the Company began to provide advertising services to clients who engaged the Company to help distribute their products. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which it believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

 

On May 25, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Hotel Purchase Agreement”) with Chengdu Aixin Shangyan Hotel Management Co., Ltd (“Aixin Shangyan Hotel”), and its two shareholders Quanzhong Lin and Yirong Shen (“Transferor”). Pursuant to the Hotel Purchase Agreement, Aixin Life purchased 100% ownership of Aixin Shangyan Hotel from Transferor. Eighty percent of the equity of Aixin Shangyan Hotel was owned by Mr. Lin, and the remaining balance was owned by Ms. Shen. Under the terms of the Hotel Purchase Agreement, Aixin Life purchased all of the outstanding equity of Aixin Shangyan Hotel for a purchase price of RMB 7,598,887, or approximately $1.16 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by Aixin Shangyan Hotel to the Transferor after December 31, 2020 and will be increased by an amount equal to any amounts contributed to Aixin Shangyan Hotel by the Transferor after December 31, 2020. The acquisition was completed in July 2021.

 

On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Pharmacies Purchase Agreement”) with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its three shareholders, Quanzhong Lin, Ting Li and Xiao Ling Li (“Transferor”). Mr. Lin owned in excess of 95% of the outstanding equity the Aixintang Pharmacies. The remaining equity interest was owned by Ting Li and Xiao Ling Li. Pursuant to the Pharmacies Purchase Agreement, AiXin HK purchased all of the outstanding equity of Aixintang Pharmacies for an aggregate purchase price of RMB 34,635,845, or approximately US$5.31 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by any of the Aixintang Pharmacies to the Transferor after December 31, 2020 and increased by an amount contributed to any of the Aixintang Pharmacies by the Transferor after such date. The acquisition was completed in September 2021.

 

F-33
 

 

On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. The remaining equity interest is owned by Yun Chen. Pursuant to the Transfer Agreement, HK Aixin agreed to purchase all of the outstanding equity of Runcangsheng for an aggregate purchase price of $4,418,095 (RMB 31,557,820), adjusted by $116,802 the amount equal to the initial net worth minus the audited net worth. In addition to transferring their respective equity interest in Runcangsheng by the Sellers, both Sellers agree to forgive any loans Runcangsheng due to them. The acquisition was completed on September 30, 2022 (see Note 17).

 

On February 17, 2023, the Company effected a 1 for 2 reverse stock split. As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.00001 per share. The Company has approximately 24,999,842 shares of outstanding common stock after the effect of reverse stock split and the elimination of fractional shares. All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies, and Runcangsheng is the Chinese Renminbi (“RMB”). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies, and Runcangsheng. Intercompany transactions and accounts were eliminated in consolidation. These unaudited interim financial statements should be read in conjunction with the annual consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

Unaudited Interim Financial Information

 

These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission that permit reduced disclosure for interim periods. Therefore, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.

 

The Company has suffered net losses of $438,156 and $4,373,511 for the three months ended September 30, 2023 and 2022, and $1,065,486 and $5,853,861 for the nine months ended September 30, 2023 and 2022, respectively, and used net cash in operating activities of $219,874 and $1,412,550 for the nine months ended September 30, 2023 and 2022, respectively, and has an accumulated deficit of $16,195,184 as of September 30, 2023. These facts and conditions raise substantial doubt about the Company’s ability to continue as a going concern. From January 1, 2023 through September 30, 2023, the Company’s cash and cash equivalents decreased from $510,128 to $412,659 mainly due to operating losses, and the use of cash to support operating activities.

 

F-34
 

 

Management believes that it has developed a liquidity plan, summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business. The plan includes:

 

● Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of higher margin products.

 

● Raising cash through loans from related parties and potential equity offerings.

 

While the Company’s management believes that the measures in its liquidity plan including those described above will be adequate to satisfy its liquidity requirements for the twelve months after the date that these financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.

 

Global Uncertainties

 

The Company’s liquidity may be adversely impacted by various risks and uncertainties, including, but not limited to future and current impacts of global events such as a widespread health crisis, the continuation of the war in the Ukraine or the conflict in Palestine, the outbreak of another conflict or the expansion of the conflict in Palestine to other countries, the ongoing tensions between the United States and China, the Russian Federation and certain countries in the Middle East, increases in inflation, and other risks detailed in in the Company’s Annual Report on Form 10-K or other reports filed with the Securities and Exchange Commission.

 

While the invasion of Ukraine, the conflict in Palestine and responses thereto have not interrupted the Company’s operations, these or future developments which disrupt the international financial markets could make it difficult to access debt and equity capital on attractive terms, if at all, and impact the Company’s ability to fund business activities, including proposed acquisitions.

 

Use of Estimates

 

In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

Significant estimates required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

 

Cash and Cash Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

 

Restricted Cash

 

The restricted cash was cash maintained in temporarily frozen bank accounts held by Aixintang Pharmacy and its branches by the court for a judgement against Aixintang Pharmacy which Aixintang Pharmacy is in the process of appealing (see Note 16 – litigation).

 

F-35
 

 

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of September 30, 2023 and December 31, 2022, the bad debt allowance was $247,753 and $272,550 respectively.

 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
   For the nine Months ended September 30, 
   2023   2022 
         
Beginning balance  $272,550   $213,787 
Provision for bad debts   62,100    115,495 
Acquisition of subsidiary   -    185,561 
Recoveries/Write offs   (72,350)   - 
Effect of translation   (14,547)   (31,497)
Ending balance  $247,753   $483,346 

 

Inventories

 

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. The Company recorded provision for inventory reserve of $8,558 and $0 for the nine months ended September 30, 2023 and 2022, respectively.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of September 30, 2023 and December 31, 2022, there were no significant impairments of its long-lived assets.

 

F-36
 

 

Goodwill

 

The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.

 

The Company completed the required testing of goodwill for impairment as of December 31, 2022, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the uncertainty of the future cash flows indicates that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $3,823,770, in non-operating expenses in the statement of operations and comprehensive income (loss) during the year ended December 31, 2022.

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At September 30, 2023 and December 31, 2022, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

F-37
 

 

Revenue Recognition

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

The Company’s revenue recognition policies for its various operating segments are as follows:

 

Products

 

The Company’s revenue from sales of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have the option of asking for an exchange for products with the same value.

 

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Pharmacies

 

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligations. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are eligible for the PRC VAT of 0% as it qualifies as a small business.

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for its sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small business subject to exemption.

 

F-38
 

 

Unearned Revenue

 

The Company’s unearned revenue primarily consists of advances received from customers for the purchase of products prior to the delivery of goods, and for the rental of hotel rooms prior to the delivery of service. The delivery of products and room rental services is (normally within one year) based upon contract terms and customer demand.

 

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

 

During the three and nine months ended September 30, 2023 and 2022, the Company had no customer that accounted for over 10% of its total revenue.

 

During the three months ended September 30, 2023, the Company had one supplier that accounted for 20% of its total purchases.

 

During the nine months ended September 30, 2023, the Company had two suppliers that accounted for 15% and 12%, respectively, of its total purchases.

 

During the three months ended September 30, 2022, the Company had one supplier that accounted for 35% of its total purchases.

 

During the nine months ended September 30, 2022, the Company had one supplier that accounted for 20% of its total purchases.

 

Leases

 

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

 

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

 

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of September 30, 2023 and December 31, 2022. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

 

F-39
 

 

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Fair Value of Financial Instruments

 

The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

As of September 30, 2023 and December 31, 2022, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 consisted of net income (loss) and foreign currency translation adjustments.

 

Earnings per Share

 

Basic income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of September 30, 2023 and December 31, 2022, the Company did not have any potentially dilutive instruments.

 

F-40
 

 

Stock-Based Compensation

 

The Company periodically grants stock options, warrants and awards to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option, stock warrant and stock award grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option, stock warrant and stock award grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

The Company manages its business as four operating segments, products, pharmacies, hotel, and manufacture and sales, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

 

The following table shows the Company’s operations by business segment for the three months ended September 30, 2023 and 2022.

 

   2023   2022 
   For the Three Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $208,699   $338,327 
Pharmacies   273,416    164,735 
Hotel   169,462    169,724 
Manufacture and sale   415,342    - 
Total revenues, net  $1,066,919   $672,786 
           
Operating costs and expenses          
Products          
Cost of goods sold  $67,709   $90,391 
Operating expenses   421,417    301,624 
Pharmacies          
Cost of goods sold   126,459    124,992 
Operating expenses   115,006    144,164 
Hotel          
Hotel operating costs   447,419    404,322 
Operating expenses   61,859    141,197 
Manufacture and sale          
Cost of goods sold   315,555    - 
Operating expenses   246,750    - 
Total operating costs and expenses  $1,802,174   $1,206,690 
           
Income (loss) from operations          
Products  $(280,427)  $(53,688)
Pharmacies   31,951    (104,421)
Hotel   (339,816)   (375,795)
Manufacture and sale   (146,963)   - 
Loss from operations  $(735,255)  $(533,904)

 

F-41
 

 

The following table shows the Company’s operations by business segment for the nine months ended September 30, 2023 and 2022.

 

           
   For the Nine Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $1,064,668   $371,016 
Pharmacies   802,118    517,674 
Hotel   892,409    623,661 
Manufacture and sale   538,494    - 
Total revenues, net  $3,297,689   $1,512,351 
           
Operating costs and expenses          
Products          
Cost of goods sold  $367,237   $98,809 
Operating expenses   1,249,461    961,885 
Pharmacies          
Cost of goods sold   446,967    395,096 
Operating expenses   361,200    467,315 
Hotel          
Hotel operating costs   1,387,993    1,334,041 
Operating expenses   106,219    300,501 
Manufacture and sale          
Cost of goods sold   322,207    - 
Operating expenses   448,398    - 
Total operating costs and expenses  $4,689,682   $3,557,647 
           
Loss from operations          
Products  $(552,030)  $(689,678)
Pharmacies   (6,049)   (344,737)
Hotel   (601,803)   (1,010,881)
Manufacture and sale   (232,111)   - 
Loss from operations  $(1,391,993)  $(2,045,296)

 

Segment assets  As of
September 30, 2023
   As of
December 31, 2022
 
Products  $288,375   $410,754 
Pharmacies   726,904    758,675 
Hotel   449,903    970,385 
Manufacture and sale   2,814,895    2,911,070 
Total assets  $4,280,077   $5,050,884 

 

As the acquisition of Runcangsheng was consummated as of September 30, 2022 (see Note 17), the revenues and operating results of the manufacture and sale segment were included in the financial statements of the Company beginning on October 1, 2022.

 

F-42
 

 

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its FV, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis. As a smaller reporting company, the standard will be effective for the Company for interim and annual reporting periods beginning after December 15, 2022, with early adoption permitted. The adoption of ASU 2017-04 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

 

3. OTHER RECEIVABLES AND PREPAID EXPENSES

 

Other receivables and prepaid expenses consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Deposits  $12,245   $15,546 
Prepaid expenses, including related party   102,704    9,490 
Employees’ social insurance   7,379    10,124 
Others   20,996    7,471 
Total  $143,324   $42,631 

 

4. ADVANCES TO SUPPLIERS

 

The Company had advances to suppliers of $144,613 and $168,523 as of September 30, 2023 and December 31, 2022, respectively. Advances to suppliers primarily include prepayments for products and equipment expected to be delivered subsequent to balance sheet dates.

 

F-43
 

 

5. INVENTORIES

 

Inventories consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Raw material  $142,519   $62,462 
Work in process   15,265    15,315 
Finished goods-health supplements   -    521 
Drugs, pharmaceutical and nutritional products   486,273    412,129 
Food and beverage, hotel supplies and consumables   77,600    82,646 
Total  $721,657   $573,073 
Less: reserve for inventory   78,034    73,821 
Total inventories, net  $643,623   $499,252 

 

6. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Vehicles  $403,505   $426,836 
Office furniture   78,037    82,549 
Electronic equipment   21,101    20,607 
Machinery   1,258,029    1,241,778 
Leasehold improvements   1,076,824    1,139,087 
Other   21,777    17,485 
Total   2,859,273    2,928,342 
Less: Accumulated depreciation   (1,200,388)   (956,549)
Property and equipment, net  $1,658,885   $1,971,793 

 

Depreciation expense for the three months ended September 30, 2023 and 2022 was $114,300 and $25,111, respectively.

 

Depreciation expense for the nine months ended September 30, 2023 and 2022 was $307,209 and $81,036, respectively

 

7. INTANGIBLE ASSET, NET

 

Intangible asset consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Software  $10,609   $8,564 
Less: Accumulated amortization   (7,769)   (7,295)
Intangible asset, net  $2,840   $1,269 

 

Amortization expense for the three months ended September 30, 2023 and 2022 was $387 and $591, respectively.

 

Amortization expense for the nine months ended September 30, 2023 and 2022 was $905 and $1,885, respectively.

 

F-44
 

 

8. TAXES PAYABLE

 

Taxes payable consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Value-added  $62,515   $56,806 
Income   28,235    30,919 
City construction   5,027    3,746 
Education   2,193    2,184 
Other   12,276    10,445 
Taxes payable  $110,246   $104,100 

 

9. ACCRUED LIABILITIES AND OTHER PAYABLES

 

Accrued liabilities and other payables consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Accrued employees’ social insurance  $281,728   $270,349 
Accrued payroll and commission   248,759    307,331 
Accrued rent expense   74,415    32,746 
Construction payable   1,196,037    1,384,674 
Payable for equipment purchase   29,213    32,278 
Accrued professional fees   247,786    233,894 
Deposit   10,690    11,308 
Other payables   47,504    83,910 
Total  $2,136,132   $2,356,490 

 

10. LOAN FROM THIRD PARTIES

 

As of September 30, 2023 and December 31, 2022, the Company had advances from unrelated third parties of Aixin Shangyan Hotel in an aggregate amount $82,237 and $86,992, respectively. There was no written agreement, and these loans are payable on demand and bear no interest.

 

11. LEASE

 

AiXinZhonghong leases its office on a monthly basis. AiXinZhonghong also has operating leases for other sales locations under various operating lease arrangements. The leases have remaining lease terms of approximately 0.58 to 2.69 years.

 

Aixin Shangyan Hotel leases its hotel premises under an operating lease arrangement. The lease has a remaining lease term of approximately 0.25 years.

 

Aixintang Pharmacies lease retail pharmacy stores under operating lease arrangements, with remaining lease terms of 1.21 to 2.92 years.

 

Runcangsheng leases its office under an operating lease arrangement. The lease has a remaining lease term of approximately 0.25 years.

 

Balance sheet information related to the Company’s leases is presented below:

 

   September 30, 2023   December 31, 2022 
Operating Leases          
Operating lease right-of-use assets  $457,793   $999,285 
           
Operating lease liabilities – current  $439,959   $883,583 
Operating lease liability – non-current   158,069    194,725 
Total operating lease liabilities  $598,028   $1,078,308 

 

F-45
 

 

The following provides details of the Company’s lease expenses:

 

   2023   2022 
   Three Months Ended September 30, 
   2023   2022 
Operating lease expenses  $200,716   $183,051 
           

 

   2023   2022 
   Nine Months Ended September 30, 
   2023   2022 
Operating lease expenses  $618,085   $632,496 
           

 

Other information related to leases is presented below:

 

   Nine Months Ended September 30, 
   2023   2022 
Cash Paid for Amounts Included In Measurement of Liabilities:          
Operating cash flows from operating leases  $500,056    525,979 
           
Weighted Average Remaining Lease Term:          
Operating leases   1.26 years    1.65 years 
           
Weighted Average Discount Rate:          
Operating leases   4.75%   4.75%

 

Maturities of lease liabilities were as follows:

 

      
For the year ending December 31:     
2023 (excluding the nine months ended September 30, 2023)  $354,246 
2024   130,992 
2025   79,844 
2026   36,366 
2027   8,224 
Thereafter   3,427 
Total lease payments   613,099 
Less: imputed interest   (15,071)
Total lease liabilities   598,028 
Less: current portion   (439,959)
Lease liabilities – non-current portion  $158,069 

 

12. RELATED PARTY TRANSACTIONS

 

Accounts receivable – related party

 

As of September 30, 2023 and December 31, 2022, accounts receivable from related parties were $11,030 and $42, respectively.

 

Prepaid expense – related party

 

Prepaid expense – related party consisted of the following as of the periods indicated:

   September 30, 2023   December 31, 2022 
Chengdu Aixin International Travel Service Co., Ltd  $94,361   $          - 

 

Accounts payable – related party

 

Accounts payable – related party consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Luquan Shengcaofeng Biotechnology Co., Ltd.  $           -   $165,958 

 

Luquan Shengcaofeng Biotechnology Co., Ltd. is an entity controlled by Mr. Huiliang Jiao, a Director of the Company.

 

F-46
 

 

Due from related parties

 

Due from related parties consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $7,573   $9,708 
Sichuan Aixin Investment Co., Ltd   8,983    145 
Huiliang Jiao   135,328    - 
Xiaoyan Zhou   11,668    - 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   25,056    26,125 
Chengdu WenJiang Aixin Huiwan Pharmacy Co., Ltd.   3,888    - 
Chengdu Heshengyuan Pharmacy Co., Ltd.   3,379    - 
Chengdu Zhiweibing Pharmacy Co., Ltd.   7,859    - 
Chengdu Tongtai Tang Pharmacy Co. Ltd.   2,810    - 
Chengdu city Wuhou District Xiaofei Pharmacy Co., Ltd   8,115    - 
Chongqing Aixin Hui Pharmacy Co., Ltd.   402    - 
Sichuan Xintang Xinfu Pharmacy Chain Co, Ltd   344    - 
Sichuan Aixintang Xinfu Chain Pharmacy Co., Ltd.   302    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   26,822    34,622 
Chengdu Cigu Foshou Pharmacy   2,028    - 
Mianyang Aixin Cunshan Pharmacy   5,874    - 
Chengdu Aixin International Travel Service Co., Ltd   356    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   133,801    12,502 
Total  $384,588   $83,102 

 

Due to related parties

 

Due to related parties consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Quanzhong Lin  $243,323   $140,644 
Yirong Shen   84,978    89,892 
Sichuan Haosen Haichuan business management Co. Ltd   57    - 
Sichuan Yunxi Pharmacy Co. Ltd   449    - 
Chengdu Yi Yan Tang Pharmacy Co. Ltd.   162    - 
Chengdu Aixin International travel service Co, Ltd   4,950    6,346 
Total  $333,919   $236,882 

 

The amounts due to and from related parties were for working capital purposes, payable on demand, and bear no interest. All the related party entities listed above are controlled by Mr. Quanzhong Lin (the Chairman, President and major shareholder of Aixin Life). Yirong Shen was a major shareholder of Aixin Shangyan Hotel prior to the closing of Hotel Purchase Agreement, and she serves as the supervisor of Aixin Shangyan Hotel. Tianming Long is a branch manager of Aixintang Pharmacies. Mr. Huiliang Jiao is the Director of the Company. Xiaoyan Zhou is the wife of Mr. Huiliang Jiao.

 

Office leases

 

In May 2014, the Company entered a lease with its major shareholder for an office. The lease term was for three years expiring in May 2017 with an option to renew. The monthly rent was RMB 5,000 ($690). The Company was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease until May 28, 2028 with monthly rent of RMB 5,000 ($690), payable quarterly. The future annual minimum lease payments at September 30, 2023 are $8,224, $8,224, $8,224, $8,224, and $5,482 for each of the years ended September 30, 2024, 2025, 2026, 2027, and 2028, respectively.

 

Runcangsheng has an office lease with Xiaoyan Zhou, wife of Huiliang Jiao, the Company’s Director, from March 2020 to February 2023 with a monthly rent of RMB 3,000 ($414). Runcangsheng renewed the lease until February 28, 2026 with monthly rent of RMB 5,000 ($690). In July 2023, Xiaoyan Zhou entered into an agreement with Runcangsheng to increase the monthly rent for 2022 by RMB 2,000 and to change the lease expiration date to December 31, 2023. The lease will be converted to an annual contract starting from January 1, 2024.

 

F-47
 

 

13. INCOME TAXES

 

The Company was incorporated in the United States of America (“USA”) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its sales from its operations in the PRC for the three and nine months ended September 30, 2023 and 2022, and recorded income tax provision for the periods.

 

China has a tax rate of 25% for all enterprises (including foreign-invested enterprises).

 

Uncertain Tax Positions

 

Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the three and nine months ended September 30, 2023 and 2022, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

 

14. STOCKHOLDERS’ EQUITY

 

On August 17, 2020, by unanimous written consent in lieu of a meeting, the Board adopted resolutions authorizing a one (1)-for-four (4) reverse stock. The reverse stock split became effective on October 27, 2020. According to the Articles of Amendment, the Company is authorized to issue 20,000,000 shares of blank check preferred stock at $0.001 par value and 500,000,000 shares of common stock at $.00001 par value per share.

 

Pursuant to resolutions adopted by the Board of Directors and the holders of a majority of the outstanding shares of common stock of AiXin Life International, Inc. on January 6, 2023, the Company filed an amendment to its Articles of Incorporation with respect to a proposed 1 for 2 “reverse” split of its common stock (the “Amendment”). Completion of the proposed reverse stock split was to be effected on a date determined by the Board of Directors only upon receipt of notice from the Financial Industry Regulatory Authority (“FINRA”) that it would process the proposed reverse stock split. The Company received notice from FINRA and its common stock began trading on a post-split basis on February 17, 2023.

 

As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock were automatically combined and converted into one issued and outstanding share of common stock. The Company has approximately 24,999,842 shares of outstanding common stock after giving effect to the reverse stock split and the elimination of fractional shares.

 

All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

As of September 30, 2023, and December 31, 2022, the Company had 24,999,842 common shares issued and outstanding.

 

Stock Awards Issued for Services

 

On October 22, 2019, the Company granted and issued 18,750 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $337,500 based on the post-split closing price of $18 on the grant date.

 

On October 24, 2019, the Company granted and issued 275,000 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $1,520,200 based on the post-split closing price of $5.528 on the grant date.

 

F-48
 

 

The stock awards will vest over five (5) years from the grant date, and the grantee will forfeit a portion of the shares granted (“Shares Granted”) if the grantee is no longer employed by or contracted with the Company. Specifically, the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture.

 

For the three months ended September 30, 2023 and 2022, stock-based compensation expenses were $92,885 and $92,885, respectively. For the nine months ended September 30, 2023 and 2022, stock-based compensation expenses were $278,655 and $278,655, respectively. As of September 30, 2023, unrecognized compensation expenses related to these stock awards are $394,012. These expenses are expected to be recognized over 1.07 years.

 

Capital Contribution

 

During the nine months ended September 30, 2023, the Company received capital contributions in the aggregate amount of $145,300 from Yunnan Shengshengyuan and Yun Chen, the former shareholders of Runcangsheng (see Note 1), who remained as related parties of the Company after the completion of acquisition of Runcangsheng.

 

15. STATUTORY RESERVES

 

Pursuant to the PRC corporate law, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings.

 

Surplus reserve fund

 

The Company is required to transfer 10% of its net income, as determined under PRC accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the Company’s registered capital. During the three and nine months ended September 30, 2023 and 2022, the Company made $0 and $0 contribution to statutory reserve fund.

 

The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital.

 

Common welfare fund

 

Common welfare fund is a voluntary fund to which the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations. The Company did not make any contribution to this fund during the three and nine months ended September 30, 2023 and 2022.

 

This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

 

16. OPERATING CONTINGENCIES

 

The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

 

The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.

 

F-49
 

 

Litigation

 

The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.

 

In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $392,305 (RMB 2,500,000) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $392,305 (RMB 2,500,000) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.

 

In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.

 

In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of September 30, 2023.

 

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

 

17. ACQUISITION OF SUBSIDIARIES

 

Runcangsheng

 

On July 19, 2022, the Company entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd (“Shengshengyuan”) and Yun Chen (collectively “the Sellers”), who own 95% and 5% equity interest of Yunnan Runcangsheng Technology Co., Ltd (“Runcangsheng”), respectively.

 

Under the terms of the Transfer Agreement, the Company purchased all of the outstanding equity interest of Yunnan Runcangsheng for an aggregate purchase price of RMB 31,557,820, or $4,418,095, adjusted by $116,802, the amount equal to the initial net worth estimate minus the audited net worth of Runcangsheng as of December 31, 2021.

 

In addition to transferring their respective equity interest in Runcangsheng, both Sellers agreed to forgive any loans due to them from Runcangsheng. The acquisition was completed on September 30, 2022.

 

F-50
 

 

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition. Goodwill as a result of the acquisition of Runcangsheng is calculated as follows:

 

      
Total purchase considerations  $4,301,293 
Estimated fair value of assets acquired:     
Cash  $446,381 
Accounts receivable   144,813 
Accounts receivable-related party   133,011 
Advance to suppliers   3,455 
Other receivables and prepaid expense   127,909 
Inventory   469,594 
Property and equipment   1,677,272 
Intangible assets   1,406 
Operating lease right-of-use assets   1,990 
Total assets acquired   3,005,831 
Estimated fair value of liabilities assumed:     
Accounts payable   (89,801)
Accounts payable-related party   (160,911)
Advance from customers   (4,790)
Government grant   (921,473)
Taxes payable   (21,156)
Operating lease liability   (15,182)
Accrued liabilities and other payables   (1,314,995)
Total liabilities assumed   (2,528,308)
Total net assets acquired   477,523 
Goodwill as a result of the acquisition  $3,823,770 

 

During the year ended December 31, 2022, the Company recorded a goodwill impairment equal to the goodwill resulting from the acquisition of Runcangsheng.

 

The following condensed unaudited pro forma consolidated results of operations for the Company, Runcangsheng, Aixin Shangyan Hotel and Aixintang Pharmacies for the three and nine months ended September 30, 2022 present the results of operations of the Company, Runcangsheng, Aixin Shangyan Hotel, and Aixintang Pharmacies as if the acquisition of Runcangsheng occurred on January 1, 2022, respectively.

 

The pro forma results are not necessarily indicative of the actual results that would have occurred had the acquisition been completed as of the beginning of the periods presented, nor are they necessarily indicative of future consolidated results.

 

  

For the

Three Months Ended

September 30, 2022

 
Revenue  $804,470 
Operating costs and expenses   1,205,371 
Loss from operations   (400,901)
Other expense   (25,455)
Income tax expense (benefit)   (322)
Net loss  $(426,034)

 

  

For the

Nine Months Ended

September 30, 2022

 
Revenue  $1,854,617 
Operating costs and expenses   3,826,342 
Loss from operations   (1,971,725)
Other income   25,313 
Income tax expense   643 
Net loss  $(1,947,055)

 

18. SUBSEQUENT EVENT

 

The Company follows the guidance in FASB ASC 855-10 for the disclosure of subsequent events. The Company evaluated subsequent events through the date the financial statements were issued and determined the Company has no material subsequent events.

 

F-51
 

 

AIXIN LIFE IINTERNATIONAL, INC.

 

 

[$9,500,000]

Shares of Common Stock

 

PRELIMINARY PROSPECTUS

 

Underwriter

 

BOUSTEAD SECURITIES, LLC

 

 ___________, 2024

 

You should rely only on the information contained in this prospectus. No dealer, salesperson or other person is authorized to give information that is not contained in this prospectus. This prospectus is not an offer to sell nor is it seeking an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this prospectus is correct only as of the date of this prospectus, regardless of the time of the delivery of this prospectus or the sale of these securities.

 

Until   , 2024, 25 days after the date of this prospectus, all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriter with respect to their unsold allotments or subscriptions.

 

The date of this prospectus is [   ], 2024

 

 
 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

 

The following table sets forth the various expenses, all of which will be borne by us, in connection with the sale and distribution of the securities being registered, other than the underwriter commissions. All amounts shown are estimates except for the Securities and Exchange Commission registration fee and the FINRA filing fee.

 

Description   Amount  
       
Filing Fee - Securities and Exchange Commission   $ 1,322.40  
FINRA Filing Fee     9,815  
Nasdaq Application and Listing Fee     75,000  
Attorney’s fees and expenses     400,000 *
Accountant’s fees and expenses     175,000 *
Transfer agent’s and registrar fees and expenses     25,000 *
Printing and engraving expenses     125,000 *
Miscellaneous expenses     138,862.60 *
         
Total   $ 950,000.00 *

 

* Estimated expenses.

 

ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

 

The Colorado Business Corporations Act provides that a director or officer is not individually liable to the corporation or its stockholders or creditors for any damages as a result of any act or failure to act in his capacity as a director or officer unless it is proven that his act or failure to act constituted a breach of his fiduciary duties as a director or officer and his breach of those duties involved intentional misconduct, fraud or a knowing violation of law. The Articles of Incorporation or an amendment thereto may, however, provide for greater individual liability.

 

This provision is intended to afford directors and officers protection against and to limit their potential liability for monetary damages resulting from suits alleging a breach of the duty of care by a director or officer. As a consequence of this provision, stockholders of our Company will be unable to recover monetary damages against directors or officers for action taken by them that may constitute negligence or gross negligence in performance of their duties unless such conduct meets the requirements of Colorado law to impose such liability. The provision, however, does not alter the applicable standards governing a director’s or officer’s fiduciary duty and does not eliminate or limit the right of our Company or any stockholder to obtain an injunction or any other type of non-monetary relief in the event of a breach of fiduciary duty.

 

The Colorado Business Corporations Act also provides that under certain circumstances, a corporation may indemnify any person for amounts incurred in connection with a pending, threatened or completed action, suit or proceeding in which he is, or is threatened to be made, a party by reason of his being a director, officer, employee or agent of the corporation or serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, if such person (a) is not liable for a breach of fiduciary duty involving intentional misconduct, fraud or a knowing violation of law or such greater standard imposed by the corporation’s articles of incorporation; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. Additionally, a corporation may indemnify a director, officer, employee or agent with respect to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor, if such person (a) is not liable for a breach of fiduciary duty involving intentional misconduct, fraud or a knowing violation of law or such greater standard imposed by the corporation’s articles of incorporation; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, however, indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court to be liable to the corporation or for amounts paid in settlement to the corporation, unless the court determines that the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper. To the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to above, or in defense of any claim, issue or matter therein, the corporation shall indemnify him against expenses, including attorneys’ fees, actually and reasonably incurred by him in connection with the defense.

 

II-1
 

 

The Company’s By-laws provide in substance that every director and officer of the Company shall be entitled to indemnification against expense actually and necessarily incurred in any action suit or proceeding, in which he or she may be named as a party by reason of being or having been a director or officer of the Company, except to the extent that such officer is finally adjudicated to be liable for negligence or misconduct.

 

Neither our Bylaws nor our Articles of Incorporation include any specific indemnification provisions for our officers or directors against liability under the Securities Act. Additionally, insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

 

ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES.

 

Not Applicable

 

ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) Exhibits.

 

Pursuant to Item 601 of Regulation S-K:

 

A list of exhibits filed with this registration statement on Form S-1 is set forth on the Exhibit Index and is incorporated herein by reference.

 

ITEM 17. UNDERTAKINGS.

 

The undersigned registrant hereby undertakes:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement to:

 

(i) Include any prospectus required by Section 10(a)(3) of the Securities Act;

 

(ii) Reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

 

(iii) Include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

 

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

II-2
 

 

(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date

 

(5) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

II-3
 

 

EXHIBIT INDEX

 

Exhibit
Number
  Description of Document
1.1*   Form of Underwriting Agreement
3.1   Articles of Incorporation (incorporated by reference to the Company’s Annual Report on Form 10-KSB for the fiscal year ended May 31, 2006 as filed with the SEC on March 7, 2007).
3.2   Articles of Amendment to Articles of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 3, 2008).
3.3   Articles of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.3 the Company’s Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2017 as filed with the SEC on January 16, 2018).

3.4

  Articles of Amendment to Articles of Incorporation (incorporated by reference to Appendix A to the 14C Information Schedule filed with the SEC on August 24, 2020).
3.5   Articles of Amendment to Articles of Incorporation (incorporated by reference to Appendix A to Report on Form 8-K filed with the SEC on January 12, 2023)
3.6   Statement of Correction (incorporated by reference to Report on Form 8-K filed with the SEC on February 15, 2023)
3.7***   Bylaws of the Registrant.
4.2*   Form of Underwriter’s Warrant.
5.1*   Form of Opinion of Armstrong Teasdale LLP regarding the validity of the common stock being registered.
10.1   2019 Incentive Stock Plan (incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-8 filed on January 10, 2019).
10.2   English Translation of Equity Transfer Agreement with Respect to Shangyan Hotel Company (Incorporated by reference to Report on Form 8-K dated May 25, 2021).
10.3   English Translation of Equity Transfer Agreement with respect to Chengdu AiXin Pharmacy Co., Ltd. and affiliated entities (Incorporated by reference to Report on Form 8-K dated June 2, 2021).
10.4  

English Translation of Equity Transfer Agreement among the Company, Chen Yun and Yunnan Sheng Shengyuan Technology Co., Ltd. (Incorporated by reference to Report on Form 8-K dated July 7, 2022)

10.5   English Translation of Supplementary Agreement to Equity Transfer Agreement among the Company, Yunnan Sheng Shengyuan Technology Co., Ltd. And Chen Yun. (Incorporated by reference to Report on Form 8-K/A filed October 10, 2022).
10.6   English Translation of Supplementary 2 Agreement to Equity Transfer Agreement among the Company, Yunnan Sheng Shengyuan Technology Co., Ltd. And Chen Yun. (Incorporated by reference to Report on Form 8-K/A filed October 27, 2022).
10.7***   English translation of Framework Agreement for Project Cooperation in Intelligent Deep Processing of Agricultural Products with Plateau Characteristics.
10.8***   Contribution Agreement dated March 1, 2023, by Mr. Quanzhong Lin in favor of the Company.
21.1***   List of Subsidiaries
23.1*   Consent of KCCW Accountancy Corp.
23.2*   Consent of Armstrong Teasdale LLP (included in Exhibit 5.1)
23.3**   Consent of Dentons (Included in Exhibit 99.2)
24.1***   Powers of Attorney (included on signature page to Registration Statement on Form F-1)
99.1   Code of Business Conduct and Ethics (Incorporated by reference to Report on Form 8-K filed September 25, 2020)
99.2**   Opinion of Dentons regarding certain PRC law matters
99.3   Form of Audit Committee Charter (Incorporated by reference to Report on Form 8-K filed September 25, 2020)
99.4   Form of Compensation Committee Charter (Incorporated by reference to Report on Form 8-K filed September 25, 2020)
99.5   Form of Nominating and Corporate Governance Committee Charter (Incorporated by reference to Report on Form 8-K filed September 25, 2020)
107*   Calculation of Filing Fee table

 

* Filed herewith
** To be filed by amendment
*** Previously filed

 

II-4
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Amendment to this Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Chengdu, China, on February 9, 2024.

 

  AIXIN LIFE INTERNATIONAL, INC.
   
  /s/ Quanzhong Lin
  Quanzhong Lin
  CEO, President, Secretary and Director
  (Principal Executive Officer)

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this amendment to this registration statement to be signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Quanzhong Lin   CEO, President, Secretary and Director   February 9, 2024

Quanzhong Lin

 

 

(Principal Executive Officer)

 

 

 

 

/s/ Tianfeng Li   CFO and Treasurer   February 9, 2024
Tianfeng Li   (Principal Financial and Accounting Officer)    
         
*   Independent Director   February 9, 2024
Yao-Te Wang        
         
*   Independent Director   February 9, 2024
Christopher Lee        
         
*   Independent Director   February 9, 2024
Huiliang Jiao        

 

  /s/ Quanzhong Lin        
By Quanzhong Lin, Attorney-in-Fact        

  

 

II-5

EX-1.1 2 ex1-1.htm

 

Exhibit 1.1

 

AiXin Life International, Inc.

 

UNDERWRITING AGREEMENT

 

__________, 2024

Boustead Securities, LLC

6 Venture, Suite 395

Irvine, CA 92618

Attn: Keith Moore, Chief Executive Officer

Attn: Daniel J. McClory, Managing Director

 

Ladies and Gentlemen:

 

This underwriting agreement (this “Agreement”) constitutes the agreement between AiXin Life International, Inc., a Colorado corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereafter defined) as being subsidiaries or affiliates of the Company, the “Company”), on the one hand, and Boustead Securities, LLC (the “Underwriter”), on the other hand, pursuant to which the Underwriter shall serve as the underwriter for the Company in connection with the proposed offering (the “Offering”) by the Company of its Common Stock (as defined below) on a “Firm Commitment” basis.

 

The Company proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriter an aggregate of [*] authorized but unissued shares of common stock (the “Underwritten Shares”), par value $0.00001 per share (the “Common Stock”), of the Company.

 

The Company hereby confirms its agreement with the Underwriter as follows:

 

Section 1. Agreement to Act as Underwriter.

 

(a) Underwriting Fees/Commissions; Expenses.

 

(i) Underwriting Fees/Commissions. The Company hereby agrees to pay the Underwriter a fee/commission equivalent to eight percent (8.0%) of the gross proceeds of the sale of the Shares.

 

(ii) Non-Accountable Expenses. The Company agrees that, in addition to the expenses payable pursuant to Section 1(a)(iii) below, on the Closing Date it shall pay to the Underwriter, by deduction from the net proceeds of the Offering contemplated herein, a non-accountable expense allowance equal to one percent (1.0%) of the gross proceeds received by the Company from the sale of the Shares.

 

(iii) Expenses. Whether or not the transactions contemplated by this Agreement and the Registration Statement are consummated or this Agreement is terminated, the Company hereby agrees to pay all costs and expenses incident to the Offering, including the following:

 

  A. all expenses in connection with the preparation, printing, formatting for EDGAR and filing of the Registration Statement, and any and all amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriter and dealers;
     
  B. all fees and expenses in connection with filings with FINRA’s Public Offering System;

 

  C. all fees, disbursements, and expenses of the Company’s counsel and accountants in connection with the registration of the Shares under the Securities Act of 1933, as amended (the “Securities Act”) and the Offering;

 

 
 

 

  D. all reasonable expenses in connection with the qualifications of the Shares for offering and sale under state or blue-sky laws, when applicable;
     
  E. all fees and expenses in connection with listing the Shares on the NYSE Amex or Nasdaq (a “Senior Exchange”);
     
  F. any stock transfer taxes incurred in connection with this Agreement or the Offering;
     
  G. the cost and charges of any transfer agent or registrar for the Shares;
     
  H.

all of the Underwriter’s reasonable out-of-pocket expenses in connection with the performance of its services hereunder, with the aggregate amount not to exceed $125,000, including the following:

 

(i) Underwriter’s counsel’s fees and expenses up to $75,000;

 

(ii) due diligence and other expenses incurred prior to completion of the Offering, which shall not exceed $2,500;

 

(iii) preparation of bound volumes and Lucite cube mementos in such quantities as the Underwriter may reasonably request up to an amount of $2,500; and

 

(iv) an amount equal to $7,500 for background checks on the Company’s officers, directors and major shareholders.

 

Any expense exceeding $5,000 shall be pre-approved in writing by the Company.

 

Any advances made by the Company and shall be made for reasonably anticipated out-of-pocket accountable expenses in connection with the Offering, and any unused portion will be returned to the Company to the extent not actually incurred.

 

In the event that this Agreement is terminated pursuant to Section 9 hereof, or subsequent to a Material Adverse Change, the Company will pay all documented out-of-pocket and unreimbursed expenses of the Underwriter (including but not limited to fees and disbursements of Underwriter’s counsel, expenses associated with a due diligence report and reasonable travel specified in Sections 1(a)(iii)(H) incurred in connection herewith which shall be limited to expenses which are actually incurred as allowed under FINRA Rule 5110 and in any event, the aggregate amount of such expenses to be paid or reimbursed by the Company directly or indirectly to or on behalf of the Underwriter shall not exceed $87,500.

 

(b) Exclusivity. The term of the Underwriter’s exclusive engagement (the “Exclusive Term”) will be until the termination of the engagement agreement by and between the Company and the Underwriter dated December 30, 2023 (the “Engagement Letter”). Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality, indemnification and contribution contained herein will survive any expiration or termination of this Agreement, and the Company’s obligation to pay fees actually earned and payable and to reimburse expenses actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rule 5110(g)(4)(A), will survive any expiration or termination of this Agreement. Nothing in this Agreement shall be construed to limit the ability of the Underwriter or its Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory or any other business relationship with Persons (as defined below) other than the Company. As used herein (i) “Persons” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind and (ii) “Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act. If during the Exclusive Term, or within twelve (12) months after the date of termination or expiration of the Engagement Letter, no Closing has occurred, the Company sells securities to investors introduced to the Company by the Underwriter or its Affiliates prior to such termination or expiration, then the Company shall pay to the Underwriter, at the time of each such sale, the compensation, set forth in Section 1(a) above, with respect to any such sale.

 

 
 

 

Section 2. Representations, Warranties and Covenants of the Company. The Company hereby represents, warrants and covenants to the Underwriter, as of the date hereof, and as of each Closing Date and each Option Closing Date (if any), except as set out in the Registration Statement, as follows:

 

(a) Securities Law Filings. The Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement, and an amendment or amendments thereto, on Form S-1 (Registration File No. 333-268190), including any prospectus or prospectuses, under the Securities Act and the rules and regulations (the “Rules and Regulations”) of the Commission promulgated thereunder for the registration of the Shares and the Underwriter’s Securities (as defined in Section 3(d)). At the time of the effective date of the Registration Statement, the Registration Statement and amendments will materially meet the requirements of Form S-1 under the Securities Act. The Company will file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act, a final prospectus included in such registration statement relating to the Offering and the underwriting thereof (the “Final Prospectus”) and has advised the Underwriter of all further information (financial and other) with respect to the Company required to be set forth therein. Such registration statement, including the exhibits thereto, as amended at the date of this Agreement, is hereinafter called the “Registration Statement”; such prospectus in the form in which it appears in the Registration Statement as amended at the date of this Agreement is hereinafter called the “Prospectus.” All references in this Agreement to financial statements and schedules and other information that is “contained,” “included,” “described,” “referenced,” “set forth” or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is or is deemed to be incorporated by reference in the Registration Statement or the Prospectus, as the case may be. The Registration Statement has been declared effective on the date hereof. The Company shall, prior to the initial Closing Date, file with the Commission a Form 8-A providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock.

 

(b) Assurances. The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required by the Securities Act. Each of (i) the Registration Statement at the time it became effective, (ii) the Prospectus at the time the Registration Statement became effective, (iii) any post-effective amendment to the Registration Statement at the time it becomes effective and (iv) and the Final Prospectus filed with the Commission pursuant to Rule 424(b) at the time of such filing, and at all other subsequent times at each Closing Date and at any Option Closing Date (if any), complied in all material respects with the Securities Act and the applicable Rules and Regulations, as amended or supplemented, if applicable, and did not and will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not materially misleading (provided, however, that the preceding representations and warranties contained in this sentence shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by the Underwriter expressly for use therein (the “Underwriter Information”). The Prospectus, as of its date, complies in all material respects with the Securities Act and the applicable Rules and Regulations, and the Final Prospectus, as of its date, will comply in all material respects with the Securities Act and the applicable Rules and Regulations. As of its date, the Prospectus did not and will and the Final Prospectus will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and warranties contained in this sentence shall not apply to any Underwriter Information). All post-effective amendments to the Registration Statement reflecting facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein have been so filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are no material contracts or other documents required to be described in the Prospectus (or the Final Prospectus) or filed as exhibits or schedules to the Registration Statement that have not been (or will not be) described or filed as required. The Company is eligible to use free writing prospectuses in connection with the Offering pursuant to Rules 164 and 433 under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable Rules and Regulations. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or behalf of or used by the Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable Rules and Regulations. The Company will not, without the prior consent of the Underwriter, prepare, use or refer to, any free writing prospectus. Except as set out on Schedule 2(b), there are no free-writing prospectuses in connection with this offering.

 

 
 

 

(c) Offering Materials. The Company has delivered, or will as promptly as practicable deliver, to the Underwriter complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement (without exhibits) and the Prospectus, as amended or supplemented (including the Final Prospectus), in such quantities and at such places as the Underwriter reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to any Closing Date or any Option Closing Date, any offering material in connection with the offering and sale of the Shares other than the Prospectus, the Final Prospectus, the Registration Statement, and any other materials permitted by the Securities Act (collectively, the “Offering Materials”).

 

(d) Subsidiaries. All of the direct, indirect subsidiaries, variable interest entities of the Company and the latter’s subsidiaries (the “Subsidiaries”) are described in the Registration Statement to the extent necessary. The Company owns, directly or indirectly, all of its capital stock or other equity interests of each Subsidiary free and clear of any liens, charges, security interests, encumbrances, rights of first refusal, preemptive rights or other restrictions (collectively, “Liens”), and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

(e) Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing (where applicable) under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws, memorandum and articles of association or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of this Agreement, the Underwriter’s Warrant (as defined in Section 3(e)(i)) or any other agreement entered into between the Company and the Underwriter (“Transaction Documents”), (ii) a material adverse effect on the results of operations, assets, business, prospects (as such prospects are described in the Prospectus) or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under this Agreement or the Offering (any of (i), (ii) or (iii), a “Material Adverse Effect”) and to the best knowledge of the Company, no action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened (“Proceeding”) has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(f) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into, and to consummate the transactions contemplated by, this Agreement, the Underwriter’s Warrant and each of the other Transaction Documents and the Offering and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery by the Company of this Agreement, the Underwriter’s Warrant and each of the other Transaction Documents and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Company’s Board of Directors (the “Board of Directors”) or the Company’s shareholders in connection therewith other than in connection with the Required Approvals (as defined below). This Agreement, the Underwriter’s Warrant, and each other Transaction Document to which it is a party has been duly and validly authorized by the Company and, when executed and delivered by the Company, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with their respective terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

 
 

 

(g) No Conflicts. The execution, delivery and performance by the Company of this Agreement, the Underwriter’s Warrant and the other Transaction Documents to which it is a party and the transactions contemplated hereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws, memorandum and articles of association or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (i), (ii) and (iii), such conflict, default or violation could not reasonably be expected to result in a Material Adverse Effect.

 

(h) Filings, Consents and Approvals. The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of this Agreement, the Underwriter’s Warrant or the other Transaction Documents to which it is a party and the transactions contemplated hereby, other than: (i) the filing with the Commission of the Final Prospectus as required by Rule 424 under the Securities Act, (ii) an application to a Senior Exchange (the “Trading Market”) for the listing of the Common Stock for trading thereon in the time and manner required thereby, the approval of which shall occur prior to the Offering, and (iii) if applicable, such filings as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

(i) Issuance of the Securities; Registration. The Shares and the Underwriter’s Warrant have been duly authorized for issuance and sale and, when issued and paid for in accordance with this Agreement, the Underwriter’s Warrant and the other Transaction Documents to which it is a party, and the terms of the Offering as described in the Prospectus, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Shares and Underwriter’s Warrant are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Shares and Underwriter’s Warrant has been duly and validly taken; the Common Stock issuable upon exercise of the Underwriter’s Warrant have been duly authorized and reserved for issuance by all necessary corporate action on the part of the Company and when issued in accordance with such Underwriter’s Warrant, as the case may be, such Common Stock will be validly issued, fully paid and non-assessable. The Shares and the Underwriter’s Warrant conform in all material respects to all statements with respect thereto contained in the Registration Statement, the Permitted Free Writing Prospectus and the Prospectus. The Company has sufficient shares of Common Stock for the issuance of the maximum number of Shares and the maximum number of shares of Common Stock underlying the Underwriter’s Warrant pursuant to the Offering as described in the Prospectus.

 

 
 

 

(j) Capitalization. The capitalization of the Company as of the date hereof is as set forth in the Registration Statement, and the Prospectus. The Company has not issued any Common Stock since the date of this Agreement, other than pursuant to the Company’s equity incentive plans, the issuance of Common Stock to employees, directors or consultants pursuant to the Company’s equity incentive plans and pursuant to the conversion and/or exercise of any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire Common Stock at any time, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive (“Common Stock Equivalents”). No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Offering Materials. Except as a result of the purchase and sale of the Shares or as disclosed in the Registration Statement, and the Prospectus, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Shares will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Underwriter) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no securities of the Company or any Subsidiary that have any anti-dilution or similar adjustment rights (other than adjustments for stock splits, recapitalizations, and the like) to the exercise or conversion price, have any exchange rights, or reset rights. Except as set forth in the Registration Statement, and the Prospectus, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any share appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of Common Stock of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance in all material respects with all federal and state securities laws, and none of such outstanding shares of Common Stock was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of the Shares. There are no shareholders agreements, voting agreements or other similar agreements with respect to the Company’s Common Stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s shareholders.

 

(k) Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included within the Registration Statement, except as specifically disclosed in the Registration Statement, the Prospectus and the Final Prospectus, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to United States generally accepted accounting principles (“GAAP”) or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any Common Stock of the Company and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans, if any. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Shares contemplated by the Prospectus or disclosed in the Registration Statement or the Prospectus, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective business, prospects (as such prospects are described in the Prospectus), properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one trading day prior to the date that this representation is made.

 

 
 

 

(l) Litigation. Except for such matter disclosed in the Offering Materials, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability of this Agreement, the Underwriter’s Warrant, any of the Transaction Documents, the Offering or the Shares or (ii) could, if there were an unfavorable decision, reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has within the last 10 years been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company.

 

(m) Labor Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. No executive officer, to the knowledge of the Company, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. To the Company’s actual knowledge, the Company and its Subsidiaries are in compliance with all applicable laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(n) Compliance. Except as set forth in the Offering Materials, neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or governmental body or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not reasonably be expected to result in a Material Adverse Effect.

 

(o) Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the Prospectus, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

 
 

 

(p) Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for Liens disclosed in the Prospectus, Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties. Except as disclosed in the Offering Materials, any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.

 

(q) Patents and Trademarks. Except as disclosed in the Offering Materials and to the best of the Company’s actual knowledge, the Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the Offering Materials and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or be abandoned, within two (2) years from the date of this Agreement, except where such action would not reasonably be expected to have a Material Adverse Effect. Except as disclosed in the Offering Materials, neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the Offering Materials, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.

 

(r) Transactions with Affiliates and Employees. Except as set forth in the Registration Statement and the Prospectus, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.

 

(s) Sarbanes-Oxley; Internal Accounting Controls. Except as disclosed in the Registration Statement and in the Prospectus, the Company is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective and applicable to the Company as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of each Closing Date and each Option Closing Date (if any). Except as set forth in the Offering Materials, the Company and the Subsidiaries maintains a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms.

 

 
 

 

(t) Certain Fees, FINRA Affiliation. Except as set forth herein and in the Prospectus, contemplated by this Agreement, or a separate agreement regarding the Offering with a soliciting dealer in the sole discretion of the Underwriter, no brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. Except as set forth in the Registration Statement, and the Prospectus, to the Company’s knowledge, there are no other arrangements, agreements or understandings of the Company or, to the Company’s knowledge, any of its stockholders that may affect the Underwriter’s compensation, as determined by FINRA. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to (i) any person, as a finder’s fee, investing fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who provided capital to the Company, (ii) any FINRA member, or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member within the 12-month period prior to the date on which the Registration Statement was filed with the Commission (the “Filing Date”) or thereafter. To the Company’s knowledge, no (i) officer or director of the Company or its subsidiaries, (ii) owner of 5% or more of the Company’s unregistered securities or that of its subsidiaries or (iii) owner of any amount of the Company’s unregistered securities acquired within the 180-day period prior to the Filing Date, has any direct or indirect affiliation or association with any FINRA member. The Company will advise the Underwriter if it becomes aware that any officer, director or stockholder of the Company or its Subsidiaries is or becomes an Affiliate or associated person of a FINRA member participating in the Offering.

 

(u) Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

 

(v) Registration Rights. Except as set forth in the Registration Statement or the Prospectus, no Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company.

 

(w) Registration. The Company shall use its commercially reasonable efforts to maintain the effectiveness of the Registration Statement and a current Prospectus relating thereto for as long as the Shares and the Underwriter’s Warrant remain outstanding.

 

(x) Solvency. Based on the consolidated financial condition of the Company, as of each Closing Date and Option Closing Date (if any), after giving effect to the receipt by the Company of the proceeds from the sale of the Shares hereunder, the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, are sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). Except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from each Closing Date and Option Closing Date (if any). The Registration Statement and the Prospectus sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, “Indebtedness” means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Except as set forth in the Registration Statement and the Prospectus, neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

 

 
 

 

(y) Tax Status. Except for matters that would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, the Company and each Subsidiary (i) has made or filed all income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.

 

(z) Accountants. KCCW Accountancy Corp. (“KCCW”) is the Company’s independent registered public accounting firm. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) has expressed its opinion with respect to the audited financial statements of the Company for the years ended December for the fiscal years ended December 31, 2022, and 2021.

 

(aa) Office of Foreign Assets Control. Neither the Company nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(bb) Company Not Ineligible Issuer. (i) At the time of filing the Registration Statement and (ii) as of the date of the execution and delivery of this Agreement (with such date being used as the determination date for purposes of this clause (ii)), the Company met all the requirements set forth in General Instruction I of Form S-1.

 

(cc) Emerging Growth Company. From the time of the initial confidential submission of the Registration Statement to the Commission (or, if earlier, the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters Communications) through the date hereof, the Company has been and is an “emerging growth company,” as defined in Section 2(a) of the Securities Act (an “Emerging Growth Company”). “Testing-the-Waters Communication” means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act.

 

(dd) Certificates. Any certificate signed by an officer of the Company and delivered to the Underwriter or to Underwriter’s Counsel shall be deemed to be a representation and warranty by the Company to the Underwriter as to the matters set forth therein.

 

(ee) Reliance. The Company acknowledges that the Underwriter will rely upon the accuracy and truthfulness of the foregoing representations and warranties and hereby consents to such reliance.

 

(ff) Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in either the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.

 

(gg) Statistical or Market-Related Data. Any statistical, industry-related and market-related data included or incorporated by reference in the Registration Statement or the Prospectus, are based on or derived from sources that the Company reasonably and in good faith believes to be reliable and accurate, and such data agree with the sources from which they are derived.

 

 
 

 

(hh) Listing and Maintenance Requirements. The shares of Common Stock are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Shares under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as disclosed in the Offering Materials, the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer. The issuance and sale of the Shares hereunder does not contravene the rules and regulations of a Senior Exchange.

 

(ii) Foreign Corrupt Practices. Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

 

(jj) Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Shares, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Underwriter in connection with the Offering.

 

(kk) Testing the Waters Communications. The Company (a) has not alone engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with the consent of the Underwriter with entities that are qualified institutional buyers within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and (b) has not authorized anyone other than the Underwriter to engage in Testing-the-Waters Communications. The Company reconfirms that the Underwriter has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed any Written Testing-the-Waters Communications.

 

(ll) Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

(mm) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility (including, without limitation, directors and officers insurance coverage equal to at least $[*]), against such losses and risks and in such amounts as the Company believes are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

 

 
 

 

(nn) Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five percent or more of the outstanding shares of any class of voting securities or 25 percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(oo) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Underwriter’s request.

 

(pp) Senior Exchange Listing. The Shares and the Common Stock underlying the Underwriter’s Warrant have been approved for listing on a Senior Exchange, subject to official notice of issuance, and the Company has taken no action designed to, or likely to have the effect of, delisting the Shares or the Common Stock underlying the Underwriter’s Warrant from the Senor Exchange, nor has the Company received any notification that the Senor Exchange is contemplating terminating such listing.

 

(qq) D&O Questionnaires. To the Company’s knowledge, all information contained in the questionnaires (the “Questionnaires”) completed by each of the Company’s directors, officers and 5% shareholders immediately prior to the Offering (the “Insiders”) as supplemented by all information concerning the Company’s directors, officers and principal shareholders as described in the Offering Materials, provided to the Underwriter and Underwriter’s Counsel, is true and correct in all material respects and the Company has not become aware of any information which would cause the information disclosed in the Questionnaires to become materially inaccurate and incorrect.

 

(rr) Electronic Road Show. The Company has made available a “bona fide electronic road show” in compliance with Rule 433(d)(8)(ii) of the Securities Act Regulations such that no filing of any “road show” (as defined in Rule 433(h) of the Securities Act Regulations) is required in connection with the Offering.

 

(ss) Margin Securities. The Company owns no “margin securities” as that term is defined in Regulation U of the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”), and none of the proceeds of Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the Securities to be considered a “purpose credit” within the meanings of Regulation T, U or X of the Federal Reserve Board.

 

(tt) Export and Import Laws. The Company and, to the Company’s knowledge, each of its Affiliates, and any director, officer, agent or employee of, or other person associated with or acting on behalf of the Company, has acted at all times in compliance with applicable Export and Import Laws (as defined below) and there are no claims, complaints, charges, investigations or Proceedings pending or expected or, to the knowledge of the Company, threatened between the Company or any of its subsidiaries and any governmental authority under any Export or Import Laws. The term “Export and Import Laws” means the Arms Export Control Act, the International Traffic in Arms Regulations, the Export Administration Act of 1979, as amended, the Export Administration Regulations, and all other laws and regulations of the United States government regulating the provision of services to non-U.S. parties or the export and import of articles or information from and to the United States of America, and all similar laws and regulations of any foreign government regulating the provision of services to parties not of the foreign country or the export and import of articles and information from and to the foreign country to parties not of the foreign country.

 

(uu) Integration. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration of any such securities under the Securities Act.

 

 
 

 

(vv) No Fiduciary Duties. The Company acknowledges and agrees that the Underwriter’s responsibility to the Company is solely contractual in nature and that none of the Underwriter or their Affiliates or any selling agent shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its Affiliates in connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this Agreement to the contrary, the Company acknowledges that the Underwriter may have financial interests in the success of the Offering that are not limited to the difference between the Per Share Price to the public and the purchase price paid to the Company by the Underwriter for the Shares and the Underwriter has no obligation to disclose, or account to the Company for, any of such additional financial interests. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriter with respect to any breach or alleged breach of fiduciary duty.

 

(w)(w) SAFE Compliance. Except as disclosed in the Offering Material, each of the Company and the Subsidiaries has taken all necessary steps to comply in all material respects with, and to request all of the Company’s direct or indirect shareholders, directors and officers who are, or to the Company’s knowledge, are directly or indirectly owned or controlled by, a resident or citizen of the People’s Republic of China (“PRC”) with any applicable rules and regulations of the relevant PRC government agencies (including but not limited to the Ministry of Commerce, the National Development and Reform Commission, the China Securities Regulatory Commission (“CSRC”) and the State Administration of Foreign Exchange (the “SAFE”) relating to overseas investment by PRC residents and citizens (the “PRC Overseas Investment and Listing Regulations”), including, without limitation, requesting each such Person that is, or is directly or indirectly owned or controlled by, a PRC resident or citizen, to complete any registration and other procedures required under applicable PRC Overseas Investment and Listing Regulations (including any applicable rules and regulations of the SAFE).

 

Section 3. Delivery and Payment.

 

(a) On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth, the Company agrees to issue and sell the Underwritten Shares to the Underwriter, and the Underwriter agrees to purchase the Underwritten Shares. The purchase price for each Underwritten Share shall be $[*] (the “Per Share Price”).

 

(b) [Intentionally omitted].

 

(c) The Underwritten Shares will be delivered by the Company to the Underwriter against payment of the purchase price therefor by wire transfer in Federal (same day) funds payable to the order of the Company’s offices, or such other location as may be mutually acceptable, at 10:00 a.m. Eastern Time, on the second (or if the Underwritten Shares are priced, as contemplated by Rule 15c6-1(c) under the Exchange Act, after 4:30 p.m. Eastern Time, the third) full business day following the date hereof, or at such other time and date as the Underwriter and the Company determine pursuant to Rule 15c6-1(a) under the Exchange Act, at the offices of Bevilacqua PLLC (“Underwriter’s Counsel”), or at such other place (or remotely by facsimile or other electronic transmission) as shall be agreed upon by the Underwriter and the Company. The time and date of delivery of the Underwritten Shares is referred to herein as the “Closing Date”. If the Underwriter so elects, delivery of the Underwritten Shares may be made by credit through full fast transfer to the account at The Depository Trust Company (“DTC”) designated by the Underwriter. The Underwritten Shares shall be registered in such name or names and in such authorized denominations as the Underwriter may request in writing prior to the Closing Date. The Company shall not be obligated to sell or deliver the Underwritten Shares except upon tender of payment by the Underwriter for all of the Underwritten Shares.

 

 
 

 

(d) Over-allotment Option.

 

(i) Option Shares. For the purposes of covering any over-allotments in connection with the distribution and sale of the Underwritten Shares, the Company hereby grants to the Underwriter an option (the “Over-allotment Option”) to purchase, in the aggregate, up to [*] additional shares of Common Stock (the “Option Shares”, and along with the Underwritten Shares, the “Shares”), representing fifteen percent (15%) of the Underwritten Shares sold in the offering, from the Company. The purchase price to be paid per Option Share shall be equal to the Price Per Share for the Underwritten Shares. The Shares shall be issued directly by the Company and shall have the rights and privileges described in the Registration Statement, the Permitted Free Writing Prospectus and the Prospectus referred to below.

 

(ii) Exercise of Option. The Over-allotment Option granted pursuant to Section 3(d)(i) hereof may be exercised by the Underwriter as to all (at any time) or any part (from time to time) of the Option Shares within forty-five (45) days after the Effective Date. The Underwriter shall not be under any obligation to purchase any of the Option Shares prior to the exercise of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the giving of written notice to the Company from the Underwriter, setting forth the number of the Option Shares to be purchased and the date and time for delivery of and payment for the Option Shares (the “Option Closing Date”), which shall not be later than five (5) full Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the Underwriter, at the offices of Underwriter’s Counsel or at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Underwriter. If such delivery and payment for the Option Shares does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment Option with respect to all or any portion of the Option Shares subject to the terms and conditions set forth herein, (i) the Company shall become obligated to sell to the Underwriter the number of the Option Shares specified in such notice.

 

(iii) Payment and Delivery. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same day) funds, payable to the order of the Company’s offices upon delivery to the Underwriter of certificates (in form and substance satisfactory to the Underwriter) representing the Option Shares (or through the facilities of DTC or via DWAC transfer) for the account of the Underwriter. The Option Shares shall be registered in such name or names and in such authorized denominations as the Underwriter may request in writing prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Option Shares except upon tender of payment by the Underwriter for applicable Option Shares.

 

(e) Underwriter’s Warrant.

 

(i) Purchase Warrant. The Company hereby agrees to issue and sell to the Underwriter (and/or its designees) on the Closing Date and the Option Closing Date (if any), an option, as applicable, a five-year warrant for the purchase of a number of the shares of Common Stock equal to 5% of the number of the Underwritten Shares or Option Shares, as applicable, issued in the Offering, pursuant to a warrant in the form attached hereto as Exhibit A (the “Underwriter’s Warrant”), at an initial exercise price of $[*] (or 125% of the public offering price per Underwritten Share). The Underwriter’s Warrant and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as the “Underwriter’s Securities.” The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying shares of Common Stock during the one hundred eighty (180) days following commencement of sales in the Offering and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following commencement of sales in the Offering other than as permitted by FINRA Rule 5110(e)(2).

 

(ii) Delivery. Delivery of the Underwriter’s Warrant shall be made on the Closing Date and the Option Closing Date, as applicable, and shall be issued in the name or names and in such authorized denominations as the Underwriter may request.

 

 
 

 

Section 4. Covenants and Agreements of the Company. The Company further covenants and agrees with the Underwriter as follows:

 

(a) Registration Statement Matters. The Registration Statement and any amendments thereto have been declared effective, and if Rule 430A is used or the filing of the Prospectus is otherwise required under Rule 424(b), the Company will file the Prospectus (properly completed if Rule 430A has been used) pursuant to Rule 424(b) within the prescribed time period and will provide evidence satisfactory to the Underwriter of such timely filing. The Company will advise the Underwriter promptly after they receive notice thereof of the time when any amendment to the Registration Statement has been filed or becomes effective or any supplement or amendment to the Prospectus has been filed and will furnish the Underwriter with copies thereof. The Company will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the Offering. The Company will advise the Underwriter, promptly after it receives notice thereof (i) of any request by the Commission to amend the Registration Statement or to amend or supplement the Prospectus or for additional information, and (ii) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any order preventing or suspending the use of the Prospectus or any amendment or supplement thereto or any post-effective amendment to the Registration Statement, of the suspension of the qualification of the Shares and the Underwriter’s Warrant for offering or sale in any jurisdiction, of the institution or threatened institution of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information. The Company shall use its commercially reasonable efforts to prevent the issuance of any such stop order or prevention or suspension of such use. If the Commission shall enter any such stop order or order or notice of prevention or suspension at any time, the Company will use its commercially reasonable efforts to obtain the lifting of such order at the earliest possible moment, or will file a new registration statement and use its commercially reasonable efforts to have such new registration statement declared effective as soon as practicable. Additionally, the Company agrees that it shall comply with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the timely filing of documents thereunder, and will use its commercially reasonable efforts to confirm that any filings made by the Company under such Rule 424(b) are received in a timely manner by the Commission.

 

(b) Blue Sky Compliance. The Company will cooperate with the Underwriter in endeavoring to qualify the Shares for sale under the securities laws of such jurisdictions (United States and foreign) as the Underwriter may reasonably request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose, provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company shall not be required to produce any new disclosure document other than the Prospectus. The Company will, from time to time, prepare and file such statements, reports and other documents as are or may be required to continue such qualifications in effect for so long a period as the Underwriter may reasonably request for distribution of the Shares. The Company will advise the Underwriter promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Shares for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall use its commercially reasonable efforts to obtain the withdrawal thereof at the earliest possible moment.

 

(c) Amendments and Supplements to the Prospectus and Other Matters. The Company will comply with the Rules and Regulations so as to permit the completion of the distribution of the Shares as contemplated in this Agreement and the Prospectus. If during the period in which a prospectus is required by law to be delivered in connection with the distribution of Shares contemplated by the Prospectus (the “Prospectus Delivery Period”), any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Underwriter or the Underwriter’s Counsel, it becomes necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances under which they were made, as the case may be, not misleading, or if it is necessary at any time to amend or supplement the Prospectus to comply with any law, the Company will promptly prepare and file with the Commission, and furnish at its own expense to the Underwriter and to dealers, an appropriate amendment to the Registration Statement or supplement to the Registration Statement or the Prospectus that is necessary in order to make the statements in the Prospectus as so amended or supplemented, in the light of the circumstances under which they were made, as the case may be, not misleading, or so that the Registration Statement or the Prospectus, as so amended or supplemented, will comply with law. Before amending the Registration Statement or supplementing the Prospectus in connection with the Offering, the Company will furnish the Underwriter with a copy of such proposed amendment or supplement and will not file any such amendment or supplement to which the Underwriter reasonably objects; the Underwriter, and its counsel shall have at least three (3) business days to review and return any comments to the Company.

 

 
 

 

(d) Copies of any Amendments and Supplements to the Prospectus. The Company will furnish the Underwriter and the Underwriter’s Counsel, without charge, during the period beginning on the date hereof and ending on the final Closing Date and Option Closing Date (if any) of the Offering, as many copies of the Prospectus and any amendments and supplements thereto as the Underwriter may reasonably request.

 

(e) Free Writing Prospectus. The Company covenants that it will not, unless it obtains the prior consent of the Underwriter, make any offer relating to the Shares that would constitute a Company Free Writing Prospectus (as defined below) or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Securities Act. In the event that the Underwriter expressly consents in writing to any such free writing prospectus (a “Permitted Free Writing Prospectus”), the Company covenants that it shall (i) treat each Permitted Free Writing Prospectus as a Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433 of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. “Company Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 of the Securities Act Regulations (“Rule 433”), including without limitation any “free writing prospectus” (as defined in Rule 405 of the Securities Act Regulations) relating to the public securities that is (i) required to be filed with the Commission by the Company, (ii) a “road show that is a written communication” within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the public securities or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g).

 

(f) Transfer Agent. The Company will maintain, at its expense, a registrar and transfer agent for its Common Stock for so long as the Common Stock is publicly traded.

 

(g) Earnings Statement. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later than 18 months after the last Closing Date, the Company will make generally available to its security holders and to the Underwriter an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies the provisions of Section 11(a) and Rule 158 under the Securities Act.

 

(h) Periodic Reporting Obligations. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange Act.

 

(i) Additional Documents. The Company will enter into any subscription, purchase or other customary agreements as the Underwriter deems necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable to the Company and the Underwriter.

 

(j) No Manipulation of Price. The Company will not take, directly or indirectly, any action designed to cause or result in, or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the Company.

 

(k) Company Lock-Up.

 

 
 

 

(i) The Company will not, without the prior written consent of the Underwriter, from the date of execution of this Agreement and continuing for a period of 12 months from the date on which the trading of the Common Stock on a Senior Exchange commences (the “Lock-Up Period”), (i) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, change the terms of or grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, or file with the Commission a registration statement under the Securities Act relating to, any Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of Common Stock or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, except to the Underwriter pursuant to this Agreement. The Company agrees not to accelerate the vesting of any option or warrant or the lapse of any repurchase right prior to the expiration of the Lock-Up Period.

 

(ii) The restrictions contained in Section 4(k)(i) hereof shall not apply to: (A) the Shares and the Underwriter’s Warrant and shares of Common Stock underlying the Underwriter’s Warrant to be sold hereunder, (B) any Common Stock previously issued under incentive plans as described as outstanding in the Registration Statement and the Prospectus, (C) any options and other awards granted under an incentive plan or Common Stock issued pursuant to an employee stock purchase plan, in each case, as described in the Registration Statement and the Prospectus, and (C) Common Stock or other securities issued in connection with a transaction with an unaffiliated third party that includes a bona fide commercial relationship (including joint ventures, marketing or distribution arrangements, collaboration agreements or intellectual property license agreements) or any acquisition of assets or acquisition of not less than a majority or controlling portion of the equity of another entity; provided that (x) the aggregate number of shares of Common Stock issued pursuant to clause (C) shall not exceed five percent (5%) of the total number of outstanding shares of Common Stock immediately following the issuance and sale of the Shares pursuant to this Agreement and (y) the recipient of any such shares of Common Stock or other securities issued or granted pursuant to clauses (B), and (C) during the Lock-Up Period shall enter into an agreement substantially in the form of Exhibit B hereto.

 

(l) Acknowledgment. The Company acknowledges that any advice given by the Underwriter to the Company is solely for the benefit and use of the Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without such Underwriter’s prior written consent.

 

(m) Listing. The Company shall use its commercially reasonable efforts to maintain the listing of the Shares and the shares of Common Stock underlying the Underwriter’s Warrant on a Senior Exchange for five (5) years after the date of this Agreement.

 

(n) Application of Net Proceeds. The Company shall apply the net proceeds from the Offering of the Shares received by it in a manner consistent with the application thereof described under the caption “Use of Proceeds” in the Registration Statement, the Prospectus and the Final Prospectus.

 

(o) Rule 158. The Company will timely file such reports pursuant to the Exchange Act as are necessary in order to make generally available to its security holders as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriter the benefits contemplated by Rule 158(a) under Section 11(a) of the Securities Act.

 

(p) Stabilization. Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Underwriter) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.

 

 
 

 

(q) Internal Controls. The Company shall maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

(r) Accountants. The Company shall retain an independent registered public accounting firm reasonably acceptable to the Underwriter (it being understood that Friedman LLP is an independent registered public accounting firm that is reasonably acceptable to the Underwriter), and the Company shall continue to retain a nationally recognized independent registered public accounting firm for a period of at least five (5) years after the date of this Agreement.

 

(s) FINRA. The Company shall advise the Underwriter (who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or director of the Company, (ii) any beneficial owner of 5% or more of any class of the Company’s securities or (iii) any beneficial owner of the Company’s unregistered equity securities which were acquired during the 180 days immediately preceding the original filing of the Registration Statement is or becomes an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations of FINRA).

 

(t) Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as Board members and the overall composition of the Board comply with the Sarbanes-Oxley Act and the rules promulgated thereunder and with the listing requirements of the Senior Exchange and (ii) if applicable, at least one member of the Board qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act and the rules promulgated thereunder.

 

(u) CSRC Filings. The Company will comply with all applicable requirements and timely submit all requisite filings in connection with the Offering with the CSRC in accordance with the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies promulgated by the CSRC on February 17, 2023 and the supporting guidelines (collectively, the “Trial Measures”). The information shall be provided by the Company to the CSRC during the filing procedures in accordance with the Trial Measures and other applicable laws and regulations and will be true and accurate in all material respects and no material fact will be omitted from such filings which would make the information therein misleading. The Company shall promptly advise the Underwriter in writing of: (i) the receipt of any comments of, or requests for additional or supplemental information from, the CSRC; (ii) the time and date of the review by the CSRC. The Company shall furnish to the Underwriter, without charge, copies of the CSRC filings as the Underwriter may reasonably request.

 

Section 5. Conditions of the Obligations of the Underwriter. The obligations of the Underwriter hereunder shall be subject to the accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date hereof and as of each Closing Date and Option Closing Date (if any), as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder on and as of such dates, and to each of the following additional conditions:

 

(a) Accountants’ Comfort Letter. On the date hereof, the Underwriter shall have received, and the Company shall have caused to be delivered to the Underwriter, a letter from KCCW addressed to the Underwriter, dated as of the date hereof, in form and substance satisfactory to the Underwriter. The letter shall not disclose any change in the condition (financial or other), earnings, operations, business or prospects of the Company from that set forth in the Prospectus, which, in the Underwriter’s sole judgment, is material and adverse and that makes it, in the Underwriter’s sole judgment, impracticable or inadvisable to proceed with the Offering of the Shares as contemplated by the Prospectus.

 

 
 

 

(b) Compliance with Registration Requirements; No Stop Order; No Objection from the FINRA. The Registration Statement shall have become effective and all necessary regulatory and listing approvals shall have been received not later than 5:30 P.M., New York City time, on the date of this Agreement, or at such later time and date as shall have been consented to in writing by the Underwriter. The Prospectus (in accordance with Rule 424(b)) and “free writing prospectus” (as defined in Rule 405 of the Securities Act), if any, shall have been duly filed with the Commission in a timely fashion in accordance with the terms thereof. At or prior to each Closing Date and Option Closing Date (if any) and the actual time of such closing, no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing or suspending the use of the Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order having the effect of ceasing or suspending the distribution of the Shares or any other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock exchange and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory authority or stock exchange; all requests for additional information on the part of the Commission shall have been complied with; and the FINRA shall have raised no objections to the fairness and reasonableness of the placement terms and arrangements. On the Closing Date, the Underwritten Shares shall have been approved for listing on the Senior Exchange. On the Option Closing Date (if any), the Option Shares shall have been approved for listing on the Senior Exchange.

 

(c) Corporate Proceedings. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and the Prospectus, and the registration, sale and delivery of the Shares, shall have been completed or resolved in a manner reasonably satisfactory to the Underwriter’s counsel.

 

(d) No Material Adverse Effect. Subsequent to the execution and delivery of this Agreement and prior to each Closing Date and Option Closing Date (if any), in the Underwriter’s sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect.

 

(e) Opinions of Counsel for the Company. The Underwriter shall have received on each Closing Date and Option Closing Date (if any):

 

(i) the favorable opinion of Ellenoff Grossman & Schole LLP, the Company’s U.S. securities counsel, dated as of such Closing Date or Option Closing Date, as applicable, including, without limitation, a customary negative assurance letter, addressed to the Underwriter in customary form reasonably satisfactory to the Underwriter;

 

(ii) the favorable opinion of [*], the Company’s Colorado counsel, dated as of such Closing Date or Option Closing Date, as applicable, including, without limitation, a customary negative assurance letter, addressed to the Underwriter in customary form reasonably satisfactory to the Underwriter;

 

(iii) the favorable opinion of [*], the Company’s British Virgin Islands counsel, dated as of such Closing Date or Option Closing Date, as applicable, including, without limitation, a customary negative assurance letter for applicable sections, addressed to the Underwriter in customary form reasonably satisfactory to the Underwriter;

 

(iii) the favorable opinion of [*], the Company’s HK SAR counsel, dated as of such Closing Date or Option Closing Date, as applicable, including, without limitation, a customary negative assurance letter for applicable sections, addressed to the Underwriter in customary form reasonably satisfactory to the Underwriter; and 

 

(iv) the favorable opinion of [*], the Company’s PRC counsel, dated as of such Closing Date or Option Closing Date, as applicable, including, without limitation, a customary negative assurance letter for applicable sections, addressed to the Underwriter in customary form reasonably satisfactory to the Underwriter.

 

 
 

 

(f) Officers’ Certificate. The Underwriter shall have received on each Closing Date and Option Closing Date, if any, a certificates of the Company, dated as of such Closing Date or Option Closing Date, as applicable, signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Underwriter shall be satisfied that, the signers of such certificates have reviewed the Registration Statement and the Prospectus, and this Agreement and to the further effect that:

 

(i) The representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date or such Option Closing Date, as applicable, and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to such Closing Date or Option Closing Date, as applicable;

 

(ii) No stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus has been issued and no proceedings for that purpose have been instituted or are pending or, to the Company’s knowledge, threatened under the Securities Act; no order having the effect of ceasing or suspending the distribution of the Shares or any other securities of the Company has been issued by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory authority or stock exchange in the United States;

 

(iii) When the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate, the Registration Statement, when it became effective, contained all material information required to be included therein by the Securities Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects conformed to the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and the Registration Statement, did not and does not include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information) and, since the effective date of the Registration Statement, there has occurred no event required by the Securities Act and the rules and regulations of the Commission thereunder to be set forth in the Registration Statement which has not been so set forth; and

 

(iv) Subsequent to the respective dates as of which information is given in the Registration Statement and the Prospectus, there has not been: (a) any Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries taken as a whole, except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise of outstanding options or warrants or conversion of outstanding indebtedness into Common Stock of the Company) or outstanding indebtedness of the Company or any Subsidiary (except for the conversion of such indebtedness into Common Stock of the Company); (e) any dividend or distribution of any kind declared, paid or made on Common Stock of the Company; or (f) any loss or damage (whether or not insured) to the property of the Company or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.

 

(g) Secretary’s Certificate. As of each Closing Date and Option Closing Date (if any), the Underwriter shall have received a certificate of the Company signed by the Secretary of the Company, dated such Closing Date or Option Closing Date, as applicable, certifying: (i) that the Company’s Articles of Incorporation, as amended, and Bylaws, each attached to such certificate are true and complete, has not been modified and is in full force and effect; (ii) that each of the Subsidiaries’ formation documents or charter documents attached to such certificate is true and complete, has not been modified and is in full force and effect; (iii) that the resolutions of the Company’s Board of Directors relating to the Offering attached to such certificate are in full force and effect and have not been modified; and (iv) the good standing of the Company and each of the Subsidiaries. The documents referred to in such certificate shall be attached to such certificate.

 

 
 

 

(h) Bring-down Comfort Letter. On each Closing Date and Option Closing Date (if any), the Underwriter shall have received from KCCW, or such other independent registered public accounting firm engaged by the Company at such time, a letter dated as of such Closing Date or Option Closing Date, as applicable, in form and substance satisfactory to the Underwriter, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (a) of this Section 5, except that the specified date referred to therein for the carrying out of procedures shall be no more than three business days prior to such Closing Date or Option Closing Date, as applicable.

 

(i) Additional Documents. On or before each Closing Date and Option Closing Date ( if any), the Underwriter and the Underwriter’s Counsel shall have received such customary information and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Shares and the Underwriter’s Warrant as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained. If any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Underwriter by notice to the Company at any time on or prior to such Closing Date or Option Closing Date , as applicable, which termination shall be without liability on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution) and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.

 

(j) Subsequent to the execution and delivery of this Agreement or, if earlier, the dates as of which information is given in the Registration Statement (exclusive of any amendment thereof) and the Prospectus (exclusive of any supplement thereto), there shall not have been any change in the capital stock or long-term debt of the Company (other than as described in the Registration Statement or the Prospectus) or any change or development involving a change, whether or not arising from transactions in the ordinary course of business, in the business, condition (financial or otherwise), results of operations, shareholders’ equity, properties or prospects of the Company, taken as a whole, including but not limited to the occurrence of any fire, flood, storm, explosion, accident, act of war or terrorism or other calamity, the effect of which, in any such case described above, is, in the sole judgment of the Underwriter, so material and adverse as to make it impracticable or inadvisable to proceed with the sale of Shares or Offering as contemplated hereby.

 

(k) Subsequent to the execution and delivery of this Agreement and up to each Closing Date and Option Closing Date (if any), there shall not have occurred any of the following: (i) trading in securities generally on a Senior Exchange or any Trading Market shall not have commenced, (ii) a banking moratorium shall have been declared by federal or state authorities or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States, (iii) the United States shall have become engaged in hostilities in which it is not currently engaged, the subject of an act of terrorism, there shall have been an escalation in hostilities involving the United States, or there shall have been a declaration of a national emergency or war by the United States, or (iv) there shall have occurred any other calamity or crisis or any change in general economic, political or financial conditions in the United States or elsewhere, if the effect of any such event in clause (ii) or (iv) makes it, in the sole judgment of the Underwriter, impracticable or inadvisable to proceed with the sale or delivery of the Shares on the terms and in the manner contemplated by the Prospectus.

 

(l) The Underwriter shall have received a lock-up agreement from each Lock-Up Party set forth on Schedule A, duly executed by the applicable Lock-Up Party, in each case substantially in the form attached as Exhibit B.

 

(m) No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of any Closing Date or Option Closing Date (if any), prevent the issuance or sale of the Shares; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of such Closing Date or Option Closing Date, as applicable, prevent the issuance or sale of the Shares or materially and adversely affect or potentially materially and adversely affect the business or operations of the Company.

 

 
 

 

If any of the conditions specified in this Section 5 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written statements or letters furnished to the Underwriter or to Underwriter’s counsel pursuant to this Section 5 shall not be reasonably satisfactory in form and substance to the Underwriter and to Underwriter’s counsel, all obligations of the Underwriter hereunder may be cancelled by the Underwriter at, or at any time prior to, the consummation of the Offering. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.

 

Section 6. Payment of Company Expenses. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses incident to the issuance, delivery and qualification of the Shares (including all printing and engraving costs); (ii) all fees and expenses of the registrar and transfer agent of the Shares; (iii) all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Shares; (iv) all fees and expenses of the Company’s counsel, independent public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Prospectus, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys’ fees and expenses incurred by the Company or the Underwriter in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Shares for offer and sale under the state securities or blue sky laws or the securities laws of any other country, and, if reasonably requested by the Underwriter, preparing and printing a “Blue Sky Survey,” an “International Blue Sky Survey” or other memorandum, and any supplements thereto, advising any of the Underwriter of such qualifications, registrations and exemptions; (vii) if applicable, the filing fees incident to the review and approval by the FINRA of the Underwriter’s participation in the offering and distribution of the Shares; (viii) the fees and expenses associated with including the Common Stock on the Trading Market; and (ix) all costs and expenses incident to the travel and accommodation of the Company’s employees on the “roadshow,” as described in Section 1(a)(iii) of this Agreement.

 

Section 7. Indemnification and Contribution.

 

(a) The Company agrees to indemnify, defend and hold harmless the Underwriter, its Affiliates, directors and officers and employees, and each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each an “Underwriter Indemnified Party”), from and against any losses, claims, damages or liabilities (including in settlement of any litigation if such settlement is effected with the prior written consent of the Company) arising out of (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, including the information deemed to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Securities Act Regulations, or arise out of or are based upon the omission from the Registration Statement, or alleged omission to state therein, a material fact required to be stated therein or necessary to make the statements therein not misleading; or (ii) an untrue statement or alleged untrue statement of a material fact contained in the Prospectus, or any amendment or supplement thereto, or in any other materials used in connection with the Offering, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and will reimburse such Underwriter Indemnified Party for any legal or other expenses reasonably incurred by it in connection with evaluating, investigating or defending against such loss, claim, damage, liability or action; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Prospectus, or any amendment or supplement thereto, or, in reliance upon and in conformity with the Underwriter Information. The indemnification obligations under this Section 7(a) are not exclusive and will be in addition to any liability which the Company might otherwise have and shall not limit any rights or remedies which may otherwise be available at law or in equity to each Underwriter Indemnified Party.

 

 
 

 

(b) The Underwriter will indemnify, defend and hold harmless the Company, its Affiliates, directors, officers and employees, and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each a “Company Indemnified Party”), from and against any losses, claims, damages or liabilities to which such Company Indemnified Party may become subject, under the Securities Act or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of the Underwriter), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Prospectus, or any amendment or supplement thereto, in reliance upon and in conformity with the Underwriter Information, and will reimburse such Company Indemnified Party for any legal or other expenses reasonably incurred by it in connection with defending against any such loss, claim, damage, liability or action; provided, however, that the Underwriter shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Prospectus, or any amendment or supplement thereto, or, in reliance upon and in conformity with information furnished in writing to the Underwriter by the Company. The indemnification obligations under this Section 7(b) are not exclusive and will be in addition to any liability which the Underwriter might otherwise have and shall not limit any rights or remedies which may otherwise be available at law or in equity to each Company Indemnified Party.

 

(c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof, but the failure to notify the indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party except to the extent such indemnifying party has been materially prejudiced by such failure. In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of the indemnifying party’s election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof; provided, however, that if (i) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (ii) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party), or (iii) the indemnifying party has not in fact employed counsel reasonably satisfactory to the indemnified party to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, the indemnified party shall have the right to employ a single counsel to represent it in any claim in respect of which indemnity may be sought under subsection (a) or (b) of this Section 7, in which event the reasonable fees and expenses of such separate counsel shall be borne by the indemnifying party or parties and reimbursed to the indemnified party as incurred.

 

(d) The indemnifying party under this Section 7 shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is a party or could be named and indemnity was or would be sought hereunder by such indemnified party, unless such settlement, compromise or consent (i) includes an unconditional release of such indemnified party from all liability for claims that are the subject matter of such action, suit or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. Notwithstanding the foregoing, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel pursuant to Section 7(c), such indemnifying party agrees that it shall be liable for any settlement effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

 

 
 

 

(e) If the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless an indemnified party under subsection (a) or (b) above, then the indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a) or (b) above, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriter on the other hand from the offering and sale of the Shares or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company on the one hand and the Underwriter on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriter on the other hand shall be deemed to be in the same proportion as the total net proceeds from the Offering (before deducting expenses) received by the Company bear to the total cash compensation received by the Underwriter. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriter and the parties’ relevant intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriter agree that it would not be just and equitable if contributions pursuant to this subsection (e) were to be determined by pro rata allocation (even if the Underwriter was treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in the first sentence of this subsection (e). The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection (e) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending against any action or claim that is the subject of this subsection (e). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 

(f) For purposes of this Agreement, the Underwriter confirms, and the Company acknowledges, that there is no information concerning the Underwriter furnished in writing to the Company by the Underwriter specifically for preparation of or inclusion in the Registration Statement or the Prospectus other than the Underwriter Information.

 

Section 8. Representations and Indemnities to Survive Delivery. The respective indemnities, agreements, representations, warranties and other statements of the Company or any person controlling the Company, of its officers, and of the Underwriter set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Underwriter, the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment for the Shares sold hereunder and any termination of this Agreement. A successor to the Underwriter, or to the Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements contained in this Agreement.

 

Section 9. Termination.

 

(a) This Agreement shall become effective upon the later of: (i) receipt by the Underwriter and the Company of notification of the effectiveness of the Registration Statement or (ii) the execution of this Agreement. The Underwriter shall have the right to terminate this Agreement at any time upon 15 days written notice to the Company, or as practical as possible prior to any Closing Date if: (i) any domestic or international event or act or occurrence has materially disrupted, or in the reasonable opinion of the Underwriter will in the immediate future materially disrupt, the market for the Company’s securities or securities in general; or (ii) trading on a Senior Exchange has been rejected by such Senior Exchange or made subject to material limitations, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices for securities have been required, on the Senior Exchange or by order of the Commission, FINRA or any other governmental authority having jurisdiction; or (iii) a banking moratorium has been declared by any state or federal authority or any material disruption in commercial banking or securities settlement or clearance services has occurred; or (iv) (A) there has occurred any outbreak or escalation of hostilities or acts of terrorism involving the United States or China or there is a declaration of a national emergency or war by the United States or China or (B) there has been any other calamity or crisis or any change in political, financial or economic conditions, if the effect of any such event in (A) or (B), in the reasonable judgment of the Underwriter, is so material and adverse that such event makes it impracticable or inadvisable to proceed with the Offering, sale and delivery of the Underwritten Shares or the Option Shares on the terms and in the manner contemplated by the Prospectus.

 

 
 

 

(b) Any notice of termination pursuant to this Section 9 shall be in writing.

 

(c) If this Agreement shall be terminated pursuant to any of the provisions hereof, or if the sale of the Underwritten Shares provided for herein is not consummated because any condition to the obligations of the Underwriter set forth herein is not satisfied or because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof, the Company will, subject to demand by the Underwriter, reimburse the Underwriter for only those out-of-pocket expenses (including the reasonable fees and expenses of their counsel, and expenses associated with a due diligence report), actually incurred by the Underwriter in connection herewith as allowed under FINRA Rule 5110, less any amounts previously paid by the Company, subject to the cap on expenses set forth in Section 1(a)(iii) hereof. To the extent that the Underwriter’s out-of-pocket expenses are less than the sums already advanced by the Company to the Underwriter (“Advances”), the Underwriter will return to the Company that portion of the Advances not offset by actual expenses.

 

Section 10. Future Services. The Underwriter shall be entitled to be paid the cash Success Fee and be issued the warrants Success Fee provided for in paragraph 2(A)(ii) above with respect to future financings consummated solely with investors (a) with whom the Company has had a conference call or a meeting arranged by Boustead during the Engagement Period, and (b) provided that the future financing is consummated during the term hereof or within twelve (12) months of the consummation of the Uplist Offering.

 

Section 11. Notices. All communications hereunder shall be in writing and shall be mailed, hand delivered, delivered by reputable overnight courier (i.e., Federal Express) or delivered by facsimile or e-mail transmission to the parties hereto as follows:

 

If to the Underwriter, then to:

 

Boustead Securities, LLC

6 Venture, Suite 395

Irvine, CA 92618

  Attn: Keith Moore
  Attn: Daniel J. McClory
  Email: Keith@boustead1828.com
    Dan@boustead1828.com

 

With a copy (which shall not constitute notice) to:

 

Bevilacqua PLLC

1050 Connecticut Avenue NW, Suite 500

Washington, DC 20036

  Attn: Louis A. Bevilacqua Esq.
    Kevin (Qixiang) Sun, Esq.
  Email: lou@bevilacquapllc.com
    kevin@bevilacquapllc.com

 

If to the Company:

 

Hongxing International Business Building 2, 14th Floor

No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China

  Attn: Mr. Quanzhong Lin, CEO
  Email: mailto:linquanzhong@aixinjituan.com

 

 
 

 

With a copy (which shall not constitute notice) to:

 

Ellenoff Grossman & Schole LLP

1185 Avenue of the Americas, 37th Floor

New York, NY 10036

  Attn:

Vincent McGill, Esq.

Mark Orenstein, Esq.

  Email:

vmcgill@egsllp.com

morenstein@egsllp.com

 

Any party hereto may change the address for receipt of communications by giving written notice to the others.

 

Section 12. Successors. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and no other person will have any right or obligation hereunder.

 

Section 13. Partial Unenforceability. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.

 

Section 14. Governing Law Provisions. This Agreement shall be deemed to have been made and delivered in New York and both this Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Underwriter and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement and/or the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, (ii) waives any objection which it may now or hereafter have to the venue of any such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Underwriter and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York and agrees that service of process upon the Company mailed by certified mail to the Company’s address shall be deemed in every respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Underwriter mailed by certified mail to the Underwriter address(es) shall be deemed in every respect effective service process upon the Underwriter, in any such suit, action or proceeding.

 

Section 15. General Provisions.

 

(a) This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations solely with respect to the subject matters hereof. Notwithstanding anything to the contrary set forth herein, it is understood and agreed by the parties hereto that all other terms and conditions of the Engagement Letter shall remain in full force and effect. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified unless in writing and signed by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.

 

(b) The Company acknowledges that in connection with the Offering of the Shares: (i) the Underwriter has acted at arm’s length, is not an agent of, and owes no fiduciary duties to the Company or any other person, (ii) the Underwriter owes the Company only those duties and obligations set forth in this Agreement and (iii) the Underwriter may have interests that differ from those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Underwriter arising from an alleged breach of fiduciary duty in connection with the Offering of the Offered Shares.

 

[The remainder of this page has been intentionally left blank.]

 

 
 

 

If the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become a binding agreement in accordance with its terms.

 

  Very truly yours,
   
  AiXin Life International, Inc.
     
  By:  
  Name:  Quanzhong Lin
  Title: Chief Executive Officer

 

The foregoing Underwriting Agreement is hereby confirmed and agreed to of the date first above written.

 

  BOUSTEAD SECURITIES, LLC
     
  By:  
  Name:  Keith Moore
  Title: Chief Executive Officer

 

 
 

 

Schedule A

 

Lock-up Party

 

Locked-up Parties  

Common Stock

Beneficially Owned

  Lock Up Period
         

 

 
 

 

Exhibit A

Form of Underwriter’s Warrant

 

 
 

 

Exhibit B

Form of Lock-up Agreement

 

 

 

EX-4.2 3 ex4-2.htm

 

Exhibit 4.2

 

THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCMENT OF SALES OF COMMON STOCK IN THE OFFERING TO ANYONE OTHER THAN (I) BOUSTEAD SECURITIES, LLC, OR A REPRESENTATIVE OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF BOUSTEAD SECURITIES, LLC, OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.

 

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [  ], 2024 (THE DATE OF ISSUANCE). VOID AFTER 5:00 P.M., EASTERN TIME, [  ], 2029 (THE DATE THAT IS FIVE YEARS FROM COMMENCEMENT OF SALES OF COMMON STOCK IN THE OFFERING).

 

UNDERWRITER’S WARRANT

 

FOR THE PURCHASE OF [  ] COMMON STOCK

 

OF

 

 AIXIN LIFE INTERNATIONAL, INC.

 

1. Purchase Warrant. THIS CERTIFIES THAT, pursuant to that certain Underwriting Agreement by and between Aixin Life International, Inc., a Colorado Corporation (the “Company”), on one hand, and Boustead Securities, LLC (the “Holder”), on the other hand, dated [  ], 2024 (the “Underwriting Agreement”), the Holder, as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from [  ], 2024 (the “Exercise Date”), and at or before 5:00 p.m., Eastern time, on [  ], 2029 (the “Expiration Date”), which date shall be no more than five years from the commencement of sales of the initial public offering (the “Offering”), pursuant to the Underwriting Agreement, but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [  ] shares of common stock of the Company, par value $0.00001 per share (the “Common Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[  ] per Common Share (125% of the price per Common Share in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Common Share and the number of Common Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price as set forth above or the adjusted exercise price as a result of the events set forth in Section 6 below, depending on the context. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement. 

 

2. Exercise.

 

2.1 Exercise Form. In order to exercise this Purchase Warrant, the exercise form attached hereto as Exhibit A must be duly executed and completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Common Shares being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.

 

2.2 Cashless Exercise. This Purchase Warrant may be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Common Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = the Fair Market Value of one Common Share;

 

(B) = the Exercise Price of this Purchase Warrant, as adjusted hereunder; and

 

1
 

 

  (X) = the number of Common Shares for which the Purchase Warrant is being exercised.

 

If Common Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Common Shares shall take on the registered characteristics of the Purchase Warrants being exercised. The Company agrees not to take any position contrary to this Section 2.2.

 

Notwithstanding anything herein to the contrary, on the Expiration Date, this Purchase Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2.2.

 

Fair Market Value” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed or quoted on a Trading Market, the value shall be deemed to be the highest daily price on any trading day on such Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on New York City time) during the twenty trading days preceding the exercise, (b) if OTCQB or OTCQX is not a Trading Market, the value shall be deemed to be the highest daily price on any trading day on the OTCQB or OTCQX on which the Common Shares are then quoted as reported by Bloomberg L.P. (based on New York City time) during the twenty trading days preceding the exercise, as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the “OTC Markets Group”, the value shall be deemed to be the highest daily price on any trading day on the Pink Sheets on which the Common Shares are then quoted as reported by OTC Markets Group (based on New York City time) during the twenty trading days preceding the exercise, or (d) in all other cases, the fair market value of a share of Common Shares as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Trading Market” means the NASDAQ Stock Market LLC, or any of the following other markets or exchanges on which the Common Shares are listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).

 

2.3 Legend. Each certificate for the securities purchased under this Purchase Warrant shall bear the following legends unless such securities have been registered under the Securities Act of 1933, as amended (the “Act”), or are exempt from registration under the Act:

 

(i) “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE LAW. NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW WHICH, IN THE OPINION OF COUNSEL TO THE COMPANY, IS AVAILABLE.”

 

(ii) Any legend required by the securities laws of any state to the extent such laws are applicable to the Common Shares represented by a certificate, instrument, or book entry so legended.

 

2
 

 

2.4 Resale of Shares. Holder and the Company acknowledge that as of the date hereof the Staff of the Division of Corporation Finance of the SEC has published Compliance & Disclosure Interpretation 528.04 in the Securities Act Rules section thereof, stating that the holder of securities issued in connection with a public offering may not rely upon Rule 144 promulgated under the Act to establish an exemption from registration requirements under Section 4(a)(1) under the Act, but may nonetheless apply Rule 144 constructively for the resale of such shares in the following manner: (a) provided that six months has elapsed since the last sale under the registration statement, an underwriter or finder may resell the securities in accordance with the provisions of Rule 144(c), (e), and (f), except for the notice requirement; (b) a purchaser of the shares from an underwriter receives restricted securities unless the sale is made with an appropriate, current prospectus, or unless the sale is made pursuant to the conditions contained in (a) above; (c) a purchaser of the shares from an underwriter who receives restricted securities may include the underwriter’s holding period, provided that the underwriter or finder is not an affiliate of the issuer; and (d) if an underwriter transfers the shares to its employees, the employees may tack the firm’s holding period for purposes of Rule 144(d), but they must aggregate sales of the distributed shares with those of other employees, as well as those of the underwriter or finder, for a six-month period from the date of the transfer to the employees. Holder and the Company also acknowledge that the Staff of the Division of Corporation Finance of the SEC has advised in various no-action letters that the holding period associated with securities issued without registration to a service provider commences upon the completion of the services, which the Company agrees and acknowledges shall be the final closing of the Offering, and that Rule 144(d)(3)(ii) provides that securities acquired from the issuer solely in exchange for other securities of the same issuer shall be deemed to have been acquired at the same time as the securities surrendered for conversion (which the Company agrees is the date of the initial issuance of this Purchase Warrant). In the event that following a reasonably-timed written request by Holder to transfer the Shares in accordance with Compliance & Disclosure Interpretation 528.04 counsel for the Company in good faith concludes that Compliance & Disclosure Interpretation 528.04 no longer may be relied upon as a result of changes in applicable laws, regulations, or interpretations of the SEC Division of Corporation Finance, or as a result of judicial interpretations not known by the Company or its counsel on the date hereof, then the Company shall promptly, and in any event within five (5) business days following the request, provide written notice to Holder of such determination. As a condition to giving such notice, the parties shall negotiate in good faith a single demand registration right pursuant to an agreement in customary form reasonably acceptable to the parties; provided that notwithstanding anything to the contrary, the obligations of the Company pursuant to this Section 2 shall terminate on [*], 2029. In the absence of such conclusion by counsel for the Company, the Company shall, upon such a request of Holder given no earlier than six months after the final closing of the Offering, instruct its transfer agent to permit the transfer of such shares in accordance with Compliance & Disclosure Interpretation 528.04, provided that Holder has provided such documentation as shall be reasonably be requested by the Company to establish compliance with the conditions of Compliance & Disclosure Interpretation 528.04. Notwithstanding anything to the contrary, pursuant to FINRA Rule 5110(g)(8)(B)-(D), the Holder shall not be entitled to more than one demand registration right hereunder and the duration of the registration rights hereunder shall not exceed [*], 2029.  

 

3. Transfer.

 

3.1 General Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant (or any Shares issuable upon the exercise of this Purchase Warrant) for a period of one hundred eighty (180) days following the commencement of sales of Common Shares in the Offering (the “Effective Date”) to anyone other than: (i) the Underwriter or a selected dealer participating in the Offering, or (ii) a bona fide officer or partner of the Underwriter or of any such selected dealer, in each case in accordance with FINRA Conduct Rule 5110(e)(1), or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in FINRA Rule 5110(e)(2). On and after that date that is one hundred eighty (180) days after the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company the assignment form attached hereto as Exhibit B duly executed and completed, together with this Purchase Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Common Shares purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.

 

3.2 Restrictions Imposed by the Act. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) the Company has received the opinion of counsel for the Company that the securities may be transferred pursuant to an exemption from registration under the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company, (ii) a registration statement or a post-effective amendment to the registration statement relating to the offer and sale of such securities that has been declared effective by the U.S. Securities and Exchange Commission (the “Commission”) and includes a current prospectus or (iii) a registration statement, pursuant to which the Holder has exercised its registration rights pursuant to Section 4.1 herein, relating to the offer and sale of such securities has been filed and declared effective by the Commission and compliance with applicable state securities law has been established.

  

3
 

 

4. Registration Rights.

 

4.1 “Piggy-Back” Registration. Unless all of the Common Shares underlying the Purchase Warrant (collectively, the “Registrable Securities”) are included in an effective registration statement with a current prospectus, the Holder shall have the right, for a period of seven (7) years from the commencement of sales of the Offering, to include the remaining Registrable Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Forms S-8, F-3, F-4 or any equivalent forms); provided, however, that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of Registrable Securities which may be included in the registration statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such registration statement only such limited portion of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit; and further provided that no such piggy-back rights shall exist for so long as the Registrable Securities (which term shall include those paid as consideration pursuant to the cashless exercise provisions of this Purchase Warrant) may be sold pursuant to Rule 144 of the Act without restriction. Any exclusion of Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such registration statement or are not entitled to pro rata inclusion with the Registrable Securities. In the event of such a proposed registration, the Company shall furnish the then Holders of outstanding Registrable Securities with not less than fifteen (15) days written notice prior to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The Holders of the Registrable Securities shall exercise the “piggy-back” rights provided for herein by giving written notice, within seven (7) days of the receipt of the Company’s notice of its intention to file a registration statement. Except as otherwise provided in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration under this Section 4.1.

  

4.2 General Terms.

 

4.2.1 Expenses of Registration. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4 hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities.

 

4.2.2 Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section 20 (a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under the Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriter contained in the Underwriting Agreement.

 

4.2.3 Exercise of Purchase Warrant. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise their Purchase Warrant prior to or after the initial filing of any registration statement or the effectiveness thereof.

  

4.2.4 Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any registration statement filed by the Company shall furnish to the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.

 

4.2.5 Documents Delivered to Holders. The Company shall deliver promptly to each Holder participating in the offering requesting the correspondence and memoranda described below, copies of all correspondence between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and independent auditors, all to such reasonable extent and at such reasonable times, during normal business hours, as any such Holder shall reasonably request.

  

4
 

 

4.2.6 Damages. Should the registration or the effectiveness thereof required by Section 4 hereof be delayed by the Company or the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other security.

 

5. New Purchase Warrants to be Issued.

 

5.1 Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised pursuant to Section 2.1 hereof, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of Common Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.

 

5.2 Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company. 

 

6. Adjustments.

 

6.1 Adjustments to Exercise Price and Number of Common Shares. The Exercise Price and the number of Common Shares underlying this Purchase Warrant shall be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1 Share Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Common Shares is increased by a stock dividend payable in Common Shares or by a split up of Common Shares or other similar event, then, on the effective day thereof, the number of Common Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Common Shares, and the Exercise Price shall be proportionately decreased.

 

6.1.2 Aggregation of Common Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Common Shares is decreased by a consolidation, combination or reclassification of Common Shares or other similar event, then, on the effective date thereof, the number of Common Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Common Shares, and the Exercise Price shall be proportionately increased.

  

6.1.3 Replacement of Common Shares upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Common Shares other than a change covered by Section 6.1.1 or Section 6.1.2 hereof or that solely affects the par value of such Common Shares, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation (other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Common Shares), or in the case of any sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the kind and amount of Common shares or other securities or property (including cash) receivable upon such reclassification, reorganization, share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the number of Common Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification also results in a change in Common Shares covered by Section 6.1.1 or Section 6.1.2, then such adjustment shall be made pursuant to Section 6.1.1Section 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications, reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.

 

5
 

 

6.1.4   Changes in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section 6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Common Shares as are stated in the Purchase Warrant initially issued pursuant to the Underwriting Agreement. The acceptance by any Holder of the issuance of new Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the date hereof or the computation thereof.

 

6.2 Substitute Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification or change of the outstanding Common Shares), the corporation formed by such consolidation or share reconstruction or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the Holder of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of Common Shares and other securities and property receivable upon such consolidation or share reconstruction or amalgamation, by a holder of the number of Common Shares of the Company for which such Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided for in this Section 6. The above provision of this Section 6 shall similarly apply to successive consolidations or share reconstructions or amalgamations. 

 

6.3 Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Common Shares upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may be, to the nearest whole number of Common Shares or other securities, properties or rights.

  

7. Reservation and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance upon exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price therefor, in accordance with the terms hereby, all Common Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. As long as this Purchase Warrant shall be outstanding, the Company shall use its commercially reasonable efforts to cause all Common Shares issuable upon exercise of this Purchase Warrant to be listed (subject to official notice of issuance) on all national securities exchanges (or, if applicable, on the OTCQB Market or any successor quotation system) on which the Common Shares issued to the public in the Offering may then be listed and/or quoted (if at all).

 

8. Certain Notice Requirements.

 

8.1 Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company. If, however, at any time prior to the expiration of this Purchase Warrant and its exercise, any of the events described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen days prior to the date fixed as a record date or the date of closing the transfer books (the “Notice Date”) for the determination of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice is given to the shareholders.

 

8.2 Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the following events: (i) if the Company shall take a record of the holders of its Common Shares for the purpose of entitling them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to all the holders of its Common Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed. 

  

6
 

 

8.3 Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the Company’s Chief Financial Officer.

 

8.4 Transmittal of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be deemed to have been duly made if made in accordance with the notice provisions of the Underwriting Agreement to the addresses and contact information for the Holder appearing on the books and records of the Company.

 

If to the Holder, then to:

 

Boustead Securities, LLC

6 Venture, Suite 395

Irvine, CA 92618

  Attn: Keith Moore
  Attn: Daniel J. McClory
  Email: Keith@boustead1828.com
    Dan@boustead1828.com

 

With a copy (which shall not constitute notice) to:

 

Louis A. Bevilacqua, Esq.

Bevilacqua PLLC

1050 Connecticut Avenue, NW, Suite 500

Washington, DC 20036

Email: lou@bevilacquapllc.com

 

If to the Company:

 

AiXin Life International, Inc.

Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave.

Jinjiang District, Chengdu City, Sichuan Province, China

Attn: Quanzhong Lin

Email:

 

With a copy (which shall not constitute notice) to:

 

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas, 11th floor

New York, New York 10105

Attn: Vincent J. McGill, Esq.

Email: vmcgill@egsllp.com

 

9. Miscellaneous.

 

9.1 Amendments. The Company and the Underwriter may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the Underwriter may deem necessary or desirable and that the Company and the Underwriter deem shall not adversely affect the interest of the Holders, in their sole and absolute discretion. All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or amendment is sought.

 

7
 

 

9.2 Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

9.3. Entire Agreement. This Purchase Warrant constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4 Binding Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.

 

9.5 Governing Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

  

9.6 Waiver, etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

 

9.7 Exchange Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and the Underwriter enter into an agreement (“Exchange Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

9.8 Holder Not Deemed a Shareholder. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Purchase Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Purchase Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Purchase Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of share, reclassification of share, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Common Shares which it is then entitled to receive upon the due exercise of this Purchase Warrant. In addition, nothing contained in this Purchase Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Purchase Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

 

[Signature Page to Follow]

 

8
 

 

IN WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the th day of [  ] 2024.

 

  Aixin Life International, Inc.
     
  By:   
  Name:
  Title: Chief Executive Officer

 

9
 

 

EXHIBIT A

 

Exercise Notice

 

Form to be used to exercise Purchase Warrant:

 

Date: __________, 20___

 

The undersigned hereby elects irrevocably to exercise the Purchase Warrant for ______ Common Shares of Aixin Life International, Inc., a Colorado Corporation (the “Company”) and hereby makes payment of $____ (at the rate of $____ per Common Share) in payment of the Exercise Price pursuant thereto. Please issue the Common Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Common Shares for which this Purchase Warrant has not been exercised.

 

or

 

The undersigned hereby elects irrevocably to convert its right to purchase ___ Common Shares under the Purchase Warrant for ______ Common Shares, as determined in accordance with the following formula:

 

dividing [(A-B) (X)] by (A), where:

 

(A) = the Fair Market Value of one Common Share;

 

(B) = the Exercise Price of this Purchase Warrant, as adjusted hereunder; and

 

  (X)

= the number of Common Shares underlying the Purchase Warrant that would be issuable upon exercise of this Purchase Warrant in accordance with the terms of this Purchase Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

The undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation shall be resolved by the Company in its sole discretion.

 

Please issue the Common Shares as to which this Purchase Warrant is exercised in accordance with the instructions given and, if applicable, a new Purchase Warrant representing the number of Common Shares for which this Purchase Warrant has not been converted.

 

Signature

 

10
 

 

EXHIBIT B

 

Form to be used to assign Purchase Warrant: ASSIGNMENT

 

(To be executed by the registered Holder to effect a transfer of the within Purchase Warrant):

 

FOR VALUE RECEIVED, does hereby sell, assign and transfer unto the right to purchase [●] Common Shares of Aixin Life International, Inc., a Colorado corporation (the “Company”), evidenced by the Purchase Warrant and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated: , 20__

 

Signature

 

NOTICE: The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national securities exchange.

 

INSTRUCTIONS FOR REGISTRATION OF SECURITIES

 

Name:

(Print in Block Letters)

Address:

 

NOTICE: The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national securities exchange.

  

 

11

 

EX-5.1 4 ex5-1.htm

 

Exhibit 5.1

 

Armstrong Teasdale LLP

4643 S. Ulster St., Ste. 800

Denver, CO 80237

 

February 9, 2024

 

AiXin Life International, Inc.

Hongxing International Business Building 2, 14th Floor

No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China

 

 Re:Registration Statement on Form S-1 of AiXin Life International, Inc. (File No. 333-268190)

 

Ladies and Gentlemen:

 

We have acted in a limited capacity as special local counsel to AiXin Life International, Inc., a Colorado corporation (the “Company”), in connection with the proposed issuance and sale by the Company of: (i) of up to 2,731,250 shares (the “Offering Shares”) of common stock, par value $0.00001 per share, of the Company (the “Common Stock”) in an underwritten public offering (the “Offering”) as described in the Registration Statement on Form S-1, File No. 333-268190 (the “Registration Statement”) filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), which includes 356,250 shares subject to the underwriter’s over-allotment option, as described in the Registration Statement; and (ii) the proposed issuance and sale by the Company of a warrant (the “Underwriter’s Warrant”) to purchase up to 136,563 shares of Common Stock (the “Underwriter’s Warrant Shares”) to be issued to the underwriter in the Offering.

 

As such special local counsel, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the Registration Statement and the exhibits thereto and such documents, corporate records and other instruments as we have deemed necessary or appropriate for the purpose of this opinion, including, without limitation: (i) the Registration Statement; (ii) the Articles of Incorporation of the Company, as amended, (iii) the Bylaws of the Company, (iv) certain resolutions adopted by the board of directors of the Company relating to the Offering, the Offering Shares, the Underwriter’s Warrant Shares, and other related matters and (v) a form of the share certificate representing the common stock of the Company (the “Share Certificate”).

 

As to questions of fact material to this opinion, we have relied on certificates or comparable documents of public officials and of officers and representatives of the Company. In rendering the opinion expressed below, we have assumed without verification the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to the originals of all documents submitted to us as copies and the authenticity of the originals of such copies.

 

Based on the foregoing, and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that:

 

1. The Offering Shares have been duly authorized and, when the Offering Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the underwriter of the Offering, and have been issued by the Company against payment therefor (not less than par value) pursuant to the terms of the form of underwriting agreement most recently filed as an exhibit to the Registration Statement (the “Underwriting Agreement”) as described in the Registration Statement, the Offering Shares will be validly issued, fully paid, and nonassessable.

 

 

 

 

2. The Underwriter’s Warrant has been duly authorized and, when the Offering Shares are delivered by the Company in accordance with the Underwriting Agreement upon payment of the agreed upon consideration therefor as described in the Registration Statement, and the Underwriter’s Warrant is executed, countersigned, issued and delivered pursuant to the terms of the Underwriting Agreement as described in the Registration Statement, the Underwriter’s Warrant will constitute the legally valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.

 

3. The Underwriter’s Warrant Shares have been duly authorized and, when the Underwriter’s Warrant Shares shall have been paid for and issued in accordance with the terms of the Underwriter’s Warrant as described in the Registration Statement, the Underwriter’s Warrant Shares will be validly issued, fully paid, and nonassessable.

 

The opinions stated herein are subject to the following qualifications:

 

(a) we do not express any opinion with respect to the effect on the opinions stated herein of any bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer, preference and other similar laws or governmental orders affecting creditors’ rights generally, and the opinions stated herein are limited by such laws and by general principles of equity (regardless of whether enforcement is sought in equity or at law);

 

(b) we do not express any opinion with respect to the enforceability of any provision contained in the Underwriter’s Warrant relating to any indemnification, contribution, non-reliance, exculpation, release, limitation or exclusion of remedies, waiver or other provisions having similar effect that may be contrary to public policy or violative of federal or state securities laws, rules or regulations, or to the extent any such provision purports to, or has the effect of, waiving or altering any statute of limitations;

 

(c) we call to your attention that irrespective of the agreement of the parties to the Underwriter’s Warrant, a court may decline to hear a case on grounds of forum non conveniens or other doctrine limiting the availability of such court as a forum for resolution of disputes; in addition, we call to your attention that we do not express any opinion with respect to the subject matter jurisdiction of the federal courts of the United States of America in any action arising out of or relating to the Underwriter’s Warrant; and

 

(d) to the extent that any opinion relates to the enforceability of the choice of law and choice of forum provisions contained in the Offering Shares or the Underwriter’s Warrant, the opinions stated herein are subject to the qualification that such enforceability may be subject to, in each case, (i) the exceptions and limitations in CBCA (as defined below) and (ii) principles of comity and constitutionality.

 

In addition, in rendering the foregoing opinions we have assumed that:

 

(a) neither the execution and delivery by the Company of the Underwriter’s Warrant nor the performance by the Company of its obligations under the Underwriter’s Warrant, the Share Certificate or the Underwriting Agreement, including the issuance and sale of the Offering Shares and/or the Underwriter’s Warrant Shares, (i) constitutes or will constitute a violation of, or a default under, any lease, indenture, instrument or other agreement to which the Company or its property is subject, (ii) contravenes or will contravene any order or decree of any governmental authority to which the Company or its property is subject, or (iii) violates or will violate any law, rule or regulation to which the Company or its property is subject (except that we do not make the assumption set forth in this clause (a) with respect to the CBCA); and

 

 

 

 

(b) neither the execution and delivery by the Company of the Underwriter’s Warrant, the Share Certificate or the Underwriting Agreement nor the performance by the Company of its obligations thereunder, including the issuance and sale of the Offering Shares and the Underwriter’s Warrant Shares, requires or will require the consent, approval, licensing or authorization of, or any filing, recording or registration with, any governmental authority under any law, rule or regulation of any jurisdiction.

 

Our opinion herein is expressed solely with respect to the Colorado Business Corporation Act of the State of Colorado (the “CBCA”). Our opinion is based on the CBCA as in effect on the date hereof and as of the effective date of the Registration Statement, and we assume no obligation to revise or supplement this opinion after the effective date of the Registration Statement should the law be changed by legislative action, judicial decision or otherwise. Where our opinions expressed herein refer to events to occur at a future date, we have assumed that there will have been no changes in the relevant law or facts between the date hereof and such future date. Our opinions expressed herein are limited to the matters expressly stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Not in limitation of the foregoing, we are not rendering any opinion as to the compliance with any other federal or state law, rule or regulation relating to securities, or to the sale or issuance thereof.

 

We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the use of our name under the caption “Legal Matters” in the Prospectus included in the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

 

  Very truly yours,
   
  ARMSTRONG TEASDALE LLP

 

 

EX-21.1 5 ex21-1.htm

 

Exhibit 21.1

 

SUBSIDIARIES

 

Name of Subsidiary   Jurisdiction   Ownership  
           
AiXin (BVI) International Group Co., Ltd   British Virgin Islands     100 %(1)
             
HK AiXin International Group Co., Limited   Hong Kong     100 %(2)
             
Chengdu AiXin Zhonghong Biological Technology Co., Ltd.,   China     100 %(3)
             
AiXin Life International Group, Inc. (4)   Nevada     100 %
             
Aixin Shangyan Hotel Management Co., Ltd.   China     100 %
             
Aixintang Pharmacy Co., Ltd.   China     100 %
             
Chengdu Aixintang Pharmacy Co., Ltd. Jianyang Branch   China     100 %
             
Chengdu Aixintang Pharmacy Co., Ltd. Mianyang Branch   China     100 %
             
Chengdu Aixintang Liucheng Pharmacy Co., Ltd.   China     100 %
             
Chengdu Aixintang Pharmacy Co., Ltd. Xinjin Branch   China     100 %
             
Chengdu Aixintang Pharmacy Co., Ltd.   China     100 %
             
Qionglai Weide Pharmacy   China     100 %
             
Chengdu Wenjiang Aixinhui Pharmacy Co., Ltd.   China     100 %
             
Chengdu Beibang Pharmacy Co., Ltd.   China     100 %
             
Chengdu Xindu District Cundetang Pharmacy Co., Ltd.   China     100 %
             
Chengdu Ai Xin Tang Hai Chuan Da Pharmacy Co., Ltd.   China     100 %
             
Chengdu Aixintang Liucheng Pharmacy Co., Ltd.   China     100 %
             
Chengdu Bebang Pharmacy Co., Ltd.   China     100 %
             
Chengdu Xindu District Cundetang Pharmacy Co., Ltd.   China     100 %
             
Chengdu Wenjiang Ai Xin Hui Da Pharmacy Co., Ltd   China     100 %
             
Chengdu Ai Xin Tang Big Pharmacy Co., Ltd. Jian Yang Shop   China     100 %
             
Chengdu Ai Xin Tang Da Pharmacy Co., Ltd. Mianyang Branch   China     100 %
             
Chengdu Ai Xin Tang Da Pharmacy Co., Ltd. Xinjin Branch   China     100  

 

(1) Holding company which owns all of the outstanding shares of HK AiXin International Group Co., Limited.

 

(2) Intermediate holding company which owns all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd.,

 

(3) Operating company.

 

(4) Inactive. Has no assets and conducts no operations.

 

Chengdu Aixintang Pharmacy Co., Ltd. Jianyang Branch            
Chengdu Aixintang Pharmacy Co., Ltd. Mianyang Branch            
Chengdu Aixintang Liucheng Pharmacy Co., Ltd.            
Chengdu Aixintang Pharmacy Co., Ltd. Xinjin Branch            
Chengdu Aixintang Pharmacy Co., Ltd.            
Qionglai Weide Pharmacy            
Chengdu Wenjiang Aixinhui Pharmacy Co., Ltd.            
Chengdu Beibang Pharmacy Co., Ltd.            
Chengdu Xindu District Cundetang Pharmacy Co., Ltd.            

 

 

 

EX-23.1 6 ex23-1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the inclusion in this Amendment No. 7 to the Registration Statement of AiXin Life International, Inc. (the “Company”) on Form S-1 of our report dated April 27, 2023, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, on our audits of the consolidated financial statements of the Company as of and for the years ended December 31, 2022 and 2021, respectively, which report was included in the Annual Report on Form 10-K of the Company filed May 1, 2023.

 

/s/ KCCW Accountancy Corp.

Diamond Bar, California

February 9, 2024

 

 

 

EX-FILING FEES 7 ex107.htm

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

S-1

(Form Type)

 

AIXIN LIFE INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in its Charter)

 

   

Security

Type

 

Security

Class Title

 

Fee

Calculation

or Carry

Forward

Rule

    Amount Registered  

Proposed

Maximum

Offering

Price Per

Unit

   

Maximum

Aggregate

Offering

Price(1)

    Fee Rate  

Amount of

Registration

Fee(2)

 
Fees to Be Paid   Equity   Common Stock, $0.00001 par value per share(3)     457(o)         $ 4.00     $ 10,925,000     $110.20 per million   $ 1212.20  
Fees Previously Paid   Equity   Common Stock, $0.00001 par value per share(3)     457(o)                 $ 57,500,000     $110.20 per million   $ 6,336.50  
Fees to Be Paid   Equity   Common Stock, $0.00001 par value per share, underlying underwriter’s warrants(3)     457(o)         $ 5.00     $ 682,815     $110.20 per million   $ 110.20  
Fees Previously Paid   Equity   Common Stock, $0.0001 par value per share, underlying underwriter’s warrants(3)     457(o)                 $ 4,600,000     $110.20 per million   $ 506.92  
Total Offering Amounts   $ 11,607,815         $ 1,322.40  
Total Fees Previously Paid   $  62,100,000           6,843.42  
Net Fee Due     0           0  

 

(1) The registration fee for securities is based on an estimate of the Proposed Maximum Aggregate Offering Price of the securities, assuming the sale of the maximum number of shares at the highest expected offering price, and such estimate is solely for the purpose of calculating the registration fee pursuant to Rule 457(o). Includes the offering price attributable to 356,250 additional common stocks that the underwriters have the option to purchase to cover over-allotments, if any.
   
(2) Calculated pursuant to Rule 457(o) under the Securities Act, based on an estimate of the proposed maximum aggregate offering price.
   
(3) In accordance with Rule 416(a), we are also registering an indeterminate number of additional common stocks that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions.

 

  

 

GRAPHIC 8 forms-1_001.jpg begin 644 forms-1_001.jpg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end GRAPHIC 9 chart_001.jpg begin 644 chart_001.jpg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�[.33K2&UTCXHIXNT^*V6> V[1 MWMZ+CVW7/V=_@_JOP:U'X V/AS4O _PJU'1AI)T#X2>-/''P5U.QL?[2.LW# M:'XR^$/B3P1XW\.:CJ.I&>ZUC6?#_B+3-9UN2[OUUB_O4U"^6X]R:RB9"A>4 M9C$>04W8#*V?N8W9452C# M"5+SH1P<\-7GB'XJ3^+I/BUK4/A^]ENK;1;'4?'%SI^FZ'?:EX>M+:+0M4U M+3KKKOVE/^"27[!O[6GA;X5^ OC?\&=8UWX;_!32K#2?A9\+?"7QJ^/7PE^$ M_@>+1H-1M]$OM#^%WP@^)_@3X?VVOZ=;ZG=:9!XI/AQ_$W]ANOAV35F\/QKI M@_2CRP<' M9S=WC6L(G635N6HUEV!3J+WOW4-?W40A3Y=;RYOJF+R]-3E=8+,/K3QM)-N2 M4*OU_%J5-+EFIM->]9<'\-_AMX:^%G@OP]X#\+3^+;S0O"^DQZ)I-YXZ^(/C MWXI>,7T^)LHFL?$3XF^)/%WQ!\17 ('^F^(/$^IWA"HIGVQ1A.KOM)L-0M+J MPO[2WO[*]M9K&]M;Z&&\M[NQN5"7-G=V]S'+#/H8396 MKA/&7C#6U\R%9 %_\$B/V&OA5^T'J/[5W M@7P?\<]'_:*UZXTR?Q7\5+C]M7]MC7/$/C>TTJ\TV_L?#OQ C\0?M#:KI7Q! M\&VTVCZ5&G@?QMIVO>$#;:7I]JVB&"VB1?LKXX?L\?!/]I3X>:Q\)_CS\,_" M/Q6^&^MM82:AX2\8Z3;:KI NM*N&N]+U&P61!<:1JNFW0CN-/UG1Y['5K":* M*2SO8'C4CVH0J!C<_4'.1DXV]< ?W?U;UX;Y"^68]SX8$$Y&[G=WVXXW'''8 M9SSE*$G3P,6Y0>7\JPRA.RI6]I'FIV2Y&XK9:+ZWB.KFYJ:E4JU)U%S?65_M M+DU)R?N6O=-R;3LY7_YA"XM MWCA11]O>2F",GD8R<9Z;U A126!;)QG)&.%V@],]/?\ 3BBI!5'A M:GLHPJ4<7',&XRBI0Q<(.2E&:BG)N\1>!_$G_!/SP[\!/!GQ%\ M/?&B'P5$OC/)X;OK[1+'5?A#XXTCQ=#J M5_>^#$U-?%,OV&/^SPQ*<\MSCH1QCTXJJVG6Y0H&F122=LJ47&*M>T4]G8\,^"7[+OP2_9[ ML_$$7PP\)WUCK'B^XL;KQGXZ\6^,O''Q-^*OCJ?2DO(]'F^('Q?^)GB/Q=\4 MO'\^BQZA>IH]SXS\7Z])VW5[\4^4 8XS^/MCIZ4\C(QS^% &!CG M\:/L\GV>W0UM>?M&O?MO?_@?TA:***!GY]_\%8_^46?_ 4I_P"S _VQ_P#U MGSXA5^ ?_!EA_P HL_C]_P!G\?%#_P!9\_9>K]_/^"L?_*+/_@I3_P!F!_MC M_P#K/GQ"K\ _^#+#_E%G\?O^S^/BA_ZSY^R]0!_8!1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %?S^?\'1/_*"W]NCZ?LQ_^MD_ 2OZ Z_G\_X.B?\ ME!;^W1]/V8__ %LGX"4 ??\ _P $G/\ E%G_ ,$UO^S _P!CC_UGSX>U^@E? MGW_P2<_Y19_\$UO^S _V./\ UGSX>U^@E !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 ?C-^T1_P4.^(_B?]MSP[_P30_8ETSP3J'[0]KX)M/BW M^T1\:_BEI&N>)/A1^S1\'9;O2O[,W^$_#FO^%-8^(GQ<^(D6MZ=I?@_PHGBS MPKIFB7=_8Z]KEYJ>G"?3XO?M2_9G_;2\*:5X@\1?"_\ X**?$[QW\29+?4[W M0/ _[1_P3_9:UW]G.+5]3U0ZJEE?:#\#/@=\"OC]!HUA&6TW3(W_ &@+V^M] M-D2.[O-0NPM[#^!G_!".Z\3ZM_P6-_X. M7^*2M/\1;?X]>$]#LKC65A&K0> M!+'XB_&C2?#.GV%U*!=WWA=_!>D_#BWTQ0JV,.GVWA^2*+=>6KU_7P(]@>09 M++&C1C)/S8"Y9OOR-ALMYKOE@&;)R3BIU)99PU7A%-XW+J&9XF2DY.=&M2=3 MEEN_:Q?)%T+\]^9MI[S6_<9MG&$FU..5RC"C*%IP?NI\U.2LI*2U322LUIKI M\1_\$\/BG\?OC'^R5\-_'?[4^BZ)X5_:0/B#XL^%?C)X2\*07EAX;\/^._!/ MQC\<>#M3T;P[9:A?:YJ<7AVS/AJW@T:6\U;4Y9=%9+V34+B*195^WO[1&"/* M?.67=(I$:R*4$D4C1K,R"'>IDN5CDLE!_P"/@'Y!^*/_ 6I_:P\??LJ?LS_ M J\%?!W68?AW\0_VQ_VK_@S^R?H?Q/T^UT]+KX60?&C6KO4/''Q-L+>6.6" M]UVS\(Z3XBTG3;NX@F:TUO4[+7KNWODM6AF\J_X*4_L#_!_X,_L7?&G]JW]D MKPW9_LZ?M??LS_#6^^._AO\ :<^&A@\,_&?QV?@SH]KXO\3^'OCOXZAMIM9_ M:'\-^+_#_@R]L_$/AOXUR^.=,U2>6!E@M3%&4,7C:-/#U,WQ//2RRE5JT9JC M2=7$QJT*>3U<5%82,X5)+!QSW+_K-JB]DY5XI598>?-KA,&JF-R[+L-)SQ.; M14L)&M)4H.,L[?#\55JR;C06>Z[B,GN&^Z<$8!Q4U?%/_ 3V_:=U']L3]BK]F7]IK6M*MM$U[XP?";PW MXM\1Z59)<1Z?I_B>ZM5M?$5EIT=U-FIJ%?#?6X*<.2:HIM/GAS2Y:B::<.:3NM)- M6;@>XQ(!G^-0/^!2HH^OWB.WZ\_S"_\ !?KXY_MX?L6>%_@%\9OV2?VY_B1\ M,[/XX_M0_"S]GW4OA+K_ ,)_V6/'GP\\%Z3XS\+ZQ"?$7@V\\2_L]ZC\3S+% M<: M]K%MXL^(?BR%KO49CI<6GP+;VT']-A5G59#]\R0'"_=^_ [#G)/S''7@ M9!]:_EV_X.A85C_9K_83E>/._#W!X]2:BWE6;9OA\OQR:<6VY>U<94TXRY6Y\Z4= M:E4Y,IXJKI)XC+^ O$O&X+FBIQ6:Y-X:>)&=9=-)Z-0S')_%#P[\#O".M6B+'8H/#N MC:1\!O@Y\&/"5MX:1[21XH[WPYJ6MR->7?VC7)T>".WZ'XL^%]:\<_#?Q]X" MT'Q]X@^&GB'QMX0\2>%_#_Q&\,)IK>*/ VJ:[H%]8:=XI\+QZQ#>:5J&N>'I M)+?5[:*[BEMGO+>61I(XML<'JWEQ@%E9\A<*Q=G*GD;@KEE#'/4KR,YR"17Y MK_\ !6#P1XN\8?L"_M,7?@KX[?'']GGQ)\/?@[\2_BI9^./V?_$^E^!_&NKR M_#KX=>+==TWPEJ_BN_\ #OB+7+#PAK6IV=N_B%_!U_X5\8R64,4.E>+M'>:X MEGY,ZK\F75\14/H8>FU.I7G! M4G)KEYG4A&+E)II+GE%:IK5WNE8^A_V4/@]X\_9\_9O^%'P:^)OQQ\;?M-^. MOAUX3T_PUXM^-GQ)CN_^$R^).HV^^35->UJ.YU+Q7J4DMQ#,L]C:ZMXD\4:R MR*MC>^(+^7==+]*F=_GV*OF[7WQ".5V4 W,<;X86XV2S0_(\I@@=$D9+@JT; MU_*!X%\*?$SXC_\ !KCX \:^%?VFOV@O@GXV^&G['7QF^,DOC'X3^,]'T;Q- MX_UCP5HWQ7\06/AGQUXN\0>%?%/BU?"FI:O:6MWJ_P#P@VN^"?%$PMH;>T\4 M65L/L[^3^)?V!?A+^TO_ ,&\WPA_:3^.?BKXP^+/C7^S]_P3PC^.G[/GBK0_ MC#\3O!FA_"/QIX$^#4NO>$_$WAGP#X9\3:9X!U?Q+K3:(MYXM\9>./#/BSQQ M?W.NZ[)I?B/18I[)+/T,RQ2P]7B6IC$J4ER3Q>*]&U#5[=9(+/6/#DWESG^:#QI^QMX$_X M**_\$,O!7[9?[6OC?XS?$_\ :7\)?L*3_&?X3>.A\8/B-X1\/?"CXE_##X0Z MSJNA^,= ^&G@G7O#WPSUOQ7K&L:%<:MXI\:>/O"/B_QI?7WB/Q NF^(M)LGT M:ST;3^-7CWX^_M)?\&PGP]_::G_:G_:(^%OQ>\$?LDV/Q-\2^,/A%XUTGP9X MA^,&L^ K"_\ #%UI/Q2\3CPSJ7B^]T/5H[%M4U__ (0WQ#X)UOQ)JX$_B#6] M2M&ELI.;-*-+!KB;"2J.-;**V"H8QJ,G353'RE'#^PEI[=.49*IR*/)L^=,6 M6XEXRMD-7#Q2CF-7&0H2FHP:G@?X[J1ES*G%6;IRG=323M _HK'Q \&?L8?L MF:7XK_:0^.$^I^&/V>OA'H@^*/QX^)+_BY)\,O *O%-CXR\:^%_'TFG^)K@ZEJ MNC:A9S:C9W'?C(+#YIGN#JR2Q&'XARCAR@_=C3I9CG;S&.!>(F],-A'/+\2\ M5B&G3PD51,*L9 M8>A*]3$M5%"5/E3?]-C:@4?R65EG=7,,311I)*^^%1%#$]XKW'V07$!O+F'- MC^\R+J(JZHY+YFE92$6*-XEE8GG^7W]K/_@FY^W!\9/"NF^(_V7OV;/\ @G_^QG^V/X8\5^ ]=\,_MS_#O]N_ M]HWQC\;-4E\/:OHDVKZ'\:]7M_\ @G1X#\2_M#Z)XMTO15TC6O#GQL\8^*M% MM;BZBUB6UOHK5M,/TY\>/C1XZ^-O_!0O]C/_ ()I_$;7!H^G1?LN:Y^V!^U1 M!\.M3\6Z)I7QGU+0[C3_ !X6^#EOXITJ+0M3?X,:A\1CJ_CSQYX7$GAZ/QS MI?A;P3X3\6Z7?>"M9U[PIJ\4H^UJTL-&4%BJOM7'"2E;$Q5'(\XXAG*I149. M"_L_(\TP\(K.LDR!?O8 MR47*>8<09/!GPU?P9JS_P#"K_ &B>)=3G^('Q9E\5>)M<^)%AXA MU?5+W^S_ QIVG_"SP[I.GVMA;#0O&EREQ>O_1-$ K+_ -TOX5Z%K5CXG\.?#KPW#IGA3POKUX^I7D.N7/ARPTR#Q)Y=HVN6VH3QS2S? MU4N\JL^T*=OF*.&/"RWC#N.28D!Z<%NA((Y<-4C7R:FH?QYYCQE@%=QJ.\:J=3EC'V5_\.O\ A=_B[P-;_#3]J;]G7XP^)?$'@;X:_M,_#O3X M-)ATS4M+\8>%_"?C34_ /Q1T6+1_#YT[7M1\)ZWI'F^&]-^VZ1,DVIV^K_?G MPV_:3_:4^(._1_$?[ 'QI^!'B)+%I7USXP_&']E#4?A9<7:>8'MM'USX&?'7 MXS_%74U"+%(LE[\%=##K(45 MW#*U*+5-[*\5S6IOWE:RDE)H3C&6(GB)7J_$YO#_QJT'QGX?\ C3\*/C++I&=1U#4 M]&O[/1";^[T?PC#8:G?^%4T^WOI=6A\,W*(=9.LQMJ]QY;XUB_X*!?M??L=? M$;]D+XM?LOO\ OBU\5?A1_PJ#XH?M*-\4O@CXR_9FF\.^+=//A3XH?$'X/:9 MX1^*6N_M ZSJ>I^&-3UJ\\%>#_B+\&? .D6M])$-<\=7MK:G^UOVX^RIM5=\ MNU J@%]Y*JNW:[N&>3_\ M::@E-I0N:4ZDZ%>GBZ+Y<1@T_J332Y/]N6:))VM!+'KVBT]UMRC9NY^8'QC\ M+?M3_L:?LE? #X+?\$P?@-\+/B]KOPJUSX*?"-O!?QI\97'A#2M-^ ^GR#2? M'GC-=6L=0\,V]WXKL]'LTU26Z2=EBN+K4M2T7PKX_P!=BM?A]J#?^"E'[1G[ M>?[-O@OX;?$?]CCX ?!3XU^#O"NK^*/%_P"UI=_%CXDV/@5_ OP4\$>&+SQ1 MJ+>!9]0\7^#87\7^*8[&ZTG2-=OX?$>E>&-4_LN75_"6L:%J6IZWX8_3QM*M M7<.YE?:I55=D=%##D;'C8,N<,$?=&KJK*BD"O/\ X@_"+PQ\3X]'TWQA=:S? M^$],NC?ZAX&CN;*W\*^*K^WOM.U+1;GQ7;IIQU358?#U[8-=:;I":M:Z!=75 MV]YKVDZU>:=H-QH_;4J.OB\)B,0G44\Z^OYE*Z=2IAVZCJ*+ M;]]**MCAZ-&C'!TDDJ=#)_J,[J4OWRM9I7YI65[5+I7UE&5VY=7HFJ)K.F:7 MJ@MY;2/5=-M=22VN%VW%N+B&&X\F<#@.J[5Z*"0Q(&0!_-)_P7Z^"7[=?[:G MAO\ 9[^"?[*?[#/Q*^)>G? C]K#X6_M"^)?BKJWQA_9,^'O@+Q9I'@?P]K2Q M^'/ ]MXR_:)TOXB2ZE+=^)H8+RX\5_#SPO S:?=IIZW2E)Q_3FFGPH(PKR@1 MHJ* 8P B=%P(P,>N,<8 P '"PA!)WSDD8.93D<2*-I !C($K &,J0-H!PB! M<;S6*H8NG",)X/.L%F6#A*3FJ4"?&*V_;9^(O\ P37_ &E;?Q;^S+XE\5_M5?M.^#OC=X:TO]F+P7\5?@O' M;?!RP^)OAC7/AEX!\,ZW\2_'WQ'\(^!-1TOP)X7M_#VM_%/7O"7B'Q-#KGBS M5]?U'X=:7J6C7=AI=C^Q)MHRZR<[E& 2$)QSU9E+]^S#/>F_9(MV[,IRS,RF M1F5]ZNI1U8D&(;RRQ?<5@K*H(%9XRBL5A<;AW&+6(C:,7=)Z6:;=^5/57U9O MAJDL#B<%B,.E-X>47/VFGPRC.+2^U:4(O1Q]3^7_ .$WPD_;Y^'W_! 76?V# M[S]@/XKS?M2M\!OB?^RQIG@T?&;]CP^%=2/Q+\/^.H[#XOIXX/[28TB+P)I5 MKK\5AJFB2#_A8?\ PDAABM_![^$3<^,K;KO OP__ &Z- _X(++^Q+K/[ _Q= MG_:?M_V6/$G[&J^![7XS_L>Q^&L7_P )/$?@K1_C(?';_M(-H$GP^MH&T\ZC MHD5S_P +%3Q S0P>$!X2DC\8K_24FF0HAC\V=D9][JYA*R9C"NC+Y(4+)(// MDV!6,I8!A"?)I_\ 9UN,D&0,S,S.&4.Q;?C<^S>0KPC&GG,\IG6<7)R;P/,ZSLV^5R=2:UYE)R;ARPM%&!Q%?+*N2U<*HN63U M'7HN3Y>2K*>3U&TG?F498&K97VC'6]1-?S7_ 8\"?MU?#;_ ((4I^Q5JW_! M/KXQ3_M1Z3^SEXO_ &2K'P&GQH_8Z/AO6-1\5_#GQ=X?TOXMQ>/5_:7&CP_# MVQ^WP+K.C2+'\0_[698+3PF?"AD\:P>$:#^SU_P4(TW_ (-ZI_\ @G W_!/? MXM#]IX?!K7?V=(])C^.7[&7_ A-Q::_=^(-<'Q1M_'#?M*?96\,0Z8]OIEY MH9TY?' \47(@3PP?"C?\)C%_6/\ V= 8_+9Y7!QYA=E(E.XM(9(]@B)E);>! M&JA6*1B-,*'&PA8$,TK R/* 7R0[R"48<@R!4?<8X]_EJCM%M,.V-3'1GF.) MSRM7C",7-9(_"+2_V5OVB/VA/^"%.I_L*?$'X1:M^SE^T1 M;_L7VG[-,'ACXC>-?A7XJTBX\?\ @OX2Z1X7\*^(X_%'P9\-<>"5EAA:;RSP%^PM^U?^W?_ ,$>=3_8,_;\^#_@[]D_ MQGIGP0^&/PE^'MQX;^).D?&KQ-%X^^!UMI:>'OC/XHC\#P)X&\/:)J7B+P=X M0N[7X;>$?$GB>Y32)/$:MXQ@N-0TS^S?Z,UM(D964L&2,Q*0(QM0XX $8 P M"J@;%P-J@9S7.E6C3"$QV7PSI8>IA%=W3>903BOAY;\UH/FR MPV%HX*CEU/#Q4GEN$Q>7X?FNN3!YBTL9!2;;=X1BDK>_&/*]W?\ DX_8]\(? M\'1W@;4/"G[(7QKM/V-9/@-X-L=/\,7O[=_B6^/Q"^*VI^!=/2W@D;X?^'=) M^(VB:IXB^(.E:4PTOP[J?QD_9PL;*[FMA>^+]2UZY9[O4OJG_@HW_P $]/VK M]/\ VB_V3/\ @HK_ ,$Y8_"'BG]IK]DKX<7'P9\4_ WXI^);C3=&_:7^ >HP M:E;0>"U\::E=1V.C^/+83:RUOK/CF72- FOO$&FZO=^-(;CP9%;ZK_1"NG6Z MKL4S!>-H\UOW>-@VQ#I%"1&@-K&%M,+_ *CELN^P0^4T3/*X964N[*S?. "0 M"GE9 !Q^[P-\A S)(655U)U<)6BH1QU&\JF;P485YSE@\;EDW*BG[_M,#FF/ MIOE<8VJ/F4IR4EO1C##K&0A",LOQ$6HY*TEA9?[7@LQ49U9-NWUW+,!.+DFH M.DI1Y7!-?RN_MA?LU?\ !8G]NSXV?\$R/VGM%^!'[,W[(OCW]E[XG?$CXA:Y M\-_B=\;KWX]>%_A]:Z[8^!]*LI/B)XO^&EE\/+WXA:_XQBCUBQT;X=?"G2$T M'1;;P])+KWQQED\7:=#H?]/OAO\ M^/0-)@\7W6BWGBN#3+-/$E_X>TZ^TCP M[?:VMH7UBXT#3=3U36M3T_1VOGG>PM]0U;4[N"V:.*YO;N56G?=31[6,$*T_ M*;"PD"N%*A2!(BK(HXW!58*C;3&J>7$(YFTZ%BY,DV9.&)9&&PERT85XV4(Z MNR-@;B@4!@44C/V:/)WC7?:+?U"K*--J[E;W[32 MBFG6J0K5X4U..39/E[Y$W>K@'C75O)MN2OF>-<:CLIN=U%.1?HHHKH _L HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "OY_/\ @Z)_Y06_MT?3]F/_ -;)^ E?T!U\??MY_L3_ M K_ ."B'[*'Q7_8\^-6O_$#PO\ #/XP_P#""?\ "3:Y\+M5\.:+XZL?^%?? M$OPC\5-%_L+4_%GA3QMX?MOM7B'P7I=GJG]H>&-3\[1KB_M[3[%?2V^HVH!Y MI_P2@G5/^"6__!-P(Z3Q0_L%_LA6[26Q%R=UG^S]X#2XC9(7<&ZMYK:XM9[2 MTDO9H[E=K* K5^A.6]1_W[;_ .*K^1";_@RV_P""6T^1)\>OV^V^6-49OBG^ MSQ)+$D*K%;QQW$G[++W'E6UND=K!"\KPI!'&/++HKBO_ ,05O_!+/_HO?[?G M_AS_ -G'_P"A3H _KWRWJ/\ OVW_ ,51EO4?]^V_^*K^0C_B"M_X)9_]%[_; M\_\ #G_LX_\ T*='_$%;_P $L_\ HO?[?G_AS_VH_P"_;?\ Q5&6]1_W[;_XJOY"/^(*W_@EG_T7 MO]OS_P .?^SC_P#0IT?\05O_ 2S_P"B]_M^?^'/_9Q_^A3H _KWRWJ/^_;? M_%49;U'_ '[;_P"*K^0C_B"M_P""6?\ T7O]OS_PY_[./_T*='_$%;_P2S_Z M+W^WY_X<_P#9Q_\ H4Z /Z]\MZC_ +]M_P#%49;U'_?MO_BJ_D(_X@K?^"6? M_1>_V_/_ Y_[./_ -"G1_Q!6_\ !+/_ *+W^WY_X<_]G'_Z%.@#^O?+>H_[ M]M_\51EO4?\ ?MO_ (JOY"/^(*W_ ()9_P#1>_V_/_#G_LX__0IT?\05O_!+ M/_HO?[?G_AS_ -G'_P"A3H _KWRWJ/\ OVW_ ,51EO4?]^V_^*K^0C_B"M_X M)9_]%[_;\_\ #G_LX_\ T*='_$%;_P $L_\ HO?[?G_AS_VH_P"_;?\ Q5&6]1_W[;_XJOY"/^(* MW_@EG_T7O]OS_P .?^SC_P#0IT?\05O_ 2S_P"B]_M^?^'/_9Q_^A3H _KW MRWJ/^_;?_%49;U'_ '[;_P"*K^0C_B"M_P""6?\ T7O]OS_PY_[./_T*='_$ M%;_P2S_Z+W^WY_X<_P#9Q_\ H4Z /Z]\MZC_ +]M_P#%49;U'_?MO_BJ_D(_ MX@K?^"6?_1>_V_/_ Y_[./_ -"G1_Q!6_\ !+/_ *+W^WY_X<_]G'_Z%.@# M^O?+>H_[]M_\51EO4?\ ?MO_ (JOY"/^(*W_ ()9_P#1>_V_/_#G_LX__0IT M?\05O_!+/_HO?[?G_AS_ -G'_P"A3H _KWRWJ/\ OVW_ ,51EO4?]^V_^*K^ M0C_B"M_X)9_]%[_;\_\ #G_LX_\ T*=?C'\:_P#@W _8?^&__!;C]C?_ ()L M:'\4_P!JJ[^!G[0W[,?Q,^-'C3Q7JWC3X/3_ !8TOQ3X,L?C%%]=L_@ M58^#[+0)Y/A]HHO[75O FMZC*EUJ@M]5M6FM&L@#_23RWJ/^_;?_ !5&6]1_ MW[;_ .*K^0C_ (@K?^"6?_1>_P!OS_PY_P"SC_\ 0IT?\05O_!+/_HO?[?G_ M (<_]G'_ .A3H _KWRWJ/^_;?_%49;U'_?MO_BJ_D(_X@K?^"6?_ $7O]OS_ M ,.?^SC_ /0IT?\ $%;_ ,$L_P#HO?[?G_AS_P!G'_Z%.@#^O?+>H_[]M_\ M%49;U'_?MO\ XJOY"/\ B"M_X)9_]%[_ &_/_#G_ +./_P!"G1_Q!6_\$L_^ MB]_M^?\ AS_VH_[]M_\51EO4?]^V_^*K^0C_B"M_X)9_\ M1>_V_/\ PY_[./\ ]"G1_P 05O\ P2S_ .B]_M^?^'/_ &_P!OS_PY_P"SC_\ M0IT?\05O_!+/_HO?[?G_ (<_]G'_ .A3H _KWRWJ/^_;?_%49;U'_?MO_BJ_ MD(_X@K?^"6?_ $7O]OS_ ,.?^SC_ /0IT?\ $%;_ ,$L_P#HO?[?G_AS_P!G M'_Z%.@#^O?+>H_[]M_\ %49;U'_?MO\ XJOY"/\ B"M_X)9_]%[_ &_/_#G_ M +./_P!"G1_Q!6_\$L_^B]_M^?\ AS_VH_[]M_\51EO4?] M^V_^*K^0C_B"M_X)9_\ 1>_V_/\ PY_[./\ ]"G1_P 05O\ P2S_ .B]_M^? M^'/_ &_P!OS_PY_P"SC_\ 0IT?\05O_!+/_HO?[?G_ (<_]G'_ .A3H _>[_@J M_.K_ /!+?_@I&'=((IOV"_VO;=9+DBV.Z\_9^\>);QJDSH!=7$US;VL%I=R6 M4TERVU5(9:_ O_@RP_Y19_'[_L_CXH?^L^?LO5>A_P"#+;_@EM!@1_'K]OM? MED5V7XI_L\1RRI,K17$TM+( _2 M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^6S]J MS_E; _X)?_\ 9@WQY_\ 33^TY7]2=?RV?M6?\K8'_!+_ /[,&^//_II_:HRR7QCEOI[R6"ULH#':6Y1_P!HAC*E/X<"L Z[E[K7]I8K M'8/#*"L^=NOEV)557C[*"IS?.JD8Q5:2H4Z-2H[1KXW&8"GR^])8C X&.8UU M-67+3^JR3IU+M5*B=-1BTY'Z7T5^4UY^V?\ &S]HC]ISX^?LO_L7W'P@\,R_ MLE0>"4^/_P ;/C9\/_&OQ9\)R^/_ !_HS>)/#_P1\ ?#_P"'_P 6O@WJEUKU MKX:,>M>-OB1J7CR72?!L\VG:!IO@+QOJ%[JL_AKT']EO_@H1X/\ CC\)_P!H M?QA\2;'1?@YXZ_8Y^(7Q7^%G[4_A6_U>XU/0_A]K?PDCN]9O?&NF>(+BSTNX MU;X;^+_A_'IWQ+\+:TVF1,^@:LVFO)=7VD7EQ-"FG16(LU3&KT<0FZ=2*%&2E4=)*7M%G']A*#BTY9A]5P^+48; MJ5"4<3'#QKII2QE/$854W4HRE+]&**_#*S_X*-?M7>(OV1]>_P""G7A?X:_" M>3]CK2? ^J?%O1OV=M4\,^-5_:>\7_ #PQKUW+K?QPL_C/:?$AOAOH.LZU\- M-+U'XB^$_@7JGP,N-EI+IVE^+/C;X=NI+MK7V#XT_P#!1ZXUWQS^PG\$/V0] M5^&&O>/O^"A'A;QW\4/A5\6OB#HWB3QI\,O!'P7^&W@.S\?>(/'VI_#WPSXN M^&OB3XAZUJ=OK/AKP_HOP_T[XC^ ]174]:U"]N=9>#PMJ5G=/F?-0BZ=6,ZV M,PN E"5*:GA<3C,-F.,H1QL+.6$B\+E.8UYSJIJ%/"U&XRDG"-7C:I+GI\E+ MZYSS]I%P7U&O2PV(M)-J5J^(P]*FXW566(H%?C7^RW^TE\4OV5OC1I/@_^U?^$2UCQM\,+_3?LOCSP9:Z MQ?:GJND^$OB%X'-7UC6M9T*YO[KP[J&MZI=Z7/>R?4?@+XJ^)OB M+XO\8SZ%;^'X?A;X4O;WP=8:]H2:EXU\;Z5<26_B#4_#5Z-7AL#X)\.ZE M#+X/FGETV:]U;QM9>)M/L[BWTGPU9ZQXI56<:,G&I>+6$PF.VWPV/P,,?@9I MN4;O&4JV'H8=:>TQ^(HX!26+]M2PN6+:EB(XR6$Y:+ MNO:P?L\1C(S2@I9=AL1C$N2-.EB/H2BF@DYR,?Y_+\J=5)W-'H[?EJOO"BBB MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %?RV?M6?\K8'_ 2__P"S!OCS_P"FG]IR MOZDZ_EL_:L_Y6P/^"7__ &8-\>?_ $T_M.4 ?U)T444 %%%% 'F_CN-?^$'\ M7\8;_A$-8^<$B0?Z#, 5D&'5@)&VLK!ER=I&3G\4O^#:6)#_ ,$7OV.FP%/V M;XTRKY:I&J/+\?\ XPEF6-%6,G+L071B,GKDU^O/QT;XP7/PH\1VGP(\'_#; MQI\3-5TF32M/T'XL_$KQ;\*?!,-M?Q36MSJ5_P"+/"?P>^,/B4?9I%SI]C!X M 8ZWLD6.[L4'GC\YO^"+W[*'[6?[!G[%_@?]D+]I72OV>+J/X.Q^(D\#?$;X M)?%KXD>.I?'5OXO^)7C[Q=K M5TVY1BXNM1P<*?Q4,\S?'U+OE7U;&\/K+:+3^U.6*O&=-6<*?[QR:]T^)?\ M@WTLYD\??\%D[OQ-YUOXM?\ X*L?M!6NM)<&033:5'/&-&EN[=M[0?:UOY[J MSDD*W1M[LWEK,EI=W"3?FK\8U\;X8_ "U%XLTL^CR: MK8_ G7_^%@VMC?R%Y6O?^$0FO4U2RMIH+=;/5;6VN;8V\-K''_1EJ/[('QQ_ M9\_:F^.?[2O[&]K\&O%UK^UH/ MQ^T)\$/C+X\\=?"#P[I/Q#\%Z1JV@6GQW M^'_C+X>?"/X\:C=>(?$F@7FGZ3XT^'GB3P-H6E:Z=!TK5+/XBZ-J"WKWGIG[ M*W_!/OP#\"_A!\?O!OQ,U&#XT^-_VQ/'GQ+^*?[5GBO4M%71=&^)/BCXH0W6 MG:KX4T+PI=2WUSH'P\\.>&[B/PGX-T.^U/5M8TWP_8VD.IZ_K%X9[PX5(58X M:G3IQA4J4?#'"<&0A.7+"IFF&P_!N5O&592C*TYX'@^GBWBU&=L3F-:*BZBJ M3GV.M"69U,4Z48X=\:1S^'(DIQP/UO$9N^2GHH5:>-S3'8"-'F4I8;!X:KS1 MIU(0I?+_ ,#[72-,_P""#GPM>SDL$\.6?_!+30+MYOM$?V!8!^S+I>ISW4MY M.)!,N]M0O+F[N7FEES,]U),#)7YX_P#!,#]COXQ_%+]@+_@B]^V1\.KCPI%^ MTI^R'\)/BS8>'_!/Q>U/7?"G@7XN_ CXS0^,M"TSP1JOC+PSX5\>:KX! T<^ M!_%'@_Q_IWPR\>ZA;Q:0\5[H.K6VKJL?W5IO_!.S]J/1_P!D/5?^"8]E\2/A MC;_L>:AX6\1_"C3_ -H1/%'C%_VG-'^ ?B35M2@G^!D7P9'P[7X5_P#"2Z5\ M.=2F\ :/\<'^.C:9!%#:R7/[/]YL:Q'IVK7%M#I^G6-G#]KFTR^ MO"+8N7DD,[MZF9XV.,SKC+B*E!PH\4<29+FM'#/E4<'@\OQ7B1FN(<:5E:JG MQ\^&:5&-G4RW TL4Y*G"-(\'#X6LL-EN2UI/EIO.Y9C5513=7Z]A>&\HPL:< MK)2C./#>'XEFTU*CF&)JX67M*W-6?Y8?LE?LI^/?V:['XP_"2;QUI>K_ +1' M[9WQ\^)W[9_[5/CKP!#J5QX/^#OAWXD:Q9Z1_P (-\.]3OQI^IW=UJ.@Z'-\ M._A3XG\7VNDZOJ=SX;\30A/X0;P2?FOQ!_P5?\5_#'X._M*?M/\ PQ^& MOPLM?V#/V _VF=-_8X\;?#YM(\7W/QK\;Z3X7U_X=?#/XD?%/P+\0(O&MEX3 M\(V?PHU/QD;;3/AEJ_PI\?ZQ\4[7PG>/8?$7PY/J%DR_N?\ "/X32>!?#VI7 M?B/5(/$'Q"\;ZZ/&GQ0\26J-#9:UXSN;/3],O#I,5^;J_L/#?A?1M+TCPKX* MLYKVZU#2/"VAZ+I-SJ5Z;,3'\3?B1_P1Y^*FN_#3]J_]B[P'X]^&&C?L5_MG M_M3?\--_$+Q=JFK>*K;X]?"S2O$GC7X=>/\ XQ_!/X>?#^+PC>^#O$>C>/\ M7/">N#1OB-JWQ3\&ZA\++'Q7<6X^&WCR6ULIXO-I0A_:456NY2R;A_ SYHPF MXU%L,[54W>GDO#V'S_"X.<8WQN/Q&89["$<^S;+ZF#]--5ZF%Q.(BX4I MYY]=S&$9.3E@Y8/BFM4G"$914ZKS^OPYB:=)2C*&5X3+\ I29[2ZLTN86'S8+L&+< )A2-X8UL%L)U(YY) M/\C^7'\ZSM)T33]$TZPTK38OL]CIEK;V5E "NV"WM8%MX47"@?+$H7)'/6M( MQ*PQEA],?U!K7$>]_![]?=TUWWUV_$QPL:T<-&.(M[>WO6!B!CIE<\Y9<8OH_P#W[D_^)K\O M?^"MG[2_QQ_94_93TCXA_LYZKX*T#XM^*_V@_P!G3X(Z%K7Q"\)W7C?P?HK_ M !N^*WACX>7.JZYH=CJ>A:E?0Z?;Z\TMFUGJUF$O?LWGB>W66W;Q[_A1O_!> M/_H_7_@G[_X@_P#$O_Z(N@#]H_,7T?\ []R?_$T>8OH__?N3_P")K\7/^%&_ M\%X_^C]?^"?O_B#_ ,2__HBZ/^%&_P#!>/\ Z/U_X)^_^(/_ !+_ /HBZ /V MC\Q?1_\ OW)_\31YB^C_ /?N3_XFOQ<_X4;_ ,%X_P#H_7_@G[_X@_\ $O\ M^B+H_P"%&_\ !>/_ */U_P""?O\ X@_\2_\ Z(N@#]H_,7T?_OW)_P#$T>8O MH_\ W[D_^)K\7/\ A1O_ 7C_P"C]?\ @G[_ .(/_$O_ .B+H_X4;_P7C_Z/ MU_X)^_\ B#_Q+_\ HBZ /VC\Q?1_^_/_H_7_@G[_X@_P#$O_Z(N@#]H_,7 MT?\ []R?_$T>8OH__?N3_P")K\7/^%&_\%X_^C]?^"?O_B#_ ,2__HBZ/^%& M_P#!>/\ Z/U_X)^_^(/_ !+_ /HBZ /VC\Q?1_\ OW)_\31YB^C_ /?N3_XF MOQ<_X4;_ ,%X_P#H_7_@G[_X@_\ $O\ ^B+H_P"%&_\ !>/_ */U_P""?O\ MX@_\2_\ Z(N@#]H_,7T?_OW)_P#$T>8OH_\ W[D_^)K\7/\ A1O_ 7C_P"C M]?\ @G[_ .(/_$O_ .B+H_X4;_P7C_Z/U_X)^_\ B#_Q+_\ HBZ /VC\Q?1_ M^_/_H_7_@G[_X@_P#$O_Z(N@#]H_,7T?\ []R?_$T>8OH__?N3_P")K\7/ M^%&_\%X_^C]?^"?O_B#_ ,2__HBZ/^%&_P#!>/\ Z/U_X)^_^(/_ !+_ /HB MZ /VC\Q?1_\ OW)_\31YB^C_ /?N3_XFOQ<_X4;_ ,%X_P#H_7_@G[_X@_\ M$O\ ^B+H_P"%&_\ !>/_ */U_P""?O\ X@_\2_\ Z(N@#]H_,7T?_OW)_P#$ MT>8OH_\ W[D_^)K\7/\ A1O_ 7C_P"C]?\ @G[_ .(/_$O_ .B+H_X4;_P7 MC_Z/U_X)^_\ B#_Q+_\ HBZ /VC\Q?1_^_/_H_7_@G[_X@_P#$O_Z(N@#] MH_,7T?\ []R?_$T>8OH__?N3_P")K\7/^%&_\%X_^C]?^"?O_B#_ ,2__HBZ M/^%&_P#!>/\ Z/U_X)^_^(/_ !+_ /HBZ /VC\Q?1_\ OW)_\31YB^C_ /?N M3_XFOQ<_X4;_ ,%X_P#H_7_@G[_X@_\ $O\ ^B+H_P"%&_\ !>/_ */U_P"" M?O\ X@_\2_\ Z(N@#]H_,7T?_OW)_P#$T>8OH_\ W[D_^)K\7/\ A1O_ 7C M_P"C]?\ @G[_ .(/_$O_ .B+H_X4;_P7C_Z/U_X)^_\ B#_Q+_\ HBZ /VC\ MQ?1_^_/_H_7_@G[_X@_P#$O_Z(N@#]H_,7T?\ []R?_$T>8OH__?N3_P") MK\7/^%&_\%X_^C]?^"?O_B#_ ,2__HBZ/^%&_P#!>/\ Z/U_X)^_^(/_ !+_ M /HBZ /VC\Q?1_\ OW)_\31YB^C_ /?N3_XFOQ<_X4;_ ,%X_P#H_7_@G[_X M@_\ $O\ ^B+H_P"%&_\ !>/_ */U_P""?O\ X@_\2_\ Z(N@#]H_,7T?_OW) M_P#$T>8OH_\ W[D_^)K\7/\ A1O_ 7C_P"C]?\ @G[_ .(/_$O_ .B+H_X4 M;_P7C_Z/U_X)^_\ B#_Q+_\ HBZ /VC\Q?1_^_/_H_7_@G[_X@_P#$O_Z( MN@#]H_,7T?\ []R?_$T>8OH__?N3_P")K\7/^%&_\%X_^C]?^"?O_B#_ ,2_ M_HBZ/^%&_P#!>/\ Z/U_X)^_^(/_ !+_ /HBZ /VC\Q?1_\ OW)_\31YB^C_ M /?N3_XFOQ<_X4;_ ,%X_P#H_7_@G[_X@_\ $O\ ^B+H_P"%&_\ !>/_ */U M_P""?O\ X@_\2_\ Z(N@#]H_,7T?_OW)_P#$T>8OH_\ W[D_^)K\7/\ A1O_ M 7C_P"C]?\ @G[_ .(/_$O_ .B+H_X4;_P7C_Z/U_X)^_\ B#_Q+_\ HBZ M/VC\Q?1_^_/_H_7_@G[_X@_P#$O_Z(N@#]H_,7T?\ []R?_$T>8OH__?N3 M_P")K\7/^%&_\%X_^C]?^"?O_B#_ ,2__HBZ/^%&_P#!>/\ Z/U_X)^_^(/_ M !+_ /HBZ /VC\Q?1_\ OW)_\31YB^C_ /?N3_XFOQ<_X4;_ ,%X_P#H_7_@ MG[_X@_\ $O\ ^B+K\Z/VE/CG_P '#_PA_:K^!W[(OP@^-O\ P3U^.'Q&^-?P MA^,'QFM;_6?@#XZ^$/A[P[X:^#>J> -(UJUO[[4OB?XQ:XOM6N_']A_9;0QK M B02-=-&N6 !_5UYB^C_ /?N3_XFCS%]'_[]R?\ Q-?RO[/^#NW^_P#\$H/^ M^/B#_P#&J-G_ =V_P!__@E!_P!\?$'_ .-4 ?U0>8OH_P#W[D_^)H\Q?1_^ M_8OH M_P#W[D_^)H\Q?1_^_8OH_P#W[D_^)H\Q?1_^_8OH_P#W[D_^)H\Q?1_^_%A\'=5T.3X8:1X<\46WCJSU"/QKX:\<_'G]G7Q M3>ZZL7Q#UN:QNM \:Q:?$;*P-U9W+1W"7P!_>-17\B'_ W3_P '8W_2+W]F M#_PC/#W_ --8H_X;I_X.QO\ I%[^S!_X1GA[_P"FL4 ?UWT5_(A_PW3_ ,'8 MW_2+W]F#_P (SP]_]-8H_P"&Z?\ @[&_Z1>_LP?^$9X>_P#IK% ']& M>3+_ 'WWMYA)=W;]Y_K "7*H%8+ H5;80A%PC6B,GEF24H058,X<2+^\"K(K MJRR;?,Y9U9Y]B?:6G .?Y&!^W/\ \'8P.1_P2]_9A_\ ",\._P#TUBG']NG_ M (.QC_SB^_9@'T\&>'L_^O6*F7,E^[2O\D!_71]FAP@V B-E9%.&5&5BX=58 M%1)N)/G8\[))\S)S3UB"[L-)\P.09&?GU!Y[*W[NVU_P!+"M[_ +6W[RUKW_6WZ']1'%%%#&F(U1%B55!2*...&/B-,1Q1I! M&4'DQ1@L&_D:_P"&Y_\ @[%QC_AU]^S#V_YDSP[VS_UE7]Z/^&Y_^#L7&/\ MAU]^S#W_ .9,\.]\?]95_:CECS>TM^\VOY>O]=A>]S_^FL4 ?UWT5_(A_PW3_P=C?\ 2+W]F#_PC/#W_P!-8H_X;I_X.QO^D7O[ M,'_A&>'O_IK% ']=]%?R(?\ #=/_ =C?](O?V8/_",\/?\ TUBC_ANG_@[& M_P"D7O[,'_A&>'O_ *:Q0!_7?17\B'_#=/\ P=C?](O?V8/_ C/#W_TUBC_ M (;I_P"#L;_I%[^S!_X1GA[_ .FL4 ?UWT5_(A_PW3_P=C?](O?V8/\ PC/# MW_TUBC_ANG_@[&_Z1>_LP?\ A&>'O_IK% ']=]%?R(?\-T_\'8W_ $B]_9@_ M\(SP]_\ 36*/^&Z?^#L;_I%[^S!_X1GA[_Z:Q0!_7?17\B'_ W3_P '8W_2 M+W]F#_PC/#W_ --8H_X;I_X.QO\ I%[^S!_X1GA[_P"FL4 ?UWT5_,-^PI^V M7_P7L_;:TGX\R3Z3_P $S?V>_&/[-_QUUO\ 9]^*/PZ^*_P#_:8U/Q%I7C/1 M?!'A/QS-<6VJ?#S]LOQ=X2O;$Z;XUT5&%OX@D*N+@O.A,*O]X?V!_P ' '_1 M6_\ @CQ_XCK^VK_]%!0!^Q-%?CM_8'_!P!_T5O\ X(\?^(Z_MJ__ $4%']@? M\' '_16_^"/'_B.O[:O_ -%!0!^Q-%?CM_8'_!P!_P!%;_X(\?\ B.O[:O\ M]%!1_8'_ < ?]%;_P""/'_B.O[:O_T4% '[$T5^.W]@?\' '_16_P#@CQ_X MCK^VK_\ 104?V!_P< ?]%;_X(\?^(Z_MJ_\ T4% '[$T5^.W]@?\' '_ $5O M_@CQ_P"(Z_MJ_P#T4%']@?\ !P!_T5O_ ((\?^(Z_MJ__104 ?L317X[?V!_ MP< ?]%;_ ."/'_B.O[:O_P!%!1_8'_!P!_T5O_@CQ_XCK^VK_P#104 ?L317 MX[?V!_P< ?\ 16_^"/'_ (CK^VK_ /104?V!_P ' '_16_\ @CQ_XCK^VK_] M%!0!^Q-%?CM_8'_!P!_T5O\ X(\?^(Z_MJ__ $4%']@?\' '_16_^"/'_B.O M[:O_ -%!0!^Q-%?CM_8'_!P!_P!%;_X(\?\ B.O[:O\ ]%!1_8'_ < ?]%; M_P""/'_B.O[:O_T4% '[$T5^.W]@?\' '_16_P#@CQ_XCK^VK_\ 104?V!_P M< ?]%;_X(\?^(Z_MJ_\ T4% '[$T5^.W]@?\' '_ $5O_@CQ_P"(Z_MJ_P#T M4%']@?\ !P!_T5O_ ((\?^(Z_MJ__104 ?L317X[?V!_P< ?]%;_ ."/'_B. MO[:O_P!%!1_8'_!P!_T5O_@CQ_XCK^VK_P#104 ?L317X[?V!_P< ?\ 16_^ M"/'_ (CK^VK_ /104?V!_P ' '_16_\ @CQ_XCK^VK_]%!0!^Q-%?CM_8'_! MP!_T5O\ X(\?^(Z_MJ__ $4%']@?\' '_16_^"/'_B.O[:O_ -%!0!^Q-%?C MM_8'_!P!_P!%;_X(\?\ B.O[:O\ ]%!1_8'_ < ?]%;_P""/'_B.O[:O_T4 M% '[$T5^.W]@?\' '_16_P#@CQ_XCK^VK_\ 104?V!_P< ?]%;_X(\?^(Z_M MJ_\ T4% '[$T5^.W]@?\' '_ $5O_@CQ_P"(Z_MJ_P#T4%']@?\ !P!_T5O_ M ((\?^(Z_MJ__104 ?L317X[?V!_P< ?]%;_ ."/'_B.O[:O_P!%!1_8'_!P M!_T5O_@CQ_XCK^VK_P#104 ?L317X[?V!_P< ?\ 16_^"/'_ (CK^VK_ /10 M4?V!_P ' '_16_\ @CQ_XCK^VK_]%!0!^Q-%?CM_8'_!P!_T5O\ X(\?^(Z_ MMJ__ $4%']@?\' '_16_^"/'_B.O[:O_ -%!0!^Q-%?CM_8'_!P!_P!%;_X( M\?\ B.O[:O\ ]%!1_8'_ < ?]%;_P""/'_B.O[:O_T4% '[$T5^.W]@?\' M'_16_P#@CQ_XCK^VK_\ 104?V!_P< ?]%;_X(\?^(Z_MJ_\ T4% '[$T5^.W M]@?\' '_ $5O_@CQ_P"(Z_MJ_P#T4%']@?\ !P!_T5O_ ((\?^(Z_MJ__104 M ?L317X[?V!_P< ?]%;_ ."/'_B.O[:O_P!%!1_8'_!P!_T5O_@CQ_XCK^VK M_P#104 ?L317X[?V!_P< ?\ 16_^"/'_ (CK^VK_ /104?V!_P ' '_16_\ M@CQ_XCK^VK_]%!0!^Q-%?CM_8'_!P!_T5O\ X(\?^(Z_MJ__ $4%']@?\' ' M_16_^"/'_B.O[:O_ -%!0!^Q-%?AO\4O$?\ P7P^%OPR^(GQ-OOB7_P2#U;3 M_AUX)\5^.-0TRR_9Z_;1BN[NQ\):/J6LZA:6\S_M.R1BX-O8 (S1X+,_R ;& M/Z'?L"_'SQC^U/\ L1?LF_M*?$'3?#6C^.OCO^SU\)_BSXNTGP;9ZII_A/3O M$?COP9I/B+5[+PW8ZWK/B'6+/1+:]OYHM-MM3UW6+Z&U6-+K4KR8-.X!]=44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% 'XK_ /!=J,)^QS\*#N=C_P -]_\ !/D@EBFT']KKX7!5 B\M2L2SLD8= M6(5$+%G#,W[3X'H/R%?BY_P7=_Y,Y^%'_9_7_!/?_P!:Z^$]?M)0 F!Z#\A1 M@>@_(4M% "8'H/R%&!Z#\A41D8;!@9;KP?7''/\ C3MYR>@ S^G3//KC-3S* MU-Z_O?@TUU5]5TT]25)-U%K^Z^.ZLMKZ/KIZ#\#T'Y"C ]!^0I:*;=N_R5RA M,#T'Y"C ]!^0IOF+@'_=_P#'NGO['BD,@P3]<9]L9_G_ /7J(U:_0=GV?W#\#T'Y"C ]!^0J@;F8=%3&.N&//E*Y'#>I./; Z\T" MYG_NQ_DW_/,OC._GD?EGO@U-*O3K2Y8<]W_-!Q7^\XG";MO_ )>X2KT_ANG4 MVJ12SYXVOK]VO^[?6]K_ //G_P J?N]]2_@>@_(48'H/R%+16Q8F!Z#\A1@> M@_(4M% "8'H/R%&!Z#\A2T4 )@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "8' MH/R%&!Z#\A2T4 )@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%&!Z#\A M2T4 )@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%&!Z#\A2T4 )@>@_( M48'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%&!Z#\A2T4 )@>@_(48'H/R%+10 M F!Z#\A1@>@_(4M% "8'H/R%&!Z#\A2T4 )@>@_(48'H/R%+10 F!Z#\A1@> M@_(4M% "8'H/R%?BS\<4'_#][]@M M_P"9_P :6B@!,#W_ #/^-&![_F?\:6B@!,#W_,_XT8'O^9_QI1GOC/M3&8CH M!C^OYU,9*:NKV\U8!V![_F?\:,#W_,_XTWTUY?37[OQ]-177/[/7F]-/O_#UT'8'O^9_QHP/?\S_ (TM%,8F![_F?\:, M#W_,_P"-+10 F![_ )G_ !HP/?\ ,_XTM% "8'O^9_QHP/?\S_C2T4 )@>_Y MG_&C ]_S/^-+10 F![_F?\:,#W_,_P"-+10 F![_ )G_ !HP/?\ ,_XTM% " M8'O^9_QJ$6\8*'DF,N4SM)7>NPB,EZ;^.WR\=>3G[6%[>]_X"_P#H&^M]_P#GS_Y4_=[ZF?M( MVOK_ . O_H*^J=_^?W_E/]YMH7J***/:1[2_\!_X)H%%9PN;DLHV1 '=GA\Y M AQCY_5W]>B^AR+Z@:I-J]FO71[U5M M?_IT_E.D_P#EY&RNN7FO=>6K_P"8GI_W*U?FZ?\ S\5M&BBBD,**** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ JD;EE:=I&A6&!07D <^28@9;AK@ML5%:!X6 MA5=Q&YW)>/!%VOQ*_P""]O[.'[0WQZ_X)W_%/7/V3_BY\;_A-^T+\!WE^-7@ M&;X*?$GQU\-];\:Z9X/T[68/&'P\OX_ ^MZ,VNQ:[X2U/7+C0;:4Q3'7M,\. MRR7$MM#?6FI@%K_@NQ-O_8Y^$Q=H8P?V_?\ @GNN9)1% P7]K?X5.5%Y/Y4: M!T*3B8Q/#'!%/-/L]'\??MC?M3^.]$M=7T'Q'I^D>-_P!H7XO^*-'L_$7A>]2\\,^(K6PU MOQ?>VL6J>&-7MK>_T2\\DSZ?>VMM7[=6W_"8:[X:2\M[JWU+^SP ?Z^[3L"R# D18GD5D::=]P&,"M:@"!< G^'I_3Z8Y)/OCFOD7XD?MS?LK?"GXN_#[] MG_QS\;_!.A_&KXL^,+/P)\/_ (:I+?:YXMUKQ3?6%OJ$&CW&DZ!;ZA+HDT5C MJ&C:M?RZZ^FV^FZ9KGAV35I-/_X2;P]+J7UHLC%0>.45CC/4G&.O3BOY_O\ M@L/''#^U[_P0Z141H8?^"BF^*"2..2%)H?A)XEFAG".AS-#Y:1P.Q/V=$1K< M13(LHYY34*==^'WQ,\'_"3XO^)HK"[U&3PW\"_CIXN\'Z+\$/CGXD@MM,UAK_PU M\(OB-XU\0Z4VBZU'JFF6)H$?"5EKOC; MQYXZ\6W _#/B?Q1K>H*T>DZ+JEX\6EOA?!7]I3X2_M Z?K=W\-M M?U6;4?#%V+'Q=X.\;^!OB'\(?B7X(O;VS74-*MO'GPG^,/A/P#\5? S:MIZ7 ME_HS^)_!&FP:S86?B_\+=;U6REE:QN=;\(:W4N!O]8(X"$ZJ4/8O&?ZK9[[>=2+C&6#M=\S< M.&CF%&M@UC8>W5%Y'D/$?+4HN%:.6\1Y9D>;9:Y4G.7+BOJ?$66O%8/VCJ86 MJ\51J5*D\+.4_P!5]1_;_P#V3M)^,T7P%U+XJV\'C^3QQ!\+/MB>#/B/$/^%%Z3\=)M'N(-5;X%7?Q$/Q831[VPUIO"B:7<)= M/]9:EK5MI5K>:A=RVEO8V%H;Z\GNYFL[:TLTB>2XO[R^E!MK:RL47S=19QML M+$/J$TQ4QP2?Q%^-/#GCMO\ @G5\>?\ @F,M[-'_ ,%(_&7_ 57NO&W@SX; MR6=L?BWXG\.:A^UYX&^..E_M9:+X:FDDOG^"-C\+;*?5I/C%?B)X)U>Q\<>'_B=XOTOP9^SU\%-&B\4?M0^/O$%^-*\, MW=O8Z3)JFF?"F75HIC;16]]:OIOC+XD>5(^H+X3U;PCX8.G2OXXN?["YZ*]I MEU"O3C)5,2L#[-2@H+_;^%.'>(,/*4TO==3,\XQN42@U)PSBG_9U_K$G-77F ML-F;PU2,Y034;TH>TYE4XIQ^0X2I"*DKPS#+LWFN^$WT2+QQX \>> OB?\)/BAX) M'B.":\\,WGC#X.?&7POX'^)_A#1_&FGVE]JW@G5/$'@G1=.\7^'[.?Q'X;CHW?:G0\Y;';&TK0C2E*44JSM"\DFW[]TT[6M[ M.K>^WLJO\C*]I'GJPM+FH_Q%R[:UE9.^K_( M/%VC_%GPG>^9XG\*:MJ_@WXX^ /#D%CJOAG5_#7B/PFDFAQ7EQ;P^+X3NV/.2UC+KNCZ]IT;G &9M,GP M!A0 3D T&OGQ&PCP&0&0C8T,9D3S8Y/M,L]K'-''%',9DM5N'P4?*(O[UYNG M1B'>,J)5B#+&QYN9C%:N!'-,2BO_ *--Y@AW3))*#%'A*_"7_@A5\5OC'\4O M O\ P4)B^,_Q@^(_QIU7X6_\%//VH/@IX0\4?$SQ =:U[3/A]\-[7P/H'A?0 M[1;&UTK1-)@M[9+FZF@\/Z-HUF;_ %&_GMK2UCECAAU/&?[0/B/]L;_@J'\4 M?^"=OA_QOX]\ _ +]E#X&>%OB=^T%JOPF\=>-/A)\1_B)\8?B==Z%-\/_AM9 M_%CX;:]X8\=^"_!F@> ]0G\7:XGP]\0^#_$=_P"+]2T";_A((M*TB\TC4YNJ MCPL:%F\;E#SS#WBUS991E"-1.,713Q%E!:I"(\@7SXG1$ MN+FVCAV21^:)7FF26""X55!:.4?B9\ /VPM3^ 7[8W[;?[!7QV\)-3TNXUB]\0_8SO?V@_P#@I#^Q/K/_ 4. MN/C3\;/A'\;OC%<_''Q;^Q_X0\#?%3Q[X:^$'P&\':)J7B;X>_!?PSXV^!NC M^((/@]\?+R_N?"-CXL\8ZG\:?!7Q$BU&3Q3JY\.CPO;R:;#IG.L51]AB,:W. M.7X; 0S*K6E2G&^$J8O/\#&5.$DI5)_6.&,YA*DK2A'#T)S<5CL#'%"3E6HX M318S$8S^SZ:;2I_6?J5',+2J[1I_5L1AY^TY7'FKT86O-37]#[Z@4,H"!V@C M:5XU!DE9-MV\16*V-S,WGQVOFV\=M%>7SA:B.^D?>+=<^&>H:!H'BI99?$'AGP!XBNO$6DW0U;25NYOL?_@GM\:/B-X8_ M;S_X*5_L(:WXJ^(7Q)^%'[-LW[.WQ'^!WB+XL^-_%/Q3\>^%_"GQM^&]U>>) M/AOK7Q+\=ZMXE^(WC?1]*\2^&;W7?"^M>/O$WBKQ%>RZYX@TVYUF6+1HG/I5 M<+6HXFMA:D8JMAUQ4ZL5.,HQ_P!3*F0TL_\ ?5HR^KRXDROZORW^N1EBGA[_ M %2K&6$<32E!S]^"C#)JEJE.<).&?9YG?#N6M*2WJYEP]F,:L7RRPV&6&Q-: M,88F%.'[:-?2K-%#Y<6^9EVJYN$9%(A;=B.WGW1;!=8N)Q91F[%GINWS[L2I MIU\E>"M?U[XI^/KKXC0:E>:9\)_!AUC2/AKI%MZ)XP^)NO M0VTMK<:WX*-O+<:3\+K?4X[K0-OVOU.MT2KL6CX+X&U MD,8&=HE#.3N&&WX"]#@8KEG)4VE)2M[/!RE))N,*F-47'"U)7]W&8;VE%8W# M\KEA77H*[K&I&^,;"2?X;"(ZUX3OM2TO4-1L"_B MA#-X:O;FRMM1T37$,T6L^']1L=7LH7MKF-Z /TX_X)$?\ES_ ."TG_:67XG_ M /K/W[/M?MK7^=S^Q)_P=2_LI_LO_$']O3QCXG_9N_:%\2VG[6?[9?C/]I[P MO!X&_$5[K5S*=/\ "UIJ-EX9T[6_'GP^T3Q9JUKH M-IJVK:WJ=II%MJ6IRV^G0:CK.J7D-F(8[K4+N=7N7B,X2P^,Q7,HT<"\(L0Y M-1DGC<#C,QH#IR:E+'_7OJZI^__P B M[ZC]9]HU94VEF.%=-/F]HI5&N7V;YOJ2BOR#^'7[;?[1_P"V)XD^.OB3]BVW M^!6E? []F_XJ^-/@E)K_ ,9O"'C?QEK'[4'Q1^&]I;1^/M(^'&M>"?BIX#TS MX$^ M&\47=KX/T3XF^*O#OQLO_%UZOB+5K'X:6&G>&+-?%NKI_\ P5Z_9[D_ MX)PZQ_P4AUVUU7PUX$\(^'-83QK\+;T13_$;0?B]HGB1_ =U\#I[426\<7C2 M7XA(GA.VEF@%L\M[::F\:6(F=7S7HJO:7*WDT5#E?M>;B&I3H9+'V7Q\V8XB MOA<-ATKN>)QV6T5>IF>6K&D7S8I81755XO&9>W+W:4AC:JDHY9FRRO]9Z*_&OX@?MS?M2_LD>#?@Y^T1^VKH?P&TGX ?& M/XC?"WX<_$+PO\,?#?CO3/&7[%-]\7&;3/#VM?%?XN:_\2?%?@[XZ>%/#_C. M]T3P/\0?$VA?#'X!VWAB^NVUO3;/Q/9.+.W[?X\_MK?&[5OVQ(_V#_V3(_@[ MI_QB\.?LSR?M7?$7QY\:/"?C'QYX/TWPE=>.8O O@WX9Z#X+\(_$CX0ZE?>* M_B%?#4KZ/QNWCV;0O ]EIEJ=5\+:_/K]E#:UB?\ 98U9U/>C0QV-R^JZ+57D MQ&7)5<>[1<7*EA,&UF52K%257+'''82GC*4H0DHRC*E1K)VIUL$\P@Y6C;#_ M %RG@*/.F_W=7%8FM0CA*4FGB(XBA.,H1J)+]7:*_/[_ ()]_MW>'_VZ_P!C MOX6_M4VF@VO@";Q=9:_I_CGP?=ZD-0M? GC;P!XIU_P3\1=&/B*5;"VU+1]( MUWPQJ]]I^NK!%#<^'/LFJ-&PN%0_1/P?^(_C'XFVNN^-+C1],TOX=:E?M;_# M!9+#4[/Q3K_AW39)+4?$#5OM6H36L>@_$*8OK/@/1X;"TU&Q\#V^B>)]:OKN M_P#&I\,^#E4?LJSH23PMN M6 (TKMD!?)&'!.,[L V*^>_VF_ /Q/\ BC^SW\8?A_\ !3XGZI\&?C%XJ^'W MBG3?A7\5]+M=.O)O ?Q&_LRY3PCXBN;34+.ZMKZP77TLQJUJMLKW6DM=6]DU MG=21W2 &9^U]=*/V2OVHP2J-%^SG\&M7^*OP#^-_P"V1\7=)U[PUJGCCX._%7P%KWAG MX5!]/U/0[_4O"7CWPQK\EOX'ADAFLM1MM;T=C:37AN[FT:R@EE^S"2Y\X^"7 M_!;G_@K[\.O!/PL_9^^!'[7GQ3T3PEX+T'PK\,?A=\.O"_A?X=ZG)I^BV2:/ MX5\)>%="-SX+O=#K75OC7\1?$3Z*UY>?$'Q(TWB+6M!L%T#1-!T>ZT3PS>:C_PB.@) MIFFV$L?AO0])BNKO4-1AN-3N_LV@#Y!A_;D_9:O/VB=!_9+TWXT>#=7_ &C? M$NE>*]>TCX4Z/_:&KZ])X?\ \EU:^*-8U"]TJ&^T/0K&QOM*UC0EGUS4]/\ MSQ1INK>%(DF\2>&_$&E67T/XC\8Z-X2T#6_%'B;5]"\-^'/#FG7NKZ_XB\0Z ME::1X=T'1M(MKC4=5UO7=>OKN#3M)T:#1K:74;K4;N18M)LHS>7BS*Z6]?A1 M^TFSI_P<(?\ !--P6$C?L>?MD1N%9D66-E\,JPD52JL SB1>FV1%88^8'B_^ M#@[QQXAF\._\$X?V6+&\2+P;^V1_P46^ GPX^,.G72QW=GXQ^%FE>([+Q%KO M@754N(Y5G\/:WKG_ C,VIZ7(LMKJECI2Z-J$=QH]U>V-UST*BQ.#RJ5&WM< MVS:634)5%[.,<7'B7%9')U9-2]CAHX?"U)/$24XN"C)0M)1.7ZQ36(S6I+FC MA+[[3-;\0^%M"^(OPO^+OP7OOB3X/\-3:+!KWC[X/Q_&?P)\/ MU^,_P\T]]?TAY/B'\(V\<^ OL>LZ#J'_ E'V;6]+-WWGQO_ &C/A5^SQH6G M>(?BKXJ70;?7]7CT#PAH.B^&_%GQ \?^._$$=I?ZS<>%_A]\-? 6D:_\0?B% MXOD\/Z+XAUB#PEX%\,>(_$G]D:!K6MVNE:G8Z1JJ67XG?\'!GC[4_@1\$OV. M/VH_!UW<:)X\_9O_ &[O@#KGAJ_T@BWGN] \7CQ!\/OB#X'N9F#"'1/%_@W7 M]6T;4H87M%>-HIDE2YMK6>+F?AI\1-:^.W_!R-\>M(\2W(O_ U^P]^PAX*\ M)?"G0[L)+IGACQA^T!J7@?QOXZ\8:';S>>;#Q!XD\.WFE^#=5UFV>&^F\.:= M#HID%G$J5*FF,Q%/ J'PM\5-SA:F_W<^#/Q^^%_Q\\,7_ (K^%GB>/7[/1-:?PUXJTG5-$\2>"?&G M@;Q;!IFBZOJ'@_XC_#OQOI.@>/\ X9^.-/T[7-,O=1\"^./#6C^*=*M;ZP?5 M=.LC>($\;^'7[?O[)_Q4^*T7P7\#?%)-6\;:CJOB[0_"$UYX)^(_ASP#\3=7 M^':22_$K2O@Q\8/%'@_1?A!\.O'M[X*CT^];Q*FG-;W M"0_BW\0O$OC_ ,,?\%[?VA_V=_A/X@?PO#^V9_P2;>6TFGI?&;^R-):Q^*_@A9:Y\3O@7 M_P $"OV/_AC:SZ1^UY^Q?^UEX+\;_M:_"][&TTWXA_LV^ _A;X3^*,?Q1U+X MX:8TEOXF^'<'QD74(3X!D\2V^FCXT)X@L+JS;7#-EJRI1QWU7%8I>RPF.I4: MN'=",ZSBJF<^(>0XA5(W@_\ 83<04;6M=XW X['PP2<4L1C$L+"49R]H?V.>,/&^A>!O# MFL^+/$NI6NE>'M L[B_U74[A)9(X+6/,2"*"(^=>7[WNVQ@TBU674=0O7@L+ M*%]2OK"RN>AL=1COK*WU%5FCMKJW%W']IMI;.:& HK@7,,Y\Q),$D@JO SMQ M@G\__B[\;/A79W9^*_QF\4V_A[]G7X,^.[#1=#MXM%U[Q7J/QP_:33Q!9:3X M=T[P)X%\)VOB'Q/\1Y?!'B=Y-'\"^!? ^C>*_$?C7XUM/>V^A+XB^%6@7VL? M2_P9_:#^%W[07A&?QW\)O$R>(])L=9U+PIKUCJ>B>)O!WC+PEXMTHQOJ/@CX M@?#KQII.A>._AQXST>*[L9O$G@[QUX9\.^*O#L5W#)K&C6/F,(W%P M;51)IM:0<+:V?M%5HNG[R;]O1YE2=2*'[2*=FW'5)\RY4G[W,FV]'3Y*GM$[ M&;_QO^SO_ ,$S_@W\>_ VE:_?>%-3\9_!7]C?]MKXK>&+ M#Q3I^GZ5JEWX8O->\ _'[Q!HEMXCM]+UO1M8FT674Q=)INL:;(Y5+J*=_4?^ M'^W_ =,?](6D_\ %<__ 42_P#GRT ?W^T5_ %_P_V_X.F/^D+2?^*Y_P#@ MHE_\^6C_ (?[?\'3'_2%I/\ Q7/_ ,%$O_GRT ?W^T5_ %_P_P!O^#IC_I"T MG_BN?_@HE_\ /EH_X?[?\'3'_2%I/_%<_P#P42_^?+0!_?[17\ 7_#_;_@Z8 M_P"D+2?^*Y_^"B7_ ,^6C_A_M_P=,?\ 2%I/_%<__!1+_P"?+0!_?[17\ 7_ M _V_P"#IC_I"TG_ (KG_P""B7_SY:/^'^W_ =,?](6D_\ %<__ 42_P#G MRT ?W^T5_ %_P_V_X.F/^D+2?^*Y_P#@HE_\^6C_ (?[?\'3'_2%I/\ Q7/_ M ,%$O_GRT ?W^T5_ %_P_P!O^#IC_I"TG_BN?_@HE_\ /EH_X?[?\'3'_2%I M/_%<_P#P42_^?+0!_?[17\ 7_#_;_@Z8_P"D+2?^*Y_^"B7_ ,^6C_A_M_P= M,?\ 2%I/_%<__!1+_P"?+0!_?[17\ 7_ _V_P"#IC_I"TG_ (KG_P""B7_S MY:/^'^W_ =,?](6D_\ %<__ 42_P#GRT ?W^T5_ %_P_V_X.F/^D+2?^*Y M_P#@HE_\^6C_ (?[?\'3'_2%I/\ Q7/_ ,%$O_GRT ?W^T5_ %_P_P!O^#IC M_I"TG_BN?_@HE_\ /EH_X?[?\'3'_2%I/_%<_P#P42_^?+0!_?[5>2VCEQYF M6"F1E#87MQ=RZO\ ;F_KK_X-#_\ @G*/V>?V2O$_ M[P^'AO($BU+P]^SWX8O[^XTR:WW0B6VA^*_BRU/BJYN' MGDBU'0]&\ M%#;OI[377\\O_ 4T_:4_X+X?\%7OAQ\.OAQ^TO\ \$7/'^AP M_"SQZ_CWPCXO^$_[ /[=GAWQM:27VB7&@>(O"LNJ^*O&GCBP;PAXNL&TX^(] M-@TBVO[F[\/^'[VRU6PN=,CD?]"/!?\ P6__ .#F[X=^$O"O@/P/_P $/]/\ M,>#?!'AO0_!_A3P[I7_!.'_@H?!INA^&/#.FPZ1X?T2QC;XR/)'8Z3I]O!;V M:^89$2-=\CY;(!_H445_ %_P_P!O^#IC_I"TG_BN?_@HE_\ /EH_X?[?\'3' M_2%I/_%<_P#P42_^?+0!_?9]T'V1./J1Q^M?S'?\%M_VH_V;? '[;/\ P1W\ M.^.?CW\'?"'B#X4_MT:;X^^*F@>)/B3X.T;6/AKX%UKX8:[I>G^-/B#97NKQ MS>"_",US?VH7Q/XE33= D4O(-36-2R_CZ?\ @O?_ ,'2QS_QI;'(4''_ 3G M_P""B'12"/\ FL?MS^F*JK_P7C_X.D4>1U_X(ME3*H60+_P3F_X*&HK +"@R M$^,"@D) B*QR50LBD+@+SU:S:LFG_4/_P %>_V4 M+K_@IG_P31^+_P )/@5XD\/Z_P",/$^@>#OC'\"]>T?4M,U3PIXV\4^ ]6TC MXB>%;'2_$]O=2Z)=:/X\TVQ_X1^R\0Z?J,FE6IUR*Z?5&M0[U\:_MY?M!Z9_ MP4D_X)TR_L2?LX7<>K?M=?M)+\!OA;\8?@EY'/$'Q@\5?M M/>#%9/$OP7TGP5X>\(>+QI,OQ#T_P^/'&I_\(Y;>%3K(UZVC?\07_P""\/\ MP='R +)_P1;:0+RHD_X)T?\ !0Z15DW(ZS!'^,+1^;'-''-"VS$$L:F%8U!4 MH_\ P7A_X.CW )_X(M8D6&6W6W= MY43G]Y%&Z3*BYX2K@I4X/#8G.WF>(I2=XSB\5@J;YE'EYF\MRO TW"/*[J5- M--)QUA5JTG"O"*^M85/ZG-3M;_8G.TFXOE7]J/VE_P"5<]FM#]X/C[^S5I?[ M#?\ P47_ &%_V_+"WFMOV8OA]^R?J'[ '[0OBL;(]#^!O@#2M.NO$7P<^,/C M*X4JFC_#:/Q!8'PKX_\ %5\\NB^!$N=!U_Q)J.A^'([S4Y>OL_ ^G?M\?\%= M_P!G;]LWX7W>D^-OV4?V&_V=OB+H?P_^.7A[4(M?^'OQ@_:#_:&C;2=?TGX6 M^)M*^UZ!XX\+_"_X:6,%WXC\<>&M6U7PI)XQ\06O@&VU0>(?#?BJST[^>MO^ M"[?_ =''D?\$7IT?IYB?\$[/^"B"RA&AA@FCB?_ (7#NMUN%@22;[,86-P6 MN49+@B43-_P7B_X.CWE,S_\ !%HM(P==Q_X)T?\ !0_*J^P'RV'QB#Q,/+3] MY$R2MLBWNWV>W\KT5B:\L53Q%67//"QS+ZI45DX/.7F3Q[44^:#D\XSV3:E: MH\_Q=]:3O@Z%..$6&IP48QP&795%7VP&4XO+J.!A>R5J>493@**C;3V4:6\> M9_V\_%SXA:UX;L]!\%^ (M,O_BY\2+C4+/P7!JB:I>Z'X?TZR5%U_P"*/B%8 M1%/_ ,(?X LKNUU&^TZ&]T:VU?7-7\*^ K#Q!9ZGXL\/75S^5O\ P6"_9P\6 MS_\ !._2O"WP8T?Q7XYT?X0?M&?LV?'+XK^%M,T;_A,/''Q,^&GPW^.OAGQS M\7]3O-&MX[.'Q[XHDG;4?BOK_G6OVSQ1>Z/J%R\7_ (.C ME&%_X(JQ*P\[9(O_ 3C_P""AJRQ_:)#+,8W'QA#*9)L3.V2TDP$LA=\DUY/ M^"[W_!TE(5_XTQ7*!55<1?\ !.O_ (*&Q!O+7;&3L^+X(V,7D**5BE:619XY M8BL2\-*#IT\!%P]I+"3R.K*U10C*65YMDV9SBE9JRKY=4Q,)#P"=WEEY8J+?&VE?$']D ?\$_O@Q\"+SXK>!KZW\0_"?XL?'*#XT^//&46G M>#?'6FSR^%_%FI?#?PC(-87P;XEET_7 =,'[W^7)W;H M$).3T7[06Z],;E)QZ5_ 0/\ @O+_ ,'28B$0_P""+TF %&\_\$ZO^"B!D)18 MT5G8_&+]XZI$B[Y0[$*&8E_FJP?^"]W_ =+8(_XY)S_T!**_@"_X?[?\ M'3'_ $A:3_Q7/_P42_\ GRT?\/\ ;_@Z8_Z0M)_XKG_X*)?_ #Y:W.@_O]HK M^ +_ (?[?\'3'_2%I/\ Q7/_ ,%$O_GRT?\ #_;_ (.F/^D+2?\ BN?_ (*) M?_/EH _O]HK^ +_A_M_P=,?](6D_\5S_ /!1+_Y\M'_#_;_@Z8_Z0M)_XKG_ M ."B7_SY: /[_:*_@"_X?[?\'3'_ $A:3_Q7/_P42_\ GRT?\/\ ;_@Z8_Z0 MM)_XKG_X*)?_ #Y: /[_ &BOX O^'^W_ =,?](6D_\ %<__ 42_P#GRT?\ M/]O^#IC_ *0M)_XKG_X*)?\ SY: /[_:*_@"_P"'^W_!TQ_TA:3_ ,5S_P#! M1+_Y\M?0_P#P3!_X.)/^"I7[3O\ P5<^!W_!._\ ;._9;_9__9ZC\%%.@_%+XX^(6\//X@;PWX;OV76/ ^ MJFY\+:TQL3'-=6FKP ']NU%%% !17SC^U%^U;\#_ -C'X%^-OVE/VD/&,OPZ M^"GPY;PG_P )MXU_X1CQ3XK&A)XU\7>'? 6@-)X:\&:5K_C&[^T>*O%6AV-GBN?VVQ%,AB1T'[-7[7^(Y2WE743B3X M Q7"FSE25I#<6UINB:(*N\L ?T T5^ '_$49_P0L_Z/E3_Q&G]L#_YP%'_$ M49_P0L_Z/E3_ ,1I_; _^WCN+.^E34X/\8W4-%N]&U+4M&UR MRU'1]7T>^NM*U;3=0M9+6]TS4["YNK/4;&_M9D2:UO+&>VE6>SF19UEM[BT. MV4!E_P!=9_\ @Z#_ ."$[XS^W(FT%2R_\,S_ +7Q#F-VEA+,?V?2ZF&9C-$\ M;HZ2@/N)%?QF_M#>)?\ @B%\5O\ @O'X3_:QT_\ :UT*;]@?Q_K,'[2OQYT= MOV?_ -J.R>'X[^')+BYO/A/;^"$^!B>);_PY\8/&%IH_Q&U'6DTY["PT_4_B MCH]W+:/:>!T\2@']C?\ P;;_ /!-Y?V O^"='@74O&V@2Z7\??VFKG1?CA\8 M?M=DD.LZ58:E81I\+_AW=KY<4UK;^!/#EQ;:K=V<\MU+!XI\0>+KE9Q::D+" MU_H>K^?A/^#H/_@A/&"$_;D50QC9@O[-/[7Z M'''$& 3]GY0NZ**.-E4*@5 M $526)L?\11G_!"S_H^5/_$:?VP/_G 4 ?O_ %1^U."RLJAUB24QC_6>7)A1 M))YS00PE'#^9#YTK;1P^2 WX'?\ $49_P0L_Z/E3_P 1I_; _P#G 5QOC?\ MX.8?^"'WBSP?XB\,:'_P4@\5_#35];TS4[#3?B!X'_9A_:-N_&'@^\U+=MU[ MPU;?$+]E#QYX'EUC3R[FP_X2?P7XETM=S"[TN[#," 7O^#?])T\(?\%2G5&, M_"_ M_@X#_P""O^C>*K.\L-0^.?P4_90^-_PW6]@CC3Q'\.=!\-W7PU\4:]I-T]U$ M'TS2O'DL>&=>^,/Q%N]*N_$GQ+COOA[_ ,$Z M_AKXWTW7)/[)A@M=$T_QC;^!889[EW\(S77V:YMO=_CW_P %P/\ @WL^.?C' MP/\ %FP_X*,_$3X)?'_X8V_B#3/AY^T'\'?V;OV@8_B5X7\,^,8;:U\:>#)- M.^*7['WQ2^%_B[P?XJM;2!;[0/B#\.?%UGI=_#:>(?"XT#Q1IVF:W951BL'B M\FK8>HJD<#P(N&J[G3DHK&1X&X3R""4)OFJ4EF7"=%2Q$+)X?&U,0J3Y9TG- M:52I1SZE:,GF?$$\SH2YG%QP[XXJ<00<]/=J?V?5?-3?-:O%4H2^/'P M2\9?M)?\%I_^"GUO\-56^G\*_P#!%*;]G'7C$LT4VE?%SXYZGXO\2_#K0YYU M$UO#J%UX:MX;YH[IHY9='U6UU"UT[4;">+5H_O7_ ((5^.O#\'_!$?\ 9;UB M^NY])T_X9?!/XA>'OB!%K%NVEW'A[5?AQXK\=:/XRL]2@9;>XTPZ;/I5\$:\ M6QNK:UCCN;I)95F>W^7/@1_P7H_X-UOV>M.\7KX)_;9U+4_%WQ+\777Q ^+/ MQ1\6_LY_M9ZS\2OBOX[N]/@TAO%/CCQ%!^S=I\-U<6.D6EEHGA[1=&T[1?"? MA#P]96?AGP?X>T'PY;0Z4GSCX@_X*K_\&X>JZI\3]-T#_@I9\+?C_^RU\/O@C^T9HOP+^,?BCQK:PV_C?6=8>^_8\U;XP_#U_',MO'J'CS M3/@7\7?A/H7CK4)]9N/&&E:V/%/BR/7>2MA:<\CQO#T>7ZG5R"GEE*LU)3=> MGGG&^86<.>&/C7_P $1?V: M?!OQXT35]*C\4_&'Q9^U3\*M;T.^_L;QW\-_$-A\6O$6M_![XJ^#KVYL[RRT M[Q+8VVE:/XET>"_TC5?#^KZ1JAT[Q+H>NZ1JVJV-_P#IM\-_V4O!OPO\;_&# MX4?#KQ;\0?B!\6?VA=;TGXF?MR_M,?$K5- C^+OBWP[8:"W@OX:^#;C6OA=X M7^'/@WPGJ'BKPKX?@\'^#]$^'?@OPAI?@CX>6'B_Q1)8V_C_ %O2=1USY"\- M_P#!R[_P0,\':#H7A;PM^VK:Z!X:\,:/IGA[PYH.E?LQ?MC6<6G: M5I.G6EO^STB6]C86,$-I;0#*101(BC KG/A__P ''G_! _X=:3J&G:9^WIJ^ MKWFN:_K?BGQ-XBU_]G#]K&Z\0>*?$>OW+S7VK:[>6/[-NFVT\\=LMCHVG6]K M96=CI7A[1M#\/Z=:6VCZ59V;8['YK5<%%0<52Q^;8 M^KE*N_[);C."7,XR\W^,OQ?^+7Q9^+W_ 6>L_#/Q.^*OP.L/^"6OP5^',?[ M)'A7X3>,?%W@#PU8>.KG]G[Q/\:]4\?_ !,\ >&=2L/"/QPTO7=4ATO0-'\! M?%32?'O@>P\+^'Y-;L/!EEK^IWM]<_MS^PI^T'XB_:;_ &,/V6_VAO%NC6>B M^)OC?\!_AO\ $SQ!I5@LS:7!K'C#PC:ZOJ8TZ6XFN+B/2KJ_EEN-&BN;B[O( M]+EBCNKF]N5ENG_F]_: _P""J/\ P;8_M!^-OBIXUU/_ (**?&#X:G]HCP#X M>^%'[4OAKX3_ /_ &E_#WAW]IOX7^%K76-/T7P9\4SKO[(_BCQ#I(M-,U_5 M]'7QI\)/$'PP^)G]B7TFACQN-(6.R3[G\(_\')G_ 0!\!>%_#7@KP=^V=9> M'?"/@[1-)\-^%_#FE?LP_M<6>DZ'X?T&RBTW1-'T^UA_9Y1+>PTO3H(K*SA3 M&RWC569V&ZN"A&JL![*O-/$REDJ>BE%8G+H<1PS3-W-+]YB,]EB^&ZM7#RN\ M,\G48NZ3F\9"4L1*KA;1C)7CS1I4W3PF^#/V@/VL?V8?@1XRU MG1+?Q+I?A;XT?'KX9_"[7KSPU<7U]IJ>)+31_''B/0=3O-"NK_2M7LM)U>.T M31M6O-)O;6#5(YD=8@#ZOHK\_/\ A[-_P2Q_Z25?L!?^)B_L\_\ SPZ/^'LW M_!+'_I)5^P%_XF+^SS_\\.@#] Z*_/S_ (>S?\$L?^DE7[ 7_B8O[//_ ,\. MC_A[-_P2Q_Z25?L!?^)B_L\__/#H _0.BOS\_P"'LW_!+'_I)5^P%_XF+^SS M_P#/#H_X>S?\$L?^DE7[ 7_B8O[//_SPZ /T#HK\_/\ A[-_P2Q_Z25?L!?^ M)B_L\_\ SPZ/^'LW_!+'_I)5^P%_XF+^SS_\\.@#] Z*_/S_ (>S?\$L?^DE M7[ 7_B8O[//_ ,\.C_A[-_P2Q_Z25?L!?^)B_L\__/#H _0.BOS\_P"'LW_! M+'_I)5^P%_XF+^SS_P#/#H_X>S?\$L?^DE7[ 7_B8O[//_SPZ /T#HK\_/\ MA[-_P2Q_Z25?L!?^)B_L\_\ SPZ/^'LW_!+'_I)5^P%_XF+^SS_\\.@#] Z* M_/S_ (>S?\$L?^DE7[ 7_B8O[//_ ,\.C_A[-_P2Q_Z25?L!?^)B_L\__/#H M _0.BOS\_P"'LW_!+'_I)5^P%_XF+^SS_P#/#H_X>S?\$L?^DE7[ 7_B8O[/ M/_SPZ /T#HK\_/\ A[-_P2Q_Z25?L!?^)B_L\_\ SPZ/^'LW_!+'_I)5^P%_ MXF+^SS_\\.@#] Z*_/S_ (>S?\$L?^DE7[ 7_B8O[//_ ,\.C_A[-_P2Q_Z2 M5?L!?^)B_L\__/#H _0.O\\?_@\@_P"";]MX6\:_##_@IE\-O#R)IGC^31_@ M?^TK]@MXYHH_'NBZ-<_\*A^)&IHML9X?[:\&Z3/\/-6NKJ\_LB0>#/AKIR6$ M>M>(;R]U3^S7_A[-_P $L?\ I)5^P%_XF+^SS_\ /#KY2_;/_:N_X(Z?MM?L ML_'/]E7XH_\ !2#]@67P;\#;K4(OVPOV<;F\\-:[),=5\$>--&$WQ! MO+6UUSPCXJM]/\6Z/^&6@S^)_B)\4?&GAKP-X#\/VX2>35?$_BS5K+P[I5NZ3Q,QAN-3N;9W:4/% MIUDMQ?7:/:V\S-_M@?\ !/;]C3P;^P+^QI\!OV3_ &=/N+7X3>#X-/\4:_! M8I;'QKX_U::XUOXB>*9BZFXSXF\<7U_?,]T)98=/:VL(W6*UMO*_SX?^#9#X M'_L;_ 3]N+X[?M+?MH_M@_L5_#F\_9.U#Q;\(O@7;>-/VF/@QHNA?$+XG:M- MJ_A+Q9\:_AGJOB#Q?IL/CGX:^'_"%EJMKX*\>^&FN?#OB6Z\<6NK:%JL$NBL M8O[]U_X*O_\ !*]2Q_X>6?L"G>'0!QW_ 5_BCC_ ."5O_!1!P 7_P"&,OVBBY(4K*Y^$OB:-S*@ M41R%TSN+J>5C*[3!!Y5[_@G0=0'_ 2P_8T?22(]03]AKX'#3=H/_'Y!\$O" M[6 P#N/F.$\P*P9@(]4NOB#X7^! MM[X(U[4O[/=[OPFVG^*;6)E$\7B9D=[2WY'AEBLJSW"2E*%;,9Y2Z&CMRX+( M<]RZMS25E"V)S'#QBFI<]-2J)Q5-J4S3CB,CJTO?CE\L]EB.=\K7]H?ZOO#* M',G[3F>6XEU+->SM#FYO:KE\C_X-=K2WB_X(_?!]KN,0:_J7Q7_:(O/%=Q>" M:WOI]>B^+.L6JS7B2M)'#(=&32PY,=M%8-#9V+6GVJ.21_YQ/B3:^*-0_P"" M9'[5J7L&H#X;:I_P%4\5Z+\=O ^M:[H\/CFP^&N MK>.?V?KC2?$&I:O;P^)7T>XL+:PZBWTK_@A./^";FL?\$XM6_P""F'[%6N> MO$/A;5?[<^).H?MD_LTR_$/4?BMJ_B6[^(C_ !OFGB\'EA:>8U895+H1K82O@JM1THUL^XAQL<1!2E7A_ M:?"WBQPOA<\;IUI2PV52QOI7_!RW96EK_P19_: MV$#6S2FX_9]33O*4NS3VG[1?PC_LZTL_+ =)_P!P;*S^SG,,U^C*$D!8^LZK M^R!^T=IOQ[^%O[=O[.]S\*M5^.NN_L/^'_V5OBY\,/C]XK\8>"/">M63ZSIG MC7PA\2K?QKX+\#_$W4++Q1\/?%D_B.SN_A]'X%.A?$C2M;>UE\>^"+[2["_7 MXQ\>?M$_LJ_M>>%/@E\!OVW/^"H7_!)>]^!WP1^(?PF^(OC?6?@]^W-\,-=\ M6?MB:[\*9X+KPY%\0OAWXUD\/>&/V?\ P1JOC2ST[QOXN\%:+\3?VAM=U%=* MT_3]-\:>'7C>YG_4KQE_P5,_X)UP>&-:C^&W_!2O_@G';>-7LIK70'\9?MD? M )/"UC>3F4P:GJNGZ)\1C#-&T?Q1!\< MOAF/$7B?QYX$^#'Q@\9^.)_&FI>#?&&F?$;6_!&F?VI\*=)^$'P_OOA-'XI@ MGU;X@>)YM*U4/]L^#OV_O^"1G@SX?R_#V#_@I7^PEK%AJ46MMXFU+5_VSOV= M+W7/&&J>*+N^U+Q3X@\27C?$-%NM8\0ZOJFH:I?26<%A8P37/V32K#3M)MK/ M3K;\,_ '@?\ 8/TKP/\ L>?L;^)_^"KW_!+V]_8J_8E_:K;]I[P#XDT;]MCX M27_Q_P#C#:>'/''Q*\?_ 8^!WC3P#/J5KX3\)Z)\.];\?6-MK'C^P^+7CO4 MOBMIWA^.*7X<>";RX>\32C4G7S*J\;*-*DY<+JG*E3E5DHX?&9A3XHJ6O!>U MK9!2R3),GB_? M_GAT?\/9O^"6/_22K]@+_P 3%_9Y_P#GAU!UGZ!T5^?G_#V;_@EC_P!)*OV MO_$Q?V>?_GAT?\/9O^"6/_22K]@+_P 3%_9Y_P#GAT ?H'17Y^?\/9O^"6/_ M $DJ_8"_\3%_9Y_^>'1_P]F_X)8_])*OV O_ !,7]GG_ .>'0!^@=%?GY_P] MF_X)8_\ 22K]@+_Q,7]GG_YX='_#V;_@EC_TDJ_8"_\ $Q?V>?\ YX= 'Z!T M5^?G_#V;_@EC_P!)*OV O_$Q?V>?_GAT?\/9O^"6/_22K]@+_P 3%_9Y_P#G MAT ?H'17Y^?\/9O^"6/_ $DJ_8"_\3%_9Y_^>'1_P]F_X)8_])*OV O_ !,7 M]GG_ .>'0!^@=%?GP_\ P5D_X)>)M"_\%(OV!9'#HLB+^V+^SHAC5I(UE+O) M\2EB#6D3O/.B2RN\=O*(D,C1H?M;PAXX\-?$'POX:\<^!/$GASQKX'\9Z'I? MB;P=XR\*:SIGB'POXM\-Z[I\.J:%XD\,>(=&O]0T3Q#X;UW2[FUUK2-;T74; M^SO-+N(983()!* #L:*** "BOXD/VJO^#QI_V9/VIOVE_P!FIO\ @G4GC5/V M=OCQ\8O@H?&I_:WG\.'Q:OPE^(FO?#]?$S^'8?V7O$W_ CLGBF31X-2MM%F MUS4[726U*'3I_$-\T37;?.G_ !'-'_I%VO\ XFXG_P!"30!_?U17\ O_ !'- M'_I%VO\ XFXG_P!"31_Q'-'_ *1=K_XFXG_T)- ']_5%?P"_\1S1_P"D7:_^ M)N)_]"31_P 1S1_Z1=K_ .)N)_\ 0DT ?W]45_ +_P 1S1_Z1=K_ .)N)_\ M0DT?\1S1_P"D7:_^)N)_]"30!_?U17\ O_$0!A&1&O\!G_$A'4/@K^Q2VE^+M&6^C TK7OV@_$4=W%\/=+D\RTF MBU2#P)I^G:M\3K^&QNK6;3]=TCX^N_\ !1+_ (.J?AW_ ,%& M?V/?C5^R%\1?^";+^'K7XJ>'[6+PSXUA_:Y?Q)?_ [^(7A^^L_$GPZ\?Z7H M2?LV:#-?W?AOQE9V,NM:!IWB#0KC7_#S:GX7O=2?2-1OX'\Z_P""67_!S?\ M#K_@E?\ L?>"OV4OA]_P3DD\?ZCI&K>(_&GQ'^*UY^U=:^#M5^*?CSQ/J;S7 M?BF]\.Q?LN:W'I6GV&@6VA^#-!TNXUO5;^R\*Z#HEI/JU_?V\^I7 !_J'>0. MTDBG<.5\L8C5B1"H$>$C .W<@68@#,NX!JGK^ 7_ (CFC_TB[7_Q-Q/_ *$F MC_B.:/\ TB[7_P 3<3_Z$F@#]8/VMOVPOV3?"G_!P?\ L&S^)_VF_@%H*?"S M]FG]K'X<_$Z74_BUX'L+'X9_$GQ+)X4_X1WP'\0M0O-;BM_"7BO7O)O4TO0= M?.EZU,\28TQ@Z[_MK_@M;^S#\0OCE\*_V8_CY\'M$U+QA\3?V"_VMO@M^UKI MOP^T'3EO_%'Q,\$>!-9,GQ*\(^$=- \W5/%+>$9I_$&@Z/%-:2ZS>^%Y=*20 M7%[:&/\ FW/_ ?%Q'.?^"7K\QF(_P#&;Z8V_P )*_\ #(^QG0!0KNK-A5W% MB,U /^#X. *%7_@F#=( D\;;/VY I=+J3S9P6'[)&Y&:7#QRQ&.:VQLM)((V M9&RP\'0P>7P2B\1E^*_M*E"R=/ZZ\7/,FG)IQ<'C:M52;C:5.75[V M_LM_LK>,] ^-7P_L?VK_ (#9(]>\*?!OX4_ NUN/%&O\ P]^* MNJ6MP$\!_&?Q/XEU'PMX.M/@AXGBTKXIVK^" M-<^*7BA5N/#W@OX=>/\ X?:5=^&M+\9>*M2TG0;'QQID&A7^NP/K?AZVU+\! ME_X/AK95"?\ #KHE0(PH;]MV-E00^6(EBC/[(QC@6(1CRU@2,1NTLJ!9I99' MB7_@^"A21I$_X)@RH61HV5/VV[- 0\]Q/(S,O[( D>20W#(TDDCR*J^9&R7$ MMS-/I1C'#2YZ$>6<98]Q;LDO[6P.!RO'OO[^!RK 02O>7(H[PN%6FZZ_>Q3Y MLEP>!FN:Z>*R['K-L)+16<5C_?E[D<'3Y$THN"3Q>-S/&)4Y7O_:V/S+&5*UG%4'-3L[1L M M!?!GQ:\7.\WV71? OPMO;[3'USQ%=P+H_@'0=3;Q3KFJ:5X:T&2_B7_@EAH? MB'Q9^V#_ ,%7_P!JGPO//>_LK_M&_'3X!?\ #//B:UMK9?!GQ0N?A_\ O1] M!^(WQ7^'^K-+/_PEW@KQGKFMZ3#X?\8V'G>&_&%YH$O]@ZMJ4#7$B?ST'_@^ M$@)D/_#K^8&0 /C]M^)6($IF4"1?V11*FV9I)%*.I4RLH(C2%(IC_P 'Q46[ M0.=T8_9%"%@ 8DDV^8D;.%<.[.5A*<<*L6XRJ3E6 MEQ+*FI3EOQ14X7JYES^]RODGPKA%E3E?^S*>+Q4(V4V9UL-]8;YVX\RX83:: MEIPK6XIK9=:]Y?O9\5X[^UFG_P **PU!;X_.)5/] BBOX!?^(YH_](NU_P#$ MW$_^A)H_XCFC_P!(NU_\3<3_ .A)JSK/[^J*_@%_XCFC_P!(NU_\3<3_ .A) MH_XCFC_TB[7_ ,3<3_Z$F@#^_JBOX!?^(YH_](NU_P#$W$_^A)H_XCFC_P!( MNU_\3<3_ .A)H _OZHK^ 7_B.:/_ $B[7_Q-Q/\ Z$FC_B.:/_2+M?\ Q-Q/ M_H2: /[^J*_@%_XCFC_TB[7_ ,3<3_Z$FC_B.:/_ $B[7_Q-Q/\ Z$F@#^_J MBOX!?^(YH_\ 2+M?_$W$_P#H2:/^(YH_](NU_P#$W$_^A)H _OZHK^ 7_B.: M/_2+M?\ Q-Q/_H2:^B/V4?\ @\;D_:=_:G_9M_9G/_!.NW\"O^T/\>_@]\$5 M\8O^U]'XCD\&+\5?B1X=^'4OB.3PP_[,_AUM?N- GUN75T\.OKOAVYU>WM8K M=;^P%TMV@!_;E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 ?R _\&6[-<_\ !+;X_/,2[#]OOXG2!F^9E9/V>/V6H5*R-F16 M6*)8Q('$H!9A)YAWC^OW ]_S/^-?R ?\&6'_ "BS^/W_ &?Q\4/_ %GS]EZO M[ * $P/?\S_C1@>_YG_&EHH 3 ]_S/\ C1@>_P"9_P :6B@!,#W_ #/^-&![ M_F?\:6B@!,#W_,_XT8'O^9_QIN7[;>W!SGI]?7(_SFE^;T']^@_ ]_P S_C1@>_YG_&E&>_7VHI)W5[->35G]S&)@>_YG_&C ]_S/ M^-+2'=V /KG_ /6*:U=OST7WB;LKV;]%=_<@P/?\S_C1@>_YG_&D!8GD8 ]O M_KTISVQU[YZ?XYI2:BKZM?W5S/[D/^O(,#W_ #/^-&![_F?\:I&XF!.$0_N? M,Z-]_&<9W8V_K[T?:)L?=3/D>9T;&[T^\>,]LD^]0ZL4[6E_NWUO2+:]EVO_ M ,_/^G?Q>9FJD7_-_O7U36+7[[O_ ->_^GGP^1=P/?\ ,_XT8'O^9_QI:*T- M!,#W_,_XT8'O^9_QI:* $P/?\S_C1@>_YG_&D8D#(]:,G:" ,^G/KCBI@"X'O\ F?\ &C ]_P S_C4)D<= O\'4'HPY[]CP/UI?,<] .C]C M_#G'?Z9^M9?6:=VK3NOJOV';_:_X.M^G_+S_ )]_:N5R/R^_^NY+@>_YG_&C M ]_S/^-+16Y(F![_ )G_ !HP/?\ ,_XTM% "8'O^9_QHP/?\S_C3%=,KT'//3KS_A4N27M-_W7QV5^E]._X$J2?L]_WOP75O/7M^)) M@>_YG_&C ]_S/^-+15%"8'O^9_QHP/?\S_C2T4 )@>_YG_&C ]_S/^-+10 F M![_F?\:,#W_,_P"-+10 F![_ )G_ !HP/?\ ,_XTM% "8'O^9_QK^ %69?\ M@^C^S[F9/G.YR6=BW_!'T,A?=E9#"H2.,R*Y*H'E,D[22O\ W_U_G_\ _.]7 M_G_I#U0!_H 4444 ?S]_\'1 (_X(6_MS#-_&_[$W[*/ MB_QEXO\ $_[+7P,U[Q/XM\4>)/@EX#UWQ+KOB;7M5\!W>JZ_JGB+5KBXOM8O M-6N[R:\GN)G9U9R:P?\ @Z)_Y06_MT?3]F/_ -;)^ E??_\ P2<_Y19_\$UO M^S _V./_ %GSX>T 2?\ #IS_ ()9_P#2-;]@7_Q#S]GK_P"=W1_PZ<_X)9_] M(UOV!?\ Q#S]GK_YW=?H!10!^?\ _P .G/\ @EG_ -(UOV!?_$//V>O_ )W= M'_#IS_@EG_TC6_8%_P#$//V>O_G=U^@%% 'Y_P#_ Z<_P""6?\ TC6_8%_\ M0\_9Z_\ G=T?\.G/^"6?_2-;]@7_ ,0\_9Z_^=W7Z 44 ?G_ /\ #IS_ ()9 M_P#2-;]@7_Q#S]GK_P"=W1_PZ<_X)9_](UOV!?\ Q#S]GK_YW=?H!2'=V /K MG_\ 6*%J[?GHOO$W97LWZ*[^Y'P!_P .G/\ @EG_ -(UOV!?_$//V>O_ )W= M'_#IS_@EG_TC6_8%_P#$//V>O_G=U]_;@>A&>VO_G=T?\.G/^"6?_2-;]@7_P 0\_9Z M_P#G=U]])(S D@< ],]L>]/+':#QDG_'_"B3Y/B_#4F$XSBI1O9]U9_?L]?_.[H_X=.?\ !+/_ *1K?L"_^(>?L]?_ #NZ^_QG'.,^U+3;L[:^JU7W M@G=7U^:L_N/S_P#^'3G_ 2S_P"D:W[ O_B'G[/7_P [NC_ATY_P2S_Z1K?L M"_\ B'G[/7_SNZ_0"B@9^?\ _P .G/\ @EG_ -(UOV!?_$//V>O_ )W=-_X= M-?\ !+0^7N_X)M?L$L(E=(T;]C_]GIHU22?[2Z",_#O9M,Q9T!4B$22QP>5% M-*C_ *!44 ?G_P#\.G/^"6?_ $C6_8%_\0\_9Z_^=W1_PZ<_X)9_](UOV!?_ M !#S]GK_ .=W7Z 44 ?G_P#\.G/^"6?_ $C6_8%_\0\_9Z_^=W1_PZ<_X)9_ M](UOV!?_ !#S]GK_ .=W7Z 44 ?G_P#\.G/^"6?_ $C6_8%_\0\_9Z_^=W1_ MPZ<_X)9_](UOV!?_ !#S]GK_ .=W7Z 44 ?G_P#\.G/^"6?_ $C6_8%_\0\_ M9Z_^=W1_PZ<_X)9_](UOV!?_ !#S]GK_ .=W7Z 44 ?G_P#\.G/^"6?_ $C6 M_8%_\0\_9Z_^=W1_PZ<_X)9_](UOV!?_ !#S]GK_ .=W7WQYDF <+SMSP<#/ M7OZ].?K2^9)M)PN07]<';C;W[GK6,:].3:7-HL,[N+2MBTW2L[V>B_>?\^VT MG>X^5VYK:=NOW;GP-_PZ<_X)9_\ 2-;]@7_Q#S]GK_YW='_#IS_@EG_TC6_8 M%_\ $//V>O\ YW=??NY@,XYS^GY],]O3^?UJU-.'.KJ-KZIIV]'J( M^ ?^'3G_ 2S_P"D:W[ O_B'G[/7_P [NC_ATY_P2S_Z1K?L"_\ B'G[/7_S MNZ_0"BK _/\ _P"'3G_!+/\ Z1K?L"_^(>?L]?\ SNZ/^'3G_!+/_I&M^P+_ M .(>?L]?_.[K[^RQ&< '/0YZ?XTI+<8 /U_R/\_C1\TO5V0F[*]F_17?W(^ M/^'3G_!+/_I&M^P+_P"(>?L]?_.[H_X=.?\ !+/_ *1K?L"_^(>?L]?_ #NZ M^_06*@D#)/;.,?F3U_QQ2L2/3KQZ^_\ 2HC-3C"24DJEN52BXM73?O)N\=NH M^MM-[;Z7]3X!_P"'3G_!+/\ Z1K?L"_^(>?L]?\ SNZ/^'3G_!+/_I&M^P+_ M .(>?L]?_.[K] **L#\__P#ATY_P2S_Z1K?L"_\ B'G[/7_SNZ/^'3G_ 2S M_P"D:W[ O_B'G[/7_P [NOT HH _/_\ X=.?\$L_^D:W[ O_ (AY^SU_\[NC M_ATY_P $L_\ I&M^P+_XAY^SU_\ .[K] ** /X_?^#+%0?\ @EM\>7SCR?V] M_BD%4*BJV[]GS]E[F3"AI&4&1%=F+!)60DK' (?[ J_C_P#^#+#_ )19_'[_ M +/X^*'_ *SY^R]7]@% !7^>)_P<@_"[P)\:?^#D3_@E1\%OB?H*^*?AK\8_ M O[#_P ,OB-X>;4=6T67Q#X(^(?[>/QP\&^*=%.N^&[_ $;Q%IIO/#^HW=E; M:EI&K6&KZ<9%FL+^WEBB9/\ 0[K^ /\ X+X?\K2W_!%K_>_X)T?^O&OC%0!_ M0!_Q"Z?\$*O^C'&_\2;_ &Q/_H@Z/^(73_@A5_T8XW_B3?[8G_T0=?OY10!^ M ?\ Q"Z?\$*O^C'&_P#$F_VQ/_H@Z/\ B%T_X(5?]&.-_P")-_MB?_1!U^_E M% 'X!_\ $+I_P0J_Z,<;_P 2;_;$_P#H@Z/^(73_ ((5?]&.-_XDW^V)_P#1 M!U^_E% 'X!_\0NG_ 0J_P"C'&_\2;_;$_\ H@Z/^(73_@A5_P!&.-_XDW^V M)_\ 1!U^_E(:KV] M[.=Q8[?VE?VO(P5.< M1E8_CXB[$R I $F%7<[?^"&&PQG]B"4QEHG,?\ PTW^ MV&L?F0>=Y4@1/V@5563[1/L"A5C\U_+5=[99_P 0NG_!"K_HQQO_ !)O]L3_ M .B#K]_** /P#_XA=/\ @A5_T8XW_B3?[8G_ -$'1_Q"Z?\ !"K_ *,<;_Q) MO]L3_P"B#K]_** /P#;_ (->/^"%LI#2?L/M+A=@#?M+_M?X50Q95C4?'Y1# M&F6"10^7$%8@H<+M5?\ @UX_X(8J1C]B.4A8XHU'_#2_[7@9%C^TAPD@^/@F M5+A;ITN(5D$#JL8$2E23^_(4 Y&:<1GU'TZU,N=+W+7]; ?@++_P:\?\$+YY M#)+^P^7<@C/^#7O_@A@!N_X8BD M)+>83)^TO^U[,6D#.RNXF^/LBOAI92T3 V\QEI/0?7\*AR:A!Z^UGLULO.3^SWU]/,A-NI^!'_ !"Z?\$*O^C'&_\ $F_VQ/\ Z(.C_B%T_P""%7_1CC?^)-_MB?\ MT0=?OY15EGX!_P#$+I_P0J_Z,<;_ ,2;_;$_^B#H_P"(73_@A5_T8XW_ (DW M^V)_]$'7[^44 ?@'_P 0NG_!"K_HQQO_ !)O]L3_ .B#H_XA=/\ @A5_T8XW M_B3?[8G_ -$'7[^44 ?@'_Q"Z?\ !"K_ *,<;_Q)O]L3_P"B#H_XA=/^"%7_ M $8XW_B3?[8G_P!$'7[^44 ?@'_Q"Z?\$*O^C'&_\2;_ &Q/_H@Z/^(73_@A M5_T8XW_B3?[8G_T0=?OY10!^ ?\ Q"Z?\$*O^C'&_P#$F_VQ/_H@Z/\ B%T_ MX(5?]&.-_P")-_MB?_1!U^_E% '\0W_!>'_@A#_P2G_8H_X)1?M8?M+_ +,O M[+'_ K7XV_#>/X&1^"_&P^-W[1?B\Z(OC7]I/X._#OQ/Y?AOQY\7/%'A&[; M5O"/B+6])FDU#0+N2%=1FGMF@N4MY8?Z.[H\A#CX%_P"#HG_E!;^W1]/V8_\ MULGX"5]__P#!)S_E%G_P36_[,#_8X_\ 6?/A[0!^@E%%% '\ _\ P04D,O\ MP=)?\%HHBJI'&W_!1+:L>Y/]5_P49^$!^9@VY]\LC3,7+$-^ZC,=J3;G^_78 M?[[_ )C_ .)K^ ;_ (('_P#*TM_P6E_WO^"B_P#Z\:^#M?W^4 ,V'^^_YC_X MFC8?[[_F/_B:?10 S8?[[_F/_B:-A_OO^8_^)HW-MW8'7]/S]:-S;=V!U_3\ M_6E=7TU^[\?345US^SUYO33[_P]= V'^^_YC_XFC8?[[_F/_B:I_:9^ M?D3_ %.\?*_WNX/S?=S^/O1]IGX^1/\ 4ES\K?>QP/O?=S^/O5N$DKV^[_%R M_P#!_P /O;$^TCY_[S]4V?\ &_\ E?\ T\^'R+FP_P!]_P Q_P#$T;#_ 'W_ M #'_ ,33Z*DL9L/]]_S'_P 31L/]]_S'_P 33Z* &;#_ 'W_ #'_ ,31L/\ M??\ ,?\ Q-/HH 9L/]]_S'_Q-&P_WW_,?_$T$ME< 8.-W!R/IZ?C2Y;+<<#. M.#SZ?7\*3:7)O[^UEM_B_E^8DT^??W-[K?\ P_S?(38?[[_F/_B:-A_OO^8_ M^)I]%,8S8?[[_F/_ (FC8?[[_F/_ (FGT4F[=_DKB3OW^:L,V'^^_P"8_P#B M:-A_OO\ F/\ XFGT4QC-A_OO^8_^)HV'^^_YC_XFGT4 5#90$%6!9'8M)&P1 MH9"Q9I"T!0PJTLC-++)%''*\K,Q?#$&4P(%"QYAP'"F$A I=2I,'&.Q'/Y\FG"0Y8';A1U&?\ 'IG'X4*[CS6>S=OM:.WP[WN3 MS*U-_P#/WX.^U]>VG>X[8?[[_F/_ (FC8?[[_F/_ (FDWG!/'4#O_C].E(SO MM!4 ^NW4T[:7T>MM&GK_6P[KGY-I>>B^3V';#_ 'W_ #'_ ,31L/\ M??\ ,?\ Q-/HI#&;#_??\Q_\31L/]]_S'_Q-+ELC@8/7V/?OVIH:0ELJ!C[O M!Y_4Y]NE)M+DW]_;3;2_O?R_,2::F_Y-^[TO[O?Y"[#_ 'W_ #'_ ,31L/\ M??\ ,?\ Q-/HIC&;#_??\Q_\31L/]]_S'_Q-/HH 9L/]]_S'_P 31L/]]_S' M_P 33Z* &;#_ 'W_ #'_ ,31L/\ ??\ ,?\ Q-/HH 9L/]]_S'_Q-?R#_P#! MQE(UO_P5$_X-FK-&8P3_ +?E^[1M)(45X?V@OV"XTDCC#B&.18[B5(9$C$EH M'8V36S/(S_U]U_(#_P ''/\ RE._X-E/^S^M5_\ 6A/V!* /Z_J*** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^/_ /X,L/\ ME%G\?O\ L_CXH?\ K/G[+U?V 5_'_P#\&6'_ "BS^/W_ &?Q\4/_ %GS]EZO M[ * "BBB@ HHHH J^>5SO"K@ LS!EVM)DQQ*HW^=(HP)-C+DD;1EBJ_(/Q0_ M;Q_9M^$?CC5/AAKWBSQ?XY^)_AZ#2[OQ=\,/V>?@E\=?VJ/B5X#T_6X[RXT3 M5?B!X _9K^''Q6\9^!-'UZ"T>/0M6\9Z!X>L=8F0G2Y;Y7")Y?\ \%0_VGO$ M_P"Q]^P#^U9^T=X.EAB\:?"[X/>+=1\$S7%N;JWM?&FMQ6VB>$KRZC:1 ;2Q M\3ZKILER#+&PTZ.X59$FVSQ^%?\ !#_X2:+\*/\ @F=^RWKEA:27'CCX[_#/ MP]^T9\9O'&J7-/B1\4_C5HZ?$?Q7XJ\8>(9W-YK&J2W.MQ:3:S73//8: M5:PV<4OVF-KILZ56%:&/G!Z9=6RBAB5).,G/.Z.%/'7BSX]^!-.BM) M[B'1O&/P!TCPS/\ %_PSXWU9(HX_"WPXUOPC8?$3Q7#!X]^)'P[M['XF^&3X'\6R:[\+O$.I>#?$?]H^ M%'U#5->\+PKXBTNZBCLO%5AHWBBTMXRVL^%M)E9(SV1_9_\ 6G?'VY_:1T; M3[/3O'NI?""^^#7BZ[M--TRWO?&?AW3/$&F>(/!4.MZBEDFJ7K^";F/QA!H' MFZC]G@M/%>J1R6URYM)[/^<']@3XO_M-? +_ ((_?M$_M _ >W^#LUO^SM^T M5_P4#^,NM>$OBMX2\:^+[GXM^#_ WQN^+GC#Q3\/_"!\$^/? %G\+M>O=/TZ M,>$OB"8?C!I%I<*R2?#RZCE!7EH5HQ6/59\GU' +,9U*DU[%4'Q?4P_*JB48 MSJ?V8X?NTXS4E.FWS1YQ1I5JE3!4:47*KC\?3R^AJG%UY\'RK251VM3I_P!K MPER591:]G*%1JUT?UK45^1/Q3_X*R_!SP%\#_P!BCXEZMXX^#'P:S^T=\1O#WPP^'GPW\'3> ;#XA>-O&7CG4_$WB'PQ)KB>#M+U?1=$T? MPEHVI:5J7CGQSKN@>%7UGP=I^H:AXKT/YE_9F_X+ ^./C)^TQ\%?@ ?VA?@-\=OV:_B/XA\'_LR_$K2XMP>>&Q-/%8:CBJ2J*C7622INI3E"3 MCQ!45#+Y./OM+ZPXX?%7;EA:LH\\:M)_6#^A"BOYQ? O_!5#]MWXF_\ !)34 MO^"G6@^"_P!E;PW?_#.W^,GQ'\>?!W4='^)WBFR^)7PR^%7Q(\9Z)<^#_!GC MRQ^)GAE?A-XPF\%>%DN]+^(_B'P]\6]#\4:Y.;F?X8>"]/FAL$^\OVB_^"B4 MW@+P!^P\WPC\)Z5J_P 3/^"A?CWP#X"^"D_CS^U8?A_X"MO&/P\U#XI:UXY^ M(BZ1+8Z[K%OX2\':?)<:?X$T>YT/6_''B"?3_#T&N^%K6XU'Q'HEU\-5P\_9 MU>3F^O4\N]V<9+ZU6P*S&A&^G[NOA7S4*EG&I4_=Q7-J^B34,0\++^-%YDFO MLIY1C?[/S%.6R^JXG2HFKJG>HU%)Q7ZB*<*3UP?\/\:\W^)?Q-TCX6?#[Q1\ M1_$&C>--+?%&H,2$% MMX>TK4I2Y+B(1)*\?Y6_#K]N/]LO0_V_[#_@G;\5OAS^R_\ $_Q"WP6T_P#: M3U#]HCP5XK^+7[/6F7OPBO/'$7@'5M/\.?L]ZIX7_:L$WQ%\)ZV#/_8_B+]I MKPYH7B_0[VTU2VUOPSJ%KJ&@0^A^&?VH_P!H[]JG4OC+XQ_9-_X4EHWP%^!' MQ.\<_!F+4OBQX3^(/C7Q+^T]XR^&27FD_%2V^'6O^$/B5X,TCX->&/#GC:SO M_ GA[Q[KO@CX_)XMU'1]:U2R\(V.F6VGQ:QY6,G4^H3K4I1Y_8XG$1O44'*A M@L9/ 8BM&Z;=+Z]!X*G42<:F)3I1:DG8@E3JNE.RE'#X+$OJE',,&LPPM&Z_ MYBIX!/&RPUO:4\-^]D^70^E_V)OVU_A1^WI^SUX<_:8^"FG>--.^&WBWQ%X^ MT#PZWQ$T&+PEKNI1_#KQ[XC^'VL:X-)CU'5WL]*OM3\,W]]IT-Y/%J\&GR6Y MUO3-(N7DAC^PR<#(P?2OXAOV.?VP_P!I']A+_@W'^'G[6O[/5C\$+RY^''QP M^,!\<>!?CA\,_'OC&;Q/I_Q _;'\2?#;3QHOB#P#\7OA?=>!-:\#S:Q/)<7& MH6?C==7L[)(K3^R)$5YOWE_;9_;:_:E_9J_:1_X)R^'O!@^ 6L_ C]L7X^^% MO@#\0_#WBGX;?$:X^+/A;5-8\+>*?&.H>*_!?Q#TOXS:1X0DM%T[0X].L_#> MK?"G5;V._CGG?5[P7D-C9>SB\,HYA[##.+I2SM9!3YIV?U^KD%/B6@Y]'O"?A/0=2\ M5>)=?U606VFZ5XPN]0U75+JY:0+!;Z?:6DE]!?V2]4TZWUGP_\ERW%TD0^ WPT3PU=^/M,NV MMHTCGF\;^)_$_P -_AA>:+'?6=W+X4\<^(?%%G<+E(_*Q"K2H.CA[/%6T M4I\L-+[S::6MNG_ TP[I*LJM=M86\>9QBYS4;WDU!--NUTM=VNQ]%?"CXM^! M/C7\-? OQA^%_B*R\8?#7XE^$='\<^!_%M@L]OIFO>&/$>GVFJ:!J<*WL=O> MQ1:C97D,D:260F0LR30PRJ8CS/CKXV2>!OBM\&OA6WPI^,7B\_&2Y\=0Q?$7 MP3X.M]:^%_PP7P-X>'B*1_B]XGN-;T^?P>/$Z9T;P6;?2]:/B'6P;6);< LO MXK?\$*O&'B/X.>&_VIO^"8OC77+W6O&__!.K]H'7_ GA&[UV[N+ZZUK]F7XF M->^-?V=M4@OY;[48S;PZ#<7ND+H=I)"= CTW2=*N)%N&D:;Z7_:%_;R^/GP7 M_P""E_[!W[&UM\-_@U+\#OVPX_C9>#XG77C#QOK?Q5M;OX,_"^X^(.M:/%X) M_P"$-/B5:ZUI5EXHM7T?P7=2:=?:?Z%6$'F64X M;"1E6AGM.E6RY-.#J4JV1U^(H.LDY.A4I99AL3]9IOFE0Q6%Q&%G^\I3F<=) M5:.'S:&(:E7R3$RPN.E"7/!-2P25:C)**KX:V8X63Q$8QIVG-I6IVGL?%[_@ MMK_P3R^ GQVM_P!FCXO_ !0^*G@/XYWVKCP_HOPQUK]C?]MF;Q5XNOKG6+KP MUIEYX 32OV>=1TKXB^']9\2V-SI7AKQ1X$U/Q'X1\7HZZAX8\3:C:);-J/TU M^U-^WU^S/^Q9X&\)?$S]I+Q!\0O W@/QI=6.E:3XDT7X!?'WXE:;9ZUJT^E6 M?A_0?%#_ P^&OC"X\"ZQXIU'6K+3?#%CXWM/#\NLZM%?Z):"36;.[L+;Y=_ MX*Q?\$_+G]N/X$:/J?PDUB/X=_MB_LU^*],^.7[&_P 7UF-AJ?@?XN>&6AU6 MQT&XU4AHU\(^.CIJ^'_$.E7RR:##/#H6LO8^?H>G%?)?^"9W[9=E_P %8OAA MX=^*?C_1O#7A/5_V:_$FF^"/C/\ L^KK.D>(7@_:O\&;8M>\<^(-+TW4=:@D M^'OA;5H)?%GP$CU6WN4G\03#QCJ%Q!XL^&O@_6M"\_+ZT,50S&GROV^58Q+$ M\_NQQ&42KQPD)Y?4DN7%R>8*P\OTLUS]JO0;/P'\'?B5X3^$?[ M1OQ'\,?&KXB^ _ &CVWAOX$>/?#7B_P-8^.RXB^)7Q7\!_%2P^'?CCX>_#3P MWB.3Q?K?B3PYI^I:#%+&\FC7(?Y?J:OQ[_X*2_MV_'O]C/Q]^P[I'PZ^&7P> M\4_#+]J?]KGX-?LS>,O%_BWQEXWC\=^%=2^)/BAYM0U#PGX T/0-"T/5+*W\ M#:)XHFMO&6K?%&Q6+6KC25U'P9K>F)/'?7O&G[;W[56B_P#!3WX?_L.Z?\+? M@)8?"GXG?L_?%+XR>#OB;=>,_'_B7QS*O@+5O /AV>Y\4^'(?#?A'PUX8DTC M6?%&I^5X)T37O'EQXXLH-->X\>?#!FN6/5AKXN%"I13Y<1BL_P '3]I^[?UC MAK!_7LSC).[BOJ[3PDG?ZW-J%-4VTS;$KZI#VE9Q47@<)F*49*4GA<;FO]BT M9)>[>:S!>QJPO>DO?E*7P'Z[45^6/[#W[:'QF^+7[1?[;/['7[0]G\*=0^,' M[&?BOX+M/\2O@]X8\7_#[P-\3?AQ^T%X!N?B!X UQ?ACXW\>_%3Q%\/?$FCQ MV-]X5\2:+>?$[Q<+K5[<:I9_8;"1;6OT]CNY7ZJ@!BW A6^^6D 'WCQ\G3KG M//H[/DI5+>[7PL,;3;TYL/-)QE;=2:?P/71]B9-1K5J$M*E!VJ)[)\F$G[LM MI>[C!M*^%WP8^-_[ M07C7Q'XU3P_K_B>;1+;X??L^?#;XI>,8HK32?"WB&:]UAM(?2K:33##-<)-> M6<JQ*%MH#8-3FT?6+Z>81Z';ZO9K9:Q>VKW-T;-3>Z/;W)EU+BXM[**[ MB:9HY[Q9/YQ/A6FH?\%HO^"BK?M':XD^H_\ !-'_ ()S>.M;\-_LV:7JEE-/ MX7_:L_:VTB>YLO&/QI%G<-RN;3P=.T$5F=7?2;O3KF9+O6K/2 M,L#*-7%8C#U;QI86G.I6JRTIP@I0ITK5'>#>+Q-7#X+!WNL3C*].C"RC7K8: M:E2-/#4\5.ZA5<(TX6?MY2E&=6I'V+M+FPN&I8C&8M.2^KX3#5ZTG*U&GB?U MW\7?\%(_@1X4_:7_ &:OV49/#/QSF^*/[5-AJ>L?#*^U3X%_$7P)X!32-#^' M&M_$[6&U;QS\4-(\"Z#N37\_G_!2*YUJU_P""M_\ P0ZDT*STB]U8>(?V^ETZ MUU?4+C2]-5;_ /9ST)+J6ZN[?3M4E$^^0303V8M;N&>-3;RJCRI-]3_L]?MI M?&V]_;Q_:6_8._:+A^$6M>(?AC\(O ?[1WPK^*/PG\(^,_AKH^N_"'QUXHU_ MPA>Z!XX\&>,OB+\6KK3O&G@W6=$9'UVQ\766C>,+:9KG3_#^AQP3;$ZF'GE5 M+%TJE!5&N+9RC*M!35/A6K!5YO+#9?HDF_;XJ,L,K+2NXTUSRDC]8J*_%GPG^VS^VI^U'\!_$G[8/[&? MA_\ 9GOO@UI>I?%%_A-\&OBEH?C_ %KXE?M->$OA9XQ\1>#)O$EG\;/"OQ2\ M,>#/V>;SQWJ7A'6V\$>'K[X.?M R16^H>$9?&6I^%6UO58/#?BGQD_X+/_$# M5_V+OV,OVW?V1_A;\(O%7PJ_:6^,_P '/A%\0;;XO>-_&FG?$/X4^(_B)\7= M$^%VN>#]-\ >'?"=CH/B?6?#FJ1>.-$U[Q1KGQ6\%Z-X>U70K'6-$T3XDZ/= M/;GH5.3J1HI?O>?)X5J3NJF$GQ!)4,FCC8.*EAO[0QU\JH.:FEFRE@*TJ%:+ MD9SE"$*]24XJGAGFZJSNW",L@P5?,,YBI6%Q$*+KNE)G] M"-%?DQXT_;2_:(^!G_!0C]F#]F+XOZ5\&O%7P@_;6\'?&R]^%.H_#WPKX\\- M>/O@]X]^!OA/2?'&K>&O'WBK7_'OBSPO\5_#WB_P_>W:Z!XFTOP-\%+S3K^W M6*]\/7JAMU.X_;/_ &C_ -H;]J7]K+]F#]D%_@9\/-1_8HA^#MK\2?&/[0/P M\^(7Q1B^*/CKXP^#-<\<:5\/?!?A?P-\6_@G/\/M'TO2[?P_::Q\5];U[Q^E MMK&K7-GI7PQ\06-B^K'&,U*%.I:2A5ABYP;C;F6">$6(5KM\T/KN'LOM8+"7DHZ<[RG,5)-7@\)433YJ/M_L+]KC]KOX M;?L4_ [Q3^T+\8]%^)NK?#WP392ZEXA/PD^%?CKXKZWIEA96FHZEJ^I:OI7A M#1[]O#'AS0M/TVYN-9\:^,I_#7@[208O[:UG2?,C5O8?A9\2--^+7PU^'_Q4 M\/66HZ?H/Q-\$>&?B!H&GZ];P6?B"WT7Q9HUAXCTJSU'3K6]O;:'4SI5ZHN8 MXM1ECMKI=F)D5\?SK_%3]MWXN_M\?\$/O^"CGQM^(OP,^&/P%TP?L\?M-?#. MRT+PA\'()O!S:'XP^ M(]Q/::ZMQJ%[X=NK*0/[-=?ME_M#?L5?LN?\$Q?B?J.B_!K6_P!FWXFK^R1^ MS3\1/A]%X9\4K\6O"4GQ@\'Z/X3\)_%'1/BM8>.;/P EMH7B.71;;6OAI=?! MN\M+BPDN8[;XMV\DL-U'>'HU/K.*PM51]O6Q&18:C34XR<\1Q)'_ (2,+&SM M]8Q/-3;I-\U-3@IN3=ESXNK2IRP<8/E='"\0XVJW=)T.%X\V<6>O-5P\5-4Z M,5S5W%J#@]#^A*BOS?\ BO\ M9_%#Q'^U5=_L/\ [-%U\+-#^,'AOX)Z?\>? MB=\4?BKX4\3?$WP3\-/"WB3Q>W@WP%H<7PJ\&_$CX2^)/'FO^-=4T;QBT[P? M$_P=;>#M-T6TU;48]6BU2UM'\>^!?[>_[17BKXL_M4?L2_$_XSE5N^18.>/IMI+ZSA:3FJ\\)[]L0\ M.Z&,]O",H2I?V=F-V_J5:^TWR2C"2?,W255*S^J?6/K'U=XUW2PJQ'L:/L?: M*;+XE?#+X5?$CQGHESX/\&>/+'XF>&5^$WC";P5X62[T MOXC^(?#WQ;T/Q1KDYN9_AAX+T^:&P3[R_:+_ ."B4W@+P!^P\WPC\)Z5J_Q, M_P""A?CWP#X"^"D_CS^U8?A_X"MO&/P\U#XI:UXY^(BZ1+8Z[K%OX2\':?)< M:?X$T>YT/6_''B"?3_#T&N^%K6XU'Q'HG=7PU7#S]G5Y.;Z]3R[W9QDOK5; MK,:$;Z?NZ^%?-0J6<:E3]W%\/:!XOT+4+?5+?6?#&H6][H$'['[C@GC@+^O6L6FHTI_9K*]/S6NZ^SL][D M>TCSU87]ZC\>FBVV?VM_(?1112+"BBB@ K_/_P#^=ZO_ #_TAZK_ $ *_P _ M_P#YWJ_\_P#2'J@#_0 HHHH _G\_X.B?^4%O[='T_9C_ /6R?@)7W_\ \$G/ M^46?_!-;_LP/]CC_ -9\^'M? '_!T3_R@M_;H^G[,?\ ZV3\!*^__P#@DY_R MBS_X)K?]F!_L!_$_Q!\;:L #<6FB>%=/GU.^M[:T>2,W6I75M M&D6DVDQ MB-2!\QRW7CG''IQZ]Z_+G]LGP=X:_;(^* MWPT_8*\4Z/9^)/@[-X'HTL/_O.)_A<\N2&BYGSU&I* MGIU<9:Z6+H2HPK5JV)YOJF&LZ_+!SGRJSE[.G&495'9V7+*.KWT/MG]GSX[> M"?VE?@C\*_V@/AI?O?\ P]^+_@7PU\1/"5Y=VZ6M]_8/BG3+/5[6UU2U6]F& MG:OH\=Q/H^N6DDKFVUBPO(U^6)8GXC]L;X_?$;]FW]G'XL?&GX3?L]>._P!J MGX@_#WPPVO\ AKX!?#6XEMO&_P 1[S[>EB-*T>:VT7Q+?H4CD?4S'H'AGQEX MEO+*SNXM%\(:M>!(J_";_@W9\?>)?@?9_MD_\$E?BI>7%WXZ_P"">WQPUNU^ M'EUJJQ>=XJ_9\^+NJZGXB^'VK::7N)9KG[/>_P!HWFK1I;+I-I9^-/"EE:WJ MM'! MOA1IM_J^E>&-,\2>-+#5=0N/'7B1=2\2^*+728O#WPY\*ZMJ=U8-J2>*M?\ M!:BUU=>O-_JM*KA,30J57@<;A,+F&%J^S:E+!XW#4\50C7CSOV.)I*5;"XNA M4FY8;&X+'8:I+GPTW*,MPF+GC,7EM14ZF*P>88K+JL(58R7UC"7O*E.T54H8 MB+H5,'6A'EQ4,;@W3BOK$%']-/ 'BG6O%7@CP9XHU_PGJ7@77/$WA7PSX@UO MP5K#]4\0:)#?WGA'5+R 1VT^L:!JDC:/J%Q#$EN]S$PBCPRM7>G[B_ M7_&OQJ_:Z_:)_P""CVB?L#>!OVNOV(?"_P"S#XS^(MG\"= ^-'Q(^"7Q7^&7 MQ<\7/XY@UWPIX6\7ZU:_!S7_ +\;/ -WHVIZ'%>Z[)I?ACQ)I/BW4O&%Q%I M]EI^LZ/=P,NI>=_!C]OK]K']LO\ 8J_8K^+?[&_Q%_8Z\2?'KX\26^I_&7_A M-/@K\8M1^%GP_P##FD/>6WQ4\WP7X<_:3T[X@> ];^&.O1P>!+6SUKQ;X\/Q M%\=W>AZ?HT.A^'O$%QXG\-[XK#U(5,QHRY56RS.*&2XRC=^TIU:\LU@LPBN6 MU3):+R?,?K.;1G]7PZH+VE)RJT(UN# XFC4R[)<=&I_LN>8&OF& KM24.2AE M^69G]4Q+2:PV8UL+F^7/"X&IS5<35Q*I4JC=+$2P_P"DW[:?[1'Q2_9B_9U\ M=?&CX/\ [,OQ&_:Y\?>$[GPQ'I7P'^%TDUEXV\50:_XCT/1K^;2Y[?1/%5U< MKX=TW5+[7]2_L?P_K;_8-)O/W47DR.OTMX>UB^U?0]*U;4])N/#]]J&E66IW MNA7A6>]T5[B%99K"\F@/ESW4)\R,^5'& \;@JQ&#^-W_ 6&_P""C_[0?_!, MO]DR#XZ>#?V7;+]HZ;2X=,T?XE?$:?QAX>^&?PF^%^M:]J?AWP;H6M:U\/\ M4_%GB;XI>-[+QSXE\11V&@>$O" UNWTBS%T/&?Q,\-/##>7G&_\ !6[_ (*K M_M&_\$[_ -EGX:_'CX8_LFVOQ&?AA\&_$_CJ>Q MTK1(=;^'ECXKN?BSX[N;G7+M8_['T2XTKP_%9O MQ\2H[KS 6BOYX_V[/^"F7_!17]B/Q-\&/VB?&G[- MG[,UE_P3Q\8_%GX9_"CX@P77CKXC:_\ MB>%+7XE:M8Z/IWQ+UW1M*L]+^$? M@[2[>]O!;OX!\/ZE\:?$"S2ZNZIXE^)_C"S\ ?"3X9> /"NO\ C7XI?%?QM<6[WDWAKP!X(\/6FIZE MK%U9Z7::CKFJZK=OI?AKPYI-N+_Q5KFAZ4LFKU\T^*O^"GW@7X.VO@FZ_:I_ M9P_:K_9+'Q2\>>$/A?\ "Q?BEX%^&WQ)TWQOX_\ '.J:9H?AGPQ+XQ_94^,/ M[17@/X<:CJ^M:M%IEG'\:?$_PR1KFPOLRD26P;\X/^"XG[.?[:EO\7OV'O\ M@IM^PUX)T[XV_$W]@'7?BOJ/BG]G6<+>>(/B5\-OB1X>L(_%=SX2M(I[;4_% M?B32]!TG6;;2O FD7NJ>*;F37]-U?X?^';_7=,O-$U?O?V-?^"Q/[ __ 5Y M\)W?[.GB2_;X#_M,7&M:<=:_9B^..DIIOC'2_B-\.=>M_$T.I?#[5[\Z3H/C M[6?"&O:%:ZK'8:-?V/Q!\.3>'TNO%'A728I%CN'E\?;QO-I5+.H\+*2CC(X= M6_VEX9OVOU=J]I:U/=E?#QM+A%O!QQ+_ .866)OR1Q&J M?*XNEK_O*=TOIW]OG_@KS\/_ -@WXM?LX?!37_V??V@?B/XG_:5^+7PU^$OA MCQ[HW@?6= ^ /AS6_B)XVG\(0:?KOQMU#2[_ ,,ZGXW@AM+S7[3X:>#;?Q1X MN_LRW:7Q1;>#[:2"\E_7>-]V?\/\^U?S&_\ !R==_P!G^$O^"4UW%%>W\=E_ MP5J_97(K2J!]J%P1'CVK]H#_@I#_P M4+_9#_; _93L_P!HC]GK]EW2/V%OVP_CAX>_9F\"7O@3XB?$+Q;^TQ\,OB;X MU$K^$/$/Q@U6?3])^$L6E7J6=\UYX1^'ND^-[")+6\D3XM 6MBFM+!4ZM;#4 M$X.5>KCZN5Q2UYL?3IX*I]63V=6V/PZC%)N4I22BW%78J[O9(_ '@KX]^!_B/!=S:+ M86GPV^*?C?QM=?"[Q5I>ISZ'X4NH]0^,OCO0-1U=]4U*XUCPWI\$< SI5J=9 M7IR;]S.*EG&:DH9#*,,RDXN-U[-R_<1=IXU*4L%#$1BVW)\D/:3]V/\ L7Q- M)OZ^[8>ROWM[35>RNN:]]/V,HK^<7]E;_@K3_P % _VS/C)_P4"_9\^'7[$7 MP@^#/QE_93\0?#CP;X4\,?'CXV75_P"#O">J>)8OB->ZSKGQT^)WP9T_XB6^ MLWNI:=H'A2X\+?#WX0>$-6L+:27Q FH_%S4(FM)K'ZL_X)1_\%"/C[^UW+^U M/\$_VM_AM\+_ (:?M6?L9?&7_A4WQ=L/@O>>(;[X4^*;?5])CUOPMXR\#OXJ MUK7-;T_2[^SCOUFLM5UO5+MQ##3NK.._;:_P"Q MU%?B%\(OVZ/VT?VY?AY\9_VA?V(]._9@\)_!CX4_%+XI?#7X8>&?CMX0^)7Q M"\6?M72?"&YMM*\0:UI7Q$^'_P 7?AQH'[.6AZYXLM=>\(:#K-_\._VBHXX; M:U\9W5C)I^[0YX/V)/\ @H;^V9_P4N_8@\2_M+_ 'X3?LI_LZ^,M3.N:1\)= M-^)'Q,^+O[35C+X_\">*M;\/>-O GQI\%>'_ (;_ +*$GP[,YT>T;0/%'A'X ML?$RUBL?$-GX@N]'O;73YM+O8NN1S7OQ6#P6/?)[S6'QZ3P[:T?M-4JE-7E2 M>DF];=TZ?PEXCTV?P];^$K'0[#5Y[ M2ZN-OA?\ 8Y_:3_:V^(7PV^&'[6ESH&M>-]/_ &3/@E^R M5\"_B?\ "[Q]\9?#7A+QUK'@31/B)KDOC+]H#]H6YNO#OCF2UMO&T6F^#O#= MQJ'AKX96">+_;*BOP>_:-_;Y_;@_81\6_L;^+/VE[+]F'XN_!7 M]KO]H?P!^S?JOA3X0_"WXL?!GXK? /Q=\7C)/X,U.3Q1XW^.WQFTOXWZ7X8A MM=4L_&4*?"[X(7]])I(OM-M],NM5MO#MM'^W/_P5F_:._9._;A_8Y_96T']C M#4/$'PT_:@^):>"=/^/&J^.O!UZWC>]TO2=$U?Q'X,^$WP\TSQAIFJZ5KL4V MMVOANV\;_&K5OAUX7MM4$()=:-J+=2A33CS8C'RRND^9*+Q\<']? MEAY2VC-8=J6NG,U#=\RAU(1HU:\FHTZ.6O-YN349?V>L9+ O$PC*47.*Q$)) MJ%WR1=3X4TOWEHK^?^Z_X*1_M_? '_@I!^S?^S!^V?\ O\ 94\/_L^?MOZE M\2?#7[.WB;]G[Q]\4/'?Q+^&?B_X:^%[;Q%<^&_CCK7C#1/"?AGQ'J.N+>Z8 M@/@7P5HFDZ#'J\#2:WK0L+N23]]A.VW+; >!C!ZX?TBZ< M:L;U(2Q.+PB=-.?[_ RJQQ,'R](2I6C)-QG[2@XMJM"3JOU>3DVESMT*ZJ0M>G*A64FW3D?BI^TO_ ,%KO!G[*7[3GPK_ &2/ MB/\ L,_MV:S\5OCYXA\0:!^S]-X"T/\ 9+\2^%_C8OA_68]$;7/!NKO^U]IW M]BZ5?//;:L+#XCP^!?%VB:-=6USXK\+>'UE:2/\ 0#XL_M)>.?A5\$M)^,0_ M9._:)^(>JRZ(/$'BOX)_#F\_9MU#XP?#_38M#O\ 7]<;Q%#XG_:/\)_#KQ)> M^$DL$T'6=-^$WQ!^)M[K&O:IIB>!X_%>GO<7<'\^W_!:+QYHGPP_X+#?\$'_ M !SKUOXQU3P]X;\:_M1:E?6G@/X>^.?BQXMOX6\-_#BV*Z!\.?AAX8\8>.O& MEZ8[P>7!H/A?7+O386DO-,CT\&YGK]B?%_\ P46_9\N_"GB:TM?A_P#M[1S3 MZ'K)MWO?^"5W_!3VPM5N/L,[QRW%Y>_L=(D,:2R*YDEFCAA6W0#RXPZR\=>4 MZ?#[Q=*"EB4L_P"5MVBWEF,82SV&%::H26 O&[_Y MF$N6CUZ6DYO3DLN:]].<_P""DV?QK^-?A_P" ?A?P/K'BKP^^FPZCX8T/2/"'[1'CSXD:I?K-J:J-5M_ MG_"'0MI^HPW'BR.ZB$ _54L 1WZ?A7\RG_!J=<6\/\ P1O^&%Q,T%O'8?%_ M]H.XNIIP$2)4^(^OB61IW;S(EAM'4(Z21E-\N]V5W%?>WP9_:Z_:D_;T\$>* M_C?^Q)KW[-WPY^ WA_XG>/OA]\-O%7QW^%OQ,^,][^TM8?#K66\+ZQX\\,7' MPV^./P9M/@]X U?Q;HWB?1/"?B*\L?C1?:WI%G;>,)?#FG6I&BW7K8U4J>-G MA:49-0PT<55:BW'#T*BI.C]::TH5:[J5%0ISBG5>$QL8-O"U+^=AG4]E*M5: M4%CL9EZ:ES+ZS@)8Z.(BNKC?+L4ZTD0RXD7\?_ -F']O\ ^(/[>G[//[47A7P(OA_]DG]N M?]EOQ;XV^"GQQ\#>,O#E]\=/#OPK^(^D7NH/#XG\*Z5%XJ^"=U\2/!WB[1]" MU6]^'/B2XU;PW9?:$NGO;?6K31[N'5/BK_@WF^+O[36N_P#!-KP;^U+^TO\ MM%_"?Q9\(];O?VM/BKX_;6O@SXUM?C=%XA3X]_$?6?''C_QA\=9OVA+[P/KG MAN6?2?$&IVFA:+^SEX7GL- E\/V5KJ873+LZGDHWI8BOS05'#4Z=>M4<#]._P"=? 7_ 4/_P""@O@;_@G1^SQX@_:*^(OP MG^./Q5\.:):W(NCU^6/QC_X+B>&O^%"WW[4/P"_;5_X)0PV>B> O$'Q/M/V+ M/BU\:-#U+]I7XA>'-)TB\\0Z3X2/Q&\(?M%Z+:_"7XU>(M&BM[5OA=ZME2VDF\/\ B+2]8T-+B&"UMM4M;**[ M@C;3KR"$\&9NK2P.8U.2I3GEE>G1QD9Q<)PE.I"%J<7K43YI)3@N6\6KJ243 MIP,*=;'Y;1DXU(9FTL/&#;>ZO[;2+HV4D_>YK[=VOVB_9:^.W_#2?[.7P+_: M!C\.Q^$X_C;\)? 'Q7MO"L>MQ>(SX?MO'OA?3/$UIH9U]+'2+76[BTAOVMWO MX;&PA=XPXMUC97;Z$# LV1TSQZG^@S]:_/O_ ()>LQ_X)P?L&,764?"(&=@,'] 54%G )R>",C'('Z_7VKVL\P MZP'$&>8*G%0P]#,,=@,%'F-?&*O[_*_@#_X+X?\ *TM_P1:_WO\ @G1_ MZ\:^,5 ']_E%%% !1110 4444 >)_''X^> ?V=_A[KOQ3^)A\;_\(9X;C:;6 MKCX>_"3XK_&77K"TA :[U:3P9\&O!WQ!\:2Z!81L)M9\0P^'7T+PW KS:_J= MC&I8?$/[*'_!9+]@+]NKQ>_@7]D?XJ_$+XU:Y:R11:WJ'A_]EC]KBQ\$>#I; MBWU6[L4^(/Q-U[X%Z1\-OA]'JRZ%K%II-QXP\6Z-'J=_9?9])&J3S16S?IV\ M22$ \[BC;]QR6C),9/.&*': 6!+;5WEBN:_D>_:KTZ[_ ."%?_!3W2?V[?!& M@V^C?\$X_P#@H3XGT+X'_#UJ;71_@1\>[F8CPC\<9+.%Q!I&E^*=0U# M6?$VNQV$7]D:AY/Q"T^73(-3O?"#/GAW?,:-"JTH8I25"3:]FYQBY*,YMQC3 MO9*/,[-M)M)W6>)E? 8J="$YU\*KU(13=227+?V<%>51ZWLK72=M59_T'_MC M_P#!1#]EC]@3PUHOC/\ :J\8^-_AUX(\074UC9>.]+^!/Q[^)W@?3KZ*[@L( MM.\3^,OA+\-/'GACPCJFHWDPBT33?%VK>'[_ %T^8^D6M[::?J][I_NOP0^/ MG@#]H;X>Z-\4_AHOCH>#/$*)-HUS\1_A)\5_@GK]]:3DM:ZJG@KXT>"_ 'C: M+0;^%3/HOB&7PXN@^)(72;0-4OX_F/Q=XFBT[]M7]HJS\!W&E:;XE_9=_9/\ M4^'O&/C&>_ACOO#OQJ_:@M].TCQ!X!\,0-?6.HZ9XG\(_L\>']8TWQ[XIO#? M/:W_ ,9M4^&NDQ74%S\/?%]E7G?_ 5._P""BWQL_P"";7@7P=\:/#W[+O@3 MX^_!37/'O@#X;>+=>;]HGQ'\-_B%X)\7_$?Q->Z#IU^G@"']GOXF:%XB\'03 M)H\$]]IOQ"L_%4FK:]%I\7@Z#3X)M<>L/"3H9=0<91QV93P-'#4:GN2^LYEC M*6 P>%K1FH^RQ-3$XC#1=*7,Z<<30E)OVL4B=:G".85&_P!WEN$QF.Q4XV<% MAL!@JV88F=*7-:M*&&PV)E&G!J_Q*^ 'PL\6_ OX\_$'4_C]\2?AQ\.M-^(>A_#OQ'HGP'\)7?Q \37.@+%K M/QDU'3KKP_KOC:PL=/U?Q'_PJSP/:>*/&8TK2I)-6M]%2^L9Y5AJD<9.-/#W MJ3EF&$RJ,5:[S#&X7!XO#X5^\^6K*AC\+*496<)5'%I\DF#JP2DW>T_V M"OBQ\$OV9/VIOB!:?"#X%_M>>./B9\-F/B?XIZJKGP_H7B3X#Z3>7GC#X;:- MXC*Q)I=[X_\ $N@>,R;DEOAVRV-X5Z[]HG_@LY\,_P!GS]NOX$_L(:E^S[^T M?KGC#XU77B'[)\4I?A/XT\/?"FZL_"_@.]\;:S8_"75[_0KC5_V@O%MLX\/Z M!)I'PLT75?#%OJWBK3M.G\$?%OC7]E M7X@^,?BW\)/B3;?&O1_A]:MJ?C2T\1:+\,=:UW2/A;XDL=(@NM2T_P ,'QMX MYU(VP@?Q.?"9N+1+KZ+^)G[=WQ!F_:N\5?L6?LO_ (\/?%_XV?#WX/>%OCE M\0M9^,?Q5\0?L_\ P;\->#?&7BC7/"NA:3!XY\-?!SX^^+-=\975QH-WJD6F M:1\,[G19=,7,OB*UN/,CBERY88.;3MC_ *Q]62Y7*7U-\N8.7RJZW@HYJF\N:FM)+&V:H.*M)IJ3@T[?I717 MY/\ [*O_ 5.T']HCX8_M4>)/$_P'^*GP_\ BY^Q/\0]=^%/[17P(\%Z9+\> M_%R>-] 6"5O^%*1?#RV3Q7\8/"WB*W:YE\'ZK+X!\#>)]<^RW'_%#VPA!F^6 MO@+_ ,%O_B5^V+^SY\8/C!^QG_P3:_:'^,_C[X;?&[QI\)[#X(>,O'/PX^!N MO1:/X(\/^%]0U3Q1\4_&_CNZ?P-\.O%3^(M=U/PI'\'O"NJ?%GX@"X\.7.IO M:"ROK<1)S2A4J13J0I8+!9C4E32FHX+,,5#!X7$M*2?LIUJD.::7+3@^>%])?&JM\-/@U\8_CAKME JB6XU*3P=\%/ 7Q!\ M:'0K*W#SW_B/_A'%\/Z;&JOJ^IZ8LBFOF+_@G!^W_P"#O^"CG[,VA?M#>#?! MVN?#FZ;Q5XL^'OCOX;>*&-UXB^'?Q%\"ZI=Z;XF\+:W=+!IR32PK!;7EO48-2F M%:$_;488G XBA&5DIU8*FDI227Y6_##_ M (+;?\$^/C/X%O\ XH_![QC^T=\5_A?I%YJ&FZO\1/AI_P $]?\ @H;X[\$: M=J.DK =1TO4?%OA;]E_5] TV_P!)BNK-K^"ZO_-59ED\J%67/W9\!?VE_@3^ MT[X$M/BC^SO\6/AW\:/AY>7MUID'C#X=^)M+\1Z''JUE=JESH5_?Z1>ZBNDZ MWIT4]L;W2]5CL;W-U:2_9X(KQ%3^=+_@U\\5>&? ?_!,;X\>)/&WBCPIX0\& M>'_VV?VC[K7M;\5Z]8Z7X7T+3H_^%?6]W/KNNZO/8Z%9V$SM(AOKK4+C3[D; M_LMXC&:./F_^"%7A[5O&W_!1+_@KU^US\"-%U70/V!OC7\5]-B^$6J6FDZEI MOPY^,WQ)T#5;U?B!\3?AE=W-HEGK.@G68O&DMWJ>AR7.E:DWC'2TMTAFTVQA MTWUJ5*G6Q?L*:<:<<@CFGM9J"H_VC5PN08NE@Y5'RJ&+Q/\ :N98?"THWG5Q M67X^G%2IX>6+EA4YJ7USVCC#ZCQ!6RN7,[^URW#YAQ7@*^(H\J;GAJ*X=PN. MJXAJG3IX+$X"K.,:F-HX6/\ 6K17X\ZW_P %*/CGX#_X*=_!_P#X)[_$W]EC MX?Z%X.^/O@GXN?$CX6_M$>$?VC==\8-=^%/A79>(KVXL/%7PHUK]GSP'>>'? M&B>'?C!\)OB#\9?A;\=_"OQVUKQ=VU_4B)E3DA5C4AEM2+]W-L1B\+@FW%.=; MO'+$QJ)R_=*']G8MISNYJFG&-IQOK4KTZ4\UIRYN;)L'@\?CN5*2CAL?]46' ME1:DE7FWC<.JE.FE.DY24_X<[?K;17X8^%/^"WWA;Q_^VY\9/V&O G['7[66 MM?$KX/\ PAUKXBQ-XF^'^&W@_XK3^$GL/!?B6/ M6=5N[/XQ?&#Q%\)O BKX:N[M;F;P_J%EK]>C_L$_\%4?%O[57[1'[0?[('[1 M'[)_BK]C#]J3]GW2O#_C34_A9XD^)O@KXQ:?XM^%OC">"U\-^._#?CKP&EGH MM\\=S-:Q>)=*TBVU[0]$;6=*2/QKJ$ZW4"ZP3G'!R2LL=@JF88;F<4YX6C*I M&M)KG;A*A*C6C6IR]ZDZ-93*L[ M2C76(H>QJ*7+4=>BHW]I%O\ 8>BOS[U_]L3XE^//&7Q;^'7['7P<\!_'?Q-\ M _$UGX*^+GB?XL?&+Q!^S[\)])\>W.C2:]J/PP\*^+/#OP9^/OBWQ?\ $;PM MI-_X1U/Q+:Q_#K2_ MC9^)TT]_B!%XQTV]\'IXG\)O\ @KK\*?'?[$_[2/[9 MOCOX3?�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�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end GRAPHIC 10 image_001.jpg begin 644 image_001.jpg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end GRAPHIC 11 image_002.jpg begin 644 image_002.jpg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end GRAPHIC 12 forms-1_003.jpg begin 644 forms-1_003.jpg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end EX-101.SCH 13 aixn-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ADVANCES TO SUPPLIERS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INTANGIBLE ASSET, NET link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - TAXES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - ACCRUED LIABILITIES AND OTHER PAYABLES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - LOAN FROM THIRD PARTIES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - LEASE link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STATUTORY RESERVES link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - OPERATING CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - ACQUISITION OF SUBSIDIARIES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUBSEQUENT EVENT link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INTANGIBLE ASSET, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - TAXES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - ACCRUED LIABILITIES AND OTHER PAYABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - LEASE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - ACQUISITION OF SUBSIDIARIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SCHEDULE OF SEGMENTS INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - ADVANCES TO SUPPLIERS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF INTANGIBLE ASSET (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - INTANGIBLE ASSET, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF TAX PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - LOAN FROM THIRD PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF OPERATING LEASE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF OTHER INFORMATION RELATED LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF MATURITIES OF LEASE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - LEASE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - STATUTORY RESERVES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - OPERATING CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF BUSINESS ACQUISITION PRO FORMA (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - ACQUISITION OF SUBSIDIARIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 14 aixn-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 15 aixn-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 16 aixn-20230930_lab.xml XBRL LABEL FILE Related Party, Type [Axis] Related Party [Member] Nonrelated Party [Member] Product and Service [Axis] Product [Member] Advertising [Member] Room Revenue [Member] Food And Beverage Revenues [Member] Other [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Statutory Reserves [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Title of Individual [Axis] Quanzhong Lin [Member] Investment, Name [Axis] China Concentric Capital Group [Member] Equity Transfer Agreement [Member] Business Acquisition [Axis] Aixin Shangyan Hotel Management [Member] AiXintang Pharmacises [Member] Yunnan Shengshengyuan Technology Co Ltd [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Transfer Agreement [Member] Legal Entity [Axis] Chengdu Aixintang Pharmacy Co Ltd [Member] Pharmacies Purchase Agreement [Member] Award Date [Axis] Prior to May 1, 2018 [Member] Hotel [Member] Health Care [Member] Manufacture and Sale [Member] Since April One Two Thousand Nineteen [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] No Customer [Member] Cost of Sales [Member] Supplier Concentration Risk [Member] Supplier One [Member] Supplier Two [Member] Long-Lived Tangible Asset [Axis] Office Furniture [Member] Electronic Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Machinery [Member] Leasehold Improvements [Member] Vehicles [Member] Customer A [Member] Customer B [Member] Supplier C [Member] Supplier D [Member] Supplier E [Member] Advertising and Product [Member] Pharmacies [Member] Manufactue And Sale [Member] Product S [Member] Vehicle [Member] Property, Plant and Equipment, Other Types [Member] Scenario [Axis] Value-added [Member] Income [Member] City Construction [Member] Education [Member] Related Party Transaction [Axis] Ai Xin Zhonghong Biological Technology Co Ltd [Member] Runcansheng [Member] Renewed [Member] Accounts Receivable [Member] Office Leases [Member] Xiaoyan Zhou [Member] Yunnan Runcangsheng [Member] Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd. [Member] Sichuan Aixin Investment Co., Ltd [Member] Chengdu Fuxiang Tang Pharmacy Co Ltd [Member] Chengdu Wenjiang District Heneng Hupu Pharmacy Co Ltd [Member] Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd. [Member] Yirong Shen [Member] Branch Manager [Member] Chengdu Aixin E-Commerce Company Ltd. [Member] Chengdu Aixin International travel service Co, Ltd [Member] Aixin Life Beauty [Member] Huiliang Jiao [Member] Xiaoyan [Member] Chengdu Wen Jiang Aixin Huiwan Pharmacy Co Ltd [Member] Chengdu Heshengyuan Pharmacy Co Ltd [Member] Chengdu Zhiweibing Pharmacy Co Ltd [Member] Chengdu Tongtai Tang Pharmacy Co Ltd [Member] Wuhou District Xiaofei Pharmacy Co Ltd [Member] Aixin Hui Pharmacy Co Ltd [Member] Sichuan Xintang Xinfu Pharmacy Chain Co Ltd [Member] Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd [Member] Chengdu Cigu Foshou Pharmacy [Member] Mianyang Aixin Cunshan Pharmacy [Member] Sichuan Haosen Haichuan Business Management Co Ltd [Member] Sichuan Yunxi Pharmacy Co Ltd [Member] Chengdu Yi Yan Tang Pharmacy Co Ltd [Member] Income Tax Authority [Axis] Foreign Tax Authority [Member] Aixin Shangyan Hotel and Aixintang Pharmacies [Member] Employees and Contractors [Member] Plan Name [Axis] 2019 Equity Incentive Plan [Member] Two Thousand And Nineteen Equity Incentive Plan [Member] Guarantor Obligations, Nature [Axis] Indemnification Agreement [Member] Yunnan Shengshengyuan [Member] Yun Chen [Member] Runcangsheng Aixin Shangyan Hotel and Aixintang Pharmacies [Member] Luquan Shengcaofeng Biotechnology Co Ltd [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Assets Current assets Cash and cash equivalents Restricted cash Accounts receivable, including related parties, net Other receivables and prepaid expenses, including related party Advances to suppliers Inventory, net Due from related parties Total current assets Property and equipment, net Intangible asset, net Deferred tax asset Security deposit Operating lease right-of-use assets Goodwill, net Total assets Liabilities and stockholders’ equity Current liabilities Accounts payable Accounts payable-related party Unearned revenue Taxes payable Accrued liabilities and other payables Government grant Loan from third parties Operating lease liabilities Due to related parties Total current liabilities Operating lease liabilities - non-current Total liabilities Stockholders’ equity (deficit) Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding Common stock, par value $0.00001 per share, 500,000,000 shares authorized; 24,999,842 shares issued and outstanding as of September 30, 2023 and December 31, 2022 and 2021 Additional paid in capital Statutory reserve Accumulated deficit Accumulated other comprehensive income Total stockholders’ deficit Total liabilities and stockholders’ deficit Statement of Financial Position [Abstract] Undesignated preferred stock, par value Undesignated preferred stock, shares authorized Undesignated preferred stock, shares outstanding Undesignated preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Sales revenue: Total revenue, net Operating costs and expenses Cost of goods sold Hotel operating costs Selling General and administrative (Reversal of) provision for bad debts Stock-based compensation Total operating costs and expenses Loss from operations Non-operating income (expenses) Interest income Impairment loss Other income Government grant income Other expenses Total non-operating income (loss), net Loss before income tax Income tax expense (benefit) Net loss Other comprehensive items Foreign currency translation gain (loss) Comprehensive loss Earnings Per Share, Basic Earnings Per Share, Diluted Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Beginning balance, value Beginning balance, shares Stock-based compensation Acquisition of subsidiaries Debt forgiven by major shareholder Net loss Foreign currency translation Disposal of subsidiary Shareholder contribution Ending balance, value Ending balance, shares CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments required to reconcile net loss to net cash used in operating activities: Depreciation and amortization (Reversal of) provision for bad debts Provision for inventory reserve Operating lease expense Stock based compensation Deferred tax Impairment loss Government grant income Changes in assets and liabilities: Accounts receivable Accounts receivable - related parties Other receivables and prepaid expenses Prepaid expense - related party Advances to suppliers Inventory Accounts payable Accounts payable - related party Unearned revenue Taxes payable Payment of lease liability Accrued liabilities and other payables Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Cash acquired at acquisition of subsidiaries Cash disposed at disposal of subsidiary Purchase of property and equipment Payment for acquisition of subsidiaries Purchase of intangible asset Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Change in advance from related parties Repayment of loan from third parties Capital contribution Proceeds from government grant Net cash provided by (used in) financing activities EFFECT OF EXCHANGE RATE CHANGE ON CASH NET DECREASE IN CASH & RESTRICTED CASH CASH & RESTRICTED CASH, BEGINNING OF PERIOD CASH & RESTRICTED CASH, END OF PERIOD Supplemental Cash flow data: Income tax paid Interest paid Non-cash investing and financing activities: Capital contribution from forgiveness of related party loan Accrual of unpaid investment in subsidiary Investment in subsidiary paid by shareholder on behalf of the Company Accounting Policies [Abstract] ORGANIZATION AND DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Other Receivables And Prepaid Expenses OTHER RECEIVABLES AND PREPAID EXPENSES Advances To Suppliers ADVANCES TO SUPPLIERS Inventory Disclosure [Abstract] INVENTORIES Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSET, NET Taxes Payable TAXES PAYABLE Payables and Accruals [Abstract] ACCRUED LIABILITIES AND OTHER PAYABLES Debt Disclosure [Abstract] LOAN FROM THIRD PARTIES Lease LEASE Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Equity [Abstract] STOCKHOLDERS’ EQUITY Statutory Reserves STATUTORY RESERVES Commitments and Contingencies Disclosure [Abstract] OPERATING CONTINGENCIES Business Combination and Asset Acquisition [Abstract] ACQUISITION OF SUBSIDIARIES Subsequent Events [Abstract] SUBSEQUENT EVENT Basis of Presentation Going Concern Global Uncertainties Use of Estimates Reclassification Cash and Cash Equivalents Restricted Cash Accounts Receivable Inventories Property and Equipment Impairment of Long-Lived Assets Goodwill Income Taxes Revenue Recognition Unearned Revenue Concentration of Credit Risk Leases Statement of Cash Flows Fair Value of Financial Instruments Fair Value Measurements and Disclosures Foreign Currency Translation and Comprehensive Income (Loss) Earnings per Share Stock-Based Compensation Segment Reporting New Accounting Pronouncements Unaudited Interim Financial Information SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS SCHEDULE OF SEGMENTS INFORMATION SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES SCHEDULE OF INVENTORIES SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSET SCHEDULE OF TAX PAYABLE SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES SCHEDULE OF OPERATING LEASE LIABILITIES SCHEDULE OF OPERATING LEASE EXPENSES SCHEDULE OF OTHER INFORMATION RELATED LEASES SCHEDULE OF MATURITIES OF LEASE LIABILITIES SCHEDULE OF RELATED PARTY TRANSACTIONS SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF EFFECTIVE INCOME TAX RATE SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF BUSINESS ACQUISITION PRO FORMA Common stock, shares, outstanding Equity Method Investment, Ownership Percentage Purchase price of common stock Stock issued during period, shares, new issues Business combination consideration transferred Business Acquisition, Description of Acquired Entity Business Combination, Consideration Transferred, Other Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Stockholders' Equity, Reverse Stock Split Beginning balance Additions Provision for bad debts Acquisition of subsidiary Recoveries/Write offs Effect of translation Ending balance Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property plant and equipment useful life Schedule of Product Information [Table] Product Information [Line Items] Total revenue Concentration Risk, Percentage Total purchases Total revenues, net Cost of goods sold Operating expenses Total operating costs and expenses Loss from operations Total assets Operating income loss Net cash used in operating activities Accumulated deficit Accounts receivable, allowance for credit loss Inventory valuation reserves Property, plant and equipment, salvage value, percentage Advertisement revenue Vat of gross sales price percentage Cash, FDIC Insured Amount Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [custom:ProvisionForInventoryReserve] Schedule Of Other Receivables And Prepaid Expenses Deposits Prepaid expenses, including related party Employees’ social insurance Others Total Prepaid supplies Raw material Work in process Finished goods-health supplements Drugs, pharmaceutical and nutritional products Food and beverage, hotel supplies and consumables Total Less: reserve for inventory Total inventories, net Total Less: Accumulated depreciation Property and equipment, net Depreciation expense Depreciation Software Less: Accumulated amortization Intangible asset, net Amortization expense Accrued employees’ social insurance Accrued payroll and commission Accrued rent expense Construction payable Payable for equipment purchase Accrued professional fees Deposit Other payables Total Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Due to related parties Short-Term Non-bank Loans and Notes Payable Schedule Of Operating Lease Liabilities Operating lease liabilities – current Operating lease liability – non-current Total operating lease liabilities Schedule Of Operating Lease Expenses Operating lease expenses Operating cash flows from operating leases Weighted average operating lease term Weighted average operating lease discount rate 2023 (excluding the nine months ended September 30, 2023) 2024 2025 2026 2027 Thereafter Total lease payments Less: imputed interest Total lease liabilities Less: current portion Lease liabilities – non-current portion Lessee, Operating Lease, Term of Contract Operating lease right-of-use asset Operating Lease, Weighted Average Discount Rate, Percent Lease Expiration Date Lease term Total Accounts payable-related party Prepaid Rent [custom:OperatingLeasesFutureMinimumPaymentDue-0] Accounts Receivable, after Allowance for Credit Loss Payments for Rent Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Current: China Total current Deferred: China Total deferred Total income tax expense Accumulated amortization Statutory U.S. federal income tax rate Foreign tax rate differential Change in valuation allowances Other Effective combined tax rate Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Effective income tax rate Net operating loss carry-forward Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Preferred Stock, Shares Authorized Preferred stock,par value Common Stock, par value Reverse stock split Common stock shares issued Common stock shares outstanding Issuance of shares Issuance of value Price per share Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share based payment award description Unrecognized compensation expenses Employee services expected to be recognized Forgiveness of shareholder's loan Business Combination, Consideration Transferred [custom:IncreaseDecreaseInAdditionalPaidinCapital] Proceeds from Contributed Capital Net income transfer, rate Capital reserve, rate Statutory reserve fund Schedule of Guarantor Obligations [Table] Guarantor Obligations [Line Items] Long-Term Purchase Commitment, Amount Litigation Settlement, Expense Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Total purchase considerations Estimated fair value of assets acquired: Cash Accounts receivable Accounts receivable-related party Advance to suppliers Other receivables and prepaid expense Inventory Property and equipment Intangible assets Operating lease right-of-use assets Total assets acquired Estimated fair value of liabilities assumed: Accounts payable Accounts payable-related party Advance from customers Government grant Taxes payable Operating lease liability Accrued liabilities and other payables Total liabilities assumed Total net assets acquired Goodwill as a result of the acquisition Operating lease liability Total liabilities assumed Total net assets acquired Revenue Operating costs and expenses Loss from operations Other income (expense) Income tax expense Net loss Payments to Acquire Businesses and Interest in Affiliates Business Acquisition, Percentage of Voting Interests Acquired Equity interest percentage Advances and accounts payable to related party China Concentric [Member] Purchase price of common stock. Statutory reserves. Quanzhong Lin [Member] Equity Transfer Agreement [Member] Aixin Shangyan Hotel Management [Member] AiXintang Pharmacises [Member] Cost of goods and service sold. Hotel operating costs. Room Revenue [Member] Food And Beverage Revenues [Member] Other [Member] Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block] Office Furniture [Member] Machinery [Member] Shares cancelled during the period shares. Shares Cancelled During The Period Value. Acquisition Of Subsidiaries. Services advertisement revenue. VAT of gross sales price percentage. Stock issued during period statutory reserve. Prior to May 1, 2018 [Member] Return of prepayment for acquisition. Customer B [Member] Customer A [Member] Supplier C [Member] Supplier A [Member] Supplier E [Member] Supplier D [Member] Statement Of Cash Flows [Policy Text Block] Advances To Suppliers [Text Block] Electronic Equipment [Member] Taxes Payables [Text Block] Schedule Of Taxes Payable [Table Text Block] Value-added [Member] Income [Member] City Construction [Member] Education [Member] Loan from third party [Text Block] Schedule of other information related leases [Table text block] Operating lease future minimum lease payment. Deferred tax assets accumulated amortization. Statutory reserves [Text Block] Increase decrease in additional paid-in capital. Net income transfer percentage. Capital reserve percentage. Statutory reserve fund. Capital contribution from forgiveness of related party loan. Advertising and Product [Member] Pharmacies [Member] Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd. [Member] Qionglai Weide Pharmacy [Member] Sichuan Aixin Investment Co., Ltd [Member] Chengdu Xindu Cundetang Pharmacy Co., Ltd. [Member] Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd. [Member] Yirong Shen [Member] Branch Manager [Member] Chengdu Aixin E-Commerce Company Ltd. [Member] Chengdu Aixin International travel service Co, Ltd [Member] Chengdu Beibang Pharmacy [Member] Aixin Life Beauty [Member] Renewed [Member] December 31, 2022 [Member] December 31, 2023 [Member] Employees and Contractors [Member] 2019 Equity Incentive Plan [Member] Aixin Shangyan Hotel and Aixintang Pharmacies [Member] Reversal of provision for bad debts. Loan to Third Party Disclosure [Text Block] Business Acquisitions Pro Forma Cost of Goods and Services Sold. Business Acquisitions Pro Forma Cost Loss from Operations. Business Acquisitions Pro Forma Other Nonoperating Income Expense. Business Acquisitions Pro Forma Income Tax Expense Benefit. Purchase Cost. Prepayment for acquisition. Covid -19 [Policy Text Block] Accounts payable-related party. Government grant. Accrual of unpaid investment in subsidiary. Business combination consideration transferred. Unaudited Interim Financial Information [Policy Text Block] Schedule of other receivables and prepaid expenses [Table Text Block] Inventory drugs pharmaceutical and nutritional products gross. Inventory food and beverage hotel supplies and consumables gross. Inventory allowance. Payable for equipment purchase current. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Curren tLiabilities Accounts Receivable. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Receivable Related Party. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Advance To Suppliers. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Operating Lease Right Use Of Assets. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Related Party. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Advance From Customer. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Government Grant. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Taxes Payable. Operating lease liabilities. Yunnan Shengshengyuan Technology Co Ltd [Member] Advertising revenues. Aixintang Haichuan Pharmacy Co Ltd [Member] Chengdu Aixintang Haichuan Pharmacy Co Ltd [Member] Pharmacies Purchase Agreement [Member] Statutory Reserves [Member] Chengdu Aixintang Pharmacy Co Ltd [Member] Manufacture and Sale [Member] Chengdu Fuxiang Tang Pharmacy Co Ltd [Member] Runcangsheng [Member] Runcangsheng Aixin Shangyan Hotel and Aixintang Pharmacies [Member] Cash disposed at disposal of subsidiary. Accounts payable related party current. Adjustments to additional paid in capital acquisition of subsidiaries Provision for inventory reserve. Increase decrease in accounts payable related party. Going Concern [Policy Text Block] Allowance for doubtful accounts receivable additions. Advertisement revenue. Other Receivables And Prepaid Expenses Disclosure [Text Block] Disposal of subsidiary. Changes in deferred tax asset. Schedule of Accounts Receivable Allowance for Doubtful Accounts [Table Text Block] Assets, Current Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Other Nonoperating Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Accounts Receivable, Credit Loss Expense (Reversal) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Receivable, Related Parties Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense Increase (Decrease) in Due to Related Parties Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Accrued Taxes Payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment PrepaymentForAcquisition Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Accounts Receivable, Allowance for Credit Loss, Recovery Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) Cost of Goods and Services Sold Prepaid Expense and Other Assets Inventory, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Net Accounts Payable and Other Accrued Liabilities, Current Other Liabilities Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount AdvanceFromRelatedParties Current Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseRightUseOfAssetst Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableRelatedParty BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceFromCustomer BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesGovernmentGrant BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesTaxesPayable OperatingLeaseLiabilities Accrued Liabilities and Other Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold BusinessAcquisitionsProFormaLossFromOperations Business Acquisition, Pro Forma Net Income (Loss) EX-101.PRE 17 aixn-20230930_pre.xml XBRL PRESENTATION FILE XML 18 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
9 Months Ended
Sep. 30, 2023
Cover [Abstract]  
Document Type S-1/A
Amendment Flag true
Amendment Description Amendment No.7
Entity Registrant Name AIXIN LIFE INTERNATIONAL, INC.
Entity Central Index Key 0000835662
Entity Primary SIC Number 5149
Entity Tax Identification Number 84-1085935
Entity Incorporation, State or Country Code CO
Entity Address, Address Line One Hongxing International Business Building 2, 14th FL
Entity Address, Address Line Two No. 69 Qingyun South Ave.
Entity Address, Address Line Three Jinjiang District
Entity Address, City or Town Chengdu City
City Area Code +(86)
Local Phone Number 313-6732526
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false

XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Current assets      
Cash and cash equivalents $ 412,659 $ 510,128 $ 8,556,642
Restricted cash 85,676 109,772 44,211
Accounts receivable, including related parties, net 250,561 562,581 45,923
Other receivables and prepaid expenses, including related party 143,324 42,631 143,281
Advances to suppliers 144,613 168,523 162,969
Inventory, net 643,623 499,252 233,454
Due from related parties   83,102 19,055
Total current assets 2,065,044 1,975,989 9,205,535
Property and equipment, net 1,658,885 1,971,793 290,148
Intangible asset, net 2,840 1,269 1,940
Deferred tax asset 13,278 15,556 18,795
Security deposit 82,237 86,992 94,153
Operating lease right-of-use assets 457,793 999,285 2,049,775
Goodwill, net  
Total assets 4,280,077 5,050,884 11,660,346
Current liabilities      
Accounts payable   398,469 406,163
Accounts payable-related party   165,958
Unearned revenue 466,804 139,502 171,408
Taxes payable 110,246 104,100 232,637
Accrued liabilities and other payables 2,136,132 2,356,490 752,400
Government grant 898,424 950,371
Loan from third parties 82,237 86,992 94,153
Operating lease liabilities 439,959 883,583 848,230
Due to related parties 333,919 236,882 1,947,154
Total current liabilities 5,067,094 5,322,347 4,452,145
Operating lease liabilities - non-current 158,069 194,725 1,138,710
Total liabilities 5,225,163 5,517,072 5,590,855
Stockholders’ equity (deficit)      
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding
Common stock, par value $0.00001 per share, 500,000,000 shares authorized; 24,999,842 shares issued and outstanding as of September 30, 2023 and December 31, 2022 and 2021 250 250 250
Additional paid in capital 14,882,538 14,458,583 14,087,043
Statutory reserve 151,988 151,988 151,988
Accumulated deficit (16,195,184) (15,249,858) (8,880,613)
Accumulated other comprehensive income 215,322 172,849 710,823
Total stockholders’ deficit (945,086) (466,188) 6,069,491
Total liabilities and stockholders’ deficit 4,280,077 5,050,884 11,660,346
Related Party [Member]      
Current assets      
Due from related parties 384,588 83,102  
Current liabilities      
Accounts payable 165,958
Due to related parties 333,919 236,882  
Nonrelated Party [Member]      
Current liabilities      
Accounts payable $ 599,373 $ 398,469  
XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]      
Undesignated preferred stock, par value $ 0.001 $ 0.001 $ 0.001
Undesignated preferred stock, shares authorized 20,000,000 20,000,000 20,000,000
Undesignated preferred stock, shares outstanding 0 0 0
Undesignated preferred stock, shares issued 0 0 0
Common stock, par value $ 0.00001 $ 0.00001 $ 0.00001
Common stock, shares authorized 500,000,000 500,000,000 500,000,000
Common stock, shares issued 24,999,842 24,999,842 24,999,842
Common stock, shares outstanding 24,999,842 24,999,842 24,999,842
XML 21 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Sales revenue:            
Total revenue, net $ 1,066,919 $ 672,786 $ 3,297,689 $ 1,512,351 $ 2,708,560 $ 3,066,233
Operating costs and expenses            
Cost of goods sold 509,723 215,383 1,136,411 493,905 1,103,160 535,485
Hotel operating costs 447,419 404,322 1,387,993 1,334,041 1,739,948 744,594
Selling 210,906 193,820 628,754 583,438 787,637 470,798
General and administrative 499,638 232,642 1,268,119 752,113 1,395,008 1,033,830
(Reversal of) provision for bad debts 41,603 67,638 (10,250) 115,495 (119,274) (63,076)
Stock-based compensation 92,885 92,885 278,655 278,655 371,540 371,540
Total operating costs and expenses 1,802,174 1,206,690 4,689,682 3,557,647 5,278,019 3,093,171
Loss from operations (735,255) (533,904) (1,391,993) (2,045,296) (2,569,459) (26,938)
Non-operating income (expenses)            
Interest income 135 1,024 692 3,636 4,876 4,113
Impairment loss (3,823,770) (3,823,770) (3,823,770)
Other income 13,293 12,134 52,395 41,789 51,856 63,064
Government grant income 284,321 284,321    
Other expenses (135) (29,317) (5,022) (29,577) (31,651) (33,154)
Total non-operating income (loss), net 297,614 (3,839,929) 332,386 (3,807,922) (3,798,689) 34,023
Loss before income tax (437,641) (4,373,833) (1,059,607) (5,853,218) (6,368,148) 7,085
Income tax expense (benefit) 515 (322) 5,879 643 1,097 274,321
Net loss (438,156) (4,373,511) (1,065,486) (5,853,861) (6,369,245) (267,236)
Other comprehensive items            
Foreign currency translation gain (loss) 16,086 (139,053) 42,473 (152,137) (537,974) 122,283
Comprehensive loss $ (422,070) $ (4,512,564) $ (1,023,013) $ (6,005,998) $ (6,907,219) $ (144,953)
Earnings Per Share, Basic $ (0.018) $ (0.175) $ (0.043) $ (0.234) $ (0.255) $ (0.011)
Earnings Per Share, Diluted $ (0.018) $ (0.175) $ (0.043) $ (0.234) $ (0.255) $ (0.011)
Weighted Average Number of Shares Outstanding, Basic 24,999,842 24,999,842 24,999,842 24,999,842 24,999,842 24,999,842
Weighted Average Number of Shares Outstanding, Diluted 24,999,842 24,999,842 24,999,842 24,999,842 24,999,842 24,999,842
Product [Member]            
Sales revenue:            
Total revenue, net $ 897,457 $ 503,062 $ 2,405,280 $ 888,690 $ 1,851,676 $ 742,624
Advertising [Member]            
Sales revenue:            
Total revenue, net         1,944,811
Room Revenue [Member]            
Sales revenue:            
Total revenue, net 74,265 71,562 473,167 166,278 262,605 114,086
Food And Beverage Revenues [Member]            
Sales revenue:            
Total revenue, net 77,524 64,321 356,009 356,840 475,746 201,755
Other [Member]            
Sales revenue:            
Total revenue, net $ 17,673 $ 33,841 $ 63,233 $ 100,543 $ 118,533 $ 62,957
XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Statutory Reserves [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 250 $ 11,116,015 $ 151,988 $ (4,964,711) $ 588,540 $ 6,892,082
Beginning balance, shares at Dec. 31, 2020 24,999,842          
Stock-based compensation 371,540 371,540
Acquisition of subsidiaries (4,313,025) (3,648,666) (7,961,691)
Debt forgiven by major shareholder 6,912,513 6,912,513
Net loss (267,236) (267,236)
Foreign currency translation 122,283 122,283
Ending balance, value at Dec. 31, 2021 $ 250 14,087,043 151,988 (8,880,613) 710,823 6,069,491
Ending balance, shares at Dec. 31, 2021 24,999,842          
Stock-based compensation 92,885 92,885
Net loss (752,081) (752,081)
Foreign currency translation 31,864 31,864
Ending balance, value at Mar. 31, 2022 $ 250 14,179,928 151,988 (9,632,694) 742,687 5,442,159
Ending balance, shares at Mar. 31, 2022 24,999,842          
Beginning balance, value at Dec. 31, 2021 $ 250 14,087,043 151,988 (8,880,613) 710,823 6,069,491
Beginning balance, shares at Dec. 31, 2021 24,999,842          
Net loss           (5,853,861)
Foreign currency translation           (152,137)
Ending balance, value at Sep. 30, 2022 $ 250 14,365,698 151,988 (14,734,474) 558,686 342,148
Ending balance, shares at Sep. 30, 2022 24,999,842          
Beginning balance, value at Dec. 31, 2021 $ 250 14,087,043 151,988 (8,880,613) 710,823 6,069,491
Beginning balance, shares at Dec. 31, 2021 24,999,842          
Stock-based compensation 371,540 371,540
Net loss (6,369,245) (6,369,245)
Foreign currency translation (537,974) (537,974)
Ending balance, value at Dec. 31, 2022 $ 250 14,458,583 151,988 (15,249,858) 172,849 (466,188)
Ending balance, shares at Dec. 31, 2022 24,999,842          
Beginning balance, value at Mar. 31, 2022 $ 250 14,179,928 151,988 (9,632,694) 742,687 5,442,159
Beginning balance, shares at Mar. 31, 2022 24,999,842          
Stock-based compensation 92,885 92,885
Net loss (728,269) (728,269)
Foreign currency translation (44,948) (44,948)
Ending balance, value at Jun. 30, 2022 $ 250 14,272,813 151,988 (10,360,963) 697,739 4,761,827
Ending balance, shares at Jun. 30, 2022 24,999,842          
Stock-based compensation 92,885 92,885
Net loss (4,373,511) (4,373,511)
Foreign currency translation (139,053) (139,053)
Ending balance, value at Sep. 30, 2022 $ 250 14,365,698 151,988 (14,734,474) 558,686 342,148
Ending balance, shares at Sep. 30, 2022 24,999,842          
Beginning balance, value at Dec. 31, 2022 $ 250 14,458,583 151,988 (15,249,858) 172,849 (466,188)
Beginning balance, shares at Dec. 31, 2022 24,999,842          
Stock-based compensation 92,885 92,885
Net loss (529,784) (529,784)
Foreign currency translation 24,542 24,542
Disposal of subsidiary 120,160 120,160
Ending balance, value at Mar. 31, 2023 $ 250 14,551,468 151,988 (15,659,482) 197,391 (758,385)
Ending balance, shares at Mar. 31, 2023 24,999,842          
Beginning balance, value at Dec. 31, 2022 $ 250 14,458,583 151,988 (15,249,858) 172,849 (466,188)
Beginning balance, shares at Dec. 31, 2022 24,999,842          
Net loss           (1,065,486)
Foreign currency translation           42,473
Ending balance, value at Sep. 30, 2023 $ 250 14,882,538 151,988 (16,195,184) 215,322 (945,086)
Ending balance, shares at Sep. 30, 2023 24,999,842          
Beginning balance, value at Mar. 31, 2023 $ 250 14,551,468 151,988 (15,659,482) 197,391 (758,385)
Beginning balance, shares at Mar. 31, 2023 24,999,842          
Stock-based compensation 92,885 92,885
Net loss (97,546) (97,546)
Foreign currency translation 1,845 1,845
Shareholder contribution 145,300 145,300
Ending balance, value at Jun. 30, 2023 $ 250 14,789,653 151,988 (15,757,028) 199,236 (615,901)
Ending balance, shares at Jun. 30, 2023 24,999,842          
Stock-based compensation 92,885 92,885
Net loss (438,156) (438,156)
Foreign currency translation 16,086 16,086
Ending balance, value at Sep. 30, 2023 $ 250 $ 14,882,538 $ 151,988 $ (16,195,184) $ 215,322 $ (945,086)
Ending balance, shares at Sep. 30, 2023 24,999,842          
XML 23 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (1,065,486) $ (5,853,861) $ (6,369,245) $ (267,236)
Adjustments required to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 308,114 82,921 185,565 96,106
(Reversal of) provision for bad debts (10,250) 115,495 45,953
Provision for inventory reserve 8,558 54,899
Operating lease expense 618,085 632,496 837,425 411,607
Stock based compensation 278,655 278,655 371,540 371,540
Deferred tax 1,481 1,419 1,858 (18,570)
Impairment loss 3,823,770 3,823,770
Government grant income (284,321)    
Changes in assets and liabilities:        
Accounts receivable     (425,961) (7,731)
Accounts receivable - related parties     (42) 13,618
Other receivables and prepaid expenses (18,596) 100,801 109,439 94,992
Prepaid expense - related party (97,872)    
Advances to suppliers     103,016 1,372
Inventory (186,658) (192,791) 150,872 69,738
Accounts payable     (71,153) (27,341)
Accounts payable - related party     140,608
Unearned revenue 347,347 (9,444) (24,401) (122,897)
Taxes payable 12,273 (187,009) (137,711) (57,467)
Payment of lease liability (500,056) (525,979) (710,865) (473,508)
Accrued liabilities and other payables (136,638) 232,910 289,868 (142,027)
Net cash used in operating activities (219,874) (1,412,550) (1,624,565) (57,804)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Cash acquired at acquisition of subsidiaries 446,381 446,381 87,448
Cash disposed at disposal of subsidiary (3,341)
Purchase of property and equipment (212,607) (52,485) (156,723) (1,341)
Payment for acquisition of subsidiaries     (3,812,027) (4,517,620)
Purchase of intangible asset (2,608)    
Net cash used in investing activities (218,556) 393,896 (3,522,369) (4,431,513)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Change in advance from related parties (79,072) (1,525,860) (2,389,593) 1,204,442
Repayment of loan from third parties     (368,648)
Capital contribution 142,200 4,386,070
Proceeds from government grant 284,321    
Net cash provided by (used in) financing activities 347,449 (1,525,860) (2,389,593) 5,221,864
EFFECT OF EXCHANGE RATE CHANGE ON CASH (30,584) (677,533) (444,426) 191,617
NET DECREASE IN CASH & RESTRICTED CASH (121,565) (3,222,047) (7,980,953) 924,164
CASH & RESTRICTED CASH, BEGINNING OF PERIOD 619,900 8,600,853 8,600,853 7,676,689
CASH & RESTRICTED CASH, END OF PERIOD 498,335 5,378,806 619,900 8,600,853
Supplemental Cash flow data:        
Income tax paid 4,398 72,495 71,163 404,276
Interest paid
Non-cash investing and financing activities:        
Capital contribution from forgiveness of related party loan     $ 2,446,238
Accrual of unpaid investment in subsidiary 3,907,139    
Investment in subsidiary paid by shareholder on behalf of the Company 734,290    
Nonrelated Party [Member]        
Changes in assets and liabilities:        
Accounts receivable 313,060 (126,720)    
Advances to suppliers 133,520 13,038    
Accounts payable 233,112 58,507    
Related Party [Member]        
Changes in assets and liabilities:        
Accounts receivable (11,434)    
Accounts payable $ (162,768) $ 143,242    
XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
ORGANIZATION AND DESCRIPTION OF BUSINESS
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
ORGANIZATION AND DESCRIPTION OF BUSINESS

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Aixin Life International, Inc. (the “Company” or “Aixin Life” or “we”) was incorporated under the laws of the State of Colorado on August 31, 2001. On February 2, 2017, Mr. Quanzhong Lin (Mr. Lin) purchased 65.0% of the Company’s outstanding shares from China Concentric Capital Group for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of the Company.

 

On December 12, 2017, pursuant to a Share Exchange Agreement, in consideration for all of the outstanding shares of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), the Company issued to Mr. Lin, the sole stockholder of AiXin BVI, shares of common stock then representing 71% of the outstanding of common stock of the Company.

 

As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXinZhonghong”), which markets and sells premium-quality nutritional products in China.

 

AiXin BVI was incorporated on September 21, 2017 as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 as an intermediate holding company. AiXinZhonghong was established in the People’s Republic of China (“PRC”) on March 4, 2013, and on May 27, 2017, the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXinZhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

 

For accounting purposes, the acquisition of AiXin BVI was accounted for as a reverse acquisition and treated as a recapitalization of the Company effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical consolidated financial statements of AiXinZhonghong are now the historical consolidated financial statements of the Company. The assets and liabilities of AiXinZhonghong were brought forward at their book value and no goodwill was recognized.

 

Effective February 1, 2018, the Company changed its name to AiXin Life International, Inc. (“Aixin Life”).

 

The Company, through its indirectly owned AiXinZhonghong subsidiary, develops and distributes consumer products by offering a line of nutritional products. The Company sells the products through exhibition events, conferences, and person-to-person marketing. Beginning in 2019, the Company began to provide advertising services to clients who engaged the Company to help distribute their products. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which it believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

 

On May 25, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Hotel Purchase Agreement”) with Chengdu Aixin Shangyan Hotel Management Co., Ltd (“Aixin Shangyan Hotel”), and its two shareholders Quanzhong Lin and Yirong Shen (“Transferor”). Pursuant to the Hotel Purchase Agreement, Aixin Life purchased 100% ownership of Aixin Shangyan Hotel from Transferor. Eighty percent of the equity of Aixin Shangyan Hotel was owned by Mr. Lin, and the remaining balance was owned by Ms. Shen. Under the terms of the Hotel Purchase Agreement, Aixin Life purchased all of the outstanding equity of Aixin Shangyan Hotel for a purchase price of RMB 7,598,887, or approximately $1.16 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by Aixin Shangyan Hotel to the Transferor after December 31, 2020 and will be increased by an amount equal to any amounts contributed to Aixin Shangyan Hotel by the Transferor after December 31, 2020. The acquisition was completed in July 2021.

 

On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Pharmacies Purchase Agreement”) with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its three shareholders, Quanzhong Lin, Ting Li and Xiao Ling Li (“Transferor”). Mr. Lin owned in excess of 95% of the outstanding equity the Aixintang Pharmacies. The remaining equity interest was owned by Ting Li and Xiao Ling Li. Pursuant to the Pharmacies Purchase Agreement, AiXin HK purchased all of the outstanding equity of Aixintang Pharmacies for an aggregate purchase price of RMB 34,635,845, or approximately US$5.31 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by any of the Aixintang Pharmacies to the Transferor after December 31, 2020 and increased by an amount contributed to any of the Aixintang Pharmacies by the Transferor after such date. The acquisition was completed in September 2021.

 

 

On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. The remaining equity interest is owned by Yun Chen. Pursuant to the Transfer Agreement, HK Aixin agreed to purchase all of the outstanding equity of Runcangsheng for an aggregate purchase price of $4,418,095 (RMB 31,557,820), adjusted by $116,802 the amount equal to the initial net worth minus the audited net worth. In addition to transferring their respective equity interest in Runcangsheng by the Sellers, both Sellers agree to forgive any loans Runcangsheng due to them. The acquisition was completed on September 30, 2022 (see Note 17).

 

On February 17, 2023, the Company effected a 1 for 2 reverse stock split. As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.00001 per share. The Company has approximately 24,999,842 shares of outstanding common stock after the effect of reverse stock split and the elimination of fractional shares. All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Aixin Life International, Inc. (the “Company” or “Aixin Life” or “we”) was incorporated under the laws of the State of Colorado on August 31, 2001 under the name Mercari Communications Group, Ltd (“Mercari”). On February 2, 2017, Mr. Quanzhong Lin (Mr. Lin) purchased 3,690,176 shares of the Company’s common stock, 65.0% of its outstanding shares from China Concentric Capital Group for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of our Company.

 

On December 12, 2017, the Company issued 28,419,075 shares of common stock to Mr. Lin, the sole stockholder of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), for his shares of AiXin BVI, pursuant to a Share Exchange Agreement.

 

As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXinZhonghong”), which markets and sells premium-quality nutritional products in China.

 

AiXin BVI was incorporated on September 21, 2017 as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 as an intermediate holding company. AiXinZhonghong was established in the People’s Republic of China (“PRC”) on March 4, 2013, and on May 27, 2017, the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXinZhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

 

For accounting purposes, the acquisition of AiXin BVI was accounted for as a reverse acquisition and treated as a recapitalization of the Company effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical consolidated financial statements of AiXinZhonghong are now the historical consolidated financial statements of the Company. The assets and liabilities of AiXinZhonghong were brought forward at their book value and no goodwill was recognized.

 

Effective February 1, 2018, the Company changed its name to AiXin Life International, Inc. (“Aixin Life”).

 

The Company, through its indirectly owned AiXinZhonghong subsidiary, develops and distributes consumer products by offering a line of nutritional products. The Company sells the products through exhibition events, conferences, and person-to-person marketing. Beginning in 2019, the Company began to provide advertising services to clients who engaged the Company to help distribute their products. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which it believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

 

On May 25, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Hotel Purchase Agreement”) with Chengdu Aixin Shangyan Hotel Management Co., Ltd (“Aixin Shangyan Hotel”), and its two shareholders Quanzhong Lin and Yirong Shen (“Transferor”). Pursuant to the Hotel Purchase Agreement, Aixin Life purchased 100% ownership of Aixin Shangyan Hotel from Transferor. Eighty percent of the equity of Aixin Shangyan Hotel was owned by Mr. Lin, and the remaining balance was owned by Ms. Shen. Under the terms of the Hotel Purchase Agreement, Aixin Life purchased all of the outstanding equity of Aixin Shangyan Hotel for a purchase price of RMB7,598,887, or approximately $1.16 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by Aixin Shangyan Hotel to the Transferor after December 31, 2020 and will be increased by an amount equal to any amounts contributed to Aixin Shangyan Hotel by the Transferor after December 31, 2020. The acquisition was completed in July 2021.

 

 

On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Pharmacies Purchase Agreement”) with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its three shareholders, Quanzhong Lin, Ting Li and Xiao Ling Li (“Transferor”). Mr. Lin owned in excess of 95% of the outstanding equity the Aixintang Pharmacies. The remaining equity interest was owned by Ting Li and Xiao Ling Li. Pursuant to the Pharmacies Purchase Agreement, AiXin HK purchased all of the outstanding equity of Aixintang Pharmacies for an aggregate purchase price of RMB34,635,845, or approximately US$5.31 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by any of the Aixintang Pharmacies to the Transferor after December 31, 2020 and increased by an amount contributed to any of the Aixintang Pharmacies by the Transferor after such date. The acquisition was completed in September 2021.

 

On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. The remaining equity interest is owned by Yun Chen. Pursuant to the Transfer Agreement, HK Aixin agreed to purchase all of the outstanding equity of Runcangsheng for an aggregate purchase price of $4,418,095 (RMB31,557,820), adjusted by $116,802 the amount equal to the initial net worth minus the audited net worth. In addition to transferring their respective equity interest in Runcangsheng by the Sellers, both Sellers agree to forgive any loans Runcangsheng due to them. The acquisition was completed on September 30, 2022 (see Note 17).

 

On February 17, 2023, the Company effected a 1 for 2 reverse stock split. As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.00001 per share. The Company has approximately 24,999,842 shares of outstanding common stock after the effect of reverse stock split. All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies, and Runcangsheng is the Chinese Renminbi (“RMB”). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies, and Runcangsheng. Intercompany transactions and accounts were eliminated in consolidation. These unaudited interim financial statements should be read in conjunction with the annual consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

Unaudited Interim Financial Information

 

These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission that permit reduced disclosure for interim periods. Therefore, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.

 

The Company has suffered net losses of $438,156 and $4,373,511 for the three months ended September 30, 2023 and 2022, and $1,065,486 and $5,853,861 for the nine months ended September 30, 2023 and 2022, respectively, and used net cash in operating activities of $219,874 and $1,412,550 for the nine months ended September 30, 2023 and 2022, respectively, and has an accumulated deficit of $16,195,184 as of September 30, 2023. These facts and conditions raise substantial doubt about the Company’s ability to continue as a going concern. From January 1, 2023 through September 30, 2023, the Company’s cash and cash equivalents decreased from $510,128 to $412,659 mainly due to operating losses, and the use of cash to support operating activities.

 

 

Management believes that it has developed a liquidity plan, summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business. The plan includes:

 

● Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of higher margin products.

 

● Raising cash through loans from related parties and potential equity offerings.

 

While the Company’s management believes that the measures in its liquidity plan including those described above will be adequate to satisfy its liquidity requirements for the twelve months after the date that these financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.

 

Global Uncertainties

 

The Company’s liquidity may be adversely impacted by various risks and uncertainties, including, but not limited to future and current impacts of global events such as a widespread health crisis, the continuation of the war in the Ukraine or the conflict in Palestine, the outbreak of another conflict or the expansion of the conflict in Palestine to other countries, the ongoing tensions between the United States and China, the Russian Federation and certain countries in the Middle East, increases in inflation, and other risks detailed in in the Company’s Annual Report on Form 10-K or other reports filed with the Securities and Exchange Commission.

 

While the invasion of Ukraine, the conflict in Palestine and responses thereto have not interrupted the Company’s operations, these or future developments which disrupt the international financial markets could make it difficult to access debt and equity capital on attractive terms, if at all, and impact the Company’s ability to fund business activities, including proposed acquisitions.

 

Use of Estimates

 

In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

Significant estimates required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

 

Cash and Cash Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

 

Restricted Cash

 

The restricted cash was cash maintained in temporarily frozen bank accounts held by Aixintang Pharmacy and its branches by the court for a judgement against Aixintang Pharmacy which Aixintang Pharmacy is in the process of appealing (see Note 16 – litigation).

 

 

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of September 30, 2023 and December 31, 2022, the bad debt allowance was $247,753 and $272,550 respectively.

 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
   For the nine Months ended September 30, 
   2023   2022 
         
Beginning balance  $272,550   $213,787 
Provision for bad debts   62,100    115,495 
Acquisition of subsidiary   -    185,561 
Recoveries/Write offs   (72,350)   - 
Effect of translation   (14,547)   (31,497)
Ending balance  $247,753   $483,346 

 

Inventories

 

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. The Company recorded provision for inventory reserve of $8,558 and $0 for the nine months ended September 30, 2023 and 2022, respectively.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of September 30, 2023 and December 31, 2022, there were no significant impairments of its long-lived assets.

 

 

Goodwill

 

The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.

 

The Company completed the required testing of goodwill for impairment as of December 31, 2022, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the uncertainty of the future cash flows indicates that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $3,823,770, in non-operating expenses in the statement of operations and comprehensive income (loss) during the year ended December 31, 2022.

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At September 30, 2023 and December 31, 2022, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

 

Revenue Recognition

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

The Company’s revenue recognition policies for its various operating segments are as follows:

 

Products

 

The Company’s revenue from sales of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have the option of asking for an exchange for products with the same value.

 

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Pharmacies

 

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligations. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are eligible for the PRC VAT of 0% as it qualifies as a small business.

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for its sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small business subject to exemption.

 

 

Unearned Revenue

 

The Company’s unearned revenue primarily consists of advances received from customers for the purchase of products prior to the delivery of goods, and for the rental of hotel rooms prior to the delivery of service. The delivery of products and room rental services is (normally within one year) based upon contract terms and customer demand.

 

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

 

During the three and nine months ended September 30, 2023 and 2022, the Company had no customer that accounted for over 10% of its total revenue.

 

During the three months ended September 30, 2023, the Company had one supplier that accounted for 20% of its total purchases.

 

During the nine months ended September 30, 2023, the Company had two suppliers that accounted for 15% and 12%, respectively, of its total purchases.

 

During the three months ended September 30, 2022, the Company had one supplier that accounted for 35% of its total purchases.

 

During the nine months ended September 30, 2022, the Company had one supplier that accounted for 20% of its total purchases.

 

Leases

 

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

 

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

 

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of September 30, 2023 and December 31, 2022. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

 

 

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Fair Value of Financial Instruments

 

The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

As of September 30, 2023 and December 31, 2022, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 consisted of net income (loss) and foreign currency translation adjustments.

 

Earnings per Share

 

Basic income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of September 30, 2023 and December 31, 2022, the Company did not have any potentially dilutive instruments.

 

 

Stock-Based Compensation

 

The Company periodically grants stock options, warrants and awards to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option, stock warrant and stock award grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option, stock warrant and stock award grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

The Company manages its business as four operating segments, products, pharmacies, hotel, and manufacture and sales, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

 

The following table shows the Company’s operations by business segment for the three months ended September 30, 2023 and 2022.

 

   2023   2022 
   For the Three Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $208,699   $338,327 
Pharmacies   273,416    164,735 
Hotel   169,462    169,724 
Manufacture and sale   415,342    - 
Total revenues, net  $1,066,919   $672,786 
           
Operating costs and expenses          
Products          
Cost of goods sold  $67,709   $90,391 
Operating expenses   421,417    301,624 
Pharmacies          
Cost of goods sold   126,459    124,992 
Operating expenses   115,006    144,164 
Hotel          
Hotel operating costs   447,419    404,322 
Operating expenses   61,859    141,197 
Manufacture and sale          
Cost of goods sold   315,555    - 
Operating expenses   246,750    - 
Total operating costs and expenses  $1,802,174   $1,206,690 
           
Income (loss) from operations          
Products  $(280,427)  $(53,688)
Pharmacies   31,951    (104,421)
Hotel   (339,816)   (375,795)
Manufacture and sale   (146,963)   - 
Loss from operations  $(735,255)  $(533,904)

 

 

The following table shows the Company’s operations by business segment for the nine months ended September 30, 2023 and 2022.

 

           
   For the Nine Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $1,064,668   $371,016 
Pharmacies   802,118    517,674 
Hotel   892,409    623,661 
Manufacture and sale   538,494    - 
Total revenues, net  $3,297,689   $1,512,351 
           
Operating costs and expenses          
Products          
Cost of goods sold  $367,237   $98,809 
Operating expenses   1,249,461    961,885 
Pharmacies          
Cost of goods sold   446,967    395,096 
Operating expenses   361,200    467,315 
Hotel          
Hotel operating costs   1,387,993    1,334,041 
Operating expenses   106,219    300,501 
Manufacture and sale          
Cost of goods sold   322,207    - 
Operating expenses   448,398    - 
Total operating costs and expenses  $4,689,682   $3,557,647 
           
Loss from operations          
Products  $(552,030)  $(689,678)
Pharmacies   (6,049)   (344,737)
Hotel   (601,803)   (1,010,881)
Manufacture and sale   (232,111)   - 
Loss from operations  $(1,391,993)  $(2,045,296)

 

Segment assets  As of
September 30, 2023
   As of
December 31, 2022
 
Products  $288,375   $410,754 
Pharmacies   726,904    758,675 
Hotel   449,903    970,385 
Manufacture and sale   2,814,895    2,911,070 
Total assets  $4,280,077   $5,050,884 

 

As the acquisition of Runcangsheng was consummated as of September 30, 2022 (see Note 17), the revenues and operating results of the manufacture and sale segment were included in the financial statements of the Company beginning on October 1, 2022.

 

 

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its FV, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis. As a smaller reporting company, the standard will be effective for the Company for interim and annual reporting periods beginning after December 15, 2022, with early adoption permitted. The adoption of ASU 2017-04 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies and Runcangsheng is the Chinese Renminbi (“RMB”). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies and Runcangsheng. Intercompany transactions and accounts were eliminated in consolidation.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.

 

The Company has suffered losses from operations of $2,569,459, used net cash in operating activities of $1,624,565 for the year ended December 31, 2022, and has accumulated deficit of $15,249,858 as of December 31, 2022. These facts and conditions have raised substantial doubt about the Company’s ability to continue as a going concern. During the year ended December 31, 2022, the Company’s cash and cash equivalents decreased from $8,556,642 to $510,128 mainly due to operating losses, and net cash used in investing and financing activities.

 

 

Management believes that it has developed a liquidity plan, as summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business. The plan includes:

 

Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of higher margin products.

Raising additional cash through loans from related parties and potential equity offerings

 

While the Company’s management believes that the measures described in the above liquidity plan will be adequate to satisfy its liquidity requirements for the twelve months after the date that the financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.

 

COVID – 19; The Invasion of Ukraine

 

On March 11, 2020, the World Health Organization announced that infections caused by the corona virus disease of 2019 (“COVID-19”) had become pandemic. In furtherance of its zero tolerance policy, the Government of China has adopted various regulations and orders, including mandatory quarantines, limits on the number of people that may gather in one location, closing non-essential businesses and travel bans to limit the spread of the disease. Many of these measures have been relaxed from time to time in various localities. However, beginning in the second half of 2021 to the end of 2022, the rate of COVID-19 cases has fluctuated in China and has increased in many provinces and cities including in Sichuan Province, where the Company is located. As a result of such increases there have been periodic short-term lockdowns and restrictions on travel in Sichuan Province. All of the Company’s operations, in particular its direct sales business and hotel, have been adversely impacted by the travel and work restrictions imposed on a temporary basis in China and Chengdu to limit the spread of COVID-19. Since January 2023, China has dropped all COVID restrictions.

 

In response to COVID-19, the Company has implemented procedures to promote employee and customer safety. These measures will not significantly increase its operating costs. However, the Company cannot predict with certainty what measures may be taken by its suppliers and customers and the impact these measures may have on its future financial position, results of operations or cash flows.

 

The invasion of Ukraine by the Russian Federation had an immediate impact on the global economy resulting in higher prices for oil and other commodities. The United States, United Kingdom, European Union and other countries responded to Russia’s invasion of Ukraine by imposing various economic sanctions and bans. Russia has responded with its own retaliatory measures. These measures have disrupted financial and economic markets. The global impact of these measures is continually evolving and cannot be predicted with certainty and there is no assurance that Russia’s invasion of Ukraine and responses thereto will not further disrupt the global economy and financial markets.

 

While the invasion of Ukraine and responses thereto have not interrupted the Company’s operations, these or future developments resulting from the invasion of Ukraine could make it difficult to access debt and equity capital on attractive terms, if at all, and impact the Company’s ability to fund business activities, including proposed acquisitions.

 

Use of Estimates

 

In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

 

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

 

Cash and Cash Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

 

Restricted Cash

 

The restricted cash reflects the temporary freeze of bank accounts of Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”) and its branches by the court during the appeal of a judgement against Aixintang Pharmacy (see Note 16 – litigation).

 

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of December 31, 2022 and 2021, the bad debt allowance was $272,550 and $213,787, respectively.

 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the years ended December 31, 2022 and 2021:

 

               
   Years Ended December 31, 
   2022   2021 
         
Beginning balance  $213,787   $148,520 
Additions*   196,164    124,242 
Provisions for bad debt   45,953    - 
Recoveries/Write offs   (165,227)   (63,076)
Effect of translation   (18,127)   4,101 
Ending balance  $272,550   $213,787 

 

*Due to the acquisition of subsidiaries during the years ended December 31, 2022 and 2021

 

Inventories

 

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. Management periodically evaluates the composition of its inventories to identify slow-moving and obsolete inventories to determine if a valuation allowance is required. The balance of reserve for inventory valuation as of December 31, 2022 and 2021 was $73,821 and $0, respectively.

 

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of December 31, 2022 and 2021, there were no significant impairments of its long-lived assets.

 

Goodwill

 

The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.

 

The Company completed the required testing of goodwill for impairment as of December 31, 2022, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the Company anticipates future cash flows indicate that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $3,823,770, in non-operating expenses in the statement of operation and comprehensive income(loss).

 

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At December 31, 2022 and 2021, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and have been primarily from the delivery of products and the performance of services, and the Company has no significant post-delivery obligations, this did not result in a material recognition of revenue on the Company’s accompanying consolidated financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

 

 

The Company’s revenue recognition policies for its various operating segments are as follows:

 

Advertising and Products

 

Advertising Revenue

 

Commencing in the third quarter of 2019, AiXin Zhonghong began to provide advertising services to its clients. Advertising contracts are signed to establish the price and advertising services to be provided. Pursuant to the advertising contracts, the Company provides advertising and marketing services to its clients through exhibition events, conferences, and person-to-person marketing. The Company performs a credit assessment of the customer to assess the collectability of the contract price prior to entering into contracts.

 

Most of the advertisement contracts designated that the Company perform such advertising services for its clients through exhibition events, conferences, and person-to-person marketing during the contracted period, regardless of the number of such events. As such, the Company determined that the performance obligation is satisfied over time during the contracted period and revenue is recognized accordingly. Such advertising revenue amounted to $0 and $1,944,811 for the years ended December 31, 2022 and 2021, respectively.

 

All of the advertising revenue is subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Product Revenue

 

The Company’s revenue from sale of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have options of asking for an exchange for products with the same value.

 

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Pharmacies

 

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligation. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are eligible for the PRC VAT of 0% as it qualifies as a small business.

 

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for the sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small subject to exemption.

 

Unearned Revenue

 

The Company’s unearned revenue primarily consists of advances received from customers for the rental of hotel rooms prior to the delivery of service. The room rental services are delivered (normally within one year) based upon contract terms and customer demand.

 

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

 

During the year ended December 31, 2022, the Company had no customer that accounted for over 10% of its total revenue.

 

During the year ended December 31, 2021, the Company had two major customers that accounted for over 10% of its total revenue.

 

Customer  Net sales for the year ended
December 31, 2021
   % of total revenue 
A(1)  $1,286,792    42%
B   658,018    21%

 

During the year ended December 31, 2022, the Company had three major suppliers that accounted for over 10% of its total purchases.

 

Supplier  Net purchases for the
year ended
December 31, 2022
   % of total purchase 
C  $189,150    14%
D (2)   149,806    11%

 

 

During the year ended December 31, 2021, the Company had one major supplier accounted for over 10% of its total purchase.

 

Supplier  Net purchases for the
year ended
December 31, 2021
   % of total purchase 
E  $233,187    40%

 

(1) Represented advertising revenues from this customer during the year ended December 31, 2021. The Company also purchased inventory from this customer in year ended December 31, 2021.
(2) The Company purchased inventory from this supplier, Runcangsheng, in the year ended December 31, 2022. The Company acquired all of the outstanding equity of Runcangsheng on September 30, 2022 (see Note 17).

 

Leases

 

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

 

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

 

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of December 31, 2022 and 2021. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

 

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Fair Value of Financial Instruments

 

The carrying amounts of certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

 

  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

As of December 31, 2022 and 2021, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the year ended December 31, 2022 and 2021 consisted of net income (loss) and foreign currency translation adjustments.

 

Earnings per Share

 

Basic income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of December 31, 2022 and 2021, the Company did not have any potentially dilutive instruments.

 

Stock-Based Compensation

 

The Company periodically grants stock options, warrants and stock awards to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option, stock warrant and stock award grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option, stock warrant and stock award grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

 

The Company manages its business as four operating segments, advertising and products, pharmacies, hotels, and manufacture and sale, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

 

The following table shows the Company’s operations by business segment for the year ended December 31, 2022 and 2021. Revenues and expenses for the Pharmacies, Hotel and Manufacture and sale segments commenced as of the respective dates of the completion of their acquisitions:

 

               
   For the Years Ended December 31, 
   2022   2021 
Net revenue          
Advertising and products  $823,930   $2,406,988 
Pharmacies   789,347    280,447 
Hotel   856,884    378,798 
Manufacture and sale   238,399    - 
Total revenues, net  $2,708,560   $3,066,233 
           
Operating costs and expenses          
Advertising and products          
Cost of goods sold  $171,345   $316,750 
Operating expenses   1,526,246    1,344,543 
Pharmacies          
Cost of goods sold   578,092    218,735 
Operating expenses   622,835    252,513 
Hotel          
Hotel operating costs   1,739,948    744,594 
Operating expenses   310,902    216,036 
Manufacture and sale          
Cost of goods sold   353,723    - 
Operating expense   (25,072)   - 
Total operating costs and expenses  $5,278,019   $3,093,171 
           
(Loss) income from operations          
Advertising and products  $(873,661)  $745,695 
Pharmacies   (411,580)   (190,801)
Hotel   (1,193,966)   (581,832)
Manufacture and Sale   (90,252)   - 
(Loss) income from operations  $(2,569,459)  $(26,938)

 

         
Segment assets  As of
December 31, 2022
   As of
December 31, 2021
 
Advertising and products  $410,754   $8,914,211 
Pharmacies   758,675    931,706 
Hotel   970,385    1,814,429 
Manufacture and sale   2,911,070    - 
Total assets  $5,050,884   $11,660,346 

 

As the acquisition of Runcangsheng has been consummated as of December 31, 2022 (see Note 17), the revenues and operating results of the manufacture and sale segment will be included in the financial statements of the Company beginning on October 1, 2022.

 

 

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis. As a smaller reporting company, the standard will be effective for the Company for interim and annual reporting periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on the Company’s consolidated financial statements presentation or disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

 

XML 26 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER RECEIVABLES AND PREPAID EXPENSES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Other Receivables And Prepaid Expenses    
OTHER RECEIVABLES AND PREPAID EXPENSES

3. OTHER RECEIVABLES AND PREPAID EXPENSES

 

Other receivables and prepaid expenses consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Deposits  $12,245   $15,546 
Prepaid expenses, including related party   102,704    9,490 
Employees’ social insurance   7,379    10,124 
Others   20,996    7,471 
Total  $143,324   $42,631 

 

3. OTHER RECEIVABLES AND PREPAID EXPENSES

 

Other receivables and prepaid expenses consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Deposits  $15,546   $68,433 
Prepaid expenses   9,490    50,221 
Employees’ social insurance   10,124    13,839 
Others   7,471    10,788 
Total  $42,631   $143,281 

 

 

XML 27 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
ADVANCES TO SUPPLIERS
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Advances To Suppliers    
ADVANCES TO SUPPLIERS

4. ADVANCES TO SUPPLIERS

 

The Company had advances to suppliers of $144,613 and $168,523 as of September 30, 2023 and December 31, 2022, respectively. Advances to suppliers primarily include prepayments for products and equipment expected to be delivered subsequent to balance sheet dates.

 

 

4. ADVANCES TO SUPPLIERS

 

The Company had advances to suppliers of $168,523 and $162,969 as of December 31, 2022 and 2021, respectively. Advances to suppliers primarily include prepayments for products and equipment expected to be delivered subsequent to balance sheet dates.

 

XML 28 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORIES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
INVENTORIES

5. INVENTORIES

 

Inventories consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Raw material  $142,519   $62,462 
Work in process   15,265    15,315 
Finished goods-health supplements   -    521 
Drugs, pharmaceutical and nutritional products   486,273    412,129 
Food and beverage, hotel supplies and consumables   77,600    82,646 
Total  $721,657   $573,073 
Less: reserve for inventory   78,034    73,821 
Total inventories, net  $643,623   $499,252 

 

5. INVENTORIES

 

Inventories consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Raw material  $62,462   $- 
Work in process   15,315    - 
Finished goods-health supplements   521    6,201 
Drugs, pharmaceutical and nutritional products   412,129    122,966 
Food and beverage, hotel supplies and consumables   82,646    104,287 
Total  $573,073   $233,454 
Less: reserve for inventory   73,821    - 
Total inventories, net  $499,252   $233,454 

 

XML 29 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT, NET
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Abstract]    
PROPERTY AND EQUIPMENT, NET

6. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Vehicles  $403,505   $426,836 
Office furniture   78,037    82,549 
Electronic equipment   21,101    20,607 
Machinery   1,258,029    1,241,778 
Leasehold improvements   1,076,824    1,139,087 
Other   21,777    17,485 
Total   2,859,273    2,928,342 
Less: Accumulated depreciation   (1,200,388)   (956,549)
Property and equipment, net  $1,658,885   $1,971,793 

 

Depreciation expense for the three months ended September 30, 2023 and 2022 was $114,300 and $25,111, respectively.

 

Depreciation expense for the nine months ended September 30, 2023 and 2022 was $307,209 and $81,036, respectively

 

6. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Vehicles  $426,836   $295,502 
Office furniture   82,549    64,263 
Electronic equipment   20,607    22,304 
Machinery   1,241,778    106,080 
Leasehold improvements   1,139,087    256,548 
Other   17,485    6,374 
Total   2,928,342    751,071 
Less: Accumulated depreciation   (956,549)   (460,923)
Property and equipment, net  $1,971,793   $290,148 

 

 

Depreciation expense for the years ended December 31, 2022 and 2021 was $183,542 and $95,026, respectively.

 

XML 30 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLE ASSET, NET
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
INTANGIBLE ASSET, NET

7. INTANGIBLE ASSET, NET

 

Intangible asset consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Software  $10,609   $8,564 
Less: Accumulated amortization   (7,769)   (7,295)
Intangible asset, net  $2,840   $1,269 

 

Amortization expense for the three months ended September 30, 2023 and 2022 was $387 and $591, respectively.

 

Amortization expense for the nine months ended September 30, 2023 and 2022 was $905 and $1,885, respectively.

 

 

7. INTANGIBLE ASSET, NET

 

Intangible asset consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Software  $8,564   $7,896 
Less: Accumulated amortization   (7,295)   (5,956)
Intangible asset, net  $1,269   $1,940 

 

Amortization expense for the years ended December 31, 2022 and 2021 was $2,023 and $1,080.

 

 

XML 31 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
TAXES PAYABLE
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Taxes Payable    
TAXES PAYABLE

8. TAXES PAYABLE

 

Taxes payable consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Value-added  $62,515   $56,806 
Income   28,235    30,919 
City construction   5,027    3,746 
Education   2,193    2,184 
Other   12,276    10,445 
Taxes payable  $110,246   $104,100 

 

8. TAXES PAYABLE

 

Taxes payable consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Value-added  $56,806   $97,917 
Income   30,919    109,396 
City construction   3,746    7,018 
Education   2,184    5,064 
Other   10,445    13,242 
Taxes payable  $104,100   $232,637 

 

XML 32 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCRUED LIABILITIES AND OTHER PAYABLES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
ACCRUED LIABILITIES AND OTHER PAYABLES

9. ACCRUED LIABILITIES AND OTHER PAYABLES

 

Accrued liabilities and other payables consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Accrued employees’ social insurance  $281,728   $270,349 
Accrued payroll and commission   248,759    307,331 
Accrued rent expense   74,415    32,746 
Construction payable   1,196,037    1,384,674 
Payable for equipment purchase   29,213    32,278 
Accrued professional fees   247,786    233,894 
Deposit   10,690    11,308 
Other payables   47,504    83,910 
Total  $2,136,132   $2,356,490 

 

9. ACCRUED LIABILITIES AND OTHER PAYABLES

 

Accrued liabilities and other payables consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Accrued employees’ social insurance  $270,349   $327,735 
Accrued payroll and commission   307,331    179,183 
Accrued rent expense   32,746    29,000 
Construction payable   1,384,674    111,807 
Payable for equipment purchase   32,278    - 
Accrued professional fees   233,894    50,840 
Deposit   11,308    12,239 
Other payables   83,910    41,596 
Total  $2,356,490   $752,400 

 

XML 33 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
LOAN FROM THIRD PARTIES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
LOAN FROM THIRD PARTIES

10. LOAN FROM THIRD PARTIES

 

As of September 30, 2023 and December 31, 2022, the Company had advances from unrelated third parties of Aixin Shangyan Hotel in an aggregate amount $82,237 and $86,992, respectively. There was no written agreement, and these loans are payable on demand and bear no interest.

 

10. LOAN FROM THIRD PARTIES

 

As of December 31, 2022 and 2021, the Company had advances from former shareholders and unrelated third parties in an aggregate amount of $86,992 and $94,153, respectively. There was no written agreement, and these loans are payable on demand and bear no interest.

 

XML 34 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASE
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Lease    
LEASE

11. LEASE

 

AiXinZhonghong leases its office on a monthly basis. AiXinZhonghong also has operating leases for other sales locations under various operating lease arrangements. The leases have remaining lease terms of approximately 0.58 to 2.69 years.

 

Aixin Shangyan Hotel leases its hotel premises under an operating lease arrangement. The lease has a remaining lease term of approximately 0.25 years.

 

Aixintang Pharmacies lease retail pharmacy stores under operating lease arrangements, with remaining lease terms of 1.21 to 2.92 years.

 

Runcangsheng leases its office under an operating lease arrangement. The lease has a remaining lease term of approximately 0.25 years.

 

Balance sheet information related to the Company’s leases is presented below:

 

   September 30, 2023   December 31, 2022 
Operating Leases          
Operating lease right-of-use assets  $457,793   $999,285 
           
Operating lease liabilities – current  $439,959   $883,583 
Operating lease liability – non-current   158,069    194,725 
Total operating lease liabilities  $598,028   $1,078,308 

 

 

The following provides details of the Company’s lease expenses:

 

   2023   2022 
   Three Months Ended September 30, 
   2023   2022 
Operating lease expenses  $200,716   $183,051 
           

 

   2023   2022 
   Nine Months Ended September 30, 
   2023   2022 
Operating lease expenses  $618,085   $632,496 
           

 

Other information related to leases is presented below:

 

   Nine Months Ended September 30, 
   2023   2022 
Cash Paid for Amounts Included In Measurement of Liabilities:          
Operating cash flows from operating leases  $500,056    525,979 
           
Weighted Average Remaining Lease Term:          
Operating leases   1.26 years    1.65 years 
           
Weighted Average Discount Rate:          
Operating leases   4.75%   4.75%

 

Maturities of lease liabilities were as follows:

 

      
For the year ending December 31:     
2023 (excluding the nine months ended September 30, 2023)  $354,246 
2024   130,992 
2025   79,844 
2026   36,366 
2027   8,224 
Thereafter   3,427 
Total lease payments   613,099 
Less: imputed interest   (15,071)
Total lease liabilities   598,028 
Less: current portion   (439,959)
Lease liabilities – non-current portion  $158,069 

 

11. LEASE

 

Concurrent with the completion of the sale of its rights to a portion of a building completed in 2019, the Company entered into an agreement to lease a portion of the building back from the buyer over a lease term of 2 years. The Company accounted for this lease as an operating lease right-of-use asset and a corresponding operating lease liability in accordance with the Lease Standard. As a result, $207,049 (RMB1,389,731) was recorded as operating lease right-of-use asset and lease liability on March 31, 2019 when the lease commenced based on a 4.75% discount factor. The lease agreement expired on March 31, 2021. Commencing in April, 2021, the Company continues to lease the office on a monthly basis.

 

The Company also has operating leases for other sales locations under various operating lease arrangements. The leases have remaining lease terms of approximately 0.41 to 3.44 years.

 

Aixin Shangyan Hotel leases its hotel premises under an operating lease arrangement. The lease has a remaining lease term of approximately 1.00 year.

 

Aixintang Pharmacies lease retail pharmacy stores under operating lease arrangements, with remaining lease terms of 0.37 to 3.67 years.

 

 

Balance sheet information related to the Company’s leases is presented below:

 

   December 31, 2022   December 31, 2021 
Operating Leases          
Operating lease right-of-use assets  $999,285   $2,049,775 
           
Operating lease liabilities – current  $883,583   $848,230 
Operating lease liability – non-current   194,725    1,138,710 
Total operating lease liabilities  $1,078,308   $1,986,940 

 

The following provides details of the Company’s lease expenses:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Operating lease expenses  $837,425   $411,607 
           

 

Other information related to leases is presented below:

 

   Years Ended December 31, 
   2022   2021 
Cash Paid For Amounts Included In Measurement of Liabilities:        
Operating cash flows from operating leases  $710,865   $473,508 
           
Weighted Average Remaining Lease Term:          
Operating leases   1.45 years    2.32 years 
           
Weighted Average Discount Rate:          
Operating leases   4.75%   4.75%

 

Maturities of lease liabilities were as follows:

 

    
For the year ending December 31:    
2023  $899,044 
2024   127,361 
2025   53,196 
2026   22,433 
Total lease payments   1,102,034 
Less: imputed interest   (23,726)
Total lease liabilities   1,078,308 
Less: current portion   (883,583)
Lease liabilities – non-current portion  $194,725 

 

XML 35 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Related Party Transactions [Abstract]    
RELATED PARTY TRANSACTIONS

12. RELATED PARTY TRANSACTIONS

 

Accounts receivable – related party

 

As of September 30, 2023 and December 31, 2022, accounts receivable from related parties were $11,030 and $42, respectively.

 

Prepaid expense – related party

 

Prepaid expense – related party consisted of the following as of the periods indicated:

   September 30, 2023   December 31, 2022 
Chengdu Aixin International Travel Service Co., Ltd  $94,361   $          - 

 

Accounts payable – related party

 

Accounts payable – related party consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Luquan Shengcaofeng Biotechnology Co., Ltd.  $           -   $165,958 

 

Luquan Shengcaofeng Biotechnology Co., Ltd. is an entity controlled by Mr. Huiliang Jiao, a Director of the Company.

 

 

Due from related parties

 

Due from related parties consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $7,573   $9,708 
Sichuan Aixin Investment Co., Ltd   8,983    145 
Huiliang Jiao   135,328    - 
Xiaoyan Zhou   11,668    - 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   25,056    26,125 
Chengdu WenJiang Aixin Huiwan Pharmacy Co., Ltd.   3,888    - 
Chengdu Heshengyuan Pharmacy Co., Ltd.   3,379    - 
Chengdu Zhiweibing Pharmacy Co., Ltd.   7,859    - 
Chengdu Tongtai Tang Pharmacy Co. Ltd.   2,810    - 
Chengdu city Wuhou District Xiaofei Pharmacy Co., Ltd   8,115    - 
Chongqing Aixin Hui Pharmacy Co., Ltd.   402    - 
Sichuan Xintang Xinfu Pharmacy Chain Co, Ltd   344    - 
Sichuan Aixintang Xinfu Chain Pharmacy Co., Ltd.   302    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   26,822    34,622 
Chengdu Cigu Foshou Pharmacy   2,028    - 
Mianyang Aixin Cunshan Pharmacy   5,874    - 
Chengdu Aixin International Travel Service Co., Ltd   356    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   133,801    12,502 
Total  $384,588   $83,102 

 

Due to related parties

 

Due to related parties consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Quanzhong Lin  $243,323   $140,644 
Yirong Shen   84,978    89,892 
Sichuan Haosen Haichuan business management Co. Ltd   57    - 
Sichuan Yunxi Pharmacy Co. Ltd   449    - 
Chengdu Yi Yan Tang Pharmacy Co. Ltd.   162    - 
Chengdu Aixin International travel service Co, Ltd   4,950    6,346 
Total  $333,919   $236,882 

 

The amounts due to and from related parties were for working capital purposes, payable on demand, and bear no interest. All the related party entities listed above are controlled by Mr. Quanzhong Lin (the Chairman, President and major shareholder of Aixin Life). Yirong Shen was a major shareholder of Aixin Shangyan Hotel prior to the closing of Hotel Purchase Agreement, and she serves as the supervisor of Aixin Shangyan Hotel. Tianming Long is a branch manager of Aixintang Pharmacies. Mr. Huiliang Jiao is the Director of the Company. Xiaoyan Zhou is the wife of Mr. Huiliang Jiao.

 

Office leases

 

In May 2014, the Company entered a lease with its major shareholder for an office. The lease term was for three years expiring in May 2017 with an option to renew. The monthly rent was RMB 5,000 ($690). The Company was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease until May 28, 2028 with monthly rent of RMB 5,000 ($690), payable quarterly. The future annual minimum lease payments at September 30, 2023 are $8,224, $8,224, $8,224, $8,224, and $5,482 for each of the years ended September 30, 2024, 2025, 2026, 2027, and 2028, respectively.

 

Runcangsheng has an office lease with Xiaoyan Zhou, wife of Huiliang Jiao, the Company’s Director, from March 2020 to February 2023 with a monthly rent of RMB 3,000 ($414). Runcangsheng renewed the lease until February 28, 2026 with monthly rent of RMB 5,000 ($690). In July 2023, Xiaoyan Zhou entered into an agreement with Runcangsheng to increase the monthly rent for 2022 by RMB 2,000 and to change the lease expiration date to December 31, 2023. The lease will be converted to an annual contract starting from January 1, 2024.

 

 

12. RELATED PARTY TRANSACTIONS

 

Account payables to related parties

 

As of December 31, 2022 and 2021, the Company had accounts payable to related party in the amount of $165,958 and $0, respectively, which was for the purchase of raw materials from Luquan Shengcaofeng Biotechnology Co., Ltd. (“Shengcaofeng”), an affiliate entity of Runcangsheng.

 

Advance to related parties

 

Advance to related parties consisted of the following as of the periods indicated:

 

   December 31, 2022   December 31, 2021 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $9,708   $4,583 
Sichuan Aixin Investment Co., Ltd.   145    4,237 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   26,125    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   34,622    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   12,502    10,235 
Total  $83,102   $19,055 

 

 

Advance from related parties

 

Advance from related parties consisted of the following as of the periods indicated:

 

   December 31, 2022   December 31, 2021 
Quanzhong Lin  $140,644   $1,822,705 
Yirong Shen   89,892    97,292 
Branch manager   -    1,667 
Chengdu Aixin E-Commerce Company Ltd.   -    15,378 
Chengdu Aixin International travel service Co, Ltd   6,346    2,388 
Aixin Life Beauty   -    7,724 
Total  $236,882   $1,947,154 

 

All the related party entities are controlled by Mr. Quanzhong Lin (the Chairman, President and major shareholder of Aixin Life). These advances to and from related parties were for working capital purpose, payable on demand, and bear no interest. Yirong Shen was a major shareholder of Aixin Shangyan Hotel prior to the closing of Hotel Purchase Agreement, and she serves as the supervisor of Aixin Shangyan Hotel.

 

Office lease from a Major Shareholder

 

In May 2014, the Company entered a lease with its major shareholder for an office. The lease term was for three years expiring in May 2017 with an option to renew. The monthly rent was RMB5,000 ($725), the Company was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease until May 28, 2023 with monthly rent of RMB5,000 ($725), payable quarterly. The future annual minimum lease payment at December 31, 2022 is $3,625 for the year ended December 31, 2023.

 

XML 36 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
INCOME TAXES

13. INCOME TAXES

 

The Company was incorporated in the United States of America (“USA”) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its sales from its operations in the PRC for the three and nine months ended September 30, 2023 and 2022, and recorded income tax provision for the periods.

 

China has a tax rate of 25% for all enterprises (including foreign-invested enterprises).

 

Uncertain Tax Positions

 

Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the three and nine months ended September 30, 2023 and 2022, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

 

13. INCOME TAXES

 

The Company was incorporated in the United States of America (“USA”) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its sales from its operations in the PRC for the years ended December 31, 2022 and 2021, and recorded income tax provision for the periods.

 

China has a tax rate of 25% for all enterprises (including foreign-invested enterprises).

 

The components of the provision for income taxes for the years ended December 31, 2022 and 2021 consisted of the following:

 

   2022   2021 
   For the Year Ended December 31, 
   2022   2021 
Current:        
China  $(761)  $292,891 
Total current   (761)   292,891 
Deferred:          
China   1,858    (18,570)
Total deferred   1,858    (18,570)
Total income tax expense  $1,097   $274,321 

 

Deferred tax assets as of December 31, 2022 and 2021 consisted of the following:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Accumulated amortization  $15,556   $18,795 

 

 

The following table reconciles the statutory rates to the Company’s effective tax rate for years ended December 31, 2022 and 2021:

 

   2022   2021 
Statutory U.S. federal income tax rate   (21.0)%   21.0%
Foreign tax rate differential   (3.8)%   216.5%
Change in valuation allowances   25.0%   3,634.4%
Other   (0.2)%   -%
Effective combined tax rate   0.0%   3,871.9%

 

 

As of December 31, 2022, the Company had approximately $4,139,357 net operating loss carry-forwards available to offset future taxable income in China primarily from Aixin Shangyan Hotel and Aixintang Pharmacies. The Company’s net operating loss carry-forwards begins to expire in 2023. After consideration of all information available, management believes that uncertainty exists with respect to future realization of its deferred tax assets resulted from net operating loss carry-forwards due to the Company’s net loss, and established a full valuation allowance of deferred tax assets resulted from net operating loss carry-forwards.

 

Uncertain Tax Positions

 

Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the years ended December 31, 2022 and 2021, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

 

XML 37 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS’ EQUITY
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
STOCKHOLDERS’ EQUITY

14. STOCKHOLDERS’ EQUITY

 

On August 17, 2020, by unanimous written consent in lieu of a meeting, the Board adopted resolutions authorizing a one (1)-for-four (4) reverse stock. The reverse stock split became effective on October 27, 2020. According to the Articles of Amendment, the Company is authorized to issue 20,000,000 shares of blank check preferred stock at $0.001 par value and 500,000,000 shares of common stock at $.00001 par value per share.

 

Pursuant to resolutions adopted by the Board of Directors and the holders of a majority of the outstanding shares of common stock of AiXin Life International, Inc. on January 6, 2023, the Company filed an amendment to its Articles of Incorporation with respect to a proposed 1 for 2 “reverse” split of its common stock (the “Amendment”). Completion of the proposed reverse stock split was to be effected on a date determined by the Board of Directors only upon receipt of notice from the Financial Industry Regulatory Authority (“FINRA”) that it would process the proposed reverse stock split. The Company received notice from FINRA and its common stock began trading on a post-split basis on February 17, 2023.

 

As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock were automatically combined and converted into one issued and outstanding share of common stock. The Company has approximately 24,999,842 shares of outstanding common stock after giving effect to the reverse stock split and the elimination of fractional shares.

 

All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

As of September 30, 2023, and December 31, 2022, the Company had 24,999,842 common shares issued and outstanding.

 

Stock Awards Issued for Services

 

On October 22, 2019, the Company granted and issued 18,750 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $337,500 based on the post-split closing price of $18 on the grant date.

 

On October 24, 2019, the Company granted and issued 275,000 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $1,520,200 based on the post-split closing price of $5.528 on the grant date.

 

 

The stock awards will vest over five (5) years from the grant date, and the grantee will forfeit a portion of the shares granted (“Shares Granted”) if the grantee is no longer employed by or contracted with the Company. Specifically, the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture.

 

For the three months ended September 30, 2023 and 2022, stock-based compensation expenses were $92,885 and $92,885, respectively. For the nine months ended September 30, 2023 and 2022, stock-based compensation expenses were $278,655 and $278,655, respectively. As of September 30, 2023, unrecognized compensation expenses related to these stock awards are $394,012. These expenses are expected to be recognized over 1.07 years.

 

Capital Contribution

 

During the nine months ended September 30, 2023, the Company received capital contributions in the aggregate amount of $145,300 from Yunnan Shengshengyuan and Yun Chen, the former shareholders of Runcangsheng (see Note 1), who remained as related parties of the Company after the completion of acquisition of Runcangsheng.

 

14. STOCKHOLDERS’ EQUITY

 

On August 17, 2020, by unanimous written consent in lieu of a meeting, the Board adopted resolutions authorizing a one (1)-for-four (4) reverse stock. The reverse stock split became effective on October 27, 2020. According to the Articles of Amendment, the Company is authorized to issue 20,000,000 shares of blank check preferred stock at $0.001 par value and 500,000,000 shares of common stock at $.00001 par value per share

 

Pursuant to resolutions adopted by the Board of Directors and the holders of a majority of the outstanding shares of common stock of AiXin Life International, Inc. on January 6, 2023, the Company filed an amendment to its Articles of Incorporation with respect to a proposed 1 for 2 “reverse” split of our common stock (the “Amendment”). Completion of the proposed reverse stock split was to be effected on a date determined by our Board of Directors only upon receipt of notice from the Financial Industry Regulatory Authority (“FINRA”) that it would process the proposed reverse stock split. The Company received notice from FINRA and its common stock began trading on a post-split basis on February 17, 2023.

 

As a result of the reverse split, every two shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock. The Company has approximately 24,999,842 shares of outstanding common stock after the effect of reverse stock split.

 

All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

 

As of December 31, 2022 and 2021, the Company had 24,999,842 common shares issued and outstanding.

 

Stock Awards Issued for Services

 

On October 22, 2019, the Company granted and issued 18,750 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $337,500 based on the post-split closing price of $18 on the grant date.

 

 

On October 24, 2019, the Company granted and issued 275,000 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $1,520,200 based on the post-split closing price of $5.528 on the grant date.

 

The stock awards will vest over five (5) years from the grant date, and the grantee will forfeit a portion of the shares granted (“Shares Granted”) if the grantee is no longer employed by or contracted with the Company. Specifically, the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture.

 

For the years ended December 31, 2022 and 2021, stock-based compensation expenses were $371,540 each. As of December 31, 2022, unrecognized compensation expenses related to these stock awards are $672,667. These expenses are expected to be recognized over 2 years.

 

Forgiveness of shareholder’s loan

 

As of December 31, 2021, the Company’s major shareholder Mr. Lin forgave his loan to the Company for $6,912,513. The Company recorded this forgiveness of shareholder loan as additional paid-in capital.

 

Acquisition of Subsidiaries

 

As of December 31, 2021, the Company completed the acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies (see Note 1). The acquisitions were accounted for as acquisitions of entities under common control. In connection with the acquisitions, the Company made payments to Mr. Lin in the aggregate amount of $4.50 million, or RMB29 million. The difference between the consideration given and the net assets received was recognized in equity, resulting in a decrease of additional paid-in capital of $4,313,025.

 

XML 38 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATUTORY RESERVES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Statutory Reserves    
STATUTORY RESERVES

15. STATUTORY RESERVES

 

Pursuant to the PRC corporate law, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings.

 

Surplus reserve fund

 

The Company is required to transfer 10% of its net income, as determined under PRC accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the Company’s registered capital. During the three and nine months ended September 30, 2023 and 2022, the Company made $0 and $0 contribution to statutory reserve fund.

 

The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital.

 

Common welfare fund

 

Common welfare fund is a voluntary fund to which the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations. The Company did not make any contribution to this fund during the three and nine months ended September 30, 2023 and 2022.

 

This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

 

15. STATUTORY RESERVES

 

Pursuant to the PRC corporate law, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings.

 

Surplus reserve fund

 

The Company is required to transfer 10% of its net income, as determined under PRC accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the Company’s registered capital. During the years ended December 31, 2022 and 2021, the Company make $0 and $0 contribution to statutory reserve fund.

 

The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital.

 

Common welfare fund

 

Common welfare fund is a voluntary fund to which the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations. The Company did not make any contribution to this fund during the years ended December 31, 2022 and 2021.

 

 

This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

 

XML 39 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
OPERATING CONTINGENCIES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
OPERATING CONTINGENCIES

16. OPERATING CONTINGENCIES

 

The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

 

The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.

 

 

Litigation

 

The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.

 

In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $392,305 (RMB 2,500,000) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $392,305 (RMB 2,500,000) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.

 

In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.

 

In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of September 30, 2023.

 

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

 

16. OPERATING CONTINGENCIES

 

The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

 

The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.

 

Litigation

 

The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.

 

In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Haichuan Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang City People’s Court of Jiangsu Province. The complaint alleges that Jian Yiao is entitled to RMB2,500,000 ($392,305) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay RMB2,500,000 ($392,305) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court of Jiangsu Province against the determination reached from the first trial.

 

In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. As of the date of this report, this legal proceeding remains pending.

 

In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of December 31, 2022 and 2021.

 

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

 

XML 40 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITION OF SUBSIDIARIES
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]    
ACQUISITION OF SUBSIDIARIES

17. ACQUISITION OF SUBSIDIARIES

 

Runcangsheng

 

On July 19, 2022, the Company entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd (“Shengshengyuan”) and Yun Chen (collectively “the Sellers”), who own 95% and 5% equity interest of Yunnan Runcangsheng Technology Co., Ltd (“Runcangsheng”), respectively.

 

Under the terms of the Transfer Agreement, the Company purchased all of the outstanding equity interest of Yunnan Runcangsheng for an aggregate purchase price of RMB 31,557,820, or $4,418,095, adjusted by $116,802, the amount equal to the initial net worth estimate minus the audited net worth of Runcangsheng as of December 31, 2021.

 

In addition to transferring their respective equity interest in Runcangsheng, both Sellers agreed to forgive any loans due to them from Runcangsheng. The acquisition was completed on September 30, 2022.

 

 

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition. Goodwill as a result of the acquisition of Runcangsheng is calculated as follows:

 

      
Total purchase considerations  $4,301,293 
Estimated fair value of assets acquired:     
Cash  $446,381 
Accounts receivable   144,813 
Accounts receivable-related party   133,011 
Advance to suppliers   3,455 
Other receivables and prepaid expense   127,909 
Inventory   469,594 
Property and equipment   1,677,272 
Intangible assets   1,406 
Operating lease right-of-use assets   1,990 
Total assets acquired   3,005,831 
Estimated fair value of liabilities assumed:     
Accounts payable   (89,801)
Accounts payable-related party   (160,911)
Advance from customers   (4,790)
Government grant   (921,473)
Taxes payable   (21,156)
Operating lease liability   (15,182)
Accrued liabilities and other payables   (1,314,995)
Total liabilities assumed   (2,528,308)
Total net assets acquired   477,523 
Goodwill as a result of the acquisition  $3,823,770 

 

During the year ended December 31, 2022, the Company recorded a goodwill impairment equal to the goodwill resulting from the acquisition of Runcangsheng.

 

The following condensed unaudited pro forma consolidated results of operations for the Company, Runcangsheng, Aixin Shangyan Hotel and Aixintang Pharmacies for the three and nine months ended September 30, 2022 present the results of operations of the Company, Runcangsheng, Aixin Shangyan Hotel, and Aixintang Pharmacies as if the acquisition of Runcangsheng occurred on January 1, 2022, respectively.

 

The pro forma results are not necessarily indicative of the actual results that would have occurred had the acquisition been completed as of the beginning of the periods presented, nor are they necessarily indicative of future consolidated results.

 

  

For the

Three Months Ended

September 30, 2022

 
Revenue  $804,470 
Operating costs and expenses   1,205,371 
Loss from operations   (400,901)
Other expense   (25,455)
Income tax expense (benefit)   (322)
Net loss  $(426,034)

 

  

For the

Nine Months Ended

September 30, 2022

 
Revenue  $1,854,617 
Operating costs and expenses   3,826,342 
Loss from operations   (1,971,725)
Other income   25,313 
Income tax expense   643 
Net loss  $(1,947,055)

 

17. ACQUISITIONS OF SUBSIDIARIES

 

 ACQUISITION OF SUBSIDIARIES

Aixin Shangyan Hotel and Aixintang Pharmacies

 

In July and September, 2021, the Company completed the required governmental procedures and obtained the documents necessary to consider the acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies completed.

 

 

Pursuant to the Hotel Purchase Agreement, AiXin HK purchased all of the outstanding equity of Aixin Shangyan Hotel from Mr. Lin and the other shareholder for a purchase price of RMB7,598,887, or $1.16 million.

 

Pursuant to the Pharmacies Purchase Agreement, AiXin HK purchased 100% ownership of Aixintang Pharmacies from Mr. Lin and the other two shareholders for a purchase price of RMB34,635,845 or $5.31 million.

 

The acquisitions will be accounted for as acquisitions of entities under common control under ASC 805-50-15-6, and the assets and liabilities acquired will be measured and recorded at the carrying amount under ASC 805-50-30-5.

 

Runcangsheng

 

On July 19, 2022, the Company entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd (“Shengshengyuan”) and Yun Chen (collectively “the Sellers”), who own 95% and 5% equity interest of Yunnan Runcangsheng Technology Co., Ltd (“Runcangsheng”), respectively.

 

Under the terms of the Transfer Agreement, the Company agreed to purchase all of the outstanding equity interest of Yunnan Runcangsheng for an aggregate purchase price of RMB31,557,820, or $4,418,095, adjusted by $116,802, the amount equal to the initial net worth estimate minus the audited net worth of Runcangsheng as of December 31, 2021. In addition to transferring their respective equity interest in Runcangsheng, both Sellers agree to forgive any loans due to them from Runcangsheng. The acquisition was completed on September 30, 2022.

 

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition. Goodwill as a result of the acquisition of Runcangsheng is calculated as follows:

 

     
Total purchase considerations  $4,301,293 
Estimated fair value of assets acquired:     
Cash  $446,381 
Accounts receivable   144,813 
Accounts receivable-related party   133,011 
Advance to suppliers   3,455 
Other receivables and prepaid expense   127,909 
Inventory   469,594 
Property and equipment   1,677,272 
Intangible assets   1,406 
Operating lease right-of-use assets   1,990 
Total assets acquired   3,005,831 
Estimated fair value of liabilities assumed:     
Accounts payable   (89,801)
Accounts payable-related party   (160,911)
Advance from customers   (4,790)
Government grant   (921,473)
Taxes payable   (21,156)
Operating lease liability   (15,182)
Accrued liabilities and other payables   (1,314,995)
Total liabilities assumed   (2,528,308)
Total net assets acquired   477,523 
Goodwill as a result of the acquisition  $3,823,770 

 

During the year ended December 31, 2022, the Company has recorded goodwill impairment in full amount.

 

The following condensed unaudited pro forma consolidated results of operations for the Company, Runcangsheng, Aixin Shangyan Hotel and Aixintang Pharmacies for the years ended December 31, 2022 and 2021 present the results of operations of the Company, Runcangsheng, Aixin Shangyan Hotel, and Aixintang Pharmacies as if the acquisitions occurred on January 1, 2022 and 2021, respectively.

 

 

The pro forma results are not necessarily indicative of the actual results that would have occurred had the acquisitions been completed as of the beginning of the periods presented, nor are they necessarily indicative of future consolidated results.

 

  

For the

Year Ended

December 31, 2022

 
Revenue  $3,168,061 
Operating costs and expenses   5,605,508 
Loss from operations   (2,437,447)
Other income   34,839 
Income tax expense   1,097 
Net loss  $(2,403,705)

 

  

For the

Year Ended

December 31, 2021

 
Revenue  $5,025,140 
Operating costs and expenses   6,052,664 
Loss from operations   (1,027,524)
Other income   100,086 
Income tax expense   284,903 
Net loss  $(1,212,341)

 

XML 41 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUBSEQUENT EVENT
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Subsequent Events [Abstract]    
SUBSEQUENT EVENT

18. SUBSEQUENT EVENT

 

The Company follows the guidance in FASB ASC 855-10 for the disclosure of subsequent events. The Company evaluated subsequent events through the date the financial statements were issued and determined the Company has no material subsequent events.

18. SUBSEQUENT EVENT

 

The Company follows the guidance in FASB ASC 855-10 for the disclosure of subsequent events. The Company evaluated subsequent events through the date the financial statements were issued and determined the Company has no material subsequent events need to be disclosed.

XML 42 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Basis of Presentation

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies, and Runcangsheng is the Chinese Renminbi (“RMB”). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies, and Runcangsheng. Intercompany transactions and accounts were eliminated in consolidation. These unaudited interim financial statements should be read in conjunction with the annual consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies and Runcangsheng is the Chinese Renminbi (“RMB”). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

 

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel, Aixintang Pharmacies and Runcangsheng. Intercompany transactions and accounts were eliminated in consolidation.

 

Going Concern

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.

 

The Company has suffered net losses of $438,156 and $4,373,511 for the three months ended September 30, 2023 and 2022, and $1,065,486 and $5,853,861 for the nine months ended September 30, 2023 and 2022, respectively, and used net cash in operating activities of $219,874 and $1,412,550 for the nine months ended September 30, 2023 and 2022, respectively, and has an accumulated deficit of $16,195,184 as of September 30, 2023. These facts and conditions raise substantial doubt about the Company’s ability to continue as a going concern. From January 1, 2023 through September 30, 2023, the Company’s cash and cash equivalents decreased from $510,128 to $412,659 mainly due to operating losses, and the use of cash to support operating activities.

 

 

Management believes that it has developed a liquidity plan, summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business. The plan includes:

 

● Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of higher margin products.

 

● Raising cash through loans from related parties and potential equity offerings.

 

While the Company’s management believes that the measures in its liquidity plan including those described above will be adequate to satisfy its liquidity requirements for the twelve months after the date that these financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.

 

The Company has suffered losses from operations of $2,569,459, used net cash in operating activities of $1,624,565 for the year ended December 31, 2022, and has accumulated deficit of $15,249,858 as of December 31, 2022. These facts and conditions have raised substantial doubt about the Company’s ability to continue as a going concern. During the year ended December 31, 2022, the Company’s cash and cash equivalents decreased from $8,556,642 to $510,128 mainly due to operating losses, and net cash used in investing and financing activities.

 

 

Management believes that it has developed a liquidity plan, as summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business. The plan includes:

 

Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of higher margin products.

Raising additional cash through loans from related parties and potential equity offerings

 

While the Company’s management believes that the measures described in the above liquidity plan will be adequate to satisfy its liquidity requirements for the twelve months after the date that the financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.

 

Global Uncertainties

Global Uncertainties

 

The Company’s liquidity may be adversely impacted by various risks and uncertainties, including, but not limited to future and current impacts of global events such as a widespread health crisis, the continuation of the war in the Ukraine or the conflict in Palestine, the outbreak of another conflict or the expansion of the conflict in Palestine to other countries, the ongoing tensions between the United States and China, the Russian Federation and certain countries in the Middle East, increases in inflation, and other risks detailed in in the Company’s Annual Report on Form 10-K or other reports filed with the Securities and Exchange Commission.

 

While the invasion of Ukraine, the conflict in Palestine and responses thereto have not interrupted the Company’s operations, these or future developments which disrupt the international financial markets could make it difficult to access debt and equity capital on attractive terms, if at all, and impact the Company’s ability to fund business activities, including proposed acquisitions.

 

COVID – 19; The Invasion of Ukraine

 

On March 11, 2020, the World Health Organization announced that infections caused by the corona virus disease of 2019 (“COVID-19”) had become pandemic. In furtherance of its zero tolerance policy, the Government of China has adopted various regulations and orders, including mandatory quarantines, limits on the number of people that may gather in one location, closing non-essential businesses and travel bans to limit the spread of the disease. Many of these measures have been relaxed from time to time in various localities. However, beginning in the second half of 2021 to the end of 2022, the rate of COVID-19 cases has fluctuated in China and has increased in many provinces and cities including in Sichuan Province, where the Company is located. As a result of such increases there have been periodic short-term lockdowns and restrictions on travel in Sichuan Province. All of the Company’s operations, in particular its direct sales business and hotel, have been adversely impacted by the travel and work restrictions imposed on a temporary basis in China and Chengdu to limit the spread of COVID-19. Since January 2023, China has dropped all COVID restrictions.

 

In response to COVID-19, the Company has implemented procedures to promote employee and customer safety. These measures will not significantly increase its operating costs. However, the Company cannot predict with certainty what measures may be taken by its suppliers and customers and the impact these measures may have on its future financial position, results of operations or cash flows.

 

The invasion of Ukraine by the Russian Federation had an immediate impact on the global economy resulting in higher prices for oil and other commodities. The United States, United Kingdom, European Union and other countries responded to Russia’s invasion of Ukraine by imposing various economic sanctions and bans. Russia has responded with its own retaliatory measures. These measures have disrupted financial and economic markets. The global impact of these measures is continually evolving and cannot be predicted with certainty and there is no assurance that Russia’s invasion of Ukraine and responses thereto will not further disrupt the global economy and financial markets.

 

While the invasion of Ukraine and responses thereto have not interrupted the Company’s operations, these or future developments resulting from the invasion of Ukraine could make it difficult to access debt and equity capital on attractive terms, if at all, and impact the Company’s ability to fund business activities, including proposed acquisitions.

 

Use of Estimates

Use of Estimates

 

In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

Significant estimates required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Use of Estimates

 

In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

 

 

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

 

Reclassification

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

 

Cash and Cash Equivalents

 

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

 

Restricted Cash

Restricted Cash

 

The restricted cash was cash maintained in temporarily frozen bank accounts held by Aixintang Pharmacy and its branches by the court for a judgement against Aixintang Pharmacy which Aixintang Pharmacy is in the process of appealing (see Note 16 – litigation).

 

 

Restricted Cash

 

The restricted cash reflects the temporary freeze of bank accounts of Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”) and its branches by the court during the appeal of a judgement against Aixintang Pharmacy (see Note 16 – litigation).

 

Accounts Receivable

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of September 30, 2023 and December 31, 2022, the bad debt allowance was $247,753 and $272,550 respectively.

 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
   For the nine Months ended September 30, 
   2023   2022 
         
Beginning balance  $272,550   $213,787 
Provision for bad debts   62,100    115,495 
Acquisition of subsidiary   -    185,561 
Recoveries/Write offs   (72,350)   - 
Effect of translation   (14,547)   (31,497)
Ending balance  $247,753   $483,346 

 

Accounts Receivable

 

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of December 31, 2022 and 2021, the bad debt allowance was $272,550 and $213,787, respectively.

 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the years ended December 31, 2022 and 2021:

 

               
   Years Ended December 31, 
   2022   2021 
         
Beginning balance  $213,787   $148,520 
Additions*   196,164    124,242 
Provisions for bad debt   45,953    - 
Recoveries/Write offs   (165,227)   (63,076)
Effect of translation   (18,127)   4,101 
Ending balance  $272,550   $213,787 

 

*Due to the acquisition of subsidiaries during the years ended December 31, 2022 and 2021

 

Inventories

Inventories

 

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. The Company recorded provision for inventory reserve of $8,558 and $0 for the nine months ended September 30, 2023 and 2022, respectively.

 

Inventories

 

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. Management periodically evaluates the composition of its inventories to identify slow-moving and obsolete inventories to determine if a valuation allowance is required. The balance of reserve for inventory valuation as of December 31, 2022 and 2021 was $73,821 and $0, respectively.

 

 

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of September 30, 2023 and December 31, 2022, there were no significant impairments of its long-lived assets.

 

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds its fair value. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Based on its review, the Company believes that, as of December 31, 2022 and 2021, there were no significant impairments of its long-lived assets.

 

Goodwill

Goodwill

 

The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.

 

The Company completed the required testing of goodwill for impairment as of December 31, 2022, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the uncertainty of the future cash flows indicates that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $3,823,770, in non-operating expenses in the statement of operations and comprehensive income (loss) during the year ended December 31, 2022.

 

Goodwill

 

The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate the carrying value may not be recoverable. In testing goodwill for impairment, the Company may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the qualitative assessment indicates that goodwill impairment is more likely than not, the Company performs a two-step impairment test. The Company tests goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. The Company estimates the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions.

 

The Company completed the required testing of goodwill for impairment as of December 31, 2022, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the Company anticipates future cash flows indicate that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $3,823,770, in non-operating expenses in the statement of operation and comprehensive income(loss).

 

 

Income Taxes

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At September 30, 2023 and December 31, 2022, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits is classified as interest expense and penalties are classified in selling, general and administrative expenses in the statement of income.

 

At December 31, 2022 and 2021, the Company did not take any uncertain positions that would necessitate recording a tax related liability.

 

Revenue Recognition

Revenue Recognition

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

The Company’s revenue recognition policies for its various operating segments are as follows:

 

Products

 

The Company’s revenue from sales of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have the option of asking for an exchange for products with the same value.

 

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Pharmacies

 

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligations. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are eligible for the PRC VAT of 0% as it qualifies as a small business.

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for its sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small business subject to exemption.

 

 

Revenue Recognition

 

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and have been primarily from the delivery of products and the performance of services, and the Company has no significant post-delivery obligations, this did not result in a material recognition of revenue on the Company’s accompanying consolidated financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
     
  identification of performance obligation in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation of the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

 

 

The Company’s revenue recognition policies for its various operating segments are as follows:

 

Advertising and Products

 

Advertising Revenue

 

Commencing in the third quarter of 2019, AiXin Zhonghong began to provide advertising services to its clients. Advertising contracts are signed to establish the price and advertising services to be provided. Pursuant to the advertising contracts, the Company provides advertising and marketing services to its clients through exhibition events, conferences, and person-to-person marketing. The Company performs a credit assessment of the customer to assess the collectability of the contract price prior to entering into contracts.

 

Most of the advertisement contracts designated that the Company perform such advertising services for its clients through exhibition events, conferences, and person-to-person marketing during the contracted period, regardless of the number of such events. As such, the Company determined that the performance obligation is satisfied over time during the contracted period and revenue is recognized accordingly. Such advertising revenue amounted to $0 and $1,944,811 for the years ended December 31, 2022 and 2021, respectively.

 

All of the advertising revenue is subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Product Revenue

 

The Company’s revenue from sale of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have options of asking for an exchange for products with the same value.

 

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

 

Hotel

 

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

 

Pharmacies

 

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligation. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are eligible for the PRC VAT of 0% as it qualifies as a small business.

 

 

Manufacture and Sale

 

The Company’s new subsidiary Runcangsheng recognizes revenue at the time products are shipped as this satisfies its performance obligation. The Company records a receivable for the sales when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 13% unless it is a qualified small subject to exemption.

 

Unearned Revenue

Unearned Revenue

 

The Company’s unearned revenue primarily consists of advances received from customers for the purchase of products prior to the delivery of goods, and for the rental of hotel rooms prior to the delivery of service. The delivery of products and room rental services is (normally within one year) based upon contract terms and customer demand.

 

Unearned Revenue

 

The Company’s unearned revenue primarily consists of advances received from customers for the rental of hotel rooms prior to the delivery of service. The room rental services are delivered (normally within one year) based upon contract terms and customer demand.

 

Concentration of Credit Risk

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

 

During the three and nine months ended September 30, 2023 and 2022, the Company had no customer that accounted for over 10% of its total revenue.

 

During the three months ended September 30, 2023, the Company had one supplier that accounted for 20% of its total purchases.

 

During the nine months ended September 30, 2023, the Company had two suppliers that accounted for 15% and 12%, respectively, of its total purchases.

 

During the three months ended September 30, 2022, the Company had one supplier that accounted for 35% of its total purchases.

 

During the nine months ended September 30, 2022, the Company had one supplier that accounted for 20% of its total purchases.

 

Concentration of Credit Risk

 

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

 

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB500,000 ($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

 

During the year ended December 31, 2022, the Company had no customer that accounted for over 10% of its total revenue.

 

During the year ended December 31, 2021, the Company had two major customers that accounted for over 10% of its total revenue.

 

Customer  Net sales for the year ended
December 31, 2021
   % of total revenue 
A(1)  $1,286,792    42%
B   658,018    21%

 

During the year ended December 31, 2022, the Company had three major suppliers that accounted for over 10% of its total purchases.

 

Supplier  Net purchases for the
year ended
December 31, 2022
   % of total purchase 
C  $189,150    14%
D (2)   149,806    11%

 

 

During the year ended December 31, 2021, the Company had one major supplier accounted for over 10% of its total purchase.

 

Supplier  Net purchases for the
year ended
December 31, 2021
   % of total purchase 
E  $233,187    40%

 

(1) Represented advertising revenues from this customer during the year ended December 31, 2021. The Company also purchased inventory from this customer in year ended December 31, 2021.
(2) The Company purchased inventory from this supplier, Runcangsheng, in the year ended December 31, 2022. The Company acquired all of the outstanding equity of Runcangsheng on September 30, 2022 (see Note 17).

 

Leases

Leases

 

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

 

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

 

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of September 30, 2023 and December 31, 2022. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

 

 

Leases

 

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

 

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

 

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other assets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of December 31, 2022 and 2021. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

 

Statement of Cash Flows

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Statement of Cash Flows

 

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

Fair Value of Financial Instruments

 

The carrying amounts of certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

 

Fair Value Measurements and Disclosures

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

As of September 30, 2023 and December 31, 2022, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

 

Fair Value Measurements and Disclosures

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

 

  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

As of December 31, 2022 and 2021, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

 

Foreign Currency Translation and Comprehensive Income (Loss)

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 consisted of net income (loss) and foreign currency translation adjustments.

 

Foreign Currency Translation and Comprehensive Income (Loss)

 

The functional currency of the Company is RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

 

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

 

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the year ended December 31, 2022 and 2021 consisted of net income (loss) and foreign currency translation adjustments.

 

Earnings per Share

Earnings per Share

 

Basic income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of September 30, 2023 and December 31, 2022, the Company did not have any potentially dilutive instruments.

 

 

Earnings per Share

 

Basic income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during the period.

 

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

As of December 31, 2022 and 2021, the Company did not have any potentially dilutive instruments.

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company periodically grants stock options, warrants and awards to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option, stock warrant and stock award grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option, stock warrant and stock award grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Stock-Based Compensation

 

The Company periodically grants stock options, warrants and stock awards to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option, stock warrant and stock award grants to employees based on the authoritative guidance provided by the FASB where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option, stock warrant and stock award grants to non-employees in accordance with the authoritative guidance of the FASB where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Segment Reporting

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

The Company manages its business as four operating segments, products, pharmacies, hotel, and manufacture and sales, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

 

The following table shows the Company’s operations by business segment for the three months ended September 30, 2023 and 2022.

 

   2023   2022 
   For the Three Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $208,699   $338,327 
Pharmacies   273,416    164,735 
Hotel   169,462    169,724 
Manufacture and sale   415,342    - 
Total revenues, net  $1,066,919   $672,786 
           
Operating costs and expenses          
Products          
Cost of goods sold  $67,709   $90,391 
Operating expenses   421,417    301,624 
Pharmacies          
Cost of goods sold   126,459    124,992 
Operating expenses   115,006    144,164 
Hotel          
Hotel operating costs   447,419    404,322 
Operating expenses   61,859    141,197 
Manufacture and sale          
Cost of goods sold   315,555    - 
Operating expenses   246,750    - 
Total operating costs and expenses  $1,802,174   $1,206,690 
           
Income (loss) from operations          
Products  $(280,427)  $(53,688)
Pharmacies   31,951    (104,421)
Hotel   (339,816)   (375,795)
Manufacture and sale   (146,963)   - 
Loss from operations  $(735,255)  $(533,904)

 

 

The following table shows the Company’s operations by business segment for the nine months ended September 30, 2023 and 2022.

 

           
   For the Nine Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $1,064,668   $371,016 
Pharmacies   802,118    517,674 
Hotel   892,409    623,661 
Manufacture and sale   538,494    - 
Total revenues, net  $3,297,689   $1,512,351 
           
Operating costs and expenses          
Products          
Cost of goods sold  $367,237   $98,809 
Operating expenses   1,249,461    961,885 
Pharmacies          
Cost of goods sold   446,967    395,096 
Operating expenses   361,200    467,315 
Hotel          
Hotel operating costs   1,387,993    1,334,041 
Operating expenses   106,219    300,501 
Manufacture and sale          
Cost of goods sold   322,207    - 
Operating expenses   448,398    - 
Total operating costs and expenses  $4,689,682   $3,557,647 
           
Loss from operations          
Products  $(552,030)  $(689,678)
Pharmacies   (6,049)   (344,737)
Hotel   (601,803)   (1,010,881)
Manufacture and sale   (232,111)   - 
Loss from operations  $(1,391,993)  $(2,045,296)

 

Segment assets  As of
September 30, 2023
   As of
December 31, 2022
 
Products  $288,375   $410,754 
Pharmacies   726,904    758,675 
Hotel   449,903    970,385 
Manufacture and sale   2,814,895    2,911,070 
Total assets  $4,280,077   $5,050,884 

 

As the acquisition of Runcangsheng was consummated as of September 30, 2022 (see Note 17), the revenues and operating results of the manufacture and sale segment were included in the financial statements of the Company beginning on October 1, 2022.

 

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the Company for making operating decisions assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

 

 

The Company manages its business as four operating segments, advertising and products, pharmacies, hotels, and manufacture and sale, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

 

The following table shows the Company’s operations by business segment for the year ended December 31, 2022 and 2021. Revenues and expenses for the Pharmacies, Hotel and Manufacture and sale segments commenced as of the respective dates of the completion of their acquisitions:

 

               
   For the Years Ended December 31, 
   2022   2021 
Net revenue          
Advertising and products  $823,930   $2,406,988 
Pharmacies   789,347    280,447 
Hotel   856,884    378,798 
Manufacture and sale   238,399    - 
Total revenues, net  $2,708,560   $3,066,233 
           
Operating costs and expenses          
Advertising and products          
Cost of goods sold  $171,345   $316,750 
Operating expenses   1,526,246    1,344,543 
Pharmacies          
Cost of goods sold   578,092    218,735 
Operating expenses   622,835    252,513 
Hotel          
Hotel operating costs   1,739,948    744,594 
Operating expenses   310,902    216,036 
Manufacture and sale          
Cost of goods sold   353,723    - 
Operating expense   (25,072)   - 
Total operating costs and expenses  $5,278,019   $3,093,171 
           
(Loss) income from operations          
Advertising and products  $(873,661)  $745,695 
Pharmacies   (411,580)   (190,801)
Hotel   (1,193,966)   (581,832)
Manufacture and Sale   (90,252)   - 
(Loss) income from operations  $(2,569,459)  $(26,938)

 

         
Segment assets  As of
December 31, 2022
   As of
December 31, 2021
 
Advertising and products  $410,754   $8,914,211 
Pharmacies   758,675    931,706 
Hotel   970,385    1,814,429 
Manufacture and sale   2,911,070    - 
Total assets  $5,050,884   $11,660,346 

 

As the acquisition of Runcangsheng has been consummated as of December 31, 2022 (see Note 17), the revenues and operating results of the manufacture and sale segment will be included in the financial statements of the Company beginning on October 1, 2022.

 

 

New Accounting Pronouncements

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its FV, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis. As a smaller reporting company, the standard will be effective for the Company for interim and annual reporting periods beginning after December 15, 2022, with early adoption permitted. The adoption of ASU 2017-04 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

New Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company is currently evaluating the impact that the standard will have on its consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis. As a smaller reporting company, the standard will be effective for the Company for interim and annual reporting periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of adopting this standard on the Company’s consolidated financial statements presentation or disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. For SEC filers, excluding smaller reporting companies, ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of the fiscal year of adoption and cannot adopt the guidance in an interim reporting period. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

Unaudited Interim Financial Information

Unaudited Interim Financial Information

 

These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission that permit reduced disclosure for interim periods. Therefore, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023.

 

 
XML 43 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
   For the nine Months ended September 30, 
   2023   2022 
         
Beginning balance  $272,550   $213,787 
Provision for bad debts   62,100    115,495 
Acquisition of subsidiary   -    185,561 
Recoveries/Write offs   (72,350)   - 
Effect of translation   (14,547)   (31,497)
Ending balance  $247,753   $483,346 

The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the years ended December 31, 2022 and 2021:

 

               
   Years Ended December 31, 
   2022   2021 
         
Beginning balance  $213,787   $148,520 
Additions*   196,164    124,242 
Provisions for bad debt   45,953    - 
Recoveries/Write offs   (165,227)   (63,076)
Effect of translation   (18,127)   4,101 
Ending balance  $272,550   $213,787 

 

*Due to the acquisition of subsidiaries during the years ended December 31, 2022 and 2021
SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 

 

Office furniture   5 years 
Electronic equipment   2-3 years 
Machinery   3 years 
Leasehold improvements   3 years 
Vehicles   5 years 
SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS  

During the year ended December 31, 2021, the Company had two major customers that accounted for over 10% of its total revenue.

 

Customer  Net sales for the year ended
December 31, 2021
   % of total revenue 
A(1)  $1,286,792    42%
B   658,018    21%

 

During the year ended December 31, 2022, the Company had three major suppliers that accounted for over 10% of its total purchases.

 

Supplier  Net purchases for the
year ended
December 31, 2022
   % of total purchase 
C  $189,150    14%
D (2)   149,806    11%

 

 

During the year ended December 31, 2021, the Company had one major supplier accounted for over 10% of its total purchase.

 

Supplier  Net purchases for the
year ended
December 31, 2021
   % of total purchase 
E  $233,187    40%

 

(1) Represented advertising revenues from this customer during the year ended December 31, 2021. The Company also purchased inventory from this customer in year ended December 31, 2021.
(2) The Company purchased inventory from this supplier, Runcangsheng, in the year ended December 31, 2022. The Company acquired all of the outstanding equity of Runcangsheng on September 30, 2022 (see Note 17).
SCHEDULE OF SEGMENTS INFORMATION

The following table shows the Company’s operations by business segment for the three months ended September 30, 2023 and 2022.

 

   2023   2022 
   For the Three Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $208,699   $338,327 
Pharmacies   273,416    164,735 
Hotel   169,462    169,724 
Manufacture and sale   415,342    - 
Total revenues, net  $1,066,919   $672,786 
           
Operating costs and expenses          
Products          
Cost of goods sold  $67,709   $90,391 
Operating expenses   421,417    301,624 
Pharmacies          
Cost of goods sold   126,459    124,992 
Operating expenses   115,006    144,164 
Hotel          
Hotel operating costs   447,419    404,322 
Operating expenses   61,859    141,197 
Manufacture and sale          
Cost of goods sold   315,555    - 
Operating expenses   246,750    - 
Total operating costs and expenses  $1,802,174   $1,206,690 
           
Income (loss) from operations          
Products  $(280,427)  $(53,688)
Pharmacies   31,951    (104,421)
Hotel   (339,816)   (375,795)
Manufacture and sale   (146,963)   - 
Loss from operations  $(735,255)  $(533,904)

 

 

The following table shows the Company’s operations by business segment for the nine months ended September 30, 2023 and 2022.

 

           
   For the Nine Months Ended September 30, 
   2023   2022 
Net revenue          
Products  $1,064,668   $371,016 
Pharmacies   802,118    517,674 
Hotel   892,409    623,661 
Manufacture and sale   538,494    - 
Total revenues, net  $3,297,689   $1,512,351 
           
Operating costs and expenses          
Products          
Cost of goods sold  $367,237   $98,809 
Operating expenses   1,249,461    961,885 
Pharmacies          
Cost of goods sold   446,967    395,096 
Operating expenses   361,200    467,315 
Hotel          
Hotel operating costs   1,387,993    1,334,041 
Operating expenses   106,219    300,501 
Manufacture and sale          
Cost of goods sold   322,207    - 
Operating expenses   448,398    - 
Total operating costs and expenses  $4,689,682   $3,557,647 
           
Loss from operations          
Products  $(552,030)  $(689,678)
Pharmacies   (6,049)   (344,737)
Hotel   (601,803)   (1,010,881)
Manufacture and sale   (232,111)   - 
Loss from operations  $(1,391,993)  $(2,045,296)

 

Segment assets  As of
September 30, 2023
   As of
December 31, 2022
 
Products  $288,375   $410,754 
Pharmacies   726,904    758,675 
Hotel   449,903    970,385 
Manufacture and sale   2,814,895    2,911,070 
Total assets  $4,280,077   $5,050,884 

The following table shows the Company’s operations by business segment for the year ended December 31, 2022 and 2021. Revenues and expenses for the Pharmacies, Hotel and Manufacture and sale segments commenced as of the respective dates of the completion of their acquisitions:

 

               
   For the Years Ended December 31, 
   2022   2021 
Net revenue          
Advertising and products  $823,930   $2,406,988 
Pharmacies   789,347    280,447 
Hotel   856,884    378,798 
Manufacture and sale   238,399    - 
Total revenues, net  $2,708,560   $3,066,233 
           
Operating costs and expenses          
Advertising and products          
Cost of goods sold  $171,345   $316,750 
Operating expenses   1,526,246    1,344,543 
Pharmacies          
Cost of goods sold   578,092    218,735 
Operating expenses   622,835    252,513 
Hotel          
Hotel operating costs   1,739,948    744,594 
Operating expenses   310,902    216,036 
Manufacture and sale          
Cost of goods sold   353,723    - 
Operating expense   (25,072)   - 
Total operating costs and expenses  $5,278,019   $3,093,171 
           
(Loss) income from operations          
Advertising and products  $(873,661)  $745,695 
Pharmacies   (411,580)   (190,801)
Hotel   (1,193,966)   (581,832)
Manufacture and Sale   (90,252)   - 
(Loss) income from operations  $(2,569,459)  $(26,938)

 

         
Segment assets  As of
December 31, 2022
   As of
December 31, 2021
 
Advertising and products  $410,754   $8,914,211 
Pharmacies   758,675    931,706 
Hotel   970,385    1,814,429 
Manufacture and sale   2,911,070    - 
Total assets  $5,050,884   $11,660,346 
XML 44 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER RECEIVABLES AND PREPAID EXPENSES (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Other Receivables And Prepaid Expenses    
SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES

Other receivables and prepaid expenses consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Deposits  $12,245   $15,546 
Prepaid expenses, including related party   102,704    9,490 
Employees’ social insurance   7,379    10,124 
Others   20,996    7,471 
Total  $143,324   $42,631 

 

Other receivables and prepaid expenses consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Deposits  $15,546   $68,433 
Prepaid expenses   9,490    50,221 
Employees’ social insurance   10,124    13,839 
Others   7,471    10,788 
Total  $42,631   $143,281 
XML 45 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORIES (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
SCHEDULE OF INVENTORIES

Inventories consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Raw material  $142,519   $62,462 
Work in process   15,265    15,315 
Finished goods-health supplements   -    521 
Drugs, pharmaceutical and nutritional products   486,273    412,129 
Food and beverage, hotel supplies and consumables   77,600    82,646 
Total  $721,657   $573,073 
Less: reserve for inventory   78,034    73,821 
Total inventories, net  $643,623   $499,252 

 

Inventories consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Raw material  $62,462   $- 
Work in process   15,315    - 
Finished goods-health supplements   521    6,201 
Drugs, pharmaceutical and nutritional products   412,129    122,966 
Food and beverage, hotel supplies and consumables   82,646    104,287 
Total  $573,073   $233,454 
Less: reserve for inventory   73,821    - 
Total inventories, net  $499,252   $233,454 
XML 46 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT, NET (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Abstract]    
SCHEDULE OF PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Vehicles  $403,505   $426,836 
Office furniture   78,037    82,549 
Electronic equipment   21,101    20,607 
Machinery   1,258,029    1,241,778 
Leasehold improvements   1,076,824    1,139,087 
Other   21,777    17,485 
Total   2,859,273    2,928,342 
Less: Accumulated depreciation   (1,200,388)   (956,549)
Property and equipment, net  $1,658,885   $1,971,793 

Property and equipment consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Vehicles  $426,836   $295,502 
Office furniture   82,549    64,263 
Electronic equipment   20,607    22,304 
Machinery   1,241,778    106,080 
Leasehold improvements   1,139,087    256,548 
Other   17,485    6,374 
Total   2,928,342    751,071 
Less: Accumulated depreciation   (956,549)   (460,923)
Property and equipment, net  $1,971,793   $290,148 
XML 47 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLE ASSET, NET (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
SCHEDULE OF INTANGIBLE ASSET

Intangible asset consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Software  $10,609   $8,564 
Less: Accumulated amortization   (7,769)   (7,295)
Intangible asset, net  $2,840   $1,269 

Intangible asset consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Software  $8,564   $7,896 
Less: Accumulated amortization   (7,295)   (5,956)
Intangible asset, net  $1,269   $1,940 
XML 48 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
TAXES PAYABLE (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Taxes Payable    
SCHEDULE OF TAX PAYABLE

Taxes payable consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Value-added  $62,515   $56,806 
Income   28,235    30,919 
City construction   5,027    3,746 
Education   2,193    2,184 
Other   12,276    10,445 
Taxes payable  $110,246   $104,100 

 

Taxes payable consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Value-added  $56,806   $97,917 
Income   30,919    109,396 
City construction   3,746    7,018 
Education   2,184    5,064 
Other   10,445    13,242 
Taxes payable  $104,100   $232,637 
XML 49 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCRUED LIABILITIES AND OTHER PAYABLES (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES

Accrued liabilities and other payables consisted of the following at September 30, 2023 and December 31, 2022:

 

   September 30, 2023   December 31, 2022 
Accrued employees’ social insurance  $281,728   $270,349 
Accrued payroll and commission   248,759    307,331 
Accrued rent expense   74,415    32,746 
Construction payable   1,196,037    1,384,674 
Payable for equipment purchase   29,213    32,278 
Accrued professional fees   247,786    233,894 
Deposit   10,690    11,308 
Other payables   47,504    83,910 
Total  $2,136,132   $2,356,490 

 

Accrued liabilities and other payables consisted of the following at December 31, 2022 and 2021:

 

   December 31, 2022   December 31, 2021 
Accrued employees’ social insurance  $270,349   $327,735 
Accrued payroll and commission   307,331    179,183 
Accrued rent expense   32,746    29,000 
Construction payable   1,384,674    111,807 
Payable for equipment purchase   32,278    - 
Accrued professional fees   233,894    50,840 
Deposit   11,308    12,239 
Other payables   83,910    41,596 
Total  $2,356,490   $752,400 
XML 50 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASE (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Lease    
SCHEDULE OF OPERATING LEASE LIABILITIES

Balance sheet information related to the Company’s leases is presented below:

 

   September 30, 2023   December 31, 2022 
Operating Leases          
Operating lease right-of-use assets  $457,793   $999,285 
           
Operating lease liabilities – current  $439,959   $883,583 
Operating lease liability – non-current   158,069    194,725 
Total operating lease liabilities  $598,028   $1,078,308 

Balance sheet information related to the Company’s leases is presented below:

 

   December 31, 2022   December 31, 2021 
Operating Leases          
Operating lease right-of-use assets  $999,285   $2,049,775 
           
Operating lease liabilities – current  $883,583   $848,230 
Operating lease liability – non-current   194,725    1,138,710 
Total operating lease liabilities  $1,078,308   $1,986,940 
SCHEDULE OF OPERATING LEASE EXPENSES

The following provides details of the Company’s lease expenses:

 

   2023   2022 
   Three Months Ended September 30, 
   2023   2022 
Operating lease expenses  $200,716   $183,051 
           

 

   2023   2022 
   Nine Months Ended September 30, 
   2023   2022 
Operating lease expenses  $618,085   $632,496 
           

The following provides details of the Company’s lease expenses:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Operating lease expenses  $837,425   $411,607 
           
SCHEDULE OF OTHER INFORMATION RELATED LEASES

Other information related to leases is presented below:

 

   Nine Months Ended September 30, 
   2023   2022 
Cash Paid for Amounts Included In Measurement of Liabilities:          
Operating cash flows from operating leases  $500,056    525,979 
           
Weighted Average Remaining Lease Term:          
Operating leases   1.26 years    1.65 years 
           
Weighted Average Discount Rate:          
Operating leases   4.75%   4.75%

Other information related to leases is presented below:

 

   Years Ended December 31, 
   2022   2021 
Cash Paid For Amounts Included In Measurement of Liabilities:        
Operating cash flows from operating leases  $710,865   $473,508 
           
Weighted Average Remaining Lease Term:          
Operating leases   1.45 years    2.32 years 
           
Weighted Average Discount Rate:          
Operating leases   4.75%   4.75%
SCHEDULE OF MATURITIES OF LEASE LIABILITIES

Maturities of lease liabilities were as follows:

 

      
For the year ending December 31:     
2023 (excluding the nine months ended September 30, 2023)  $354,246 
2024   130,992 
2025   79,844 
2026   36,366 
2027   8,224 
Thereafter   3,427 
Total lease payments   613,099 
Less: imputed interest   (15,071)
Total lease liabilities   598,028 
Less: current portion   (439,959)
Lease liabilities – non-current portion  $158,069 

Maturities of lease liabilities were as follows:

 

    
For the year ending December 31:    
2023  $899,044 
2024   127,361 
2025   53,196 
2026   22,433 
Total lease payments   1,102,034 
Less: imputed interest   (23,726)
Total lease liabilities   1,078,308 
Less: current portion   (883,583)
Lease liabilities – non-current portion  $194,725 
XML 51 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Related Party Transactions [Abstract]    
SCHEDULE OF RELATED PARTY TRANSACTIONS

Due from related parties consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $7,573   $9,708 
Sichuan Aixin Investment Co., Ltd   8,983    145 
Huiliang Jiao   135,328    - 
Xiaoyan Zhou   11,668    - 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   25,056    26,125 
Chengdu WenJiang Aixin Huiwan Pharmacy Co., Ltd.   3,888    - 
Chengdu Heshengyuan Pharmacy Co., Ltd.   3,379    - 
Chengdu Zhiweibing Pharmacy Co., Ltd.   7,859    - 
Chengdu Tongtai Tang Pharmacy Co. Ltd.   2,810    - 
Chengdu city Wuhou District Xiaofei Pharmacy Co., Ltd   8,115    - 
Chongqing Aixin Hui Pharmacy Co., Ltd.   402    - 
Sichuan Xintang Xinfu Pharmacy Chain Co, Ltd   344    - 
Sichuan Aixintang Xinfu Chain Pharmacy Co., Ltd.   302    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   26,822    34,622 
Chengdu Cigu Foshou Pharmacy   2,028    - 
Mianyang Aixin Cunshan Pharmacy   5,874    - 
Chengdu Aixin International Travel Service Co., Ltd   356    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   133,801    12,502 
Total  $384,588   $83,102 

 

Due to related parties

 

Due to related parties consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Quanzhong Lin  $243,323   $140,644 
Yirong Shen   84,978    89,892 
Sichuan Haosen Haichuan business management Co. Ltd   57    - 
Sichuan Yunxi Pharmacy Co. Ltd   449    - 
Chengdu Yi Yan Tang Pharmacy Co. Ltd.   162    - 
Chengdu Aixin International travel service Co, Ltd   4,950    6,346 
Total  $333,919   $236,882 

Advance to related parties consisted of the following as of the periods indicated:

 

   December 31, 2022   December 31, 2021 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd.  $9,708   $4,583 
Sichuan Aixin Investment Co., Ltd.   145    4,237 
Chengdu Fuxiang Tang Pharmacy Co., Ltd.   26,125    - 
Chengdu Wenjiang district Heneng hupu Pharmacy Co., Ltd   34,622    - 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.   12,502    10,235 
Total  $83,102   $19,055 

 

 

Advance from related parties

 

Advance from related parties consisted of the following as of the periods indicated:

 

   December 31, 2022   December 31, 2021 
Quanzhong Lin  $140,644   $1,822,705 
Yirong Shen   89,892    97,292 
Branch manager   -    1,667 
Chengdu Aixin E-Commerce Company Ltd.   -    15,378 
Chengdu Aixin International travel service Co, Ltd   6,346    2,388 
Aixin Life Beauty   -    7,724 
Total  $236,882   $1,947,154 
SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY

Prepaid expense – related party

 

Prepaid expense – related party consisted of the following as of the periods indicated:

   September 30, 2023   December 31, 2022 
Chengdu Aixin International Travel Service Co., Ltd  $94,361   $          - 

 

Accounts payable – related party

 

Accounts payable – related party consisted of the following as of the periods indicated:

 

   September 30, 2023   December 31, 2022 
Luquan Shengcaofeng Biotechnology Co., Ltd.  $           -   $165,958 

 

Luquan Shengcaofeng Biotechnology Co., Ltd. is an entity controlled by Mr. Huiliang Jiao, a Director of the Company.

 
XML 52 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES

The components of the provision for income taxes for the years ended December 31, 2022 and 2021 consisted of the following:

 

   2022   2021 
   For the Year Ended December 31, 
   2022   2021 
Current:        
China  $(761)  $292,891 
Total current   (761)   292,891 
Deferred:          
China   1,858    (18,570)
Total deferred   1,858    (18,570)
Total income tax expense  $1,097   $274,321 
SCHEDULE OF DEFERRED TAX ASSETS

Deferred tax assets as of December 31, 2022 and 2021 consisted of the following:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Accumulated amortization  $15,556   $18,795 
SCHEDULE OF EFFECTIVE INCOME TAX RATE

The following table reconciles the statutory rates to the Company’s effective tax rate for years ended December 31, 2022 and 2021:

 

   2022   2021 
Statutory U.S. federal income tax rate   (21.0)%   21.0%
Foreign tax rate differential   (3.8)%   216.5%
Change in valuation allowances   25.0%   3,634.4%
Other   (0.2)%   -%
Effective combined tax rate   0.0%   3,871.9%
XML 53 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITION OF SUBSIDIARIES (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]    
SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition. Goodwill as a result of the acquisition of Runcangsheng is calculated as follows:

 

      
Total purchase considerations  $4,301,293 
Estimated fair value of assets acquired:     
Cash  $446,381 
Accounts receivable   144,813 
Accounts receivable-related party   133,011 
Advance to suppliers   3,455 
Other receivables and prepaid expense   127,909 
Inventory   469,594 
Property and equipment   1,677,272 
Intangible assets   1,406 
Operating lease right-of-use assets   1,990 
Total assets acquired   3,005,831 
Estimated fair value of liabilities assumed:     
Accounts payable   (89,801)
Accounts payable-related party   (160,911)
Advance from customers   (4,790)
Government grant   (921,473)
Taxes payable   (21,156)
Operating lease liability   (15,182)
Accrued liabilities and other payables   (1,314,995)
Total liabilities assumed   (2,528,308)
Total net assets acquired   477,523 
Goodwill as a result of the acquisition  $3,823,770 

The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition. Goodwill as a result of the acquisition of Runcangsheng is calculated as follows:

 

     
Total purchase considerations  $4,301,293 
Estimated fair value of assets acquired:     
Cash  $446,381 
Accounts receivable   144,813 
Accounts receivable-related party   133,011 
Advance to suppliers   3,455 
Other receivables and prepaid expense   127,909 
Inventory   469,594 
Property and equipment   1,677,272 
Intangible assets   1,406 
Operating lease right-of-use assets   1,990 
Total assets acquired   3,005,831 
Estimated fair value of liabilities assumed:     
Accounts payable   (89,801)
Accounts payable-related party   (160,911)
Advance from customers   (4,790)
Government grant   (921,473)
Taxes payable   (21,156)
Operating lease liability   (15,182)
Accrued liabilities and other payables   (1,314,995)
Total liabilities assumed   (2,528,308)
Total net assets acquired   477,523 
Goodwill as a result of the acquisition  $3,823,770 
SCHEDULE OF BUSINESS ACQUISITION PRO FORMA

The pro forma results are not necessarily indicative of the actual results that would have occurred had the acquisition been completed as of the beginning of the periods presented, nor are they necessarily indicative of future consolidated results.

 

  

For the

Three Months Ended

September 30, 2022

 
Revenue  $804,470 
Operating costs and expenses   1,205,371 
Loss from operations   (400,901)
Other expense   (25,455)
Income tax expense (benefit)   (322)
Net loss  $(426,034)

 

  

For the

Nine Months Ended

September 30, 2022

 
Revenue  $1,854,617 
Operating costs and expenses   3,826,342 
Loss from operations   (1,971,725)
Other income   25,313 
Income tax expense   643 
Net loss  $(1,947,055)

 

  

For the

Year Ended

December 31, 2022

 
Revenue  $3,168,061 
Operating costs and expenses   5,605,508 
Loss from operations   (2,437,447)
Other income   34,839 
Income tax expense   1,097 
Net loss  $(2,403,705)

 

  

For the

Year Ended

December 31, 2021

 
Revenue  $5,025,140 
Operating costs and expenses   6,052,664 
Loss from operations   (1,027,524)
Other income   100,086 
Income tax expense   284,903 
Net loss  $(1,212,341)
XML 54 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)
Feb. 17, 2023
$ / shares
shares
Jul. 19, 2022
USD ($)
Jul. 19, 2022
CNY (¥)
Jul. 19, 2022
Jun. 02, 2021
USD ($)
Jun. 02, 2021
CNY (¥)
May 25, 2021
USD ($)
May 25, 2021
CNY (¥)
Aug. 17, 2020
Dec. 12, 2017
shares
Feb. 02, 2017
USD ($)
shares
Sep. 30, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Common stock, shares, outstanding | shares 24,999,842                     24,999,842 24,999,842 24,999,842
Common stock, par value | $ / shares $ 0.00001                     $ 0.00001 $ 0.00001 $ 0.00001
Stockholders' Equity, Reverse Stock Split 1 for 2 reverse stock split               one (1)-for-four (4) reverse stock          
China Concentric Capital Group [Member]                            
Purchase price of common stock | $                     $ 300,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent                     65.00%      
Aixin Shangyan Hotel Management [Member]                            
Business combination consideration transferred             $ 1,160,000 ¥ 7,598,887            
AiXintang Pharmacises [Member]                            
Business combination consideration transferred         $ 5,310,000 ¥ 34,635,845                
Yunnan Shengshengyuan Technology Co Ltd [Member]                            
Business combination consideration transferred   $ 4,418,095 ¥ 31,557,820                      
Business Combination, Consideration Transferred, Other | $   $ 116,802                        
Yunnan Shengshengyuan Technology Co Ltd [Member] | Transfer Agreement [Member]                            
Business Acquisition, Description of Acquired Entity   On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. On July 19, 2022, HK Aixin entered into an Equity Transfer Agreement with Yunnan Shengshengyuan Technology Co., Ltd, (“Yunnan Shengshengyuan”) and Yun Chen (together, the “Sellers”), the shareholders of Yunnan Runcangsheng Technology Company Ltd. (“Runcangsheng”). Yunnan Shengshengyuan owns in excess of 95% of the outstanding equity of Runcangsheng. The remaining equity interest is owned by Yun Chen.                    
Chengdu Aixintang Pharmacy Co Ltd [Member] | Pharmacies Purchase Agreement [Member]                            
Business Acquisition, Description of Acquired Entity         On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Pharmacies Purchase Agreement”) with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its three shareholders, Quanzhong Lin, Ting Li and Xiao Ling Li (“Transferor”). Mr. Lin owned in excess of 95% of the outstanding equity the Aixintang Pharmacies. The remaining equity interest was owned by Ting Li and Xiao Ling Li. On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement (the “Pharmacies Purchase Agreement”) with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its three shareholders, Quanzhong Lin, Ting Li and Xiao Ling Li (“Transferor”). Mr. Lin owned in excess of 95% of the outstanding equity the Aixintang Pharmacies. The remaining equity interest was owned by Ting Li and Xiao Ling Li.                
China Concentric Capital Group [Member]                            
Equity Method Investment, Ownership Percentage                   71.00% 65.00%      
Purchase price of common stock | $                     $ 300,000      
Equity Transfer Agreement [Member] | Aixin Shangyan Hotel Management [Member]                            
Equity Method Investment, Ownership Percentage             100.00% 100.00%            
Quanzhong Lin [Member]                            
Common stock, shares, outstanding | shares                     3,690,176      
Stock issued during period, shares, new issues | shares                   28,419,075        
XML 55 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]        
Beginning balance $ 272,550 $ 213,787 $ 213,787 $ 148,520
Additions [1]     196,164 124,242
Provision for bad debts 62,100 115,495 45,953
Acquisition of subsidiary 185,561    
Recoveries/Write offs (72,350) (165,227) (63,076)
Effect of translation (14,547) (31,497) (18,127) 4,101
Ending balance $ 247,753 $ 483,346 $ 272,550 $ 213,787
[1] Due to the acquisition of subsidiaries during the years ended December 31, 2022 and 2021
XML 56 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES (Details)
Sep. 30, 2023
Dec. 31, 2022
Office Furniture [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life 5 years 5 years
Office Furniture [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life 2 years  
Electronic Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life   2 years
Electronic Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life 3 years 3 years
Machinery [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life 3 years 3 years
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life 3 years 3 years
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property plant and equipment useful life 5 years 5 years
XML 57 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]            
Total revenue $ 1,066,919 $ 672,786 $ 3,297,689 $ 1,512,351 $ 2,708,560 $ 3,066,233
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]            
Product Information [Line Items]            
Total revenue           $ 1,286,792
Concentration Risk, Percentage           42.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]            
Product Information [Line Items]            
Total revenue           $ 658,018
Concentration Risk, Percentage           21.00%
Cost of Sales [Member] | Supplier Concentration Risk [Member] | Supplier C [Member]            
Product Information [Line Items]            
Concentration Risk, Percentage         14.00%  
Total purchases         $ 189,150  
Cost of Sales [Member] | Supplier Concentration Risk [Member] | Supplier D [Member]            
Product Information [Line Items]            
Concentration Risk, Percentage         11.00%  
Total purchases         $ 149,806  
Cost of Sales [Member] | Supplier Concentration Risk [Member] | Supplier E [Member]            
Product Information [Line Items]            
Concentration Risk, Percentage           40.00%
Total purchases           $ 233,187
XML 58 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF SEGMENTS INFORMATION (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]            
Total revenues, net $ 1,066,919 $ 672,786 $ 3,297,689 $ 1,512,351 $ 2,708,560 $ 3,066,233
Operating expenses 1,802,174 1,206,690 4,689,682 3,557,647 5,278,019 3,093,171
Hotel operating costs 447,419 404,322 1,387,993 1,334,041 1,739,948 744,594
Total operating costs and expenses 1,802,174 1,206,690 4,689,682 3,557,647 5,278,019 3,093,171
Loss from operations (735,255) (533,904) (1,391,993) (2,045,296) (2,569,459) (26,938)
Total assets 4,280,077   4,280,077   5,050,884 11,660,346
Advertising and Product [Member]            
Product Information [Line Items]            
Total revenues, net         823,930 2,406,988
Cost of goods sold         171,345 316,750
Operating expenses         1,526,246 1,344,543
Loss from operations         (873,661) 745,695
Total assets         410,754 8,914,211
Pharmacies [Member]            
Product Information [Line Items]            
Total revenues, net 273,416 164,735 802,118 517,674 789,347 280,447
Cost of goods sold 126,459 124,992 446,967 395,096 578,092 218,735
Operating expenses 115,006 144,164 361,200 467,315 622,835 252,513
Loss from operations 31,951 (104,421) (6,049) (344,737) (411,580) (190,801)
Total assets 726,904   726,904   758,675 931,706
Hotel [Member]            
Product Information [Line Items]            
Total revenues, net 169,462 169,724 892,409 623,661 856,884 378,798
Operating expenses 61,859 141,197 106,219 300,501 310,902 216,036
Hotel operating costs 447,419 404,322 1,387,993 1,334,041 1,739,948 744,594
Loss from operations (339,816) (375,795) (601,803) (1,010,881) (1,193,966) (581,832)
Total assets 449,903   449,903   970,385 1,814,429
Manufactue And Sale [Member]            
Product Information [Line Items]            
Total revenues, net         238,399
Manufacture and Sale [Member]            
Product Information [Line Items]            
Total revenues, net 415,342 538,494    
Cost of goods sold 315,555 322,207 353,723
Operating expenses 246,750 448,398 (25,072)
Loss from operations (146,963) (232,111) (90,252)
Total assets 2,814,895   2,814,895   2,911,070
Product S [Member]            
Product Information [Line Items]            
Total revenues, net 208,699 338,327 1,064,668 371,016    
Cost of goods sold 67,709 90,391 367,237 98,809    
Operating expenses     1,249,461 961,885    
Loss from operations (280,427) $ (53,688) (552,030) $ (689,678)    
Total assets $ 288,375   $ 288,375   $ 410,754  
XML 59 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 30, 2023
CNY (¥)
Dec. 31, 2022
CNY (¥)
Dec. 31, 2020
USD ($)
Product Information [Line Items]                  
Operating income loss $ 735,255 $ 533,904 $ 1,391,993 $ 2,045,296 $ 2,569,459 $ 26,938      
Net cash used in operating activities     219,874 1,412,550 1,624,565 57,804      
Accumulated deficit 16,195,184   16,195,184   15,249,858 8,880,613      
Cash and cash equivalents 412,659   412,659   510,128 8,556,642      
Accounts receivable, allowance for credit loss 247,753 483,346 247,753 483,346 272,550 213,787     $ 148,520
Inventory valuation reserves $ 78,034   $ 78,034   $ 73,821 0      
Property, plant and equipment, salvage value, percentage 5.00%   5.00%   5.00%   5.00% 5.00%  
Impairment loss 3,823,770 3,823,770 $ 3,823,770      
Advertisement revenue         $ 0 1,944,811      
Vat of gross sales price percentage         6.00%        
Cash, FDIC Insured Amount 72,500   72,500   $ 72,500   ¥ 500,000 ¥ 500,000  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 438,156 $ 4,373,511 1,065,486 5,853,861          
[custom:ProvisionForInventoryReserve]     $ 8,558 $ 0          
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | No Customer [Member]                  
Product Information [Line Items]                  
Concentration Risk, Percentage       10.00%          
Cost of Sales [Member] | Supplier Concentration Risk [Member] | Supplier One [Member]                  
Product Information [Line Items]                  
Concentration Risk, Percentage 20.00% 35.00% 15.00% 20.00%          
Cost of Sales [Member] | Supplier Concentration Risk [Member] | Supplier Two [Member]                  
Product Information [Line Items]                  
Concentration Risk, Percentage     12.00%            
Hotel [Member]                  
Product Information [Line Items]                  
Operating income loss $ 339,816 $ 375,795 $ 601,803 $ 1,010,881 $ 1,193,966 581,832      
Vat of gross sales price percentage     6.00%   6.00%        
Health Care [Member]                  
Product Information [Line Items]                  
Vat of gross sales price percentage     0.00%   0.00%        
Manufacture and Sale [Member]                  
Product Information [Line Items]                  
Operating income loss $ 146,963 $ 232,111 $ 90,252      
Vat of gross sales price percentage     13.00%   13.00%        
Prior to May 1, 2018 [Member]                  
Product Information [Line Items]                  
Vat of gross sales price percentage         13.00%        
Since April One Two Thousand Nineteen [Member]                  
Product Information [Line Items]                  
Vat of gross sales price percentage     13.00%            
XML 60 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Other Receivables And Prepaid Expenses      
Deposits $ 12,245 $ 15,546 $ 68,433
Prepaid expenses, including related party 102,704 9,490 50,221
Employees’ social insurance 7,379 10,124 13,839
Others 20,996 7,471 10,788
Total $ 143,324 $ 42,631 $ 143,281
XML 61 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
ADVANCES TO SUPPLIERS (Details Narrative) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Advances To Suppliers      
Prepaid supplies $ 144,613 $ 168,523 $ 162,969
XML 62 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF INVENTORIES (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]      
Raw material $ 142,519 $ 62,462
Work in process 15,265 15,315
Finished goods-health supplements 521 6,201
Drugs, pharmaceutical and nutritional products 486,273 412,129 122,966
Food and beverage, hotel supplies and consumables 77,600 82,646 104,287
Total 721,657 573,073 233,454
Less: reserve for inventory 78,034 73,821 0
Total inventories, net $ 643,623 $ 499,252 $ 233,454
XML 63 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]      
Total $ 2,859,273 $ 2,928,342 $ 751,071
Less: Accumulated depreciation (1,200,388) (956,549) (460,923)
Property and equipment, net 1,658,885 1,971,793 290,148
Vehicle [Member]      
Property, Plant and Equipment [Line Items]      
Total   426,836 295,502
Office Furniture [Member]      
Property, Plant and Equipment [Line Items]      
Total 78,037 82,549 64,263
Electronic Equipment [Member]      
Property, Plant and Equipment [Line Items]      
Total 21,101 20,607 22,304
Machinery [Member]      
Property, Plant and Equipment [Line Items]      
Total 1,258,029 1,241,778 106,080
Leasehold Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Total 1,076,824 1,139,087 256,548
Property, Plant and Equipment, Other Types [Member]      
Property, Plant and Equipment [Line Items]      
Total 21,777 17,485 $ 6,374
Vehicles [Member]      
Property, Plant and Equipment [Line Items]      
Total $ 403,505 $ 426,836  
XML 64 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]            
Depreciation expense         $ 183,542 $ 95,026
Depreciation $ 114,300 $ 25,111 $ 307,209 $ 81,036    
XML 65 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF INTANGIBLE ASSET (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]      
Software $ 10,609 $ 8,564 $ 7,896
Less: Accumulated amortization (7,769) (7,295) (5,956)
Intangible asset, net $ 2,840 $ 1,269 $ 1,940
XML 66 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLE ASSET, NET (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]            
Amortization expense $ 387 $ 591 $ 905 $ 1,885 $ 2,023 $ 1,080
XML 67 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF TAX PAYABLE (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Taxes payable $ 110,246 $ 104,100 $ 232,637
Value-added [Member]      
Taxes payable 62,515 56,806 97,917
Income [Member]      
Taxes payable 28,235 30,919 109,396
City Construction [Member]      
Taxes payable 5,027 3,746 7,018
Education [Member]      
Taxes payable 2,193 2,184 5,064
Other [Member]      
Taxes payable $ 12,276 $ 10,445 $ 13,242
XML 68 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]      
Accrued employees’ social insurance $ 281,728 $ 270,349 $ 327,735
Accrued payroll and commission 248,759 307,331 179,183
Accrued rent expense 74,415 32,746 29,000
Construction payable 1,196,037 1,384,674 111,807
Payable for equipment purchase 29,213 32,278
Accrued professional fees 247,786 233,894 50,840
Deposit 10,690 11,308 12,239
Other payables 47,504 83,910 41,596
Total $ 2,136,132 $ 2,356,490 $ 752,400
XML 69 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
LOAN FROM THIRD PARTIES (Details Narrative) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]      
Short-Term Non-bank Loans and Notes Payable $ 82,237 $ 86,992 $ 94,153
Related Party [Member]      
Related Party Transaction [Line Items]      
Due to related parties   $ 86,992 $ 94,153
XML 70 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OPERATING LEASE LIABILITIES (Details)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Mar. 31, 2019
USD ($)
Mar. 31, 2019
CNY (¥)
Lease          
Operating lease right-of-use assets $ 457,793 $ 999,285 $ 2,049,775 $ 207,049 ¥ 1,389,731
Operating lease liabilities – current 439,959 883,583 848,230    
Operating lease liability – non-current 158,069 194,725 1,138,710    
Total operating lease liabilities $ 598,028 $ 1,078,308 $ 1,986,940    
XML 71 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OPERATING LEASE EXPENSES (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Lease            
Operating lease expenses $ 200,716 $ 183,051 $ 618,085 $ 632,496 $ 837,425 $ 411,607
XML 72 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OTHER INFORMATION RELATED LEASES (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2019
Lease          
Operating cash flows from operating leases $ 500,056 $ 525,979 $ 710,865 $ 473,508  
Weighted average operating lease term 1 year 3 months 3 days 1 year 7 months 24 days 1 year 5 months 12 days 2 years 3 months 25 days  
Weighted average operating lease discount rate 4.75% 4.75% 4.75% 4.75% 4.75%
XML 73 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF MATURITIES OF LEASE LIABILITIES (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Lease      
2023 (excluding the nine months ended September 30, 2023) $ 354,246    
2024 130,992 $ 899,044  
2025 79,844 127,361  
2026 36,366 53,196  
2027 8,224 22,433  
Thereafter 3,427    
Total lease payments 613,099 1,102,034  
Less: imputed interest (15,071) (23,726)  
Total lease liabilities 598,028 1,078,308 $ 1,986,940
Less: current portion (439,959) (883,583) (848,230)
Lease liabilities – non-current portion $ 158,069 $ 194,725 $ 1,138,710
XML 74 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASE (Details Narrative)
1 Months Ended 12 Months Ended
May 31, 2014
Dec. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
Dec. 31, 2021
USD ($)
Mar. 31, 2019
USD ($)
Mar. 31, 2019
CNY (¥)
Lessee, Operating Lease, Term of Contract   2 years          
Operating lease right-of-use asset   $ 999,285 $ 457,793   $ 2,049,775 $ 207,049 ¥ 1,389,731
Operating Lease, Weighted Average Discount Rate, Percent   4.75% 4.75% 4.75% 4.75% 4.75% 4.75%
Lease Expiration Date May 28, 2028 Mar. 31, 2021          
Aixin Shangyan Hotel Management [Member]              
Lease term   1 year 3 months        
Runcansheng [Member]              
Lease term     3 months        
Minimum [Member]              
Lease term   4 months 28 days          
Minimum [Member] | AiXintang Pharmacises [Member]              
Lease term   4 months 13 days 1 year 2 months 15 days        
Minimum [Member] | Ai Xin Zhonghong Biological Technology Co Ltd [Member]              
Lease term     6 months 29 days        
Maximum [Member]              
Lease term   3 years 5 months 8 days          
Maximum [Member] | AiXintang Pharmacises [Member]              
Lease term   3 years 8 months 1 day 2 years 11 months 1 day        
Maximum [Member] | Ai Xin Zhonghong Biological Technology Co Ltd [Member]              
Lease term     2 years 8 months 8 days        
XML 75 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]      
Due from related parties   $ 83,102 $ 19,055
Due to related parties $ 333,919 236,882 1,947,154
Total   236,882 1,947,154
Related Party [Member]      
Related Party Transaction [Line Items]      
Due from related parties 384,588 83,102  
Due to related parties 333,919 236,882  
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd. [Member]      
Related Party Transaction [Line Items]      
Due from related parties 7,573 9,708 4,583
Sichuan Aixin Investment Co., Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 8,983 145 4,237
Chengdu Fuxiang Tang Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 25,056 26,125
Chengdu Wenjiang District Heneng Hupu Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 26,822 34,622
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd. [Member]      
Related Party Transaction [Line Items]      
Due from related parties 133,801 12,502 10,235
Quanzhong Lin [Member]      
Related Party Transaction [Line Items]      
Due to related parties 243,323 140,644 1,822,705
Yirong Shen [Member]      
Related Party Transaction [Line Items]      
Due to related parties 84,978 89,892 97,292
Branch Manager [Member]      
Related Party Transaction [Line Items]      
Due to related parties   1,667
Chengdu Aixin E-Commerce Company Ltd. [Member]      
Related Party Transaction [Line Items]      
Due to related parties   15,378
Chengdu Aixin International travel service Co, Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 356  
Due to related parties 4,950 6,346 2,388
Aixin Life Beauty [Member]      
Related Party Transaction [Line Items]      
Due to related parties   $ 7,724
Huiliang Jiao [Member]      
Related Party Transaction [Line Items]      
Due from related parties 135,328  
Xiaoyan [Member]      
Related Party Transaction [Line Items]      
Due from related parties 11,668  
Chengdu Wen Jiang Aixin Huiwan Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 3,888  
Chengdu Heshengyuan Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 3,379  
Chengdu Zhiweibing Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 7,859  
Chengdu Tongtai Tang Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 2,810  
Wuhou District Xiaofei Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 8,115  
Aixin Hui Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 402  
Sichuan Xintang Xinfu Pharmacy Chain Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 344  
Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due from related parties 302  
Chengdu Cigu Foshou Pharmacy [Member]      
Related Party Transaction [Line Items]      
Due from related parties 2,028  
Mianyang Aixin Cunshan Pharmacy [Member]      
Related Party Transaction [Line Items]      
Due from related parties 5,874  
Sichuan Haosen Haichuan Business Management Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due to related parties 57  
Sichuan Yunxi Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due to related parties 449  
Chengdu Yi Yan Tang Pharmacy Co Ltd [Member]      
Related Party Transaction [Line Items]      
Due to related parties $ 162  
XML 76 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS (Details Narrative)
1 Months Ended 6 Months Ended 12 Months Ended 35 Months Ended
May 31, 2014
USD ($)
May 31, 2014
CNY (¥)
Dec. 31, 2023
CNY (¥)
Dec. 31, 2022
USD ($)
Feb. 28, 2023
USD ($)
Feb. 28, 2023
CNY (¥)
Sep. 30, 2023
USD ($)
Dec. 31, 2021
USD ($)
May 31, 2014
CNY (¥)
Related Party Transaction [Line Items]                  
Accounts payable-related party       $ 398,469       $ 406,163  
Prepaid Rent $ 725               ¥ 5,000
[custom:OperatingLeasesFutureMinimumPaymentDue-0]       $ 3,625          
Payments for Rent $ 690 ¥ 5,000              
Lease Expiration Date May 28, 2028 May 28, 2028   Mar. 31, 2021          
Lessee, Operating Lease, Liability, to be Paid, Year One       $ 899,044     $ 130,992    
Lessee, Operating Lease, Liability, to be Paid, Year Two       127,361     79,844    
Lessee, Operating Lease, Liability, to be Paid, Year Three       53,196     36,366    
Lessee, Operating Lease, Liability, to be Paid, Year Four       22,433     8,224    
Renewed [Member]                  
Related Party Transaction [Line Items]                  
Prepaid Rent $ 725               ¥ 5,000
Payments for Rent $ 690 ¥ 5,000              
Office Leases [Member]                  
Related Party Transaction [Line Items]                  
Lessee, Operating Lease, Liability, to be Paid, Year One             8,224    
Lessee, Operating Lease, Liability, to be Paid, Year Two             8,224    
Lessee, Operating Lease, Liability, to be Paid, Year Three             8,224    
Lessee, Operating Lease, Liability, to be Paid, Year Four             8,224    
Lessee, Operating Lease, Liability, to be Paid, Year Five             5,482    
Office Leases [Member] | Yunnan Runcangsheng [Member]                  
Related Party Transaction [Line Items]                  
Payments for Rent         $ 690 ¥ 5,000      
Office Leases [Member] | Xiaoyan Zhou [Member]                  
Related Party Transaction [Line Items]                  
Payments for Rent | ¥     ¥ 2,000            
Office Leases [Member] | Xiaoyan Zhou [Member]                  
Related Party Transaction [Line Items]                  
Payments for Rent     ¥ 3,000   $ 414        
Related Party [Member]                  
Related Party Transaction [Line Items]                  
Accounts payable-related party       165,958      
Accounts Receivable [Member]                  
Related Party Transaction [Line Items]                  
Accounts Receivable, after Allowance for Credit Loss       $ 42     $ 11,030    
XML 77 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Current:            
China         $ (761) $ 292,891
Total current         (761) 292,891
Deferred:            
China         1,858 (18,570)
Total deferred     $ 1,481 $ 1,419 1,858 (18,570)
Total income tax expense $ 515 $ (322) $ 5,879 $ 643 $ 1,097 $ 274,321
XML 78 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Accumulated amortization $ 15,556 $ 18,795
XML 79 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Statutory U.S. federal income tax rate 21.00% 21.00%
Foreign tax rate differential (3.80%) 216.50%
Change in valuation allowances 25.00% 3634.40%
Other (0.20%)
Effective combined tax rate 0.00% 3871.90%
XML 80 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]        
Effective income tax rate     0.00% 3871.90%
Unrecognized tax benefits     $ 0 $ 0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense   $ 0    
Foreign Tax Authority [Member]        
Operating Loss Carryforwards [Line Items]        
Effective income tax rate 25.00%   25.00%  
Foreign Tax Authority [Member] | Aixin Shangyan Hotel and Aixintang Pharmacies [Member]        
Operating Loss Carryforwards [Line Items]        
Net operating loss carry-forward     $ 4,139,357  
XML 81 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS’ EQUITY (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Feb. 17, 2023
$ / shares
shares
Jul. 19, 2022
USD ($)
Jul. 19, 2022
CNY (¥)
Aug. 17, 2020
Oct. 24, 2019
USD ($)
$ / shares
shares
Oct. 22, 2019
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2021
CNY (¥)
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Preferred Stock, Shares Authorized | shares             20,000,000   20,000,000   20,000,000 20,000,000  
Preferred stock,par value | $ / shares             $ 0.001   $ 0.001   $ 0.001 $ 0.001  
Common stock, shares authorized | shares             500,000,000   500,000,000   500,000,000 500,000,000  
Common Stock, par value | $ / shares $ 0.00001           $ 0.00001   $ 0.00001   $ 0.00001 $ 0.00001  
Reverse stock split | shares                 24,999,842   24,999,842    
Common stock shares issued | shares             24,999,842   24,999,842   24,999,842 24,999,842  
Common stock shares outstanding | shares 24,999,842           24,999,842   24,999,842   24,999,842 24,999,842  
Stock based compensation | $             $ 92,885 $ 92,885 $ 278,655 $ 278,655 $ 371,540 $ 371,540  
Unrecognized compensation expenses | $             $ 394,012   $ 394,012   $ 672,667    
Employee services expected to be recognized                 1 year 25 days   2 years    
Stockholders' Equity, Reverse Stock Split 1 for 2 reverse stock split     one (1)-for-four (4) reverse stock                  
Proceeds from Contributed Capital | $                 $ 142,200 4,386,070  
Common Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Common stock shares outstanding | shares                     24,999,842    
Aixin Shangyan Hotel and Aixintang Pharmacies [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Business Combination, Consideration Transferred                       4,500,000 ¥ 29,000,000
[custom:IncreaseDecreaseInAdditionalPaidinCapital] | $                       4,313,025  
Yunnan Shengshengyuan Technology Co Ltd [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Business Combination, Consideration Transferred   $ 4,418,095 ¥ 31,557,820                    
Proceeds from Contributed Capital | $                 $ 145,300        
Quanzhong Lin [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Forgiveness of shareholder's loan | $                       $ 6,912,513  
Employees and Contractors [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period                 5 years        
Share based payment award description                 the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture.        
Employees and Contractors [Member] | 2019 Equity Incentive Plan [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of shares | shares         275,000 18,750              
Issuance of value | $         $ 1,520,200 $ 337,500              
Price per share | $ / shares         $ 5.528 $ 18              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period                     5 years    
Share based payment award description                     the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture    
Employees and Contractors [Member] | Two Thousand And Nineteen Equity Incentive Plan [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of shares | shares         275,000 18,750              
Issuance of value | $         $ 1,520,200 $ 337,500              
Price per share | $ / shares         $ 5.528 $ 18              
XML 82 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATUTORY RESERVES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Net income transfer, rate     10.00%   10.00%  
Capital reserve, rate     50.00%   50.00%  
Statutory reserve fund $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Minimum [Member]            
Net income transfer, rate     5.00%   5.00%  
Capital reserve, rate     25.00%   25.00%  
Maximum [Member]            
Net income transfer, rate     10.00%   10.00%  
XML 83 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
OPERATING CONTINGENCIES (Details Narrative) - 1 months ended Dec. 31, 2020
USD ($)
CNY (¥)
Guarantor Obligations [Line Items]    
Long-Term Purchase Commitment, Amount $ 392,305 ¥ 2,500,000
Litigation Settlement, Expense 392,305 2,500,000
Indemnification Agreement [Member]    
Guarantor Obligations [Line Items]    
Long-Term Purchase Commitment, Amount $ 392,305 ¥ 2,500,000
XML 84 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) - USD ($)
Jul. 19, 2022
Dec. 31, 2022
Dec. 31, 2021
Estimated fair value of liabilities assumed:      
Goodwill as a result of the acquisition  
Yunnan Runcangsheng [Member]      
Business Acquisition [Line Items]      
Total purchase considerations $ 4,301,293    
Estimated fair value of assets acquired:      
Cash 446,381    
Accounts receivable 144,813    
Accounts receivable-related party 133,011    
Advance to suppliers 3,455    
Other receivables and prepaid expense 127,909    
Inventory 469,594    
Property and equipment 1,677,272    
Intangible assets 1,406    
Operating lease right-of-use assets 1,990    
Total assets acquired 3,005,831    
Estimated fair value of liabilities assumed:      
Accounts payable (89,801)    
Accounts payable-related party (160,911)    
Advance from customers (4,790)    
Government grant (921,473)    
Taxes payable (21,156)    
Operating lease liability (15,182)    
Accrued liabilities and other payables (1,314,995)    
Total liabilities assumed (2,528,308)    
Total net assets acquired 477,523    
Goodwill as a result of the acquisition 3,823,770    
Operating lease liability (15,182)    
Total liabilities assumed (2,528,308)    
Total net assets acquired $ 477,523    
XML 85 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF BUSINESS ACQUISITION PRO FORMA (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Revenue $ 804,470 $ 1,854,617    
Operating costs and expenses 1,205,371 3,826,342    
Loss from operations (400,901) (1,971,725)    
Other income (expense) (25,455) 25,313    
Income tax expense (322) 643    
Net loss $ (426,034) $ (1,947,055)    
Runcangsheng Aixin Shangyan Hotel and Aixintang Pharmacies [Member]        
Revenue     $ 3,168,061 $ 5,025,140
Operating costs and expenses     5,605,508 6,052,664
Loss from operations     (2,437,447) (1,027,524)
Other income (expense)     34,839 100,086
Income tax expense     1,097 284,903
Net loss     $ (2,403,705) $ (1,212,341)
XML 86 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITION OF SUBSIDIARIES (Details Narrative)
12 Months Ended
Jul. 19, 2022
USD ($)
Jun. 02, 2021
USD ($)
Jun. 02, 2021
CNY (¥)
May 25, 2021
USD ($)
May 25, 2021
CNY (¥)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CNY (¥)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CNY (¥)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CNY (¥)
Yunnan Shengshengyuan [Member]                      
Business Acquisition [Line Items]                      
Equity interest percentage 95.00%                    
Yunnan Runcangsheng [Member]                      
Business Acquisition [Line Items]                      
Equity interest percentage 5.00%                    
Yun Chen [Member]                      
Business Acquisition [Line Items]                      
Equity interest percentage 5.00%                    
Aixin Shangyan Hotel Management [Member]                      
Business Acquisition [Line Items]                      
Payments to Acquire Businesses and Interest in Affiliates           $ 1,160,000 ¥ 7,598,887        
Business Combination, Consideration Transferred       $ 1,160,000 ¥ 7,598,887            
AiXintang Pharmacises [Member]                      
Business Acquisition [Line Items]                      
Payments to Acquire Businesses and Interest in Affiliates                   $ 5,310,000 ¥ 34,635,845
Business Acquisition, Percentage of Voting Interests Acquired                   100.00% 100.00%
Business Combination, Consideration Transferred   $ 5,310,000 ¥ 34,635,845                
Yunnan Runcangsheng [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred $ 4,301,293                    
Yunnan Runcangsheng [Member] | Transfer Agreement [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred               $ 4,418,095 ¥ 31,557,820    
Business Combination, Consideration Transferred, Other               $ 116,802      
XML 87 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Related Party Transaction [Line Items]    
Advances and accounts payable to related party $ 94,361
Luquan Shengcaofeng Biotechnology Co Ltd [Member]    
Related Party Transaction [Line Items]    
Advances and accounts payable to related party $ 165,958
EXCEL 89 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 90 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 91 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 93 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 367 324 1 true 103 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://aixinlifeinternationalinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://aixinlifeinternationalinc.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES Sheet http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpenses OTHER RECEIVABLES AND PREPAID EXPENSES Notes 9 false false R10.htm 00000010 - Disclosure - ADVANCES TO SUPPLIERS Sheet http://aixinlifeinternationalinc.com/role/AdvancesToSuppliers ADVANCES TO SUPPLIERS Notes 10 false false R11.htm 00000011 - Disclosure - INVENTORIES Sheet http://aixinlifeinternationalinc.com/role/Inventories INVENTORIES Notes 11 false false R12.htm 00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 12 false false R13.htm 00000013 - Disclosure - INTANGIBLE ASSET, NET Sheet http://aixinlifeinternationalinc.com/role/IntangibleAssetNet INTANGIBLE ASSET, NET Notes 13 false false R14.htm 00000014 - Disclosure - TAXES PAYABLE Sheet http://aixinlifeinternationalinc.com/role/TaxesPayable TAXES PAYABLE Notes 14 false false R15.htm 00000015 - Disclosure - ACCRUED LIABILITIES AND OTHER PAYABLES Sheet http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayables ACCRUED LIABILITIES AND OTHER PAYABLES Notes 15 false false R16.htm 00000016 - Disclosure - LOAN FROM THIRD PARTIES Sheet http://aixinlifeinternationalinc.com/role/LoanFromThirdParties LOAN FROM THIRD PARTIES Notes 16 false false R17.htm 00000017 - Disclosure - LEASE Sheet http://aixinlifeinternationalinc.com/role/Lease LEASE Notes 17 false false R18.htm 00000018 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://aixinlifeinternationalinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAXES Sheet http://aixinlifeinternationalinc.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 00000020 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://aixinlifeinternationalinc.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 20 false false R21.htm 00000021 - Disclosure - STATUTORY RESERVES Sheet http://aixinlifeinternationalinc.com/role/StatutoryReserves STATUTORY RESERVES Notes 21 false false R22.htm 00000022 - Disclosure - OPERATING CONTINGENCIES Sheet http://aixinlifeinternationalinc.com/role/OperatingContingencies OPERATING CONTINGENCIES Notes 22 false false R23.htm 00000023 - Disclosure - ACQUISITION OF SUBSIDIARIES Sheet http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiaries ACQUISITION OF SUBSIDIARIES Notes 23 false false R24.htm 00000024 - Disclosure - SUBSEQUENT EVENT Sheet http://aixinlifeinternationalinc.com/role/SubsequentEvent SUBSEQUENT EVENT Notes 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 00000027 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES (Tables) Sheet http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpensesTables OTHER RECEIVABLES AND PREPAID EXPENSES (Tables) Tables http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpenses 27 false false R28.htm 00000028 - Disclosure - INVENTORIES (Tables) Sheet http://aixinlifeinternationalinc.com/role/InventoriesTables INVENTORIES (Tables) Tables http://aixinlifeinternationalinc.com/role/Inventories 28 false false R29.htm 00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNet 29 false false R30.htm 00000030 - Disclosure - INTANGIBLE ASSET, NET (Tables) Sheet http://aixinlifeinternationalinc.com/role/IntangibleAssetNetTables INTANGIBLE ASSET, NET (Tables) Tables http://aixinlifeinternationalinc.com/role/IntangibleAssetNet 30 false false R31.htm 00000031 - Disclosure - TAXES PAYABLE (Tables) Sheet http://aixinlifeinternationalinc.com/role/TaxesPayableTables TAXES PAYABLE (Tables) Tables http://aixinlifeinternationalinc.com/role/TaxesPayable 31 false false R32.htm 00000032 - Disclosure - ACCRUED LIABILITIES AND OTHER PAYABLES (Tables) Sheet http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayablesTables ACCRUED LIABILITIES AND OTHER PAYABLES (Tables) Tables http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayables 32 false false R33.htm 00000033 - Disclosure - LEASE (Tables) Sheet http://aixinlifeinternationalinc.com/role/LeaseTables LEASE (Tables) Tables http://aixinlifeinternationalinc.com/role/Lease 33 false false R34.htm 00000034 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://aixinlifeinternationalinc.com/role/RelatedPartyTransactions 34 false false R35.htm 00000035 - Disclosure - INCOME TAXES (Tables) Sheet http://aixinlifeinternationalinc.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://aixinlifeinternationalinc.com/role/IncomeTaxes 35 false false R36.htm 00000036 - Disclosure - ACQUISITION OF SUBSIDIARIES (Tables) Sheet http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesTables ACQUISITION OF SUBSIDIARIES (Tables) Tables http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiaries 36 false false R37.htm 00000037 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Details http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusiness 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) Details 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS (Details) Details 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF SEGMENTS INFORMATION (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails SCHEDULE OF SEGMENTS INFORMATION (Details) Details 41 false false R42.htm 00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES (Details) Details 43 false false R44.htm 00000044 - Disclosure - ADVANCES TO SUPPLIERS (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/AdvancesToSuppliersDetailsNarrative ADVANCES TO SUPPLIERS (Details Narrative) Details http://aixinlifeinternationalinc.com/role/AdvancesToSuppliers 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 46 false false R47.htm 00000047 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetTables 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF INTANGIBLE ASSET (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails SCHEDULE OF INTANGIBLE ASSET (Details) Details 48 false false R49.htm 00000049 - Disclosure - INTANGIBLE ASSET, NET (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/IntangibleAssetNetDetailsNarrative INTANGIBLE ASSET, NET (Details Narrative) Details http://aixinlifeinternationalinc.com/role/IntangibleAssetNetTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF TAX PAYABLE (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails SCHEDULE OF TAX PAYABLE (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES (Details) Details 51 false false R52.htm 00000052 - Disclosure - LOAN FROM THIRD PARTIES (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative LOAN FROM THIRD PARTIES (Details Narrative) Details http://aixinlifeinternationalinc.com/role/LoanFromThirdParties 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails SCHEDULE OF OPERATING LEASE LIABILITIES (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF OPERATING LEASE EXPENSES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseExpensesDetails SCHEDULE OF OPERATING LEASE EXPENSES (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF OTHER INFORMATION RELATED LEASES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfOtherInformationRelatedLeasesDetails SCHEDULE OF OTHER INFORMATION RELATED LEASES (Details) Details 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF MATURITIES OF LEASE LIABILITIES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails SCHEDULE OF MATURITIES OF LEASE LIABILITIES (Details) Details 56 false false R57.htm 00000057 - Disclosure - LEASE (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative LEASE (Details Narrative) Details http://aixinlifeinternationalinc.com/role/LeaseTables 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) Details 58 false false R59.htm 00000059 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsTables 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) Details 62 false false R63.htm 00000063 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://aixinlifeinternationalinc.com/role/IncomeTaxesTables 63 false false R64.htm 00000064 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://aixinlifeinternationalinc.com/role/StockholdersEquity 64 false false R65.htm 00000065 - Disclosure - STATUTORY RESERVES (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative STATUTORY RESERVES (Details Narrative) Details http://aixinlifeinternationalinc.com/role/StatutoryReserves 65 false false R66.htm 00000066 - Disclosure - OPERATING CONTINGENCIES (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative OPERATING CONTINGENCIES (Details Narrative) Details http://aixinlifeinternationalinc.com/role/OperatingContingencies 66 false false R67.htm 00000067 - Disclosure - SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF BUSINESS ACQUISITION PRO FORMA (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails SCHEDULE OF BUSINESS ACQUISITION PRO FORMA (Details) Details 68 false false R69.htm 00000069 - Disclosure - ACQUISITION OF SUBSIDIARIES (Details Narrative) Sheet http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative ACQUISITION OF SUBSIDIARIES (Details Narrative) Details http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesTables 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY (Details) Sheet http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY (Details) Details 70 false false All Reports Book All Reports aixn-20230930.xsd aixn-20230930_cal.xml aixn-20230930_def.xml aixn-20230930_lab.xml aixn-20230930_pre.xml forms-1a.htm chart_001.jpg forms-1_001.jpg forms-1_003.jpg image_001.jpg image_002.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 95 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "forms-1a.htm": { "nsprefix": "AIXN", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "dts": { "schema": { "local": [ "aixn-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "aixn-20230930_cal.xml" ] }, "definitionLink": { "local": [ "aixn-20230930_def.xml" ] }, "labelLink": { "local": [ "aixn-20230930_lab.xml" ] }, "presentationLink": { "local": [ "aixn-20230930_pre.xml" ] }, "inline": { "local": [ "forms-1a.htm" ] } }, "keyStandard": 260, "keyCustom": 64, "axisStandard": 19, "axisCustom": 0, "memberStandard": 22, "memberCustom": 75, "hidden": { "total": 199, "http://aixinlifeinternationalinc.com/20230930": 29, "http://fasb.org/us-gaap/2023": 168, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 367, "entityCount": 1, "segmentCount": 103, "elementCount": 560, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1488, "http://xbrl.sec.gov/dei/2023": 17 }, "report": { "R1": { "role": "http://aixinlifeinternationalinc.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R2": { "role": "http://aixinlifeinternationalinc.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:RestrictedCashCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R3": { "role": "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockSharesIssued", "span", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R4": { "role": "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "AIXN:CostOfGoodsAndServiceSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R5": { "role": "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)", "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R6": { "role": "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R7": { "role": "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusiness", "longName": "00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R8": { "role": "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R9": { "role": "http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpenses", "longName": "00000009 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES", "shortName": "OTHER RECEIVABLES AND PREPAID EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R10": { "role": "http://aixinlifeinternationalinc.com/role/AdvancesToSuppliers", "longName": "00000010 - Disclosure - ADVANCES TO SUPPLIERS", "shortName": "ADVANCES TO SUPPLIERS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:AdvancesToSuppliersTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:AdvancesToSuppliersTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R11": { "role": "http://aixinlifeinternationalinc.com/role/Inventories", "longName": "00000011 - Disclosure - INVENTORIES", "shortName": "INVENTORIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R12": { "role": "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNet", "longName": "00000012 - Disclosure - PROPERTY AND EQUIPMENT, NET", "shortName": "PROPERTY AND EQUIPMENT, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R13": { "role": "http://aixinlifeinternationalinc.com/role/IntangibleAssetNet", "longName": "00000013 - Disclosure - INTANGIBLE ASSET, NET", "shortName": "INTANGIBLE ASSET, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R14": { "role": "http://aixinlifeinternationalinc.com/role/TaxesPayable", "longName": "00000014 - Disclosure - TAXES PAYABLE", "shortName": "TAXES PAYABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:TaxesPayablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:TaxesPayablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R15": { "role": "http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayables", "longName": "00000015 - Disclosure - ACCRUED LIABILITIES AND OTHER PAYABLES", "shortName": "ACCRUED LIABILITIES AND OTHER PAYABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R16": { "role": "http://aixinlifeinternationalinc.com/role/LoanFromThirdParties", "longName": "00000016 - Disclosure - LOAN FROM THIRD PARTIES", "shortName": "LOAN FROM THIRD PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R17": { "role": "http://aixinlifeinternationalinc.com/role/Lease", "longName": "00000017 - Disclosure - LEASE", "shortName": "LEASE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R18": { "role": "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactions", "longName": "00000018 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R19": { "role": "http://aixinlifeinternationalinc.com/role/IncomeTaxes", "longName": "00000019 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R20": { "role": "http://aixinlifeinternationalinc.com/role/StockholdersEquity", "longName": "00000020 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R21": { "role": "http://aixinlifeinternationalinc.com/role/StatutoryReserves", "longName": "00000021 - Disclosure - STATUTORY RESERVES", "shortName": "STATUTORY RESERVES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:StatutoryReservesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:StatutoryReservesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R22": { "role": "http://aixinlifeinternationalinc.com/role/OperatingContingencies", "longName": "00000022 - Disclosure - OPERATING CONTINGENCIES", "shortName": "OPERATING CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LossContingencyDisclosures", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LossContingencyDisclosures", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R23": { "role": "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiaries", "longName": "00000023 - Disclosure - ACQUISITION OF SUBSIDIARIES", "shortName": "ACQUISITION OF SUBSIDIARIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R24": { "role": "http://aixinlifeinternationalinc.com/role/SubsequentEvent", "longName": "00000024 - Disclosure - SUBSEQUENT EVENT", "shortName": "SUBSEQUENT EVENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R25": { "role": "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R26": { "role": "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R27": { "role": "http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpensesTables", "longName": "00000027 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES (Tables)", "shortName": "OTHER RECEIVABLES AND PREPAID EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:ScheduleOfOtherReceivablesAndPrepaidExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "AIXN:OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:ScheduleOfOtherReceivablesAndPrepaidExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "AIXN:OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R28": { "role": "http://aixinlifeinternationalinc.com/role/InventoriesTables", "longName": "00000028 - Disclosure - INVENTORIES (Tables)", "shortName": "INVENTORIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R29": { "role": "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetTables", "longName": "00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R30": { "role": "http://aixinlifeinternationalinc.com/role/IntangibleAssetNetTables", "longName": "00000030 - Disclosure - INTANGIBLE ASSET, NET (Tables)", "shortName": "INTANGIBLE ASSET, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R31": { "role": "http://aixinlifeinternationalinc.com/role/TaxesPayableTables", "longName": "00000031 - Disclosure - TAXES PAYABLE (Tables)", "shortName": "TAXES PAYABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:ScheduleOfTaxesPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "AIXN:TaxesPayablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:ScheduleOfTaxesPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "AIXN:TaxesPayablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R32": { "role": "http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayablesTables", "longName": "00000032 - Disclosure - ACCRUED LIABILITIES AND OTHER PAYABLES (Tables)", "shortName": "ACCRUED LIABILITIES AND OTHER PAYABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R33": { "role": "http://aixinlifeinternationalinc.com/role/LeaseTables", "longName": "00000033 - Disclosure - LEASE (Tables)", "shortName": "LEASE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R34": { "role": "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsTables", "longName": "00000034 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R35": { "role": "http://aixinlifeinternationalinc.com/role/IncomeTaxesTables", "longName": "00000035 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R36": { "role": "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesTables", "longName": "00000036 - Disclosure - ACQUISITION OF SUBSIDIARIES (Tables)", "shortName": "ACQUISITION OF SUBSIDIARIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R37": { "role": "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "longName": "00000037 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2023-02-17", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2017-02-012017-02-02_custom_ChinaConcentricCapitalGroupMember285877593", "name": "AIXN:PurchasePriceOfCommonStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R38": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails", "longName": "00000038 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "AIXN:AllowanceForDoubtfulAccountsReceivableAdditions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "AIXN:ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsTableTextBlock", "us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R39": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails", "longName": "00000039 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES (Details)", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-09-30_custom_OfficeFurnitureMember", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "AIXN:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_custom_OfficeFurnitureMember", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "AIXN:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R40": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "longName": "00000040 - Disclosure - SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS (Details)", "shortName": "SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R41": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "longName": "00000041 - Disclosure - SCHEDULE OF SEGMENTS INFORMATION (Details)", "shortName": "SCHEDULE OF SEGMENTS INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R42": { "role": "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "AIXN:AdvertisementRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R43": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails", "longName": "00000043 - Disclosure - SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES (Details)", "shortName": "SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DepositAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "AIXN:ScheduleOfOtherReceivablesAndPrepaidExpensesTableTextBlock", "AIXN:OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DepositAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "AIXN:ScheduleOfOtherReceivablesAndPrepaidExpensesTableTextBlock", "AIXN:OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R44": { "role": "http://aixinlifeinternationalinc.com/role/AdvancesToSuppliersDetailsNarrative", "longName": "00000044 - Disclosure - ADVANCES TO SUPPLIERS (Details Narrative)", "shortName": "ADVANCES TO SUPPLIERS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:Supplies", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails", "longName": "00000045 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "shortName": "SCHEDULE OF INVENTORIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R46": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "00000046 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R47": { "role": "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetDetailsNarrative", "longName": "00000047 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R48": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails", "longName": "00000048 - Disclosure - SCHEDULE OF INTANGIBLE ASSET (Details)", "shortName": "SCHEDULE OF INTANGIBLE ASSET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R49": { "role": "http://aixinlifeinternationalinc.com/role/IntangibleAssetNetDetailsNarrative", "longName": "00000049 - Disclosure - INTANGIBLE ASSET, NET (Details Narrative)", "shortName": "INTANGIBLE ASSET, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R50": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails", "longName": "00000050 - Disclosure - SCHEDULE OF TAX PAYABLE (Details)", "shortName": "SCHEDULE OF TAX PAYABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:TaxesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_custom_ValueAddedMember", "name": "us-gaap:TaxesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "AIXN:ScheduleOfTaxesPayableTableTextBlock", "AIXN:TaxesPayablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R51": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails", "longName": "00000051 - Disclosure - SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES (Details)", "shortName": "SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedInsuranceCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedInsuranceCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R52": { "role": "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative", "longName": "00000052 - Disclosure - LOAN FROM THIRD PARTIES (Details Narrative)", "shortName": "LOAN FROM THIRD PARTIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:ShortTermNonBankLoansAndNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_RelatedPartyMember285882531", "name": "us-gaap:OtherLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R53": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "longName": "00000053 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details)", "shortName": "SCHEDULE OF OPERATING LEASE LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseExpensesDetails", "longName": "00000054 - Disclosure - SCHEDULE OF OPERATING LEASE EXPENSES (Details)", "shortName": "SCHEDULE OF OPERATING LEASE EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherInformationRelatedLeasesDetails", "longName": "00000055 - Disclosure - SCHEDULE OF OTHER INFORMATION RELATED LEASES (Details)", "shortName": "SCHEDULE OF OTHER INFORMATION RELATED LEASES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OperatingLeasePayments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "AIXN:ScheduleOfOtherInformationRelatedLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R56": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails", "longName": "00000056 - Disclosure - SCHEDULE OF MATURITIES OF LEASE LIABILITIES (Details)", "shortName": "SCHEDULE OF MATURITIES OF LEASE LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R57": { "role": "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "longName": "00000057 - Disclosure - LEASE (Details Narrative)", "shortName": "LEASE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R58": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "longName": "00000058 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:OtherReceivablesNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "AIXN:AdvanceFromRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R59": { "role": "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000059 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2014-05-31", "name": "us-gaap:PrepaidRent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R60": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails", "longName": "00000060 - Disclosure - SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES (Details)", "shortName": "SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R61": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfDeferredTaxAssetsDetails", "longName": "00000061 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "AIXN:DeferredTaxAssetsAccumulatedAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "AIXN:DeferredTaxAssetsAccumulatedAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R62": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails", "longName": "00000062 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)", "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R63": { "role": "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative", "longName": "00000063 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R64": { "role": "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative", "longName": "00000064 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R65": { "role": "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative", "longName": "00000065 - Disclosure - STATUTORY RESERVES (Details Narrative)", "shortName": "STATUTORY RESERVES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:NetIncomeTransferPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "AIXN:StatutoryReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "AIXN:NetIncomeTransferPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "AIXN:StatutoryReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R66": { "role": "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative", "longName": "00000066 - Disclosure - OPERATING CONTINGENCIES (Details Narrative)", "shortName": "OPERATING CONTINGENCIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2020-12-012020-12-31", "name": "us-gaap:LongTermPurchaseCommitmentAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:LossContingencyDisclosures", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2020-12-012020-12-31", "name": "us-gaap:LongTermPurchaseCommitmentAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:LossContingencyDisclosures", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R67": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "longName": "00000067 - Disclosure - SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "shortName": "SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2022-07-172022-07-19_custom_YunnanRuncangshengMember", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-07-19_custom_YunnanRuncangshengMember285888984", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "unique": true } }, "R68": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails", "longName": "00000068 - Disclosure - SCHEDULE OF BUSINESS ACQUISITION PRO FORMA (Details)", "shortName": "SCHEDULE OF BUSINESS ACQUISITION PRO FORMA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2022-07-012022-09-30", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-07-012022-09-30", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R69": { "role": "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "longName": "00000069 - Disclosure - ACQUISITION OF SUBSIDIARIES (Details Narrative)", "shortName": "ACQUISITION OF SUBSIDIARIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "AsOf2022-07-19_custom_YunnanShengshengyuanMember", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-07-19_custom_YunnanShengshengyuanMember", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } }, "R70": { "role": "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails", "longName": "00000070 - Disclosure - SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY (Details)", "shortName": "SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsPayableCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "AIXN:ScheduleOfAdvancesAndAccountsPayableToRelatedPartyTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsPayableCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "AIXN:ScheduleOfAdvancesAndAccountsPayableToRelatedPartyTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "forms-1a.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayables" ], "lang": { "en-us": { "role": { "label": "ACCRUED LIABILITIES AND OTHER PAYABLES", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r23" ] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Accounts Payable and Other Accrued Liabilities, Current", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "verboseLabel": "Accounts payable-related party", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r22", "r571" ] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Advances and accounts payable to related party", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r85", "r702" ] }, "AIXN_AccountsPayableRelatedPartyCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AccountsPayableRelatedPartyCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable-related party", "documentation": "Accounts payable related party current." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r542" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r490", "r541", "r577", "r703" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, including related parties, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r238", "r239" ] }, "AIXN_AccrualOfUnpaidInvestmentInSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AccrualOfUnpaidInvestmentInSubsidiary", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrual of unpaid investment in subsidiary", "documentation": "Accrual of unpaid investment in subsidiary." } } }, "auth_ref": [] }, "us-gaap_AccruedInsuranceCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedInsuranceCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued employees\u2019 social insurance", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued liabilities and other payables", "label": "Accrued Liabilities and Other Liabilities", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued professional fees", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_AccruedRentCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedRentCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued rent expense", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26", "r551" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r64", "r156", "r440" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r172", "r173", "r380", "r381", "r382", "r383", "r384", "r385" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r29", "r30", "r98", "r161", "r436", "r459", "r460" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r172", "r173", "r380", "r381", "r382", "r383", "r384", "r385" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r5", "r17", "r30", "r369", "r372", "r396", "r455", "r456", "r622", "r623", "r624", "r633", "r634", "r635" ] }, "AIXN_AcquisitionOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AcquisitionOfSubsidiary", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Acquisition of subsidiary" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r90", "r571", "r708" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r327", "r328", "r329", "r471", "r633", "r634", "r635", "r683", "r709" ] }, "AIXN_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalAcquisitionOfSubsidiaries", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Acquisition of subsidiaries", "documentation": "Adjustments to additional paid in capital acquisition of subsidiaries" } } }, "auth_ref": [] }, "AIXN_AdjustmentsToAdditionalPaidInCapitalDebtForgivenByMajorShareholder": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalDebtForgivenByMajorShareholder", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Debt forgiven by major shareholder" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shareholder contribution", "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments required to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "AIXN_AdvanceFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AdvanceFromRelatedParties", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "label": "AdvanceFromRelatedParties" } } }, "auth_ref": [] }, "AIXN_AdvancesToSuppliersTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AdvancesToSuppliersTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/AdvancesToSuppliers" ], "lang": { "en-us": { "role": { "label": "ADVANCES TO SUPPLIERS", "documentation": "Advances To Suppliers [Text Block]" } } }, "auth_ref": [] }, "AIXN_AdvertisementRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AdvertisementRevenue", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertisement revenue", "documentation": "Advertisement revenue." } } }, "auth_ref": [] }, "AIXN_AdvertisingAndProductMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AdvertisingAndProductMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Advertising and Product [Member]", "documentation": "Advertising and Product [Member]" } } }, "auth_ref": [] }, "us-gaap_AdvertisingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Advertising [Member]", "documentation": "Announcement promoting product, service, or event." } } }, "auth_ref": [ "r652" ] }, "AIXN_AiXinZhonghongBiologicalTechnologyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AiXinZhonghongBiologicalTechnologyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ai Xin Zhonghong Biological Technology Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_AixinHuiPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AixinHuiPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Aixin Hui Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_AixinLifeBeautyMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AixinLifeBeautyMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Aixin Life Beauty [Member]", "documentation": "Aixin Life Beauty [Member]" } } }, "auth_ref": [] }, "AIXN_AixinShangyanHotelAndAixintangPharmaciesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AixinShangyanHotelAndAixintangPharmaciesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aixin Shangyan Hotel and Aixintang Pharmacies [Member]", "documentation": "Aixin Shangyan Hotel and Aixintang Pharmacies [Member]" } } }, "auth_ref": [] }, "AIXN_AixinShangyanHotelManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AixinShangyanHotelManagementMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aixin Shangyan Hotel Management [Member]", "documentation": "Aixin Shangyan Hotel Management [Member]" } } }, "auth_ref": [] }, "AIXN_AixintangPharmacisesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AixintangPharmacisesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "AiXintang Pharmacises [Member]", "documentation": "AiXintang Pharmacises [Member]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r325", "r330" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Accounts receivable, allowance for credit loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r162", "r240", "r247", "r248", "r251", "r703" ] }, "AIXN_AllowanceForDoubtfulAccountsReceivableAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "AllowanceForDoubtfulAccountsReceivableAdditions", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Additions", "documentation": "Allowance for doubtful accounts receivable additions." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Effect of translation", "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r639" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Recoveries/Write offs", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery." } } }, "auth_ref": [ "r250" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/IntangibleAssetNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization expense", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r58", "r62" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r599" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r360" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r131", "r160", "r188", "r216", "r229", "r233", "r244", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r362", "r366", "r378", "r433", "r496", "r571", "r584", "r648", "r649", "r693" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r151", "r166", "r188", "r244", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r362", "r366", "r378", "r571", "r648", "r649", "r693" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r599" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "AIXN_BranchManagerMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BranchManagerMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Branch Manager [Member]", "documentation": "Branch Manager [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r358", "r564", "r565" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r74", "r77", "r358", "r564", "r565" ] }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Description of Acquired Entity", "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information." } } }, "auth_ref": [ "r75" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r358" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r76" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BUSINESS ACQUISITION PRO FORMA", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r609", "r610" ] }, "AIXN_BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails": { "parentTag": "AIXN_BusinessAcquisitionsProFormaLossFromOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating costs and expenses", "documentation": "Business Acquisitions Pro Forma Cost of Goods and Services Sold.", "label": "BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold" } } }, "auth_ref": [] }, "AIXN_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails": { "parentTag": "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "label": "Income tax expense", "documentation": "Business Acquisitions Pro Forma Income Tax Expense Benefit." } } }, "auth_ref": [] }, "AIXN_BusinessAcquisitionsProFormaLossFromOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessAcquisitionsProFormaLossFromOperations", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails": { "parentTag": "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "documentation": "Business Acquisitions Pro Forma Cost Loss from Operations.", "label": "BusinessAcquisitionsProFormaLossFromOperations" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Net loss", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r356", "r357" ] }, "AIXN_BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails": { "parentTag": "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "label": "Other income (expense)", "documentation": "Business Acquisitions Pro Forma Other Nonoperating Income Expense." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails": { "parentTag": "AIXN_BusinessAcquisitionsProFormaLossFromOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "label": "Revenue", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r356", "r357" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business combination consideration transferred", "verboseLabel": "Business Combination, Consideration Transferred", "terseLabel": "Total purchase considerations", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r2", "r3", "r14" ] }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredOther1", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Other", "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash." } } }, "auth_ref": [ "r15" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiaries" ], "lang": { "en-us": { "role": { "label": "ACQUISITION OF SUBSIDIARIES", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r125", "r359" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r79" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Estimated fair value of assets acquired:" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r79" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables and prepaid expense", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r79" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts payable", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r79" ] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableRelatedParty", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts payable-related party", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Related Party.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableRelatedParty" } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsReceivable", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Curren tLiabilities Accounts Receivable." } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsReceivableRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsReceivableRelatedParty", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Accounts receivable-related party", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Receivable Related Party." } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceFromCustomer": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceFromCustomer", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Advance from customers", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Advance From Customer.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceFromCustomer" } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceToSuppliers", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Advance to suppliers", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Advance To Suppliers." } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesGovernmentGrant": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesGovernmentGrant", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Government grant", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Government Grant.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesGovernmentGrant" } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseRightUseOfAssetst": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseRightUseOfAssetst", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease right-of-use assets", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Operating Lease Right Use Of Assets.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseRightUseOfAssetst" } } }, "auth_ref": [] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesTaxesPayable", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Taxes payable", "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Taxes Payable.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesTaxesPayable" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r79" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r78", "r79" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total liabilities assumed", "negatedLabel": "Total liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r79" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Estimated fair value of liabilities assumed:" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Total net assets acquired", "totalLabel": "Total net assets acquired", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r78", "r79" ] }, "AIXN_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Operating lease liability", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r78", "r79" ] }, "AIXN_CapitalContributionFromForgivenessOfRelatedPartyLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CapitalContributionFromForgivenessOfRelatedPartyLoan", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Capital contribution from forgiveness of related party loan", "documentation": "Capital contribution from forgiveness of related party loan." } } }, "auth_ref": [] }, "AIXN_CapitalReservePercentage": { "xbrltype": "percentItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CapitalReservePercentage", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Capital reserve, rate", "documentation": "Capital reserve percentage." } } }, "auth_ref": [] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash acquired at acquisition of subsidiaries", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r32" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r35", "r154", "r547" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r36" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Restricted Cash", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r36", "r129" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH & RESTRICTED CASH, BEGINNING OF PERIOD", "periodEndLabel": "CASH & RESTRICTED CASH, END OF PERIOD", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r35", "r106", "r184" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET DECREASE IN CASH & RESTRICTED CASH", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r106" ] }, "AIXN_CashDisposedAtDisposalOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CashDisposedAtDisposalOfSubsidiary", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash disposed at disposal of subsidiary", "documentation": "Cash disposed at disposal of subsidiary." } } }, "auth_ref": [] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC Insured Amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "AIXN_ChengduAixinECommerceCompanyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduAixinECommerceCompanyLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Aixin E-Commerce Company Ltd. [Member]", "documentation": "Chengdu Aixin E-Commerce Company Ltd. [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduAixinInternationalTravelserviceCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduAixinInternationalTravelserviceCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Aixin International travel service Co, Ltd [Member]", "documentation": "Chengdu Aixin International travel service Co, Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduAixintangPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduAixintangPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chengdu Aixintang Pharmacy Co Ltd [Member]", "documentation": "Chengdu Aixintang Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduCiguFoshouPharmacyMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduCiguFoshouPharmacyMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Cigu Foshou Pharmacy [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduFuxiangTangPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduFuxiangTangPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Fuxiang Tang Pharmacy Co Ltd [Member]", "documentation": "Chengdu Fuxiang Tang Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduHeshengyuanPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduHeshengyuanPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Heshengyuan Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduLishengHuirenTangPharmacyCoLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduLishengHuirenTangPharmacyCoLimitedMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd. [Member]", "documentation": "Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.\t[Member]" } } }, "auth_ref": [] }, "AIXN_ChengduTongtaiTangPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduTongtaiTangPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Tongtai Tang Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduWenJiangAixinHuiwanPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduWenJiangAixinHuiwanPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Wen Jiang Aixin Huiwan Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduWenJiangAixinNanjiangPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduWenJiangAixinNanjiangPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd. [Member]", "documentation": "Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd. [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Wenjiang District Heneng Hupu Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduYiYanTangPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduYiYanTangPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Yi Yan Tang Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChengduZhiweibingPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChengduZhiweibingPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chengdu Zhiweibing Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_ChinaConcentricCapitalGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ChinaConcentricCapitalGroupMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "China Concentric Capital Group [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "AIXN_CityConstructionMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CityConstructionMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "lang": { "en-us": { "role": { "label": "City Construction [Member]", "documentation": "City Construction [Member]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r633", "r634", "r683", "r706", "r709" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "verboseLabel": "Common Stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r89" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r89", "r482" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r89" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "verboseLabel": "Common stock, shares, outstanding", "terseLabel": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r18", "r89", "r482", "r502", "r709", "r710" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, par value $0.00001 per share, 500,000,000 shares authorized; 24,999,842 shares issued and outstanding as of September 30, 2023 and December 31, 2022 and 2021", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r89", "r435", "r571" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r31", "r168", "r170", "r175", "r427", "r445" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r44", "r46", "r80", "r81", "r237", "r542" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r44", "r46", "r80", "r81", "r237", "r461", "r542" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r44", "r46", "r80", "r81", "r237", "r542", "r608" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r87", "r140" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r44", "r46", "r80", "r81", "r237" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r44", "r46", "r80", "r81", "r237", "r542" ] }, "us-gaap_ConstructionPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionPayableCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Construction payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r22" ] }, "AIXN_CostOfGoodsAndServiceSold": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CostOfGoodsAndServiceSold", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "Cost of goods and service sold." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of goods sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r101", "r411" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current:" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "China", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r612", "r630", "r681" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total current", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r124", "r345", "r351", "r630" ] }, "AIXN_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CustomerAMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails" ], "lang": { "en-us": { "role": { "label": "Customer A [Member]", "documentation": "Customer A [Member]" } } }, "auth_ref": [] }, "AIXN_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "CustomerBMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails" ], "lang": { "en-us": { "role": { "label": "Customer B [Member]", "documentation": "Customer B [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r45", "r237" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/LoanFromThirdParties" ], "lang": { "en-us": { "role": { "label": "LOAN FROM THIRD PARTIES", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r117", "r186", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293" ] }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentDecreaseForgiveness", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Forgiveness of shareholder's loan", "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument." } } }, "auth_ref": [ "r628" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "China", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r630", "r680", "r681" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred:" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred tax asset", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r334", "r335" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 }, "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred tax", "totalLabel": "Total deferred", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r10", "r124", "r146", "r350", "r351", "r630" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Unearned revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r616" ] }, "AIXN_DeferredTaxAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DeferredTaxAssetsAccumulatedAmortization", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization", "documentation": "Deferred tax assets accumulated amortization." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DepositAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositAssets", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement." } } }, "auth_ref": [ "r615" ] }, "us-gaap_DepositLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositLiabilityCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Deposit", "documentation": "The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits." } } }, "auth_ref": [ "r26" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r63" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r10", "r63" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r219" ] }, "AIXN_DisclosureAdvancesToSuppliersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DisclosureAdvancesToSuppliersAbstract", "lang": { "en-us": { "role": { "label": "Advances To Suppliers" } } }, "auth_ref": [] }, "AIXN_DisclosureLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DisclosureLeaseAbstract", "lang": { "en-us": { "role": { "label": "Lease", "verboseLabel": "Schedule Of Operating Lease Liabilities", "terseLabel": "Schedule Of Operating Lease Expenses" } } }, "auth_ref": [] }, "AIXN_DisclosureOtherReceivablesAndPrepaidExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DisclosureOtherReceivablesAndPrepaidExpensesAbstract", "lang": { "en-us": { "role": { "label": "Other Receivables And Prepaid Expenses", "verboseLabel": "Schedule Of Other Receivables And Prepaid Expenses" } } }, "auth_ref": [] }, "AIXN_DisclosureStatutoryReservesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DisclosureStatutoryReservesAbstract", "lang": { "en-us": { "role": { "label": "Statutory Reserves" } } }, "auth_ref": [] }, "AIXN_DisclosureTaxesPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DisclosureTaxesPayableAbstract", "lang": { "en-us": { "role": { "label": "Taxes Payable" } } }, "auth_ref": [] }, "AIXN_DisposalOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "DisposalOfSubsidiary", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Disposal of subsidiary", "documentation": "Disposal of subsidiary." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r598" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r596", "r598", "r599" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r597" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r585" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r598" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r598" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r600" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r588" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r176", "r197", "r198", "r199", "r200", "r201", "r206", "r208", "r210", "r211", "r212", "r213", "r376", "r377", "r428", "r446", "r553" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r176", "r197", "r198", "r199", "r200", "r201", "r208", "r210", "r211", "r212", "r213", "r376", "r377", "r428", "r446", "r553" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r41", "r42" ] }, "AIXN_EducationMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "EducationMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "lang": { "en-us": { "role": { "label": "Education [Member]", "documentation": "Education [Member]" } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "EFFECT OF EXCHANGE RATE CHANGE ON CASH", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r685" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective combined tax rate", "verboseLabel": "Effective income tax rate", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r337" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Statutory U.S. federal income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r189", "r337", "r352" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Change in valuation allowances", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r679", "r682" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Foreign tax rate differential", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile." } } }, "auth_ref": [ "r679", "r682" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments." } } }, "auth_ref": [] }, "AIXN_ElectronicEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ElectronicEquipmentMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Electronic Equipment [Member]", "documentation": "Electronic Equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued payroll and commission", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation expenses", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r326" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employee services expected to be recognized", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r326" ] }, "AIXN_EmployeesAndContractorsMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "EmployeesAndContractorsMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees and Contractors [Member]", "documentation": "Employees and Contractors [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r591" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r587" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r587" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r604" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r587" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r601" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r599" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r587" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r587" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r587" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r587" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r602" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r18", "r149", "r172", "r173", "r174", "r192", "r193", "r194", "r196", "r202", "r204", "r215", "r245", "r246", "r307", "r327", "r328", "r329", "r346", "r347", "r368", "r369", "r370", "r371", "r372", "r373", "r375", "r380", "r381", "r382", "r383", "r384", "r385", "r396", "r455", "r456", "r457", "r471", "r526" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "auth_ref": [ "r241", "r242", "r243" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Equity interest percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r241" ] }, "AIXN_EquityTransferAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "EquityTransferAgreementMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Transfer Agreement [Member]", "documentation": "Equity Transfer Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_EstimatedInsuranceRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimatedInsuranceRecoveries", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Employees\u2019 social insurance", "documentation": "Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts." } } }, "auth_ref": [ "r615" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements and Disclosures", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r12", "r19" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r158", "r259" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails" ], "lang": { "en-us": { "role": { "label": "Software", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r113", "r413" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfIntangibleAssetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Intangible asset, net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r113", "r412" ] }, "AIXN_FoodAndBeverageRevenuesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "FoodAndBeverageRevenuesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Food And Beverage Revenues [Member]", "documentation": "Food And Beverage Revenues [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Translation and Comprehensive Income (Loss)", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r379" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r102", "r506" ] }, "AIXN_GoingConcernPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "GoingConcernPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Going Concern", "documentation": "Going Concern [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, net", "verboseLabel": "Goodwill as a result of the acquisition", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r157", "r256", "r426", "r560", "r571", "r641", "r642" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r255", "r257", "r560" ] }, "AIXN_GovernmentGrant": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "GovernmentGrant", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Government grant", "documentation": "Government grant." } } }, "auth_ref": [] }, "AIXN_GovernmentGrantIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "GovernmentGrantIncome", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 }, "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Government grant income", "negatedLabel": "Government grant income" } } }, "auth_ref": [] }, "us-gaap_GuaranteeObligationsByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsByNatureAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Guarantor Obligations, Nature [Axis]", "documentation": "Information by nature of guarantee." } } }, "auth_ref": [ "r270", "r271", "r272", "r273" ] }, "us-gaap_GuaranteeObligationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Guarantor Obligations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r270", "r271", "r272", "r273" ] }, "us-gaap_GuaranteeObligationsNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsNatureDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees." } } }, "auth_ref": [ "r270", "r271", "r272", "r273" ] }, "us-gaap_HealthCareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HealthCareMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Health Care [Member]", "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health." } } }, "auth_ref": [ "r652" ] }, "srt_HotelMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "HotelMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hotel [Member]" } } }, "auth_ref": [ "r411", "r652", "r711", "r712" ] }, "AIXN_HotelOperatingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "HotelOperatingCosts", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Hotel operating costs", "documentation": "Hotel operating costs." } } }, "auth_ref": [] }, "AIXN_HuiliangJiaoMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "HuiliangJiaoMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Huiliang Jiao [Member]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 }, "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment loss", "label": "Impairment loss", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r626", "r643" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r116" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r99", "r133", "r216", "r228", "r232", "r234", "r429", "r442", "r555" ] }, "AIXN_IncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "IncomeMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "lang": { "en-us": { "role": { "label": "Income [Member]", "documentation": "Income [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r189", "r331", "r338", "r340", "r343", "r348", "r353", "r354", "r355", "r466" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfComponentsOfProvisionForIncomeTaxesDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income tax expense (benefit)", "totalLabel": "Total income tax expense", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r136", "r147", "r203", "r204", "r220", "r336", "r349", "r447" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r171", "r332", "r333", "r340", "r341", "r342", "r344", "r463" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income tax paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r37" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r9" ] }, "AIXN_IncreaseDecreaseInAccountsPayableRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "IncreaseDecreaseInAccountsPayableRelatedParty", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable - related party", "documentation": "Increase decrease in accounts payable related party." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable - related parties", "label": "Increase (Decrease) in Accounts Receivable, Related Parties", "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued liabilities and other payables", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r625" ] }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedTaxesPayable", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Taxes payable", "label": "Increase (Decrease) in Accrued Taxes Payable", "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes." } } }, "auth_ref": [ "r625" ] }, "AIXN_IncreaseDecreaseInAdditionalPaidinCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "IncreaseDecreaseInAdditionalPaidinCapital", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:IncreaseDecreaseInAdditionalPaidinCapital]", "documentation": "Increase decrease in additional paid-in capital." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r409", "r625" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Advances to suppliers", "label": "Increase (Decrease) in Due to Related Parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other receivables and prepaid expenses", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expense - related party", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IndemnificationGuaranteeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndemnificationGuaranteeMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Indemnification Agreement [Member]", "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor." } } }, "auth_ref": [ "r647" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/IntangibleAssetNet" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSET, NET", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r258" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible asset, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r57", "r60" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r179", "r182", "r183" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "INVENTORIES", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r252" ] }, "AIXN_InventoryDrugsPharmaceuticalAndNutritionalProductsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "InventoryDrugsPharmaceuticalAndNutritionalProductsGross", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Drugs, pharmaceutical and nutritional products", "documentation": "Inventory drugs pharmaceutical and nutritional products gross." } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods-health supplements", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r617" ] }, "AIXN_InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Food and beverage, hotel supplies and consumables", "documentation": "Inventory food and beverage hotel supplies and consumables gross." } } }, "auth_ref": [] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryGross", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r620" ] }, "AIXN_InventoryImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "InventoryImpairment", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for inventory reserve" } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 }, "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, net", "totalLabel": "Total inventories, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r164", "r548", "r571" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r137", "r153", "r163", "r252", "r253", "r254", "r410", "r552" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Raw material", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r619" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory valuation reserves", "verboseLabel": "Less: reserve for inventory", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r55", "r620" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Work in process", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r618" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE EXPENSES", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r689" ] }, "us-gaap_LeaseExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseExpirationDate1", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease Expiration Date", "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r115" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r390" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF MATURITIES OF LEASE LIABILITIES", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r690" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r394" ] }, "AIXN_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "2024", "verboseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r394" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r394" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "2027", "verboseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r394" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "2026", "verboseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r394" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "2025", "verboseLabel": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r394" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "2023 (excluding the nine months ended September 30, 2023)", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r690" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r394" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r687" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r688" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/Lease" ], "lang": { "en-us": { "role": { "label": "LEASE", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r386" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r25", "r188", "r244", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r363", "r366", "r367", "r378", "r481", "r554", "r584", "r648", "r693", "r694" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 deficit", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r94", "r132", "r438", "r571", "r629", "r638", "r684" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and stockholders\u2019 equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r27", "r152", "r188", "r244", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r363", "r366", "r367", "r378", "r571", "r648", "r693", "r694" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "us-gaap_LitigationSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationSettlementExpense", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement, Expense", "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermPurchaseCommitmentAmount", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment, Amount", "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LossContingencyDisclosures": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyDisclosures", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingencies" ], "lang": { "en-us": { "role": { "label": "OPERATING CONTINGENCIES", "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made." } } }, "auth_ref": [ "r260", "r261", "r262", "r264", "r266", "r267", "r268", "r269" ] }, "AIXN_LuquanShengcaofengBiotechnologyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "LuquanShengcaofengBiotechnologyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Luquan Shengcaofeng Biotechnology Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "MachineryMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Machinery [Member]", "documentation": "Machinery [Member]" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r237", "r563", "r651", "r704", "r705" ] }, "AIXN_ManufactueAndSaleMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ManufactueAndSaleMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Manufactue And Sale [Member]" } } }, "auth_ref": [] }, "AIXN_ManufactureAndSaleMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ManufactureAndSaleMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Manufacture and Sale [Member]", "documentation": "Manufacture and Sale [Member]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails", "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r263", "r265", "r266", "r267", "r320", "r408", "r454", "r473", "r474", "r534", "r535", "r536", "r537", "r538", "r543", "r544", "r557", "r561", "r566", "r573", "r650", "r695", "r696", "r697", "r698", "r699", "r700" ] }, "AIXN_MianyangAixinCunshanPharmacyMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "MianyangAixinCunshanPharmacyMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Mianyang Aixin Cunshan Pharmacy [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails", "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r263", "r265", "r266", "r267", "r320", "r408", "r454", "r473", "r474", "r534", "r535", "r536", "r537", "r538", "r543", "r544", "r557", "r561", "r566", "r573", "r650", "r695", "r696", "r697", "r698", "r699", "r700" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r237", "r563", "r651", "r704", "r705" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r181" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r181" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r106", "r107", "r108" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r100", "r108", "r134", "r150", "r167", "r169", "r174", "r188", "r195", "r197", "r198", "r199", "r200", "r203", "r204", "r209", "r216", "r228", "r232", "r234", "r244", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r377", "r378", "r444", "r504", "r524", "r525", "r555", "r582", "r648" ] }, "AIXN_NetIncomeTransferPercentage": { "xbrltype": "percentItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "NetIncomeTransferPercentage", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net income transfer, rate", "documentation": "Net income transfer percentage." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "AIXN_NoCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "NoCustomerMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "No Customer [Member]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-operating income (loss), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r103" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Non-operating income (expenses)" } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonrelatedPartyMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r631", "r632" ] }, "AIXN_OfficeFurnitureMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "OfficeFurnitureMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Office Furniture [Member]", "documentation": "Office Furniture [Member]" } } }, "auth_ref": [] }, "AIXN_OfficeLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "OfficeLeasesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Office Leases [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Total operating costs and expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating costs and expenses", "label": "Operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Operating costs and expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Loss from operations", "negatedLabel": "Operating income loss", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r216", "r228", "r232", "r234", "r555" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseExpensesDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease expense", "verboseLabel": "Operating lease expenses", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r686" ] }, "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLeaseIncomeTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE LIABILITIES", "documentation": "Tabular disclosure of components of income from operating lease." } } }, "auth_ref": [ "r214", "r395" ] }, "AIXN_OperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "OperatingLeaseLiabilities", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Operating lease liability", "documentation": "Operating lease liabilities.", "label": "OperatingLeaseLiabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease liabilities", "label": "Total lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r388" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "verboseLabel": "Operating lease liabilities \u2013 current", "negatedLabel": "Less: current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r388" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 }, "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities - non-current", "verboseLabel": "Operating lease liability \u2013 non-current", "terseLabel": "Lease liabilities \u2013 non-current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r388" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherInformationRelatedLeasesDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of lease liability", "label": "Operating cash flows from operating leases", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r389", "r391" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right-of-use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r387" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherInformationRelatedLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average operating lease discount rate", "verboseLabel": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r393", "r570" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherInformationRelatedLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average operating lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r392", "r570" ] }, "AIXN_OperatingLeasesFutureMinimumPaymentDue": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "OperatingLeasesFutureMinimumPaymentDue", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:OperatingLeasesFutureMinimumPaymentDue-0]", "documentation": "Operating lease future minimum lease payment." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carry-forward", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r73" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r72" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusiness" ], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r109", "r110", "r111", "r127" ] }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities and other payables", "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Other payables", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r26" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Others", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r130", "r159", "r432", "r584" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive items" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation gain (loss)", "verboseLabel": "Foreign currency translation", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r6" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Due to related parties", "label": "Other Liabilities", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r86", "r431", "r477", "r478", "r584", "r707" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Due to related parties", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r26", "r571" ] }, "AIXN_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "OtherMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other [Member]", "documentation": "Other [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingExpense", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Other expenses", "label": "Other Nonoperating Expense", "documentation": "Amount of expense related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r104" ] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r178" ] }, "AIXN_OtherReceivablesAndPrepaidExpensesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "OtherReceivablesAndPrepaidExpensesDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpenses" ], "lang": { "en-us": { "role": { "label": "OTHER RECEIVABLES AND PREPAID EXPENSES", "documentation": "Other Receivables And Prepaid Expenses Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Due from related parties", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r598" ] }, "AIXN_PayableForEquipmentPurchaseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PayableForEquipmentPurchaseCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccruedLiabilitiesAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Payable for equipment purchase", "documentation": "Payable for equipment purchase current." } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for Rent", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses and Interest in Affiliates", "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment)." } } }, "auth_ref": [ "r33" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of intangible asset", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r105" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r105" ] }, "AIXN_PharmaciesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PharmaciesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Pharmacies [Member]", "documentation": "Pharmacies [Member]" } } }, "auth_ref": [] }, "AIXN_PharmaciesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PharmaciesPurchaseAgreementMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Pharmacies Purchase Agreement [Member]", "documentation": "Pharmacies Purchase Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r592" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r593" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Undesignated preferred stock, par value", "verboseLabel": "Preferred stock,par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r88", "r295" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Undesignated preferred stock, shares authorized", "verboseLabel": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r88", "r482" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Undesignated preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r88", "r295" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Undesignated preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r88", "r482", "r502", "r709", "r710" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, none issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r88", "r434", "r571" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Prepaid Expense and Other Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other receivables and prepaid expenses, including related party", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r621" ] }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrentAndNoncurrent", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses, including related party", "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs." } } }, "auth_ref": [ "r84", "r165", "r495", "r701" ] }, "us-gaap_PrepaidRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidRent", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid Rent", "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r549", "r558", "r640" ] }, "AIXN_PrepaymentForAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PrepaymentForAcquisition", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment for acquisition of subsidiaries", "documentation": "Prepayment for acquisition.", "label": "PrepaymentForAcquisition" } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassification", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r613" ] }, "AIXN_PriorToMayOneTwpThousandEighteenMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PriorToMayOneTwpThousandEighteenMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prior to May 1, 2018 [Member]", "documentation": "Prior to May 1, 2018 [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromContributedCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromContributedCapital", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Capital contribution", "verboseLabel": "Proceeds from Contributed Capital", "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period." } } }, "auth_ref": [ "r7" ] }, "AIXN_ProceedsFromGovernmentGrant": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ProceedsFromGovernmentGrant", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from government grant" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in advance from related parties", "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts." } } }, "auth_ref": [] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Product [Member]", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r562" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r235", "r411", "r448", "r449", "r450", "r451", "r452", "r453", "r546", "r562", "r572", "r611", "r645", "r646", "r651", "r704" ] }, "AIXN_ProductSMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ProductSMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails" ], "lang": { "en-us": { "role": { "label": "Product S [Member]" } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r235", "r411", "r448", "r449", "r450", "r451", "r452", "r453", "r546", "r562", "r572", "r611", "r645", "r646", "r651", "r704" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r150", "r167", "r169", "r180", "r188", "r195", "r203", "r204", "r216", "r228", "r232", "r234", "r244", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r361", "r364", "r365", "r377", "r378", "r429", "r443", "r470", "r504", "r524", "r525", "r555", "r568", "r569", "r583", "r624", "r648" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT, NET", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r114", "r141", "r144", "r145" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r115", "r155", "r441" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r11", "r430", "r441", "r571" ] }, "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentOtherTypesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Other Types [Member]", "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r11", "r141", "r144", "r439" ] }, "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentSalvageValuePercentage", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, salvage value, percentage", "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY AND EQUIPMENT", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r115" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Property plant and equipment useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "AIXN_ProvisionForBadDebts": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ProvisionForBadDebts", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsDetails" ], "lang": { "en-us": { "role": { "label": "Provision for bad debts" } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "(Reversal of) provision for bad debts", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r177", "r249" ] }, "AIXN_ProvisionForInventoryReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ProvisionForInventoryReserve", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:ProvisionForInventoryReserve]", "documentation": "Provision for inventory reserve." } } }, "auth_ref": [] }, "AIXN_PurchaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PurchaseCost", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails" ], "lang": { "en-us": { "role": { "label": "Total purchases", "documentation": "Purchase Cost." } } }, "auth_ref": [] }, "AIXN_PurchasePriceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "PurchasePriceOfCommonStock", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price of common stock", "documentation": "Purchase price of common stock." } } }, "auth_ref": [] }, "AIXN_QuanzhongLinMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "QuanzhongLinMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Quanzhong Lin [Member]", "documentation": "Quanzhong Lin [Member]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails", "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r263", "r265", "r266", "r267", "r318", "r320", "r322", "r323", "r324", "r407", "r408", "r454", "r473", "r474", "r534", "r535", "r536", "r537", "r538", "r543", "r544", "r557", "r561", "r566", "r573", "r576", "r644", "r650", "r696", "r697", "r698", "r699", "r700" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails", "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "auth_ref": [ "r263", "r265", "r266", "r267", "r318", "r320", "r322", "r323", "r324", "r407", "r408", "r454", "r473", "r474", "r534", "r535", "r536", "r537", "r538", "r543", "r544", "r557", "r561", "r566", "r573", "r576", "r644", "r650", "r696", "r697", "r698", "r699", "r700" ] }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable", "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized." } } }, "auth_ref": [ "r54" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r319", "r400", "r401", "r476", "r477", "r478", "r479", "r480", "r501", "r503", "r533" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r190", "r191", "r400", "r401", "r402", "r403", "r476", "r477", "r478", "r479", "r480", "r501", "r503", "r533" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r400", "r401", "r692" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r507", "r508", "r511" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r319", "r400", "r401", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r476", "r477", "r478", "r479", "r480", "r501", "r503", "r533", "r692" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r397", "r398", "r399", "r401", "r404", "r467", "r468", "r469", "r509", "r510", "r511", "r530", "r532" ] }, "AIXN_RenewedMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "RenewedMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Renewed [Member]", "documentation": "Renewed [Member]" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of loan from third parties", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r34" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Restricted cash", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r614", "r627" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r91", "r119", "r437", "r458", "r460", "r465", "r483", "r571" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r149", "r192", "r193", "r194", "r196", "r202", "r204", "r245", "r246", "r327", "r328", "r329", "r346", "r347", "r368", "r370", "r371", "r373", "r375", "r455", "r457", "r471", "r709" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Total revenue, net", "verboseLabel": "Total revenue", "terseLabel": "Total revenues, net", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r217", "r218", "r227", "r230", "r231", "r235", "r236", "r237", "r316", "r317", "r411" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r148", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r545" ] }, "us-gaap_RevenueRecognitionDeferredRevenue": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionDeferredRevenue", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Unearned Revenue", "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services." } } }, "auth_ref": [] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Sales revenue:" } } }, "auth_ref": [] }, "AIXN_ReversalOfProvisionForBadDebts": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ReversalOfProvisionForBadDebts", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "(Reversal of) provision for bad debts", "documentation": "Reversal of provision for bad debts." } } }, "auth_ref": [] }, "AIXN_RoomRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "RoomRevenueMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Room Revenue [Member]", "documentation": "Room Revenue [Member]" } } }, "auth_ref": [] }, "AIXN_RuncangshengAixinShangyanHotelAndAixintangPharmaciesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "RuncangshengAixinShangyanHotelAndAixintangPharmaciesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails" ], "lang": { "en-us": { "role": { "label": "Runcangsheng Aixin Shangyan Hotel and Aixintang Pharmacies [Member]", "documentation": "Runcangsheng Aixin Shangyan Hotel and Aixintang Pharmacies [Member]" } } }, "auth_ref": [] }, "AIXN_RuncanshengMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "RuncanshengMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Runcansheng [Member]" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r237", "r607" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "auth_ref": [ "r205", "r321", "r605", "r636" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/AccruedLiabilitiesAndOtherPayablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "AIXN_ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ScheduleOfAccountsReceivableAllowanceForDoubtfulAccountsTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS", "documentation": "Schedule of Accounts Receivable Allowance for Doubtful Accounts [Table Text Block]" } } }, "auth_ref": [] }, "AIXN_ScheduleOfAdvancesAndAccountsPayableToRelatedPartyTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ScheduleOfAdvancesAndAccountsPayableToRelatedPartyTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ADVANCES AND ACCOUNTS PAYABLE TO RELATED PARTY" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r74", "r77", "r358" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF THE PROVISION FOR INCOME TAXES", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r123" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAX ASSETS", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r122" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r13", "r65", "r66", "r67", "r68" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r121" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r241", "r242", "r243" ] }, "AIXN_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED LIVES", "documentation": "Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/IntangibleAssetNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTANGIBLE ASSET", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r59", "r61" ] }, "us-gaap_ScheduleOfGuaranteeObligationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGuaranteeObligationsTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/OperatingContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Guarantor Obligations [Table]", "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties." } } }, "auth_ref": [ "r270", "r271", "r272", "r273" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVENTORIES", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r20", "r95", "r96", "r97" ] }, "AIXN_ScheduleOfOtherInformationRelatedLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ScheduleOfOtherInformationRelatedLeasesTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER INFORMATION RELATED LEASES", "documentation": "Schedule of other information related leases [Table text block]" } } }, "auth_ref": [] }, "AIXN_ScheduleOfOtherReceivablesAndPrepaidExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ScheduleOfOtherReceivablesAndPrepaidExpensesTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/OtherReceivablesAndPrepaidExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER RECEIVABLES AND PREPAID EXPENSES", "documentation": "Schedule of other receivables and prepaid expenses [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfSegmentsInformationDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUES OF THE ASSETS ACQUIRED AND LIABILITIES ASSUMED", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r126" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfAdvancesAndAccountsPayableToRelatedPartyDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r82", "r83", "r507", "r508", "r511" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RELATED PARTY TRANSACTIONS", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SEGMENTS INFORMATION", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r51", "r52", "r53", "r56" ] }, "AIXN_ScheduleOfTaxesPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ScheduleOfTaxesPayableTableTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/TaxesPayableTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TAX PAYABLE", "documentation": "Schedule Of Taxes Payable [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r43", "r44", "r46", "r47", "r80", "r128" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r586" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r590" ] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecurityDeposit", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Security deposit", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r615" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r589" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r594" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r226", "r236", "r556" ] }, "us-gaap_SellingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingExpense", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Selling", "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services." } } }, "auth_ref": [ "r102" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r567" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based payment award description", "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance." } } }, "auth_ref": [ "r69", "r70" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "documentation": "Purchase price of common stock expressed as a percentage of its fair value." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermNonBankLoansAndNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermNonBankLoansAndNotesPayable", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/LoanFromThirdPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan from third parties", "verboseLabel": "Short-Term Non-bank Loans and Notes Payable", "documentation": "Amount of borrowings from a creditor other than a bank with a maturity within one year or operating cycle, if longer." } } }, "auth_ref": [ "r21", "r479", "r480" ] }, "AIXN_SichuanAixinInvestmentCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SichuanAixinInvestmentCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sichuan Aixin Investment Co., Ltd [Member]", "documentation": "Sichuan Aixin Investment Co., Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_SichuanAixintangXinfuPharmacyChainCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SichuanAixintangXinfuPharmacyChainCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_SichuanHaosenHaichuanBusinessManagementCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SichuanHaosenHaichuanBusinessManagementCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sichuan Haosen Haichuan Business Management Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_SichuanXintangXinfuPharmacyChainCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SichuanXintangXinfuPharmacyChainCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sichuan Xintang Xinfu Pharmacy Chain Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_SichuanYunxiPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SichuanYunxiPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Sichuan Yunxi Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r109", "r185" ] }, "AIXN_SinceAprilOneTwoThousandNineteenMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SinceAprilOneTwoThousandNineteenMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Since April One Two Thousand Nineteen [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r595" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r18", "r28", "r149", "r172", "r173", "r174", "r192", "r193", "r194", "r196", "r202", "r204", "r215", "r245", "r246", "r307", "r327", "r328", "r329", "r346", "r347", "r368", "r369", "r370", "r371", "r372", "r373", "r375", "r380", "r381", "r382", "r383", "r384", "r385", "r396", "r455", "r456", "r457", "r471", "r526" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit", "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r192", "r193", "r194", "r215", "r411", "r462", "r472", "r475", "r476", "r477", "r478", "r479", "r480", "r482", "r485", "r486", "r487", "r488", "r489", "r491", "r492", "r493", "r494", "r497", "r498", "r499", "r500", "r501", "r503", "r505", "r506", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r526", "r577" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "auth_ref": [] }, "AIXN_StatementOfCashFlowsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "StatementOfCashFlowsPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows", "documentation": "Statement Of Cash Flows [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r205", "r321", "r605", "r606", "r636" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://aixinlifeinternationalinc.com/role/LeaseDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfBusinessAcquisitionProFormaDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails", "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit", "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r192", "r193", "r194", "r215", "r411", "r462", "r472", "r475", "r476", "r477", "r478", "r479", "r480", "r482", "r485", "r486", "r487", "r488", "r489", "r491", "r492", "r493", "r494", "r497", "r498", "r499", "r500", "r501", "r503", "r505", "r506", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r526", "r577" ] }, "AIXN_StatutoryReserveFund": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "StatutoryReserveFund", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatutoryReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statutory reserve fund", "documentation": "Statutory reserve fund." } } }, "auth_ref": [] }, "AIXN_StatutoryReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "StatutoryReserves", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Statutory reserve", "documentation": "Statutory reserves." } } }, "auth_ref": [] }, "AIXN_StatutoryReservesMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "StatutoryReservesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Statutory Reserves [Member]", "documentation": "Statutory Reserves [Member]" } } }, "auth_ref": [] }, "AIXN_StatutoryReservesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "StatutoryReservesTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatutoryReserves" ], "lang": { "en-us": { "role": { "label": "STATUTORY RESERVES", "documentation": "Statutory reserves [Text Block]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of shares", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, shares, new issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r18", "r88", "r89", "r119", "r464", "r526", "r539" ] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reverse stock split", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r18" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of value", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/StatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 deficit", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r89", "r92", "r93", "r112", "r484", "r502", "r527", "r528", "r571", "r584", "r629", "r638", "r684", "r709" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity (deficit)" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r118", "r187", "r294", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r374", "r529", "r531", "r540" ] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Reverse Stock Split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r120" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SubsequentEvent" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENT", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r405", "r406" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash flow data:" } } }, "auth_ref": [] }, "AIXN_SupplierCMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SupplierCMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails" ], "lang": { "en-us": { "role": { "label": "Supplier C [Member]", "documentation": "Supplier C [Member]" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails", "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r45" ] }, "AIXN_SupplierDMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SupplierDMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails" ], "lang": { "en-us": { "role": { "label": "Supplier D [Member]", "documentation": "Supplier D [Member]" } } }, "auth_ref": [] }, "AIXN_SupplierEMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SupplierEMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfConcentrationOfRiskByRiskFactorsDetails" ], "lang": { "en-us": { "role": { "label": "Supplier E [Member]", "documentation": "Supplier E [Member]" } } }, "auth_ref": [] }, "AIXN_SupplierOneMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SupplierOneMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier One [Member]" } } }, "auth_ref": [] }, "AIXN_SupplierTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "SupplierTwoMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier Two [Member]" } } }, "auth_ref": [] }, "us-gaap_Supplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Supplies", "crdr": "debit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/AdvancesToSuppliersDetailsNarrative", "http://aixinlifeinternationalinc.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Advances to suppliers", "verboseLabel": "Prepaid supplies", "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r550", "r559", "r640" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://aixinlifeinternationalinc.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://aixinlifeinternationalinc.com/role/BalanceSheets", "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "lang": { "en-us": { "role": { "label": "Taxes payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r24" ] }, "AIXN_TaxesPayablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "TaxesPayablesTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/TaxesPayable" ], "lang": { "en-us": { "role": { "label": "TAXES PAYABLE", "documentation": "Taxes Payables [Text Block]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r637", "r691" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "AIXN_TransferAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "TransferAgreementMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transfer Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_TransferToInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransferToInvestments", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investment in subsidiary paid by shareholder on behalf of the Company", "documentation": "Value of investments transferred to the entity's investments in noncash transactions." } } }, "auth_ref": [ "r38", "r39", "r40" ] }, "AIXN_TwoThousandAndNineteenEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "TwoThousandAndNineteenEquityIncentivePlanMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Nineteen Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "AIXN_TwoThousandAndNinettenEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "TwoThousandAndNinettenEquityIncentivePlanMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2019 Equity Incentive Plan [Member]", "documentation": "2019 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r360" ] }, "AIXN_UnauditedInterimFinancialInformationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "UnauditedInterimFinancialInformationPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Unaudited Interim Financial Information", "documentation": "Unaudited Interim Financial Information [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized tax benefits", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r339" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://aixinlifeinternationalinc.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r339" ] }, "AIXN_UnusualOrInfrequentItemsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "UnusualOrInfrequentItemsPolicyTextBlock", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Global Uncertainties", "documentation": "Covid -19 [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r48", "r49", "r50", "r138", "r139", "r142", "r143" ] }, "AIXN_ValueAddedMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "ValueAddedMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfTaxPayableDetails" ], "lang": { "en-us": { "role": { "label": "Value-added [Member]", "documentation": "Value-added [Member]" } } }, "auth_ref": [] }, "AIXN_VatOfGrossSalesPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "VatOfGrossSalesPricePercentage", "presentation": [ "http://aixinlifeinternationalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vat of gross sales price percentage", "documentation": "VAT of gross sales price percentage." } } }, "auth_ref": [] }, "AIXN_VehicleMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "VehicleMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Vehicle [Member]" } } }, "auth_ref": [] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VehiclesMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://aixinlifeinternationalinc.com/role/ScheduleOfPropertyAndEquipmentEstimatedLivesDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r207", "r212" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://aixinlifeinternationalinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r206", "r212" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://aixinlifeinternationalinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r603" ] }, "AIXN_WuhouDistrictXiaofeiPharmacyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "WuhouDistrictXiaofeiPharmacyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Wuhou District Xiaofei Pharmacy Co Ltd [Member]" } } }, "auth_ref": [] }, "AIXN_XiaoyanMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "XiaoyanMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Xiaoyan [Member]" } } }, "auth_ref": [] }, "AIXN_XiaoyanZhouMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "XiaoyanZhouMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Xiaoyan Zhou [Member]" } } }, "auth_ref": [] }, "AIXN_YirongShenMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "YirongShenMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Yirong Shen [Member]", "documentation": "Yirong Shen [Member]" } } }, "auth_ref": [] }, "AIXN_YunChenMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "YunChenMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Yun Chen [Member]" } } }, "auth_ref": [] }, "AIXN_YunnanRuncangshengMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "YunnanRuncangshengMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative", "http://aixinlifeinternationalinc.com/role/RelatedPartyTransactionsDetailsNarrative", "http://aixinlifeinternationalinc.com/role/ScheduleOfFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Yunnan Runcangsheng [Member]" } } }, "auth_ref": [] }, "AIXN_YunnanShengshengyuanMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "YunnanShengshengyuanMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/AcquisitionOfSubsidiariesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Yunnan Shengshengyuan [Member]" } } }, "auth_ref": [] }, "AIXN_YunnanShengshengyuanTechnologyCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://aixinlifeinternationalinc.com/20230930", "localname": "YunnanShengshengyuanTechnologyCoLtdMember", "presentation": [ "http://aixinlifeinternationalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://aixinlifeinternationalinc.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Yunnan Shengshengyuan Technology Co Ltd [Member]", "documentation": "Yunnan Shengshengyuan Technology Co Ltd [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-9" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450-20/tableOfContent" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450-30/tableOfContent" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r552": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r553": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r554": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r555": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r556": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r557": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r558": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r570": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r571": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r572": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r574": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r576": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r581": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r583": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r584": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r591": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r592": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r593": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r605": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r606": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" } } } ZIP 96 0001493152-24-005769-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-005769-xbrl.zip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

5M*5&53:01MQ:?_S/WW_9Y<%_DN8 MDGYMO9.>-1T*P"HR";IAF91BB,HYK5XWJ1?[NS(-L"R1GT &UC>7 ^1NV&&2 M5=ICMQG^JEK)!@0SFO:?KC*2?P]>_**=1:FU8)7.&,BRIJL<-LVN:W54Z8/I MGZH!88[3V"NW6#:I]XRC*F&PP<38W +9E!) MZ@PJFT_$B1?R!WE;.4K=6M-YA%.=>"YC75BD&@^,+L$F>V;>SZAMVRG4BD- MJZA,H')G/&H=MG?A1VH\O":-5M M#"$@80DT"VN:>1&[[^$YS&AD4I+>>,$M?A3K;.T(G>R3J-#BQFF0,6GJK+$\1T$5-& MK;;SAA,>/M;)KS/[C@SL,KX)!^X?9/*&.I:HS& MB-E#]4UY[YJ;\IK\UVM75^6I/L!]DF4T@+4Z7D:>C.( K_YZREZ*_:@RI];* MZ-W6'KC29B=,'Y*XN4>P/*$Q^WS <<8?:CC>U.MA@9$?8QE17IO6M8JJ1!:5 M77#,J([J>)\K@#7.JH,NDEH3C[ESLLP M;:VX8NT^A%5> F1<7'@EPAIB1\GB#3-YOXX,WB,S=R]AY>O^$!=902:+-)5" MBO]>$%SS'.^U>2L-]6 5U3C0_+W.SV& KM]\/S9CY4FW/OE)$>=UMK.TUFF RA/X&;OVD&/&D79@T>(T)_B<2)4U%%!SZ-"S MQT@1MQ;I[BDS65X0Z:2?:!#?)0F-TKBAF[O>$V;[\55"_RH,)ROVC-L:-HPT M!)0.QWDAY\.6V&/E_UA91#L6\9!5-MDSO[5J0(D3!K,-KDD4)9_H!0[*C]&1 MLC8TE4/D*=>( "73$)^<)EXMZ6:UM5Q\N$O2YM*(9I6X($-9P2J 7@56F1CC MY=9BJUL Z$(L;J[4.-0KY'ZI['3[J3.A(<.;Y"D._T&&O@&-F-N&%'R=3_/O M]'@N;=[NR9_#B'1'I%'+2-.#@^HC=!]42U/MB,ED*GA1 + HY MZ?XAPXMM:4P>X.,$S>^I1IA]"F?5H[UO@.%##" B".F-8Z7A+["V#+;$ 8RE M!$A^3[5$_QG?=5_^>2"[PVQG#>[<).Z%W M?V;4P<:Q42H)BSPZF+J[WJ)6PTF!_%+$L1?3%)U/_U]YU[;97GHH$;+9D4D/#ZZ=IR^.)$@<"% 2L8HO_OX>!;OXP%V< M%GM@B5/?V[2XQYNGHMR5C\Y<]]Z4L 06"EM+:LKHT9 !ZCF02;Q$WCZE5 6- MAB_:?@H-/%Y-S99SK;>#-)43D6U@*8P=H*M\2"6:'LM_HLM1\5?*LZX[RE,, M1N-%MYR&! QCF+ED@@B8#ODC-F8I8/%<;TXTQ64;)0P)*D+UQ'G:4NM+:CC%M5 M95S!U59+Q=P.EGC<(.VE .^Z6K1 LGV/2FYX+XDGMQ3NLP1"6OG^3HMVFVYH M 7&:]2;=V?)HVAK"$M,$RK%LE.8\00\A@#"7+MLW6OSL/FPVN:E@"2H$LFU& M"6*M:,L2A]R[MMBDXD9O/\N:6BUV9+5#[#/_:4U@:8D5GY;A3VD8-_6B F3/ MA)OS6<$5XD$2<0Z$?3I9.2_2^FF5UR]EC;.SAO]%@\L=,?/3)+!$[8U7+X!< M/Z%,4**T$7_S^'G/4/FCV9SL?B>V&)-I$EAR\\8[E05D5* Z9HS)6?9OR],M MU/?E69;)H$B6R$$4W%82&BE*:GI>VHL;,&$?8"BZ*;OC23.AIAU7)%)?H(TH M<:ZDA!K,;<([3KJN/HMP%]0FKM6ZT/%[01M5D@@]' M6U@"G :JIW:B[X""!$I:CBX.F*PCJ[)=-]MVIP/Z:(9[@X_@Y M369X\KW,@K -P,$7/Q7X??\ MO5P32-^XOBI6F&.Z27?1-HZ=NO=8C(>X!:R=>/2#EFL52(=S"-]9,73VO&E M]5: /K<#G%:1J&\*Z,-/?'&8G]KG&T?ZM-\;LFH]E;L,5S4O-VCZPGJKAS_ M?&@'.*U<)OOG!)TU396OVX:MWDU)0VQ!:#?U-_$2R!0-S'G@ANJ8'.PQEC>/ M)"2MKH^AR-%46T!"F81HO@A0:-! QD1EFI28) M/; #TO'AX,+3G M:8TSJEA$J]B2P(YX-R]L=;C#W%,#B[*EM[C*RTS$F8]+FBW<-:"YO/2(-?O* M[=5%@E@/7U@7-&"?/6B=514UGM*_B5:R?A+4>050JQ@K5ZIT$DE?56^5L2W0 MI&2N]H TPPNFU:.N-V4FZ*+"1*]X85E90/*3K&H>\;AH\5$Q)UX.H0,DQ2"X M5A^<3Y+\,WW*, @9L! 57R.+%2^#9$??#B?5R^SXGE MYJS(F!F!6_/]=,"'$V@]"!J IRZ,W ^8=8P;:#@_:'K@L,Q,T9R";*?L-'Y2 M!".T58OORSGKM8$0M/A<>#UE2%C0ZS'4=5BZ;7N+4"$ +3H33D^1*:1@Y#1R MS X['LE$;Y#E9<,:>O@1]& $1TVB5;II_LF;)YFN5+Y;&1_N EF %JH?\WY(!-43GNZ)Y1D.R-S6@R3X#M*$T8!>K*Y@@R25!C$_2^>TP M5G%B<\DEFP&]+"LE(EF5I+,A@$GIAT^/Q3430)ED5RRQ1M[EN/::6V,BR%/* MBM5G)O7$<6UZEHV 7J+KV7N?@1J0(&> #MS[.E;Q][X[N4C4-ULU'GR%U\;= MSM4>D R]8&HY@3HBZ@]ICO,'@WKILHW1/WH/Y#CV/ 'I27W\=#O;IM=FS&WW@T+?KLCJOSG M=HLWQDF]+ ) >A9IX*;,50G75H4_?=Z572/>A!ZG1S\.*3@F9+AR,Z\=C@Q) M:(AB0QS<*2I_-R(9 ?RU*ML70D'#L;FS*LYZ5]6#JWY@_P"N$E&'?3RU[U6[ MBP5GF!BEBDIQ7([E5^F5$(3ZT[UBV[M=* ] *^YLZ%X^;L-X7<7C+4&"9:QG M!+]QF[>4^2I@YG=RZC QC'U5P[YI1HM7J)N;[=>RS%C('/?FK;^7N\RXA5E; M Q*T!T@]6*%F 0F,B*?6%F2(TD7S,U9]?J9=VESM V "0&"S#]24TT2Q!K&&M3VVS:YY:925;XI<*;G!VMR-\[3/^@>9F? MRZK)?[+?@YY5#L4;D' //B3#QB<[0&H/">KZX&FME5X26(\V\EM=YD7>X&_Y M*[7[#.WHRBC5@9B4*)P+('79 _Q8,3BK+XR7_K20(%5Q5(;PA'^-C:N%F^(T MA*H"#14@H8VW!ZB>?=W)0?,=<24G"N0!2)ZSH5LO+8*3>IC2/65B9^1AP"9\ MH\9M $G-"LV<]B*^"](W3"8Z-A?^?9?OQZO6:"KPI04DGV#(6NX8QB!1W<@H M#\6=-*&O[6N,:(PM1*'^*#)JMR1+ @T:(I?>FFS,K27EV!Q&IR+N2?QS9*\R M19PKXFPC94UF-C#RBSWNQMT2@#0] 1H2*)LI8AG?^,;:Y5(1QHUS7.!M;GX^ M=5( D$P@4,T0Q\F4%"]] +F@C64IE6&5ES@CDWT7(#0_2D#""P2L)4F6F6\% M/21ILI7CO*WS@JS#%^7S.B_8]5-DE?A)[DH94* MP_<":/T\XN!L&HJ4OA+4]X;4[H0-1WK^9NSBKP;%B#Z3N(\JQYUU'@&PBP+X M1?76?]P+J;0\6@Y,6Y&C?1?8^D(JD$5#\C%.(3X?8-D3B /1+S@3^MN_C/E> M>@;H"#Z(YCL&OK#&ZTA^/4W_2MT/"VJY_EJEAGJ_B_;^,33<-NAEM7N$XM?3 M;%LFC(6[_A@Z;1SQL@JM0HA2Z-#X4&1Z+K&VA*(KTP"U%VD;13S_#TN2D GW M "]"0/?P,+P&]PY'MI/X8CSDBC$A^"-U!6!*+S7"A8PS\;3RX/NH_Y:Q2*\ MEK4(@SWF*07*MCCXK$K6E?JV*B_+ZCGUB^W9@PV =? 0Z&W*$L8.FO1E#1]S M4/(,\E.0M@-UB)1U-I'/2B:0U[CIJS6Y3C^3Q #VB/F8K2<4A06+/$&,":L] M-"A'9!"M^M,W\A?Y6?Y$_K,FRS[YY7]02P,$% @ J(M)6 >4."UL5P M#Y8% !4 !A:7AN+3(P,C,P.3,P7W!R92YX;6SM?6USXSB2YO>+N/^@ZXW8 MV(W8?JGJ[IGIF9V[D&6I2CNRI)'DZJ[YTD%3D(1IBO3PQ;;ZUQ] BA)%$D"" M(I20RQNS7>4R "*?!V^92&3^]_][V7J=)Q)&-/#_^M6[;[[[JD-\-UA2?_W7 MK^[G7W?GO>'PJTX4._[2\0*?_/4K/_CJ__W?__V_.NS__OO_?/UU9T")M_QS MYS9POQ[ZJ^ OG;&S)7_N?" ^"9TX"/_2^>1X"?^78$ ]$G9ZP?;1(S%AO\@^ M_.?.C]^\?^=TOOX:T.XGXB^#\'XV/+2[B>/'Z,_??OO\_/R-'SPYST'X6_2- M&VQA#N]^^NFG;]/?YD4K M)5\>0B__QO??YMTYM,Q^2R7E"SV)Z)^CM'NCP'7BE';E9SK"$ORGK_-B7_-_ M^OK=^Z^_?_?-2[3\*@<_13 ,/#(CJP[_D[%W^*I#7ZCOT16A?DQ"/^V2PVJX MG,%O>>EO>P$;H:SK:3N;D*S^^A6KY;//O?_^NY^^_XY_[-]."L6[1S92(\H' MVE>=;]OJR(WC<13G&T+B2-6AVL*7Z-C4"8D?;TA,7/ _6T3>$NVQ/7_E=!X M=TM6U*6QCC3*1BX@2,^)-@,O>-:BH5+)4$_IKQCAMR1R0_K(?YJL M;I*(^D0]?'3:,(5WLMTZX8X13M<^90P[?MQUW2#Q8[813P./<4[4!&BU8HH1 MMGR$,^(2^N0\>(1/PVE('AVZ[+\\LIFH%@/>@B$1NLLGOB1&BV">/#YZE$T^ M59\E50QUF8<#6WWC'*./+U2-?#<9$N>0IJAE#D!V) MUI0-L6X4$4@_Q34,=7'AO!"V*>_X/%!UKJZLJ0GBNF%"EB/J/%"/QC2=H^FT MW7]?/5_ +1@2810X_B ,MHL-#9?LV!,#YI&LCJENDNR0+^]7L9"ACLR(QW;W M5.K=(G3\R''34Y:J;ZIZQN8V^RM)IX1Z4E>*&CM5E4]SZB.5J(;!@U_"MHK= MC$0D? *<.4053!TOLO.]O^X%Z:F&^)"3D;R6L562,1;1[" Y3QXBNJ0.9+]6 M5C1V"GV(R+\2MOGV^8%!?=RL+8YZ1&[WJ'RA(S.L,PO0QMJD+31- ":2;COF M#]RP?@LK7/;P#>LLJ/+%#N)0@.7U+G HAW547 /M@ [KN&X[)D_!L![7%+WP MB1C63UAM\Z=CZ$P35+CTT0DZ;$'5$6V2MR1VJ!>-G9"?2Y^4*MXY;9HZM;@; MLDP\,EGMSQ?1<8_N>E[PS UB@R"\#9*'>)5X>:E]-Y4'F7::-RY\W<;9CV*Z MY=-[Q&C0%UB[2>-",K7)99W(;E8FJQF-?KO9\?\.V+(5A/HB:C9H7, Y6:.-RF9;5E4K>!JC_H+CGGM6J<,;56H$V@=I.7NW_0)4^C">-,%?0@;4K$ M=5$6]E:6\LL((E#H= >29C,7&$PG.E^# 26K?S$%5Y<&> O&&6!:P%[YTP9? M6/421U2%(MOD6*K7Y 5OLG2'ETX;YG?VW%B?ZO(%?/4W=&!+%Q:I^0$%TLQE M3EZ%0^[>E)'VJ>&A"]B:<='NG#@)TQ$R69T]^C0:,VDWTUX+9)6,,R"RBVFC M#VSHPL9!73)TV[F )6#[&/B9DQ\[&SY1[K\]",*"A;"!,4"W3>-BWI(5"4.R M9!]/#USZ0JE:,"Y"?[4B+A\;!QAG;"AIRP%JQKR=6O_ K*QZ,2\/;8'H2P!LX*)>(MI&=ZU6C$_H@4/#](T*6R:S)26]YV!K#%,\BFI(%"5;LM2> MZ>>U;US\_)JC<+G#-HL!/S=JBPIOZ](77-J&/MV&S*O:>],C&S3YG4Q^]1T4 MCS/Z"G>SAF4"/X9L??+C5* 1^X>3*N0E)OZ2+/.&N)R-7RW%-.:U]R_+WG6^ MYL_0$FY-8W_-2NY[EO?-"]R3[GC\N590>@:5/WU+'V5%Q/UF'3Q]NR3T6XXA M_TL*9@HD^^'7]$/=AR@.V3DR;\ES'HB7MO\K*U,J\NT%>I4CL6 MUG?JM$2Y M3T46NZ';"4*VLZZ'LU0$B.<[#$!KI<%"M'#MK@#VI"00W_>H^-;( M=F&8\[DS(VL:[:^&#V_*Y.N"H H0^.\Q5PJIM$@,='T_<;P9>0Q"!?"G)8%X M_X")=YUL2##_/6''%1)Z.PC2E<) L'_$!%L@(1+>J0&-9D9F->#5TD#$_X!Z M\!#(B 3Y?$,\C]OW'!\TRNO* V'_(R;L8CDM #Y]GG'+MA8X]H4J0/C_9 O\ M%6F1&)B2D 9+MJ6' .PKA8&H_X2)ND!"5+S[_A**]J$H6/_!![LD'A+4 QJY MCI?U:,#^+9+#75,<"CF*SJD4$Q7VS\0)P: 7"D,A1U%#%2)>&/!>$H8GG9&N M*N+24,A1%%"5D!?&O._'--[Q &'C9/MP-)R>8ETM!<481>D4"86";6YI\&,> M]TR&;[DD%&,475,F' K.O?1A@S?TE^3E;V0G [I2%(HTBHXI%0\%ZFE(^1N% M.775BT:U+!1L%,U2+B *V@OG9;AD4J6/03A(:M"%5:#8HZB5('%1*.!N+>%C M4# 7]_A%:+CK!4OIDJZH"*4#1=_4$!V%E.YR&7)G@NR/$?7).QD5M<7!=T1X M!$C$M 3V]WJPOX?#CJ*'*L6T!/;O]6#_'@X[BBZJ%!,3]A[[ZR1'8HZHN,H$O;2!,>.=&RU$KD2E(E!\47356G$N M#2EG."2.>/B>EH "BJ* U@ES83Q' ;_[V 2^U!Y;+07%%463% EUZ867>Q9' MPJE?^#78@PUE62V+<6$8?PYIS'K0"[;;Q-_;: 2W8H*B4'A1U#^I>!>&>IZ& M>^&/8.[8"3&DQ^P0ISC7E8."C*+LB06[,,+3D'"F"3MVIWY<_.E!.%FM1"NO MK#P4<11=3RTH+O+#*$I(J(M_32TH"RAJ'U3H2Z\SQ.5OYG?OWC\L^(L9P2I3 M*07%&D7E$PEU86S'P2)T>&*O^6[[$'CBYR&U!:$(HRAX$M$N#/))/^KA+16! M HNBV=6*@[0F]%_.OB=A[H;XD%& 434\F'-K:NP:MO6O-M1=%XQ,)A81M MYAO.9M3DP:-K1_R23%H!_,X&$W&)J)=^OY<^^2G$&.(/O>MA%Q2% H[S1%(F MWJ6A3I8TY@$#>)<&U'=\EZE4Q\QP M25M: $X+RA! J-8M[_F7C>W_S@V9\3 M)PI\LLR.^C(+O[ *E 7$.T2%N"@4? J\A*$4IHZ@H6 ."(I"(4>\.Q2(A^-[ MF3DU'_:>++>O#'%1#2CPB)>(6AN*,^K!0+>F'D]QD?CN>GM#-#IK?)G![4M: L MH*BK4*%Q]M;"2W[IUGI2#HHWHF):)QC.FZGDP:/NP L#]7*]CQ2,'^?A$!]W_FZ M4JB;Y>.\YC-@2)%T?YOQS'XOX? M?CUT;K(ZV/2G0:8N2$*H[JO#:I\_KQI)5@Q2SS3]Y0WQV5_B*0,]NJ61ZP51 M$NZS94I$U&M&->LJH[G=J:?%R^FL;"9O,6H0#L_5;AY[R:8\X4?^.OO5OCZP MNB6\-AG3)8*! A>?XN(0*\H*PK>)XV^Z+U3"KDX;KX=B':D+88_Q:;X-M@ZM M\Q6I$2PO:P=M^H-5PEDNVC'$-SXU=T1@*JKI?UX6+5*N!%,E^*>"MJH>-.%@ M'/BA!@V"XFA!7769D(J+3L8^88CR7%PN!X3?%/I:1Z02(?4B6\+$WKH"):12 M'!P3TQ Q G#K&!"(BDY$SXDV77_)_^!9G)X@RF#/ @LHTT #G;EY M\OCH42(Q&1Q+8!^:=3@HRX4.]-#G$>J#<,>FKQCLTU) P-N_L6@ >)U\Z*#O MG1[RE3.";!VR.D!"VG?E:T"(6G9T>H ;1+.MH'W7OB:[MV+19WW/$@:/,JF% M/4R[%P>QXZ4E\3;ZX)&$\8[KS#';V?B!_I%?K$A7-7DML-*)JG5")$>?4$,& MF[^F;+IG,K&^]5]<+^$7_!^"8/E,O;KGR8ND4 '"73:\JSAA_35 MASY+[^F$=: 4&38/*"A22XU.3/ZJ]98\\MMBR2&Y7!!*@6$+@.J47"\?.NZ' M'-PCXD1D1M>;>+*ZC[*Y+#FZR:M!.3&L]ZO.;1#9T1E2[R;Z.X9AY5V!NW6[ M0M9KU;$8#J]AO1QT$GX%1^ 1=1ZH1V.:YB1/G2DW@<<@COB1,-ZI+U_@+4"I M-68!..>F3!,7.!-@-" FV];+=X2_C,MQ%+P8Q]+PFI"+X3A.? M ZA(ELR27-.:D2?B)^I9(BH/9$'"[3CP^6N_4>#X_( Y#N+#S):8 MRD"UH509LQEHSPT=5- I/#4RY;)*#G&UQJEJ/2AMQFP1^DL:" E\POC*6Q5. ML0_558!29,RFT&S7$0[J4==J_ /71>2#<_X]T0R3[U1$'$GO.JH#H':SA3QNP5+1RA7X&>I%(K0,JOH":48ENM%5!L6J7?K@!LTQ3F M#8FI6SAVG41C^QX>C:WS'R?M_>=;=#:3&C3#>A*FW5VF&LV4A&G 1JA2+:Z/ M''GCC$!L>@BA;[*GW!.$]/?C#%<16:V'':*C-09%D%C)G#Q"K$2^ M)B%B#=JX6N7.=/38MLA+DT%I3KF\#G8@CY8I.X4"G:V"Y4Y_RP-5Q@[U<09_ M&N#81"1\JY-6P@[XT0YQUFYRE3ZJ%DEA!>RH(&T29>_RJ'$,:25,O4$K6WMT MP0X@Z&KY,2?H9+5WHPA2U\ 3@R$W%=:KZ3_(U/1CXYU@U3DVWV&X=$X^T$F_ M@!27@!M##UU5J^K""E@6TWU'5,'12^7LB,6K0+]B*SV5 3^B^:%'(W7X\KJR M=K!0/X9$X(^,1QZ/PK@ /OOI"#S[@4=Z629NS(Z=)'RB+A'$%6=%ZTM> ^C" MSIL) @Y#/#589YV)A/&_CSVO*XZ,O1!6$?IU,F#'^MYW315?NE0,S5P@!U-@ M'ZB1$/W,VUT^D3"F$3O3J;"O*8JF-3; 7RBI(=^861!L]^\@A*Z2 (EJQC-^R3H;,F^T]'4GP5==#"V^EB#9+=$.ZIOX44Y9,2>#'+ M=$&M$0Q]2*BU:]C+: /V"2,;T_[=O/--[TDBAF2EUX M"&K'X^NP_RVE3EF-&K/FQA'(81.HT&D^/*_91XT&3#9)%6LN&E64*<4VM'_T M@BB>K'C(K\*R/ ^\.@,XKR ICWU#J(8P ,EA%.^/04R\0T]Y+T2>V;4EL6_Q MM#"6R(J^S,R)YQW%D)C12N6P;^/ ! CZ;PG\'XC/Y/!XR(SEEOJ4RQ#3)Z+D M0UD1^Q9.ER @$J948:ZS1(XW6;'#^1-3P0-_$(0WSO*6/ A7)E4E[)LUK44* MA@#ZA.EZ:;MDF5[XW3CLU,;OM)AX*:S*>0.MCQW87W?ZZ.&"3F-%/(U3+7[ M?UURA-)>\6.#@TS'=RT #HN%TG@N4)BI2:)J J>E8 M,+M@'-!7S2'W*"%1?-)+1?H@40WTE !PV"N)'*0@X+.T?71HF'DTE;-.#-C) MEBF#[%PK\:P#-X">4Z QAWH0Z2^R/V6+K$_6_$R$NU%R WX5*,EF*:J GJZ@ M*=T*""X3$U((>TUD15W$C9DYM!&7"&/)\E@9#$J=35P#/=-!:S-"K*!=WXHG M!*7!@=*"E =-.5;"<,6ZPU$1RB_7J)\P.8_NQC=D%83DD,J)1/T7!A8CB_I. MN$O/XSQ4'+^6"U+3;'ZNDQUF#7X4/3<#6%^Y /97/S*9U/O)ML]4HAI5-170 M4T!HC@BAS.A;/M/.(%:B4C'T] ]P"T*=?%<\AT3!:P9L5:%K/XOPZNX6['09 ML?V/\^$OTY^\C)WE/Y,HWN?"3$/=3$E( Y[8+^3!0F])]B? I>'B/4%/:0&W M2B*QA+Z?Q">^SWT5!UH(P@VD-OA$WVXUDBF'G/22NAY0BP9. !D MKW@7SH,#YF_[;YR(NN(1(RB.GN($O)])Y46?Q>7>W5(OB656?&$%]$PFC1DI MR8S.R<^$)\,ERV[VX&"<<"_YR:KR%EPQ0Y U=^B))P5F*1!?-FWF E&.;$D9D(3 K(!Q'67P.?+DR"00EF8^FK72$N] M)&9"+.B<\$^[)0RUD!^.ZXM;1HALL)5/^_4"%1X*H >]4@4 J"EJS6-%#2:$ M$J.?S05)/-2!&:35K'F=J,$1"(E+)361/GP7EL9^J*@%NU022V9'.:V':EJ( MRF._;FPR'^2RHU,#2,VA7,3@36"_CFRTH.DBA,[IA=*6X-_T&DA7\9C>M[ > MA#%N;D>X.<_F^.E*!@$6N>LD\'B5%RT"P:&H_DUB.JHGCZG'VHRP81W1F.PC M$&37@3/B!FL_;5%VMKQ0!ZPY+JD&VX4I:3R$GTCX$$3DG.$K."!#$.BZF7SL M-Y/5/'F(Z)(Z87V.8-[HF6U:P:RJ86M.?&?3"X,0_?!GU*<4_^I6Y5+ZYGEW <\[_'O>B[G&V;)S MW]+H,4C#D!QVECJMCI>M+XH=N .V$,O$1)_ED%TB'9CG'-3SXDV R]X M%B1\^0/.UJQ M#=SU@BAA T3EW*37C&7^ Q(6RW-73TY\CZAJ-X^]K"Q455Z!U2WAL\E8+A$, M%!C?TVI&TENLJ1/&1:THNMD5?R-WN])IX_50K",UNK]6L4LJ9ZVZLG;0IC]8 M)9S9DBMG'/AAH5NJFW5!<6R;JGB 52-]B,5%UP)G&DS4E<4VEH%I$ N*SL&8 MQ/PX^(LNA?P@LV663_HG&%!+FOTE;R%DWM(Y:54MX0^AL8-W< M'84Q;?T,P*_A#N/$C,>OLWV7>N2DKXN@M'%I MR@K[NT?V=S/=;1#&]'='[M<"JXWME&*4P++^"8<3G?MB$/W;('F(5XG7==T@ M\6O3">RKR6MANY!7@[])X9.$.Z. 6X%EY>U);$5GDL0+!3>DHE[ M$&7$ Y"H8Y/6%\?V,[G@5)4"ADYGO9^CX@*MICRV$GQ!0N60H3-ZNU_JM0,] M*BMBNXY<]"P% A&=;.MBZ1MS0[D@^'9CWBF7.C!!([I?7ZSP6T:\*(B5HS2 M*YO[54$+=SKU3W,T0"NWA9X^YR)#I1[!5S9PIB%A9YIE?JS-$S3XV5/F[&BC M,WA@[:$GY#$P@'20?)V#2&GS4==$SQMD;F"\ID0U52%O$\(/\DWWG-KJZ$F* M# P&"4Z89GD#(R*W56N.A)-JZ"F,#(R &EQ>V5J0'Z6FSJZI8G*HBIY=R.!1 MLX2/E==RBKX7/<>$%W9:;: G#VI.> -IK;4O\.Q87,:?:;SI)5$<;$DXHLX# M]:2/X;0;0L]59&!^@[![9;L]&^5A0I9ITK1FZWZU.GI&(3-KOPBGJQX1IY?9 M3++4M@^]_C^61T_MWU&/#^=\=>/&][W!XPC#\7<-5@1PR^BI?[2+SCRTS,CB \3,RCP$<[]T/7: /*L#$; M7VM34!\Y3'U ,)O3^ZI4CD$0RA=87EY<',JK,5->.S-7A<=5JW25$5OV:]28 MXM6JX$=6]HX N+"O8#3 X6KC. T?'Y=V*M0?'_K(O3[M:T!]QW?;T;ZD;4&' MC3$CH0'M"P >_L$P#%Q"EA'7+F;YIAA-5B>!)LB#[%@(;@'*L3%[WAD\59YD M:J&&3G,S:MNA\])V-GTZ-2F\OD- <;RF5YGT@>?&W1NQ87.[KAYT"!BSF1F9 MT6*$#!E;BA\O/6\1:FB2&E!6+FW_TF!%*:,EZRIFZOUH1-YZL^B_NAJF89,9VA(G/Y>?_SRU(3XY'TJ<*##3JIBM/M.GZR]-_ M*)0<^JZ7\+# N=WQ0Q@DCZP&/[:R!8SZ"5GN;XH"7S+\;.@;=%@;,Q>><_JW M 4!+EL.SA,Z2*E6OS/=0%.'-()=?#UVR']#Q:\PL>L[XQ2'MBE=S.]9M*U?H M'XR9?=%&^/EK\74F,_SR1KE&?H@?C)FOKV6\/+[_T%\% MX38C79VO =H =&Q9:>/6A G]*'J(YL.=LNF2J9M25]5*62A9YE*<:@)>\3P5 MB&\!,S%A8,8 6DH%H9R82QQZ)B>U@J,3,@Y\EPESO-CTEP:E=^F"IYM%!F9QYKE(2E6XR1H$CP_>^X]I%CTN%U]IAK[2YQ)8%\J9.>/Q.9QI 82^IJ;I2]A9>!$< M.RI1.&PG[83+[T!T/_]%=#"?C3G=\V[GMSWNSX33]>3+HW-S/A^/^ M?(Z3FV[_AIGQ. T\ZL("^$OJ(+U1+-!U3 3(?KAQ(LH6\6EAK.3T%3CE$=,K M,BW8&+IAW?U-#(3ASR)G*%$/C?+[R$NP8.-J,4^V6[;K3%9SNO;IBKK<);PB M2OUZ\:?R>C&_O[OKSC[SI6$^_# >#H:][GC1Z?9ZD_OQ8CC^T)E.1L/>L/^V M8IQC[I$Q!9CZT/K7-H?U<+%Q,J:O:(^Q_OC#VM,X78*)^%-EXUY\[,\ZLWZO M/_S4O1GUY^GN/9WUI]WA;:?_R[0_GC>^RC;,+QQAJVA37YFA-0U7?.@M'&^=E=/C'%@2TF06I&HR2LGY#OOBM/R.[M MI^ZXQ^;A8L)VR>ET-.S/#,V_FDZ")YRT;JNV@NJ'5!-)7L6.^0+ _L0@ $#! MQGE0%RWN9/R_*X__X?A3?[R8S-".?H2UD ]Z M &HJUQ!J$&R<-_G#V^*;V^(URLD<>E^>0]/99-J?+3ZG9[G^W^^'TSLVI_ZK M,^XO<.:4\!VQ>F8!JJ*],ZCOF-9\TVL%>?Z!::P^.-"&RL9967HT*YR0WUQV@HOP'6V? TFT&[?1?T#+03 BHC3\A& M9%9OZJ$@V3@G:T,1GLS&'\JS<=']A>E7T^YG;O PHUH5>P76J>HKM:E,%;^@ M5*-$A>U0H&0(%S4GN<@VCFAQV+Q[[MYW1L'LS' T7P[UU M+[/Y[<<_DI:5BY+=A_#+;H"%75H)*:OX:7CDO&'.-8L-#2OY$4XFZQ_*DW4TZ8X[@]GDKK/X.)S=LNDY6Z#90/AC M<)W3H*@\5J;0!STE3%@!>4[)::BD]I1*;>5TX>^GZN='Q<-DU._.#1W6TFZ M3VFETCA#?$3869V(1)'O6NH:V(%D*GOE]:>HM4(\CX# MI; 22D8;)QOG8^'Y2/T4K#A-#,>]R5T_LR-@75+M^ZQW226IA/QR2=,T)ZN% M?DFEI$;T?NG*)LX\9AW5_Q<9@O)KV_?9R,;ONS^;__ MVY_>O_OC7])KJL5GG-F4=5X]@5QPFYHONXGXQF7UF)\-Y?_;)E+=>I7]@C4E2LTWC M=N4S*@.WK((=BI 2\Z*E6RV_C_)K[0C?Q]Q=&!NSET4W?QWB1U M&^^/\7S&>\%V2[-7/UU_>2*.SBE-LQDD^T,01<>N%;QK).^^9'60=YE&U)4- M$DI(;)Q^A8#PA60.PAE8\6SH]MBY;3[,WWG-[V_FP]MA%\]]+W]SPRA]H'[^ MMBV]VB[(JIZ&NNW@S,.:7FH=!*'UD>=G,U)+$U0/*QLG*Y^?Y%\):[_/W1KK MIVC%W8'/2:9=]<>+3I_[UN+,RU+? >9!<0VLX#FG_8'H6>(JR#-*14,96USVKK;4L5WV7\@6!ZQ_;8\8 M]7 Q%,GC0Y!I;BZ;@FI&>!5I#6CV='P2E*(8A?W>3R(>'R0<^JLP6Y?3"!4P M"L"UP=G-K:!#$Q3TL"GW$9FL^E%,MTXLTYO+Y1\*M!S*&7IZ %8' M\FDLSILVGUJP6$IB)=YKK32ZW$);!5)N+"A<2Y3K@8@^$@I! A:ALR2Y:WSN M3'S\?=?S@F?^:'H0A+=!\A"O$N_@U^!3A2C(6BTQXI)D!&'SF'I\#@ MM5]< \BHL5!UVHRJA$=G1_A$%,P6O 4@>\826#0X?.F!@\[F M2BM!>;+'*@3 P- E%O=7 M3?.+3%9Y?A'@!1:H)I0*"\PN8)DLF3<#IJ9\UB\8Y,_""S6:@+)IC]5%&Q]\1H.0T+7?2]BAR'=/ MGW+ZR_1'+P4\ >QL_%#WT$])W09_+R5+7S#<,(S+.R(I1->RPN M0"S0.>L%6Q[C.CLH9T^J>T&D7%,YP8$+U6X)R:X]=IBE:QGPCG61)V4*1 MIJ"DV\))_)"\$NHGV: E*'\66&H:RRCD[TI<_A?B*(KO*X'9=!S^LX:_9'=_ MD:W'W9!EXI&#OSK0AR0%5&D.:JGQJWD!T*;09DU\AT[F[K_+^XBPWO +[319 M6C7,O2;ES1N^KL<&[4&)?KS*16&]/KDEF*SX[<#-CO]WP& (0LB1N4ECU_.P MX1PI+:.;;>= MS+Z$1';'D08D"+Y#ZS=H1_"=\U+:G0^HC;.WD,]+-DTK04L+6;V0M:37DM[K M.+X.G>79 9^7PEU6IOY"WGN?4DIP(X[P8#Z-";I2XIR=_5W M3(W&7D&*L#- M'%*%U-"R29S)=3J2>(PPSJEI1G$CD.A@B)<(Y15M4/W@V87 MTX'#QJF@SC4FFR"5>*RPC&/81\]7DGJL>@,DRZ2EO\#HS/$LV9. M5?.OY3OE[LZ)DY#]"9]O#1I#N\UM)UD=$"P;#Q>BQ%^R\T8E++4XCQVR?O#Z M$MH=5QHIU(;>_*7,AE*%N,*U'-BQD-T2_H7T=JP^,PXX^8 I^_A^#WT?N.[GT_;HA/ M5K3!G7V#1M&O\743([8 (?HY^2A#'JV$]3R[,6'+SED&.LT&L=?J<_AOA)U% MW/=7*\)VIJ>#G>1EQG87'LK&=YD,*0?Z Z!)J]BNS^>,@N8HVKA7"U-OR7;N MRO,D20(NY(W\R\K$5=08T@!5OY/E<,D&#UW1/'9CVEVVBITN7NQWR98O;?HJ M6"L?>@VYO0RAC[Z#Y. 4D)B&P8 ;"@OV0HU$;^"&L$\+K:9\TX3/QMUB$JX= M-JQS( JI%B:K7,Q;$CO4B\9.R.V,3Z1^"ZF^H9A]Z(Z'_^BF>PB_KK_MSWNS MX33?4V[NY\-Q?\[VD_T'.HBMNT\_\]++N94[ABQA2L#NSL&._N2+P)EOPY49;KJOJOA(R=+1&O M9N>U>"6+WGE"%HQ/EV-:U"794JBJ@[_RM3%^"[RJ!#:S'O8V3/7+ QY0M^<\ MTMCQ/H1!\BA='@'UT.R@ #"KBR,8"$,7T%F/TQO6%0F[ZY"DJX"4!$4=M)1Y MC0@ 6"CN4BP'XD-)->SW:AD*#B V4-'9H04;RX2H4I5[:!(,>0 7)7$,K.3 M=+F%;;YQ_/7.\3\&,?'N'-]9JU"(&-I3T@[P-X33C1-N M'9=&)%)3(:B G6.Q.052! Q!_SGQ?8>13_QUQ/^S8[K7@K@;/_""]:X7C.*E ME F-^MBI$AL1HXV/(9YZ_./+I#Q. R!:J*GR!6M[LNJ&[-R8 MK:SRXYB@N!T[/>@P)I"@D,\._%#U'A;,JO_;0;<@.\J0# ML<2AMHAFCFQZVN:Y>J:Y+#+-1EYQQ3.L=@KPSP\E))HFH;OAKUQ 3 #JH6\\ M+9 "AJ?532@B[C?KX.G;):'9LL?^Q8I>1; M3%V_"ZK5)/:J89I>P%@I@8F4?Z*,-# MV-NTJT\D? @BDI9%2PU5>PTT>?9)R"]HIR3D0]192QR1-)K =A\$\ZX-BZG3 MUOX0,66+1/;@)1^.HF.6I *VD[\:?94$EJR(:6^&4920Y6T2V]ZD33L)4Y&6:8#?/T G2,<25L>\ F^@:*BC0:4M[ M\\!.:QF=RPR=7:I;?G9"9?BT]W^3"TY-1G\)K8Y&'[2,@X\_MCB MG=H$'D,\RO2P&6&J2A6B6+R+SWL7][/^KS1VG[_(OS0NZ?3GC M8]'\_=K;J[5SI)#0>21=(A&P_M5D8]24ZTQ3XF.F;\=.&)]C3A3Y9(&$Z"Z7 MJ5Y19_A(_9IT6\&V%NJE8FP(DBG#81@\,3TO\%EO;ISE+7F(1;S4%\4V%NJ! M+Q/7E*-B;:"..MM".CI$I;%M?)J#7"XT^MD1-@EY- AVC*(R&ZU^2]@6/D-[ M4Q4L_5WJIVR7\LDZC6"+>>$%$SJS7P]]-^1!66])]N>YHT74*K85T=#(D8/X M!8RB<\>+AAN#,1NDH;%1Z]_0Y,S;]\LCP2*UMRY;WR%1=YJB6ZKJ5C+W%57= M^BQ^G?Y\,;Q+0RB/AI_Z;]IMRV&\Q&GK%-%:P"W8X7-W1E)JE8#X$5Z$/:S8 MXS12,A;JVD&A[J"%)F@L"&HH5DP;5-[LN'.[_&$%J/+K)K,HJ9D8-&V0R?NH M>AL+JFP'F1J#%IPUM2"D&6?=R6I%V:$N"7T:L].(U$%74!;;H*,2-P\"G[J&3\K *XO+8EKR&J"L1,(3\GF@R'WWP.MX]A\)2]R5&]PI-6PC:R-" ((I8E?'TB&^IZDJ?Z^X+E:LU$N,$I5LQIT_Q"'&"K^VX_S3]#![*@M*6+#T^\)!GG?0DE>^IWC58]G2 M:]U&8-Y1GVZ3K0S.4A',^%PUU!? K)4%936XXCLDJ\$5U)+(&@RLAN+G #&50_K2)CM\-:_C;3R:ZZ9S3Z[6;'_SMP7#:@ MI';['[Z3V>U[DW&O/U[,NGD@]=EP_K?.S>?LST&WMYC,WLSV[9OMEXD;%\/[ M:]CKZZO:<98ZSU!?+YD5%OI2URHK3^W**JYD!UO@$5E=5\6BX5OA3U;+;*V\ M(;Z[V3KA;W(3O+KF=1.GE@_=ZE[M8MY!E7^\_+DSC*:F":_)3#Y20ZDEIN4P?>0]HA8!(F&TQ66MB* M)$2YG,D2HTH<[$\*8)I>P!B7.VUTN-XY?K)B!ZZ$\'XYGOPUL; T6FAGW<&K MD-S)7B>*F4&@,M$-EQ[E\\2T5@MH<+%A[:\5[L\B^660A%MF8 M!ZQ&ML=RM\0/0; LCO=Y<(16Y)197^<:;;$J!*[:X#YY3!-=^.O^"X^)+XOK M65/TBHR_8B&,[F_IR?#P43Z81,&$:TMB>X9I6M:?=XB\LX2.^6L6" MH"5-1[Y(?GL8&OHNVU-'003AIEC8@D@E35FIRHS.!S_*U"Y7^77 _O<61"+1 M1/U4,BOO_Y+MU@EWD]6?T0G#X83P<#'O=\2+/ZS$:L>0"'.S]X+3D ;A M(KAS=A.?+)X?%YL@B1QVAJ?K34R(KS"?PBICGYX%X^74GJJ#@RD_8G92(]W' MD'II)X*\$V.V "K)@%:&6LK,)451LZ$'!,I]XYOG2*WGR&5#_[UYCK3H.6+/ MM7O["CW^M?O9AYZ/Q/'B3<^1Q/G>%ZV6O(I;>6'OC>ZYE[Z1;S]?L6T7\F^A MJ_!#5[7\,OLL\MY"5P'%PXX=?BJ']_"5[VJ\%7C(/^. MU(13+8:W.^A&8A&):#BPS<276\5JRN$MWDVCVU2$- SJXCD @5HH!W6+Q@^U M)A02_;QR,6=0>[P28;Z@P#<&/V5^A#Y9IQG3,=\8C$G<70/XC;=6/Z1&,J<\76:>/Z'IGH(W35 V+&?4I]LNP[H<^DB[JNFVP3C_?K MEJRH2R4^G9"ZU_'ZK)\?CD8VZ;/"'X8[)_W+6)%T; MC@$"Q+$01B'^Y/"']B'3 M>M.;Y&E(7?FZQFNI*@%A-W8WH0D[# /T]8H?5 >WP][0YR\*E]TM/^'(S^TU MQ<%ZN@7DR"6QA!8FSXK&=*)S=OB2B.8"$SW1B/6('>4/I\3]X5"P M%LFK0,&VP2JAEL:2$8\9+]PF^T&S@.'XK]P/-\63>$/"HXH?R\+>CU9?.S/.K-^KS_\U+T9]>>=[OBV,YWUI]WA;:?_R[0_GO?/31PN M6$:.G5)+*'G0SMMJUA3.O+PECT%$8U4$B5(QK!N;YNC6SL9:X=&7RE,9>DG( M$6&RC=G:D?T@.S2HZZ+=NK3,'APG=$K[44RWW*B?'D>YW9$)'C#%37J5)J^% M=G?2,HT0;- )3*54+9(GA=#N-EJFIT9R=#9.)6 B@>B1UT*[PS"Z*M9CTSS. M91 [7NEB$OULVET^\54C6@2YDPPPW-(/Y;-H]_93=]QC)\S%I#._GTY'P_ZL MO9@C< R1/?!=6*C'U .O?LY"'\;^M,P8*L*A)52>6P'N3-XJ97<'F+XA63$UK8T M7C2 F%)Y;,>U,XBIE=R0;?[8S3!91_O\)B2)J>MX7%-/XI!FNTX><2&]4A.< M=AJWANUGIL'667)>ALL!&SBL&S>$G5F<-4ECN^3G(.X;%S ]?ILJ+R RM9O# M]C9KRF9#W.Q9,T5TEG'1X\F8D]D9:Z2(@/.UY2_";]"8H]D9E$+\!J\O*\1! MO#&!J"UI*6S/LC-(+$CYNFQ8)R]Q4\_(HE.D5.'^@TSAGLXFT_YL\3F]2.W_ M_7XXY5F%L75OH?>G6@,'5+4@8'A]%W7BADM;L./U.)A%611QJ9Q6!!.O[^$( M%%-<6=<.)G7'+M29>V13H'%A+R&1AD"57S>9-0&(\"*6BT4#!"("5;:#3(U! M"^6QQ0!%(O]PLJ&N(NYGJ0RVH5-C/)UX@==):LC^,EFMJ$L&2>A3'FI4BJZ@ M++8=K"'*4LD-H=WWB!N'@4_=0R>EB$O*8]M!&J*N1,!8 &$FCD_"G2)N<*D4 MME;;$&6!M.A&OQ%Q(K()O.5P^Q@&3^GK(F6D3&DE"Q[XZ!($$X_ M7$0E>QI-V/ >I2&9VD"A4[L_9"CY*Y>#DF33QB,0Q1(FA (I;D94]? #( &- M'-"Y9-<%UDF,%H:M2U-DV=\]DD+L\_>!84Q_3_]=*)68X/:^8*TBI!H+;8-\ MU>%SA-))KVGDM;!=3MI?)5[M;4[='0X3%N:5_,?R?4[]'C5[^140*!O\L4^PMBQ>+/5X$-" /HZ6/0>/XD'([W0 M_I/<@WS1'7\8WK"?NO-Y'_TJFWM1/E./^^658][H.)9K-H,SQ;(@/B,>Q*?< M284"I*Z)O#(VHK$T*Z'PH"^5DHX63O&P[:Y)6]C+KF&R%1A>M6(C$5NJVJCJ M82LWAH?$J]5T2H*"E9R?RGM\>5^W3+WYDK;YXJ)5C>0G,8(IZKV"+1X&C=U' M\87S,G5VW -(=@K_\3O9*7S1_:4S[7[F,7I,1^-AW271OL/@U]#UE9 <0QFC M!.+^62J'[( $ ;1VCI3EP'?B//2H8JF4L#"RSDFS=AR)P!\9=[U4I&@VPBWMOQD52!?J^"_=^]$AR&-3=Y=L,Y9[.%:*H>F]CN6"^'+4IY%1PKF:1$T/T9=(.LD M,P1BC\8[_H0T#A.7XR"%4U08S551%UBYM*9\0I>)ZRBQK91"\TS4!54@GRE_ M9NYO)?=B+I9 K?7F]WW;SNC8?=F.!HNAOO(NEF\W;TB MCQZ1*9>3WS!S,!Q/%OXLOT*554)S-^-,'L)9*B>SQ0FFY(D0%7L>RU]OL!XH#.W'UDSUB?H?#HIBWW!U'@NU4B, M3D;QY T]5 MH")9,F/VDYDG12%1E)X#!P2PZZCJH;\M;+JL*9! )VR?&B#?$7=*IH05L&,F MZ5.DD!V=FRRB=45?4E*DJH?^A%2;*1@2Z(3EF57S"\0\*+D^A?HMH:?S:[)" M-D+K=7D6C0+''S P%QL:+J=.&!\#3\M]BWY\7S:%C";=<6-2%0>._+57HWD;.T6H>-'3GI CFYV)[^!AL'2:LZ. MVV(YD\) 6%J2XCM4"+I;LJ6%B*:G:P"!B=,*Y:<@QIE2Q56(>ZLMB69M!@DU!BV?5H>KXN'*P5 M*N1)2>0[&NA67*H MMJ4S3\6W#C0MCP%T3;*0N_:1<#W/7Z<1G0K#7WJU+D]9.^W/NHOA^$-GU._. M^R=7[(8]XU,AP"[QI=)("^T) 3.ZWL23U7V4O9^0K+KR:G8D#ZNEH[SL0N3' MWPYKIXG:!*ZJA[9VGDL4P!)^?;NE0$1(EF% 5;3[]M:XEJ81?C5T:Y.,>%O? M&K6OTV(N.N?DB6.EAYQ*+E39(:?_R[0_GK^=<)33; \]=)(=BE_KB:8D[RO6 M)+C^//170;A-"^8.=!P$^423YD?-''*'X\%D=L43[VW" MJ28<4V73Z+S0&7S0BW$.:_Y :)=U"J("U= MK88!A\EN?CD&W'EAQE;#*0E=#34"TM+5:A5PF.Q^I7+GQ$F8FLPF*RTCFC1+ M&=OK[F>9S8S]]&9(@X3GCR)"!.I-OB5DJPB;$9/5@'7?\3X31QJ]OWF;U[-[ MGH\<^@H,$N$V(6,V[Q?/Q'LB=X$?;R2'HN8M7M&.>RYL5\,['ZR+Y^!\N@\- M7=&^VQ"DZR*7?5-B5&C0U!79]!H#=544#X+DW*WZI"6TISUF"2["9.C%%;0[ MW14[/DNHXXTU; OME8\&>6>(=V73\_QIB?@HR-QT-'*I8M$(N/>7>ZV=+/LO M+BO:W?*?&@X'<7-HSY!:'ALJP*XZ$/+%KU/;?Z!D\CK5*E(NY;C2?NPA>QQ7 M[)]ZEW5<25_?6$IVBYXK[)QFWS5L*BWL+6 EF5)F7&[KY=]K-"V_BGC%D-GS M%JBX90H$N,K!'V$'*IXY_IJ(@Q,7?GT-\)[V&"4(E*B>%L&,C*M MM4X6=%7L)HG8PLY4?O=?"8VH^C&QL,(UK+HJ&0KW8_;0P?\:$J)Z(0RH:@=% MBB$'X*HDEIGP\5VNX,PW;$[O'/]C$!/OSO&==3JXI.&0(16Q@TV!QUGQV@". MB*$KGK0#/)?/=..$6\>E43GU?!T5@@K84:2:4R!%P!CTOU#_'YO 7_/_OZ&! M%ZRIZW@+XFY\_L.N%XQB>:8%S3;0K'GG$=0 )T.:P[' =TRE#?0!N+2P!F2O<) M]+6_M/Q"'.3/&P:-W..O;V3D;^1HF!)RR\23/'^I+XT=*UMC218+B[X(U^T7 MU4GMG77WLB-IG;:!B0.Q^I"(*]29]H/(GV0.5_!4FCQSZN;.8=W/*T M3'XF_O]0QU^GQMJQX_^3'@VV #.I=BO8-@6M**.-)#1J)IU3=Y,X?MJ+H?]$ MHI@?Q-4\ >IA*X':S("Q,,3%?F0,DA<^%A9-YHVJ+G8JGJ:S!8:)65[8C$TG M*5/ XI"Z\4?BLW__F#PF398WG::P;^O.6./T$3-+XHBF-R0?^66*7QI.=$MC M1;YT[5:P[_&:4J>+DR'6_L[6X]_Y92+3%Z3$U!6$'@WLV8'$XAK"]S,-V=?F MC&HINM5B4&SMV4E$HAI"]H;GEMUD/B+R#.*U):'XVK/F2P0VNZ2GY[5^+]AN M^2T,^_/1\7? C5A5%TJ#=>LW#)0+$#,LVL*9!$_$BTCX1'FG=$@"M@.]6[1. M']0'RZ2?V8BNR UQ$DGFCX-'5K4LE 1[-EZIT(: 9FI VH#QR<$FD-* WV[/D ,Q>W_V2O8MA?ZR.IO4-ZRWX M(@_6 I0:>W;[!@!=X*;U3+*@;4#ILN<4T @DL\>!'ETG@R!B"VW>#\A!0%P+ M2HH].B80"$,TW#$U:I=K4KW$CS;'$[N4"4A%Z'VX/>9".!QFU[&/3L"0^NAD M/^4OUHYO8L&+F59#4+[LF3S-X3++W^?$?]$XL2EK01]UVS.3@$"8W5T^T\]. M^7X=IFK*:T+IL,<$KP$(^LLF_) M9!X5E\=^.Z^+NT*<"NRO(@6KXFVO(ASP3^5'OH"'O>?&"'Y[XOOVQ/?MB>_; M$]\O[8GOF\9N4F.WXSWPF\;^)6KL%]$\KE5A[[IIZ*KHJ*VJF!#7P([F"N9# M)30Z*PO6]F3590=Y/[L4DF]'@N)V+%UM[CP"0='-PH4>15U_.69ZX/%?BJ(J M)Y=N0W9P+!VOY$MQ\[?I8U M8*W.DR NCAYFI5&Z!)7X9A\EZ^\EO[Z_UL04M:)8LHOD-J&IL^/KJ=(?0E3^ M.CU6Y-)?=13[:4@>';J<2=D\*62375F#PQI!36GV)W'7HT$2)R'9ITMD(XAK MR+=)W0UXJA4#*U^C?XL>,-:L>4<[^%B6TT50W-+HGM EKU9X=&KVHR4:!*%B MY2H7Q+92-EV]Z@5&)^*"25 N'2%/1;W$TGX_YX,><_+3[V.]/9Y--P/IR,.X/)K#,F")%_(C<$)^L:*P6 ML%EKR.9G )6EN7T.:.A*Z&GG*_V%DEM3$=L&?18M,H:%(-E"YF$(:W(IK(=M MR&Z?2@5$C<]G<1 ['NKI[';?W9;6\(;-85O46QPQ9P&*OB24>J^]-$#K8]OL MS1%N:JFP097+16T\+,X=#\8N# R,A]>[9VC3?R[MQNX1]$_OEV35(M4]']1, M\&X4D5BNJ+^3*>JW_4%_-NO?4/('[";SZ]:C2>G)=@VVLOUH1EP$E& ME.<%SSS&V'FC1>M#V 8^,P.G =97,8;RX(S9/_GK].)QRG-CRMPLSV\9VZAG M9I1 T+1T6/0"M@#Z">OT_F8Y\"7>@3IM8)OSVJ):AI"-^D/UYEP>8/$/WY=U MAMIK&?7YH3KT8"?1+?^R%Q@[5/?T_MZWOO MF>@P4J?$=SR>'X4M24-N]B)1W'7=,#G:R*ILGM4H]A+>G.X6L+S*\;#WO&IW M/!P:Q;ZUN.QX*&%IHXU['@?N;YO 8[!'?7:V8?HWC9'3; MG\W__=_^]/[='__2Z?_]?KCX;(_A.Q-0;>LNET,+IY-[7*778OR!7T@V;$0= M3A]\%"MLW7JMV*$4U?-4#;BC(1B^X1O87X 57+\E.VAM,J";D6[>6/Z%!,<^ MAS)E3.R63>1O,;&K-%Y?3.S^]M$+=B0]1W&MFN\ 02@W+"GJH/E/M!,J&X0( MNJXQ]1Q_[&R)W()^6NKZU[A:L= -YWEW5%;R@E7N+$XJ*O8J_-O:2%U>LM?\R;KXER M!;/9U\1 /JWK]8!3+TV-JU(=>*]N5 MKT8;(/0M+ W5PL-A9CK#,<2D?"-35+-C-6QA.U/(60BK@^34==HMU48F*&X' M7:"A6/;5JA<(VP^<=6@;^.G-N\H)O*8H=*Y0JGK(CHU-;YFKR9\ Z%RU9^.IB$SCG(3I&K/D#]+)E(2I MU-"!(*Z/[?%H9$2HX+KJD5%8M.#K@K02MAMD2V, SZNE[HH_ZC16*K5:#:$?9'7TD!I M"*!-*T'6UTP&C24\KX =/]74\GT*R%7/\HILDR2.8L=?LO&JP?A)+>SXJ:9H MKX&F>615/OOM7=^S?Q\$X9R$3]0E39?WFG:P\ZY=8G47PH>^N NZG1Y?SB== MU QV"C6SG,O!PZ>\,"2G(>N:^CPOJ8*=Y*PM*E6@V$';C1.1)1>1R;>'..3Q M +E!]V9W+++/OM7E3[+2_WPB47P8H)),N>U^!=T/HLW1T3+VUSN@;DGDAO11 M$,W[7,A.6D>_3L8>0#586SIP=(<"G%S;S7ER/-#IRM\][ \B];T=!_X36Z9( MMF)%"Y[HH?C[7A#%XR#^3.+9X?FNY ;4W">A@\9VLZ%Q5E[ON,LV4G:TWO\3 M+ROMFJ''?97$(PU0 M%=WKH*7! 48)G<_>1QK6Y+'@#&O6AS%MKSM24UY)) M7@V_4KE04Q@O596AQ%Z%S1*&%#JKTS!P"5E& X9%^F*;/B1,?/%D/?C8R.M! MN;3=: G#I^4%V8)02_N<2C/VD? )FE3@QVJDI>[B?C&9?>[,^O/^[%.+J05$ M.?(.GZ_(( FFE*:1@]1$]FU7!% JET-VAP:C*EA%3X7!#XMTZ%%ET9!042AK MF70>A+OR&03W%JQ[+ MO*M&WDHHP+RC/MTF6QF-^J33>IF\XL\AV1Y$U$M-I-H.D MY1Q2D7]('+:FQH1,'CRZSL( JC102&4[#NJ-."VK21!Q\177NLX!=%A%-3MH MU!BN)?(4XN&GKJOKX,UNS#:*4!&[4EWS-9)W*B%ZT@S[H M 5P=RH>=MB#(3L:;7VZHF[:NT.'53$05/6P3_K0(5G)4PB! _TN:Q3XZP4) MM],D=#=.1(X[?'?+L_J)>5/71-:%03MXB34H'/B\T7@OTYS$3%%(0Z>H&L\ZD[NF7^.LZ2E X937LH/2IH-:';+2 M*MWSM46$-4>;)=KF6U18:Z+"9L$S9XGO.OOPF8!@HG7%L8^Q9X0.%4N/KFY8 M[*U^02)5ZLA%_=+Q0W/4B'M\33-<,HCIBO*- :#9[(LT.<6W]DT+EXX&(ZYE M"FQ<>AJ+V'.B#?L%=S!_P[=N31)J;"D%-$JYU/PC#U3CC^ MPG6Y?3!B31(F4+UFSOMQ^6Y@!S34&6@X"+VJ<5?,L6+)&#SM$G;<1-O'8QV! MUSDVET^.[Y)%,$\>'SW*SJLXX[&F&]@A'RT;@T*B7M?I+Q,\*SD-R:-#E_O; M(E8^??&6_>Y"AT)X=[!#56*?%76)>U7#=N@_L?)!6+>;&P"[\#GL&)C(PZX" M_*L:5M,P>"3LB,$3A,9[3>R17Z!?9IA)/H\=AA-YV"F)>57#<)CF,J.'PNEJ MOM@X_H<@6#Y33_*>_L+=P XIBKX: HFZ2EWE\#9CQ".+S.AZ$]]')'?*$;U_ M1^X3>AQ3N]08((=7'0B_?8/_)>]:+(B<:L4ER_F7?SR@W:L9B,5_N>@-8.V' MT>._(@]1"1NOZN0IML5.G9WKA?N\:K@*,O;JPNG!*:)^*T ^BAB>T: MI77L6#A$3VUMA?X+1I2D/'H(8]T!H)0=DZ^S56QV+ V34RO _HY=SO*^/K Z M>JSC!BJM%C)7/08,F9,N;M33\+*V:)P91O_YON!"3W\K9D0&ES:.F>2"_T;>C(L<)V?T%FLTEG,)G===]B6;VEX+EL'*JWA#Q&R+$D(4]$ MW&_6P=.W2T(S[-E?CI"S'WX=L9. UV=K?[P3Q()BI2J%K@'DNGZW&M%)#6[V M:6&H)E;DM 0RK'6(53 ][;&98$O%0$-=OF7/-^S'G>-_#&+B\56._R-W]Y]N M'+8=\_CNTG!,YS2(%G6E G95%SX?*'0K5UWHMOR8Q5-L^@G SU%:V?J4-SK" MM,.:PMQ5UP.>D7RRXC8[?JNT3VX>S8.CY +[E6YCV%&.8+E=SH/*8E-GG4 \ MJ2IWH]J;R]AO&G!>UPAVC*'SN19#@_=VH@'#Z2WQ./"#W"":Y=\21^Q6X:)J M$#OHS_G,PR!#6*GWJ=.5G?4MSKX6=:6J=I"H M&)2VQ-FO6C'O'-]9IX=#J8D74A';M 0>9T4M!HZ((5VS8D..%-9V605LBT]S M"J0(&(+^TEDG+OG23@T[3M:)*(P+>P;[Z;A?L!\*!W,>]RS>W9%X$Z2A^*(T M#U_U7PD9.UM1H@\WDV$15> M50*;S-^QS*IB+9=!BYC9%MBH@NG%^P=J>K+IAR.A.S^%R]5Y0_'7LW'(9"]=X2*^% MCSWBE_'CP'>._Y+FNW+<5%)5&G#MANR@5SI4R^^'=44TLW7G6V4N7T+2E^=#?G_%UOBAWUVMJ$>=6/9V MJ$E;UY>!KSEBZ&37/8<@HCVA93D'M66C$4[%^'G3H MS->K@9-GGX31ACX>11&3K=&$A19"%;_: +VV$,^VY%JUXI%R(P&_K'&1^LZU M,SCRIK!=TLR.D%/ :G8$=)^DHQZYC[O(#S2E$**+H!A$5/:(\H_?R1Y1=F\_ M=<>]_KS3'=]VNKW>Y'Z\F'>FW<_=&U9@,>G,^J/NHG_+_FFV^(S]J)([:)%_ M)=QR^I0J TH7)7$-;&>D(G]%'>9F=_(;J$>25G-V*-0J-H4.2%JRXGLA";I; M6=.J]*IK6L+D.:.Z1+-:9GRW)$$?Y;9+::4OAD=+_)0$O5/Y*"FJV<$B8'3" MN#)[KSA*_I7L+]=<)UBQ/VYH$!-WXP=>L-[U@E&\E-HK=1K UGI XZUHL-1' M!]VX43JBYJD\4X.MF_T@N12 5$:V4D(W\FHP42@N6NK(_C?\/P].1-B__']0 M2P,$% @ J(M)6''L=6%$Q0L B8IT(2H@("&Q4*1&J5M:5)HT0Q4I M$CHJ(DHG*&DJTA.1L#3)RLT^Y[OGSITYW\R]YWQSY_ZQP_PRPZSUEE]_GK7R MX9,@^6ZOS5A ^/C[(5=X?A+L L?SGO_^MSS^3_._.PWB/M=%GPT V98WDYN77U#X]^.B9^45E575SVMJFUM:VUZVO^KH M[!\8'!H>>?/VW<3DU/3,[-P\D4*E??WV?>G'\@KCY]:O;>8.\/O//WKQ0?C_ MA^K_4[TD>7KM$A#@%Q#\1R^^7;'_W" IL/O@T3U2IYT$+]^0/G3LKI#,F4=/ MF_J$#Q]WILM>N?E)1$[-B*+.^$>U_Z;9_S/%[OTO:?8_%/N_]")"Q/CY>,[C MEX3 (2"H]2P=\J_\*__*O_*_)L_M;S&>7DV>JWGL$WUSW2#SRMU;@\V^ZZ_R M\R="]"/+/:6"4/LJ[B">/=O*G<*0;G AC.CXMROPS5=<"- )*4C/^.#HQ(4D MCG A0Y^6-)]S(3TT+H3Z8Y>WCN$I"VO.#I0+D;G>6C^[OR.?9%Q(NOLDXX'LF4DU7 M]TSSN6O!:?YVL25R^=*[_KIXQ_]9NA;D7_FO%WP2G%Q%Y$(>L/FY$($O7,B] M>W%+?3 UAD12=S!Y? ['Q#-2DU!>E+$K7,A9AF8RVXDR?@]F,<,VP<R.Y93V)W .H]GRY.8'$[99!\"VNU&A\&%# >Q M1#AU)9Q_@"3>(\L^BQUTBLLBA)&2&R*,FE"VA;:XLV!O1W3AZ81DPB[6VU9. M/$\/7FR2:TB_6H+9,CR-=G,AK8YP._K="L!EZ]::WU.%90Y$,6Y\XUQPT\YR>\_P[\(1Q(A8(B MI5R(W0E,WU]P.H)UE@OYU?O\/U^/@!]+XTSS\L :<&J"=Q)VWG A(A#P+UY6 M[,< .K$W1">A3#KTES(Y*YR\" O>^Y58R;&(M&GN!"ZM^%\'3.;@T?#P5D,_0T&"I-A2]*1F>A3[/- %LU#E )]@&E; M&AB7CS*81&\?]3 M+8^??%S(GF_/1GF+V_$6?5PN\K "VMZ3NU]7X,@YI=V/\O3<+L2LWH&38KFXV"OE/H\WCA_I_ MSF30O'K25P#]F0''DI@8J Q\&PUX/SAD ):R!,"[,*0X]. M<^[\A_^-Y#2K! F(I9%O-G;9 W0!+L3[\&9$]0O<8ZF2@->D9X2O;CG??IXU MVU_ZR4KHPML3W\6ND*+VY:[59D=>AOD\;&AVB[YJ$OY[@U=^%S%]SJ AIL]< M#Q[\Q9J\E&0L(0\D. #E9&@:M.UE4U6(:6Q: UN4I7V.)J[<2VQ+:30^;182 M2Y)#^5#-X'L!.Y\[0^AVF K#J,G/R#U7@/.93LBL-[],65<>\E>=,BJ-'0 / M3T27(@?^O,B]WBYGVE-<'_JV9GG'/?904+I=XIEWX3ZK9EG])FT=:3W71P_K M((F4L"O++\)<6\05MFT=O:W+IU_'_='XHH,;>I0'!KU;WJ?]*8]SC M=D=I>X/2%SB))F=+Q:-OFSYV1PD-+OH^^EWFFG H,/CXE[YIVSU;A_?J3V$E M'SF=AG;SS<3-62X]%/AH)^4[H-W^^\[1(UO\-YJLN) TM DX#I<%-=$3I.;V M88((>I(D"Y-!60#\&%H:^C![%[W^RF8OM%6=D-EM%&V_RU#%=SPQ_*9ROU)F MT\I%BYE"JFZ\5#P-RS)8.85?_;D*BAZG8 !=?#_V/A>RCQ"& S2AZT,,D3$8 M='Y5]0BC>JVA#L7'R4,?6![HZ]0O'ZI?@0N9N]2@^(JIF@OFQP,C+#B;22B? MAK@=SYD2WQ.X>B^%0Y-+2S49Y0[)>A^9PU\:/R3$R3KJB\O1O4WF:Q&!<_D"W7F[+A6T//S"N=1&8M1 MOH2/Y)[WSIU:>6=4%&I]]X3JSQ>LVW>>-F*L"?\MHT<(,Y0:'+J:;>W6B9/L M?J1S>+=SK5-^V?D\*ZGSW]KR%,AB6V>9E],N?VU-@1L@AI& )F;]$05./ X* M>U&X$")F"/,2,V@H4TQ( 0]/@AU0[,]!S]NF!]O6+&CKO,/F5IL;\'))0AQ./D9 M\?V?\9%Q(HOY%7C+X*>T9QJ/*R#8@IPB=C#].-,)"&V88Q^8#GX%E3#&$:5] M@$"Z1%^/;C$UF90B-^(_8VY&L0CNG?&7FE;/M9ZJ;XN?6!F&V[[8V[#?'2YA M8C?_;<.ISOFXP-_MI5*4 MFFJPD4;/IRJ6J2&=1Y&J3=$EN&E"LUJIWA>'^L5=KY^_O:)CA)U/Z>K:^[#> M_;N[U_ZC?\=?:]I-/:NG>:>K\7R1PN80]K&HC8'P+W5P3YSM1XIEJE]X+TK1DGO_6V2@CQ5DG#!.2OJ M.H7^7C?":C!JPM>W2BV2WG1].6R>6W)9*2IRI9XB]-,@J(2!<''.08C)1JB; MM2DD;/YV>/[A6+Z-;K6=K/G^S[F9 ?ZB(L0(3N'VN_VYQ(@Q+1:V^$DM-.QA MI+O;WB:UJJ-@RVBN2//Y)?-]O0'7P:LPU'M7U MAY=I2I[PDS,' 2Y5.7A5; M*GPLUULK%Z(^&SS/<'%- MZ!_$H 2_#W!B4I05=GX'G1-1VU(3.L.#N,$'%,KU!Z^.:L1J?7;T<6,_0_$TV#41&1DZ=-X M>$C#\9+0F6'*5RXDOI &*T]K[G8_G"OH_/%VU$ A-'7G]Z47WSN0#AY6G2C8 MT'FQJR,:(V<8[P]+Q]^T_A[OM):67S(>*^BFI?P^TSR%7%O7=/ZW@2(DW^'$G:8]'V(C3CDQ-$&L MK&\ EB[:_XE3QZN*^KRJ>)*H>E<^>R/2L'[#C7WP>6?8Q=+EX*J\J M;IS"CXQ#Z>X2"\='",W!_8CY)4L@V-S;8Q!*)##[.#C,5=+>N"I=EZAXML-E@ZOIN"MZ]=(]EVN M1?@'HT>FB,R.EZ:G;DD__CFP>GQ83\PMOFLXV<2/1#SOH)._TO:NPR[]9MFA MDI@"Y=UZB?ZCXF)R)D>*,XANAU-ZKRA7-1C$.)1N.MG">:PK-#>(H6PR>C"$ M=C;G]*&"723=&RT?!)YU75W052M^(7-,\A;!I%N7I0",4I#K]N7L6,"/Y0]. MO*6'>] ):7J@ 3B*D(=IQFTQZ1D5/:9/+I7Q3ZD9JQBPB,O?LH@;SW4[*2%Z^N9AL3/;I,Y!QWT MN\R&+KL?'5_3T:?F_V8N(5SJOPD4VSW:2EC6+RIG5FO\5=NL0#][2:'2[!G, MVZ907#%IW+2Y3YNDK#5W??[ZCPV5#T(.3ZY+Q$VSFC8PANCPWQ$<0L]!'K Y MAQ;E?;M@R&7P9FP? =!:&C8410EQ.E%VC)G5H4Y8&]V2J_XR2_K"G_OR^X;V61URS7M=K7.3Z;14 MJ/.])Q?5U#X$O\%*__ SI>>/L+%X\ ;K<^$MUVC;G$"(3TTI*BWDM2,'=C6:Q3J%.PPHI$GN ZA'84<:' MRBK'Q(AX)/F+M!V]:UEJY+DL:[)'7UKMS0K<)$ M,XS..7M6A&S(+BJ*,9+2/9?28NO?-/LH%YJLT3\.G3>QJ@C0>O4BU%@W,;GV M1D14W:+29^6V. HQK+[Q;]\P^P2"Q_ IJZ02?*#VR?.V)[HC&+8_9IXU#5>P MID7ZJ\X%0/46BDZI>,LLO-_2RK:,;A2&]5M=/7[@LP^G6N.;N^>^%E\-"2+? M'JVR[R<0)[3XY5[^+*/X#HC7?[=SB=&K*\*&*R,6N9#H[!.?7X#]'C.S "UX M3)PZ7;S?8B>$"\%X/-LQX7%WDSDPL*GM7,#IFO/'^R4>"KS2D8\2/GP3N_^3 M.5;:]('_B;^MQ3Z-Z/=;:2 /N<<5NG1JJ>1\YE=^>*RW<*OL))K]_,EGR--# M^J].L;Y^-[[8H#C6IUVC=^%ZV:_]+@V&]/8B(]PI3?K4:LZ!XT5K25#YD2HPE<.JSF;,ZPTSEO M%#*S+CVB5G]V-[/VS7E9T94QH2^GVM-/EDOYVNLJ!*0?50A5S_\R]OK5@Y3@ MM!>5-U1%9-#:%N+N=$V]7ILVR0L]\N^S'>RZ;^]W(ZVCS4ZZGD5)"#UQSK$4C": M0=_R\Z>2X ;H]US(2XE^!)'D #11#>]Y:QT&/>*UO72?R8 M8,=TN' /#)R!R[%#6C,0N&M)3'_0HL_O,/[T4L MG>3<-K4=_KKLX)3JIFO^+WVS_D:O!8ODK,7"Q%I/W_#"(C^U8E3[P(@,?B:) M[NF+TFB(_MTX]]F\(:'&\5'K[/&RN)_3I21]A78+E8VF1[VO*KN*!D^41*,> ME6QNO")TAM1;UMI!WQK.$YU=*Z['3S1F5=D%%MGP[*UVB#)M4.7I+VYN9KYE M[MYR84;J-U.7D-?A65)>WVAS^.]'T@K?!S/4*FH?J-L\WF]JE)PBH-,8VK7N M,A<>WFUM5+X=C<=$;&S=-"I4>PH/'57S[_ZU/+_EEI$7_XB=<3_F[ MC=^TDYMR8Z:Z2GX.9W_:6N4HJBZ:B%0<4K[?:J.>8Y/1WVSP?DBLN7D<:9+7 M!/,Z-%7Y.""$.#\-7E9+J!3+9'!*\P/R4PMOEMUZN_/W["5,J6RRSZUJ][K. M+'EC9RY$ZJMSI*W9J]'"SSFW<$81D5?MN*U.OUS]'=X$+B&H6-&C]31)4O5KACF/F] M(BJ7W:\&#;^UVW\@*##9[_. LKEML%XMN6#P1+8T;3@IV&)3-S:V0(Y1_?"XEYZ)=6\&?OB?^*<\2')5X)F3#_$U2L M5N]%)!+= Z9:'Z5<2FP>W OPJ_UT:+P9>_WD\NP":;$X([-$I2-_\T41S -? M4VKZL0J)_5N1*\IF,2E\N,7Z:5,_?F@T+4&[?P&H&[ N>LIN''WOB?AT]XD2_47]>>OS84G( U_&X_^M)F MG@LID0!.QM(H3P,G80F13[)WC0, DCT89,DN?A/RXD4QK<#P%)V[4($AM7Y=@:#)S&*4_0XMZJFF;::H*@"&Y#J@Z87IS,:1' MX2,HP-X/G*:,0G=GK%YG>*^ RM/FUM5#S_TTJJGVUBCQO='!2H!OT#&)@A1! MU9_$C>H.]?1L4<&_C86Z.B8\4;=4MUW2F2^B.PP=G&.];Y3[")]Q+'IA(JB7 MJ##I$'J9DN6Y9Z7KG MN1LE6HNS7IIM=OE&BQ;DK)ZH-@&D! ^A7D::QUW/- M]\W1 9:=,Q U6(A[^E:TG<#R0:$UT_H%]4>'LT_+!%UY5-'<QS4^1!2J>-6?V&I]:VN\[%6_QM=%>YUUX\9?$GT/ZB_1L MD0]UBME_3=C>)1Y9]!E7$W[ ;%:3C[5^;Q#QS"?T[J>&HL9[Z5H5_SZ7^_^= M_'_Z7([?K5G8HI.C*[7IUS:Y'CQE^+VM93)"/Q+Y8G.IXVQ;>VL[ KYN?T,S MG]^[6&$#6=VQY6YFH__UV-<]@0M"@OC? K<39K_BV+)V"$[3]OC]C^S=G'Q, M #:-T.I7.&PW)MW/A2AU)U*0&:26D?Y$DWZ$ -[<+3R4D=I/W(^0ZSF*,F5D M-S$.#Y/VZK'/5_S0KXJ[*2'DA=WGXTO(5*)JM$EZG:]>:^\IO+5,\B\?&)8$ M31*]?6=FWXV'KT^QF9U &\L8G,- X)$)CMFDO? (W5)KYD[&D*K01\-N,RY$ M@%<\[J6R+] W[M*AE.V"!HKA?(8[W3H#5$*_5SU"-TQO7?_HR'+P7"E38NQM M>#9&)67\&?!9L:M:F OU1C[#]+5#6[F0#/ (V#O#\P5I2*';LAH5RTEFQ]2B MWT,EHZ%R/X@CR=WV$91Q44XSC>+_-)&"DY\/Z3G^\2F"W_='C]2),IV/T8[[ M2EWZB@C$Z'"K76J\J<*%7;T!1QIO?"O3/3Q@I5-Z MX4S.,IS\!*W(V!S8! Q);,D%IU3F/6"+BDGE0E113BRK<%-L+UPFKNLJIW^73>=U]EN/A+U# MRH.R,"580 O?CU](H&+8LCZ@ J"4B)=!+=":\"+)SFX&"[,7UFH%DXM,6JC?HC>I,HR'Q QZV+LI3BS*B$ MM!YI^TCD-DD$_0$48R#7=7FN&MA!'[O'=!0.Q^U#W:!"^<.+X*D-;!?!I%_B MT$$E7"K*I3ROZEMNX"NM8>.C"AZXSJ::49'0(,4=9HJL5;G#,4?13==60X?J M#H-X$Y/I!TGA04<'K6Y66\]?O9Z74WBL@"\8[K4CW76>UL@N"'7M_NV:6(S\ M_8NQ-Y>.!X7?\DJ1?@OP*:"*?38#%$IE>8 S%T-AABEV+#LHKX/W8U[B!U8S MUA.L@.3@)][";2H)9$0J3(?32?NK>]J@%2ZV AZD"SYXEC,RK"H-'"8K-]BQ M*MM?M13,S%!%N^*O5=W5R Y'O47J-TNCVB5]+S<,U2WD=X=6;.VI5+XJ=:L. MG8C^@FO>'##,(C4*#CK.YZPRW1G!0^.[P[B0O:TX =Z4T'X?TMW%W8SJ9&3K M0IR^^>X:0-X;J*.-IY!$NM43Z>]69B_,Z+]XRK \767Y]/-<7-CHT)_PGK0: M\!:O_!C@'(L\!R/>H,(0*B7IAJ;D@=YP,2AC&1C=-&$? ATQ.ER*?NW9/D<=Y[ >]^4!O<&WWIZ?+2H:&X?&RPSR?NK4N/37G+*6'7 HL,'- M/C?]F7FVVC^Z)5#()>X7%])VY//&]7[3R&,QUQ_EA-6W>)LN9>=4Z@5+UP1_ M@%^LV_8$"&SII?Y%<[H@6WX+% FE!PQA6N$CI&Q3Z_M<2)#$W7:T.,-D&"\7 M%SL(.TR/QNP+I./3C?65^SJ1*2@HF0M)!??29XJ??SXG]YA7P>*@UI^J7TZN M8=KKVT;;.KHZ&(0Y.#-H&E3']'D0R"WPYL(1##W@Y]):^3OFUOJK%,(0D M>#+\MO4@1@% CI2),DRRMA$"*VA3P". /NE*=[R[WC9VF[)F;DSW0LN%WK_0 M.-%J]L;02 O_ZXOEJL1\!D5PO8^"! R@Z_FL /9ISGVT8=QQ9@2G I1%'0/. M4PQ5QA@XYJE98X)X&$Y$SQP>+IB!"B<;BH(32COI#:C#-*%H"V<_T_'^&7]# M1D&Q_L:=PD6%&)R'J3FTT;$?LY#1BZ"[$P M[+H7(YPI $S2262/]?)*E HB MM4RK&QAE*0'E'G0]G$ /]$M<[#L@ES*^!YP@5I+F\G_+,=4A M-T%'4CB"O]:)A.)_WF(,0!:8B6O:S(A!I&#HSWJ@8>C]+9@,M"20P+(!6@8+UFE77^6NX>@O6C:.V]7>;'L M_*9YOVJHQNOE@.M&KC<^'.N*F6VU*V@K;/>NC#K?VB(6J(/8?;72X8_NSW,^ M">>B3L6TYR9.>'\/M>+^VH@ ML[_6CQ_5S1\(\L<=@7;EUOP^;7[3S./G$$L>HJ0RGGH6?:*)8;C>Q4LIB7F[ MA"K3+V8 9A"M9M6S=5@X JFZQ/%G8-=WLZZQ Q@F ] 4F##/QQCT1W@+KR5W M^]%*=69IFNN[&2,TB;7+$9?I),ITLXJ=9VXO* '(L]Q15QBD3-1EZE"ZH5"< MNU>T!=R.SNQZL4S\3JA:58HLK@DUW%>B>_F5?[N1\J3[D.!QL7Y#%^3]UX%=M:!IV_ZEI2+5>H MMGEG$-RP?_M\<@?O;DXH@-,O.HH!F[Q0V?_/CV7CI@YRGH#F0#E/>[PL^*ES MN)(N,:1J^ E*UAS@>% 0?=J_7LN[ K&\YKPH2_^U+YQ8OVC,4&W! _CAHM2L M;L2)ACALQ>H?BZS*AJ0CF+XA1 M^C=40-PX*)S*4?0%9>I07<)=A!XJ4L[10 MFD QK=2'4G@O!JZ(L@00,>$TW?/H_0!IR.2/^C"!BN/KEIMYLR@^LRU*$K<] MD'QUXJM-N=NV(:#%ZTB&"[%4#[9L,2CMW4N5;?!$-!?ZD8!\]_?M:?"G+X63OW66&Y=>/ZZ M])M6AT'1QC9C.Z2:!:K&QYR8S"P[^O4QR!?:?:G)*T4RX>K:DQ77\PD:E6M< M",^#LC^@C<@[/$A(F,Y[7U?T,^XL,LP@!6"*>$CN8)4HCK+$DAL4# M*#V55,-4C QZO__*'_=4:%JW'5UPA*2(.EH!Q XKA?N%>3NFFXO3#/>%>:LU M PD^/1,:W9/;4"%?=BE+T1O3-P*7W_YRG!S+ECG,8R[-FGVD^#AMP?/P2P;F =N:CJ<4E$=4 MANW<'_!7F336?AIAEJN3]\W$/>:@V(RYB\N^'[-5*Y<#!M;IW4\1Q([^4N^/ MGJ@_QT;W!SB75Z?8[>LA0 /&L.D#E%+34$SPJ'K-G1IW\5$9AA0X[\%TBGAE MJ[ BF7QV?4\MJ[NIFU E!..AE'C,KS,>6]8\E';Z+)3N9P@<^$OO_6HMN*!^ MC'3=L!\I+*LCHZ7NVGJ@\=J@3>)X(7XYZY";/>W6VJ^3(T+[;MR)AZB^3GR% M_]8"BHC3=T 1108.%.$976"%4]LCBND[!3L.=)%Q:]I41#;3_]C4-B:+T"28 M8GZ:X>( E,KB[VYTGZ.7GYN"AQ]:+\>G1H>@+)_XL"US>V$Z6R_$\1EL;8K' M'J%%E9^,O99IF/[>H)QA*L+M]%=SR\)J(0+5Q-C:+[-<[L5F)N>+'N MAV=X5.0Y!)^ECTE:'2>3HAC6<0 L?_#:.KI!M/I#0RD7(B@;9TUUN,^0!H5K M&(9]\%;".A]Y_?@(IGUV;9QNY@,H/XLKMYR$!W."AEE#_MJ,UTN9W8[D!MW^ M@J*1+%2 \4ZJD8J!#3N!BI.).QJM?\S,!RGH0_+U6Y'?;\V6=6%>!!)90NA9 M$OV"X0*>+)'1@R-]IG(9D$8N) V>!$+CD'W^ A/)H_6JTE?3/T6@[_(RY@-*D],!OZ8L M 6@.8EHP:Y*,\J%)M@BG#KT'G$/(>@QR(0J\A,7OJD[10\G+IY?/@.)'IN&A M9H^-$6D% UX/_,-Z9!'2;/VT(D'Z[*"$TL&'UL&@J#:=QESGO*CBK1 _PCH) M]L+ENQ$2:]N\_K&;T]*C,4;EH8:FPOOBR=7WQGZUD_;\^H1AV?F)>U %G$E^ M/F%%WYX@4YVZ3XQ3L/)Q0VJE$;]&=9S[+[X+<)\HB2-)6AYS=KKA939 ;PT] MV6:XJ.W:O[3BU$93=,[-=:.\C1MDI&G[%V&%KQSQW]A\X LT4;Y,V'^\,43? M.:%+ON\V604VP$-IO)+DNCF?R[S)&&'+FX%"A&J QL0 ^K0(..TL_.55N,): MMQ>]KA=VJ 5HDKC;(_1#G!R'UEA8 56[L",%BR(%+O"D=92SL0]2PH\OH6(H M//[Q^#2\%3X$5SS-RP!^X!0O<(M_=;=V!Y M7.[%#@*VU_L$KMJ99]:_T1\P+TE#6"*/'X;R5A/DY' AP68('N.6PES=E&2[ M9E!3UVH8CC3- 8DD4'>BVY!E"? /^"M/:4P &T EF2R.9&\ C32/!$6.L\3BN! *:0 #:!'6 M9LF)EGV@-GV_:7TJ!3O$A>P*CXW]4U!#'QX8++.8_!42TP ?:%[U/SSQK) J MCD_YM:GD'5[H7?D5(1K3Y:?C(YI1G=I/']-SR0RYM,RX%H4/EG>WC7O74BB1 MH&5=N"H\^=7MFZIU4L263H/NLDM97/V$DFW;A52-WF\ED]^J]_OO ;^X%=3F MZ4U==I]PL84'G? +7FMG\8$+!#XX,LOL'ZT%P3>8)MS::1HRZ7;U?9@Y^ ;: M@EOG9UA3$??;D ]R%E:EXAQIB'YH3[((31&29OJO&8:F:F+T6R MGVY]91QAYV):.HP/K_9!7P??P)LN<2K@Y.-50BY5,/A4@\;(/E%:-DQ>MEK&DDB5-Y? T!4L4T__4*(Q@4,>J]OM%6Q MX71$*LJ0ONI:-&K3Q$ FF9^O7/"=]T._Y@$^BP8,N1FG8-R%2(?37?&[T6,$ M'CY+Z5'5_[P(X93!@U@-=FX,[*"C8M@)I<+[RH,X^>ZSZ"-L!-T8GVJ$W!O6 M?AN?;'Z80I)JR&ZB(B27_=49-X%_H"0SC'04W4<0@4=B4DAT=RX$T#)<]V'P MPH@+81 HX[V8A73'NZ:.=\WMG[.O+!SB/'U[<!01_*Y2]IKZ>7/F3L2R M_9!S&_@2%)2XS85HH&>A+899F,!-0!?!EI0GF]R!7R,MZ Y"A;M#G[(#Z;=* MR;@TN#3*F(H71\&0=TDMG,*4;ETJ%R(<=WN4LI%&^>)!E2N7>! 3$3P(,P8* M*U%_S1ITG[[5WADSDQ^,1%8/+8.FG&)P/\\TIS#D;@+=09.3WP9-4Y6>("!Q MHN",*7P]N!*8I9GP@CQCG8%Q!ISH2PX,W'V4"U7%FDK(-@^L_QR7,^ RM6LH M2J/J3V);9?W1T#]^)0U1%B/MF+YSX#YP@22-(==#Z0Z.1$OR[)HR TL=Z<7/ M!;L#;TC[4,BGJ!!.-NIX(D-C@0:_VZU/:2VF.";!#J$G5/PY:8U_+,\/>7V3^$/^M9% M]3VO4_*][4=6)DLJOFDZ.!N/6$4O?W]8L;Y^TE&C/W#9*)>Z7_#X\Q6C!MLD M9=]7+TN";^69.*Y B?+,8$ZA,8:X0S491"ZX#'F;K&=5HRX!-^@L&TX)X1+I M 510'VTQQU8J[(N*R[!CI Z24J!BC]BA 0*$?6T6&-O);CL&T@.((;.00I;A M?+.@%C%4ZLN+M)_C['UFHT E/0 4\6,=1_E/MN%444* !0L-?D0(P%11$L!F M;!7*J96W&(QHH;@.$PI[^SP<;4XOJZ18"!M&UE/IVX0'VU^D2!RU?O67^4'% M573DV@[/R#!."0_YU1%>&@[SLI# !Y,&)S MV'5*,#WF&LP 9W#F^ M5A= ;^^]_N,B@!SL49Y$B3/DA\M.3AXL]IQY^I&M0I\=^%.=TFU]8V]I[2I! M$@W]_"7NWD\NY!.%%_+RL4H0I"V3"H$'@*G.=5='@(%P)! M!4^81[9[$P:+,6D%3$=Q0@I,PI,$]+,H[:G1IP-+K2\R\%E5C&!FG80X$9!+ M%!P%4J$&_D]])$XZ/G;DN&3+Z=2EV\'!+RF7X4&?D4JBPA\*#B%4W"E(]/ZV MS+SEB5MV1![$=6U*OYC;\J; VER -AKIZ>&9*OK1?BK/8LG LXO- SQ[OH+O MX"THD@ O%K$9WL&]7$@26@D8)Q, +. ]MV1ETO(L0^\;)9SNQO-F1G&JT(OBI$17\L0VCB+*ACPPM_)KZ MA4A9W MH!H2&/P\!M2>0#='?&/A,M$8F^@EO$&E$$/D!@S>%=#M"Q7D- MGP#H\[BU+D^33$R?/6B,BN,D@]IL=> 4*R9NEK*4#>-MV@_H8&G%#0*:MD#H MT[B!@>5RMB=]9 "+1>LQ(MJXD$S]R#6$'8+O!^S4RPF\MZ=Q:'(]+N*^CJSN MC MG);>&8J\D/%7DX'OFIZ-H\^_3'RH"3633WL;UF7YFYKG+M;?DOM=.T&NZ M6)>2S]IUVHG?F!S%W"8,IO,=MF#?P)(#$/G_@354:'2<3L#USUYFLZ:^\3$_9FZ MI5T5^G+_"%L:R\L@>0*EAD"NY2$P:XP4*@'X@B3#YXG(/7&C3#]@O2JNVH$! M'4&D((1Z3( .\;^LEU-0#+#9*#'/-6[$[@"JG^,Z%9\ 6R=8Z";=.SK,EAC M3GKZ%=AI+N0*83Z8^0_LM $6:+-]B&1XHC<>!\8E4W+YPF!8=>==80G'E M]HN[R!<+/XBJ.*KP;1W;X@87>5EG3\'^QOZ+U=I#5[2_XU9&!"^[JSX+U:8N M+\W!#M\<+X<&.]]+.>2Z8GFTTB'+VZFFA$*FK-#US[:W/*I&)J02BF3YIP12(5TUZXELB*9NMP6D U M\".AU?".D2$/WJT+DR/L'!G6([AT[ST=C%U;??[[ 0S%XO P0J8[F&PH"5@/ MXZ10-D:BX8D&$?"A3F8=.29%2*.=GOB::CS)X9%Q 4NX4H\^KR7I8D*Q\[4D M9C*C^C[;B8YC9G,:"%>Q]PC0;>4$I"S[#'"9@A%SC*H&I X9MN)1NB1/) CW:RY]BD3[<[(QEWB 2'L/#VL)O.-%T6-P$">- M"4;*@&\(/![$ZZUIB%9Y7@3?ATKC02,4'X,T(#IF0I,KI^B?!N56.W?Z-M-A M<.#NLU5B9;>JWB=DC*(YI$R2%QA7&)JJ!AG^-\K;]4,]ZBP5Y9Z.^]Q[!:N/ M.*FNMR"\5QHK&=80M*C\X'7>%)R8%ZHU+"HKU#>=M;5?W^:\M7 JC?TG-R_G M9LKYOUVI;R]7*MDOWK[R"D-TCO(?8WEH&M:,C?<1R#6+4IR_,8%00'-I )Y% M:@K*;8@K9C;R*(@V^GT9E"'/EBFFP),TZ19 M;!D3YCC/73& ,C,<<&(IV#,$:?@LW2H&^;QMULVG_?-VF6G9!N6C>W)C]7><\AZ MX_BO7AO\*J,FZMO=?4N;8D\33DV^#$QU>=X@$EO[.7!4C0NI2.0'3YL&<^)X MG?U'7D,@"!_@0@+QHX[$5!J)+9,P@&LN[,<](#01UL+)'2!L!32C5Q8.(>YC MVCR&,*FF^KA^1!*S4.D)8SP]!B'#U@::ZN/@B"E*TV1]69_Y01I&BK0LYUU1 MU _8#2L5Y,+O&X";@"3C7,]QMBQ@Q[C[2W=<#-,_!023D0]J*'7TL9H?EL/^ MTA/=#M$^W_H?)59G,%OS9%UZ#!_S!X;I:*S,%K7K:]L>B_7IL TCO>]PB?5. M_.Z)^'+Y)S'*_OQ02)OWN7-??A00X@%Y+D3025J"+75_\(U*(ZD5NK8P[/BN MFAJ4?Z?B1$?3KI#[L I(YR2F$,L]Q'G(A 88/,'+;I1Y4DW[\@Z+4 MH87-=$R+X!U03J.0G(AP9I%(+P2,&.9 MKGP/1TK[.L _<:I!$?DH5A!Z!D&W,\SB0OC9$KP,^ EL/4.A@"5R..'^>?K" M($&.MZ*9 @H:CRG_452Z,ZAB-^R.:=VHI*A84U9(;Q.?Q<6%=@Z6F3E*7%HH#AV6BFE4>&-Z,Q/7 MXKKB/WVE?)GRH];W7*X;JKF?W!QZJ:[#J"1\U"+[4MX5\"3'ZU145<[SUZ4= M+\;?XA8$F4* "PT!' CNXT(6>&CT*# ?RW(!/R :V]=6&>5DS<$%PTR,I)$^ ME *K^>?]&YJO:U*_^R!]]*]9H_'D6WCCHB_GGP,O6'T>/ "*W#",?*')Z))I M.T%XQH7P>$@$]H'2;#^O6AZ6Z(VP'NDLO-M]CN=5O5FTO"6C;J1'9=K07)^J M;2Y8Q=[?#&0PI/O1D@S8PY>=U?>[[1G60X6@(CVK\$&T!D$6FMG4R:]_&D^VT.(^=8 MCO3V) .V-!G)'Q?L#635 3..1*=?703!\",+*RW 8=M/V4]I#;8_B1* ;; !F#Q?2KTG%SV6 (N*LW=;T6 _@A'DL#9\, M'OE$HGKT8P1_+$)GD&O=472[89SLM0:V*'7Y[G0WO.;]%<:MPKJXJ+.)L7VS M<@430[4'$1^O#;,>V^< M.6N!^H*2G%ECWU]Q8]]%SD%&,%NJFLS$LBZ '[B0-OFUI_A07!/R08\"L#"H M1%KGIR#O$B3,X13L'G .QC^]'NF_U$=2-=K<2P)\'!BWVLK#CON/5;&M&6?] M=6U9E9&OJQB%;DCT*BNQ[/VV(W[.9DEI261LZ86$N$J1@6$+[]C-ZMK=O1E MG+R*_MN15\P!.#W2A%UI!NX-YX'TZY M:]X[);WO3HXU?_W1SCNC^V]4W=J4B$R'5.E%3+74AS6WWA@,%+KGJ*'QN7'/ M0O[]4QJ0LZ>"+RL$W_QPXI&<7FR!0;.VP5S6[+TKBH-7W'X'N?9?$(U/7R#% MU&K[D)@%G&_MA-7+/I^9MSA?7A*6KY1[6VKK%XAWFJC;^(Z*[KEW;3?DO(+R M,8C7%X$\>2HT;4?8]U-SN51IWS?'EI?T'OJ;"1]H=E6ZHA)Z<1C M#1&^-V,G,_]@J[T?1ZEOJ&-R++5%A03")97S%.TB70,?5=_<:AEV';RP\,V# MF"ZK^?BP$/ZNS!^WTK?N1 M3"2,,9D M'J)PP?D&BF67]78=E4F>OTLZU/)B5FB463S>VCUOI78LY;K-I=A32,*A\P;? MKW\ D85B9VW6FOIDKOQ:HBY#ZXBBFQJ## 9 MB]M3#;(EUX?V.QT?;KH'<=YU).AS[Z!@WE.LH_Z^08*:QDG0-B!TICX]2R&B MR6[75_&RL^\DR2&8*7/E77>1:A&[\MTE-Q3KIES:.];665T1,;\]W7';W MRQT.QGEW\IZ]-_^"O-SC>(']3K;GFOAGFHX0OZQD:^:FR)#ER]^2MW3>?)6- M+0S;M7Y()>M5OIOKT5KSD-7P$%KNR._O6>5EW=OL+:_A_>DB^Q!K*W.8A'#K MPEK4Z]?&.ANL;=(2!M!(6+[U4U?[^+5'BFH(4RMK,=;PC](RQ2-']ZIEW2<^ M;\VS"_W[ A=R-3,S4L\M,]WS^MET]3$G[H;OQM\7M'@13SYE5&" MAK5&[/\9OPJ ,C=1JBM<"(]*Q>[T0*,*V[L6?);Q#Q'C?UYS(>0\3$O#>_^+ M'DF1C[<$L*)RKR)VQ+PU7'I"X;O]['0LEG M!3HT;'C7'ROLD7O^;)$+:6TG1&S^27Y-"D;>7$" ?"4O"][=[+D$/^H<&#N7 M[50FL-?+??I]P(["3Q?-=S:]?BWQ%RFN&Y>>-'UF_;2+O\/N79]C#P;,'5S> M=Q8BS*[<1G:U/U_^'5/^#N'.ZKJ=C2OT[I_#?JL&U]=AZB 70J( F.7OBU8] M2[$[\"WM#"UG8[\)69>#YV*EDF)C A\I_;6&A3@_O!;H^6C^%BZOGA!LE6FP MY'9.LF:O9=)"6^$'LTJ_@=#@\W)GWE7''=88[EO!.-+++PV?VEPFJ2Y.=^>6 ME 0WZ&]_Z;H%=OW-VF$6^$]O+$S,;@+K-QM;+16M@S&/'IY_I??DU66U&KTS MIP[E[TAVRF5:WSGDV;LKO\$UVV_AE-[52R38Z:S9F^T%5P[\#I=[TQ=T)7/P M2$OC[;+;/^']6?>G&)./>"X'MXB+OBS_/SYM78(MJ9HM[1WA/G_ [LREB?7/ MMGM^2==5W/64N40+T1=XP-SX-"PE>^Q,7P,M>^:R>K-0K77C/:O'#PZ,&479 M?.I(*[)Y*:#_;5WBIU63C=I>S79H(.[]2PVE3E?ILJB1Y;\N[HT?AS\SWN_\8U[Q_C^>,=X[W>_\\=,8.Q5YEI[S=_\S>RUYT+J M[,_9[^56P':6B\PEQ]2?Z&FLC3K4WCS\9%^B<$:?/-)5!F'WZR!G?]F5B6K_;5,1Y:W-1[_$&WUQLO_* M^T&J6R/-F2UMTPN+VX^FOD7_M9B<&O][SLM(\[O!9SP!(Y)?JFEQ?] M#E\XT/9W30JJ)%!GW^F7M<$/S?[:\ZG59?(N;*HAKIWCLUXR@JWYSGY]I=7Z M@\5/ONUSKO[-#XOP\5^HSVTSCQ=4;PE*QPO7$ASX"U.KI,]'H]G845)/I@<3 MLA$;\68+A%UK%<:8"(OO2@5'GK@6_M'0;WB^QCBB?'U>]=V:1T))ZS;7!_;? MT&_IQ43

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